<SEC-DOCUMENT>0001477932-17-005712.txt : 20171120
<SEC-HEADER>0001477932-17-005712.hdr.sgml : 20171120
<ACCEPTANCE-DATETIME>20171120113937
ACCESSION NUMBER:		0001477932-17-005712
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		60
CONFORMED PERIOD OF REPORT:	20170930
FILED AS OF DATE:		20171120
DATE AS OF CHANGE:		20171120

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cosmos Holdings Inc.
		CENTRAL INDEX KEY:			0001474167
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				270611758
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-54436
		FILM NUMBER:		171213065

	BUSINESS ADDRESS:	
		STREET 1:		141 W. JACKSON BLVD
		STREET 2:		SUITE 4236
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60604
		BUSINESS PHONE:		312-536-3102

	MAIL ADDRESS:	
		STREET 1:		141 W. JACKSON BLVD
		STREET 2:		SUITE 4236
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60604

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIME ESTATES & DEVELOPMENTS INC
		DATE OF NAME CHANGE:	20091008
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>cosm_10q.htm
<DESCRIPTION>FORM 10-Q
<TEXT>
<html><head><title>cosm_10q.htm</title></head><body style="text-align:justify;font:10pt TIMES NEW ROMAN;margin:0px 7%"><p style="MARGIN: 0px" align="justify"> <table style="FONT-SIZE: 1px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td> <div style="HEIGHT: 4px; WIDTH: 100%; BACKGROUND: #000000; MARGIN: 0px 0px 2px" name="hrule"></div> <div style="HEIGHT: 2px; WIDTH: 100%; BACKGROUND: #000000" name="hrule"></div></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b><font size="3">UNITED STATES</font></b></p> <p style="MARGIN: 0px" align="center"><b><font size="3">SECURITIES AND EXCHANGE COMMISSION</font></b></p> <p style="MARGIN: 0px" align="center"><b><font size="3">Washington, D.C. 20549</font></b></p> <p style="MARGIN: 0px" align="center">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b><font size="5">FORM 10-Q</font></b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b><font face="Wingdings">x </font></b><b>QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b>For the quarterly period ended <u>September 30, 2017</u></b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b>OR</b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b><font face="Wingdings"><font style="FONT-FAMILY: Wingdings">&#168;</font> </font></b><b>TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT</b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b>For the transition period from ___________ to ___________</b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b>Commission file number: <u>000-54436</u></b></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px"> <table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="45%" align="center" border="0"> <tr height="15"> <td style="BORDER-BOTTOM: 1px solid" valign="top" width="46%"> <p style="MARGIN: 0px" align="center"><b><font size="5">COSMOS HOLDINGS INC.</font></b></p></td></tr> <tr height="15"> <td valign="top" width="46%"> <p style="MARGIN: 0px" align="center">(Exact name of registrant as specified in its charter)</p></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px"> <table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="85%" align="center" border="0"> <tr height="15"> <td style="BORDER-BOTTOM: 1px solid" valign="top" width="45%"> <p style="MARGIN: 0px" align="center"><b>Nevada</b></p></td> <td valign="top" width="10%"></td> <td style="BORDER-BOTTOM: 1px solid" valign="top" width="45%"> <p style="MARGIN: 0px" align="center"><b>27-0611758</b></p></td></tr> <tr height="15"> <td valign="top"> <p style="MARGIN: 0px" align="center">(State or other jurisdiction of incorporation or organization)</p></td> <td valign="top"></td> <td valign="top"> <p style="MARGIN: 0px" align="center">(I.R.S. Employer Identification No.)</p></td></tr> <tr height="15"> <td valign="top">&nbsp;</td> <td valign="top"></td> <td valign="top"></td></tr> <tr height="15"> <td style="BORDER-BOTTOM: 1px solid" valign="top"> <p style="MARGIN: 0px" align="center"><b>141 West Jackson Blvd, Suite 4236,</b></p> <p style="MARGIN: 0px" align="center"><b>Chicago, Illinois</b></p></td> <td valign="top"></td> <td style="BORDER-BOTTOM: 1px solid" valign="bottom"> <p style="MARGIN: 0px" align="center"><b>60604</b></p></td></tr> <tr height="15"> <td valign="top"> <p style="MARGIN: 0px" align="center">(Address of principal executive offices)</p></td> <td valign="top"></td> <td valign="top"> <p style="MARGIN: 0px" align="center">(Zip Code)</p></td></tr></table></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="center">Registrant&#8217;s telephone number: <b><u>(312) 536-3102</u></b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b><u>N/A</u></b></p> <p style="MARGIN: 0px" align="center">(Former name, former address and former three months, if changed since last report)</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes&nbsp;<font face="Wingdings">x </font>No <font face="Wingdings"><font style="FONT-FAMILY: Wingdings">&#168;</font></font></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes&nbsp;<font face="Wingdings">x </font>No <font face="Wingdings"><font style="FONT-FAMILY: Wingdings">&#168;</font></font></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px"> <table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="85%" align="center" border="0"> <tr height="15"> <td valign="bottom" width="40%"> <p style="MARGIN: 0px" align="justify">Large accelerated filer</p></td> <td valign="bottom" width="10%"> <p style="MARGIN: 0px" align="justify"><font face="Wingdings">o</font></p></td> <td valign="bottom" width="40%"> <p style="MARGIN: 0px" align="justify">Accelerated filer</p></td> <td valign="bottom" width="10%"> <p style="MARGIN: 0px" align="justify"><font face="Wingdings">o</font></p></td></tr> <tr height="15"> <td valign="bottom"> <p style="MARGIN: 0px" align="justify">Non-accelerated filer</p></td> <td valign="bottom"> <p style="MARGIN: 0px" align="justify"><font face="Wingdings">o</font></p></td> <td valign="bottom"> <p style="MARGIN: 0px" align="justify">Smaller reporting company</p></td> <td valign="bottom"> <p style="MARGIN: 0px"><font style="FONT-FAMILY: Wingdings">x</font></p></td></tr> <tr height="15"> <td valign="bottom" colspan="2"> <p style="MARGIN: 0px" align="justify">(Do not check if a smaller reporting company)</p></td> <td valign="bottom"> <p style="MARGIN: 0px" align="justify">Emerging growth company</p></td> <td valign="bottom"> <p style="MARGIN: 0px" align="justify"><font face="Wingdings">o</font></p></td></tr></table></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. <font face="Wingdings">o</font></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes&nbsp;<font face="Wingdings"><font style="FONT-FAMILY: Wingdings">&#168;</font> </font>No <font face="Wingdings">x</font></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">As of November 20, 2017 there were 128,253,932 shares issued and 126,867,038 shares outstanding of the registrant&#8217;s common stock.</p> <p style="MARGIN: 0px" align="justify">&nbsp; <table style="FONT-SIZE: 1px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td> <div style="HEIGHT: 2px; WIDTH: 100%; BACKGROUND: #000000; MARGIN: 0px 0px 2px" name="hrule"></div> <div style="HEIGHT: 4px; WIDTH: 100%; BACKGROUND: #000000" name="hrule"></div></td></tr></table></p> <p style="MARGIN: 0px"> <table id="pagebreakae25ef76-55a6-41ec-8e72-ab7f0e5c0302" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td>&nbsp;</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td>&nbsp;</td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b>COSMOS HOLDINGS INC.</b></p> <p style="MARGIN: 0px" align="center">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b><a name="TOC">TABLE OF CONTENTS</a></b></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px"> <table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr height="15"> <td valign="bottom" colspan="2"> <p style="MARGIN: 0px" align="justify"><b><a href="#PART I - FINANCIAL INFORMATION">PART I - FINANCIAL INFORMATION</a></b></p></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td></tr> <tr height="15"> <td valign="bottom" width="8%"></td> <td valign="bottom" width="80%"></td> <td valign="bottom" width="1%"></td> <td valign="bottom" width="1%"></td> <td valign="bottom" width="9%"></td> <td valign="bottom" width="1%"></td></tr> <tr height="15" bgcolor="#cceeff"> <td valign="bottom"> <p style="MARGIN: 0px" align="justify"><a href="#Item 1. Financial Statements.">Item 1.</a></p></td> <td valign="bottom"> <p style="MARGIN: 0px" align="justify"><a href="#Item 1. Financial Statements.">Financial Statements (Unaudited).</a></p></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> <p style="MARGIN: 0px" align="right">3</p></td> <td valign="bottom"></td></tr> <tr height="15" bgcolor="#ffffff"> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td></tr> <tr height="15" bgcolor="#cceeff"> <td valign="bottom"> <p style="MARGIN: 0px" align="justify"><a href="#Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.">Item 2.</a></p></td> <td valign="bottom"> <p style="MARGIN: 0px" align="justify"><a href="#Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</a></p></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> <p style="MARGIN: 0px" align="right">25</p></td> <td valign="bottom"></td></tr> <tr height="15" bgcolor="#ffffff"> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td></tr> <tr height="15" bgcolor="#cceeff"> <td valign="bottom"> <p style="MARGIN: 0px" align="justify"><a href="#Item 3. Quantitative and Qualitative Disclosures about Market Risk.">Item 3.</a></p></td> <td valign="bottom"> <p style="MARGIN: 0px" align="justify"><a href="#Item 3. Quantitative and Qualitative Disclosures about Market Risk.">Quantitative and Qualitative Disclosures about Market Risk.</a></p></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> <p style="MARGIN: 0px" align="right">31</p></td> <td valign="bottom"></td></tr> <tr height="15" bgcolor="#ffffff"> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td></tr> <tr height="15" bgcolor="#cceeff"> <td valign="bottom"> <p style="MARGIN: 0px" align="justify"><a href="#Item 4. Controls and Procedures.">Item 4.</a></p></td> <td valign="bottom"> <p style="MARGIN: 0px" align="justify"><a href="#Item 4. Controls and Procedures.">Controls and Procedures.</a></p></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> <p style="MARGIN: 0px" align="right">32</p></td> <td valign="bottom"></td></tr> <tr height="15"> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td></tr> <tr height="15"> <td valign="bottom" colspan="2"> <p style="MARGIN: 0px" align="justify"><b><a href="#PART II - OTHER INFORMATION">PART II - OTHER INFORMATION</a></b></p></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td></tr> <tr height="15"> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td></tr> <tr height="15" bgcolor="#cceeff"> <td valign="bottom"> <p style="MARGIN: 0px" align="justify"><a href="#Item 1. Legal Proceedings.">Item 1.</a></p></td> <td valign="bottom"> <p style="MARGIN: 0px" align="justify"><a href="#Item 1. Legal Proceedings.">Legal Proceedings.</a></p></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> <p style="MARGIN: 0px" align="right">33</p></td> <td valign="bottom"></td></tr> <tr height="15" bgcolor="#ffffff"> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td></tr> <tr height="15" bgcolor="#cceeff"> <td valign="bottom"> <p style="MARGIN: 0px" align="justify"><a href="#Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.">Item 2.</a></p></td> <td valign="bottom"> <p style="MARGIN: 0px" align="justify"><a href="#Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.">Unregistered Sales of Equity Securities and Use of Proceeds.</a></p></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> <p style="MARGIN: 0px" align="right">33</p></td> <td valign="bottom"></td></tr> <tr height="15" bgcolor="#ffffff"> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td></tr> <tr height="15" bgcolor="#cceeff"> <td valign="bottom"> <p style="MARGIN: 0px" align="justify"><a href="#Item 3. Defaults Upon Senior Securities.">Item 3.</a></p></td> <td valign="bottom"> <p style="MARGIN: 0px" align="justify"><a href="#Item 3. Defaults Upon Senior Securities.">Defaults Upon Senior Securities.</a></p></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> <p style="MARGIN: 0px" align="right">33</p></td> <td valign="bottom"></td></tr> <tr height="15" bgcolor="#ffffff"> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td></tr> <tr height="15" bgcolor="#cceeff"> <td valign="bottom"> <p style="MARGIN: 0px" align="justify"><a href="#Item 4. Mine Safety Disclosures.">Item 4.</a></p></td> <td valign="bottom"> <p style="MARGIN: 0px" align="justify"><a href="#Item 4. Mine Safety Disclosures.">Mine Safety Disclosures.</a></p></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> <p style="MARGIN: 0px" align="right">33</p></td> <td valign="bottom"></td></tr> <tr height="15" bgcolor="#ffffff"> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td></tr> <tr height="15" bgcolor="#cceeff"> <td valign="bottom"> <p style="MARGIN: 0px" align="justify"><a href="#Item 5. Other Information.">Item 5.</a></p></td> <td valign="bottom"> <p style="MARGIN: 0px" align="justify"><a href="#Item 5. Other Information.">Other Information.</a></p></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> <p style="MARGIN: 0px" align="right">33</p></td> <td valign="bottom"></td></tr> <tr height="15" bgcolor="#ffffff"> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td></tr> <tr height="15" bgcolor="#cceeff"> <td valign="bottom"> <p style="MARGIN: 0px" align="justify"><a href="#Item 6. Exhibits.">Item 6.</a></p></td> <td valign="bottom"> <p style="MARGIN: 0px" align="justify"><a href="#Item 6. Exhibits.">Exhibits.</a></p></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> <p style="MARGIN: 0px" align="right">34</p></td> <td valign="bottom"></td></tr> <tr height="15" bgcolor="#ffffff"> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td></tr> <tr height="15" bgcolor="#cceeff"> <td valign="bottom" colspan="2"> <p style="MARGIN: 0px" align="justify"><b><a href="#SIGNATURES">SIGNATURES</a></b></p></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> <p style="MARGIN: 0px" align="right">35</p></td> <td valign="bottom"></td></tr></table></p> <p style="MARGIN: 0px">&nbsp; <table id="pagebreakd8832245-669e-432d-a7ec-6058c1249cb3" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">2</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td>&nbsp;</td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b><a name="PART I - FINANCIAL INFORMATION">PART I - FINANCIAL INFORMATION</a></b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b><a name="Item 1. Financial Statements.">Item 1. Financial Statements.</a></b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: TIMES NEW ROMAN; WIDTH: 100%; TEXT-ALIGN: justify" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" colspan="9"> <p style="MARGIN: 0px 0px 0px 0in" align="center"><b>COSMOS HOLDINGS, INC.</b></p></td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid" valign="top" colspan="9"> <p style="MARGIN: 0px 0px 0px 0in" align="center"><b>CONSOLIDATED BALANCE SHEETS</b></p></td></tr> <tr> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px 0px 0px 0in" align="center"><b>September 30,<br>2017</b></p></td> <td style="PADDING-BOTTOM: 1px" valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px 0px 0px 0in" align="center"><b>December 31,<br>2016</b></p></td> <td style="PADDING-BOTTOM: 1px" valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" width="9%" colspan="2" align="center"> <p style="MARGIN: 0px 0px 0px 0in" align="center">(Unaudited) </p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" width="9%" colspan="2" align="center"></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr> <td valign="top" colspan="9"> <p style="MARGIN: 0px 0px 0px 0in" align="center"><b><u>ASSETS</u></b></p></td></tr> <tr> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" colspan="2" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" colspan="2" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>CURRENT ASSETS:</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" colspan="2" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" colspan="2" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Cash and cash equivalents</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%">$</td> <td id="ffcell" valign="bottom" width="9%" align="right">1,352,172</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%">$</td> <td id="ffcell" valign="bottom" width="9%" align="right">716,590</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Accounts receivable</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">2,858,518</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">661,850</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Inventory</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">2,096,818</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">464,219</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Prepaid deferred financing fees</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">361,289</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">131,900</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Prepaid expenses and other current assets</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">2,904,989</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">646,530</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Prepaid expenses and other current assets - related party</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">481,450</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">15,523</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>TOTAL CURRENT ASSETS</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">10,055,236</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">2,636,612</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Other assets</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">656,382</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">429,203</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Property and equipment, net</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">79,521</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">52,715</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Intangible assets, net</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">44,012</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">-</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>TOTAL ASSETS</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">10,835,151</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">3,118,530</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr> <td valign="top" colspan="9"> <p style="MARGIN: 0px 0px 0px 0in" align="center"><b><u>LIABILITIES AND STOCKHOLDERS' DEFICIT</u></b></p></td></tr> <tr> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>CURRENT LIABILITIES:</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Accounts payable and accrued expenses</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%">$</td> <td id="ffcell" valign="bottom" width="9%" align="right">2,338,047</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%">$</td> <td id="ffcell" valign="bottom" width="9%" align="right">577,932</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Accounts payable and accrued expenses - related party</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">981</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">13,759</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Notes payable, net of unamortized discount of $154,949 and $110,561, respectively</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">9,274,201</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">2,872,472</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Notes payable - related party </p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">116,358</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">160,391</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Loans payable</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">17,938</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Loans payable - related party</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">559,557</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">148,250</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Taxes payable</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">1,313,030</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">1,080,590</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>TOTAL CURRENT LIABILITIES</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">13,602,174</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">4,871,332</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>TOTAL LIABILITIES</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">13,602,174</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">4,871,332</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>Commitments and Contingencies (see Note 9)</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>STOCKHOLDERS' DEFICIT:</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Preferred stock, $0.001 par value; 100,000,000 shares authorized; 0 shares issued and outstanding as of September 30, 2017 and December 31, 2016, respectively</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 15px">Common stock, $0.001 par value; 300,000,000 shares authorized; 128,253,932 and 125,870,532 shares issued and outstanding as of September 30, 2017 and December 31, 2016, respectively</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">128,254</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">125,871</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Additional paid-in capital</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">2,409,735</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">174,009</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Accumulated other comprehensive loss</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(1,228,614</td> <td valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(1,050,463</td> <td valign="bottom" width="1%">)</td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Accumulated deficit</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">(4,076,398</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">(1,002,219</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%">)</td></tr> <tr bgcolor="#cceeff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>TOTAL STOCKHOLDERS' DEFICIT</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">(2,767,023</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">(1,752,802</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%">)</td></tr> <tr bgcolor="#cceeff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">10,835,151</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">3,118,530</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in" align="center">The accompanying notes are an integral part of these unaudited consolidated financial statements.</p> <p style="MARGIN: 0px 0px 0px 0in" align="left">&nbsp;</p> <p style="MARGIN: 0px"> <table id="pagebreak3a7589ff-412a-453a-a692-83baa2ace1f9" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">3</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px"> <table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cols="1" cellpadding="0" width="100%" align="center" border="0"> <tr> <td style="BORDER-BOTTOM: black 1px solid"> <p style="MARGIN: 0px" align="center"><b>COSMOS HOLDINGS, INC. </b></p> <p style="MARGIN: 0px" align="center"><b>CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME (LOSS) </b></p> <p style="MARGIN: 0px" align="center"><b>(Unaudited) </b></p></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: TIMES NEW ROMAN; WIDTH: 100%; TEXT-ALIGN: justify" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" colspan="6" align="center"> <p style="MARGIN: 0px 0px 0px 0in" align="center"><b>Three Months Ended </b></p> <p style="MARGIN: 0px 0px 0px 0in" align="center"><b>September 30,</b></p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" colspan="6" align="center"> <p style="MARGIN: 0px 0px 0px 0in" align="center"><b>Nine Months Ended </b></p> <p style="MARGIN: 0px 0px 0px 0in" align="center"><b>September 30,</b></p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" colspan="2" align="center"> <p style="MARGIN: 0px 0px 0px 0in" align="center"><b>2017</b></p></td> <td style="PADDING-BOTTOM: 1px" valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" colspan="2" align="center"> <p style="MARGIN: 0px 0px 0px 0in" align="center"><b>2016</b></p></td> <td style="PADDING-BOTTOM: 1px" valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" colspan="2" align="center"> <p style="MARGIN: 0px 0px 0px 0in" align="center"><b>2017</b></p></td> <td style="PADDING-BOTTOM: 1px" valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" colspan="2" align="center"> <p style="MARGIN: 0px 0px 0px 0in" align="center"><b>2016</b></p></td> <td style="PADDING-BOTTOM: 1px" valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" colspan="2" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" colspan="2" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" colspan="2" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" colspan="2" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>REVENUE</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" colspan="2" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" colspan="2" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" colspan="2" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" colspan="2" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Revenue</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%">$</td> <td id="ffcell" valign="bottom" width="9%" align="right">9,546,951</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%">$</td> <td id="ffcell" valign="bottom" width="9%" align="right">1,414,503</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%">$</td> <td id="ffcell" valign="bottom" width="9%" align="right">19,775,398</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%">$</td> <td id="ffcell" valign="bottom" width="9%" align="right">3,506,804</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>COST OF REVENUE</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">8,772,138</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">1,269,553</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">18,156,795</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">3,192,472</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>GROSS PROFIT</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">774,813</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">144,950</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">1,618,603</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">314,332</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>OPERATING EXPENSES</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">General and administrative expenses</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">752,198</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">173,498</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">2,416,540</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">466,293</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Depreciation and amortization expense</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">6,167</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">2,421</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">17,199</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">6,956</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Impairment of goodwill</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">-</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">-</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">1,949,884</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">-</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>TOTAL OPERATING EXPENSES</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">758,365</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">175,919</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">4,383,623</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">473,249</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>GAIN (LOSS) FROM OPERATIONS</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">16,448</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">(30,969</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">(2,765,020</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">(158,917</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%">)</td></tr> <tr bgcolor="#ffffff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>OTHER INCOME (EXPENSE)</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Other income</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">19</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Interest expense - related party</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(66</td> <td valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(919</td> <td valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(198</td> <td valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(2,741</td> <td valign="bottom" width="1%">)</td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Interest expense</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(291,224</td> <td valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(53,794</td> <td valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(572,679</td> <td valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(103,803</td> <td valign="bottom" width="1%">)</td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Other expense</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(13,295</td> <td valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(3,388</td> <td valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(26,529</td> <td valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(4,539</td> <td valign="bottom" width="1%">)</td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Foreign currency transaction gain (loss)</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">89,966</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">(5,555</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">292,937</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">(7,043</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%">)</td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>TOTAL OTHER INCOME (EXPENSE)</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">(214,619</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">(63,656</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">(306,469</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">(118,107</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%">)</td></tr> <tr bgcolor="#ffffff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>LOSS BEFORE INCOME TAXES</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(198,171</td> <td valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(94,625</td> <td valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(3,071,489</td> <td valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(277,024</td> <td valign="bottom" width="1%">)</td></tr> <tr bgcolor="#ffffff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>INCOME TAX EXPENSE</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">-</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">12</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">(2,690</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">(773</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%">)</td></tr> <tr bgcolor="#ffffff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>NET LOSS</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(198,171</td> <td valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(94,613</td> <td valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(3,074,179</td> <td valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(277,797</td> <td valign="bottom" width="1%">)</td></tr> <tr bgcolor="#ffffff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>OTHER COMPREHENSIVE LOSS</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Foreign currency translation loss</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">(51,474</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">(16,622</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">(178,151</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">(38,185</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%">)</td></tr> <tr bgcolor="#cceeff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>TOTAL OTHER COMPREHENSIVE LOSS</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">(249,645</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">(111,235</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">(3,252,330</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">(315,982</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%">)</td></tr> <tr bgcolor="#cceeff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>BASIC AND DILUTED NET LOSS PER SHARE</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">(0.00</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">(0.00</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">(0.02</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">(0.00</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%">)</td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>Basic and Diluted</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">128,236,217</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">125,630,532</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">127,647,201</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">125,630,532</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr></table> <p style="MARGIN: 0px"> <p style="MARGIN: 0px"> <p style="MARGIN: 0px 0px 0px 0in" align="center">The accompanying notes are an integral part of these unaudited consolidated financial statements.</p> <p style="MARGIN: 0px 0px 0px 0in" align="left">&nbsp;</p> <p style="MARGIN: 0px"> <table id="pagebreak6a73de88-b37b-4235-970f-334563e011da" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">4</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: TIMES NEW ROMAN; WIDTH: 100%; TEXT-ALIGN: justify" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" colspan="9"> <p style="MARGIN: 0px 0px 0px 0in" align="center"><b>COSMOS HOLDINGS, INC.</b></p></td></tr> <tr> <td valign="top" colspan="9"> <p style="MARGIN: 0px 0px 0px 0in" align="center"><b>CONSOLIDATED STATEMENTS OF CASH FLOWS</b></p></td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid" valign="top" colspan="9"> <p style="MARGIN: 0px 0px 0px 0in" align="center"><b>(Unaudited)</b></p></td></tr> <tr> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="6" align="center"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" colspan="6" align="center"> <p style="MARGIN: 0px 0px 0px 0in" align="center"><b>Nine Months Ended </b></p> <p style="MARGIN: 0px 0px 0px 0in" align="center"><b>September 30,</b></p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" colspan="2" align="center"> <p style="MARGIN: 0px 0px 0px 0in" align="center"><b>2017</b></p></td> <td style="PADDING-BOTTOM: 1px" valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" colspan="2" align="center"> <p style="MARGIN: 0px 0px 0px 0in" align="center"><b>2016</b></p></td> <td style="PADDING-BOTTOM: 1px" valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" colspan="2" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" colspan="2" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>CASH FLOWS FROM OPERATING ACTIVITIES:</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" colspan="2" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" colspan="2" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Net loss</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%">$</td> <td id="ffcell" valign="bottom" width="9%" align="right">(3,074,179</td> <td valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%">$</td> <td id="ffcell" valign="bottom" width="9%" align="right">(277,797</td> <td valign="bottom" width="1%">)</td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt"><u>Adjustments to Reconcile Net Loss to Net Cash Used In Operating Activities:</u></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 20pt">Depreciation and amortization expense</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">17,199</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">6,956</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 20pt">Amortization of debt discount</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">87,677</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">5,885</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 20pt">Stock-based compensation</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">265,529</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 20pt">Issuance of common stock for services</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">401,800</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 20pt">Loss on goodwill impairment</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">1,949,884</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt"><u>Changes in Assets and Liabilities:</u></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 20pt">Accounts receivable</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(2,137,831</td> <td valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(316,012</td> <td valign="bottom" width="1%">)</td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 20pt">Inventory</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(1,627,085</td> <td valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(189,435</td> <td valign="bottom" width="1%">)</td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 20pt">Prepaid expenses</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(2,242,785</td> <td valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(198,627</td> <td valign="bottom" width="1%">)</td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 20pt">Prepaid expenses - related party</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(465,927</td> <td valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(119,796</td> <td valign="bottom" width="1%">)</td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 20pt">Other assets</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(166,896</td> <td valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(55,880</td> <td valign="bottom" width="1%">)</td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 20pt">Accounts payable and accrued expenses</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">1,056,165</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">70,681</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 20pt">Accounts payable and accrued expenses - related party</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(12,778</td> <td valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(135,117</td> <td valign="bottom" width="1%">)</td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 20pt">Taxes payable</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">209,667</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">36,331</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 20pt">Deferred revenue</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">-</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">(62,210</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%">)</td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>NET CASH USED IN OPERATING ACTIVITIES</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">(5,739,560</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">(1,235,021</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%">)</td></tr> <tr bgcolor="#cceeff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>CASH FLOWS FROM INVESTING ACTIVITIES:</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Purchase of fixed assets</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%">$</td> <td id="ffcell" valign="bottom" width="9%" align="right">(13,925</td> <td valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%">$</td> <td id="ffcell" valign="bottom" width="9%" align="right">(11,880</td> <td valign="bottom" width="1%">)</td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Cash received from acquisition</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">40,858</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">-</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">26,933</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">(11,880</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%">)</td></tr> <tr bgcolor="#ffffff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>CASH FLOWS FROM FINANCING ACTIVITIES:</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Payment of related party note payable</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%">$</td> <td id="ffcell" valign="bottom" width="9%" align="right">(63,200</td> <td valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%">$</td> <td id="ffcell" valign="bottom" width="9%" align="right">(44,952</td> <td valign="bottom" width="1%">)</td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Payment of note payable</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(461,888</td> <td valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(148,904</td> <td valign="bottom" width="1%">)</td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Proceeds from note payable</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">6,891,203</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">1,968,940</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Payment of related party loan</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(232,051</td> <td valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(21,914</td> <td valign="bottom" width="1%">)</td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Proceeds from related party loan</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">625,641</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">51,127</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Payment of loans payable</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(20,082</td> <td valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(33,714</td> <td valign="bottom" width="1%">)</td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Sale of common stock and warrants</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">91,780</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Deferred financing fees</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(213,626</td> <td valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(140,475</td> <td valign="bottom" width="1%">)</td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Capital contribution</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">-</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">140</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>NET CASH PROVIDED BY FINANCING ACTIVITIES</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">6,617,777</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">1,630,248</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in">Effect of exchange rate changes on cash </p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%">$</td> <td id="ffcell" valign="bottom" width="9%" align="right">(269,568</td> <td valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%">$</td> <td id="ffcell" valign="bottom" width="9%" align="right">38,377</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>NET INCREASE IN CASH </b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">635,582</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">421,724</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>CASH AT BEGINNING OF PERIOD</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">716,590</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">198,049</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>CASH AT END OF PERIOD</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">1,352,172</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">619,773</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b><u>Supplemental Disclosure of Cash Flow Information</u></b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b>Cash paid during the period:</b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in">Interest</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">127,157</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">-</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in">Income Tax </p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">-</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">-</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in"><b><u>Supplemental Disclosure of Non-Cash Investing and Financing Activities</u></b></p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Acquisition of Decahedron</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">1,479,000</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">-</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 10pt">Reversal of proceeds due from noteholder due to repayment of note</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">11,813</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" align="right">-</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in" align="center">The accompanying notes are an integral part of these unaudited consolidated financial statements.</p> <p style="MARGIN: 0px 0px 0px 0in" align="left">&nbsp;</p> <p style="MARGIN: 0px" align="justify"> <table id="pagebreak17a5d05c-3225-41cc-8557-9e32732c43ef" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">5</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b>COSMOS HOLDINGS, INC.</b></p> <p style="MARGIN: 0px" align="center"><b>Notes to Unaudited Consolidated Financial Statements</b></p> <p style="MARGIN: 0px" align="center"><b>September 30, 2017</b></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b>NOTE 1&nbsp;&#8211; BASIS OF PRESENTATION</b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">The terms &#8220;COSM,&#8221; &#8220;we,&#8221; &#8220;the Company,&#8221; and &#8220;us&#8221; as used in this report refer to Cosmos Holdings Inc. The accompanying unaudited consolidated balance sheet as of September 30, 2017 and unaudited consolidated statements of operations for the three and nine months ended September 30, 2017 have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements. In the opinion of management of COSM, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the nine months ended September 30, 2017, are not necessarily indicative of the results that may be expected for the year ending December 31, 2017, or any other period. These unaudited consolidated financial statements and notes should be read in conjunction with the financial statements for each of the two years ended December 31, 2016 and 2015, included in the Company&#8217;s Annual Report on Form 10-K. The accompanying consolidated balance sheet as of December 31, 2016 has been derived from the audited financial statements filed in our Form 10-K and is included for comparison purposes in the accompanying balance sheet. Certain prior year amounts have been reclassified to conform to current year presentation. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b>NOTE 2 &#8211; ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN</b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Cosmos Holdings, Inc. (&#8220;Cosmos&#8221;, &#8220;The Company&#8221;, &#8220;we&#8221;, or &#8220;us&#8221;) was incorporated in the State of Nevada under the name Prime Estates and Developments, Inc. on July 21, 2009 for the purpose of acquiring and operating commercial real estate and real estate related assets.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On September 27, 2013 (the &#8220;Closing&#8221;), Cosmos Holding Inc. a Nevada corporation (&#8220;Cosmos Holdings, Inc.&#8221; or the &#8220;Registrant&#8221;), closed a reverse take-over transaction by which it acquired a private company whose principal activities are the trading of products, providing representation, and provision of consulting services to various sectors. Pursuant to a Share Exchange Agreement (the &#8220;Exchange Agreement&#8221;) between the Registrant and Amplerissimo Ltd, a company incorporated in Cyprus (&#8220;Amplerissimo&#8221;), the Registrant acquired 100% of Amplerissimo&#8217;s issued and outstanding common stock. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On August 1, 2014, we, through our Cypriot subsidiary Amplerissimo, formed SkyPharm S.A. a Greek corporation (&#8220;SkyPharm&#8221;) whose principal activities and operations are the development, marketing and sales of pharmaceutical, wellness and cosmetic products. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On February 10, 2017, the Company and Decahedron Ltd, a UK Corporation (&#8220;Decahedron&#8221;) consummated the transactions contemplated by the Stock Purchase Agreement, dated November 17, 2016 as amended (the &#8220;Decahedron SPA&#8221;). Pursuant to the terms of the Decahedron SPA, the shareholders of Decahedron received an aggregate of 1,700,000 shares of common stock of the Company (the &#8220;Stock Consideration&#8221;), which were delivered following the closing in exchange for all of the Ordinary Shares of Decahedron for the Stock Consideration. In accordance with the terms of the SPA, Mr. Lazarou remained as a director and officer of Decahedron.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">We are currently focusing our existing operations on expanding the business of SkyPharm and our new subsidiary Decahedron, we have concentrated our efforts on becoming an international pharmaceutical company. The Company&#8217;s focus will be on Branded Pharmaceuticals, Over-the-Counter (OTC) medicines, and Generic Pharmaceuticals. The Company also intends to expand into Cosmetic-Beauty Products as well as Food Supplements and we target areas where we can build and maintain a strong position. The Company uses a differentiated operating model based on a lean, nimble and decentralized structure, an emphasis on low risk license acquisition as well as Research &amp; Development and our ability to be better owners of pharmaceutical assets than others. This operating model and the execution of our corporate strategy are enabling the Company to achieve sustainable growth and create shareholder value.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">We regularly evaluate and, where appropriate, execute on opportunities to expand through the acquisition of branded pharmaceutical products and pharmaceutical companies in areas that will serve patients that we believe will offer above average growth characteristics and attractive margins. In particular, we look to continue to enhance our pharmaceutical and over the counter product lines by acquiring or licensing rights to additional products and regularly evaluate selective acquisition opportunities.</p> <p style="MARGIN: 0px" align="justify">&nbsp; <table id="pagebreak0d564f03-3bcd-44f3-a577-3a554b607e07" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">6</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b>COSMOS HOLDINGS, INC.</b></p> <p style="MARGIN: 0px" align="center"><b>Notes to Unaudited Consolidated Financial Statements</b></p> <p style="MARGIN: 0px" align="center"><b>September 30, 2017</b></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b>Going Concern</b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">The Company&#8217;s consolidated financial statements are prepared using U.S. GAAP applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company generated a net loss of $3,074,179 for the nine months ended September 30, 2017, and has a working capital deficit of $3,546,938 and an accumulated deficit of $4,076,398 as of September 30, 2017. These conditions raise substantial doubt of the Company&#8217;s ability to continue as a going concern. The Company has not yet established an adequate ongoing source of revenues sufficient to cover its operating costs and to allow it to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease development of operations.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">In order to continue as a going concern, develop a reliable source of revenues, and achieve a profitable level of operations the Company will need, among other things, additional capital resources. Management&#8217;s plans to continue as a going concern include raising additional capital through increased sales of product and by sale of common shares. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><i>Summary of Significant Accounting Policies</i></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b>Basis of Financial Statement Presentation</b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">The accompanying consolidated financial statements have been prepared in accordance with principles generally accepted in the United States of America.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b>Principles of Consolidation</b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Our consolidated accounts include our accounts and the accounts of our wholly-owned subsidiaries, Amplerissimo Ltd, SkyPharm S.A. and Decahedron Ltd. All significant intercompany balances and transactions have been eliminated.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><b>Reclassifications to Prior Period Financial Statements and Adjustments</b></p> <p style="MARGIN: 0px 0px 0px 0in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </p> <p style="MARGIN: 0px 0px 0px 0in">Certain reclassifications have been made in the Company&#8217;s financial statements of the prior year to conform to the current year presentation. These reclassifications have no impact on previously reported net income.</p> <p style="MARGIN: 0px" align="justify"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </b></p> <p style="MARGIN: 0px" align="justify"><b>Use of Estimates</b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">The preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b>Cash and Cash Equivalents</b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">For purposes of the statement of cash flows, the Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. As of September 30, 2017 and December 31, 2016, there were no cash equivalents.</p> <p style="MARGIN: 0px" align="justify">&nbsp; <table id="pagebreakc0ec868a-fe8e-425d-992a-b6befa27ec32" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">7</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b>COSMOS HOLDINGS, INC.</b></p> <p style="MARGIN: 0px" align="center"><b>Notes to Unaudited Consolidated Financial Statements</b></p> <p style="MARGIN: 0px" align="center"><b>September 30, 2017</b></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="justify">The Company maintains bank accounts in the United States denominated in U.S. Dollars and in the Republic of Cyprus, in Greece and in Bulgaria all of them denominated in Euros. The Company also maintains bank accounts in the United Kingdom of Great Britain, dominated in Euros and Great Britain Pound (British Pounds Sterling).</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b>Account Receivable </b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Accounts receivable are stated at their net realizable value. The allowance for doubtful accounts against gross accounts receivable reflects the best estimate of probable losses inherent in the receivables portfolio determined on the basis of historical experience, specific allowances for known troubled accounts and other currently available information.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b>Inventory </b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Inventory is stated at the lower of cost or market value using the weighted average method. Inventory consists primarily of finished goods and packaging materials, i.e. packaged pharmaceutical products and the wrappers and containers they are sold in. A periodic inventory system is maintained by 100% count.&nbsp;Inventory is replaced periodically to maintain the optimum stock on hand available for immediate shipment. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">We write-down inventories to net realizable value based on forecasted demand and market conditions, which may differ from actual results. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b>Fixed Assets</b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Fixed assets are stated at cost, less accumulated depreciation. Depreciation is provided on a straight-line basis over the useful lives (except for leasehold improvements which are depreciated over the lesser of the lease term or the useful life) of the assets as follows:</p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px"> <table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="85%" align="center" border="0"> <tr height="15"> <td valign="bottom"></td> <td valign="bottom" width="1%"></td> <td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%"> <p style="MARGIN: 0px" align="center"><b>Estimated Useful Life</b></p></td> <td width="1%"></td></tr> <tr height="15" bgcolor="#cceeff"> <td valign="bottom"> <p style="MARGIN: 0px" align="justify">Furniture and fixtures</p></td> <td valign="bottom"></td> <td valign="bottom"> <p style="MARGIN: 0px" align="center">5-7 years</p></td> <td></td></tr> <tr height="15" bgcolor="#ffffff"> <td valign="bottom"> <p style="MARGIN: 0px" align="justify">Office and computer equipment</p></td> <td valign="bottom"></td> <td valign="bottom"> <p style="MARGIN: 0px" align="center">3-5 years</p></td> <td></td></tr></table></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Depreciation expense was $10,831 and $6,956 for the nine months ended September 30, 2017 and 2016, respectively.</p> <p style="MARGIN: 0px" align="center">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b>Intangible Assets</b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">Intangible assets with definite useful lives are recorded on the basis of cost and are amortized on a straight-line basis over their estimated useful lives. The Company uses a useful life of 5 years for an import/export license. The Company evaluates the remaining useful life of intangible assets annually to determine whether events and circumstances warrant a revision to the remaining amortization period. If the estimate of the intangible asset&#8217;s remaining useful life is changed, the remaining carrying amount of the intangible asset will be amortized prospectively over that revised remaining useful life. At September 30, 2017, no revision to the remaining amortization period of the intangible assets was made.</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">Amortization expense was $6,368 and $0 for the nine months ended September 30, 2017 and 2016, respectively.</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><b>Impairment of Long-Lived Assets</b></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">In accordance with ASC 360-10, Long-lived assets, which include property and equipment and intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the assets. Fair value is generally determined using the asset&#8217;s expected future discounted cash flows or market value, if readily determinable.</p> <p style="MARGIN: 0px" align="justify">&nbsp; <table id="pagebreak8973276c-c1a9-49d8-8ad8-3b19fb8ae26b" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">8</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b>COSMOS HOLDINGS, INC.</b></p> <p style="MARGIN: 0px" align="center"><b>Notes to Unaudited Consolidated Financial Statements</b></p> <p style="MARGIN: 0px" align="center"><b>September 30, 2017</b></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b>Goodwill and Intangibles </b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">The Company periodically reviews the carrying value of intangible assets not subject to amortization, including goodwill, to determine whether impairment may exist. Goodwill and certain intangible assets are assessed annually, or when certain triggering events occur, for impairment using fair value measurement techniques. These events could include a significant change in the business climate, legal factors, a decline in operating performance, competition, sale or disposition of a significant portion of the business, or other factors. Specifically, goodwill impairment is determined using a two-step process. The first step of the goodwill impairment test is used to identify potential impairment by comparing the fair value of a reporting unit with its carrying amount, including goodwill. The Company uses level 3 inputs and a discounted cash flow methodology to estimate the fair value of a reporting unit. A discounted cash flow analysis requires one to make various judgmental assumptions including assumptions about future cash flows, growth rates, and discount rates. The assumptions about future cash flows and growth rates are based on the Company&#8217;s budget and long-term plans. Discount rate assumptions are based on an assessment of the risk inherent in the respective reporting units. If the fair value of a reporting unit exceeds its carrying amount, goodwill of the reporting unit is considered not impaired and the second step of the impairment test is unnecessary. If the carrying amount of a reporting unit exceeds its fair value, the second step of the goodwill impairment test is performed to measure the amount of impairment loss, if any. The second step of the goodwill impairment test compares the implied fair value of the reporting unit&#8217;s goodwill with the carrying amount of that goodwill. If the carrying amount of the reporting unit&#8217;s goodwill exceeds the implied fair value of that goodwill, an impairment loss is recognized in an amount equal to that excess. The implied fair value of goodwill is determined in the same manner as the amount of goodwill recognized in a business combination. That is, the fair value of the reporting unit is allocated to all of the assets and liabilities of that unit (including any unrecognized intangible assets) as if the reporting unit had been acquired in a business combination and the fair value of the reporting unit was the purchase price paid to acquire the reporting unit.</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Prior to the acquisition of Decahedron, the Company had no record goodwill value. As a result of the acquisition of Decahedron, the Company tested and expensed 100% of the goodwill allocated to the acquisition costs, an amount equal to $1,949,884 for the period ending September 30, 2017. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b>Fair Value Measurement</b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">The Company adopted FASB ASC 820-Fair Value Measurements and Disclosures, or ASC 820, for assets and liabilities measured at fair value on a recurring basis. ASC 820 establishes a common definition for fair value to be applied to existing generally accepted accounting principles that require the use of fair value measurements establishes a framework for measuring fair value and expands disclosure about such fair value measurements. The adoption of ASC 820 did not have an impact on the Company&#8217;s financial position or operating results, but did expand certain disclosures.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Additionally, ASC 820 requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below:</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Level 1:&nbsp;Observable inputs such as quoted prices (unadjusted)&nbsp;in active markets for identical assets or liabilities.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Level 2:&nbsp;Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Level 3:&nbsp;Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us, which reflect those that a market participant would use.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">The Company did not have any Level 2 or Level 3 assets or liabilities as of September 30, 2017.</p> <p style="MARGIN: 0px" align="justify">&nbsp; <table id="pagebreake429a769-a315-4084-a19f-003793446a77" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">9</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b>COSMOS HOLDINGS, INC.</b></p> <p style="MARGIN: 0px" align="center"><b>Notes to Unaudited Consolidated Financial Statements</b></p> <p style="MARGIN: 0px" align="center"><b>September 30, 2017</b></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Cash is considered to be highly liquid and easily tradable as of September 30, 2017 and therefore classified as Level 1 within our fair value hierarchy.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">In addition, FASB ASC 825-10-25 Fair Value Option, or ASC 825-10-25, was effective for January 1, 2008. ASC 825-10-25 expands opportunities to use fair value measurements in financial reporting and permits entities to choose to measure many financial instruments and certain other items at fair value. The Company did not elect the fair value options for any of its qualifying financial instruments.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b>Revenue Recognition</b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">We consider revenue recognizable when persuasive evidence of an arrangement exists, the price is fixed or determinable, goods or services have been delivered, and collectability is reasonably assured. These criteria are assumed to have been met if a customer orders an item, the goods or services have been shipped or delivered to the customer, and we have sufficient evidence of collectability, such a payment history with the customer. Revenue that is billed and received in advance such as recurring weekly or monthly services are initially deferred and recognized as revenue over the period the services are provided.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b>Stock-based Compensation</b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">The Company records stock based compensation in accordance with ASC section 718, &#8220;Stock Compensation&#8221; and Staff Accounting Bulletin (SAB) No. 107 (SAB 107) issued by the SEC in March 2005 regarding its interpretation of ASC 718. ASC 718 requires the fair value of all stock-based employee compensation awarded to employees to be recorded as an expense over the related requisite service period. The Company values any employee or non-employee stock based compensation at fair value using the Black-Scholes Option Pricing Model.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">The Company accounts for non-employee share-based awards in accordance with the measurement and recognition criteria of ASC 505-50 &#8220;Equity-Based Payments to Non-Employees&#8221;.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b>Foreign Currency Translations and Transactions</b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Assets and liabilities of all foreign operations are translated at year-end rates of exchange, and the statements of operations are translated at the average rates of exchange for the year. Gains or losses resulting from translating foreign currency financial statements are accumulated in a separate component of stockholders&#8217; equity until the entity is sold or substantially liquidated.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Gains or losses from foreign currency transactions (transactions denominated in a currency other than the entity&#8217;s local currency) are included in net earnings.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b>Income Taxes</b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">The Company accounts for income taxes under the asset and liability method, as required by the accounting standard for income taxes&nbsp;ASC 740. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis, as well as net operating loss carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">The Company is liable for income taxes in the Republic of Cyprus, Greece and the United Kingdom of England. The corporate income tax rate in Cyprus is 12.5%, 29% in Greece (tax losses are carried forward for five years effective January 1, 2013) and 20% in United Kingdom of England. Losses may also be subject to limitation under certain rules regarding change of ownership.</p> <p style="MARGIN: 0px" align="justify">&nbsp; <table id="pagebreak9fa995ff-cd41-4799-839e-193e94af8bab" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">10</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b>COSMOS HOLDINGS, INC.</b></p> <p style="MARGIN: 0px" align="center"><b>Notes to Unaudited Consolidated Financial Statements</b></p> <p style="MARGIN: 0px" align="center"><b>September 30, 2017</b></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="justify">We regularly review deferred tax assets to assess their potential realization and establish a valuation allowance for portions of such assets to reduce the carrying value if we do not consider it to be more likely than not that the deferred tax assets will be realized. Our review includes evaluating both positive (e.g., sources of taxable income) and negative (e.g., recent historical losses) evidence that could impact the realizability of our deferred tax assets.&nbsp;At September 30, 2017 the Company has maintained a valuation allowance against all net deferred tax assets in each jurisdiction in which it is subject to income tax. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">We recognize the impact of an uncertain tax position in our financial statements if, in management&#8217;s judgment, the position is&nbsp;not&nbsp;more-likely-then-not sustainable upon audit based on the position&#8217;s technical merits. This involves the identification of potential uncertain tax positions, the evaluation of applicable tax laws and an assessment of whether a liability for an uncertain tax position is necessary. As of September 30, 2017 the Company has no uncertain tax positions recorded in any jurisdiction where it is subject to income tax.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b>Basic and Diluted Net Income (Loss) per Common Share</b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Basic and diluted net loss per share calculations are calculated on the basis of the weighted average number of common shares outstanding during the periods presented. The per share amounts include the dilutive effect of common stock equivalents in periods with net income. Basic and diluted loss per share for each of the periods ended September 30, 2017 and 2016 is the same due to the anti-dilutive nature of potential common stock equivalents. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b>Recent Accounting Pronouncements</b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">In January 2017, the FASB issued ASU 2017-04, Intangibles &#8211; Goodwill and Other (Topic 350), which simplifies the measurement of goodwill by eliminating Step 2 from the current goodwill impairment test in the event that there is evidence of an impairment based on qualitative or quantitative assessments. ASU 2017-04 does not change how the goodwill impairment is identified, and the Company will continue to perform a qualitative assessment annually to determine whether the two step impairment test is required. Until the adoption, current accounting standards require the impairment loss to be recognized under Step 2 of the impairment test. This requires the Company to calculate the implied fair value of goodwill by assigning fair value to the reporting unit&#8217;s assets and liabilities as if the reporting unit has been acquired in a business combination, then subsequently subtracting the implied goodwill from the carrying amount of the goodwill. The new standard would require the Company to determine the fair value of the reporting unit and subtract the carrying value from the fair value of the reporting unit to determine if there is an impairment. ASU 2017-04 is effective for the Company for fiscal years after December 15, 2019, and early adoption is permitted. ASU 2017-04 is required to be adopted prospectively, and the adoption is effective for annual goodwill impairment tests performed in the year of adoption. The Company does not believe that the adoption of ASU No. 2017-4 will have a material effect on the Company&#8217;s consolidated financial position or the Company&#8217;s consolidated results of operations</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">In January 2017, the FASB issued ASU No. 2017-01, &#8220;Clarifying the Definition of a Business,&#8221; with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as an acquisition of assets or a business. ASU No. 2017-01 is effective for the Company&#8217;s fiscal year commencing on January 1, 2018. The effect of this guidance is to be applied prospectively and early adoption is permitted. The Company does not believe that the adoption of ASU No. 2017-01 will have a material effect on the Company&#8217;s consolidated financial position or the Company&#8217;s consolidated results of operations.</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">In February 2016, the FASB issued ASU 2016-02, &#8220;Leases,&#8221; which will require lessees to recognize assets and liabilities for the rights and obligations created by most leases on the balance sheet. The changes become effective for the Company&#8217;s fiscal year beginning July 1, 2019. Modified retrospective adoption for all leases existing at, or entered into after, the date of initial application, is required with an option to use certain transition relief. The Company expects this ASU will increase its current assets and current liabilities, but have no net material impact on its consolidated financial statements.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in">In May 2014, the FASB issued ASU 2014-09--Revenue from Contracts with Customers (Topic 606). The guidance requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The FASB delayed the effective date to annual reporting periods beginning after December 15, 2017, including interim reporting periods within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. In addition, in March and April 2016, the FASB issued new guidance intended to improve the operability and understandability of the implementation guidance on principal versus agent considerations. Both amendments permit the use of either a retrospective or cumulative effect transition method and are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017, with early application permitted. The Company is currently evaluating the impact the adoption of this ASU will have on its financial statements.&nbsp; </p> <p style="MARGIN: 0px 0px 0px 0in">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in">Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company&#8217;s financial statements. </p> <p style="MARGIN: 0px 0px 0px 0in">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in"> <table id="pagebreakd92fff7e-1c09-46a9-b19a-96a3c4009ee3" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">11</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b>COSMOS HOLDINGS, INC.</b></p> <p style="MARGIN: 0px" align="center"><b>Notes to Unaudited Consolidated Financial Statements</b></p> <p style="MARGIN: 0px" align="center"><b>September 30, 2017</b></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b>NOTE 3 &#8211; ACQUISITION OF DECAHEDRON, LTD.</b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On February 10, 2017, the Company completed the acquisition pursuant to the Decahedron SPA acquiring 100% of the outstanding shares of Decahedron, a United Kingdom company. Decahedron is a pharmaceuticals wholesaler which specializes in imports and exports of branded and generic pharmaceutical products within the EEA and around the world. At closing, the Company acquired 100% of Decahedron&#8217;s outstanding shares in exchange for 1,700,000 shares of Cosmos common stock valued at $1,479,000 (the &#8220;Acquisition&#8221;).</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">The Company recognized the Decahedron assets acquired and liabilities assumed based upon the fair value of such assets and liabilities measured as of the date of acquisition. The aggregate purchase price for Decahedron has been allocated to the tangible and identifiable intangible assets acquired and liabilities assumed based on their estimated fair values at the date of acquisition. The excess of the purchase price over the fair value of the acquired net assets represents cost and revenue synergies specific to the Company, as well as non-capitalizable intangible assets, such as the license held by Decahedron for the wholesale of pharmaceuticals in the United Kingdome and Europe, the remainder has been allocated to goodwill, none of which is tax deductible. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">During the nine months ended September&nbsp;30, 2017, we recorded an adjustment of $28,002 primarily related to other assets and an adjustment of the accounts payable associated with the Decahedron acquisition. We finalized our allocation of the purchase price during the nine months ended September&nbsp;30, 2017. The final unaudited allocation of purchase price as of September&nbsp;30, 2017, is as follows:</p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: TIMES NEW ROMAN; WIDTH: 100%; TEXT-ALIGN: justify" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>Preliminary Allocation as of </b></p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>February 10, </b></p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>Allocation</b></p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px 0px 0px 0in" align="center"><b>Final</b></p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>2017</b></p></td> <td style="PADDING-BOTTOM: 1px" valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>Adjustments</b></p></td> <td style="PADDING-BOTTOM: 1px" valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" colspan="2" align="center"> <p style="MARGIN: 0px 0px 0px 0in" align="center"><b>Allocation</b></p></td> <td style="PADDING-BOTTOM: 1px" valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Current assets</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%">$</td> <td id="ffcell" valign="bottom" width="9%" align="right">6,537</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%">$</td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%">$</td> <td id="ffcell" valign="bottom" width="9%" align="right">6,537</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Intangible assets</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">50,000</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">50,000</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Other assets</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" align="right">305,400</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" align="right">(216,562</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" align="right">88,838</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Total assets acquired</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" align="right">361,937</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" align="right">(216,562</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" align="right">145,375</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Liabilities assumed:</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Debt</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" align="right">804,819</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" align="right">(188,560</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" align="right">616,259</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Total liabilities assumed</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" align="right">804,819</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" align="right">(188,560</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" align="right">616,259</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Net assets acquired</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" align="right">(442,882</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" align="right">(28,002</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" align="right">(470,884</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%">)</td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Consideration:</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Value of Common Stock Issued at Acquisition</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" align="right">1,479,000</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" align="right">-</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" align="right">1,479,000</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Goodwill</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: 3px double" valign="bottom" width="9%" align="right">1,921,882</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: 3px double" valign="bottom" width="9%" align="right">28,002</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: 3px double" valign="bottom" width="9%" align="right">1,949,884</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr></table></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">The components of the acquired intangible assets were as follows (in thousands):</p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px"> <table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr height="15"> <td valign="bottom"></td> <td valign="bottom"> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" colspan="2"> <p style="MARGIN: 0px" align="center"><b>Amount</b></p></td> <td valign="bottom"></td> <td valign="bottom"> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" colspan="2"> <p style="MARGIN: 0px" align="center"><b>Useful Life<br>(Years)</b></p></td> <td valign="bottom"> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td></tr> <tr height="15" bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Licenses (a)</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">$</p></td> <td valign="bottom" width="9%"> <p style="MARGIN: 0px 0px 0px 0in" align="right">50,000</p></td> <td valign="bottom" width="1%"></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td valign="bottom" width="1%"></td> <td valign="bottom" width="9%"> <p style="MARGIN: 0px 0px 0px 0in" align="right">5</p></td> <td valign="bottom" width="1%"></td></tr> <tr height="15" bgcolor="#ffffff"> <td valign="top"></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td style="BORDER-BOTTOM: 3px double" valign="bottom" width="1%"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">$</p></td> <td style="BORDER-BOTTOM: 3px double" valign="bottom" width="9%"> <p style="MARGIN: 0px 0px 0px 0in" align="right">50,000</p></td> <td valign="bottom" width="1%"></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td valign="bottom" width="1%"></td> <td valign="bottom" width="9%"> <p style="MARGIN: 0px 0px 0px 0in" align="right">-</p></td> <td valign="bottom" width="1%"></td></tr></table></p> <p style="MARGIN: 0px">_____________</p> <p style="MARGIN: 0px" align="justify">(a) U.K Pharmaceutical Wholesale Distribution License </p> <p style="MARGIN: 0px" align="justify">&nbsp; <table id="pagebreakb6cd762f-cb7c-4bec-9876-04b8cd154244" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">12</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b>COSMOS HOLDINGS, INC.</b></p> <p style="MARGIN: 0px" align="center"><b>Notes to Unaudited Consolidated Financial Statements</b></p> <p style="MARGIN: 0px" align="center"><b>September 30, 2017</b></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><i>Unaudited Supplemental Pro Forma Data</i></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">The pro forma statements of operations data for the nine months ended September 30, 2017, below, give effect to the Decahedron Acquisition, described above, as if it had occurred at January 1, 2017. These amounts have been calculated after applying our accounting policies and adjusting the results of Decahedron intangible amortization that would have been charged assuming the fair value adjustments had been applied and incurred since January 1, 2017. This pro forma data is presented for informational purposes only and does not purport to be indicative of our future results of operations.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Revenue of $2,622,547 and net loss of $255,672 since the acquisition date are included in the consolidated statement of operations and comprehensive income (loss) for nine months ended September 30, 2017.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Unaudited proforma results of operations for the nine months ended September 30, 2017 and 2016 as though the Company acquired Decahedron on the first of each fiscal year are set forth below. </p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: TIMES NEW ROMAN; WIDTH: 100%; TEXT-ALIGN: justify" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" colspan="6" align="center"> <p style="MARGIN: 0px" align="center"><b>Nine Months Ended<br>September 30,</b></p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" colspan="2" align="center"> <p style="MARGIN: 0px 0px 0px 0in" align="center"><b>2017</b></p></td> <td style="PADDING-BOTTOM: 1px" valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>2016</b></p></td> <td style="PADDING-BOTTOM: 1px" valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Revenues</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%">$</td> <td id="ffcell" valign="bottom" width="9%" align="right">19,968,845</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%">$</td> <td id="ffcell" valign="bottom" width="9%" align="right">5,007,806</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Cost of revenues</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">18,356,228</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">4,672,794</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Gross profit</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">1,612,617</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">335,012</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Operating expenses</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">4,411,620</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">614,515</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Operating loss</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(2,799,003</td> <td valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">(279,503</td> <td valign="bottom" width="1%">)</td></tr> <tr bgcolor="#cceeff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Other income (expense)</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" align="right">(524,952</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" align="right">(238,528</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%">)</td></tr> <tr bgcolor="#cceeff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Net Loss</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: 3px double" valign="bottom" width="9%" align="right">(3,323,955</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%">)</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: 3px double" valign="bottom" width="9%" align="right">(518,031</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%">)</td></tr></table></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">The purchase price exceeded the estimated fair value of the net assets acquired by $1,949,884 which was recorded as Goodwill. Goodwill represents the difference between the total purchase price for the net assets purchased from Decahedron and the aggregate fair values of tangible and intangible assets acquired, less liabilities assumed. At the conclusion of the acquisition, goodwill was reviewed for impairment and it was determined that indicators of impairment existed.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">As of September 30, 2017, after our assessment of the totality of the events that could impair goodwill, it was the Company&#8217;s conclusion &#8220;it is not more likely than not&#8221; that the Goodwill was impaired. Therefore, the Company was not required to conduct a two-step quantitative goodwill impairment test. No events have occurred after September 30, 2017 that would affect the Company&#8217;s conclusion as of the September 30, 2017 assessment date. As a result of the Company&#8217;s assessment, 100% of the goodwill of $1,949,884 was recorded as an impairment of goodwill. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b>NOTE 4 &#8211; PREPAID DEFERRED FINANCING COSTS</b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On February 28, 2016, the Company entered into an agreement with Synthesis Management Limited (&#8220;Synthesis Management&#8221;) for the purpose of securing additional financing for the Company. On September 28, 2016, the Company advanced &#8364;125,000 ($133,725) to Synthesis Management. These advances are refundable if funding is not secured and if funding is secured, the amount will be applied to the note on day one as debt discount. As of September 30, 2017, the outstanding balance on the advance is &#8364;125,000 ($147,662).</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">In August, 2017 the Company entered into an agreement with Synthesis Multi Asset Architecture (&#8220;Synthesis Architecture&#8221;) for the purpose of securing additional financing for the Company. On August 14, 2017, the Company advanced Synthesis Architecture &#8364;180,840 ($213,627). These advances are refundable if funding is not secured and if funding is secured, the amount will be applied to the note on day one as debt discount. As of September 30, 2017, the outstanding balance on the advance is &#8364;180,840 ($213,627).</p> <p style="MARGIN: 0px" align="justify">&nbsp; <table id="pagebreakdcac79f4-eb18-4a58-9f20-d963d31e9881" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">13</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b>COSMOS HOLDINGS, INC.</b></p> <p style="MARGIN: 0px" align="center"><b>Notes to Unaudited Consolidated Financial Statements</b></p> <p style="MARGIN: 0px" align="center"><b>September 30, 2017</b></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b>NOTE 5&nbsp;&#8211; INCOME TAXES</b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">At September 30, 2017, the Company&#8217;s effective tax rate differs from the US federal statutory tax rate primarily due to a valuation allowance recorded against net deferred tax assets in all jurisdictions in which the Company operates. At December 31, 2016, the Company&#8217;s effective tax rate differed from the US federal statutory tax rate primarily due to earnings taxed at the lower income tax rate in Cyprus. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">We regularly review deferred tax assets to assess their potential realization and establish a valuation allowance for portions of such assets to reduce the carrying value if we do not consider it to be more likely than not that the deferred tax assets will be realized. Our review includes evaluating both positive (e.g., sources of taxable income) and negative (e.g., recent historical losses) evidence that could impact the realizability of our deferred tax assets. At September 30, 2017, the Company has a maintained a valuation allowance against all net deferred tax assets in each jurisdiction in which it is subject to income tax. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">As of September 30, 2017 the Company has no uncertain tax positions recorded in any jurisdiction where it is subject to income tax. The Company has recorded $63,724 of interest and penalties as interest expense for the nine months ended September 30, 2017 in accordance with this policy. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b>NOTE 6 &#8211; CAPITAL STRUCTURE</b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><i>Preferred Stock</i></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">The Company is authorized to issue 100 million shares of preferred stock, which have liquidation preference over the common stock and are non-voting. As of September 30, 2017 and December 31, 2016, no preferred shares have been issued.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><i>Common Stock</i></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">The Company is authorized to issue 300 million shares of common stock and had issued 100,000,000 in connection with the merger with Amplerissimo and had 25,585,532 shares issued prior to the merger. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Under the Exchange Agreement, the Registrant completed the acquisition of all of the issued and outstanding shares of Amplerissimo through the issuance of 100,000,000 restricted shares of Common Stock to Dimitrios Goulielmos, the sole shareholder of Amplerissimo. Immediately prior to the Exchange Agreement transaction, the Registrant had 25,585,532 shares of Common Stock issued and outstanding. Immediately after the issuance of the shares the Registrant had 125,585,532 shares of Common Stock issued and outstanding.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">The consideration provided pursuant to the Exchange Agreement was the issuance of 100,000,000 shares of our common stock.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On February 10, 2017 the Company and Decahedron consummated the acquisition of Decahedron SPA. Pursuant to the terms of the Decahedron SPA, the shareholders of Decahedron received an aggregate of 1,700,000 shares of common stock of the Company, which were delivered at closing in exchange for all of the Ordinary Shares of Decahedron for the Stock Consideration.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><u>Shares Issued for Services</u></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On March 1, 2017, the Company entered into a four-month consulting agreement with a third party investment advisory firm for consideration of 5,000 restricted shares of common stock to be issued during the period of the agreement for any introductions and related contributions the Company receives as a result of those introductions. As of September 30, 2017, no consideration has been earned and no shares have been issued related to this agreement.</p> <p style="MARGIN: 0px" align="justify">&nbsp; <table id="pagebreak26007d46-8277-4ccc-a067-5d6b48d94a56" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">14</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b>COSMOS HOLDINGS, INC.</b></p> <p style="MARGIN: 0px" align="center"><b>Notes to Unaudited Consolidated Financial Statements</b></p> <p style="MARGIN: 0px" align="center"><b>September 30, 2017</b></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px">On May 1, 2017, the Company entered into an 8-month consulting agreement with a third party for web design services commencing on May 1, 2017 and terminating on January 1, 2018. As compensation for creating, delivering and maintaining a website, the Company issued 20,000 shares of common stock on May 24, 2017. The shares were valued at $14,400, which was fully recognized in the nine months ended September 30, 2017.</p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px">On May 1, 2017, the Company entered into a five-month consulting agreement with a third party advisory firm for consideration of 20,000 shares of the Company&#8217;s common stock. The stock was issued on May 25, 2017 and fair valued at $0.72 per share or $14,400, which was fully recognized in the nine months ended September 30, 2017.</p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px">On May 8, 2017, the Company entered into a one-year consulting agreement for advisory services with a third party investment relations firm. On May 18, 2017, the Company issued to the consultant 300,000 shares of the Company&#8217;s common stock valued at $219,000. The shares are considered to be a fully earned, nonrefundable, non-apportionable and non-ratable retainer as consideration for undertaking the agreement. In addition, the Company will pay the consultant $5,000 per month in cash for the term of the agreement. </p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px">On May 25, 2017, the Company entered into a 20-month consulting agreement with a third party advisory firm for consideration of 200,000 shares of the Company&#8217;s common stock. The stock was issued on May 25, 2017 and fair valued at $0.77 per share or $154,000, which will be amortized over the length of the agreement. For the nine months ending September 30, 2017, the Company has recorded $32,874 in consulting expense related to this agreement.</p> <p style="MARGIN: 0px 0px 0px 0.35pt">&nbsp;</p> <p style="MARGIN: 0px">As of September 30, 2017 and December 31, 2016, the Company had 128,253,932 and 125,870,532 shares of Common Stock issued and outstanding, respectively.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><i>Potentially Dilutive Securities</i></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On October 1, 2016 the Company granted 120,000 options to an employee of the Company as compensation for being appointed the US Finance Manager of the Company. The options have an exercise period of four years with an exercise price of $0.20. In the event that he ceases to work for the Company for any reason, he will be entitled to a pro rata portion of the annual options. The options vest monthly with 120,000 options fully vested as of September 30, 2017. (See Note 10)</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On January 1, 2017 the Company granted 250,000 options to an employee of the Company as compensation for being appointed the International Finance Manager of the Company. The options have an exercise period of four years with an exercise price of $0.10 per share. In the event that he ceases to work for the Company for any reason, he will be entitled to a pro rata portion of the annual options. The options vest monthly with 187,500 options fully vested as of September 30, 2017. (See Note 10)</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On January 3, 2017 the Company granted 120,000 options to an employee of the Company as compensation for being appointed as a consultant of the Company. The options have an exercise period of five years with an exercise price of $0.20 per share. In the event that he ceases to work for the Company for any reason, he will be entitled to a pro rata portion of the annual options. The options vest monthly with 90,000 options fully vested as of September 30, 2017. (See Note 10)</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><i>Sales Pursuant to Regulation S</i></p> <p style="MARGIN: 0px 0px 0px 0.7pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.7pt" align="justify">On April 7, 2017, the Company issued shares of common stock and warrants pursuant to a private placement conducted under the exemptions from registration under Regulation S. Each unit sold to investors consists of $35,000 face value purchase price of 50,000 shares plus warrants to purchase the number of equivalent shares. The Company retains the right to accept less than the $35,000 face value from any investor at its discretion.</p> <p style="MARGIN: 0px 0px 0px 0.7pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.7pt" align="justify">The Company has entered into the following subscription agreements: </p> <p style="MARGIN: 0px 0px 0px 0.7pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.7pt" align="justify">On April 10, 2017, the Company sold 45,800 shares at $0.70 per share for a total purchase price of $32,060 to a private investor. The investor also received 45,800 warrants that were valued using the Black Scholes valuation model to have a fair value of $2,375 (See Note 10). </p> <p style="MARGIN: 0px 0px 0px 0.7pt" align="justify">&nbsp; <table id="pagebreak09be214f-516b-4524-884e-12b655ef40ad" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">15</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b>COSMOS HOLDINGS, INC.</b></p> <p style="MARGIN: 0px" align="center"><b>Notes to Unaudited Consolidated Financial Statements</b></p> <p style="MARGIN: 0px" align="center"><b>September 30, 2017</b></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.7pt" align="justify">On April 26, 2017, the Company sold 46,700 shares at $0.70 per share for a total purchase price of $32,690 to a private investor. The investor also received 46,700 warrants that were valued using the Black Scholes valuation model to have a fair value of $1,521 (See Note 10). </p> <p style="MARGIN: 0px 0px 0px 0.7pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.7pt" align="justify">On May 16, 2017, the Company sold 7,900 shares at $0.70 per share for a total purchase price of $5,530 to a private investor. The investor also received 7,900 warrants that were valued using the Black Scholes valuation model to have a fair value of $130 (See Note 10).</p> <p style="MARGIN: 0px 0px 0px 0.7pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.7pt" align="justify">On July 21, 2017, the Company sold 43,000 shares at $0.50 per share for a total purchase price of $21,500 to a private investor. The Company did not grant any warrants to the investor under this agreement.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">No options, warrants or other potentially dilutive securities other than those disclosed above have been issued as of September 30, 2017 and December 31, 2016.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b>NOTE 7 &#8211; RELATED PARTY TRANSACTIONS</b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On the date of our inception, we issued 20 million shares of our common stock to our three officers and directors which were recorded at no value (offsetting increases and decreases in Common Stock and Additional Paid in Capital).</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><i>DOC Pharma S.A.</i></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">As of September 30, 2017, the Company has a prepaid balance of &#8364;347,914 ($410,991) to DOC Pharma S.A., this comprises over 10.3% of the Company&#8217;s total prepaid balance. As of December 31, 2016, the Company owed &#8364;65 ($69) to DOC Pharma S.A.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On November 1, 2015, the Company entered into a &#8364;12,000 ($12,662) Loan Agreement with DOC Pharma S.A, pursuant to which DOC Pharma S.A., paid existing bills of the Company in the amount of &#8364;12,000, excluding the Vendor Bills. The loan bears an interest rate of 2% per annum and was due and payable in full on October 31, 2016. As of September 30, 2017, the Company has an outstanding principal balance under this note of &#8364;12,000 ($14,176) and accrued interest expense of $612. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><i>Grigorios Siokas</i></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On October 1, 2016, the Company borrowed &#8364;5,000 ($5,276) from Mr. Siokas related to its subsidiary&#8217;s purchase of additional capital of SkyPharm. The loan is non-interest bearing and has a maturity date of October 1, 2017. During the nine months ending September 30, 2017, the Company borrowed an additional &#8364;1,000 ($1,181). The outstanding balance as of September 30, 2017 was &#8364;6,000 ($7,088).</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">During the year ended December 31, 2016, the Company borrowed &#8364;90,500 ($95,496) as additional loans payable from Mr. Siokas. During the nine months ended September 30, 2017, the Company borrowed an additional &#8364;473,621 ($559,488) and paid back &#8364;123,000 ($145,300) of these loans. These loans have no formal agreements and bear no interest. As 1of September 30, 2017, the Company has an outstanding principal balance under these loans of &#8364;441,121 ($521,096).</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">As of September 30, 2017, the Company has recorded &#8364;59,646 ($70,459) in prepayments to Mr. Siokas for board of directors fees.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><i>Ourania Matsouki</i></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">During the year ended December 31, 2016, the Company borrowed &#8364;44,995 ($47,479) from Mrs. Matsouki. During the nine months ended September 30, 2017, the Company borrowed an additional &#8364;55,000 ($64,982) and paid back &#8364;73,437 ($86,751). These loans have no formal agreement and bear no interest. As of September 30, 2017, the Company has an outstanding principal balance under these loans of &#8364;26,558 ($31,373).</p> <p style="MARGIN: 0px" align="justify">&nbsp; <table id="pagebreak710e6564-d14b-42d5-93a2-1448c70b67d5" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">16</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b>COSMOS HOLDINGS, INC.</b></p> <p style="MARGIN: 0px" align="center"><b>Notes to Unaudited Consolidated Financial Statements</b></p> <p style="MARGIN: 0px" align="center"><b>September 30, 2017</b></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><i>Konstantinos Vassilopoulos</i></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">During the year ended December 31, 2016, Konstantinos Vassilopoulos, US Finance Manager, paid $10,179 of existing bills of the Company. During the nine months ended September 30, 2017, the Company paid back $9,810. There is no formal agreement related to these transactions. As of September 30, 2017 the outstanding balance under this loan is $369.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><i>Dimitrios Goulielmos</i></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On November 21, 2014, SkyPharm entered into a Loan Agreement with Dimitrios Goulielmos, former Chief Executive Officer and a current director of the Company, pursuant to which the Borrower borrowed &#8364;330,000 ($401,115) from Mr. Goulielmos. The Loan bears an interest rate of 2% per annum and was due and payable in full on May 11, 2015. On November 4, 2015, &#8364;130,000 ($142,860) in principal and the related accrued interest of &#8364;733 ($806) was forgiven and the remaining balance of &#8364;200,000 will no longer accrue interest as part of the stock purchase agreement with Grigorios Siokas on November 4, 2015 referenced above. As of December 31, 2016, &#8364;60,000 ($63,312) of the loan was paid back. During the nine months ended September 30, 2017 an additional &#8364;53,500 ($63,200) was paid back and a principal balance of &#8364;86,500 ($102,182) and &#8364;0.00 of accrued interest remains. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">In connection with the Decahedron SPA, on February 9, 2017, Decahedron, Medihelm S.A. and Nikolaos Lazarou entered into a liability transfer agreement whereby the loan previously provided Decahedron to the Mr. Lazarou prior to the acquisition would be cancelled in exchange for Mr. Lazarou&#8217;s personal assumption of approximately &#163;172,310 ($220,988) owed to MediHelm S.A., a creditor of Decahedron.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Except as set forth above, we have not entered into any material transactions with any director, executive officer, and promoter, beneficial owner of five percent or more of our common stock, or family members of such persons.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b>NOTE 8 &#8211; DEBT</b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On March 4, 2015, the Company entered into a $9,000 Loan Agreement with Mr. Angelo Drakopoulos, pursuant to which Mr. Drakopoulos paid a $9,000 outstanding bill on behalf of the Company. The loan bears an interest rate of 8% per annum and was due and payable in full on May 5, 2016. As of September 30, 2017, the Company has an outstanding principal balance under this note of $9,000 and accrued interest expense of $1,345. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">On November 5, 2015, the Company entered into a Loan Agreement pursuant to which the Company borrowed &#8364;20,000 ($21,812), of which proceeds of &#8364;10,000 ($10,906) have been received as of December 31 2016. The loan bears an interest rate of 1% per annum and was due and payable in full on November 5, 2016. The Company repaid &#8364;2,000 ($2,110) as of December 31, 2016. The Company has repaid an additional &#8364;8,000 ($9,450) as of September 30, 2017. The Company has accrued interest expense of &#8364;435 ($514) and an outstanding balance under this note of &#8364;10,000 ($11,813) as of September 30, 2017.</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">On November 5, 2015, the Company entered into a Loan Agreement pursuant to which the Company borrowed &#8364;80,000 ($87,248) of which proceeds of &#8364;70,000 ($76,342) have been received as of December 31, 2016. The loan bears an interest rate of 5% per annum and was due and payable in full on November 5, 2016. As of December 31, 2016, the outstanding balance was &#8364;65,000 ($68,588). During the nine months ended September 30, 2017, the Company repaid &#8364;55,000 ($64,972) and reversed the &#8364;10,000 ($11,813) receivable that was never received. </p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On November 16, 2015, the Company entered into a Loan Agreement with Panagiotis Drakopoulos, former Director and former Chief Executive Officer, pursuant to which the Company borrowed &#8364;40,000 ($43,624) as a note payable from Mr. Drakopoulos. The note bears an interest rate of 6% per annum and was due and payable in full on November 15, 2016. The Company repaid &#8364;10,000 ($11,813) during the nine months ended September 30, 2017. As of September 30, 2017, the Company has an outstanding principal balance under this note of &#8364;30,000 ($35,439) and accrued interest expense of &#8364;4,064 ($4,801). </p> <p style="MARGIN: 0px" align="justify">&nbsp; <table id="pagebreakb050cc1c-26f5-411d-965f-3ee0391c31d3" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">17</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b>COSMOS HOLDINGS, INC.</b></p> <p style="MARGIN: 0px" align="center"><b>Notes to Unaudited Consolidated Financial Statements</b></p> <p style="MARGIN: 0px" align="center"><b>September 30, 2017</b></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="justify">During the year ended December 31, 2015, the Company borrowed &#8364;30,000 ($32,718) as a loan payable from Mr. Panagiotis Drakopoulos, former Director and former Chief Executive Officer. The loan had no formal agreement and bore no interest. During the year ended December 31, 2016, the Company repaid &#8364;13,000 ($13,718) of the loan. During the nine months ended September 30, 2016 the Company repaid the remaining &#8364;17,000 ($20,082). As of September 30, 2017, the loan has no outstanding balance. </p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">On February 5, 2016, the Company entered into a Loan Agreement pursuant to which the Company borrowed &#8364;20,000 ($21,104). The loan bore an interest rate of 6% and had no maturity date. During the nine months ended September 30, 2017, the Company repaid the loan and accrued interest of &#8364;1,020 ($1,204) in full. </p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">On March 4, 2016, the Company entered into a Loan Agreement pursuant to which the Company borrowed &#8364;50,000 ($52,760) from a third party. On May 04, 2016, the Company entered into a Loan Agreement pursuant to which the Company borrowed an additional &#8364;50,000 ($52,760). The loans bore an interest rate of 6% and a maturity date of March 4, 2017 and May 4, 2017, respectively. During the nine months ended September 30, 2017, the Company repaid both loans and accrued interest of &#8364;750 ($886) in full. </p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">On April 19, 2016, the Company entered into a Loan Agreement pursuant to which the Company borrowed &#8364;100,000 ($105,520). The loan bore an interest rate of 6% and matured on April 19, 2017. During the nine months ended September 30, 2017, the Company repaid the loan and accrued interest of &#8364;3,100 ($3,662) in full. </p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">On April 22, 2016, the Company entered into a Loan Agreement pursuant to which the Company borrowed &#8364;38,000 ($40,098). The loan bore an interest rate of 6% and matured on April 22, 2017. During the nine months ended September 30, 2017, the Company repaid the loan and accrued interest of &#8364;1,777 ($2,099) in full. </p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">On May 24, 2016, the Company entered into a Loan Agreement pursuant to which the Company borrowed &#8364;50,000 ($52,760). The loan bears an interest rate of 6% and matured on May 24, 2017. During the nine months ended September 30, 2017, the Company repaid the principal balance of &#8364;50,000 ($59,065) in full. The Company has accrued interest expense of &#8364;2,798 ($3,305) as of September 30, 2017. </p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">On October 18, 2016, the Company entered into a Loan Agreement pursuant to which the Company borrowed &#8364;10,000 ($10,552). The loan bears an interest rate of 10% and will mature on October 18, 2017. During the nine months ended September 30, 2017, the Company repaid the principal balance of &#8364;10,000 ($11,813) in full. The Company has accrued interest expense of &#8364;239 ($283) as of September 30, 2017.</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><u>Loan Facility Agreement</u></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On August 4, 2016, the Company&#8217;s wholly owned subsidiary SkyPharm entered into a Loan Facility Agreement, guaranteed by Grigorios Siokas, with Synthesis Peer-To Peer-Income Fund (the &#8220;Loan Facility&#8221; the &#8220;Lender&#8221;). The Loan Facility initially provided SkyPharm with a credit facility of up to $1,292,769 (&#8364;1,225,141). Any advance under the Loan Facility accrues interest at a rate of 10% per annum and requires quarterly interest payments commencing on September 30, 2016. The amounts owed under the Loan Facility shall be repayable upon the earlier of (i) three months following the demand of the Lender; or (ii) August 31, 2018. No prepayment is permitted pursuant to the terms of the Loan Facility. The Synthesis Facility Agreement as amended is secured by a personal guaranty of Grigorios Siokas, which is secured by a pledge of 10,000,000 shares of common stock of the Company owned by Mr. Siokas. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On September 13, 2016, Sky Pharm entered into a First Deed of Amendment with the Loan Facility increasing the maximum loan amount to $1,533,020 as a result of the Lender having advanced $240,251 (&#8364;227,629) to SkyPharm. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On March 23, 2017, SkyPharm entered into an Amended and Restated Loan Facility Agreement (the &#8220;A&amp;R Loan Facility&#8221;), with the Loan Facility which increased the loan amount to an aggregate total of $2,664,960 (&#8364;2,491,083) as a result of the lender having advanced $174,000 (&#8364;164,898) in September 2016, $100,000 (&#8364;94,769)&nbsp;in October 2016, $250,000 (&#8364;236,922) in November 2016, $452,471 (&#8364;428,800) in December 2016, $155,516 (&#8364;131,648) in January 2017 and $342,327 (&#8364;289,788) in July 2017. The A&amp;R Loan Facility amends and restates certain provisions of the Loan Facility Agreement, dated as of August 4, 2016, by and among the same parties. Advances under the A&amp;R Loan Facility continue to accrue interest at a rate of 10% per annum from the applicable date of each drawdown and require quarterly interest payments. The A&amp;R Facility now permits prepayments at any time. The amounts owed under the A&amp;R Loan Facility shall be repayable upon the earlier of (i) seventy five days following the demand of the Lender; or (ii) August 31, 2018. The A&amp;R Loan Facility is secured by a personal guaranty of Grigorios Siokas, which is secured by a pledge of 10,000,000 shares of common stock of the Company owned by Mr. Siokas (the &#8220;Pledged Shares&#8221;). The A&amp;R Loan Facility was also amended to provide additional affirmative and negative covenants of Sky Pharm and the Guarantor during the term of loans remain outstanding, including, but not limited to, the consent of the Lender in connection with (i) the Company or any of its subsidiaries incurring any additional indebtedness; or (ii) in the event of any increase in the Company&#8217;s issued and outstanding shares of Common Stock, the Pledged Shares shall be increased to an amount equal to a minimum of ten percent (10%) of the issued and outstanding shares of the Company.</p> <p style="MARGIN: 0px" align="justify">&nbsp; <table id="pagebreak1f2e9f55-da6e-40a5-80cf-604adc62c750" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">18</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b>COSMOS HOLDINGS, INC.</b></p> <p style="MARGIN: 0px" align="center"><b>Notes to Unaudited Consolidated Financial Statements</b></p> <p style="MARGIN: 0px" align="center"><b>September 30, 2017</b></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="justify">As of September 30, 2017, the outstanding balance under this note was $3,007,287 (&#8364;2,545,744) and accrued interest expense of $143,761 (&#8364;121,697) has been recorded.&nbsp;</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">The Company recorded &#8364;120,000 ($141,756) in debt discounts related to this note. The debt discounts are being amortized over the term of the debt. During the year ended December 31, 2016 the Company amortized a total of $14,507 (&#8364;13,748). Amortization of the debt discounts for the nine months ended September 30, 2017 was $52,796 (&#8364;47,368).</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><u>Bridge Loans</u></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.7pt" align="justify">On March 16, 2017 and March 20, 2017, SkyPharm entered into loan agreements with the Synthesis Peer-To Peer-Income Fund (the &#8220;Bridge Loans&#8221;). The Bridge Loans provided to SkyPharm loans of &#8364;42,326 ($50,000) and &#8364;100,000 ($118,130), respectively. The Bridge Loans accrue interest at a rate of 10% per annum and were repayable on April 16, 2017 and April 20, 2017, respectively together with all other amounts then accrued and unpaid. On April 16, 2017, the maturity dates were amended for no additional consideration of change in terms and conditions. The maturity dates of both loans were amended and they matured on May 16, 2017 and May 20, 2017, respectively. The Company has accrued interest expense of an aggregate total of &#8364;7,335 ($8,665) for both loans and the outstanding balances of these loans was &#8364;42,326 ($50,000) and &#8364;100,000 ($118,130), respectively, as of September 30, 2017.</p> <p style="MARGIN: 0px 0px 0px 0.7pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.7pt" align="justify">On May 5, 2017, SkyPharm entered into a loan agreement with Synthesis Peer-To-Peer Income Fund for &#8364;30,449 ($34,745). The loan accrues interest at a rate of 10% per annum and matures on September 30, 2017. The Company as accrued interest expense of &#8364;1,201 ($1,418) and the outstanding balance on this loan was &#8364;29,413 ($34,745) as of September 30, 2017.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><u>Trade Facility Agreements</u></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On April 10, 2017, Decahedron entered into a Trade Finance Facility Agreement (the &#8220;Decahedron Facility&#8221;) with Synthesis Structured Commodity Trade Finance Limited (the &#8220;Lender&#8221;). The Decahedron Facility provides the following material terms:</p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px"> <table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr height="15"> <td> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td> <p style="MARGIN: 0px" align="justify"><font face="Symbol">&#183;</font></p></td> <td valign="top" colspan="2"> <p style="MARGIN: 0px" align="justify">The Lender will provide Decahedron a facility of up to &#8364;2,750,000 ($2,941,950) secured against Decahedron&#8217;s receivables from the sale of branded and generic pharmaceutical sales.</p></td></tr> <tr height="15"> <td></td> <td></td> <td colspan="2"></td></tr> <tr height="15"> <td> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td> <p style="MARGIN: 0px" align="justify"><font face="Symbol">&#183;</font></p></td> <td valign="top" colspan="2"> <p style="MARGIN: 0px" align="justify">The total facility will be calculated as 95% of the agreed upon value of Decahedron&#8217;s receivables.</p></td></tr> <tr height="15"> <td></td> <td></td> <td colspan="2"></td></tr> <tr height="15"> <td> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td valign="top"> <p style="MARGIN: 0px" align="justify"><font face="Symbol">&#183;</font></p></td> <td colspan="2"> <p style="MARGIN: 0px" align="justify">The term of the Decahedron Facility will be for 12 months.</p></td></tr> <tr height="15"> <td></td> <td></td> <td colspan="2"></td></tr> <tr height="15"> <td> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td valign="top"> <p style="MARGIN: 0px" align="justify"><font face="Symbol">&#183;</font></p></td> <td colspan="2"> <p style="MARGIN: 0px" align="justify">The obligations of Decahedron are guaranteed by the Company pursuant to a Cross Guarantee and Indemnity Agreement.</p></td></tr> <tr height="15"> <td></td> <td></td> <td colspan="2"></td></tr> <tr height="15"> <td> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td valign="top"> <p style="MARGIN: 0px" align="justify"><font face="Symbol">&#183;</font></p></td> <td colspan="2"> <p style="MARGIN: 0px" align="justify">The Lender has the right to make payments directly to Decahedron&#8217;s suppliers.</p></td></tr> <tr height="15"> <td></td> <td></td> <td colspan="2"></td></tr> <tr height="15"> <td> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td valign="top"> <p style="MARGIN: 0px" align="justify"><font face="Symbol">&#183;</font></p></td> <td colspan="2"> <p style="MARGIN: 0px" align="justify">The following fees should be paid in connection with the Decahedron Facility:</p></td></tr> <tr height="15"> <td></td> <td></td> <td colspan="2"></td></tr> <tr height="15"> <td width="4%"></td> <td width="4%"> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td width="4%"> <p style="MARGIN: 0px" align="justify">o</p></td> <td> <p style="MARGIN: 0px" align="justify">2% of the maximum principal amount as an origination fee.</p></td></tr> <tr height="15"> <td></td> <td></td> <td></td> <td></td></tr> <tr height="15"> <td></td> <td> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td> <p style="MARGIN: 0px" align="justify">o</p></td> <td> <p style="MARGIN: 0px" align="justify">A one percent (1%) monthly fee.</p></td></tr></table></p> <p style="MARGIN: 0px" align="justify">&nbsp; <table id="pagebreak581c494f-74d4-4728-89cc-a9a9419fd51b" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">19</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b>COSMOS HOLDINGS, INC.</b></p> <p style="MARGIN: 0px" align="center"><b>Notes to Unaudited Consolidated Financial Statements</b></p> <p style="MARGIN: 0px" align="center"><b>September 30, 2017</b></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="justify">The current draw on the Decahedron Facility is $0.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On May 12, 2017, SkyPharm entered into a Trade Finance Facility Agreement (the &#8220;SkyPharm Facility&#8221;) with Synthesis Structured Commodity Trade Finance Limited (the &#8220;Lender&#8221;). The SkyPharm Facility provides the following material terms:</p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px"> <table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr height="15"> <td> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td valign="top"> <p style="MARGIN: 0px" align="justify"><font face="Symbol">&#183;</font></p></td> <td valign="top" colspan="2"> <p style="MARGIN: 0px" align="justify">The Lender will provide SkyPharm a facility of up to &#8364;2,000,000 ($2,282,200) secured against SkyPharm&#8217;s receivables from the sale of branded and generic pharmaceutical sales. In the event that accounts receivable becomes uncollectible, the Company will be obligated to pay back the notes in full.</p></td></tr> <tr height="15"> <td></td> <td></td> <td colspan="2"></td></tr> <tr height="15"> <td> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td> <p style="MARGIN: 0px" align="justify"><font face="Symbol">&#183;</font></p></td> <td valign="top" colspan="2"> <p style="MARGIN: 0px" align="justify">The total facility will be calculated as 95% of the agreed upon value of Decahedron&#8217;s receivables.</p></td></tr> <tr height="15"> <td></td> <td></td> <td colspan="2"></td></tr> <tr height="15"> <td> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td valign="top"> <p style="MARGIN: 0px" align="justify"><font face="Symbol">&#183;</font></p></td> <td colspan="2"> <p style="MARGIN: 0px" align="justify">The term of the SkyPharm Facility will be for 12 months.</p></td></tr> <tr height="15"> <td></td> <td></td> <td colspan="2"></td></tr> <tr height="15"> <td> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td valign="top"> <p style="MARGIN: 0px" align="justify"><font face="Symbol">&#183;</font></p></td> <td colspan="2"> <p style="MARGIN: 0px" align="justify">The obligations of SkyPharm are guaranteed by the Company pursuant to a Cross Guarantee and Indemnity Agreement.</p></td></tr> <tr height="15"> <td></td> <td></td> <td colspan="2"></td></tr> <tr height="15"> <td> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td valign="top"> <p style="MARGIN: 0px" align="justify"><font face="Symbol">&#183;</font></p></td> <td colspan="2"> <p style="MARGIN: 0px" align="justify">The Lender has the right to make payments directly to SkyPharm&#8217;s suppliers.</p></td></tr> <tr height="15"> <td></td> <td></td> <td colspan="2"></td></tr> <tr height="15"> <td> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td valign="top"> <p style="MARGIN: 0px" align="justify"><font face="Symbol">&#183;</font></p></td> <td colspan="2"> <p style="MARGIN: 0px" align="justify">The following fees should be paid in connection with the SkyPharm Facility:</p></td></tr> <tr height="15"> <td></td> <td></td> <td colspan="2"></td></tr> <tr height="15"> <td width="4%"></td> <td width="4%"> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td width="4%"> <p style="MARGIN: 0px" align="justify">o</p></td> <td> <p style="MARGIN: 0px" align="justify">2% of the maximum principal amount as an origination fee.</p></td></tr> <tr height="15"> <td></td> <td></td> <td></td> <td></td></tr> <tr height="15"> <td></td> <td> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td> <p style="MARGIN: 0px" align="justify">o</p></td> <td> <p style="MARGIN: 0px" align="justify">A one percent (1%) monthly fee.</p></td></tr></table></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">The current draw on the SkyPharm Facility is &#8364;5,216,910 ($6,162,736) and the Company has accrued &#8364;170,711 ($201,661) in monthly fees related to this agreement. The Company obtained consents from Synthesis Peer-to-Peer Income Fund in connection with obtaining the Lender. On November 16, 2017, the Company&nbsp;signed an amendment to the agreement for the additional proceeds borrowed. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">The Company has recorded a total debt discount of &#8364;104,338 in origination fees associated with these loans, which will be amortized over the term of the agreements. Amortization of debt discount for the nine months ended September 30, 2017 was &#8364;31,295 ($34,881). </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">None of the above loans were made by any related parties.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b>NOTE 9 &#8211; COMMITMENTS AND CONTINGENCIES</b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b>Legal Matters</b></p> <p style="MARGIN: 0px; TEXT-INDENT: 0.5in" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">From time to time, the Company may be involved in litigation relating to claims arising out of the Company&#8217;s operations in the normal course of business. As of September 30, 2017, there were no pending or threatened lawsuits that could reasonably be expected to have a material effect on the results of the Company&#8217;s operations.&nbsp;</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><b>Operating Leases</b></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">The Company conducts its operations from an office located in Chicago, Illinois for which beginning in January 2015, the monthly rent expense is $730, which has been paid through December 31, 2015. The lease expired as of November 30, 2015, however, the Company has negotiated and entered into a new lease that commenced as of September 1, 2016 at a rate of $709 per month. Rent expense for the three and nine months ended September 30, 2017 was $2,126 and $6,377, respectively. Rent expense for the three and nine months ended September 30, 2016, was $2,126 and $2,834, respectively. </p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp; <table id="pagebreak51ebd5b4-1814-4cdd-883b-e02e2412b95c" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">20</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b>COSMOS HOLDINGS, INC.</b></p> <p style="MARGIN: 0px" align="center"><b>Notes to Unaudited Consolidated Financial Statements</b></p> <p style="MARGIN: 0px" align="center"><b>September 30, 2017</b></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.7pt" align="justify">The offices of Amplerissimo are located in Cyprus for which we paid approximately &#8364;110 ($122) per month on a month to month basis. Rent expense for the three and nine months ended September 30, 2017 was &#8364;330 ($368) and &#8364;990 ($1,103), respectively. Rent expense for the three and nine months ended September 30, 2016 was &#8364;330 ($368) and &#8364;990 ($1,105), respectively.</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">The offices of SkyPharm are located in Greece, Thessaloniki, for which we paid approximately &#8364;4,325 ($4,802) per month under a six year lease that commenced September 2014. In December 2015, the lease was revised to include an additional rental of the first floor at a rate of &#8364;800 ($886) per month. The lease was further revised in March 2016 to include another additional rental of the first floor at a rate of &#8364;800 ($886) per month beginning in May 2016. On May 30, 2016, the lease was revised again to include an additional rental of space at a rate of &#8364;1,825 ($2,021) per month beginning in June 2016. On March 23, 2017, SkyPharm entered into an additional three year lease at a rate of &#8364;1,250 per month that commenced May 2017. Rent expense for the three and nine months ended September 30, 2017 was &#8364;27,000 ($30,094) and &#8364;76,000 ($84,710), respectively. Rent expense for the three and nine months ended September 30, 2016 was &#8364;23,250 ($25,961) and &#8364;57,425 ($64,127), respectively. </p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">The offices of Decahedron are located in Flex Meadow, Harlow, for which we pay approximately &#8356;1,908 ($2,415) per month, under a one year amendment to a lease dated October 25, 2011, which commenced on October 25, 2016. Rent expense from the date of acquisition through September 30, 2017 was &#8356;15,267 ($19,580). </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b>Intellectual Property Sale Agreement</b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On October 1, 2016, the Company entered into an Intellectual Property Sale Agreement with Anastasios Tsekas and Olga Parthenea Georgatsou (the &#8220;IPSA&#8221;) for the purchase of certain intellectual property rights relating to proprietary pharmaceutical formulas and any related technical information arising or related thereto (the &#8220;Intellectual Property&#8221;). The IPSA provides that the sellers shall be entitled to an aggregate of 2,000,000 shares of common stock of the Company, none of which have been issued to date, and issuable as follows in equal parts to each seller:</p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px"> <table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr height="15"> <td width="4%"></td> <td valign="top" width="4%"> <p style="MARGIN: 0px" align="justify"><font face="Symbol">&#183;</font></p></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">500,000 shares upon the successful conclusion of Preclinical Trials.</p></td></tr> <tr height="15"> <td></td> <td></td> <td></td></tr> <tr height="15"> <td></td> <td valign="top"> <p style="MARGIN: 0px" align="justify"><font face="Symbol">&#183;</font></p></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">500,000 shares upon the conclusion of Phase I testing.</p></td></tr> <tr height="15"> <td></td> <td></td> <td></td></tr> <tr height="15"> <td></td> <td valign="top"> <p style="MARGIN: 0px" align="justify"><font face="Symbol">&#183;</font></p></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">500,000 shares upon the conclusion of Phase II testing.</p></td></tr> <tr height="15"> <td></td> <td></td> <td></td></tr> <tr height="15"> <td></td> <td valign="top"> <p style="MARGIN: 0px" align="justify"><font face="Symbol">&#183;</font></p></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">500,000 shares upon the conclusion of Phase III testing.</p></td></tr></table></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">The Company has agreed to pay Anastasios Tsekas &#8364;1,500 per month until the first issuance of the shares referenced above. The Company has also agreed that in the event the Company disposes of the Intellectual Property prior to the periods referenced above, the sellers shall be entitled to the issuance of all the shares referenced above. The Company is in the process of locating a suitable lab to conduct the Preclincal trial phase, which has not yet begun as of the date of filing.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b>Letter of Intent</b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On June 21, 2017, the Company signed a new Letter of Intent (LOI) to acquire the outstanding shares of CC Pharma GmbH, a leading re-importer of EU pharmaceuticals to Germany. Under the terms of the LOI, Cosmos Holdings holds the exclusive right to complete its due diligence process and complete the transaction by October 31, 2017. In connection with the non-binding LOI, the Company is required to pay a non-refundable fee of &#8364;400,000 ($454,800) to the shareholders of CC Pharma GmbH in connection with the costs of due diligence and the exclusive right to negotiate the terms of the definitive agreements. On July 6, 2017, the Company paid the &#8364;400,000 ($454,800) to CC Pharma GmbH and the Company has recorded an expense of &#8364;400,000 ($454,800) for the nine months ended September 30, 2017. The Company did not enter into any definitive agreements by October 31, 2017 and is currently negotiating with CC Pharma for an extension. The Company makes no assurances that the parties will enter into any definitive agreements in the future. </p> <p style="MARGIN: 0px" align="justify">&nbsp; <table id="pagebreak51c61df5-5cae-421f-96e4-3171c322af85" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">21</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b>COSMOS HOLDINGS, INC.</b></p> <p style="MARGIN: 0px" align="center"><b>Notes to Unaudited Consolidated Financial Statements</b></p> <p style="MARGIN: 0px" align="center"><b>September 30, 2017</b></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 1.05pt" align="justify"><b>Placement Agreement</b></p> <p style="MARGIN: 0px 0px 0px 1.05pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 1.05pt" align="justify">On August 8, 2017, the Company entered into an agreement with a third party placement agent (the &#8220;Agent&#8221;) who will serve as the Company&#8217;s exclusive placement agent or sole book running manager with respect to any offerings of equity or equity-linked securities as well as any debt offering with the two organizations named in the agreement (the &#8220;Offering&#8221;) for a period of 120 days. In the event that an Offering is agreed upon by the Agent and the Company, the Company shall provide payment as follows: (1) a cash commission of 6% of the total gross proceeds for two named investors (2) a cash commission of 4% of total gross proceeds from five named investors and (3) excluding the five named investors in &#8220;(2)&#8221; a cash commission equal to 8% of the total gross proceeds from the Offering and the issuance to the Agent or its designees of warrants covering 8% of the shares of common stock issued or issuable by the Company in the Offering. Additionally, the Agent will receive a cash fee of 8% payable within 5 business days, but only in the event of, the receipt by the Company of any cash proceeds from the exercise of any warrants with an expiration equal to or less than 24 months sold in the Offering.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b>NOTE 10&nbsp;&#8211; STOCK OPTIONS AND WARRANTS</b></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On October 1, 2016 the Company granted 120,000 options to an employee of the Company as compensation for being appointed the US Finance Manager of the Company. The options have an exercise period of four years with an exercise price of $.20 per share. In the event that he ceases to work for the Company for any reason, he will be entitled to a pro rata portion of the annual options. The options vest monthly with 120,000 options fully vested as of September 30, 2017. The options were valued at $65,290 using the Black Scholes Option Pricing Model with the following inputs: stock price on measurement date: $0.58; Exercise price: $0.20; Option term: 4 years; Computed volatility: 159%. The Company expensed $16,636 in the year ended December 31, 2016. As of September 30, 2017 the Company has expensed an additional $48,654.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On January 1, 2017 the Company entered into an agreement whereby the employee was granted compensation of &#8364;1,000 per month and an annual retainer of 250,000 stock options as compensation for being appointed the International Finance Manager of the Company. The options have an exercise period of four years with an exercise price of $0.10. In the event that he ceases to work for the Company for any reason, he will be entitled to a pro rata portion of the annual options. The options vest monthly, with a total of 187,500 options fully vested as of September 30, 2017. The options were valued at $195,307 using the Black Scholes Option Pricing Model with the following inputs: stock price on measurement date: $0.82; Exercise price: $0.10; Option term: 4 years; Computed volatility: 136.76%. The fair value of the options will be amortized over a year with $146,079 expensed during the nine months ended September 30, 2017. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On January 3, 2017 the Company determined to create an advisory board and appointed Mr. Orestes Varvitsiotes as its first member. Mr. Varvitsiotes is a registered broker dealer who is currently engaged with Aegis Capital Corp. In connection therewith, the Company entered into an Advisory Board Member Consulting Agreement, dated as of January 3, 2017 whereby an annual retainer of 120,000 stock options was granted as compensation for services. The options have an exercise period of five years with an exercise price of $0.20. In the event that he ceases to work for the Company for any reason, he will be entitled to a pro rata portion of the annual options. The options vest monthly, with a total of 90,000 options fully vested as of September 30, 2017. The options were valued at $94,830 using the Black Scholes Option Pricing Model, with the following inputs: stock price on measurement date: $0.82; Exercise price: $0.20; Option term: 5 years; Computed volatility: 155.37%. The fair value of the options will be amortized over the year with $70,796 expensed during the nine months ended September 30, 2017.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">A summary of the Company&#8217;s option activity during the nine months ended September 30, 2017 is presented below:</p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: TIMES NEW ROMAN; WIDTH: 100%; TEXT-ALIGN: justify" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>Weighted</b></p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>Weighted</b></p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>Average</b></p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>Average</b></p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>Remaining</b></p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>Aggregate</b></p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>Number of</b></p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>Exercise</b></p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>Contractual</b></p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>Intrinsic</b></p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid" valign="bottom"> <p style="MARGIN: 0px" align="justify"><b>Options</b></p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>Shares</b></p></td> <td style="PADDING-BOTTOM: 1px" valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>Price</b></p></td> <td style="PADDING-BOTTOM: 1px" valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>Term</b></p></td> <td style="PADDING-BOTTOM: 1px" valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>Value</b></p></td> <td style="PADDING-BOTTOM: 1px" valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Balance Outstanding, December 31, 2016</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">120,000</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%">$</td> <td id="ffcell" valign="bottom" width="9%" align="right">0.20</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">3.75</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%">$</td> <td id="ffcell" valign="bottom" width="9%" align="right">74,400</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 15px" align="justify">Granted</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">370,000</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">.13</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">3.58</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">150,800</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 15px" align="justify">Forfeited</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 15px" align="justify">Exercised</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 15px" align="justify">Expired</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" align="right">-</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" align="right">-</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" align="right">-</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" align="right">-</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Balance Outstanding, September 30, 2017</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 3px double" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 3px double" valign="bottom" width="9%" align="right">490,000</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: 3px double" valign="bottom" width="9%" align="right">.15</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 3px double" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 3px double" valign="bottom" width="9%" align="right">3.44</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 3px double" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 3px double" valign="bottom" width="9%" align="right">191,600</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Exercisable, September 30, 2017</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 3px double" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 3px double" valign="bottom" width="9%" align="right">397,500</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: 3px double" valign="bottom" width="9%" align="right">.15</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 3px double" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 3px double" valign="bottom" width="9%" align="right">3.41</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: 3px double" valign="bottom" width="9%" align="right">153,900</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr></table></p> <p style="MARGIN: 0px 0px 0px 0.7pt" align="justify">&nbsp; <table id="pagebreakcac370d9-bfeb-48fb-a3c7-20a0af9dfb6d" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">22</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b>COSMOS HOLDINGS, INC.</b></p> <p style="MARGIN: 0px" align="center"><b>Notes to Unaudited Consolidated Financial Statements</b></p> <p style="MARGIN: 0px" align="center"><b>September 30, 2017</b></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.7pt" align="justify">In connection with a private placement that took place on April 7, 2017, the Company issued warrants at a 1:1 ratio for shares purchased by investors. The warrants were valued using the Black Scholes valuation model. A summary of the Company&#8217;s warrant activity for the nine months ending September 30, 2017 is as follows:</p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: TIMES NEW ROMAN; WIDTH: 100%; TEXT-ALIGN: justify" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px" align="center">&nbsp;<b>September 30,<br>2017</b></p></td> <td style="PADDING-BOTTOM: 1px" valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="bottom"> <p style="MARGIN: 0px" align="justify">Volatility</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td></td> <td id="hdcell" valign="bottom" width="9%" align="center"> <p style="MARGIN: 0px 0px 0px 0in" align="right">76.66%-90.86</p></td> <td valign="bottom"> <p style="MARGIN: 0px">%</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Expected term (in years)</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">1</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Risk-free interest rate</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td></td> <td> <p style="MARGIN: 0px" align="right">1.07% - 1.11</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">% </p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Expected dividend yield</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td></td> <td> <p style="MARGIN: 0px" align="right">None</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: TIMES NEW ROMAN; WIDTH: 100%; TEXT-ALIGN: justify" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>Weighted</b></p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>Weighted</b></p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>Average</b></p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>Average</b></p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>Remaining</b></p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>Aggregate</b></p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>Number of</b></p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>Exercise</b></p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>Contractual</b></p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" valign="bottom" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>Intrinsic</b></p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr> <td style="BORDER-BOTTOM: 1px solid" valign="bottom"> <p style="MARGIN: 0px" align="justify"><b>Warrants</b></p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>Shares</b></p></td> <td style="PADDING-BOTTOM: 1px" valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>Price</b></p></td> <td style="PADDING-BOTTOM: 1px" valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>Term</b></p></td> <td style="PADDING-BOTTOM: 1px" valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="hdcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" colspan="2" align="center"> <p style="MARGIN: 0px" align="center"><b>Value</b></p></td> <td style="PADDING-BOTTOM: 1px" valign="bottom"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Balance Outstanding, December 31, 2016</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%">$</td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%">$</td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 15px" align="justify">Granted</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">100,400</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">3.00</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">1</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 15px" align="justify">Forfeited</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 15px" align="justify">Exercised</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right">-</td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 15px" align="justify">Expired</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" align="right">-</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" align="right">-</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" align="right">-</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" align="right">-</td> <td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Balance Outstanding, September 30, 2017</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 3px double" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 3px double" valign="bottom" width="9%" align="right">100,400</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: 3px double" valign="bottom" width="9%" align="right">3.00</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 3px double" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 3px double" valign="bottom" width="9%" align="right">.55</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: 3px double" valign="bottom" width="9%" align="right">-</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#cceeff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" valign="bottom" width="9%" align="right"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Exercisable, September 30, 2017</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 3px double" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 3px double" valign="bottom" width="9%" align="right">100,400</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: 3px double" valign="bottom" width="9%" align="right">3.00</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 3px double" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td id="ffcell" style="BORDER-BOTTOM: 3px double" valign="bottom" width="9%" align="right">.55</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 3px double" valign="bottom" width="1%">$</td> <td id="ffcell" style="BORDER-BOTTOM: 3px double" valign="bottom" width="9%" align="right">-</td> <td style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"> <p style="MARGIN: 0px">&nbsp;</p></td></tr></table></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b>NOTE 11 &#8211; SUBSEQUENT EVENTS</b></p> <p style="MARGIN: 0px 0px 0px 1.05pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><u>Purchase of Treasury Shares</u></p> <p style="MARGIN: 0px 0px 0px 1.05pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 1.05pt" align="justify">Effective October 2, 2017, the Company entered into to a stock purchase agreement dated September 30, 2017, whereby for consideration of $1,387 the Company purchased 1,386,894 shares of its common stock from a third party investor. The shares were transferred to the Company on October 17, 2017 and will be held in treasury.</p> <p style="MARGIN: 0px 0px 0px 1.4pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 1.4pt" align="justify"><u>Reverse Stock Split</u></p> <p style="MARGIN: 0px 0px 0px 0in" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On October 11, 2017, the Company authorized a one-for-ten (1:10) reverse stock split whereby the Company decreased, by a ratio of one-for-ten (1:10) the number of issued and outstanding shares of Common Stock. The reverse stock split was approved and filed in the state of Nevada, and reported on Form 8-K filed on October 11, 2017; however it had not been approved by FINRA as of the date of filing, and therefore the financial statements are not retroactively restated to reflect the split. The Company anticipates that the reverse split will be effective on November 21, 2017.</p> <p style="MARGIN: 0px 0px 0px 0in" align="justify">&nbsp; <table id="pagebreakd479c432-9ed1-4307-bc96-1f8401113294" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">23</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="center"><b>COSMOS HOLDINGS, INC.</b></p> <p style="MARGIN: 0px" align="center"><b>Notes to Unaudited Consolidated Financial Statements</b></p> <p style="MARGIN: 0px" align="center"><b>September 30, 2017</b></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 1.4pt" align="justify"><u>November 15, 2017 Securities Purchase Agreement</u></p> <p style="MARGIN: 0px 0px 0px 0in" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in" align="justify">On November 15, 2017, the Company entered into a Securities Purchase Agreement (the &#8220;SPA&#8221;) with certain institutional investors (the &#8220;Buyers&#8221;) with which it had no prior relationship, pursuant to which the Company has agreed to issue for a purchase price of $3,000,000,&nbsp;$3,350,000 in aggregate principal amount of Senior Convertible Notes (the &#8220;Notes&#8221;) to the Buyers, convertible into 6,700,000 shares of the Company&#8217;s common stock, par value $.001 per share (the &#8220;Common Stock&#8221;) and warrants to purchase an aggregate of 5,360,003 shares of Common Stock (the &#8220;Warrants&#8221;.)</p> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in" align="justify">The Notes provide that the Company will repay the principal amount of Notes in equal monthly installments beginning on January 1, 2018 and repeating on the first business day of each calendar month thereafter until the fourteenth month anniversary date of issuance (each a &#8220;Installment Date&#8221;), and, subject to the Blocker (as defined below), the Company shall pre-deliver up to 6,700,000 shares of Common Stock to the Buyers in connection therewith (the &#8220;Pre-Delivery Shares&#8221;). Eighty-five (85%) percent of any cash proceeds received by the Buyers from the sale of Pre-Delivery Shares shall be applied against the particular installment amount due on such Installment Date under the Note. No interest will accrue under the Notes unless and until an Event of Default (as defined) has occurred and is not cured.</p> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in" align="justify">The Notes are convertible at any time by the Holder into shares of Common Stock at the rate of $0.50 per share, subject to full ratchet anti-dilution adjustment (the &#8220;Conversion Price&#8221;). Upon an Event of Default (as defined), the Buyers may convert at an alternative conversion price equal to the lower of the then applicable Conversion Price or seventy-five (75%) percent of the Volume-Weighted Average Price (as defined, the &#8220;VWAP&#8221;).</p> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in" align="justify">The Notes are senior in right of payment to all existing and future indebtedness of the Company except Permitted Indebtedness (as defined in the Note), including $12 million of senior secured indebtedness of the Company and its subsidiaries under an existing senior loan agreement, plus defined amounts of purchase money indebtedness in connection with bona fide acquisitions.</p> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in" align="justify">The Notes include customary Events of Default and provide that the Buyers may require the Company to redeem (regardless of whether the Event of Default has been cured) all or a portion of the Notes at a redemption premium of one hundred twenty-five (125%) percent, multiplied by the greater of the conversion rate and the then current market price. The Buyers may also require redemption of the Notes upon a Change of Control (as defined) at a premium of one hundred twenty-five (125%) percent.</p> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in" align="justify">The Warrants have a five year term and are exercisable into a number of shares of Common Stock equal to approximately eighty (80%) percent of the number of shares of Common Stock the Buyers would receive if the Notes were fully converted upon the date of issuance of the Notes. The Warrants are exercisable at $0.75 per share (150% of the conversion price of the Notes) subject to full ratchet anti-dilution protection. The Warrants will be exercisable on a cashless basis if a registration statement is not effective covering the resale of the underlying Warrant Shares.</p> <p style="MARGIN: 0px 0px 0px 0in" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in" align="justify">Conversion of the Notes and exercise of the Warrants are each subject to a blocker provision which prevents any holder from converting or exercising, as applicable, the Notes or the Warrants, into shares of Common Stock if its beneficial ownership of the Common Stock would exceed 4.99% (subject to adjustment not to exceed 9.99%) of the Company&#8217;s issued and outstanding Common Stock (each, a &#8220;Blocker&#8221;).</p> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in" align="justify">The Company is required to file, within thirty (30) days of the Closing, a registration statement covering one hundred fifty (150%) percent of the maximum number of shares, underlying the Notes and Warrants pursuant to a registration rights agreement with the Buyers (the &#8220;Registration Rights Agreement&#8221;).</p> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in" align="justify">As a condition to the closing of the Financing, each Buyer, severally, will be required to execute a leak-out agreement (each, a &#8220;Leak-Out Agreement&#8221;) restricting such Buyer&#8217;s sale of shares of Common Stock underlying the Notes and Warrants on any Trading Day to not more than such Buyer&#8217;s pro rata allocation of the greater of (x) sales with net proceeds of an aggregate of $20,000 or (y) twenty-five (25%) percent of the daily average trading volume of the Company&#8217;s Common Stock. If after the closing of the Financing&nbsp;there is no&nbsp;Event of Default&nbsp;under the Notes, the VWAP of the Company&#8217;s Common Stock for three (3) trading days is less than $0.15 per share, the Company may further restrict the Buyers from selling at less than $0.15 per share; provided that the portion of the Notes subject to redemption on each Installment Date shall thereafter double.</p> <p style="MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in" align="justify">Roth Capital Partners, LLC (&#8220;Roth&#8221;), as the Company&#8217;s exclusive placement agent, will receive a cash commission for this transaction equal to eight (8%) percent of the total gross proceeds of the offering and the issuance of five-year warrants to purchase eight (8%) percent of the shares of Common Stock issued or issuable in this offering (excluding shares of Common Stock issuable upon exercise of any Warrants issued to investors); however, will receive eight (8%) percent of any cash proceeds received from the exercise of any Warrants sold in the offering with an expiration equal to or less than twenty-four (24) months.</p> <p style="MARGIN: 0px 0px 0px 0in" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><u>Amendment of Trade Facility Agreement</u></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On November 16, 2017, SkyPharm signed an amended agreement with Synthesis Structured Commodity Trade Finance Limited that increased the maximum aggregate facility limit from &#8364;2,000,000 to &#8364;6,000,000. All other terms of the original agreement remain the same (see Note 8).</p> <p style="MARGIN: 0px" align="justify">&nbsp;&nbsp; </p> <p style="MARGIN: 0px" align="justify"> <table id="pagebreak467d1ae2-7edf-4e83-8801-077e59da12c2" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">24</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b><a name="Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</a></b></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><b>Forward-Looking Statements</b></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Certain statements, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements generally are identified by the words &#8220;believes,&#8221; &#8220;project,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;estimates,&#8221; &#8220;intends,&#8221; &#8220;strategy,&#8221; &#8220;plan,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;will be,&#8221; &#8220;will continue,&#8221; &#8220;will likely result,&#8221; and similar expressions. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">We intend such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and are including this statement for purposes of complying with those safe-harbor provisions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Factors which could have a material adverse effect on our operations and future prospects on a consolidated basis include, but are not limited to: changes in economic conditions, legislative/regulatory changes, availability of capital, interest rates, competition, and generally accepted accounting principles. These risks and uncertainties should also be considered in evaluating forward-looking statements and undue reliance should not be placed on such statements. We undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise. Further information concerning our business, including additional factors that could materially affect our financial results, is included herein and in our other filings with the SEC.</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><b>Overview</b></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">Cosmos Holdings Inc. (&#8220;us&#8221;, &#8220;we&#8221;, or the &#8220;Company&#8221;) was incorporated in the State of Nevada on July 21, 2009 under the name Prime Estates and Developments, Inc. for the purpose of acquiring and operating commercial real estate and real estate related assets. On November 14, 2013, we changed our name to Cosmos Holdings Inc and changed our focus and business strategy to the healthcare and pharmaceutical industry.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">The Company, through its subsidiaries, is operating within the pharmaceutical industry and in order to compete successfully the healthcare industry, must demonstrate that its products offer medical benefits as well as cost advantages. Currently, most of the products that the Company is trading, compete with other products already on the market in the same therapeutic category, and are subject to potential competition from new products that competitors may introduce in the future.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">The pharmaceutical industry is highly competitive and subject to comprehensive government regulations. Many factors may significantly affect the Company&#8217;s sales of its products, including, but not limited to, efficacy, safety, price and cost-effectiveness, marketing effectiveness, product labeling, quality control and quality assurance as well as our research and development of new products. </p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">We are currently focusing our existing operations on expanding the business of our subsidiaries, SkyPharm (Greece) and Decahedron (UK), in order to become an international pharmaceutical company. The Company&#8217;s focus will be on Branded Pharmaceuticals, Over-the-Counter (OTC) medicines, and Generic Pharmaceuticals. The Company also intends to expand into Cosmetic-Beauty Products as well as Food Supplements and targets areas where we can build and maintain a strong position. The Company uses a differentiated operating model based on a lean, nimble and decentralized structure, with an emphasis on acquisitions of established companies and our ability to maintain better pharmaceutical assets than others. This operating model and the execution of our corporate strategy are designed to enable the Company to achieve sustainable growth and create added value for our shareholders. In particular, we look to enhance our pharmaceutical and over-the-counter product lines by acquiring or licensing rights to additional products and regularly evaluate selective company acquisition opportunities.</p> <p style="MARGIN: 0px" align="justify">&nbsp; <table id="pagebreakf6198a51-6521-49dc-b077-49003dde08bf" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">25</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="justify">In 2016, the Company leased and equipped additional office space for our subsidiary SkyPharm in Thessaloniki, Greece in order to facilitate its growing business activity. The warehouse was already equipped with the proper shelves, working tables, medicine, cold fridge and barcode machines in compliance with all regulations. The offices in Thessaloniki have been also equipped with the proper equipment and specifically with the office tables, chairs and the terminals for each one working station. The hardware systems and software programs that are needed for the efficient trading of pharmaceuticals are already installed. As of July 22, 2015 the Hellenic Ministry of Health and more specifically the National Organization for Medicines granted the license for the wholesale of pharmaceutical products for human use to SkyPharm. The license is valid for a period of five years and pursuant to the EU directive of (2013/C 343/01) the Company is subject to fulfill the Guidelines of the Good Distribution Practices of medical products for human use. The Company has already incorporated the methodologies, procedures, processes and resources in order to be in accordance with the guidelines of the Good Distribution Practices. </p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">On May 20, 2016, the Company entered into a Non-Binding Memorandum of Understanding with Doc.Pharma SA to purchase Doc.Pharma SA for a combination of cash and stock to be agreed upon. Doc.Pharma SA is controlled by Grigorios Siokas, the Company&#8217;s CEO. The Memorandum of Understanding is subject to the Company&#8217;s completion of due diligence and expired on December 31, 2016, and has not been formally renewed or extended, however is being pursued. </p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On October 1, 2016, the Company entered into an Intellectual Property Sale Agreement with Anastasios Tsekas and Olga Parthenea Georgatsou (the &#8220;IPSA&#8221;) for the purchase of certain intellectual property rights relating to the proprietary Pharmaceutical Formula called &#8220;ProCure&#8221; that derives from a herb that is believed to be able to improve the prostate health and even possibly cure a prostate gland enlargement, infection, cancer, and other urinary problems. The Company received a compound along with a document that specifies the name of the herb that the Pharmaceutical Formula derives along with the related formula and compound, chemical identity and structure; know how, trade secret, methods and the procedures to produce a specified quantity of &#8220;ProCure&#8221;. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On November 16, 2016, the Company entered into a Stock Purchase Agreement (the &#8220;Medihelm SPA&#8221;) with Medihelm Pharmaceutical Wholesellers SA (&#8220;Medihelm&#8221;), Konstantinos Metsovitis (the &#8220;Medihelm Stockholder&#8221;) and Eleni Metsovitis. The SPA provides for the following:</p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px"> <table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr height="15"> <td width="4%"> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td valign="top" width="4%"> <p style="MARGIN: 0px" align="justify"><font face="Symbol">&#183;</font></p></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">At closing, as consideration for all of the stock of Medihelm, the Company shall issue the Medihelm Stockholder two hundred thousand (200,000) shares of restricted common stock of the Company.</p></td></tr> <tr height="15"> <td></td> <td></td> <td></td></tr> <tr height="15"> <td> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td valign="top"> <p style="MARGIN: 0px" align="justify"><font face="Symbol">&#183;</font></p></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">The Company also agreed that following the closing of the Medihelm SPA, Eleni Metsovitis would receive 3,100,000 shares of the Company&#8217;s restricted common stock and shall be retained as Medihelm&#8217;s chief operating officer and director and shall be appointed to the Board of Directors of the Company.</p></td></tr></table></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">The closing of the Medihelm SPA is subject to, among other things, the completion of the Company&#8217;s due diligence of Medihelm and the delivery of audited financial statements of Medihelm by a registered PCAOB auditor. The Medihelm SPA provides Medihelm with a period of forty-five (45) days to submit all due diligence items required by the Company. The Company shall be entitled to a period of ten (10) days to review all due diligence materials and audited financials provided by Medihelm. In the event the Company does not approve of any due diligence item, the Company is entitled to terminate the transactions contemplated by the Medihelm SPA. The Company anticipates that Medihelm will deliver disclosure schedules referenced in the Medihelm SPA prior to closing. Given the delays in completing this transaction, the Company cannot give any assurances that the acquisition will be completed.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On November 17, 2016, Cosmos Holdings Inc. entered into a Stock Purchase Agreement (the &#8220;Decahedron SPA&#8221;) with Decahedron Ltd. (&#8220;Decahedron&#8221;) and the shareholders of Decahedron (as amended). The terms of the Decahedron SPA provided that the Company would acquire all of the issued and outstanding shares of Decahedron. In exchange for the shares of Decahedron, the Company will issue to the Decahedron shareholders an aggregate amount of 1,700,000 shares of the Company&#8217;s common stock. The Decahedron SPA provided that following the closing of the transaction, the principal and majority shareholder of Decahedron, Nicholas Lazarou would be retained as a Director and COO of Decahedron with a salary of 10,000 GBP per month (approximately US $12,270.00). The Company completed this transaction on February 10, 2017. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"> <table id="pagebreak0f0f9e42-9aa3-45bb-8f57-8232d9198810" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">26</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On November 11, 2016, the Company entered into a Memorandum of Understanding (the &#8220;CC Pharma MOU&#8221;) with CC Pharma GmbH (&#8220;CCP&#8221;), Dr. Thomas Weppelmann (&#8220;Weppelmann&#8221;) and Mrs. Alexandra Gerke (&#8220;Gerke&#8221; and together with Weppelmann, collectively referred to as (the &#8220;Stockholders&#8221;). The CC Pharma MOU provides that the Company intends to acquire all of the issued and outstanding shares of CCP from the Stockholders, payable in cash on a pro rata basis to the Stockholders based on their percentage ownership of CCP. The purchase price was not disclosed in the CC Pharma MOU and remains confidential. The CC Pharma MOU expired on December 31, 2016. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On November 18, 2016, the Board of Directors of Company appointed John J. Hoidas as a member of the Board of Directors of the Company. The Company has not yet entered into an agreement with Mr. Hoidas setting forth any compensation for the serves provided as a member of the Board.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">On June 21, 2017, the Company signed a new Letter of Intent (LOI) to acquire the outstanding shares of CC Pharma GmbH, a leading re-importer of EU pharmaceuticals to Germany. Under the terms of the LOI, Cosmos Holdings holds the exclusive right to complete its due diligence process and complete the transaction by October 31, 2017. In connection with the non-binding LOI, the Company is required to pay a non-refundable fee of 400,000 Euros to CC Pharma GmbH in connection with the costs of due diligence and the exclusive right to negotiate the terms of the definitive agreements. The Company makes no assurances that the parties will enter into definitive agreements prior to October 31, 2017. On July 6, 2017, the Company paid the 400,000 Euros to CC Pharma GmbH.</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">The Company, for the nine months ended September 30, 2017, has recorded total revenues of $19,775,398 and has incurred expenses of approximately $18,156,795, in connection with these operations. There can be no assurance that we will ever raise the required capital necessary to effectuate our business plan; and even if we do, there is no assurance that we will ever commence or successfully develop this line of business. </p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><b>Results of Operations</b></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><i>Three Months Ended September 30, 2017 versus September 30, 2016</i></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">For the three months ended September 30, 2017, the Company had a net loss of $198,171 on revenue of $9,546,951, versus a net loss of $94,613 on revenue of $1,414,503 for the three months ended September 30, 2016. </p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><i>Revenue</i></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">The Company had revenue for the three months ended September 30, 2017 of $9,546,951, versus revenue of $1,414,503 for the three months ended September 30, 2016. This increase is mainly because of the organic growth attributed to our subsidiary, SkyPharm, which continued even more aggressively during the three months ended September 30, 2017, as well as through the additional revenue source from our new subsidiary in the UK, Decahedron. </p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><i>Operating Expenses</i></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.7pt" align="justify">Total operating expenses for the three month period ended September 30, 2017 were $758,365, versus $175,919 during the three month period ended September 30, 2016. The approximate 331% increase in operating expenses in the three month period in 2017, against the corresponding period in 2016, is primarily attributed to the increase of the operational needs of our subsidiary SkyPharm, as well as to the addition of our new subsidiary Decahedron. Moreover, the increase of operating expenses is due to the increased stock compensation to consultants for delivering services to the Company. </p> <p style="MARGIN: 0px 0px 0px 0.7pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><i>Unrealized Foreign Currency losses </i></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Additionally, we had an unrealized foreign currency loss of $51,474 for the three months ended September 30, 2017 such that our net comprehensive gain for the period was $249,645 versus the unrealized foreign currency loss of $16,622 for the nine months ended September 30, 2016 such that our net comprehensive loss for the period was $111,235.</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp; <table id="pagebreakd696639f-da94-4da6-bc8f-4d30ecf74997" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">27</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><i>Nine Months Ended September 30, 2017 versus September 30, 2016</i></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">For the nine months ended September 30, 2017, the Company had a net loss of $3,074,179 on revenue of $19,775,398, versus a net loss of $277,797 and revenue of $3,506,804 for the nine months ended September 30, 2016. </p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><i>Revenue</i></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">The Company had revenue for the nine months ended September 30, 2017 of $19,775,398, versus revenue of $3,506,804 for the nine months ended September 30, 2016. This increase is mainly because of the organic growth attributed to our subsidiary, SkyPharm, which continued even more aggressively during the nine months ended September 30, 2017, as well as through the additional revenue source from our new subsidiary in the UK, Decahedron.</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><i>Operating Expenses</i></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">Total operating expenses for the nine month period ended September 30, 2017 were $4,383,623, versus $473,249 during the nine month period ended September 30, 2016. The approximate 826% increase in operating expenses in the nine month period in 2017, against the corresponding period in 2016, is primarily due to the result of the Company&#8217;s assessment, 100% of the goodwill of $1,949,884 was recorded as an impairment of goodwill along with an approximately $433,000 increase in stock compensation to consultants for delivering services and amortization of employee stock options to the Company and a $434,000 increase in acquisition costs related to the letter of intent for the acquisition of CC Pharma GmbH.</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><i>Unrealized Foreign Currency losses </i></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Additionally, we had an unrealized foreign currency loss of $178,151 for the nine months ended September 30, 2017 such that our net comprehensive loss for the period was $3,252,330 versus the unrealized foreign currency loss of $38,185 such that our net comprehensive loss for the period was $315,982 for the nine months ended September 30, 2016. </p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><b>Liquidity and Capital Resources</b></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">At September 30, 2017, the Company had a working capital deficit of $3,546,938 and $2,234,720 as of December 31, 2016. This increase in the working capital deficit is primarily attributed to the increase in notes payable that are outstanding as of September 30, 2017.</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">At September 30, 2017, the Company had cash of $1,352,172 versus $716,590 as of December 31, 2016. For the nine months ended September 30, 2017, net cash used in operating activities was $5,739,560 versus $1,235,021 net cash used in operating activities for the nine months ended September 30, 2016. The variation in the use of cash is mainly attributed to the loss on goodwill of $1,949,884 offset by an increase in inventory, prepaid expenses and accounts receivable in the nine month period ended September 30, 2017.</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">During the nine month period ended September 30, 2017, there was $26,933 net cash provided by investing activities versus $11,880 used in investing activities during the nine months ended September 30, 2016. This increase in net cash from investing activities is attributed mainly to the cash received from the acquisition of Decahedron that took place within the nine month period ended September 30, 2017 </p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">During the nine month period ended September 30, 2017, there was $6,617,777 of net cash provided by financing activities versus $1,630,248 provided by financing activities during the nine month period ended September 30, 2016. This variation was primarily because of the increase in financing activities of our subsidiary in Greece, SkyPharm.</p> <p style="MARGIN: 0px" align="justify">&nbsp; <table id="pagebreak75b259f6-28db-4c13-96e1-4ae24fa007ae" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">28</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">We anticipate using cash in our bank account as of September 30, 2017, cash generated from the operations of the Company and its operating subsidiary and from debt or equity financing, or from a loan from management, to the extent that funds are available to do so to conduct our business in the upcoming year. Management is not obligated to provide these or any other funds. If we fail to meet these requirements, we may lose the qualification for quotation and our securities would no longer trade on the over the counter markets. Further, as a consequence we would fail to satisfy our reporting obligations with the Securities and Exchange Commission (&#8220;SEC&#8221;), and investors would then own stock in a company that does not provide the disclosure available in quarterly and annual reports filed with the SEC and investors may have increased difficulty in selling their stock as we will be non-reporting.</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><b>Revenue Recognition</b></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">We consider revenue recognizable when persuasive evidence of an arrangement exists, the price is fixed or determinable, goods or services have been delivered, and collectability is reasonably assured. These criteria are assumed to have been met if a customer orders an item, the goods or services have been shipped or delivered to the customer, and we have sufficient evidence of collectability, such a payment history with the customer. Revenue that is billed and received in advance such as recurring weekly or monthly services are initially deferred and recognized as revenue over the period the services are provided.</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><b>Plan of Operation in the Next Twelve Months</b></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Specifically, our plan of operations for the next 12 months is as follows:</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">We are planning to develop our business through organic growth and at the same level through the acquisition of carefully targeted companies that would add value to our Company and its shareholders. Our organic growth would be driven by entering into a more profitable series of product in the pharmaceutical and over the counter segments. For our subsidiary SkyPharm and our new subsidiary Decahedron, we are committed to capitalizing on sales growth opportunities by increasing our customer pipeline across the new European Market and entering into other European countries. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">We are also committed to pursuing various forms of business development; this can include trading, alliances, licenses, joint ventures, dispositions and acquisitions. Moreover we hope to continue to build on our portfolio of pharmaceutical products and expand our product pipeline to generic cosmetic and food supplement products. We plan to formulate a sound sales distribution network specializing in generic as well as in cosmetic and food supplement products. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Our main objective is focusing on expanding the business of SkyPharm and our new subsidiary, Decahedron, in connection with and concentrating our efforts on becoming an international pharmaceutical company. The Company&#8217;s focus is on branded pharmaceuticals, over-the-counter (OTC) medicines, and generic pharmaceuticals, with plans to expand into cosmetic-beauty products as well as food supplements and to target areas where we can build and maintain a strong position.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Through our new subsidiary, Decahedron, we plan to penetrate into the English pharmaceutical market and expand our wholesale networks. We could utilize the ability of trading pharmaceutical products in and out of the English market according to the FX currency exchange rate of euro to English pounds. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">We view our business development activity as an enabler of our strategies, and we seek to generate earnings growth and enhance shareholder value by pursuing a disciplined, strategic and financial approach to evaluating business development opportunities. Under these principles we assess our businesses and assets as part of our regular, ongoing portfolio review process and continue to consider trading development activities for our businesses.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">The Company, in the following twelve months, intends to start its operation within the markets of Generic pharmaceutical products, in Cosmetic-Beauty Products as well as Food &amp; Health Supplements. The specific industries are highly competitive and many factors may significantly affect the Company&#8217;s sales of these products, including, but not limited to, price and cost-effectiveness, marketing effectiveness, product labeling, quality control and quality assurance.</p> <p style="MARGIN: 0px" align="justify">&nbsp; <table id="pagebreakc217198c-b4e9-49a0-ac70-a1351d3e51f8" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">29</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Changes in the behavior and spending patterns of purchasers of pharmaceutical and healthcare products and services, including delaying medical procedures, rationing prescription medications, reducing the frequency of doctor visits and foregoing healthcare insurance coverage, may impact the Company&#8217;s business.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">In addition to expanding our product portfolio, we also plan to evaluate offering our products to different geographical markets. We are currently focused on our customers throughout Europe. We plan on expanding our geographical reach to new eras outside of the European Union market, although we currently have no binding agreements, commitments or contracts in any of these geographical markets. Some of the methods we will use to accomplish this are: promoting our brand and marketing our products through the Internet to new geographic areas, creating strategic relationships with companies in the new geographical regions, and possibly acquiring companies that operate in new geographical regions. We anticipate that we will spend approximately $85,000 evaluating the different methods and regions we plan on expanding too. This cost is made of up primarily legal fees, consulting fees, accounting and auditing fees as well as related development expenses. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">As to potential acquisitions of companies operating in the pharmaceutical sector, SEC filing requirements are such that we will have to file audited financial statements of all our operations, including any acquired business. So we plan that our first step in any potential acquisition process we undertake is to ascertain whether we can obtain audited financials of a target company if we were to acquire them. We anticipate that we will spend approximately $120,000 to locate, conduct due diligence, and evaluate possible acquisitions. Except as described above in connection with Medihelm and CC Pharma, as of the date of this report, we do not have any binding agreements, commitments, or understandings with any potential acquisition candidates.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">We assess the foreseeable development of the Company as being positive. The pharmaceutical sector offers a large growth potential in the European trade market of medicines, if service, price and quality are strictly directed to-wards the customer requirements. We will continue to encounter the competition in the market by service, reliability and a high level of quality. On the procurement side we can access a wide range of supply possibilities. To minimize business risks we diversify our sources of supply Europe wide. We secure our high quality demands through careful supplier qualification and selection as well as active supplier management.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Over the medium term we assume that we will be able to further expand our market shares. However, during the course of further organizational optimization there may be associated extraordinary additional costs.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">We still see the risks for the future development in a difficult and competitive environment, increasing purchase prices and the stagnating selling price level. On the background of our financial stability we however see ourselves as being well-equipped for managing the future risks. Risks that could endanger the survival of the Company are currently not able to be identified.</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">We will evaluate and, where appropriate, execute on opportunities to expand our businesses through the acquisition of products and companies in areas that will serve patients and customers and that we believe will offer above average growth characteristics and attractive margins. In particular, we are looking to continue to enhance our product lines by acquiring or licensing rights to additional products and regularly evaluate selective acquisition and license opportunities. In addition, we remain committed to strategic R&amp;D across each business unit with a particular focus on assets with inherently lower risk profiles and clearly defined governmental regulatory pathways. </p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><b>Off Balance Sheet Arrangements</b></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">As of September 30, 2017 there were no off balance sheet arrangements.</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><b>Critical Accounting Policies</b></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">In December 2001, the SEC requested that all registrants list their most &#8220;critical accounting polices&#8221; in the Management Discussion and Analysis. The SEC indicated that a &#8220;critical accounting policy&#8221; is one which is both important to the portrayal of a company&#8217;s financial condition and results, and requires management&#8217;s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain.</p> <p style="MARGIN: 0px" align="justify">&nbsp; <table id="pagebreak99876455-a6d8-4d77-b58e-56f1a99d375c" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">30</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><i>Foreign Currency.</i> The Company requires translation of the Amplerissimo financial statements from euros to dollars since the reverse take-over on September 27, 2013. Assets and liabilities of all foreign operations are translated at year-end rates of exchange, and the statements of operations are translated at the average rates of exchange for the year. Gains or losses resulting from translating foreign currency financial statements are accumulated in a separate component of stockholders&#8217; equity until the entity is sold or substantially liquidated. Gains or losses from foreign currency transactions (transactions denominated in a currency other than the entity&#8217;s local currency) are included in net (loss) earnings.</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><i>Income Taxes.</i> The Company accounts for income taxes under the asset and liability method, as required by the accounting standard for income taxes, ASC 740. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis, as well as net operating loss carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">The Company is liable for income taxes in the Republic of Cyprus, Greece and the United Kingdom of England. The corporate income tax rate in Cyprus is 12.5%, 29% in Greece (tax losses are carried forward for five years effective January 1, 2013. Prior to 2013, losses were carried forward indefinitely) and 20% in United Kingdom of England. Losses may also be subject to limitation under certain rules regarding change of ownership</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">We regularly review deferred tax assets to assess their potential realization and establish a valuation allowance for portions of such assets to reduce the carrying value if we do not consider it to be more likely than not that the deferred tax assets will be realized. Our review includes evaluating both positive (e.g., sources of taxable income) and negative (e.g., recent historical losses) evidence that could impact the realizability of our deferred tax assets. </p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">We recognize the impact of an uncertain tax position in our financial statements if, in management&#8217;s judgment, the position is not more-likely-then-not sustainable upon audit based on the position&#8217;s technical merits. This involves the identification of potential uncertain tax positions, the evaluation of applicable tax laws and an assessment of whether a liability for an uncertain tax position is necessary. We operate and are subject to audit in multiple taxing jurisdictions. </p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">We record interest and penalties related to income taxes as a component of interest and other expense, respectively. </p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">Potential benefits of income tax losses are not recognized in the accounts until realization is more likely than not. The Company has adopted ASC 740 &#8220;Accounting for Income Taxes&#8221; as of its inception. Pursuant to ASC 740, the Company is required to compute tax asset benefits for net operating losses carried forward. The potential benefits of net operating losses have not been recognized in this financial statement because the Company cannot be assured it is more likely than not it will utilize the net operating losses carried forward in future years.</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">&nbsp;The Company has net operating loss carry-forwards in our parent, Cosmos Holdings, Inc. which are applicable to future taxable income in the United States (if any). Additionally, the Company has income tax liabilities in the Republic of Cyprus. The income tax assets and liabilities are not able to be netted. We therefore reserve the income tax assets applicable to the United States, but recognize the income tax liabilities in the Republic of Cyprus.</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><b><a name="Item 3. Quantitative and Qualitative Disclosures about Market Risk.">Item 3. Quantitative and Qualitative Disclosures about Market Risk.</a></b></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">Not applicable. A smaller reporting company is not required to provide the information required by this Item.</p> <p style="MARGIN: 0px" align="justify">&nbsp; <table id="pagebreakc0e5da90-3c54-439b-a53b-fe0095d364e5" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">31</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><b><a name="Item 4. Controls and Procedures.">Item 4. Controls and Procedures.</a></b></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><i>Disclosure Controls and Procedures</i></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">The Company maintains disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act) that are designed to ensure that information required to be disclosed in the Company&#8217;s Securities Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to the Company&#8217;s management, including its Principal Executive Officer/Principal Financial Officer, as appropriate, to allow timely decisions regarding required disclosures.</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><em>Evaluation of Disclosure Controls and Procedures</em></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">The Company&#8217;s management, with the participation of the Company&#8217;s Principal Executive Officer/Principal Financial Officer, has evaluated the effectiveness of the Company&#8217;s disclosure controls and procedures as of the end of the period covered by this report. Based upon that evaluation, the Principal Executive Officer and the Principal Financial Officer have concluded that, as of the end of the period covered by this report, the Company&#8217;s disclosure controls and procedures were not effective.</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><i>Changes in Internal Controls Over Financial Reporting </i></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">During the most recently completed fiscal quarter, there has been no change in our internal control over financial reporting that has materially affected or is reasonably likely to materially affect, our internal control over financial reporting. </p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="left">&nbsp; <table id="pagebreakf1d481e6-bb83-49b9-9a17-ef1471bf06de" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">32</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="center"><b><a name="PART II - OTHER INFORMATION">PART II - OTHER INFORMATION</a></b></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><b><a name="Item 1. Legal Proceedings.">Item 1. Legal Proceedings.</a></b></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">None.</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><b><a name="Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.</a></b></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">None.</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><b><a name="Item 3. Defaults Upon Senior Securities.">Item 3. Defaults Upon Senior Securities.</a></b></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">None.</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><b><a name="Item 4. Mine Safety Disclosures.">Item 4. Mine Safety Disclosures.</a></b></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">None. </p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><b><a name="Item 5. Other Information.">Item 5. Other Information.</a></b></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">Subsequent Events</p> <p style="MARGIN: 0px" align="justify">&nbsp; <table id="pagebreakf13cdbd0-c59e-4438-8082-43310358fe05" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">33</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify"><b><a name="Item 6. Exhibits.">Item 6. Exhibits.</a></b></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">(a) Exhibits.</p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px"> <table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr height="15"> <td style="BORDER-BOTTOM: 1px solid" width="8%"> <p style="MARGIN: 0px" align="justify"><b>Exhibit No.</b></p></td> <td width="2%"></td> <td style="BORDER-BOTTOM: 1px solid" width="90%"> <p style="MARGIN: 0px" align="justify"><b>Document Description</b></p></td></tr> <tr height="15"> <td> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td></td> <td></td></tr> <tr bgcolor="#cceeff"> <td> <p style="MARGIN: 0px"><a href="cosm_ex101.htm">10.1</a></p></td> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td> <p style="MARGIN: 0px"><a href="cosm_ex101.htm">Agreement between Synthesis Structured Commodity Trade Finance and SkyPharm S.A. dated November 16, 2017</a></p></td></tr> <tr> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr height="15" bgcolor="#cceeff"> <td> <p style="MARGIN: 0px" align="justify"><a href="cosm_ex311.htm">31.1</a></p></td> <td></td> <td> <p style="MARGIN: 0px" align="justify"><a href="cosm_ex311.htm">Certification of CEO/CFO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></p></td></tr> <tr height="15" bgcolor="#ffffff"> <td> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td></td> <td></td></tr> <tr height="15" bgcolor="#cceeff"> <td> <p style="MARGIN: 0px" align="justify"><a href="cosm_ex321.htm">32.1</a></p></td> <td></td> <td> <p style="MARGIN: 0px" align="justify"><a href="cosm_ex321.htm">Certification of CEO/CFO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></p></td></tr> <tr height="15" bgcolor="#ffffff"> <td> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td></td> <td></td></tr> <tr height="15" bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">101.INS</p></td> <td></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">XBRL Instance Document**</p></td></tr> <tr height="15" bgcolor="#ffffff"> <td> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td></td> <td></td></tr> <tr height="15" bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">101.SCH</p></td> <td></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">XBRL Taxonomy Extension Schema Document**</p></td></tr> <tr height="15" bgcolor="#ffffff"> <td> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td></td> <td></td></tr> <tr height="15" bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">101.CAL</p></td> <td></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">XBRL Taxonomy Extension Calculation Linkbase Document**</p></td></tr> <tr height="15" bgcolor="#ffffff"> <td> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td></td> <td></td></tr> <tr height="15" bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">101.DEF</p></td> <td></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">XBRL Taxonomy Extension Definition Linkbase Document**</p></td></tr> <tr height="15" bgcolor="#ffffff"> <td> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td></td> <td></td></tr> <tr height="15" bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">101.LAB</p></td> <td></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">XBRL Taxonomy Extension Label Linkbase Document**</p></td></tr> <tr height="15" bgcolor="#ffffff"> <td> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td></td> <td></td></tr> <tr height="15" bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">101.PRE</p></td> <td></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">XBRL Taxonomy Extension Presentation Linkbase Document**</p></td></tr></table></p> <p style="MARGIN: 0px">_________________</p> <p style="MARGIN: 0px"> <table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr height="15"> <td valign="top" width="4%"> <p style="MARGIN: 0px" align="justify">**</p></td> <td> <p style="MARGIN: 0px" align="justify">XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.</p></td></tr></table></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="left">&nbsp; <table id="pagebreak32e9b781-4ad4-4da5-95fb-9eb684b5afd8" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">34</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="center"><b><a name="SIGNATURES">SIGNATURES</a></b></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">In accordance with Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.&nbsp;</p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px"> <table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr height="15"> <td valign="top"></td> <td valign="top" colspan="2"> <p style="MARGIN: 0px" align="justify"><b>Cosmos Holdings Inc.</b></p></td> <td valign="top"></td></tr> <tr height="15"> <td valign="top" width="50%"> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td valign="top" width="3%">&nbsp;</td> <td valign="top" width="35%"></td> <td valign="top" width="12%"></td></tr> <tr height="15"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Date: November 20, 2017</p></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">By:</p></td> <td style="BORDER-BOTTOM: 1px solid" valign="top"> <p style="MARGIN: 0px" align="justify"><i>/s/ Grigorios Siokas</i></p></td> <td valign="top"></td></tr> <tr height="15"> <td></td> <td></td> <td> <p style="MARGIN: 0px" align="justify">Grigorios Siokas</p></td> <td></td></tr> <tr height="15"> <td valign="top"></td> <td valign="top"></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">Chief Executive Officer</p> <p style="MARGIN: 0px" align="justify">(Principal Executive Officer,</p> <p style="MARGIN: 0px" align="justify">Acting Principal Financial Officer and</p> <p style="MARGIN: 0px" align="justify">Acting Principal Accounting Officer )</p></td> <td valign="top"></td></tr></table></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="justify">In accordance with the Exchange Act, this report has been duly signed by the following persons on behalf of the Company and in the capacities and on the dates indicated.</p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px"> <table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr height="15"> <td style="BORDER-BOTTOM: 1px solid" valign="top" width="35%"> <p style="MARGIN: 0px" align="justify"><b>Signatures</b></p></td> <td valign="top" width="5%"></td> <td style="BORDER-BOTTOM: 1px solid" valign="top" width="35%"> <p style="MARGIN: 0px" align="center"><b>Title</b></p></td> <td valign="top" width="5%"></td> <td style="BORDER-BOTTOM: 1px solid" valign="top" width="20%"> <p style="MARGIN: 0px" align="center"><b>Date</b></p></td></tr> <tr height="15"> <td valign="bottom"> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td></tr> <tr height="15"> <td style="BORDER-BOTTOM: 1px solid" valign="bottom"> <p style="MARGIN: 0px" align="justify"><i>/s/ Grigorios Siokas</i></p></td> <td valign="top"></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">Chief Executive Officer </p></td> <td valign="top"></td> <td valign="top"> <p style="MARGIN: 0px" align="center">November 20, 2017</p></td></tr> <tr height="15"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Grigorios Siokas </p></td> <td valign="top"></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">(Principal Executive Officer, Acting Principal Financial Officer and</p> <p style="MARGIN: 0px" align="justify">Acting Principal Accounting Officer) and Director</p></td> <td valign="top"></td> <td valign="top"></td></tr> <tr height="15"> <td valign="top"> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td></tr> <tr height="15"> <td style="BORDER-BOTTOM: 1px solid" valign="top"> <p style="MARGIN: 0px" align="justify"><i>/s/ Dimitrios Goulielmos</i></p></td> <td valign="top"></td> <td valign="bottom"> <p style="MARGIN: 0px" align="justify">Director</p></td> <td valign="top"></td> <td valign="top"> <p style="MARGIN: 0px" align="center">November 20, 2017</p></td></tr> <tr height="15"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Dimitrios Goulielmos</p></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td></tr> <tr height="15"> <td style="BORDER-BOTTOM: 1px solid" valign="top"> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"><em>/s/ John J. Hoidas</em></p></td> <td valign="top"></td> <td valign="bottom"> <p style="MARGIN: 0px" align="justify">Director</p></td> <td valign="top"></td> <td valign="top"> <p style="MARGIN: 0px" align="center">&nbsp;</p> <p style="MARGIN: 0px" align="center">November 20, 2017</p></td></tr> <tr height="15"> <td valign="top"> <p style="MARGIN: 0px" align="justify">John J. Hoidas</p></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td></tr> <tr height="15"> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td></tr> <tr height="15"> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td></tr> <tr height="15"> <td style="BORDER-BOTTOM: 1px solid" valign="top"> <p style="MARGIN: 0px" align="justify"><i>/s/ Demetrios G. Demetriades</i></p></td> <td valign="top"></td> <td valign="bottom"> <p style="MARGIN: 0px" align="justify">Secretary and Director</p></td> <td valign="top"></td> <td valign="top"> <p style="MARGIN: 0px" align="center">November 20, 2017</p></td></tr> <tr height="15"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Demetrios G. Demetriades</p></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td></tr></table></p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="left">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="center"> <table id="pagebreak63b6a4f2-6d27-4489-a340-e80b58a8ee50" class="pagebreak" style="FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">35</td></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div>&nbsp;</td></tr> <tr> <td><i><a href="#TOC">Table of Contents</a></i></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0.35pt" align="center"><b>EXHIBIT INDEX</b></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px"> <table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr height="15"> <td style="BORDER-BOTTOM: 1px solid" width="8%"> <p style="MARGIN: 0px" align="justify"><b>Exhibit No.</b></p></td> <td width="2%"></td> <td style="BORDER-BOTTOM: 1px solid" width="90%"> <p style="MARGIN: 0px" align="justify"><b>Document Description</b></p></td></tr> <tr height="15"> <td> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td></td> <td></td></tr> <tr bgcolor="#cceeff"> <td> <p style="MARGIN: 0px"><a href="cosm_ex101.htm">10.1</a></p></td> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td> <p style="MARGIN: 0px"><a href="cosm_ex101.htm">Agreement between Synthesis Structured Commodity Trade Finance and SkyPharm S.A. dated November 16, 2017</a></p></td></tr> <tr bgcolor="#ffffff"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr height="15" bgcolor="#cceeff"> <td> <p style="MARGIN: 0px" align="justify"><a href="cosm_ex311.htm">31.1</a></p></td> <td></td> <td> <p style="MARGIN: 0px" align="justify"><a href="cosm_ex311.htm">Certification of CEO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></p></td></tr> <tr height="15" bgcolor="#ffffff"> <td> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td></td> <td></td></tr> <tr height="15" bgcolor="#cceeff"> <td> <p style="MARGIN: 0px" align="justify"><a href="cosm_ex321.htm">32.1*</a></p></td> <td></td> <td> <p style="MARGIN: 0px" align="justify"><a href="cosm_ex321.htm">Certification of CEO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*</a></p></td></tr> <tr height="15" bgcolor="#ffffff"> <td> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td></td> <td></td></tr> <tr height="15" bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">101.INS</p></td> <td></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">XBRL Instance Document**</p></td></tr> <tr height="15" bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td></td> <td valign="top"></td></tr> <tr height="15" bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">101.SCH</p></td> <td></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">XBRL Taxonomy Extension Schema Document**</p></td></tr> <tr height="15" bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td></td> <td valign="top"></td></tr> <tr height="15" bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">101.CAL</p></td> <td></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">XBRL Taxonomy Extension Calculation Linkbase Document**</p></td></tr> <tr height="15" bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td></td> <td valign="top"></td></tr> <tr height="15" bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">101.DEF</p></td> <td></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">XBRL Taxonomy Extension Definition Linkbase Document**</p></td></tr> <tr height="15" bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td></td> <td valign="top"></td></tr> <tr height="15" bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">101.LAB</p></td> <td></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">XBRL Taxonomy Extension Label Linkbase Document**</p></td></tr> <tr height="15" bgcolor="#ffffff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td></td> <td valign="top"></td></tr> <tr height="15" bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">101.PRE</p></td> <td></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">XBRL Taxonomy Extension Presentation Linkbase Document**</p></td></tr> <tr height="15" bgcolor="#ffffff"> <td> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td></td> <td></td></tr> <tr height="15" bgcolor="#cceeff"> <td valign="top"> <p style="MARGIN: 0px" align="justify">Exhibit 101 </p></td> <td></td> <td> <p style="MARGIN: 0px" align="justify">Interactive data files formatted in XBRL (eXtensible Business Reporting Language): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, (iii) the Consolidated Statements of Cash Flows, and (iv) the Notes to the Consolidated Financial Statements.**</p></td></tr></table></p> <p style="MARGIN: 0px">_________________</p> <p style="MARGIN: 0px"> <table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr height="15"> <td valign="top" width="4%"> <p style="MARGIN: 0px" align="justify">* </p></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">This exhibit shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 of the Securities Exchange Act of 1934, whether made before or after the date hereof and irrespective of any general incorporation language in any filings.</p></td></tr> <tr height="15"> <td valign="top"> <p style="MARGIN: 0px" align="justify">&nbsp;</p></td> <td valign="top"></td></tr> <tr height="15"> <td valign="top"> <p style="MARGIN: 0px" align="justify">** </p></td> <td valign="top"> <p style="MARGIN: 0px" align="justify">XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.</p></td></tr></table></p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify">&nbsp;</p> <p style="MARGIN: 0px" align="justify"> <table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cols="1" cellpadding="0" width="100%" align="center" border="0"> <tr> <td style="BORDER-BOTTOM: black 1px solid"> <p style="MARGIN: 0px" align="center">36</p></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p></BODY></html></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>cosm_ex101.htm
<DESCRIPTION>AGREEMENT
<TEXT>
<html><head><title>cosm_ex101.htm</title></head><body style="text-align:justify;font:10pt TIMES NEW ROMAN;margin:0px 7%"><p style="MARGIN: 0px" align="right"><b>EXHIBIT&nbsp;10.1</b></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="center"><img src="cosm_ex101img1.jpg">&nbsp;</p> <p style="MARGIN: 0px"> <table id="pagebreak2b8ea18d-01ed-48fc-a81d-e2ce09eb63bc" class="pagebreak" style="WIDTH: 100%; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">1</td></tr> <tr></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div></td></tr> <tr> <td>&nbsp;</td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="center"><img src="cosm_ex101img2.jpg">&nbsp;</p> <p style="MARGIN: 0px"> <table id="pagebreak594fc0f0-a41b-476d-9356-584eea370c41" class="pagebreak" style="WIDTH: 100%; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">2</td></tr> <tr></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div></td></tr> <tr> <td>&nbsp;</td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="center"><img src="cosm_ex101img3.jpg">&nbsp;</p> <p style="MARGIN: 0px"> <table id="pagebreak8517961c-adbf-4ca6-8525-3057fa16e79c" class="pagebreak" style="WIDTH: 100%; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">3</td></tr> <tr></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div></td></tr> <tr> <td>&nbsp;</td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="center"><img src="cosm_ex101img4.jpg">&nbsp;</p> <p style="MARGIN: 0px"> <table id="pagebreak7cb505c1-8040-42ad-84a3-d58e22ac3dac" class="pagebreak" style="WIDTH: 100%; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">4</td></tr> <tr></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div></td></tr> <tr> <td>&nbsp;</td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="center"><img src="cosm_ex101img5.jpg">&nbsp;</p> <p style="MARGIN: 0px"> <table id="pagebreakdfdbc0b6-bfd9-46f9-8ba8-b06b1a83a0b3" class="pagebreak" style="WIDTH: 100%; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">5</td></tr> <tr></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div></td></tr> <tr> <td>&nbsp;</td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="center"><img src="cosm_ex101img6.jpg">&nbsp;</p> <p style="MARGIN: 0px"> <table id="pagebreak9f3d1f08-0e98-4a06-a543-cac15cf6ab1e" class="pagebreak" style="WIDTH: 100%; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">6</td></tr> <tr></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div></td></tr> <tr> <td>&nbsp;</td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="center"><img src="cosm_ex101img7.jpg">&nbsp;</p> <p style="MARGIN: 0px"> <table id="pagebreake5105280-5a03-4a7c-9c45-aa3f7b780d63" class="pagebreak" style="WIDTH: 100%; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" border="0"> <tr> <td class="hpbhr">&nbsp;</td></tr> <tr> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">7</td></tr> <tr></tr> <tr> <td> <div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div></td></tr> <tr> <td>&nbsp;</td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px" align="center"><img src="cosm_ex101img8.jpg">&nbsp;</p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px"> <table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cols="1" cellpadding="0" width="100%" align="center" border="0"> <tr> <td style="BORDER-BOTTOM: black 1px solid"> <p style="MARGIN: 0px" align="center">8</p></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p></BODY></html></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>cosm_ex311.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<html><head><title>doc1.htm</title></head><body style="text-align:justify;font:10pt TIMES NEW ROMAN;margin:0px 7%"><p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in" align="right"><b>EXHIBIT&nbsp;31.1 </b></p> <p style="MARGIN: 0px 0px 0px 0in" align="right">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in" align="center"><b>CERTIFICATION </b></p> <p style="MARGIN: 0px 0px 0px 0in" align="center">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in">I, Grigorios Siokas, certify that: </p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px"> <table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr height="15"> <td valign="top" width="4%"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">&nbsp; 1. </p></td> <td valign="top" colspan="5"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">I have reviewed this report on Form 10-Q of Cosmos Holdings Inc.; </p></td></tr> <tr height="15"> <td valign="top"></td> <td valign="top" colspan="5"></td></tr> <tr height="15"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">2. </p></td> <td valign="top" colspan="5"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; </p></td></tr> <tr height="15"> <td valign="top"></td> <td valign="top" colspan="5"></td></tr> <tr height="15"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">3. </p></td> <td valign="top" colspan="5"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; </p></td></tr> <tr height="15"> <td valign="top"></td> <td valign="top" colspan="5"></td></tr> <tr height="15"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">4. </p></td> <td valign="top" colspan="5"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: </p></td></tr> <tr height="15"> <td valign="top" width="4%"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">&nbsp;</p></td> <td valign="top" width="4%"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">a) </p></td> <td colspan="4"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; </p></td></tr> <tr height="15"> <td valign="top"></td> <td valign="top"></td> <td valign="top" colspan="4"></td></tr> <tr height="15"> <td valign="top"></td> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">b) </p></td> <td colspan="4"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; </p></td></tr> <tr height="15"> <td valign="top"></td> <td valign="top"></td> <td valign="top" colspan="4"></td></tr> <tr height="15"> <td valign="top"></td> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">c) </p></td> <td colspan="4"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and </p></td></tr> <tr height="15"> <td valign="top"></td> <td valign="top"></td> <td valign="top" colspan="4"></td></tr> <tr height="15"> <td valign="top"></td> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">d) </p></td> <td colspan="4"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an quarterly report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and </p> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr height="15"> <td valign="top" width="4%"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">&nbsp; 5. </p></td> <td valign="top" colspan="5"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function): </p></td></tr> <tr height="15"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td colspan="5"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr height="15"> <td valign="top" width="4%"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">&nbsp;</p></td> <td valign="top" width="4%"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">a) </p></td> <td colspan="4"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and </p></td></tr> <tr height="15"> <td valign="top"></td> <td valign="top"></td> <td valign="top" colspan="4"></td></tr> <tr height="15"> <td valign="top"></td> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">b) </p></td> <td colspan="4"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. </p></td></tr> <tr height="15"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td colspan="4"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr height="15"> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td> <p style="MARGIN: 0px">&nbsp;</p></td> <td colspan="4"> <p style="MARGIN: 0px">&nbsp;</p></td></tr> <tr height="15"> <td valign="top" colspan="3"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">&nbsp;</p></td> <td valign="top" colspan="2"> <p style="MARGIN: 0px 0px 0px 0in" align="justify"><b>Cosmos Holdings Inc. </b></p></td> <td valign="top"></td></tr> <tr height="15"> <td valign="top" width="49%" colspan="3"></td> <td valign="top" width="3%"></td> <td valign="top" width="34%"></td> <td valign="top" width="11%"></td></tr> <tr height="15"> <td valign="top" colspan="3"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">Date: November 20, 2017 </p></td> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">By: </p></td> <td style="BORDER-BOTTOM: 1px solid" valign="top"> <p style="MARGIN: 0px 0px 0px 0in" align="justify"><i>/s/&nbsp;Grigorios Siokas </i></p></td> <td valign="top"></td></tr> <tr height="15"> <td valign="top" colspan="3"></td> <td valign="top"></td> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">Grigorios Siokas </p></td> <td valign="top"></td></tr> <tr height="15"> <td valign="top" colspan="3"></td> <td valign="top"></td> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">Principal Executive Officer, <p style="MARGIN: 0px">Acting Principal Financial Officer </p>and Acting Principal Accounting Officer <p style="MARGIN: 0px"></td> <td valign="top"></td></tr></table></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px">&nbsp;</p></BODY></html></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>cosm_ex321.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<html><head><title>cosm_ex321.htm</title></head><body style="text-align:justify;font:10pt TIMES NEW ROMAN;margin:0px 7%"><p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in" align="right"><b>EXHIBIT&nbsp;32.1 </b></p> <p style="MARGIN: 0px 0px 0px 0in" align="center">&nbsp;<b>CERTIFICATION PURSUANT TO <p style="MARGIN: 0px" align="center">18 U.S.C. SECTION 1350, </p> <p style="MARGIN: 0px" align="center">AS ADOPTED PURSUANT TO </p> <p style="MARGIN: 0px" align="center">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 </p> <p style="MARGIN: 0px" align="center"></b>&nbsp;</p> <p style="MARGIN: 0px"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">Pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to Pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of 2002, the undersigned hereby certifies that the&nbsp;Quarterly Report on Form 10-Q for the period ended September 30, 2017 of Cosmos Holdings Inc. (the "Company") fully complies with the requirements of Section&nbsp;13(a) or Section&nbsp;15(d) of the Securities Exchange Act of 1934 and that the information contained in such Report fairly presents, in all material respects, the financial condition and results of operations of the Company. </p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px"> <table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr height="15"> <td valign="top"></td> <td valign="top" colspan="2"> <p style="MARGIN: 0px 0px 0px 0in" align="justify"><b>Cosmos Holdings Inc. </b></p></td> <td valign="top"></td></tr> <tr height="15"> <td valign="top" width="49%"></td> <td valign="top" width="3%"></td> <td valign="top" width="34%"></td> <td valign="top" width="11%"></td></tr> <tr height="15"> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">Date: November 20, 2017 </p></td> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">By: </p></td> <td style="BORDER-BOTTOM: 1px solid" valign="top"> <p style="MARGIN: 0px 0px 0px 0in" align="justify"><i>/s/&nbsp;Grigorios Siokas </i></p></td> <td valign="top"></td></tr> <tr height="15"> <td valign="top"></td> <td valign="top"></td> <td valign="bottom"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">Grigorios Siokas </p></td> <td valign="top"></td></tr> <tr height="15"> <td valign="top"></td> <td valign="top"></td> <td valign="top"> <p style="MARGIN: 0px 0px 0px 0in" align="justify">Principal Executive Officer, Acting Principal Financial Officer and Acting Principal Accounting Officer </p></td> <td valign="top"></td></tr></table></p> <p style="MARGIN: 0px 0px 0px 0in" align="justify">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in" align="justify">A signed original of this written statement required by Section&nbsp;906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section&nbsp;906, has been provided to Cosmos Holdings Inc. and will be retained by Cosmos Holdings Inc. and furnished to the Securities and Exchange Commission or its staff upon request. </p></BODY></html></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>5
<FILENAME>cosm-20170930.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: cosm_10%2Dq1.xfr; Date: 2017%2D11%2D20T00:19:58Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2016-01-31" xmlns:us-roles="http://fasb.org/us-roles/2016-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2016-01-31" xmlns:country="http://xbrl.sec.gov/country/2016-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:COSM="http://primeestatesdevelopmentsinc.com/20170930">
    <link:schemaRef xlink:href="cosm-20170930.xsd" xlink:type="simple" />
    <xbrli:context id="From2017-01-01to2017-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-11-20">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-11-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_us-gaap_FurnitureAndFixturesMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_us-gaap_FurnitureAndFixturesMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_us-gaap_ComputerEquipmentMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_us-gaap_ComputerEquipmentMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-09-27_custom_AmplerissimoLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:AmplerissimoLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-09-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-02-28_custom_SynthesisManagementLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SynthesisManagementLimitedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_PriorToMergerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareholdersEquityClassAxis">COSM:PriorToMergerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_us-gaap_EquityIssuedInBusinessCombinationMember_us-gaap_RestrictedStockMember_custom_AmplerissimoLtdMember_custom_ExchangeAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareholdersEquityClassAxis">us-gaap:EquityIssuedInBusinessCombinationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:AmplerissimoLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">COSM:ExchangeAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_custom_DocPharmaSaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:DocPharmaSaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_DocPharmaSaMember_custom_LoanAgreementMember_custom_OnNovemberOneTwoThousandsFifteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:DocPharmaSaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">COSM:LoanAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">COSM:OnNovemberOneTwoThousandsFifteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_custom_DocPharmaSaMember_custom_LoanAgreementMember_custom_OnNovemberOneTwoThousandsFifteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:DocPharmaSaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">COSM:LoanAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">COSM:OnNovemberOneTwoThousandsFifteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_GrigoriosSiokasMember_custom_OnNovemberOneTwoThousandsFifteenMember_custom_OnOctoberOneTwoThousandSixteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:GrigoriosSiokasMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">COSM:OnOctoberOneTwoThousandSixteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_custom_GrigoriosSiokasMember_custom_OnOctoberOneTwoThousandSixteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:GrigoriosSiokasMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">COSM:OnOctoberOneTwoThousandSixteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_custom_GrigoriosSiokasMember_us-gaap_LoansPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:GrigoriosSiokasMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:UnderlyingAssetClassAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_custom_OuraniaMatsoukiMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:OuraniaMatsoukiMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_custom_KonstantinosVassilopoulosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:KonstantinosVassilopoulosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-11-21_custom_DimitriosGoulielmosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:DimitriosGoulielmosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-11-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-11-01to2014-11-21_custom_DimitriosGoulielmosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:DimitriosGoulielmosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-11-01</xbrli:startDate>
        <xbrli:endDate>2014-11-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-11-04_custom_DimitriosGoulielmosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:DimitriosGoulielmosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-11-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-11-01to2015-11-04_custom_DimitriosGoulielmosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:DimitriosGoulielmosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-11-01</xbrli:startDate>
        <xbrli:endDate>2015-11-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_custom_KonstantinosVassilopoulosMember_custom_DimitriosGoulielmosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:DimitriosGoulielmosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-03-04_custom_LoanAgreementOneMember_custom_AngeloDrakopoulosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:AngeloDrakopoulosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-03-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-03-01to2015-03-04_custom_LoanAgreementOneMember_custom_AngeloDrakopoulosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:AngeloDrakopoulosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-03-01</xbrli:startDate>
        <xbrli:endDate>2015-03-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-11-05_custom_LoanAgreementTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-11-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-11-01to2015-11-05_custom_LoanAgreementTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-11-01</xbrli:startDate>
        <xbrli:endDate>2015-11-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_LoanAgreementTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-12-01to2016-12-31_custom_LoanAgreementTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-12-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-11-05_custom_LoanAgreementThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-11-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_custom_LoanAgreementThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-12-01to2016-12-31_custom_LoanAgreementThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-12-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-11-01to2015-11-05_custom_LoanAgreementThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-11-01</xbrli:startDate>
        <xbrli:endDate>2015-11-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-11-16_custom_LoanAgreementFourMember_custom_PanagiotisDrakopoulosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:PanagiotisDrakopoulosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-11-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-11-01to2015-11-16_custom_LoanAgreementFourMember_custom_PanagiotisDrakopoulosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:PanagiotisDrakopoulosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-11-01</xbrli:startDate>
        <xbrli:endDate>2015-11-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_LoanAgreementFourMember_custom_PanagiotisDrakopoulosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:PanagiotisDrakopoulosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_LoanAgreementFiveMember_custom_PanagiotisDrakopoulosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementFiveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:PanagiotisDrakopoulosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_custom_LoanAgreementFiveMember_custom_PanagiotisDrakopoulosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementFiveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:PanagiotisDrakopoulosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_LoanAgreementSevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementSevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-02-05_custom_LoanAgreementEightMember_custom_LoanAgreementSixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementSixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-02-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-02-01to2016-02-05_custom_LoanAgreementEightMember_custom_LoanAgreementSixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementSixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-02-01</xbrli:startDate>
        <xbrli:endDate>2016-02-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_LoanAgreementSixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementSixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-03-04_custom_LoanAgreementSevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementSevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-03-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-03-01to2016-03-04_custom_LoanAgreementSevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementSevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-03-01</xbrli:startDate>
        <xbrli:endDate>2016-03-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_LoanAgreementNineMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementNineMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-04-19_custom_LoanAgreementEightMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementEightMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-04-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-04-01to2016-04-19_custom_LoanAgreementEightMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementEightMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-04-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_LoanAgreementTenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementTenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-04-22_custom_LoanAgreementNineMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementNineMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-04-01to2016-04-22_custom_LoanAgreementNineMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementNineMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_LoanAgreementElevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementElevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-05-24_custom_LoanAgreementTenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementTenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-05-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-05-01to2016-05-24_custom_LoanAgreementTenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementTenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-05-01</xbrli:startDate>
        <xbrli:endDate>2016-05-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-10-18_custom_LoanAgreementElevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementElevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-10-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-01to2016-10-18_custom_LoanAgreementElevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementElevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-01</xbrli:startDate>
        <xbrli:endDate>2016-10-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-08-04_custom_LoanFacilityAgreementMember_custom_SkyPharmMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanFacilityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-08-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-08-01to2016-08-04_custom_LoanFacilityAgreementMember_custom_SkyPharmMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanFacilityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-08-01</xbrli:startDate>
        <xbrli:endDate>2016-08-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-08-04_custom_LoanFacilityAgreementMember_custom_SynthesisFacilityAgreementMember_custom_GrigoriosSiokasMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanFacilityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">COSM:SynthesisFacilityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:GrigoriosSiokasMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-08-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-13_custom_AmendmentToLoanFacilityAgreementMember_custom_SkyPharmMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:AmendmentToLoanFacilityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-23_us-gaap_SubsequentEventMember_custom_SecondAmendmentToLoanFacilityAgreementMember_custom_SkyPharmMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:SecondAmendmentToLoanFacilityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-03-02to2017-03-23_us-gaap_SubsequentEventMember_custom_SecondAmendmentToLoanFacilityAgreementMember_custom_SkyPharmMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:SecondAmendmentToLoanFacilityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-03-02</xbrli:startDate>
        <xbrli:endDate>2017-03-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_SubsequentEventMember_custom_SecondAmendmentToLoanFacilityAgreementMember_custom_SkyPharmMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:SecondAmendmentToLoanFacilityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-10-31_us-gaap_SubsequentEventMember_custom_SecondAmendmentToLoanFacilityAgreementMember_custom_SkyPharmMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:SecondAmendmentToLoanFacilityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-11-30_us-gaap_SubsequentEventMember_custom_SecondAmendmentToLoanFacilityAgreementMember_custom_SkyPharmMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:SecondAmendmentToLoanFacilityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_us-gaap_SubsequentEventMember_custom_SecondAmendmentToLoanFacilityAgreementMember_custom_SkyPharmMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:SecondAmendmentToLoanFacilityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-01-31_us-gaap_SubsequentEventMember_custom_SecondAmendmentToLoanFacilityAgreementMember_custom_SkyPharmMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:SecondAmendmentToLoanFacilityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_custom_SecondAmendmentToLoanFacilityAgreementMember_custom_SkyPharmMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:SecondAmendmentToLoanFacilityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-01-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-06-01to2016-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-06-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-08-01to2012-08-31_custom_AmplerissimoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:AmplerissimoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-08-01</xbrli:startDate>
        <xbrli:endDate>2012-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-09-01to2014-09-30_custom_SkyPharmMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-09-01</xbrli:startDate>
        <xbrli:endDate>2014-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-12-01to2015-12-31_custom_SkyPharmMember_custom_FirstFloorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LeaseArrangementTypeAxis">COSM:FirstFloorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-12-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-05-01to2016-05-31_custom_SkyPharmMember_custom_AdditionalSpaceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LeaseArrangementTypeAxis">COSM:AdditionalSpaceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-05-01</xbrli:startDate>
        <xbrli:endDate>2016-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_IntellectualPropertySaleAgreementMember_custom_AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember_custom_OnOctoberOneTwoThousandSixteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">COSM:IntellectualPropertySaleAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">COSM:OnOctoberOneTwoThousandSixteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_IntellectualPropertySaleAgreementMember_custom_AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember_custom_ConclusionOfPreclinicalTrialsMember_custom_OnOctoberOneTwoThousandSixteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">COSM:IntellectualPropertySaleAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LeaseArrangementTypeAxis">COSM:ConclusionOfPreclinicalTrialsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">COSM:OnOctoberOneTwoThousandSixteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_IntellectualPropertySaleAgreementMember_custom_AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember_custom_ConclusionOfPhaseOneTestingMember_custom_OnOctoberOneTwoThousandSixteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">COSM:IntellectualPropertySaleAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LeaseArrangementTypeAxis">COSM:ConclusionOfPhaseOneTestingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">COSM:OnOctoberOneTwoThousandSixteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_IntellectualPropertySaleAgreementMember_custom_AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember_custom_ConclusionOfPhaseTwoTestingMember_custom_OnOctoberOneTwoThousandSixteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">COSM:IntellectualPropertySaleAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LeaseArrangementTypeAxis">COSM:ConclusionOfPhaseTwoTestingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">COSM:OnOctoberOneTwoThousandSixteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_IntellectualPropertySaleAgreementMember_custom_AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember_custom_ConclusionOfPhaseThreeTestingMember_custom_OnOctoberOneTwoThousandSixteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">COSM:IntellectualPropertySaleAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LeaseArrangementTypeAxis">COSM:ConclusionOfPhaseThreeTestingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">COSM:OnOctoberOneTwoThousandSixteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_custom_IntellectualPropertySaleAgreementMember_custom_AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember_custom_OnOctoberOneTwoThousandSixteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">COSM:IntellectualPropertySaleAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">COSM:OnOctoberOneTwoThousandSixteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_us-gaap_StockOptionMember_custom_EmployeeMember_custom_OnOctoberOneTwoThousandSixteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">COSM:EmployeeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">COSM:OnOctoberOneTwoThousandSixteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_us-gaap_StockOptionMember_custom_UsFinanceManagerMember_custom_OnOctoberOneTwoThousandSixteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">COSM:UsFinanceManagerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">COSM:OnOctoberOneTwoThousandSixteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-02-10_custom_DecahedronLtdMember_custom_StockPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">COSM:StockPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:DecahedronLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-02-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_custom_CyprusMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">COSM:CyprusMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_custom_GreeceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">COSM:GreeceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_DecahedronLtdMember_custom_PreliminaryAllocationAsOfFebruaryTenTwoThousandSeventeenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">COSM:DecahedronLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">COSM:PreliminaryAllocationAsOfFebruaryTenTwoThousandSeventeenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_DecahedronLtdMember_custom_AllocationAdjustmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">COSM:DecahedronLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">COSM:AllocationAdjustmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_DecahedronLtdMember_custom_FinalAllocationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">COSM:DecahedronLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">COSM:FinalAllocationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_LicensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">COSM:LicensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_custom_DecahedronLtdMember_us-gaap_ProFormaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">COSM:DecahedronLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:ProFormaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-09-30_custom_DecahedronLtdMember_us-gaap_ProFormaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">COSM:DecahedronLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:ProFormaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-02-25to2017-03-01_custom_ConsultingAgreementMember_custom_ArKoEuropeanBusinessServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">COSM:ConsultingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:ArKoEuropeanBusinessServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-02-25</xbrli:startDate>
        <xbrli:endDate>2017-03-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_custom_EmployeeMember_custom_PotentiallyDilutiveSecuritiesMember_custom_OnOctoberOneTwoThousandSixteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">COSM:EmployeeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">COSM:PotentiallyDilutiveSecuritiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">COSM:OnOctoberOneTwoThousandSixteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_EmployeeMember_custom_PotentiallyDilutiveSecuritiesMember_custom_OnOctoberOneTwoThousandSixteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">COSM:EmployeeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">COSM:PotentiallyDilutiveSecuritiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">COSM:OnOctoberOneTwoThousandSixteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_custom_EmployeeMember_custom_PotentiallyDilutiveSecuritiesMember_custom_OnJanuaryOneTwoThousandSeventeenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">COSM:EmployeeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">COSM:PotentiallyDilutiveSecuritiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">COSM:OnJanuaryOneTwoThousandSeventeenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_EmployeeMember_custom_PotentiallyDilutiveSecuritiesMember_custom_OnJanuaryOneTwoThousandSeventeenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">COSM:EmployeeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">COSM:PotentiallyDilutiveSecuritiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">COSM:OnJanuaryOneTwoThousandSeventeenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_custom_EmployeeMember_custom_PotentiallyDilutiveSecuritiesMember_custom_OnJanuaryThreeTwoThousandSeventeenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">COSM:EmployeeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">COSM:PotentiallyDilutiveSecuritiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">COSM:OnJanuaryThreeTwoThousandSeventeenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_EmployeeMember_custom_PotentiallyDilutiveSecuritiesMember_custom_OnJanuaryThreeTwoThousandSeventeenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">COSM:EmployeeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">COSM:PotentiallyDilutiveSecuritiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">COSM:OnJanuaryThreeTwoThousandSeventeenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_custom_LoanAgreementTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_custom_LoanAgreementThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_custom_LoanAgreementFiveMember_custom_PanagiotisDrakopoulosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementFiveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:PanagiotisDrakopoulosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_LoanAgreementEightMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementEightMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_SecondAmendmentToLoanFacilityAgreementMember_custom_SkyPharmMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:SecondAmendmentToLoanFacilityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_custom_SecondAmendmentToLoanFacilityAgreementMember_custom_SkyPharmMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:SecondAmendmentToLoanFacilityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-03-02to2017-03-16_custom_BridgeLoansMember_custom_SkyPharmMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:BridgeLoansMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-03-02</xbrli:startDate>
        <xbrli:endDate>2017-03-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-16_custom_BridgeLoansMember_custom_SkyPharmMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:BridgeLoansMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-03-02to2017-03-20_custom_BridgeLoansMember_custom_SkyPharmMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:BridgeLoansMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-03-02</xbrli:startDate>
        <xbrli:endDate>2017-03-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-20_custom_BridgeLoansMember_custom_SkyPharmMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:BridgeLoansMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_custom_DimitriosGoulielmosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:DimitriosGoulielmosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_DimitriosGoulielmosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:DimitriosGoulielmosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_custom_KonstantinosVassilopoulosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:KonstantinosVassilopoulosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_KonstantinosVassilopoulosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:KonstantinosVassilopoulosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_custom_OuraniaMatsoukiMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:OuraniaMatsoukiMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_OuraniaMatsoukiMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:OuraniaMatsoukiMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_GrigoriosSiokasMember_us-gaap_LoansPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:GrigoriosSiokasMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:UnderlyingAssetClassAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_custom_GrigoriosSiokasMember_us-gaap_LoansPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:GrigoriosSiokasMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:UnderlyingAssetClassAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_GrigoriosSiokasMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:GrigoriosSiokasMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_custom_DocPharmaSaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:DocPharmaSaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_DocPharmaSaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:DocPharmaSaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_DimitriosGoulielmosMember_custom_MediHelmSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:DimitriosGoulielmosMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">COSM:MediHelmSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-01to2016-10-25_custom_DecahedronMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">COSM:DecahedronMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-01</xbrli:startDate>
        <xbrli:endDate>2016-10-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_custom_DecahedronMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">COSM:DecahedronMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-07-01to2017-09-30_custom_SkyPharmMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-07-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-09-30_custom_SkyPharmMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-06-01to2016-06-30_custom_SkyPharmMember_custom_AdditionalSpaceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LeaseArrangementTypeAxis">COSM:AdditionalSpaceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-06-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_custom_AmplerissimoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:AmplerissimoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-09-30_custom_AmplerissimoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:AmplerissimoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_StockOptionMember_custom_EmployeeMember_custom_UsFinanceManagerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">COSM:UsFinanceManagerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_us-gaap_StockOptionMember_custom_UsFinanceManagerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">COSM:UsFinanceManagerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2016-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-07-01to2017-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-07-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_custom_UnitedKingdomofEnglandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">COSM:UnitedKingdomofEnglandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-02-25to2017-05-24_custom_ArKoEuropeanBusinessServicesMember_custom_ConsultingAgreementOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:ArKoEuropeanBusinessServicesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">COSM:ConsultingAgreementOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-02-25</xbrli:startDate>
        <xbrli:endDate>2017-05-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-05-24_custom_ArKoEuropeanBusinessServicesMember_custom_ConsultingAgreementOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:ArKoEuropeanBusinessServicesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">COSM:ConsultingAgreementOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-05-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-05-25_custom_ArKoEuropeanBusinessServicesMember_custom_ConsultingAgreementTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:ArKoEuropeanBusinessServicesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">COSM:ConsultingAgreementTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-05-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-03-02to2017-05-25_custom_ArKoEuropeanBusinessServicesMember_custom_ConsultingAgreementTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:ArKoEuropeanBusinessServicesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">COSM:ConsultingAgreementTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-03-02</xbrli:startDate>
        <xbrli:endDate>2017-05-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-05-18_custom_ArKoEuropeanBusinessServicesMember_custom_ConsultingAgreementThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:ArKoEuropeanBusinessServicesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">COSM:ConsultingAgreementThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-05-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-05-01to2017-05-18_custom_ArKoEuropeanBusinessServicesMember_custom_ConsultingAgreementThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:ArKoEuropeanBusinessServicesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">COSM:ConsultingAgreementThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-05-01</xbrli:startDate>
        <xbrli:endDate>2017-05-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-05-01to2017-05-25_custom_ArKoEuropeanBusinessServicesMember_custom_ConsultingAgreementFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:ArKoEuropeanBusinessServicesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">COSM:ConsultingAgreementFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-05-01</xbrli:startDate>
        <xbrli:endDate>2017-05-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-05-25_custom_ArKoEuropeanBusinessServicesMember_custom_ConsultingAgreementFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:ArKoEuropeanBusinessServicesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">COSM:ConsultingAgreementFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-05-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-04-07_custom_PotentiallyDilutiveSecuritiesMember_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">COSM:PotentiallyDilutiveSecuritiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-04-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-03-30to2017-04-07_custom_PotentiallyDilutiveSecuritiesMember_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">COSM:PotentiallyDilutiveSecuritiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-03-30</xbrli:startDate>
        <xbrli:endDate>2017-04-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-04-01to2017-04-10_us-gaap_InvestorMember_us-gaap_SubscriptionArrangementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">us-gaap:SubscriptionArrangementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-04-01</xbrli:startDate>
        <xbrli:endDate>2017-04-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-04-10_us-gaap_InvestorMember_us-gaap_SubscriptionArrangementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">us-gaap:SubscriptionArrangementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-04-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-04-26_us-gaap_InvestorMember_us-gaap_SubscriptionArrangementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">us-gaap:SubscriptionArrangementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-04-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-03-30to2017-04-26_us-gaap_InvestorMember_us-gaap_SubscriptionArrangementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">us-gaap:SubscriptionArrangementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-03-30</xbrli:startDate>
        <xbrli:endDate>2017-04-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_MrSiokasMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:MrSiokasMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-05-05_custom_BridgeLoansMember_custom_SkyPharmMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:BridgeLoansMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-05-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-05-01to2017-05-05_custom_BridgeLoansMember_custom_SkyPharmMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:BridgeLoansMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-05-01</xbrli:startDate>
        <xbrli:endDate>2017-05-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-04-10_custom_SkyPharmMember_custom_DecahedronMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:DecahedronMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-04-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-04-01to2017-04-10_custom_SkyPharmMember_custom_DecahedronMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:DecahedronMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-04-01</xbrli:startDate>
        <xbrli:endDate>2017-04-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_SkyPharmMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_custom_SkyPharmMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-07-01to2017-09-30_custom_AmplerissimoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:AmplerissimoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-07-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2016-09-30_custom_AmplerissimoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:AmplerissimoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2016-09-30_custom_SkyPharmMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_us-gaap_AcquisitionRelatedCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_custom_DimitriosGoulielmosMember_us-gaap_RestrictedStockMember_custom_AmplerissimoLtdMember_custom_ExchangeAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareholdersEquityClassAxis">COSM:DimitriosGoulielmosMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:AmplerissimoLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">COSM:ExchangeAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_us-gaap_OptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-05-12_custom_SkyPharmMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-05-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-05-01to2017-05-12_custom_SkyPharmMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-05-01</xbrli:startDate>
        <xbrli:endDate>2017-05-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2009-07-22_us-gaap_DirectorsAndOfficersLiabilityInsuranceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:DirectorsAndOfficersLiabilityInsuranceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2009-07-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-08-30_custom_SynthesisManagementLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SynthesisManagementLimitedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-08-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_SynthesisManagementLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SynthesisManagementLimitedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_us-gaap_OptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_us-gaap_OptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_us-gaap_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_us-gaap_StockOptionMember_custom_MrOrestesVarvitsiotesMember_custom_JanuaryThreeTwoThousandSeventeenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">COSM:MrOrestesVarvitsiotesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">COSM:JanuaryThreeTwoThousandSeventeenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_us-gaap_StockOptionMember_custom_MrOrestesVarvitsiotesMember_custom_JanuaryThreeTwoThousandSeventeenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">COSM:MrOrestesVarvitsiotesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">COSM:JanuaryThreeTwoThousandSeventeenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_us-gaap_StockOptionMember_custom_AegisCapitalCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:AegisCapitalCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_us-gaap_StockOptionMember_custom_EmployeeMember_custom_JanuaryOneTwoThousandSeventeenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">COSM:EmployeeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">COSM:JanuaryOneTwoThousandSeventeenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_us-gaap_StockOptionMember_custom_EmployeeMember_custom_OnJanuaryOneTwoThousandSeventeenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">COSM:EmployeeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">COSM:OnJanuaryOneTwoThousandSeventeenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_us-gaap_StockOptionMember_custom_InternationalFinanceManagerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">COSM:InternationalFinanceManagerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_us-gaap_StockOptionMember_custom_UsFinanceManagerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">COSM:UsFinanceManagerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-26to2017-10-02_us-gaap_SubsequentEventMember_custom_StockPurchaseAgreementMember_us-gaap_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PurchaseCommitmentExcludingLongtermCommitmentAxis">COSM:StockPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-26</xbrli:startDate>
        <xbrli:endDate>2017-10-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2017-10-11_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2017-10-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-11-01to2017-11-15_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_SeniorNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PurchaseCommitmentExcludingLongtermCommitmentAxis">COSM:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-11-01</xbrli:startDate>
        <xbrli:endDate>2017-11-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-08-01to2017-08-08_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-08-01</xbrli:startDate>
        <xbrli:endDate>2017-08-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-21_custom_CCPharmaGmbHMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:CCPharmaGmbHMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-09-30_custom_CCPharmaGmbHMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:CCPharmaGmbHMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-05-01to2017-05-16_us-gaap_InvestorMember_us-gaap_SubscriptionArrangementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">us-gaap:SubscriptionArrangementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-05-01</xbrli:startDate>
        <xbrli:endDate>2017-05-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-05-16_us-gaap_InvestorMember_us-gaap_SubscriptionArrangementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">us-gaap:SubscriptionArrangementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-05-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-07-21_us-gaap_InvestorMember_us-gaap_SubscriptionArrangementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">us-gaap:SubscriptionArrangementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-07-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-07-01to2017-07-21_us-gaap_InvestorMember_us-gaap_SubscriptionArrangementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">us-gaap:SubscriptionArrangementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-07-01</xbrli:startDate>
        <xbrli:endDate>2017-07-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_DocPharmaSaMember_custom_LoanAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:DocPharmaSaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">COSM:LoanAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_LoanAgreementOneMember_custom_AngeloDrakopoulosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:AngeloDrakopoulosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_custom_LoanAgreementFourMember_custom_PanagiotisDrakopoulosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:PanagiotisDrakopoulosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_custom_LoanAgreementTenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementTenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_PostMergerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareholdersEquityClassAxis">COSM:PostMergerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_custom_LoanAgreementElevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementElevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-07-31_custom_SecondAmendmentToLoanFacilityAgreementMember_custom_SkyPharmMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:SecondAmendmentToLoanFacilityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-11-15_us-gaap_SubsequentEventMember_custom_TradeFacilityAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PurchaseCommitmentExcludingLongtermCommitmentAxis">COSM:TradeFacilityAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-11-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-11-15_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_SeniorNotesMember_us-gaap_ConvertibleCommonStockMember111760343">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PurchaseCommitmentExcludingLongtermCommitmentAxis">COSM:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-11-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-11-15_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_custom_SeniorConvertibleNoteOneMember_custom_InstitutionalInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PurchaseCommitmentExcludingLongtermCommitmentAxis">COSM:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">COSM:SeniorConvertibleNoteOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">COSM:InstitutionalInvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-11-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-11-15_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_custom_SeniorConvertibleNoteTwoMember_custom_InstitutionalInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PurchaseCommitmentExcludingLongtermCommitmentAxis">COSM:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">COSM:SeniorConvertibleNoteTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">COSM:InstitutionalInvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-11-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-11-15_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PurchaseCommitmentExcludingLongtermCommitmentAxis">COSM:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-11-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-11-01to2017-11-15_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PurchaseCommitmentExcludingLongtermCommitmentAxis">COSM:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-11-01</xbrli:startDate>
        <xbrli:endDate>2017-11-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-11-01to2017-11-15_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_WarrantMember_custom_RegistrationRightsAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PurchaseCommitmentExcludingLongtermCommitmentAxis">COSM:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">COSM:RegistrationRightsAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-11-01</xbrli:startDate>
        <xbrli:endDate>2017-11-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-11-01to2017-11-15_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_WarrantMember_custom_LeakOutAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PurchaseCommitmentExcludingLongtermCommitmentAxis">COSM:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">COSM:LeakOutAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-11-01</xbrli:startDate>
        <xbrli:endDate>2017-11-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-05-01to2017-05-31_custom_SkyPharmMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">COSM:SkyPharmMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-05-01</xbrli:startDate>
        <xbrli:endDate>2017-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-05-04_custom_LoanAgreementSevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">COSM:LoanAgreementSevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-05-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USD_per_Share">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Number">
      <xbrli:measure>COSM:Integer</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="EUR">
      <xbrli:measure>iso4217:EUR</xbrli:measure>
    </xbrli:unit>
    <dei:EntityRegistrantName contextRef="From2017-01-01to2017-09-30">Cosmos Holdings Inc.</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="From2017-01-01to2017-09-30">0001474167</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="From2017-01-01to2017-09-30">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityVoluntaryFilers contextRef="From2017-01-01to2017-09-30">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2017-01-01to2017-09-30">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2017-01-01to2017-09-30">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:DocumentType contextRef="From2017-01-01to2017-09-30">10-Q</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2017-01-01to2017-09-30">2017-09-30</dei:DocumentPeriodEndDate>
    <dei:AmendmentFlag contextRef="From2017-01-01to2017-09-30">false</dei:AmendmentFlag>
    <dei:EntityFilerCategory contextRef="From2017-01-01to2017-09-30">Smaller Reporting Company</dei:EntityFilerCategory>
    <dei:DocumentFiscalPeriodFocus contextRef="From2017-01-01to2017-09-30">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2017-01-01to2017-09-30">2017</dei:DocumentFiscalYearFocus>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2016-12-31" unitRef="USD_per_Share" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2017-09-30" unitRef="USD_per_Share" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2016-12-31" unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2017-09-30" unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2016-12-31" unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2017-09-30" unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2016-12-31" unitRef="USD_per_Share" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2017-09-30" unitRef="USD_per_Share" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2017-11-15_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_SeniorNotesMember_us-gaap_ConvertibleCommonStockMember111760343" unitRef="USD_per_Share" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2016-12-31" unitRef="shares" decimals="INF">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2017-09-30" unitRef="shares" decimals="INF">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">716590</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">198049</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">1352172</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">619773</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2017-09-30_custom_LoanAgreementTwoMember" unitRef="USD" decimals="0">514</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2017-09-30_custom_LoanAgreementFourMember_custom_PanagiotisDrakopoulosMember" unitRef="USD" decimals="0">4801</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2017-09-30_custom_LoanAgreementSevenMember" unitRef="USD" decimals="0">886</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2017-09-30_custom_LoanAgreementSixMember" unitRef="USD" decimals="0">1204</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2017-09-30_custom_LoanAgreementNineMember" unitRef="USD" decimals="0">2099</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2017-09-30_custom_LoanAgreementTenMember" unitRef="USD" decimals="0">3305</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2017-09-30_custom_LoanAgreementElevenMember" unitRef="USD" decimals="0">283</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2017-09-30_custom_LoanAgreementEightMember" unitRef="USD" decimals="0">3662</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2017-09-30_custom_SecondAmendmentToLoanFacilityAgreementMember_custom_SkyPharmMember" unitRef="USD" decimals="0">143761</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2017-03-16_custom_BridgeLoansMember_custom_SkyPharmMember" unitRef="USD" decimals="0">4518</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2017-03-20_custom_BridgeLoansMember_custom_SkyPharmMember" unitRef="USD" decimals="0">8665</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2017-09-30_custom_DimitriosGoulielmosMember" unitRef="EUR" decimals="0">0</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2017-05-05_custom_BridgeLoansMember_custom_SkyPharmMember" unitRef="USD" decimals="0">1418</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2017-09-30_custom_DocPharmaSaMember_custom_LoanAgreementMember" unitRef="USD" decimals="0">612</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2017-09-30_custom_LoanAgreementOneMember_custom_AngeloDrakopoulosMember" unitRef="USD" decimals="0">1345</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2017-01-01to2017-09-30_us-gaap_FurnitureAndFixturesMember_us-gaap_MinimumMember">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2017-01-01to2017-09-30_us-gaap_FurnitureAndFixturesMember_us-gaap_MaximumMember">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2017-01-01to2017-09-30_us-gaap_ComputerEquipmentMember_us-gaap_MinimumMember">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2017-01-01to2017-09-30_us-gaap_ComputerEquipmentMember_us-gaap_MaximumMember">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2017-01-01to2017-09-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; border-bottom-style: solid; border-bottom-width: 1pt; font: 12pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Estimated Useful Life&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: bottom; font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Furniture and fixtures&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font: 12pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;5-7 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: bottom; font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Office and computer equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font: 12pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;3-5 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2017-11-20" unitRef="shares" decimals="INF">126867038</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2016-12-31" unitRef="shares" decimals="INF">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2017-09-30" unitRef="shares" decimals="INF">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2016-12-31" unitRef="shares" decimals="INF">125870532</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2017-09-30_custom_PriorToMergerMember" unitRef="shares" decimals="INF">25585532</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2017-09-30_us-gaap_EquityIssuedInBusinessCombinationMember_us-gaap_RestrictedStockMember_custom_AmplerissimoLtdMember_custom_ExchangeAgreementMember" unitRef="shares" decimals="INF">100000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2017-05-24_custom_ArKoEuropeanBusinessServicesMember_custom_ConsultingAgreementOneMember" unitRef="shares" decimals="INF">20000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2017-05-25_custom_ArKoEuropeanBusinessServicesMember_custom_ConsultingAgreementTwoMember" unitRef="shares" decimals="INF">20000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2017-05-18_custom_ArKoEuropeanBusinessServicesMember_custom_ConsultingAgreementThreeMember" unitRef="shares" decimals="INF">300000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2017-05-25_custom_ArKoEuropeanBusinessServicesMember_custom_ConsultingAgreementFourMember" unitRef="shares" decimals="INF">200000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2009-07-22_us-gaap_DirectorsAndOfficersLiabilityInsuranceMember" unitRef="shares" decimals="INF">20000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2017-09-30" unitRef="shares" decimals="INF">128253932</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2017-09-30_custom_PostMergerMember" unitRef="shares" decimals="INF">125585532</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2016-12-31" unitRef="shares" decimals="INF">125870532</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2017-09-30" unitRef="shares" decimals="INF">128253932</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2017-09-30_custom_PostMergerMember" unitRef="shares" decimals="INF">125585532</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">232051</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">21914</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="From2016-01-01to2016-12-31_custom_KonstantinosVassilopoulosMember_custom_DimitriosGoulielmosMember" unitRef="USD" decimals="0">63312</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="From2017-01-01to2017-09-30_custom_DimitriosGoulielmosMember" unitRef="USD" decimals="0">63200</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="From2017-01-01to2017-09-30_custom_KonstantinosVassilopoulosMember" unitRef="USD" decimals="0">9810</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="From2017-01-01to2017-09-30_custom_OuraniaMatsoukiMember" unitRef="USD" decimals="0">86751</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="From2017-01-01to2017-09-30_custom_GrigoriosSiokasMember_us-gaap_LoansPayableMember" unitRef="USD" decimals="0">145300</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2013-09-27_custom_AmplerissimoLtdMember" unitRef="Pure" decimals="INF">1.00</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <dei:EntityIncorporationStateCountryName contextRef="From2017-01-01to2017-09-30">Nevada</dei:EntityIncorporationStateCountryName>
    <dei:EntityIncorporationDateOfIncorporation contextRef="From2017-01-01to2017-09-30">2009-07-21</dei:EntityIncorporationDateOfIncorporation>
    <COSM:DescriptionForPeriodicInventorySystemMaintainance contextRef="From2017-01-01to2017-09-30">&lt;p style="margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;A periodic&#13;inventory system is maintained by 100% count&lt;/font&gt;&lt;/p&gt;</COSM:DescriptionForPeriodicInventorySystemMaintainance>
    <COSM:WorkingCapitalDeficit contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">-3546938</COSM:WorkingCapitalDeficit>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2017-01-01to2017-09-30_custom_DocPharmaSaMember_custom_LoanAgreementMember_custom_OnNovemberOneTwoThousandsFifteenMember">2016-10-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2017-01-01to2017-09-30_custom_GrigoriosSiokasMember_custom_OnOctoberOneTwoThousandSixteenMember">2017-10-01</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2014-11-01to2014-11-21_custom_DimitriosGoulielmosMember">2015-05-11</us-gaap:DebtInstrumentMaturityDate>
    <COSM:AmendmentToMaturityDate contextRef="From2012-08-01to2012-08-31_custom_AmplerissimoMember">2015-07-31</COSM:AmendmentToMaturityDate>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="AsOf2016-08-04_custom_LoanFacilityAgreementMember_custom_SynthesisFacilityAgreementMember_custom_GrigoriosSiokasMember" unitRef="shares" decimals="INF">10000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="AsOf2017-03-23_us-gaap_SubsequentEventMember_custom_SecondAmendmentToLoanFacilityAgreementMember_custom_SkyPharmMember" unitRef="shares" decimals="INF">10000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="AsOf2017-09-30_custom_IntellectualPropertySaleAgreementMember_custom_AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember_custom_OnOctoberOneTwoThousandSixteenMember" unitRef="shares" decimals="INF">2000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="AsOf2017-09-30_custom_IntellectualPropertySaleAgreementMember_custom_AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember_custom_ConclusionOfPreclinicalTrialsMember_custom_OnOctoberOneTwoThousandSixteenMember" unitRef="shares" decimals="INF">500000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="AsOf2017-09-30_custom_IntellectualPropertySaleAgreementMember_custom_AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember_custom_ConclusionOfPhaseOneTestingMember_custom_OnOctoberOneTwoThousandSixteenMember" unitRef="shares" decimals="INF">500000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="AsOf2017-09-30_custom_IntellectualPropertySaleAgreementMember_custom_AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember_custom_ConclusionOfPhaseTwoTestingMember_custom_OnOctoberOneTwoThousandSixteenMember" unitRef="shares" decimals="INF">500000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="AsOf2017-09-30_custom_IntellectualPropertySaleAgreementMember_custom_AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember_custom_ConclusionOfPhaseThreeTestingMember_custom_OnOctoberOneTwoThousandSixteenMember" unitRef="shares" decimals="INF">500000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="AsOf2017-02-10_custom_DecahedronLtdMember_custom_StockPurchaseAgreementMember" unitRef="shares" decimals="INF">1700000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="AsOf2017-11-15_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_SeniorNotesMember_us-gaap_ConvertibleCommonStockMember111760343" unitRef="shares" decimals="INF">6700000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="AsOf2017-11-15_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_WarrantMember" unitRef="shares" decimals="INF">5360003</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="From2017-01-01to2017-09-30_custom_EmployeeMember_custom_PotentiallyDilutiveSecuritiesMember_custom_OnOctoberOneTwoThousandSixteenMember" unitRef="shares" decimals="INF">120000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="From2017-01-01to2017-09-30_custom_EmployeeMember_custom_PotentiallyDilutiveSecuritiesMember_custom_OnJanuaryOneTwoThousandSeventeenMember" unitRef="shares" decimals="INF">250000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="From2017-01-01to2017-09-30_custom_EmployeeMember_custom_PotentiallyDilutiveSecuritiesMember_custom_OnJanuaryThreeTwoThousandSeventeenMember" unitRef="shares" decimals="INF">120000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="From2017-03-30to2017-04-07_custom_PotentiallyDilutiveSecuritiesMember_us-gaap_PrivatePlacementMember" unitRef="shares" decimals="INF">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="From2017-04-01to2017-04-10_us-gaap_InvestorMember_us-gaap_SubscriptionArrangementMember" unitRef="shares" decimals="INF">45800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="From2017-03-30to2017-04-26_us-gaap_InvestorMember_us-gaap_SubscriptionArrangementMember" unitRef="shares" decimals="INF">46700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="From2017-01-01to2017-09-30_us-gaap_OptionMember" unitRef="shares" decimals="INF">370000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="From2017-01-01to2017-09-30_us-gaap_WarrantMember" unitRef="shares" decimals="INF">100400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2017-01-01to2017-09-30_us-gaap_StockOptionMember_custom_UsFinanceManagerMember_custom_OnOctoberOneTwoThousandSixteenMember">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2017-01-01to2017-09-30_custom_EmployeeMember_custom_PotentiallyDilutiveSecuritiesMember_custom_OnOctoberOneTwoThousandSixteenMember">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2017-01-01to2017-09-30_custom_EmployeeMember_custom_PotentiallyDilutiveSecuritiesMember_custom_OnJanuaryOneTwoThousandSeventeenMember">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2017-01-01to2017-09-30_custom_EmployeeMember_custom_PotentiallyDilutiveSecuritiesMember_custom_OnJanuaryThreeTwoThousandSeventeenMember">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2017-01-01to2017-09-30_us-gaap_StockOptionMember_custom_MrOrestesVarvitsiotesMember_custom_JanuaryThreeTwoThousandSeventeenMember">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2017-01-01to2017-09-30_us-gaap_StockOptionMember_custom_EmployeeMember_custom_OnJanuaryOneTwoThousandSeventeenMember">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2017-01-01to2017-09-30_custom_EmployeeMember_custom_PotentiallyDilutiveSecuritiesMember_custom_OnOctoberOneTwoThousandSixteenMember" unitRef="USD_per_Share" decimals="INF">0.20</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2017-01-01to2017-09-30_custom_EmployeeMember_custom_PotentiallyDilutiveSecuritiesMember_custom_OnJanuaryOneTwoThousandSeventeenMember" unitRef="USD_per_Share" decimals="INF">0.10</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2017-01-01to2017-09-30_custom_EmployeeMember_custom_PotentiallyDilutiveSecuritiesMember_custom_OnJanuaryThreeTwoThousandSeventeenMember" unitRef="USD_per_Share" decimals="INF">0.20</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2017-01-01to2017-09-30_us-gaap_OptionMember" unitRef="USD_per_Share" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2017-01-01to2017-09-30_us-gaap_WarrantMember" unitRef="USD_per_Share" xsi:nil="true" />
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2017-09-30_custom_DocPharmaSaMember_custom_LoanAgreementMember_custom_OnNovemberOneTwoThousandsFifteenMember" unitRef="USD" decimals="0">12662</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2015-03-04_custom_LoanAgreementOneMember_custom_AngeloDrakopoulosMember" unitRef="USD" decimals="0">9000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2015-11-05_custom_LoanAgreementTwoMember" unitRef="USD" decimals="0">21812</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2015-11-05_custom_LoanAgreementThreeMember" unitRef="USD" decimals="0">87248</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2015-11-16_custom_LoanAgreementFourMember_custom_PanagiotisDrakopoulosMember" unitRef="USD" decimals="0">43624</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2015-12-31_custom_LoanAgreementFiveMember_custom_PanagiotisDrakopoulosMember" unitRef="USD" decimals="0">32718</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2016-02-05_custom_LoanAgreementEightMember_custom_LoanAgreementSixMember" unitRef="USD" decimals="0">21104</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2016-03-04_custom_LoanAgreementSevenMember" unitRef="USD" decimals="0">52760</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2016-04-19_custom_LoanAgreementEightMember" unitRef="USD" decimals="0">105520</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2016-04-22_custom_LoanAgreementNineMember" unitRef="USD" decimals="0">40098</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2016-05-24_custom_LoanAgreementTenMember" unitRef="USD" decimals="0">52760</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2016-10-18_custom_LoanAgreementElevenMember" unitRef="USD" decimals="0">10552</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2016-08-04_custom_LoanFacilityAgreementMember_custom_SkyPharmMember" unitRef="USD" decimals="0">1292769</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2016-09-13_custom_AmendmentToLoanFacilityAgreementMember_custom_SkyPharmMember" unitRef="USD" decimals="0">1533020</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2017-03-23_us-gaap_SubsequentEventMember_custom_SecondAmendmentToLoanFacilityAgreementMember_custom_SkyPharmMember" unitRef="USD" decimals="0">2664960</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2016-09-30_us-gaap_SubsequentEventMember_custom_SecondAmendmentToLoanFacilityAgreementMember_custom_SkyPharmMember" unitRef="USD" decimals="0">174000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2016-10-31_us-gaap_SubsequentEventMember_custom_SecondAmendmentToLoanFacilityAgreementMember_custom_SkyPharmMember" unitRef="USD" decimals="0">100000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2016-11-30_us-gaap_SubsequentEventMember_custom_SecondAmendmentToLoanFacilityAgreementMember_custom_SkyPharmMember" unitRef="USD" decimals="0">250000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2016-12-31_us-gaap_SubsequentEventMember_custom_SecondAmendmentToLoanFacilityAgreementMember_custom_SkyPharmMember" unitRef="USD" decimals="0">452471</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2017-01-31_us-gaap_SubsequentEventMember_custom_SecondAmendmentToLoanFacilityAgreementMember_custom_SkyPharmMember" unitRef="USD" decimals="0">155516</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2017-03-16_custom_BridgeLoansMember_custom_SkyPharmMember" unitRef="USD" decimals="0">50000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2017-03-20_custom_BridgeLoansMember_custom_SkyPharmMember" unitRef="USD" decimals="0">118130</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2017-09-30_custom_GrigoriosSiokasMember" unitRef="USD" decimals="0">1181</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2017-05-05_custom_BridgeLoansMember_custom_SkyPharmMember" unitRef="USD" decimals="0">34745</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2017-04-10_custom_SkyPharmMember_custom_DecahedronMember" unitRef="USD" decimals="0">2941950</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2017-09-30_custom_SkyPharmMember" unitRef="USD" decimals="0">6162736</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2017-05-12_custom_SkyPharmMember" unitRef="USD" decimals="0">2282200</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2017-07-31_custom_SecondAmendmentToLoanFacilityAgreementMember_custom_SkyPharmMember" unitRef="USD" decimals="0">342327</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2017-11-15_us-gaap_SubsequentEventMember_custom_TradeFacilityAgreementMember" unitRef="USD" decimals="0">2000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2016-05-04_custom_LoanAgreementSevenMember" unitRef="USD" decimals="0">52760</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <COSM:PaymentOfMiscellaneousBills contextRef="From2017-01-01to2017-09-30_custom_DocPharmaSaMember_custom_LoanAgreementMember_custom_OnNovemberOneTwoThousandsFifteenMember" unitRef="USD" decimals="0">12000</COSM:PaymentOfMiscellaneousBills>
    <COSM:PaymentOfMiscellaneousBills contextRef="From2016-01-01to2016-12-31_custom_KonstantinosVassilopoulosMember" unitRef="USD" decimals="0">10179</COSM:PaymentOfMiscellaneousBills>
    <COSM:PaymentOfMiscellaneousBills contextRef="From2015-03-01to2015-03-04_custom_LoanAgreementOneMember_custom_AngeloDrakopoulosMember" unitRef="USD" decimals="0">9000</COSM:PaymentOfMiscellaneousBills>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod contextRef="From2017-01-01to2017-09-30_custom_DocPharmaSaMember_custom_LoanAgreementMember_custom_OnNovemberOneTwoThousandsFifteenMember" unitRef="Pure" decimals="INF">0.02</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod contextRef="From2014-11-01to2014-11-21_custom_DimitriosGoulielmosMember" unitRef="Pure" decimals="INF">0.02</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod contextRef="From2015-03-01to2015-03-04_custom_LoanAgreementOneMember_custom_AngeloDrakopoulosMember" unitRef="Pure" decimals="INF">0.08</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod contextRef="From2015-11-01to2015-11-05_custom_LoanAgreementTwoMember" unitRef="Pure" decimals="INF">0.01</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod contextRef="From2015-11-01to2015-11-05_custom_LoanAgreementThreeMember" unitRef="Pure" decimals="INF">0.05</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod contextRef="From2015-11-01to2015-11-16_custom_LoanAgreementFourMember_custom_PanagiotisDrakopoulosMember" unitRef="Pure" decimals="INF">0.06</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod contextRef="From2016-02-01to2016-02-05_custom_LoanAgreementEightMember_custom_LoanAgreementSixMember" unitRef="Pure" decimals="INF">0.06</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod contextRef="From2016-03-01to2016-03-04_custom_LoanAgreementSevenMember" unitRef="Pure" decimals="INF">0.06</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod contextRef="From2016-04-01to2016-04-19_custom_LoanAgreementEightMember" unitRef="Pure" decimals="INF">0.06</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod contextRef="From2016-04-01to2016-04-22_custom_LoanAgreementNineMember" unitRef="Pure" decimals="INF">0.06</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod contextRef="From2016-05-01to2016-05-24_custom_LoanAgreementTenMember" unitRef="Pure" decimals="INF">0.06</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod contextRef="From2016-10-01to2016-10-18_custom_LoanAgreementElevenMember" unitRef="Pure" decimals="INF">0.10</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod contextRef="From2016-08-01to2016-08-04_custom_LoanFacilityAgreementMember_custom_SkyPharmMember" unitRef="Pure" decimals="INF">0.10</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod contextRef="From2017-03-02to2017-03-23_us-gaap_SubsequentEventMember_custom_SecondAmendmentToLoanFacilityAgreementMember_custom_SkyPharmMember" unitRef="Pure" decimals="INF">0.10</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod contextRef="From2017-03-02to2017-03-16_custom_BridgeLoansMember_custom_SkyPharmMember" unitRef="Pure" decimals="INF">0.10</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod contextRef="From2017-03-02to2017-03-20_custom_BridgeLoansMember_custom_SkyPharmMember" unitRef="Pure" decimals="INF">0.10</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod contextRef="From2017-05-01to2017-05-05_custom_BridgeLoansMember_custom_SkyPharmMember" unitRef="Pure" decimals="INF">0.10</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCredit contextRef="AsOf2017-09-30_custom_LoanAgreementTwoMember" unitRef="USD" decimals="0">11813</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit contextRef="AsOf2016-12-31_custom_LoanAgreementThreeMember" unitRef="USD" decimals="0">68588</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit contextRef="AsOf2017-09-30_custom_LoanAgreementFourMember_custom_PanagiotisDrakopoulosMember" unitRef="USD" decimals="0">35439</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit contextRef="AsOf2016-09-13_custom_AmendmentToLoanFacilityAgreementMember_custom_SkyPharmMember" unitRef="USD" decimals="0">240251</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit contextRef="AsOf2017-09-30_custom_SecondAmendmentToLoanFacilityAgreementMember_custom_SkyPharmMember" unitRef="USD" decimals="0">3007287</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit contextRef="AsOf2017-03-16_custom_BridgeLoansMember_custom_SkyPharmMember" unitRef="USD" decimals="0">50000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit contextRef="AsOf2017-03-20_custom_BridgeLoansMember_custom_SkyPharmMember" unitRef="USD" decimals="0">118130</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit contextRef="AsOf2017-09-30_custom_DimitriosGoulielmosMember" unitRef="USD" decimals="0">102182</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit contextRef="AsOf2017-09-30_custom_KonstantinosVassilopoulosMember" unitRef="USD" decimals="0">369</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit contextRef="AsOf2017-09-30_custom_OuraniaMatsoukiMember" unitRef="USD" decimals="0">31373</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit contextRef="AsOf2017-09-30_custom_GrigoriosSiokasMember_us-gaap_LoansPayableMember" unitRef="USD" decimals="0">521096</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit contextRef="AsOf2017-09-30_custom_GrigoriosSiokasMember" unitRef="USD" decimals="0">7088</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit contextRef="AsOf2017-05-05_custom_BridgeLoansMember_custom_SkyPharmMember" unitRef="USD" decimals="0">34745</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit contextRef="AsOf2017-09-30_custom_DocPharmaSaMember_custom_LoanAgreementMember" unitRef="USD" decimals="0">14176</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit contextRef="AsOf2017-09-30_custom_LoanAgreementOneMember_custom_AngeloDrakopoulosMember" unitRef="USD" decimals="0">9000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityExpirationDate1 contextRef="From2015-03-01to2015-03-04_custom_LoanAgreementOneMember_custom_AngeloDrakopoulosMember">2016-05-05</us-gaap:LineOfCreditFacilityExpirationDate1>
    <us-gaap:LineOfCreditFacilityExpirationDate1 contextRef="From2015-11-01to2015-11-05_custom_LoanAgreementTwoMember">2016-11-05</us-gaap:LineOfCreditFacilityExpirationDate1>
    <us-gaap:LineOfCreditFacilityExpirationDate1 contextRef="From2015-11-01to2015-11-05_custom_LoanAgreementThreeMember">2016-11-05</us-gaap:LineOfCreditFacilityExpirationDate1>
    <us-gaap:LineOfCreditFacilityExpirationDate1 contextRef="From2015-11-01to2015-11-16_custom_LoanAgreementFourMember_custom_PanagiotisDrakopoulosMember">2016-11-15</us-gaap:LineOfCreditFacilityExpirationDate1>
    <us-gaap:LineOfCreditFacilityExpirationDate1 contextRef="From2016-03-01to2016-03-04_custom_LoanAgreementSevenMember">2017-03-04</us-gaap:LineOfCreditFacilityExpirationDate1>
    <us-gaap:LineOfCreditFacilityExpirationDate1 contextRef="From2016-04-01to2016-04-19_custom_LoanAgreementEightMember">2017-04-19</us-gaap:LineOfCreditFacilityExpirationDate1>
    <us-gaap:LineOfCreditFacilityExpirationDate1 contextRef="From2016-04-01to2016-04-22_custom_LoanAgreementNineMember">2017-04-22</us-gaap:LineOfCreditFacilityExpirationDate1>
    <us-gaap:LineOfCreditFacilityExpirationDate1 contextRef="From2016-05-01to2016-05-24_custom_LoanAgreementTenMember">2017-05-24</us-gaap:LineOfCreditFacilityExpirationDate1>
    <us-gaap:LineOfCreditFacilityExpirationDate1 contextRef="From2016-10-01to2016-10-18_custom_LoanAgreementElevenMember">2017-10-18</us-gaap:LineOfCreditFacilityExpirationDate1>
    <us-gaap:LineOfCreditFacilityExpirationDate1 contextRef="From2017-03-02to2017-03-23_us-gaap_SubsequentEventMember_custom_SecondAmendmentToLoanFacilityAgreementMember_custom_SkyPharmMember">2016-08-04</us-gaap:LineOfCreditFacilityExpirationDate1>
    <us-gaap:LineOfCreditFacilityExpirationDate1 contextRef="From2017-03-02to2017-03-16_custom_BridgeLoansMember_custom_SkyPharmMember">2017-04-16</us-gaap:LineOfCreditFacilityExpirationDate1>
    <us-gaap:LineOfCreditFacilityExpirationDate1 contextRef="From2017-03-02to2017-03-20_custom_BridgeLoansMember_custom_SkyPharmMember">2017-04-20</us-gaap:LineOfCreditFacilityExpirationDate1>
    <us-gaap:LineOfCreditFacilityExpirationDate1 contextRef="From2017-05-01to2017-05-05_custom_BridgeLoansMember_custom_SkyPharmMember">2017-09-30</us-gaap:LineOfCreditFacilityExpirationDate1>
    <us-gaap:RepaymentsOfDebt contextRef="From2016-12-01to2016-12-31_custom_LoanAgreementTwoMember" unitRef="USD" decimals="0">2110</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt contextRef="From2016-01-01to2016-12-31_custom_LoanAgreementFiveMember_custom_PanagiotisDrakopoulosMember" unitRef="USD" decimals="0">13718</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt contextRef="From2017-01-01to2017-09-30_custom_LoanAgreementTwoMember" unitRef="USD" decimals="0">9450</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt contextRef="From2017-01-01to2017-09-30_custom_LoanAgreementThreeMember" unitRef="USD" decimals="0">64972</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt contextRef="From2017-01-01to2017-09-30_custom_LoanAgreementFiveMember_custom_PanagiotisDrakopoulosMember" unitRef="USD" decimals="0">20082</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt contextRef="From2017-01-01to2017-09-30_custom_LoanAgreementFourMember_custom_PanagiotisDrakopoulosMember" unitRef="USD" decimals="0">11813</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt contextRef="From2017-01-01to2017-09-30_custom_LoanAgreementTenMember" unitRef="USD" decimals="0">59065</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt contextRef="From2017-01-01to2017-09-30_custom_LoanAgreementElevenMember" unitRef="USD" decimals="0">11813</us-gaap:RepaymentsOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt contextRef="From2016-12-01to2016-12-31_custom_LoanAgreementTwoMember" unitRef="USD" decimals="0">10906</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt contextRef="From2016-12-01to2016-12-31_custom_LoanAgreementThreeMember" unitRef="USD" decimals="0">76342</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:LineOfCreditFacilityDescription contextRef="From2016-08-01to2016-08-04_custom_LoanFacilityAgreementMember_custom_SkyPharmMember">&lt;p style="margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The amounts&#13;owed under the Loan Facility shall be repayable upon the earlier of (i) three months following the demand of the lender; or (ii)&#13;August 31, 2018. No prepayment is permitted pursuant to the terms of the Loan Facility&lt;/font&gt;&lt;/p&gt;</us-gaap:LineOfCreditFacilityDescription>
    <us-gaap:LineOfCreditFacilityDescription contextRef="From2017-03-02to2017-03-23_us-gaap_SubsequentEventMember_custom_SecondAmendmentToLoanFacilityAgreementMember_custom_SkyPharmMember">&lt;p style="margin: 0"&gt;The amounts owed under the A&amp;#38;R Loan Facility shall be repayable upon the earlier of (i) seventy five&#13;days following the demand of the Lender; or (ii) August 31, 2018.&lt;/p&gt;</us-gaap:LineOfCreditFacilityDescription>
    <us-gaap:LineOfCreditFacilityDescription contextRef="From2017-04-01to2017-04-10_custom_SkyPharmMember_custom_DecahedronMember">The total facility will be calculated as 95% of the agreed upon value of Decahedrons receivables</us-gaap:LineOfCreditFacilityDescription>
    <us-gaap:LineOfCreditFacilityDescription contextRef="From2017-05-01to2017-05-12_custom_SkyPharmMember">The total facility will be calculated as 95% of the agreed upon value of Decahedrons receivables.</us-gaap:LineOfCreditFacilityDescription>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2016-12-31_us-gaap_SubsequentEventMember_custom_SecondAmendmentToLoanFacilityAgreementMember_custom_SkyPharmMember" unitRef="USD" decimals="0">141756</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2016-01-01to2016-12-31_custom_SecondAmendmentToLoanFacilityAgreementMember_custom_SkyPharmMember" unitRef="USD" decimals="0">14507</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2017-01-01to2017-09-30_custom_SecondAmendmentToLoanFacilityAgreementMember_custom_SkyPharmMember" unitRef="USD" decimals="0">52796</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2017-01-01to2017-09-30_custom_SkyPharmMember" unitRef="USD" decimals="0">34881</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:OperatingIncomeLoss contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">-2765020</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">-158917</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2017-01-01to2017-09-30_custom_DecahedronLtdMember_us-gaap_ProFormaMember" unitRef="USD" decimals="0">-2799003</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2016-01-01to2016-09-30_custom_DecahedronLtdMember_us-gaap_ProFormaMember" unitRef="USD" decimals="0">-279503</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="0">-30969</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="0">16448</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingExpenses contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">4383623</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">473249</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2017-01-01to2017-09-30_custom_DecahedronLtdMember_us-gaap_ProFormaMember" unitRef="USD" decimals="0">4411620</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2016-01-01to2016-09-30_custom_DecahedronLtdMember_us-gaap_ProFormaMember" unitRef="USD" decimals="0">614515</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="0">175919</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="0">758365</us-gaap:OperatingExpenses>
    <us-gaap:GrossProfit contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">1618603</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">314332</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2017-01-01to2017-09-30_custom_DecahedronLtdMember_us-gaap_ProFormaMember" unitRef="USD" decimals="0">1612617</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2016-01-01to2016-09-30_custom_DecahedronLtdMember_us-gaap_ProFormaMember" unitRef="USD" decimals="0">335012</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="0">144950</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="0">774813</us-gaap:GrossProfit>
    <us-gaap:CostOfRevenue contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">18156795</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">3192472</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2017-01-01to2017-09-30_custom_DecahedronLtdMember_us-gaap_ProFormaMember" unitRef="USD" decimals="0">18356228</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2016-01-01to2016-09-30_custom_DecahedronLtdMember_us-gaap_ProFormaMember" unitRef="USD" decimals="0">4672794</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="0">1269553</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="0">8772138</us-gaap:CostOfRevenue>
    <COSM:UnauditedAllocationOfPurchasePriceTableTextBlock contextRef="From2017-01-01to2017-09-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" id="hdcell" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Preliminary Allocation as of &lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;February 10, &lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Allocation&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Final&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Adjustments&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Allocation&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Current assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td id="ffcell" style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6,537&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6,537&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Intangible assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;50,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;50,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Other assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;305,400&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(216,562&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;88,838&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Total assets acquired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;361,937&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(216,562&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;145,375&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Liabilities assumed:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Debt&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;804,819&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(188,560&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;616,259&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Total liabilities assumed&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;804,819&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(188,560&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;616,259&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Net assets acquired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(442,882&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(28,002&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(470,884&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Consideration:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Value of Common Stock Issued at Acquisition&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,479,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,479,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Goodwill&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,921,882&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;28,002&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,949,884&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</COSM:UnauditedAllocationOfPurchasePriceTableTextBlock>
    <COSM:IntangibleAssetsTableTextBlock contextRef="From2017-01-01to2017-09-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Useful Life&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;(Years)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Licenses (a)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;50,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;50,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</COSM:IntangibleAssetsTableTextBlock>
    <COSM:UnauditedSupplementalProFormaDataTableTextBlock contextRef="From2017-01-01to2017-09-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" id="hdcell" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Nine Months Ended&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Revenues&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td id="ffcell" style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;19,968,845&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,007,806&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Cost of revenues&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;18,356,228&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,672,794&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Gross profit&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,612,617&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;335,012&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Operating expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,411,620&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;614,515&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Operating loss&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(2,799,003&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(279,503&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Other income (expense)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(524,952&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(238,528&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Net Loss&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(3,323,955&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(518,031&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</COSM:UnauditedSupplementalProFormaDataTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2017-01-01to2017-09-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" id="hdcell" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number of&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Contractual&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Intrinsic&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Term&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Balance Outstanding, December 31, 2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td id="ffcell" style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;120,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.20&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;74,400&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;370,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;.13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.58&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;150,800&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Balance Outstanding, September 30, 2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;490,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;.15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.44&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;191,600&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Exercisable, September 30, 2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;397,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;.15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.41&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;153,900&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:Depreciation contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">10831</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">6956</us-gaap:Depreciation>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2017-01-01to2017-09-30">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">6368</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:GoodwillAndIntangibleAssetImpairment contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">1949884</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <COSM:ImpairmentOfGoodwillPercent contextRef="From2017-01-01to2017-09-30" unitRef="Pure" decimals="INF">1.00</COSM:ImpairmentOfGoodwillPercent>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="From2017-01-01to2017-09-30_custom_CyprusMember" unitRef="Pure" decimals="INF">0.125</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="From2017-01-01to2017-09-30_custom_GreeceMember" unitRef="Pure" decimals="INF">0.29</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="From2017-01-01to2017-09-30_custom_UnitedKingdomofEnglandMember" unitRef="Pure" decimals="INF">0.20</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet contextRef="AsOf2017-09-30_custom_DecahedronLtdMember_custom_PreliminaryAllocationAsOfFebruaryTenTwoThousandSeventeenMember" unitRef="USD" decimals="0">1921882</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet contextRef="AsOf2017-09-30_custom_DecahedronLtdMember_custom_AllocationAdjustmentsMember" unitRef="USD" decimals="0">28002</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet contextRef="AsOf2017-09-30_custom_DecahedronLtdMember_custom_FinalAllocationMember" unitRef="USD" decimals="0">1949884</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <COSM:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedValueOfCommonStockIssuedAtAcquisition contextRef="AsOf2017-09-30_custom_DecahedronLtdMember_custom_PreliminaryAllocationAsOfFebruaryTenTwoThousandSeventeenMember" unitRef="USD" decimals="0">1479000</COSM:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedValueOfCommonStockIssuedAtAcquisition>
    <COSM:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedValueOfCommonStockIssuedAtAcquisition contextRef="AsOf2017-09-30_custom_DecahedronLtdMember_custom_AllocationAdjustmentsMember" unitRef="USD" xsi:nil="true" />
    <COSM:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedValueOfCommonStockIssuedAtAcquisition contextRef="AsOf2017-09-30_custom_DecahedronLtdMember_custom_FinalAllocationMember" unitRef="USD" decimals="0">1479000</COSM:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedValueOfCommonStockIssuedAtAcquisition>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet contextRef="AsOf2017-09-30_custom_DecahedronLtdMember_custom_PreliminaryAllocationAsOfFebruaryTenTwoThousandSeventeenMember" unitRef="USD" decimals="0">-442882</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet contextRef="AsOf2017-09-30_custom_DecahedronLtdMember_custom_AllocationAdjustmentsMember" unitRef="USD" decimals="0">-28002</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet contextRef="AsOf2017-09-30_custom_DecahedronLtdMember_custom_FinalAllocationMember" unitRef="USD" decimals="0">-470884</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities contextRef="AsOf2017-09-30_custom_DecahedronLtdMember_custom_PreliminaryAllocationAsOfFebruaryTenTwoThousandSeventeenMember" unitRef="USD" decimals="0">804819</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities contextRef="AsOf2017-09-30_custom_DecahedronLtdMember_custom_AllocationAdjustmentsMember" unitRef="USD" decimals="0">-188560</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities contextRef="AsOf2017-09-30_custom_DecahedronLtdMember_custom_FinalAllocationMember" unitRef="USD" decimals="0">616259</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt contextRef="AsOf2017-09-30_custom_DecahedronLtdMember_custom_PreliminaryAllocationAsOfFebruaryTenTwoThousandSeventeenMember" unitRef="USD" decimals="0">804819</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt contextRef="AsOf2017-09-30_custom_DecahedronLtdMember_custom_AllocationAdjustmentsMember" unitRef="USD" decimals="0">-188560</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt contextRef="AsOf2017-09-30_custom_DecahedronLtdMember_custom_FinalAllocationMember" unitRef="USD" decimals="0">616259</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="AsOf2017-09-30_custom_DecahedronLtdMember_custom_PreliminaryAllocationAsOfFebruaryTenTwoThousandSeventeenMember" unitRef="USD" decimals="0">361937</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="AsOf2017-09-30_custom_DecahedronLtdMember_custom_AllocationAdjustmentsMember" unitRef="USD" decimals="0">-216562</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="AsOf2017-09-30_custom_DecahedronLtdMember_custom_FinalAllocationMember" unitRef="USD" decimals="0">145375</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther contextRef="AsOf2017-09-30_custom_DecahedronLtdMember_custom_PreliminaryAllocationAsOfFebruaryTenTwoThousandSeventeenMember" unitRef="USD" decimals="0">305400</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther contextRef="AsOf2017-09-30_custom_DecahedronLtdMember_custom_AllocationAdjustmentsMember" unitRef="USD" decimals="0">-216562</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther contextRef="AsOf2017-09-30_custom_DecahedronLtdMember_custom_FinalAllocationMember" unitRef="USD" decimals="0">88838</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="AsOf2017-09-30_custom_DecahedronLtdMember_custom_PreliminaryAllocationAsOfFebruaryTenTwoThousandSeventeenMember" unitRef="USD" decimals="0">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="AsOf2017-09-30_custom_DecahedronLtdMember_custom_AllocationAdjustmentsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="AsOf2017-09-30_custom_DecahedronLtdMember_custom_FinalAllocationMember" unitRef="USD" decimals="0">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="AsOf2017-09-30_custom_LicensesMember" unitRef="USD" id="Foot-00-0" decimals="0">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets contextRef="AsOf2017-09-30_custom_DecahedronLtdMember_custom_PreliminaryAllocationAsOfFebruaryTenTwoThousandSeventeenMember" unitRef="USD" decimals="0">6537</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets contextRef="AsOf2017-09-30_custom_DecahedronLtdMember_custom_AllocationAdjustmentsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets contextRef="AsOf2017-09-30_custom_DecahedronLtdMember_custom_FinalAllocationMember" unitRef="USD" decimals="0">6537</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="From2017-01-01to2017-09-30_custom_DecahedronLtdMember_us-gaap_ProFormaMember" unitRef="USD" decimals="0">19968845</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="From2016-01-01to2016-09-30_custom_DecahedronLtdMember_us-gaap_ProFormaMember" unitRef="USD" decimals="0">5007806</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="From2017-01-01to2017-09-30_us-gaap_AcquisitionRelatedCostsMember" unitRef="USD" decimals="0">2622547</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="From2017-01-01to2017-09-30_custom_DecahedronLtdMember_us-gaap_ProFormaMember" unitRef="USD" decimals="0">-3323955</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="From2016-01-01to2016-09-30_custom_DecahedronLtdMember_us-gaap_ProFormaMember" unitRef="USD" decimals="0">-518031</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="From2017-01-01to2017-09-30_us-gaap_AcquisitionRelatedCostsMember" unitRef="USD" decimals="0">255672</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionNameOfAcquiredEntity contextRef="From2017-01-01to2017-09-30">DECAHEDRON, LTD</us-gaap:BusinessAcquisitionNameOfAcquiredEntity>
    <us-gaap:NumberOfBusinessesAcquired contextRef="From2017-01-01to2017-09-30" unitRef="Number" decimals="INF">1</us-gaap:NumberOfBusinessesAcquired>
    <COSM:AdjustmentRelatedToOtherAssetsAndAccountsPayable contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">28002</COSM:AdjustmentRelatedToOtherAssetsAndAccountsPayable>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">63724</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross contextRef="From2017-02-25to2017-03-01_custom_ConsultingAgreementMember_custom_ArKoEuropeanBusinessServicesMember" unitRef="shares" decimals="INF">5000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross contextRef="From2017-01-01to2017-09-30_custom_DimitriosGoulielmosMember_us-gaap_RestrictedStockMember_custom_AmplerissimoLtdMember_custom_ExchangeAgreementMember" unitRef="shares" decimals="INF">100000000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="AsOf2017-09-30_custom_EmployeeMember_custom_PotentiallyDilutiveSecuritiesMember_custom_OnOctoberOneTwoThousandSixteenMember" unitRef="shares" decimals="INF">120000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="AsOf2017-09-30_custom_EmployeeMember_custom_PotentiallyDilutiveSecuritiesMember_custom_OnJanuaryOneTwoThousandSeventeenMember" unitRef="shares" decimals="INF">187500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="AsOf2017-09-30_custom_EmployeeMember_custom_PotentiallyDilutiveSecuritiesMember_custom_OnJanuaryThreeTwoThousandSeventeenMember" unitRef="shares" decimals="INF">90000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:RepaymentsOfAccountsReceivableSecuritization contextRef="From2017-01-01to2017-09-30_custom_LoanAgreementThreeMember" unitRef="USD" decimals="0">11813</us-gaap:RepaymentsOfAccountsReceivableSecuritization>
    <COSM:AmendedMaturityDate contextRef="From2017-03-02to2017-03-16_custom_BridgeLoansMember_custom_SkyPharmMember">2017-05-16</COSM:AmendedMaturityDate>
    <COSM:AmendedMaturityDate contextRef="From2017-03-02to2017-03-20_custom_BridgeLoansMember_custom_SkyPharmMember">2017-05-20</COSM:AmendedMaturityDate>
    <us-gaap:DebtInstrumentDecreaseForgiveness contextRef="From2015-11-01to2015-11-04_custom_DimitriosGoulielmosMember" unitRef="USD" decimals="0">142860</us-gaap:DebtInstrumentDecreaseForgiveness>
    <COSM:DebtInstrumentDecreaseAccruedInterestForgiveness contextRef="From2015-11-01to2015-11-04_custom_DimitriosGoulielmosMember" unitRef="USD" decimals="0">806</COSM:DebtInstrumentDecreaseAccruedInterestForgiveness>
    <us-gaap:PrepaidInterest contextRef="AsOf2017-09-30_custom_DocPharmaSaMember" unitRef="USD" decimals="0">410991</us-gaap:PrepaidInterest>
    <us-gaap:PrepaidInterest contextRef="AsOf2017-09-30_custom_MrSiokasMember" unitRef="USD" decimals="0">70459</us-gaap:PrepaidInterest>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2016-12-31_custom_DocPharmaSaMember" unitRef="USD" decimals="0">69</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2017-09-30_custom_GrigoriosSiokasMember_custom_OnNovemberOneTwoThousandsFifteenMember_custom_OnOctoberOneTwoThousandSixteenMember" unitRef="USD" decimals="0">5276</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2016-12-31_custom_GrigoriosSiokasMember_us-gaap_LoansPayableMember" unitRef="USD" decimals="0">95496</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2016-12-31_custom_OuraniaMatsoukiMember" unitRef="USD" decimals="0">47479</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2014-11-21_custom_DimitriosGoulielmosMember" unitRef="USD" decimals="0">401115</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2015-11-04_custom_DimitriosGoulielmosMember" unitRef="EUR" decimals="0">200000</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2017-09-30_custom_OuraniaMatsoukiMember" unitRef="USD" decimals="0">64982</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2017-09-30_custom_GrigoriosSiokasMember_us-gaap_LoansPayableMember" unitRef="USD" decimals="0">559488</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2017-09-30_custom_DimitriosGoulielmosMember_custom_MediHelmSAMember" unitRef="USD" decimals="0">220988</us-gaap:DueToRelatedPartiesCurrent>
    <COSM:OperatingLeasePeriodicPayment contextRef="From2015-01-01to2015-01-31" unitRef="USD" decimals="0">730</COSM:OperatingLeasePeriodicPayment>
    <COSM:OperatingLeasePeriodicPayment contextRef="From2016-06-01to2016-09-30" unitRef="USD" decimals="0">709</COSM:OperatingLeasePeriodicPayment>
    <COSM:OperatingLeasePeriodicPayment contextRef="From2012-08-01to2012-08-31_custom_AmplerissimoMember" unitRef="USD" decimals="0">122</COSM:OperatingLeasePeriodicPayment>
    <COSM:OperatingLeasePeriodicPayment contextRef="From2014-09-01to2014-09-30_custom_SkyPharmMember" unitRef="USD" decimals="0">4802</COSM:OperatingLeasePeriodicPayment>
    <COSM:OperatingLeasePeriodicPayment contextRef="From2015-12-01to2015-12-31_custom_SkyPharmMember_custom_FirstFloorMember" unitRef="USD" decimals="0">886</COSM:OperatingLeasePeriodicPayment>
    <COSM:OperatingLeasePeriodicPayment contextRef="From2016-05-01to2016-05-31_custom_SkyPharmMember_custom_AdditionalSpaceMember" unitRef="USD" decimals="0">886</COSM:OperatingLeasePeriodicPayment>
    <COSM:OperatingLeasePeriodicPayment contextRef="From2017-01-01to2017-09-30_custom_IntellectualPropertySaleAgreementMember_custom_AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember_custom_OnOctoberOneTwoThousandSixteenMember" unitRef="USD" decimals="0">1500</COSM:OperatingLeasePeriodicPayment>
    <COSM:OperatingLeasePeriodicPayment contextRef="From2016-10-01to2016-10-25_custom_DecahedronMember" unitRef="USD" decimals="0">2415</COSM:OperatingLeasePeriodicPayment>
    <COSM:OperatingLeasePeriodicPayment contextRef="From2016-06-01to2016-06-30_custom_SkyPharmMember_custom_AdditionalSpaceMember" unitRef="USD" decimals="0">2021</COSM:OperatingLeasePeriodicPayment>
    <COSM:OperatingLeasePeriodicPayment contextRef="From2017-05-01to2017-05-31_custom_SkyPharmMember" unitRef="EUR" decimals="0">1250</COSM:OperatingLeasePeriodicPayment>
    <COSM:FrequencyOfPeriodicPayment contextRef="From2015-01-01to2015-01-31">Monthly</COSM:FrequencyOfPeriodicPayment>
    <COSM:FrequencyOfPeriodicPayment contextRef="From2016-06-01to2016-09-30">Monthly</COSM:FrequencyOfPeriodicPayment>
    <COSM:FrequencyOfPeriodicPayment contextRef="From2012-08-01to2012-08-31_custom_AmplerissimoMember">Monthly</COSM:FrequencyOfPeriodicPayment>
    <us-gaap:OperatingLeasesRentExpenseNet contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">6377</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">2834</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet contextRef="From2017-01-01to2017-09-30_custom_DecahedronMember" unitRef="USD" decimals="0">19580</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet contextRef="From2017-07-01to2017-09-30_custom_SkyPharmMember" unitRef="USD" decimals="0">30094</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet contextRef="From2016-01-01to2016-09-30_custom_SkyPharmMember" unitRef="USD" decimals="0">64127</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet contextRef="From2017-01-01to2017-09-30_custom_AmplerissimoMember" unitRef="USD" decimals="0">1105</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet contextRef="From2016-01-01to2016-09-30_custom_AmplerissimoMember" unitRef="USD" decimals="0">1103</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="0">2126</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="0">2126</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet contextRef="From2017-01-01to2017-09-30_custom_SkyPharmMember" unitRef="USD" decimals="0">84710</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet contextRef="From2017-07-01to2017-09-30_custom_AmplerissimoMember" unitRef="USD" decimals="0">368</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet contextRef="From2016-07-01to2016-09-30_custom_AmplerissimoMember" unitRef="USD" decimals="0">368</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet contextRef="From2016-07-01to2016-09-30_custom_SkyPharmMember" unitRef="USD" decimals="0">25961</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:LeaseExpirationDate1 contextRef="From2015-01-01to2015-01-31">2015-11-30</us-gaap:LeaseExpirationDate1>
    <us-gaap:LeaseExpirationDate1 contextRef="From2012-08-01to2012-08-31_custom_AmplerissimoMember">2013-07-31</us-gaap:LeaseExpirationDate1>
    <us-gaap:LesseeLeasingArrangementsOperatingLeasesTermOfContract contextRef="From2014-09-01to2014-09-30_custom_SkyPharmMember">P6Y</us-gaap:LesseeLeasingArrangementsOperatingLeasesTermOfContract>
    <us-gaap:LesseeLeasingArrangementsOperatingLeasesTermOfContract contextRef="From2016-10-01to2016-10-25_custom_DecahedronMember">P1Y</us-gaap:LesseeLeasingArrangementsOperatingLeasesTermOfContract>
    <us-gaap:DebtInstrumentTerm contextRef="From2017-04-01to2017-04-10_custom_SkyPharmMember_custom_DecahedronMember">P12M</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm contextRef="From2017-05-01to2017-05-12_custom_SkyPharmMember">P12M</us-gaap:DebtInstrumentTerm>
    <COSM:CreditFaciltyOriginationFeePercentage contextRef="AsOf2017-04-10_custom_SkyPharmMember_custom_DecahedronMember" unitRef="Pure" decimals="INF">0.02</COSM:CreditFaciltyOriginationFeePercentage>
    <COSM:CreditFaciltyOriginationFeePercentage contextRef="AsOf2017-05-12_custom_SkyPharmMember" unitRef="Pure" decimals="INF">0.02</COSM:CreditFaciltyOriginationFeePercentage>
    <us-gaap:CommonStockValue contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">125871</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2017-05-24_custom_ArKoEuropeanBusinessServicesMember_custom_ConsultingAgreementOneMember" unitRef="USD" decimals="0">14400</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2017-05-25_custom_ArKoEuropeanBusinessServicesMember_custom_ConsultingAgreementTwoMember" unitRef="USD" decimals="0">14400</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2017-05-18_custom_ArKoEuropeanBusinessServicesMember_custom_ConsultingAgreementThreeMember" unitRef="USD" decimals="0">219000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2017-05-25_custom_ArKoEuropeanBusinessServicesMember_custom_ConsultingAgreementFourMember" unitRef="USD" decimals="0">154000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2017-04-07_custom_PotentiallyDilutiveSecuritiesMember_us-gaap_PrivatePlacementMember" unitRef="USD" decimals="0">35000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">128254</us-gaap:CommonStockValue>
    <COSM:WarrantsWereValuedTableTextBlock contextRef="From2017-01-01to2017-09-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" id="hdcell" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;b&gt;September 30,&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;76.66%-90.86&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Expected term (in years)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td id="ffcell" style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Risk-free interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.07% - 1.11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;% &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Expected dividend yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;None&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</COSM:WarrantsWereValuedTableTextBlock>
    <COSM:WarrantsTableTextBlock contextRef="From2017-01-01to2017-09-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" id="hdcell" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number of&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Contractual&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Intrinsic&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Warrants&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Term&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Balance Outstanding, December 31, 2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td id="ffcell" style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;100,400&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Balance Outstanding, September 30, 2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;100,400&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;.55&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Exercisable, September 30, 2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;100,400&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;.55&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</COSM:WarrantsTableTextBlock>
    <invest:InvestmentMaturityDate1 contextRef="From2017-02-25to2017-05-24_custom_ArKoEuropeanBusinessServicesMember_custom_ConsultingAgreementOneMember">2018-01-01</invest:InvestmentMaturityDate1>
    <invest:InvestmentRepurchaseAgreementDateOfAgreement contextRef="From2017-02-25to2017-05-24_custom_ArKoEuropeanBusinessServicesMember_custom_ConsultingAgreementOneMember">2017-05-01</invest:InvestmentRepurchaseAgreementDateOfAgreement>
    <invest:InvestmentRepurchaseAgreementDateOfAgreement contextRef="From2017-03-02to2017-05-25_custom_ArKoEuropeanBusinessServicesMember_custom_ConsultingAgreementTwoMember">2017-05-01</invest:InvestmentRepurchaseAgreementDateOfAgreement>
    <invest:InvestmentRepurchaseAgreementDateOfAgreement contextRef="From2017-05-01to2017-05-18_custom_ArKoEuropeanBusinessServicesMember_custom_ConsultingAgreementThreeMember">2017-05-08</invest:InvestmentRepurchaseAgreementDateOfAgreement>
    <invest:InvestmentRepurchaseAgreementDateOfAgreement contextRef="From2017-05-01to2017-05-25_custom_ArKoEuropeanBusinessServicesMember_custom_ConsultingAgreementFourMember">2017-05-25</invest:InvestmentRepurchaseAgreementDateOfAgreement>
    <COSM:ConsultingAgreementPeriod contextRef="From2017-02-25to2017-05-24_custom_ArKoEuropeanBusinessServicesMember_custom_ConsultingAgreementOneMember">P8M</COSM:ConsultingAgreementPeriod>
    <COSM:ConsultingAgreementPeriod contextRef="From2017-03-02to2017-05-25_custom_ArKoEuropeanBusinessServicesMember_custom_ConsultingAgreementTwoMember">P5M</COSM:ConsultingAgreementPeriod>
    <COSM:ConsultingAgreementPeriod contextRef="From2017-05-01to2017-05-18_custom_ArKoEuropeanBusinessServicesMember_custom_ConsultingAgreementThreeMember">P1Y</COSM:ConsultingAgreementPeriod>
    <COSM:ConsultingAgreementPeriod contextRef="From2017-05-01to2017-05-25_custom_ArKoEuropeanBusinessServicesMember_custom_ConsultingAgreementFourMember">P20M</COSM:ConsultingAgreementPeriod>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2017-05-25_custom_ArKoEuropeanBusinessServicesMember_custom_ConsultingAgreementTwoMember" unitRef="USD_per_Share" decimals="INF">.72</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2017-05-25_custom_ArKoEuropeanBusinessServicesMember_custom_ConsultingAgreementFourMember" unitRef="USD_per_Share" decimals="INF">.77</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2017-04-10_us-gaap_InvestorMember_us-gaap_SubscriptionArrangementMember" unitRef="USD_per_Share" decimals="INF">0.70</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2017-04-26_us-gaap_InvestorMember_us-gaap_SubscriptionArrangementMember" unitRef="USD_per_Share" decimals="INF">0.70</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2017-05-16_us-gaap_InvestorMember_us-gaap_SubscriptionArrangementMember" unitRef="USD_per_Share" decimals="INF">0.70</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2017-07-21_us-gaap_InvestorMember_us-gaap_SubscriptionArrangementMember" unitRef="USD_per_Share" decimals="INF">.50</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:RestructuringCharges contextRef="From2017-05-01to2017-05-25_custom_ArKoEuropeanBusinessServicesMember_custom_ConsultingAgreementFourMember" unitRef="USD" decimals="0">32874</us-gaap:RestructuringCharges>
    <us-gaap:CommonStockSharesSubscribedButUnissued contextRef="AsOf2017-04-10_us-gaap_InvestorMember_us-gaap_SubscriptionArrangementMember" unitRef="shares" decimals="INF">45800</us-gaap:CommonStockSharesSubscribedButUnissued>
    <us-gaap:CommonStockSharesSubscribedButUnissued contextRef="AsOf2017-04-26_us-gaap_InvestorMember_us-gaap_SubscriptionArrangementMember" unitRef="shares" decimals="INF">46700</us-gaap:CommonStockSharesSubscribedButUnissued>
    <us-gaap:CommonStockSharesSubscribedButUnissued contextRef="AsOf2017-05-16_us-gaap_InvestorMember_us-gaap_SubscriptionArrangementMember" unitRef="shares" decimals="INF">7900</us-gaap:CommonStockSharesSubscribedButUnissued>
    <us-gaap:CommonStockSharesSubscribedButUnissued contextRef="AsOf2017-07-21_us-gaap_InvestorMember_us-gaap_SubscriptionArrangementMember" unitRef="shares" decimals="INF">43000</us-gaap:CommonStockSharesSubscribedButUnissued>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross contextRef="From2017-03-30to2017-04-07_custom_PotentiallyDilutiveSecuritiesMember_us-gaap_PrivatePlacementMember" unitRef="USD" decimals="0">35000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross contextRef="From2017-04-01to2017-04-10_us-gaap_InvestorMember_us-gaap_SubscriptionArrangementMember" unitRef="USD" decimals="0">2375</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross contextRef="From2017-03-30to2017-04-26_us-gaap_InvestorMember_us-gaap_SubscriptionArrangementMember" unitRef="USD" decimals="0">1521</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross contextRef="From2017-05-01to2017-05-16_us-gaap_InvestorMember_us-gaap_SubscriptionArrangementMember" unitRef="USD" decimals="0">130</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross>
    <COSM:DescriptionForPrepaidBalancePercentage contextRef="From2017-01-01to2017-09-30_custom_DocPharmaSaMember">&lt;p style="margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;over 10.3% of the Company&amp;#146;s&#13;total prepaid balance&lt;/font&gt;&lt;/p&gt;</COSM:DescriptionForPrepaidBalancePercentage>
    <us-gaap:ProfessionalFees contextRef="From2017-01-01to2017-09-30_custom_SkyPharmMember" unitRef="USD" decimals="0">201661</us-gaap:ProfessionalFees>
    <us-gaap:AmortizationOfDeferredLoanOriginationFeesNet contextRef="From2017-01-01to2017-09-30_custom_SkyPharmMember" unitRef="EUR" decimals="0">104338</us-gaap:AmortizationOfDeferredLoanOriginationFeesNet>
    <us-gaap:OtherRestructuringCosts contextRef="From2017-05-01to2017-05-18_custom_ArKoEuropeanBusinessServicesMember_custom_ConsultingAgreementThreeMember" unitRef="USD" decimals="0">5000</us-gaap:OtherRestructuringCosts>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2017-04-01to2017-04-10_us-gaap_InvestorMember_us-gaap_SubscriptionArrangementMember" unitRef="USD" decimals="0">32060</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2017-03-30to2017-04-26_us-gaap_InvestorMember_us-gaap_SubscriptionArrangementMember" unitRef="USD" decimals="0">32690</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2017-05-01to2017-05-16_us-gaap_InvestorMember_us-gaap_SubscriptionArrangementMember" unitRef="USD" decimals="0">5530</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2017-07-01to2017-07-21_us-gaap_InvestorMember_us-gaap_SubscriptionArrangementMember" unitRef="USD" decimals="0">21500</us-gaap:StockIssuedDuringPeriodValueOther>
    <COSM:MonthlyCreditFeePercentage contextRef="AsOf2017-04-10_custom_SkyPharmMember_custom_DecahedronMember" unitRef="Pure" decimals="INF">0.01</COSM:MonthlyCreditFeePercentage>
    <COSM:MonthlyCreditFeePercentage contextRef="AsOf2017-05-12_custom_SkyPharmMember" unitRef="Pure" decimals="INF">0.01</COSM:MonthlyCreditFeePercentage>
    <us-gaap:Assets contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">3118530</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">10835151</us-gaap:Assets>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill contextRef="AsOf2016-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:IntangibleAssetsNetIncludingGoodwill contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">44012</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">52715</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">79521</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherAssets contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">429203</us-gaap:OtherAssets>
    <us-gaap:OtherAssets contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">656382</us-gaap:OtherAssets>
    <us-gaap:AssetsCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">2636612</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">10055236</us-gaap:AssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">15523</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">481450</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">646530</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">2904989</us-gaap:PrepaidExpenseCurrent>
    <COSM:PrepaidDeferredFinancingFees contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">131900</COSM:PrepaidDeferredFinancingFees>
    <COSM:PrepaidDeferredFinancingFees contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">361289</COSM:PrepaidDeferredFinancingFees>
    <us-gaap:InventoryGross contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">464219</us-gaap:InventoryGross>
    <us-gaap:InventoryGross contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">2096818</us-gaap:InventoryGross>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">661850</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">2858518</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2016-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2017-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:Liabilities contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">4871332</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">13602174</us-gaap:Liabilities>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">4871332</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">13602174</us-gaap:LiabilitiesCurrent>
    <us-gaap:TaxesPayableCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">1080590</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">1313030</us-gaap:TaxesPayableCurrent>
    <us-gaap:OtherLoansPayable contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">148250</us-gaap:OtherLoansPayable>
    <us-gaap:OtherLoansPayable contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">559557</us-gaap:OtherLoansPayable>
    <us-gaap:LoansPayable contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">17938</us-gaap:LoansPayable>
    <us-gaap:LoansPayable contextRef="AsOf2017-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">160391</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">116358</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">2872472</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">9274201</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilities contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">13759</us-gaap:AccountsPayableAndOtherAccruedLiabilities>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilities contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">981</us-gaap:AccountsPayableAndOtherAccruedLiabilities>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">577932</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">2338047</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">3118530</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">10835151</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">-1752802</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">-2767023</us-gaap:StockholdersEquity>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">-1002219</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">-4076398</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">-1050463</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">-1228614</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">174009</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">2409735</us-gaap:AdditionalPaidInCapital>
    <us-gaap:PreferredStockValue contextRef="AsOf2016-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PreferredStockValue contextRef="AsOf2017-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">-1949884</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges contextRef="From2016-01-01to2016-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges contextRef="From2016-07-01to2016-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges contextRef="From2017-07-01to2017-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherDepreciationAndAmortization contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">17199</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">6956</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="0">2421</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="0">6167</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">2416540</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">466293</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="0">173498</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="0">752198</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:Revenues contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">19775398</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">3506804</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="0">1414503</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="0">9546951</us-gaap:Revenues>
    <us-gaap:NetIncomeLoss contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">-3074179</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">-277797</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="0">-94613</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="0">-198171</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">2690</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">773</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="0">-12</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2017-07-01to2017-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">-3071489</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">-277024</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="0">-94625</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="0">-198171</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:OtherOperatingIncomeExpenseNet contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">-306469</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">-118107</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="0">-63656</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="0">-214619</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">292937</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">-7043</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="0">-5555</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="0">89966</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:OtherExpenses contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">26529</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">4539</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="0">3388</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="0">13295</us-gaap:OtherExpenses>
    <us-gaap:InterestExpense contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">572679</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">103803</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="0">53794</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="0">291224</us-gaap:InterestExpense>
    <us-gaap:InterestExpenseOther contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">198</us-gaap:InterestExpenseOther>
    <us-gaap:InterestExpenseOther contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">2741</us-gaap:InterestExpenseOther>
    <us-gaap:InterestExpenseOther contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="0">919</us-gaap:InterestExpenseOther>
    <us-gaap:InterestExpenseOther contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="0">66</us-gaap:InterestExpenseOther>
    <us-gaap:OtherIncome contextRef="From2017-01-01to2017-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherIncome contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">19</us-gaap:OtherIncome>
    <us-gaap:OtherIncome contextRef="From2016-07-01to2016-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherIncome contextRef="From2017-07-01to2017-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2017-01-01to2017-09-30" unitRef="USD_per_Share" decimals="INF">-0.02</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2016-01-01to2016-09-30" unitRef="USD_per_Share" decimals="INF">-0.00</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2016-07-01to2016-09-30" unitRef="USD_per_Share" decimals="INF">-0.00</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2017-07-01to2017-09-30" unitRef="USD_per_Share" decimals="INF">-0.00</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">-3252330</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">-315982</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="0">-111235</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="0">-249645</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">-178151</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">-38185</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="0">-16622</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="0">-51474</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2017-01-01to2017-09-30" unitRef="shares" decimals="INF">127647201</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2016-01-01to2016-09-30" unitRef="shares" decimals="INF">125630532</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2016-07-01to2016-09-30" unitRef="shares" decimals="INF">125630532</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2017-07-01to2017-09-30" unitRef="shares" decimals="INF">128236217</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">401800</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="From2016-01-01to2016-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:ShareBasedCompensation contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">265529</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2016-01-01to2016-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">87677</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">5885</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">-5739560</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">-1235021</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="From2017-01-01to2017-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">62210</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">209667</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">36331</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">12778</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">135117</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">1056165</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">70681</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">-166896</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">-55880</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">-465927</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">-119796</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">2242785</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">198627</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">-1627085</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">-189435</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">-2137831</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">-316012</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">26933</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">-11880</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:AmortizationOfAcquisitionCosts contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">40858</us-gaap:AmortizationOfAcquisitionCosts>
    <us-gaap:AmortizationOfAcquisitionCosts contextRef="From2016-01-01to2016-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">13925</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">11880</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">6617777</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">1630248</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:ProceedsFromContributedCapital contextRef="From2017-01-01to2017-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromContributedCapital contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">140</us-gaap:ProceedsFromContributedCapital>
    <COSM:DeferredFinancingFees contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">-213626</COSM:DeferredFinancingFees>
    <COSM:DeferredFinancingFees contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">-140475</COSM:DeferredFinancingFees>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">91780</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="From2016-01-01to2016-09-30" unitRef="USD" xsi:nil="true" />
    <COSM:PaymentOfLoansPayable contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">20082</COSM:PaymentOfLoansPayable>
    <COSM:PaymentOfLoansPayable contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">33714</COSM:PaymentOfLoansPayable>
    <us-gaap:ProceedsFromRelatedPartyDebt contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">625641</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">51127</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromNotesPayable contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">6891203</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">1968940</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">461888</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">148904</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:ProceedsFromRepaymentsOfNotesPayable contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">-63200</us-gaap:ProceedsFromRepaymentsOfNotesPayable>
    <us-gaap:ProceedsFromRepaymentsOfNotesPayable contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">-44952</us-gaap:ProceedsFromRepaymentsOfNotesPayable>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">635582</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">421724</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">-269568</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="From2016-01-01to2016-09-30" unitRef="USD" decimals="0">38377</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:IncomeTaxesPaid contextRef="From2017-01-01to2017-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncomeTaxesPaid contextRef="From2016-01-01to2016-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:InterestPaid contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">127157</us-gaap:InterestPaid>
    <us-gaap:InterestPaid contextRef="From2016-01-01to2016-09-30" unitRef="USD" xsi:nil="true" />
    <COSM:ReversalOfProceedsDueFromNoteholderDueToRepaymentOfNote contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">11813</COSM:ReversalOfProceedsDueFromNoteholderDueToRepaymentOfNote>
    <COSM:ReversalOfProceedsDueFromNoteholderDueToRepaymentOfNote contextRef="From2016-01-01to2016-09-30" unitRef="USD" xsi:nil="true" />
    <COSM:AcquisitionOfDecahedron contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="0">1479000</COSM:AcquisitionOfDecahedron>
    <COSM:AcquisitionOfDecahedron contextRef="From2016-01-01to2016-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="AsOf2017-09-30" unitRef="Pure" decimals="INF">1.00</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">1479000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:CommonStockOtherSharesOutstanding contextRef="AsOf2017-09-30" unitRef="shares" decimals="INF">1700000</us-gaap:CommonStockOtherSharesOutstanding>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2017-01-01to2017-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;terms &amp;#147;COSM,&amp;#148; &amp;#147;we,&amp;#148; &amp;#147;the Company,&amp;#148; and &amp;#147;us&amp;#148; as used in this report refer to Cosmos&#13;Holdings Inc. The accompanying unaudited consolidated balance sheet as of September 30, 2017 and unaudited consolidated statements&#13;of operations for the three and nine months ended September 30, 2017 have been prepared in accordance with generally accepted&#13;accounting principles for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X.&#13;Accordingly, they do not include all of the information and footnotes required by U.S. generally accepted accounting principles&#13;for complete financial statements. In the opinion of management of COSM, all adjustments (consisting of normal recurring accruals)&#13;considered necessary for a fair presentation have been included. Operating results for the nine months ended September 30, 2017,&#13;are not necessarily indicative of the results that may be expected for the year ending December 31, 2017, or any other period.&#13;These unaudited consolidated financial statements and notes should be read in conjunction with the financial statements for each&#13;of the two years ended December 31, 2016 and 2015, included in the Company&amp;#146;s Annual Report on Form 10-K. The accompanying&#13;consolidated balance sheet as of December 31, 2016 has been derived from the audited financial statements filed in our Form 10-K&#13;and is included for comparison purposes in the accompanying balance sheet. Certain prior year amounts have been reclassified to&#13;conform to current year presentation.&lt;/font&gt;&lt;/p&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:NatureOfOperations contextRef="From2017-01-01to2017-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Cosmos&#13;Holdings, Inc. (&amp;#147;Cosmos&amp;#148;, &amp;#147;The Company&amp;#148;, &amp;#147;we&amp;#148;, or &amp;#147;us&amp;#148;) was incorporated in the&#13;State of Nevada under the name Prime Estates and Developments, Inc. on July 21, 2009 for the purpose of acquiring and operating&#13;commercial real estate and real estate related assets.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;September 27, 2013 (the &amp;#147;Closing&amp;#148;), Cosmos Holding Inc. a Nevada corporation (&amp;#147;Cosmos Holdings, Inc.&amp;#148;&#13;or the &amp;#147;Registrant&amp;#148;), closed a reverse take-over transaction by which it acquired a private company whose principal&#13;activities are the trading of products, providing representation, and provision of consulting services to various sectors. Pursuant&#13;to a Share Exchange Agreement (the &amp;#147;Exchange Agreement&amp;#148;) between the Registrant and Amplerissimo Ltd, a company incorporated&#13;in Cyprus (&amp;#147;Amplerissimo&amp;#148;), the Registrant acquired 100% of Amplerissimo&amp;#146;s issued and outstanding common stock.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;August 1, 2014, we, through our Cypriot subsidiary Amplerissimo, formed SkyPharm S.A. a Greek corporation (&amp;#147;SkyPharm&amp;#148;)&#13;whose principal activities and operations are the development, marketing and sales of pharmaceutical, wellness and cosmetic products.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;February 10, 2017, the Company and Decahedron Ltd, a UK Corporation (&amp;#147;Decahedron&amp;#148;) consummated the transactions contemplated&#13;by the Stock Purchase Agreement, dated November 17, 2016 as amended (the &amp;#147;Decahedron SPA&amp;#148;). Pursuant to the terms&#13;of the Decahedron SPA, the shareholders of Decahedron received an aggregate of 1,700,000 shares of common stock of the Company&#13;(the &amp;#147;Stock Consideration&amp;#148;), which were delivered following the closing in exchange for all of the Ordinary Shares&#13;of Decahedron for the Stock Consideration. In accordance with the terms of the SPA, Mr. Lazarou remained as a director and officer&#13;of Decahedron.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;We&#13;are currently focusing our existing operations on expanding the business of SkyPharm and our new subsidiary Decahedron, we have&#13;concentrated our efforts on becoming an international pharmaceutical company. The Company&amp;#146;s focus will be on Branded Pharmaceuticals,&#13;Over-the-Counter (OTC) medicines, and Generic Pharmaceuticals. The Company also intends to expand into Cosmetic-Beauty Products&#13;as well as Food Supplements and we target areas where we can build and maintain a strong position. The Company uses a differentiated&#13;operating model based on a lean, nimble and decentralized structure, an emphasis on low risk license acquisition as well as Research&#13;&amp;#38; Development and our ability to be better owners of pharmaceutical assets than others. This operating model and the execution&#13;of our corporate strategy are enabling the Company to achieve sustainable growth and create shareholder value.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;We&#13;regularly evaluate and, where appropriate, execute on opportunities to expand through the acquisition of branded pharmaceutical&#13;products and pharmaceutical companies in areas that will serve patients that we believe will offer above average growth characteristics&#13;and attractive margins. In particular, we look to continue to enhance our pharmaceutical and over the counter product lines by&#13;acquiring or licensing rights to additional products and regularly evaluate selective acquisition opportunities.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Going&#13;Concern&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company&amp;#146;s consolidated financial statements are prepared using U.S. GAAP applicable to a going concern, which contemplates&#13;the realization of assets and liquidation of liabilities in the normal course of business. The Company generated a net loss of&#13;$3,074,179 for the nine months ended September 30, 2017, and has a working capital deficit of $3,546,938 and an accumulated deficit&#13;of $4,076,398 as of September 30, 2017. These conditions raise substantial doubt of the Company&amp;#146;s ability to continue as&#13;a going concern. The Company has not yet established an adequate ongoing source of revenues sufficient to cover its operating&#13;costs and to allow it to continue as a going concern. The ability of the Company to continue as a going concern is dependent on&#13;the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain&#13;adequate capital, it could be forced to cease development of operations.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;order to continue as a going concern, develop a reliable source of revenues, and achieve a profitable level of operations the&#13;Company will need, among other things, additional capital resources. Management&amp;#146;s plans to continue as a going concern include&#13;raising additional capital through increased sales of product and by sale of common shares. However, management cannot provide&#13;any assurances that the Company will be successful in accomplishing any of its plans. The ability of the Company to continue as&#13;a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually&#13;secure other sources of financing and attain profitable operations. The accompanying consolidated financial statements do not&#13;include any adjustments that might be necessary if the Company is unable to continue as a going concern.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Summary&#13;of Significant Accounting Policies&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Basis&#13;of Financial Statement Presentation&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;accompanying consolidated financial statements have been prepared in accordance with principles generally accepted in the United&#13;States of America.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Principles&#13;of Consolidation&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Our&#13;consolidated accounts include our accounts and the accounts of our wholly-owned subsidiaries, Amplerissimo Ltd, SkyPharm S.A.&#13;and Decahedron Ltd. All significant intercompany balances and transactions have been eliminated.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Reclassifications&#13;to Prior Period Financial Statements and Adjustments&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Certain&#13;reclassifications have been made in the Company&amp;#146;s financial statements of the prior year to conform to the current year&#13;presentation. These reclassifications have no impact on previously reported net income.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&#13;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Use&#13;of Estimates&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires management&#13;to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets&#13;and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting&#13;period. Actual results could differ from those estimates.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Cash&#13;and Cash Equivalents&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;For&#13;purposes of the statement of cash flows, the Company considers all highly liquid investments purchased with an original maturity&#13;of three months or less to be cash equivalents. As of September 30, 2017 and December 31, 2016, there were no cash equivalents.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company maintains bank accounts in the United States denominated in U.S. Dollars and in the Republic of Cyprus, in Greece and&#13;in Bulgaria all of them denominated in Euros. The Company also maintains bank accounts in the United Kingdom of Great Britain,&#13;dominated in Euros and Great Britain Pound (British Pounds Sterling).&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Account&#13;Receivable &lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts&#13;receivable are stated at their net realizable value. The allowance for doubtful accounts against gross accounts receivable reflects&#13;the best estimate of probable losses inherent in the receivables portfolio determined on the basis of historical experience, specific&#13;allowances for known troubled accounts and other currently available information.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Inventory&#13;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Inventory&#13;is stated at the lower of cost or market value using the weighted average method. Inventory consists primarily of finished goods&#13;and packaging materials, i.e. packaged pharmaceutical products and the wrappers and containers they are sold in. A periodic inventory&#13;system is maintained by 100% count.&amp;#160;Inventory is replaced periodically to maintain the optimum stock on hand available for&#13;immediate shipment.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;We&#13;write-down inventories to net realizable value based on forecasted demand and market conditions, which may differ from actual&#13;results.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Fixed&#13;Assets&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Fixed&#13;assets are stated at cost, less accumulated depreciation. Depreciation is provided on a straight-line basis over the useful lives&#13;(except for leasehold improvements which are depreciated over the lesser of the lease term or the useful life) of the assets as&#13;follows:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font-size-adjust: none; font-stretch: normal"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; border-bottom-style: solid; border-bottom-width: 1pt; font: 12pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Estimated&#13;    Useful Life&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: bottom; font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Furniture&#13;    and fixtures&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font: 12pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5-7&#13;    years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: bottom; font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Office&#13;    and computer equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font: 12pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3-5&#13;    years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Depreciation&#13;expense was $10,831 and $6,956 for the nine months ended September 30, 2017 and 2016, respectively.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Intangible&#13;Assets&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Intangible&#13;assets with definite useful lives are recorded on the basis of cost and are amortized on a straight-line basis over their estimated&#13;useful lives. The Company uses a useful life of 5 years for an import/export license. The Company evaluates the remaining useful&#13;life of intangible assets annually to determine whether events and circumstances warrant a revision to the remaining amortization&#13;period. If the estimate of the intangible asset&amp;#146;s remaining useful life is changed, the remaining carrying amount of the&#13;intangible asset will be amortized prospectively over that revised remaining useful life. At September 30, 2017, no revision to&#13;the remaining amortization period of the intangible assets was made.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Amortization&#13;expense was $6,368 and $0 for the nine months ended September 30, 2017 and 2016, respectively.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Impairment&#13;of Long-Lived Assets&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;accordance with ASC 360-10, Long-lived assets, which include property and equipment and intangible assets, are reviewed for impairment&#13;whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability&#13;of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted&#13;future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted&#13;future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair&#13;value of the assets. Fair value is generally determined using the asset&amp;#146;s expected future discounted cash flows or market&#13;value, if readily determinable.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Goodwill&#13;and Intangibles &lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company periodically reviews the carrying value of intangible assets not subject to amortization, including goodwill, to determine&#13;whether impairment may exist. Goodwill and certain intangible assets are assessed annually, or when certain triggering events&#13;occur, for impairment using fair value measurement techniques. These events could include a significant change in the business&#13;climate, legal factors, a decline in operating performance, competition, sale or disposition of a significant portion of the business,&#13;or other factors. Specifically, goodwill impairment is determined using a two-step process. The first step of the goodwill impairment&#13;test is used to identify potential impairment by comparing the fair value of a reporting unit with its carrying amount, including&#13;goodwill. The Company uses level 3 inputs and a discounted cash flow methodology to estimate the fair value of a reporting unit.&#13;A discounted cash flow analysis requires one to make various judgmental assumptions including assumptions about future cash flows,&#13;growth rates, and discount rates. The assumptions about future cash flows and growth rates are based on the Company&amp;#146;s budget&#13;and long-term plans. Discount rate assumptions are based on an assessment of the risk inherent in the respective reporting units.&#13;If the fair value of a reporting unit exceeds its carrying amount, goodwill of the reporting unit is considered not impaired and&#13;the second step of the impairment test is unnecessary. If the carrying amount of a reporting unit exceeds its fair value, the&#13;second step of the goodwill impairment test is performed to measure the amount of impairment loss, if any. The second step of&#13;the goodwill impairment test compares the implied fair value of the reporting unit&amp;#146;s goodwill with the carrying amount of&#13;that goodwill. If the carrying amount of the reporting unit&amp;#146;s goodwill exceeds the implied fair value of that goodwill,&#13;an impairment loss is recognized in an amount equal to that excess. The implied fair value of goodwill is determined in the same&#13;manner as the amount of goodwill recognized in a business combination. That is, the fair value of the reporting unit is allocated&#13;to all of the assets and liabilities of that unit (including any unrecognized intangible assets) as if the reporting unit had&#13;been acquired in a business combination and the fair value of the reporting unit was the purchase price paid to acquire the reporting&#13;unit.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Prior&#13;to the acquisition of Decahedron, the Company had no record goodwill value. As a result of the acquisition of Decahedron, the&#13;Company tested and expensed 100% of the goodwill allocated to the acquisition costs, an amount equal to $1,949,884 for the period&#13;ending September 30, 2017.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Fair&#13;Value Measurement&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company adopted FASB ASC 820-Fair Value Measurements and Disclosures, or ASC 820, for assets and liabilities measured at fair&#13;value on a recurring basis. ASC 820 establishes a common definition for fair value to be applied to existing generally accepted&#13;accounting principles that require the use of fair value measurements establishes a framework for measuring fair value and expands&#13;disclosure about such fair value measurements. The adoption of ASC 820 did not have an impact on the Company&amp;#146;s financial&#13;position or operating results, but did expand certain disclosures.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;ASC&#13;820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction&#13;between market participants at the measurement date. Additionally, ASC 820 requires the use of valuation techniques that maximize&#13;the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Level&#13;1:&amp;#160;Observable inputs such as quoted prices (unadjusted)&amp;#160;in active markets for identical assets or liabilities.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Level&#13;2:&amp;#160;Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar&#13;assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not&#13;active.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Level&#13;3:&amp;#160;Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed&#13;by us, which reflect those that a market participant would use.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company did not have any Level 2 or Level 3 assets or liabilities as of September 30, 2017.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Cash&#13;is considered to be highly liquid and easily tradable as of September 30, 2017 and therefore classified as Level 1 within our&#13;fair value hierarchy.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;addition, FASB ASC 825-10-25 Fair Value Option, or ASC 825-10-25, was effective for January 1, 2008. ASC 825-10-25 expands opportunities&#13;to use fair value measurements in financial reporting and permits entities to choose to measure many financial instruments and&#13;certain other items at fair value. The Company did not elect the fair value options for any of its qualifying financial instruments.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Revenue&#13;Recognition&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;We&#13;consider revenue recognizable when persuasive evidence of an arrangement exists, the price is fixed or determinable, goods or&#13;services have been delivered, and collectability is reasonably assured. These criteria are assumed to have been met if a customer&#13;orders an item, the goods or services have been shipped or delivered to the customer, and we have sufficient evidence of collectability,&#13;such a payment history with the customer. Revenue that is billed and received in advance such as recurring weekly or monthly services&#13;are initially deferred and recognized as revenue over the period the services are provided.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Stock-based&#13;Compensation&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company records stock based compensation in accordance with ASC section 718, &amp;#147;Stock Compensation&amp;#148; and Staff Accounting&#13;Bulletin (SAB) No. 107 (SAB 107) issued by the SEC in March 2005 regarding its interpretation of ASC 718. ASC 718 requires the&#13;fair value of all stock-based employee compensation awarded to employees to be recorded as an expense over the related requisite&#13;service period. The Company values any employee or non-employee stock based compensation at fair value using the Black-Scholes&#13;Option Pricing Model.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company accounts for non-employee share-based awards in accordance with the measurement and recognition criteria of ASC 505-50&#13;&amp;#147;Equity-Based Payments to Non-Employees&amp;#148;.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Foreign&#13;Currency Translations and Transactions&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Assets&#13;and liabilities of all foreign operations are translated at year-end rates of exchange, and the statements of operations are translated&#13;at the average rates of exchange for the year. Gains or losses resulting from translating foreign currency financial statements&#13;are accumulated in a separate component of stockholders&amp;#146; equity until the entity is sold or substantially liquidated.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Gains&#13;or losses from foreign currency transactions (transactions denominated in a currency other than the entity&amp;#146;s local currency)&#13;are included in net earnings.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Income&#13;Taxes&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company accounts for income taxes under the asset and liability method, as required by the accounting standard for income taxes&amp;#160;ASC&#13;740. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences&#13;between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis, as well as&#13;net operating loss carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply&#13;to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred&#13;tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company is liable for income taxes in the Republic of Cyprus, Greece and the United Kingdom of England. The corporate income tax&#13;rate in Cyprus is 12.5%, 29% in Greece (tax losses are carried forward for five years effective January 1, 2013) and 20% in United&#13;Kingdom of England. Losses may also be subject to limitation under certain rules regarding change of ownership.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;We&#13;regularly review deferred tax assets to assess their potential realization and establish a valuation allowance for portions of&#13;such assets to reduce the carrying value if we do not consider it to be more likely than not that the deferred tax assets will&#13;be realized. Our review includes evaluating both positive (e.g., sources of taxable income) and negative (e.g., recent historical&#13;losses) evidence that could impact the realizability of our deferred tax assets.&amp;#160;At September 30, 2017 the Company has maintained&#13;a valuation allowance against all net deferred tax assets in each jurisdiction in which it is subject to income tax.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;We&#13;recognize the impact of an uncertain tax position in our financial statements if, in management&amp;#146;s judgment, the position&#13;is&amp;#160;not&amp;#160;more-likely-then-not sustainable upon audit based on the position&amp;#146;s technical merits. This involves the&#13;identification of potential uncertain tax positions, the evaluation of applicable tax laws and an assessment of whether a liability&#13;for an uncertain tax position is necessary. As of September 30, 2017 the Company has no uncertain tax positions recorded in any&#13;jurisdiction where it is subject to income tax.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Basic&#13;and Diluted Net Income (Loss) per Common Share&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Basic&#13;and diluted net loss per share calculations are calculated on the basis of the weighted average number of common shares outstanding&#13;during the periods presented. The per share amounts include the dilutive effect of common stock equivalents in periods with net&#13;income. Basic and diluted loss per share for each of the periods ended September 30, 2017 and 2016 is the same due to the anti-dilutive&#13;nature of potential common stock equivalents.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Recent&#13;Accounting Pronouncements&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;January 2017, the FASB issued ASU 2017-04, Intangibles &amp;#150; Goodwill and Other (Topic 350), which simplifies the measurement&#13;of goodwill by eliminating Step 2 from the current goodwill impairment test in the event that there is evidence of an impairment&#13;based on qualitative or quantitative assessments. ASU 2017-04 does not change how the goodwill impairment is identified, and the&#13;Company will continue to perform a qualitative assessment annually to determine whether the two step impairment test is required.&#13;Until the adoption, current accounting standards require the impairment loss to be recognized under Step 2 of the impairment test.&#13;This requires the Company to calculate the implied fair value of goodwill by assigning fair value to the reporting unit&amp;#146;s&#13;assets and liabilities as if the reporting unit has been acquired in a business combination, then subsequently subtracting the&#13;implied goodwill from the carrying amount of the goodwill. The new standard would require the Company to determine the fair value&#13;of the reporting unit and subtract the carrying value from the fair value of the reporting unit to determine if there is an impairment.&#13;ASU 2017-04 is effective for the Company for fiscal years after December 15, 2019, and early adoption is permitted. ASU 2017-04&#13;is required to be adopted prospectively, and the adoption is effective for annual goodwill impairment tests performed in the year&#13;of adoption. The Company does not believe that the adoption of ASU No. 2017-4 will have a material effect on the Company&amp;#146;s&#13;consolidated financial position or the Company&amp;#146;s consolidated results of operations&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;January 2017, the FASB issued ASU No. 2017-01, &amp;#147;Clarifying the Definition of a Business,&amp;#148; with the objective of adding&#13;guidance to assist entities with evaluating whether transactions should be accounted for as an acquisition of assets or a business.&#13;ASU No. 2017-01 is effective for the Company&amp;#146;s fiscal year commencing on January 1, 2018. The effect of this guidance is&#13;to be applied prospectively and early adoption is permitted. The Company does not believe that the adoption of ASU No. 2017-01&#13;will have a material effect on the Company&amp;#146;s consolidated financial position or the Company&amp;#146;s consolidated results&#13;of operations.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;February 2016, the FASB issued ASU 2016-02, &amp;#147;Leases,&amp;#148; which will require lessees to recognize assets and liabilities&#13;for the rights and obligations created by most leases on the balance sheet. The changes become effective for the Company&amp;#146;s&#13;fiscal year beginning July 1, 2019. Modified retrospective adoption for all leases existing at, or entered into after, the date&#13;of initial application, is required with an option to use certain transition relief. The Company expects this ASU will increase&#13;its current assets and current liabilities, but have no net material impact on its consolidated financial statements.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;May 2014, the FASB issued ASU 2014-09--Revenue from Contracts with Customers (Topic 606). The guidance requires an entity to recognize&#13;the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The FASB&#13;delayed the effective date to annual reporting periods beginning after December 15, 2017, including interim reporting periods&#13;within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 15,&#13;2016, including interim reporting periods within that reporting period. In addition, in March and April 2016, the FASB issued&#13;new guidance intended to improve the operability and understandability of the implementation guidance on principal versus agent&#13;considerations. Both amendments permit the use of either a retrospective or cumulative effect transition method and are effective&#13;for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017, with early application permitted.&#13;The Company is currently evaluating the impact the adoption of this ASU will have on its financial statements.&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Management&#13;does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material&#13;effect on the Company&amp;#146;s financial statements.&lt;/font&gt;&lt;/p&gt;</us-gaap:NatureOfOperations>
    <COSM:Note3AcquisitionOfDecahedronLtdTextBlock contextRef="From2017-01-01to2017-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;February 10, 2017, the Company completed the acquisition pursuant to the Decahedron SPA acquiring 100% of the outstanding shares&#13;of Decahedron, a United Kingdom company. Decahedron is a pharmaceuticals wholesaler which specializes in imports and exports of&#13;branded and generic pharmaceutical products within the EEA and around the world. At closing, the Company acquired 100% of Decahedron&amp;#146;s&#13;outstanding shares in exchange for 1,700,000 shares of Cosmos common stock valued at $1,479,000 (the &amp;#147;Acquisition&amp;#148;).&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company recognized the Decahedron assets acquired and liabilities assumed based upon the fair value of such assets and liabilities&#13;measured as of the date of acquisition. The aggregate purchase price for Decahedron has been allocated to the tangible and identifiable&#13;intangible assets acquired and liabilities assumed based on their estimated fair values at the date of acquisition. The excess&#13;of the purchase price over the fair value of the acquired net assets represents cost and revenue synergies specific to the Company,&#13;as well as non-capitalizable intangible assets, such as the license held by Decahedron for the wholesale of pharmaceuticals in&#13;the United Kingdome and Europe, the remainder has been allocated to goodwill, none of which is tax deductible.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;During&#13;the nine months ended September&amp;#160;30, 2017, we recorded an adjustment of $28,002 primarily related to other assets and an adjustment&#13;of the accounts payable associated with the Decahedron acquisition. We finalized our allocation of the purchase price during the&#13;nine months ended September&amp;#160;30, 2017. The final unaudited allocation of purchase price as of September&amp;#160;30, 2017, is&#13;as follows:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" id="hdcell" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Preliminary&#13;    Allocation as of &lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;February&#13;    10, &lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Allocation&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Final&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Adjustments&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Allocation&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Current&#13;    assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td id="ffcell" style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6,537&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6,537&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Intangible&#13;    assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;50,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;50,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other&#13;    assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;305,400&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(216,562&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;88,838&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&#13;    assets acquired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;361,937&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(216,562&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;145,375&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Liabilities&#13;    assumed:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Debt&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;804,819&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(188,560&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;616,259&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&#13;    liabilities assumed&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;804,819&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(188,560&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;616,259&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net&#13;    assets acquired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(442,882&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(28,002&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(470,884&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Consideration:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Value&#13;    of Common Stock Issued at Acquisition&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,479,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,479,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Goodwill&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,921,882&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;28,002&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,949,884&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;components of the acquired intangible assets were as follows (in thousands):&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; font-size-adjust: none; font-stretch: normal"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Useful&#13;    Life&lt;/b&gt;&lt;br /&gt;&#13;    &lt;b&gt;(Years)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Licenses&#13;    (a)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;50,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;50,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;_____________&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(a)&#13;U.K Pharmaceutical Wholesale Distribution License&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Unaudited&#13;Supplemental Pro Forma Data&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;pro forma statements of operations data for the nine months ended September 30, 2017, below, give effect to the Decahedron Acquisition,&#13;described above, as if it had occurred at January 1, 2017. These amounts have been calculated after applying our accounting policies&#13;and adjusting the results of Decahedron intangible amortization that would have been charged assuming the fair value adjustments&#13;had been applied and incurred since January 1, 2017. This pro forma data is presented for informational purposes only and does&#13;not purport to be indicative of our future results of operations.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Revenue&#13;of $2,622,547 and net loss of $255,672 since the acquisition date are included in the consolidated statement of operations and&#13;comprehensive income (loss) for nine months ended September 30, 2017.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Unaudited&#13;proforma results of operations for the nine months ended September 30, 2017 and 2016 as though the Company acquired Decahedron&#13;on the first of each fiscal year are set forth below.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Nine&#13;    Months Ended&lt;/b&gt;&lt;br /&gt;&#13;    &lt;b&gt;September 30,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Revenues&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;19,968,845&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5,007,806&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Cost&#13;    of revenues&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;18,356,228&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4,672,794&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Gross&#13;    profit&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,612,617&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;335,012&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Operating&#13;    expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4,411,620&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;614,515&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Operating&#13;    loss&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2,799,003&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(279,503&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other&#13;    income (expense)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(524,952&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(238,528&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net&#13;    Loss&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3,323,955&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(518,031&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;purchase price exceeded the estimated fair value of the net assets acquired by $1,949,884 which was recorded as Goodwill. Goodwill&#13;represents the difference between the total purchase price for the net assets purchased from Decahedron and the aggregate fair&#13;values of tangible and intangible assets acquired, less liabilities assumed. At the conclusion of the acquisition, goodwill was&#13;reviewed for impairment and it was determined that indicators of impairment existed.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;As&#13;of September 30, 2017, after our assessment of the totality of the events that could impair goodwill, it was the Company&amp;#146;s&#13;conclusion &amp;#147;it is not more likely than not&amp;#148; that the Goodwill was impaired. Therefore, the Company was not required&#13;to conduct a two-step quantitative goodwill impairment test. No events have occurred after September 30, 2017 that would affect&#13;the Company&amp;#146;s conclusion as of the September 30, 2017 assessment date. As a result of the Company&amp;#146;s assessment, 100%&#13;of the goodwill of $1,949,884 was recorded as an impairment of goodwill.&lt;/font&gt;&lt;/p&gt;</COSM:Note3AcquisitionOfDecahedronLtdTextBlock>
    <COSM:PrepaidDeferredFinancingCostsTextBlock contextRef="From2017-01-01to2017-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;February 28, 2016, the Company entered into an agreement with Synthesis Management Limited (&amp;#147;Synthesis Management&amp;#148;)&#13;for the purpose of securing additional financing for the Company. On September 28, 2016, the Company advanced &amp;#128;125,000 ($133,725)&#13;to Synthesis Management. These advances are refundable if funding is not secured and if funding is secured, the amount will be&#13;applied to the note on day one as debt discount. As of September 30, 2017, the outstanding balance on the advance is &amp;#128;125,000&#13;($147,662).&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;August, 2017 the Company entered into an agreement with Synthesis Multi Asset Architecture (&amp;#147;Synthesis Architecture&amp;#148;)&#13;for the purpose of securing additional financing for the Company. On August 14, 2017, the Company advanced Synthesis Architecture&#13;&amp;#128;180,840 ($213,627). These advances are refundable if funding is not secured and if funding is secured, the amount will be&#13;applied to the note on day one as debt discount. As of September 30, 2017, the outstanding balance on the advance is &amp;#128;180,840&#13;($213,627).&lt;/font&gt;&lt;/p&gt;</COSM:PrepaidDeferredFinancingCostsTextBlock>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2017-01-01to2017-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;At&#13;September 30, 2017, the Company&amp;#146;s effective tax rate differs from the US federal statutory tax rate primarily due to a valuation&#13;allowance recorded against net deferred tax assets in all jurisdictions in which the Company operates. At December 31, 2016, the&#13;Company&amp;#146;s effective tax rate differed from the US federal statutory tax rate primarily due to earnings taxed at the lower&#13;income tax rate in Cyprus.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;We&#13;regularly review deferred tax assets to assess their potential realization and establish a valuation allowance for portions of&#13;such assets to reduce the carrying value if we do not consider it to be more likely than not that the deferred tax assets will&#13;be realized. Our review includes evaluating both positive (e.g., sources of taxable income) and negative (e.g., recent historical&#13;losses) evidence that could impact the realizability of our deferred tax assets. At September 30, 2017, the Company has a maintained&#13;a valuation allowance against all net deferred tax assets in each jurisdiction in which it is subject to income tax.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;As&#13;of September 30, 2017 the Company has no uncertain tax positions recorded in any jurisdiction where it is subject to income tax.&#13;The Company has recorded $63,724 of interest and penalties as interest expense for the nine months ended September 30, 2017 in&#13;accordance with this policy.&lt;/font&gt;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2017-01-01to2017-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;the date of our inception, we issued 20 million shares of our common stock to our three officers and directors which were recorded&#13;at no value (offsetting increases and decreases in Common Stock and Additional Paid in Capital).&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;DOC&#13;Pharma S.A.&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;As&#13;of September 30, 2017, the Company has a prepaid balance of &amp;#128;347,914 ($410,991) to DOC Pharma S.A., this comprises over 10.3%&#13;of the Company&amp;#146;s total prepaid balance. As of December 31, 2016, the Company owed &amp;#128;65 ($69) to DOC Pharma S.A.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;November 1, 2015, the Company entered into a &amp;#128;12,000 ($12,662) Loan Agreement with DOC Pharma S.A, pursuant to which DOC&#13;Pharma S.A., paid existing bills of the Company in the amount of &amp;#128;12,000, excluding the Vendor Bills. The loan bears an interest&#13;rate of 2% per annum and was due and payable in full on October 31, 2016. As of September 30, 2017, the Company has an outstanding&#13;principal balance under this note of &amp;#128;12,000 ($14,176) and accrued interest expense of $612.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Grigorios&#13;Siokas&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;October 1, 2016, the Company borrowed &amp;#128;5,000 ($5,276) from Mr. Siokas related to its subsidiary&amp;#146;s purchase of additional&#13;capital of SkyPharm. The loan is non-interest bearing and has a maturity date of October 1, 2017. During the nine months ending&#13;September 30, 2017, the Company borrowed an additional &amp;#128;1,000 ($1,181). The outstanding balance as of September 30, 2017&#13;was &amp;#128;6,000 ($7,088).&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;During&#13;the year ended December 31, 2016, the Company borrowed &amp;#128;90,500 ($95,496) as additional loans payable from Mr. Siokas. During&#13;the nine months ended September 30, 2017, the Company borrowed an additional &amp;#128;473,621 ($559,488) and paid back &amp;#128;123,000&#13;($145,300) of these loans. These loans have no formal agreements and bear no interest. As 1of September 30, 2017, the Company&#13;has an outstanding principal balance under these loans of &amp;#128;441,121 ($521,096).&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;As&#13;of September 30, 2017, the Company has recorded &amp;#128;59,646 ($70,459) in prepayments to Mr. Siokas for board of directors fees.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Ourania&#13;Matsouki&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;During&#13;the year ended December 31, 2016, the Company borrowed &amp;#128;44,995 ($47,479) from Mrs. Matsouki. During the nine months ended&#13;September 30, 2017, the Company borrowed an additional &amp;#128;55,000 ($64,982) and paid back &amp;#128;73,437 ($86,751). These loans&#13;have no formal agreement and bear no interest. As of September 30, 2017, the Company has an outstanding principal balance under&#13;these loans of &amp;#128;26,558 ($31,373).&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Konstantinos&#13;Vassilopoulos&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;During&#13;the year ended December 31, 2016, Konstantinos Vassilopoulos, US Finance Manager, paid $10,179 of existing bills of the Company.&#13;During the nine months ended September 30, 2017, the Company paid back $9,810. There is no formal agreement related to these transactions.&#13;As of September 30, 2017 the outstanding balance under this loan is $369.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Dimitrios&#13;Goulielmos&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;November 21, 2014, SkyPharm entered into a Loan Agreement with Dimitrios Goulielmos, former Chief Executive Officer and a current&#13;director of the Company, pursuant to which the Borrower borrowed &amp;#128;330,000 ($401,115) from Mr. Goulielmos. The Loan bears&#13;an interest rate of 2% per annum and was due and payable in full on May 11, 2015. On November 4, 2015, &amp;#128;130,000 ($142,860)&#13;in principal and the related accrued interest of &amp;#128;733 ($806) was forgiven and the remaining balance of &amp;#128;200,000 will&#13;no longer accrue interest as part of the stock purchase agreement with Grigorios Siokas on November 4, 2015 referenced above.&#13;As of December 31, 2016, &amp;#128;60,000 ($63,312) of the loan was paid back. During the nine months ended September 30, 2017 an&#13;additional &amp;#128;53,500 ($63,200) was paid back and a principal balance of &amp;#128;86,500 ($102,182) and &amp;#128;0.00 of accrued interest&#13;remains.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;connection with the Decahedron SPA, on February 9, 2017, Decahedron, Medihelm S.A. and Nikolaos Lazarou entered into a liability&#13;transfer agreement whereby the loan previously provided Decahedron to the Mr. Lazarou prior to the acquisition would be cancelled&#13;in exchange for Mr. Lazarou&amp;#146;s personal assumption of approximately &amp;#163;172,310 ($220,988) owed to MediHelm S.A., a creditor&#13;of Decahedron.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Except&#13;as set forth above, we have not entered into any material transactions with any director, executive officer, and promoter, beneficial&#13;owner of five percent or more of our common stock, or family members of such persons.&lt;/font&gt;&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2017-01-01to2017-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;March 4, 2015, the Company entered into a $9,000 Loan Agreement with Mr. Angelo Drakopoulos, pursuant to which Mr. Drakopoulos&#13;paid a $9,000 outstanding bill on behalf of the Company. The loan bears an interest rate of 8% per annum and was due and payable&#13;in full on May 5, 2016. As of September 30, 2017, the Company has an outstanding principal balance under this note of $9,000 and&#13;accrued interest expense of $1,345.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;November 5, 2015, the Company entered into a Loan Agreement pursuant to which the Company borrowed &amp;#128;20,000 ($21,812), of&#13;which proceeds of &amp;#128;10,000 ($10,906) have been received as of December 31 2016. The loan bears an interest rate of 1% per&#13;annum and was due and payable in full on November 5, 2016. The Company repaid &amp;#128;2,000 ($2,110) as of December 31, 2016. The&#13;Company has repaid an additional &amp;#128;8,000 ($9,450) as of September 30, 2017. The Company has accrued interest expense of &amp;#128;435&#13;($514) and an outstanding balance under this note of &amp;#128;10,000 ($11,813) as of September 30, 2017.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;November 5, 2015, the Company entered into a Loan Agreement pursuant to which the Company borrowed &amp;#128;80,000 ($87,248) of which&#13;proceeds of &amp;#128;70,000 ($76,342) have been received as of December 31, 2016. The loan bears an interest rate of 5% per annum&#13;and was due and payable in full on November 5, 2016. As of December 31, 2016, the outstanding balance was &amp;#128;65,000 ($68,588).&#13;During the nine months ended September 30, 2017, the Company repaid &amp;#128;55,000 ($64,972) and reversed the &amp;#128;10,000 ($11,813)&#13;receivable that was never received.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;November 16, 2015, the Company entered into a Loan Agreement with Panagiotis Drakopoulos, former Director and former Chief Executive&#13;Officer, pursuant to which the Company borrowed &amp;#128;40,000 ($43,624) as a note payable from Mr. Drakopoulos. The note bears&#13;an interest rate of 6% per annum and was due and payable in full on November 15, 2016. The Company repaid &amp;#128;10,000 ($11,813)&#13;during the nine months ended September 30, 2017. As of September 30, 2017, the Company has an outstanding principal balance under&#13;this note of &amp;#128;30,000 ($35,439) and accrued interest expense of &amp;#128;4,064 ($4,801).&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;During&#13;the year ended December 31, 2015, the Company borrowed &amp;#128;30,000 ($32,718) as a loan payable from Mr. Panagiotis Drakopoulos,&#13;former Director and former Chief Executive Officer. The loan had no formal agreement and bore no interest. During the year ended&#13;December 31, 2016, the Company repaid &amp;#128;13,000 ($13,718) of the loan. During the nine months ended September 30, 2016 the&#13;Company repaid the remaining &amp;#128;17,000 ($20,082). As of September 30, 2017, the loan has no outstanding balance.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;February 5, 2016, the Company entered into a Loan Agreement pursuant to which the Company borrowed &amp;#128;20,000 ($21,104). The&#13;loan bore an interest rate of 6% and had no maturity date. During the nine months ended September 30, 2017, the Company repaid&#13;the loan and accrued interest of &amp;#128;1,020 ($1,204) in full.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;March 4, 2016, the Company entered into a Loan Agreement pursuant to which the Company borrowed &amp;#128;50,000 ($52,760) from a&#13;third party. On May 04, 2016, the Company entered into a Loan Agreement pursuant to which the Company borrowed an additional &amp;#128;50,000&#13;($52,760). The loans bore an interest rate of 6% and a maturity date of March 4, 2017 and May 4, 2017, respectively. During the&#13;nine months ended September 30, 2017, the Company repaid both loans and accrued interest of &amp;#128;750 ($886) in full.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;April 19, 2016, the Company entered into a Loan Agreement pursuant to which the Company borrowed &amp;#128;100,000 ($105,520). The&#13;loan bore an interest rate of 6% and matured on April 19, 2017. During the nine months ended September 30, 2017, the Company repaid&#13;the loan and accrued interest of &amp;#128;3,100 ($3,662) in full.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;April 22, 2016, the Company entered into a Loan Agreement pursuant to which the Company borrowed &amp;#128;38,000 ($40,098). The loan&#13;bore an interest rate of 6% and matured on April 22, 2017. During the nine months ended September 30, 2017, the Company repaid&#13;the loan and accrued interest of &amp;#128;1,777 ($2,099) in full.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;May 24, 2016, the Company entered into a Loan Agreement pursuant to which the Company borrowed &amp;#128;50,000 ($52,760). The loan&#13;bears an interest rate of 6% and matured on May 24, 2017. During the nine months ended September 30, 2017, the Company repaid&#13;the principal balance of &amp;#128;50,000 ($59,065) in full. The Company has accrued interest expense of &amp;#128;2,798 ($3,305) as of&#13;September 30, 2017.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;October 18, 2016, the Company entered into a Loan Agreement pursuant to which the Company borrowed &amp;#128;10,000 ($10,552). The&#13;loan bears an interest rate of 10% and will mature on October 18, 2017. During the nine months ended September 30, 2017, the Company&#13;repaid the principal balance of &amp;#128;10,000 ($11,813) in full. The Company has accrued interest expense of &amp;#128;239 ($283) as&#13;of September 30, 2017.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Loan&#13;Facility Agreement&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;August 4, 2016, the Company&amp;#146;s wholly owned subsidiary SkyPharm entered into a Loan Facility Agreement, guaranteed by Grigorios&#13;Siokas, with Synthesis Peer-To Peer-Income Fund (the &amp;#147;Loan Facility&amp;#148; the &amp;#147;Lender&amp;#148;). The Loan Facility&#13;initially provided SkyPharm with a credit facility of up to $1,292,769 (&amp;#128;1,225,141). Any advance under the Loan Facility&#13;accrues interest at a rate of 10% per annum and requires quarterly interest payments commencing on September 30, 2016. The amounts&#13;owed under the Loan Facility shall be repayable upon the earlier of (i) three months following the demand of the Lender; or (ii)&#13;August 31, 2018. No prepayment is permitted pursuant to the terms of the Loan Facility. The Synthesis Facility Agreement as amended&#13;is secured by a personal guaranty of Grigorios Siokas, which is secured by a pledge of 10,000,000 shares of common stock of the&#13;Company owned by Mr. Siokas.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;September 13, 2016, Sky Pharm entered into a First Deed of Amendment with the Loan Facility increasing the maximum loan amount&#13;to $1,533,020 as a result of the Lender having advanced $240,251 (&amp;#128;227,629) to SkyPharm.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;March 23, 2017, SkyPharm entered into an Amended and Restated Loan Facility Agreement (the &amp;#147;A&amp;#38;R Loan Facility&amp;#148;),&#13;with the Loan Facility which increased the loan amount to an aggregate total of $2,664,960 (&amp;#128;2,491,083) as a result of the&#13;lender having advanced $174,000 (&amp;#128;164,898) in September 2016, $100,000 (&amp;#128;94,769)&amp;#160;in October 2016, $250,000 (&amp;#128;236,922)&#13;in November 2016, $452,471 (&amp;#128;428,800) in December 2016, $155,516 (&amp;#128;131,648) in January 2017 and $342,327 (&amp;#128;289,788)&#13;in July 2017. The A&amp;#38;R Loan Facility amends and restates certain provisions of the Loan Facility Agreement, dated as of August&#13;4, 2016, by and among the same parties. Advances under the A&amp;#38;R Loan Facility continue to accrue interest at a rate of 10%&#13;per annum from the applicable date of each drawdown and require quarterly interest payments. The A&amp;#38;R Facility now permits&#13;prepayments at any time. The amounts owed under the A&amp;#38;R Loan Facility shall be repayable upon the earlier of (i) seventy five&#13;days following the demand of the Lender; or (ii) August 31, 2018. The A&amp;#38;R Loan Facility is secured by a personal guaranty&#13;of Grigorios Siokas, which is secured by a pledge of 10,000,000 shares of common stock of the Company owned by Mr. Siokas (the&#13;&amp;#147;Pledged Shares&amp;#148;). The A&amp;#38;R Loan Facility was also amended to provide additional affirmative and negative covenants&#13;of Sky Pharm and the Guarantor during the term of loans remain outstanding, including, but not limited to, the consent of the&#13;Lender in connection with (i) the Company or any of its subsidiaries incurring any additional indebtedness; or (ii) in the event&#13;of any increase in the Company&amp;#146;s issued and outstanding shares of Common Stock, the Pledged Shares shall be increased to&#13;an amount equal to a minimum of ten percent (10%) of the issued and outstanding shares of the Company.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;As&#13;of September 30, 2017, the outstanding balance under this note was $3,007,287 (&amp;#128;2,545,744) and accrued interest expense of&#13;$143,761 (&amp;#128;121,697) has been recorded.&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company recorded &amp;#128;120,000 ($141,756) in debt discounts related to this note. The debt discounts are being amortized over&#13;the term of the debt. During the year ended December 31, 2016 the Company amortized a total of $14,507 (&amp;#128;13,748). Amortization&#13;of the debt discounts for the nine months ended September 30, 2017 was $52,796 (&amp;#128;47,368).&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Bridge&#13;Loans&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;March 16, 2017 and March 20, 2017, SkyPharm entered into loan agreements with the Synthesis Peer-To Peer-Income Fund (the &amp;#147;Bridge&#13;Loans&amp;#148;). The Bridge Loans provided to SkyPharm loans of &amp;#128;42,326 ($50,000) and &amp;#128;100,000 ($118,130), respectively.&#13;The Bridge Loans accrue interest at a rate of 10% per annum and were repayable on April 16, 2017 and April 20, 2017, respectively&#13;together with all other amounts then accrued and unpaid. On April 16, 2017, the maturity dates were amended for no additional&#13;consideration of change in terms and conditions. The maturity dates of both loans were amended and they matured on May 16, 2017&#13;and May 20, 2017, respectively. The Company has accrued interest expense of an aggregate total of &amp;#128;7,335 ($8,665) for both&#13;loans and the outstanding balances of these loans was &amp;#128;42,326 ($50,000) and &amp;#128;100,000 ($118,130), respectively, as of&#13;September 30, 2017.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;May 5, 2017, SkyPharm entered into a loan agreement with Synthesis Peer-To-Peer Income Fund for &amp;#128;30,449 ($34,745). The loan&#13;accrues interest at a rate of 10% per annum and matures on September 30, 2017. The Company as accrued interest expense of &amp;#128;1,201&#13;($1,418) and the outstanding balance on this loan was &amp;#128;29,413 ($34,745) as of September 30, 2017.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Trade&#13;Facility Agreements&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;April 10, 2017, Decahedron entered into a Trade Finance Facility Agreement (the &amp;#147;Decahedron Facility&amp;#148;) with Synthesis&#13;Structured Commodity Trade Finance Limited (the &amp;#147;Lender&amp;#148;). The Decahedron Facility provides the following material&#13;terms:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font-size-adjust: none; font-stretch: normal"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;    Lender will provide Decahedron a facility of up to &amp;#128;2,750,000 ($2,941,950) secured against Decahedron&amp;#146;s receivables&#13;    from the sale of branded and generic pharmaceutical sales.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;    total facility will be calculated as 95% of the agreed upon value of Decahedron&amp;#146;s receivables.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;    term of the Decahedron Facility will be for 12 months.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;    obligations of Decahedron are guaranteed by the Company pursuant to a Cross Guarantee and Indemnity Agreement.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;    Lender has the right to make payments directly to Decahedron&amp;#146;s suppliers.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;    following fees should be paid in connection with the Decahedron Facility:&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="width: 4%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 4%; font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 4%; font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;o&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2%&#13;    of the maximum principal amount as an origination fee.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;o&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;A&#13;    one percent (1%) monthly fee.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;current draw on the Decahedron Facility is $0.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;May 12, 2017, SkyPharm entered into a Trade Finance Facility Agreement (the &amp;#147;SkyPharm Facility&amp;#148;) with Synthesis Structured&#13;Commodity Trade Finance Limited (the &amp;#147;Lender&amp;#148;). The SkyPharm Facility provides the following material terms:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font-size-adjust: none; font-stretch: normal"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;    Lender will provide SkyPharm a facility of up to &amp;#128;2,000,000 ($2,282,200) secured against SkyPharm&amp;#146;s receivables&#13;    from the sale of branded and generic pharmaceutical sales. In the event that accounts receivable becomes uncollectible, the&#13;    Company will be obligated to pay back the notes in full.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;    total facility will be calculated as 95% of the agreed upon value of Decahedron&amp;#146;s receivables.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;    term of the SkyPharm Facility will be for 12 months.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;    obligations of SkyPharm are guaranteed by the Company pursuant to a Cross Guarantee and Indemnity Agreement.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;    Lender has the right to make payments directly to SkyPharm&amp;#146;s suppliers.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;    following fees should be paid in connection with the SkyPharm Facility:&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="width: 4%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 4%; font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 4%; font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;o&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2%&#13;    of the maximum principal amount as an origination fee.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;o&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;A&#13;    one percent (1%) monthly fee.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;current draw on the SkyPharm Facility is &amp;#128;5,216,910 ($6,162,736) and the Company has accrued &amp;#128;170,711 ($201,661) in&#13;monthly fees related to this agreement. The Company obtained consents from Synthesis Peer-to-Peer Income Fund in connection with&#13;obtaining the Lender. On November 16, 2017, the Company&amp;#160;signed an amendment to the agreement for the additional proceeds&#13;borrowed.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company has recorded a total debt discount of &amp;#128;104,338 in origination fees associated with these loans, which will be amortized&#13;over the term of the agreements. Amortization of debt discount for the nine months ended September 30, 2017 was &amp;#128;31,295 ($34,881).&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;None&#13;of the above loans were made by any related parties.&lt;/font&gt;&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2017-01-01to2017-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Legal&#13;Matters&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;From&#13;time to time, the Company may be involved in litigation relating to claims arising out of the Company&amp;#146;s operations in the&#13;normal course of business. As of September 30, 2017, there were no pending or threatened lawsuits that could reasonably be expected&#13;to have a material effect on the results of the Company&amp;#146;s operations.&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Operating&#13;Leases&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company conducts its operations from an office located in Chicago, Illinois for which beginning in January 2015, the monthly rent&#13;expense is $730, which has been paid through December 31, 2015. The lease expired as of November 30, 2015, however, the Company&#13;has negotiated and entered into a new lease that commenced as of September 1, 2016 at a rate of $709 per month. Rent expense for&#13;the three and nine months ended September 30, 2017 was $2,126 and $6,377, respectively. Rent expense for the three and nine months&#13;ended September 30, 2016, was $2,126 and $2,834, respectively.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;offices of Amplerissimo are located in Cyprus for which we paid approximately &amp;#128;110 ($122) per month on a month to month basis.&#13;Rent expense for the three and nine months ended September 30, 2017 was &amp;#128;330 ($368) and &amp;#128;990 ($1,103), respectively.&#13;Rent expense for the three and nine months ended September 30, 2016 was &amp;#128;330 ($368) and &amp;#128;990 ($1,105), respectively.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;offices of SkyPharm are located in Greece, Thessaloniki, for which we paid approximately &amp;#128;4,325 ($4,802) per month under&#13;a six year lease that commenced September 2014. In December 2015, the lease was revised to include an additional rental of the&#13;first floor at a rate of &amp;#128;800 ($886) per month. The lease was further revised in March 2016 to include another additional&#13;rental of the first floor at a rate of &amp;#128;800 ($886) per month beginning in May 2016. On May 30, 2016, the lease was revised&#13;again to include an additional rental of space at a rate of &amp;#128;1,825 ($2,021) per month beginning in June 2016. On March 23,&#13;2017, SkyPharm entered into an additional three year lease at a rate of &amp;#128;1,250 per month that commenced May 2017. Rent expense&#13;for the three and nine months ended September 30, 2017 was &amp;#128;27,000 ($30,094) and &amp;#128;76,000 ($84,710), respectively. Rent&#13;expense for the three and nine months ended September 30, 2016 was &amp;#128;23,250 ($25,961) and &amp;#128;57,425 ($64,127), respectively.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;offices of Decahedron are located in Flex Meadow, Harlow, for which we pay approximately &amp;#8356;1,908 ($2,415) per month, under&#13;a one year amendment to a lease dated October 25, 2011, which commenced on October 25, 2016. Rent expense from the date of acquisition&#13;through September 30, 2017 was &amp;#8356;15,267 ($19,580).&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Intellectual&#13;Property Sale Agreement&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;October 1, 2016, the Company entered into an Intellectual Property Sale Agreement with Anastasios Tsekas and Olga Parthenea Georgatsou&#13;(the &amp;#147;IPSA&amp;#148;) for the purchase of certain intellectual property rights relating to proprietary pharmaceutical formulas&#13;and any related technical information arising or related thereto (the &amp;#147;Intellectual Property&amp;#148;). The IPSA provides&#13;that the sellers shall be entitled to an aggregate of 2,000,000 shares of common stock of the Company, none of which have been&#13;issued to date, and issuable as follows in equal parts to each seller:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font-size-adjust: none; font-stretch: normal"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="width: 4%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 4%; font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;500,000&#13;    shares upon the successful conclusion of Preclinical Trials.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;500,000&#13;    shares upon the conclusion of Phase I testing.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;500,000&#13;    shares upon the conclusion of Phase II testing.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;500,000&#13;    shares upon the conclusion of Phase III testing.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company has agreed to pay Anastasios Tsekas &amp;#128;1,500 per month until the first issuance of the shares referenced above. The&#13;Company has also agreed that in the event the Company disposes of the Intellectual Property prior to the periods referenced above,&#13;the sellers shall be entitled to the issuance of all the shares referenced above. The Company is in the process of locating a&#13;suitable lab to conduct the Preclincal trial phase, which has not yet begun as of the date of filing.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Letter&#13;of Intent&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;June 21, 2017, the Company signed a new Letter of Intent (LOI) to acquire the outstanding shares of CC Pharma GmbH, a leading&#13;re-importer of EU pharmaceuticals to Germany. Under the terms of the LOI, Cosmos Holdings holds the exclusive right to complete&#13;its due diligence process and complete the transaction by October 31, 2017. In connection with the non-binding LOI, the Company&#13;is required to pay a non-refundable fee of &amp;#128;400,000 ($454,800) to the shareholders of CC Pharma GmbH in connection with the&#13;costs of due diligence and the exclusive right to negotiate the terms of the definitive agreements. On July 6, 2017, the Company&#13;paid the &amp;#128;400,000 ($454,800) to CC Pharma GmbH and the Company has recorded an expense of &amp;#128;400,000 ($454,800) for the&#13;nine months ended September 30, 2017. The Company did not enter into any definitive agreements by October 31, 2017 and is currently&#13;negotiating with CC Pharma for an extension. The Company makes no assurances that the parties will enter into any definitive agreements&#13;in the future.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Placement&#13;Agreement&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05pt; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;August 8, 2017, the Company entered into an agreement with a third party placement agent (the &amp;#147;Agent&amp;#148;) who will serve&#13;as the Company&amp;#146;s exclusive placement agent or sole book running manager with respect to any offerings of equity or equity-linked&#13;securities as well as any debt offering with the two organizations named in the agreement (the &amp;#147;Offering&amp;#148;) for a period&#13;of 120 days. In the event that an Offering is agreed upon by the Agent and the Company, the Company shall provide payment as follows:&#13;(1) a cash commission of 6% of the total gross proceeds for two named investors (2) a cash commission of 4% of total gross proceeds&#13;from five named investors and (3) excluding the five named investors in &amp;#147;(2)&amp;#148; a cash commission equal to 8% of the&#13;total gross proceeds from the Offering and the issuance to the Agent or its designees of warrants covering 8% of the shares of&#13;common stock issued or issuable by the Company in the Offering. Additionally, the Agent will receive a cash fee of 8% payable&#13;within 5 business days, but only in the event of, the receipt by the Company of any cash proceeds from the exercise of any warrants&#13;with an expiration equal to or less than 24 months sold in the Offering.&lt;/font&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:ScheduleOfStockByClassTextBlock contextRef="From2017-01-01to2017-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;October 1, 2016 the Company granted 120,000 options to an employee of the Company as compensation for being appointed the US Finance&#13;Manager of the Company. The options have an exercise period of four years with an exercise price of $.20 per share. In the event&#13;that he ceases to work for the Company for any reason, he will be entitled to a pro rata portion of the annual options. The options&#13;vest monthly with 120,000 options fully vested as of September 30, 2017. The options were valued at $65,290 using the Black Scholes&#13;Option Pricing Model with the following inputs: stock price on measurement date: $0.58; Exercise price: $0.20; Option term: 4&#13;years; Computed volatility: 159%. The Company expensed $16,636 in the year ended December 31, 2016. As of September 30, 2017 the&#13;Company has expensed an additional $48,654.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;January 1, 2017 the Company entered into an agreement whereby the employee was granted compensation of &amp;#128;1,000 per month and&#13;an annual retainer of 250,000 stock options as compensation for being appointed the International Finance Manager of the Company.&#13;The options have an exercise period of four years with an exercise price of $0.10. In the event that he ceases to work for the&#13;Company for any reason, he will be entitled to a pro rata portion of the annual options. The options vest monthly, with a total&#13;of 187,500 options fully vested as of September 30, 2017. The options were valued at $195,307 using the Black Scholes Option Pricing&#13;Model with the following inputs: stock price on measurement date: $0.82; Exercise price: $0.10; Option term: 4 years; Computed&#13;volatility: 136.76%. The fair value of the options will be amortized over a year with $146,079 expensed during the nine months&#13;ended September 30, 2017.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;January 3, 2017 the Company determined to create an advisory board and appointed Mr. Orestes Varvitsiotes as its first member.&#13;Mr. Varvitsiotes is a registered broker dealer who is currently engaged with Aegis Capital Corp. In connection therewith, the&#13;Company entered into an Advisory Board Member Consulting Agreement, dated as of January 3, 2017 whereby an annual retainer of&#13;120,000 stock options was granted as compensation for services. The options have an exercise period of five years with an exercise&#13;price of $0.20. In the event that he ceases to work for the Company for any reason, he will be entitled to a pro rata portion&#13;of the annual options. The options vest monthly, with a total of 90,000 options fully vested as of September 30, 2017. The options&#13;were valued at $94,830 using the Black Scholes Option Pricing Model, with the following inputs: stock price on measurement date:&#13;$0.82; Exercise price: $0.20; Option term: 5 years; Computed volatility: 155.37%. The fair value of the options will be amortized&#13;over the year with $70,796 expensed during the nine months ended September 30, 2017.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;A&#13;summary of the Company&amp;#146;s option activity during the nine months ended September 30, 2017 is presented below:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" id="hdcell" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Number&#13;    of&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Contractual&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Intrinsic&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Term&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance&#13;    Outstanding, December 31, 2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td id="ffcell" style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;120,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.20&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;74,400&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;370,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;.13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.58&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;150,800&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance&#13;    Outstanding, September 30, 2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;490,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;.15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.44&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;191,600&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercisable,&#13;    September 30, 2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;397,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;.15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.41&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;153,900&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;connection with a private placement that took place on April 7, 2017, the Company issued warrants at a 1:1 ratio for shares purchased&#13;by investors. The warrants were valued using the Black Scholes valuation model. A summary of the Company&amp;#146;s warrant activity&#13;for the nine months ending September 30, 2017 is as follows:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;b&gt;September&#13;    30,&lt;/b&gt;&lt;br /&gt;&#13;    &lt;b&gt;2017&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;76.66%-90.86&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expected&#13;    term (in years)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Risk-free&#13;    interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.07% - 1.11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&#13;    &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expected&#13;    dividend yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;None&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Number&#13;    of&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Contractual&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Intrinsic&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Warrants&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Term&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance&#13;    Outstanding, December 31, 2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;100,400&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance&#13;    Outstanding, September 30, 2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;100,400&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;.55&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercisable,&#13;    September 30, 2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;100,400&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;.55&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfStockByClassTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2017-01-01to2017-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Purchase&#13;of Treasury Shares&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05pt; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Effective&#13;October 2, 2017, the Company entered into to a stock purchase agreement dated September 30, 2017, whereby for consideration of&#13;$1,387 the Company purchased 1,386,894 shares of its common stock from a third party investor. The shares were transferred to&#13;the Company on October 17, 2017 and will be held in treasury.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.4pt; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.4pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Reverse&#13;Stock Split&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;October 11, 2017, the Company authorized a one-for-ten (1:10) reverse stock split whereby the Company decreased, by a ratio of&#13;one-for-ten (1:10) the number of issued and outstanding shares of Common Stock. The reverse stock split was approved and filed&#13;in the state of Nevada, and reported on Form 8-K filed on October 11, 2017; however it had not been approved by FINRA as of the&#13;date of filing, and therefore the financial statements are not retroactively restated to reflect the split. The Company anticipates&#13;that the reverse split will be effective on November 21, 2017.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.4pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;November&#13;15, 2017 Securities Purchase Agreement&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;November 15, 2017, the Company entered into a Securities Purchase Agreement (the &amp;#147;SPA&amp;#148;) with certain institutional&#13;investors (the &amp;#147;Buyers&amp;#148;) with which it had no prior relationship, pursuant to which the Company has agreed to issue&#13;for a purchase price of $3,000,000,&amp;#160;$3,350,000 in aggregate principal amount of Senior Convertible Notes (the &amp;#147;Notes&amp;#148;)&#13;to the Buyers, convertible into 6,700,000 shares of the Company&amp;#146;s common stock, par value $.001 per share (the &amp;#147;Common&#13;Stock&amp;#148;) and warrants to purchase an aggregate of 5,360,003 shares of Common Stock (the &amp;#147;Warrants&amp;#148;.)&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Notes provide that the Company will repay the principal amount of Notes in equal monthly installments beginning on January 1,&#13;2018 and repeating on the first business day of each calendar month thereafter until the fourteenth month anniversary date of&#13;issuance (each a &amp;#147;Installment Date&amp;#148;), and, subject to the Blocker (as defined below), the Company shall pre-deliver&#13;up to 6,700,000 shares of Common Stock to the Buyers in connection therewith (the &amp;#147;Pre-Delivery Shares&amp;#148;). Eighty-five&#13;(85%) percent of any cash proceeds received by the Buyers from the sale of Pre-Delivery Shares shall be applied against the particular&#13;installment amount due on such Installment Date under the Note. No interest will accrue under the Notes unless and until an Event&#13;of Default (as defined) has occurred and is not cured.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Notes are convertible at any time by the Holder into shares of Common Stock at the rate of $0.50 per share, subject to full ratchet&#13;anti-dilution adjustment (the &amp;#147;Conversion Price&amp;#148;). Upon an Event of Default (as defined), the Buyers may convert at&#13;an alternative conversion price equal to the lower of the then applicable Conversion Price or seventy-five (75%) percent of the&#13;Volume-Weighted Average Price (as defined, the &amp;#147;VWAP&amp;#148;).&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Notes are senior in right of payment to all existing and future indebtedness of the Company except Permitted Indebtedness (as&#13;defined in the Note), including $12 million of senior secured indebtedness of the Company and its subsidiaries under an existing&#13;senior loan agreement, plus defined amounts of purchase money indebtedness in connection with bona fide acquisitions.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Notes include customary Events of Default and provide that the Buyers may require the Company to redeem (regardless of whether&#13;the Event of Default has been cured) all or a portion of the Notes at a redemption premium of one hundred twenty-five (125%) percent,&#13;multiplied by the greater of the conversion rate and the then current market price. The Buyers may also require redemption of&#13;the Notes upon a Change of Control (as defined) at a premium of one hundred twenty-five (125%) percent.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Warrants have a five year term and are exercisable into a number of shares of Common Stock equal to approximately eighty (80%)&#13;percent of the number of shares of Common Stock the Buyers would receive if the Notes were fully converted upon the date of issuance&#13;of the Notes. The Warrants are exercisable at $0.75 per share (150% of the conversion price of the Notes) subject to full ratchet&#13;anti-dilution protection. The Warrants will be exercisable on a cashless basis if a registration statement is not effective covering&#13;the resale of the underlying Warrant Shares.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Conversion&#13;of the Notes and exercise of the Warrants are each subject to a blocker provision which prevents any holder from converting or&#13;exercising, as applicable, the Notes or the Warrants, into shares of Common Stock if its beneficial ownership of the Common Stock&#13;would exceed 4.99% (subject to adjustment not to exceed 9.99%) of the Company&amp;#146;s issued and outstanding Common Stock (each,&#13;a &amp;#147;Blocker&amp;#148;).&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company is required to file, within thirty (30) days of the Closing, a registration statement covering one hundred fifty (150%)&#13;percent of the maximum number of shares, underlying the Notes and Warrants pursuant to a registration rights agreement with the&#13;Buyers (the &amp;#147;Registration Rights Agreement&amp;#148;).&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;As&#13;a condition to the closing of the Financing, each Buyer, severally, will be required to execute a leak-out agreement (each, a&#13;&amp;#147;Leak-Out Agreement&amp;#148;) restricting such Buyer&amp;#146;s sale of shares of Common Stock underlying the Notes and Warrants&#13;on any Trading Day to not more than such Buyer&amp;#146;s pro rata allocation of the greater of (x) sales with net proceeds of an&#13;aggregate of $20,000 or (y) twenty-five (25%) percent of the daily average trading volume of the Company&amp;#146;s Common Stock.&#13;If after the closing of the Financing&amp;#160;there is no&amp;#160;Event of Default&amp;#160;under the Notes, the VWAP of the Company&amp;#146;s&#13;Common Stock for three (3) trading days is less than $0.15 per share, the Company may further restrict the Buyers from selling&#13;at less than $0.15 per share; provided that the portion of the Notes subject to redemption on each Installment Date shall thereafter&#13;double.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Roth&#13;Capital Partners, LLC (&amp;#147;Roth&amp;#148;), as the Company&amp;#146;s exclusive placement agent, will receive a cash commission for&#13;this transaction equal to eight (8%) percent of the total gross proceeds of the offering and the issuance of five-year warrants&#13;to purchase eight (8%) percent of the shares of Common Stock issued or issuable in this offering (excluding shares of Common Stock&#13;issuable upon exercise of any Warrants issued to investors); however, will receive eight (8%) percent of any cash proceeds received&#13;from the exercise of any Warrants sold in the offering with an expiration equal to or less than twenty-four (24) months.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Amendment&#13;of Trade Facility Agreement&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;November 16, 2017, SkyPharm signed an amended agreement with Synthesis Structured Commodity Trade Finance Limited that increased&#13;the maximum aggregate facility limit from &amp;#128;2,000,000 to &amp;#128;6,000,000. All other terms of the original agreement remain&#13;the same (see Note 8).&amp;#160;&lt;/font&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="From2017-01-01to2017-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;accompanying consolidated financial statements have been prepared in accordance with principles generally accepted in the United&#13;States of America.&lt;/font&gt;&lt;/p&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2017-01-01to2017-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Our&#13;consolidated accounts include our accounts and the accounts of our wholly-owned subsidiaries, Amplerissimo Ltd, SkyPharm S.A.&#13;and Decahedron Ltd. All significant intercompany balances and transactions have been eliminated.&lt;/font&gt;&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="From2017-01-01to2017-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Certain&#13;reclassifications have been made in the Company&amp;#146;s financial statements of the prior year to conform to the current year&#13;presentation. These reclassifications have no impact on previously reported net income.&lt;/font&gt;&lt;/p&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:UseOfEstimates contextRef="From2017-01-01to2017-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires management&#13;to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets&#13;and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting&#13;period. Actual results could differ from those estimates.&lt;/font&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2017-01-01to2017-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;For&#13;purposes of the statement of cash flows, the Company considers all highly liquid investments purchased with an original maturity&#13;of three months or less to be cash equivalents. As of September 30, 2017 and December 31, 2016, there were no cash equivalents.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company maintains bank accounts in the United States denominated in U.S. Dollars and in the Republic of Cyprus, in Greece and&#13;in Bulgaria all of them denominated in Euros. The Company also maintains bank accounts in the United Kingdom of Great Britain,&#13;dominated in Euros and Great Britain Pound (British Pounds Sterling).&lt;/font&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:PolicyLoansReceivablePolicy contextRef="From2017-01-01to2017-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts&#13;receivable are stated at their net realizable value. The allowance for doubtful accounts against gross accounts receivable reflects&#13;the best estimate of probable losses inherent in the receivables portfolio determined on the basis of historical experience, specific&#13;allowances for known troubled accounts and other currently available information.&lt;/font&gt;&lt;/p&gt;</us-gaap:PolicyLoansReceivablePolicy>
    <us-gaap:InventoryPolicyTextBlock contextRef="From2017-01-01to2017-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Inventory&#13;is stated at the lower of cost or market value using the weighted average method. Inventory consists primarily of finished goods&#13;and packaging materials, i.e. packaged pharmaceutical products and the wrappers and containers they are sold in. A periodic inventory&#13;system is maintained by 100% count.&amp;#160;Inventory is replaced periodically to maintain the optimum stock on hand available for&#13;immediate shipment.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;We&#13;write-down inventories to net realizable value based on forecasted demand and market conditions, which may differ from actual&#13;results.&lt;/font&gt;&lt;/p&gt;</us-gaap:InventoryPolicyTextBlock>
    <COSM:FixedAssetsPolicyTextBlock contextRef="From2017-01-01to2017-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Fixed&#13;assets are stated at cost, less accumulated depreciation. Depreciation is provided on a straight-line basis over the useful lives&#13;(except for leasehold improvements which are depreciated over the lesser of the lease term or the useful life) of the assets as&#13;follows:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font-size-adjust: none; font-stretch: normal"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 9%; border-bottom-style: solid; border-bottom-width: 1pt; font: 12pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Estimated&#13;    Useful Life&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: bottom; font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Furniture&#13;    and fixtures&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font: 12pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5-7&#13;    years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: bottom; font: 12pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Office&#13;    and computer equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font: 12pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3-5&#13;    years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Depreciation&#13;expense was $10,831 and $6,956 for the nine months ended September 30, 2017 and 2016, respectively.&lt;/font&gt;&lt;/p&gt;</COSM:FixedAssetsPolicyTextBlock>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="From2017-01-01to2017-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Intangible&#13;assets with definite useful lives are recorded on the basis of cost and are amortized on a straight-line basis over their estimated&#13;useful lives. The Company uses a useful life of 5 years for an import/export license. The Company evaluates the remaining useful&#13;life of intangible assets annually to determine whether events and circumstances warrant a revision to the remaining amortization&#13;period. If the estimate of the intangible asset&amp;#146;s remaining useful life is changed, the remaining carrying amount of the&#13;intangible asset will be amortized prospectively over that revised remaining useful life. At September 30, 2017, no revision to&#13;the remaining amortization period of the intangible assets was made.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Amortization&#13;expense was $6,368 and $0 for the nine months ended September 30, 2017 and 2016, respectively.&lt;/font&gt;&lt;/p&gt;</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2017-01-01to2017-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;accordance with ASC 360-10, Long-lived assets, which include property and equipment and intangible assets, are reviewed for impairment&#13;whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability&#13;of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted&#13;future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted&#13;future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair&#13;value of the assets. Fair value is generally determined using the asset&amp;#146;s expected future discounted cash flows or market&#13;value, if readily determinable.&lt;/font&gt;&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="From2017-01-01to2017-09-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company periodically reviews the carrying value of intangible assets not subject to amortization, including goodwill, to determine&#13;whether impairment may exist. Goodwill and certain intangible assets are assessed annually, or when certain triggering events&#13;occur, for impairment using fair value measurement techniques. These events could include a significant change in the business&#13;climate, legal factors, a decline in operating performance, competition, sale or disposition of a significant portion of the business,&#13;or other factors. Specifically, goodwill impairment is determined using a two-step process. The first step of the goodwill impairment&#13;test is used to identify potential impairment by comparing the fair value of a reporting unit with its carrying amount, including&#13;goodwill. The Company uses level 3 inputs and a discounted cash flow methodology to estimate the fair value of a reporting unit.&#13;A discounted cash flow analysis requires one to make various judgmental assumptions including assumptions about future cash flows,&#13;growth rates, and discount rates. The assumptions about future cash flows and growth rates are based on the Company&amp;#146;s budget&#13;and long-term plans. Discount rate assumptions are based on an assessment of the risk inherent in the respective reporting units.&#13;If the fair value of a reporting unit exceeds its carrying amount, goodwill of the reporting unit is considered not impaired and&#13;the second step of the impairment test is unnecessary. If the carrying amount of a reporting unit exceeds its fair value, the&#13;second step of the goodwill impairment test is performed to measure the amount of impairment loss, if any. The second step of&#13;the goodwill impairment test compares the implied fair value of the reporting unit&amp;#146;s goodwill with the carrying amount of&#13;that goodwill. If the carrying amount of the reporting unit&amp;#146;s goodwill exceeds the implied fair value of that goodwill,&#13;an impairment loss is recognized in an amount equal to that excess. The implied fair value of goodwill is determined in the same&#13;manner as the amount of goodwill recognized in a business combination. That is, the fair value of the reporting unit is allocated&#13;to all of the assets and liabilities of that unit (including any unrecognized intangible assets) as if the reporting unit had&#13;been acquired in a business combination and the fair value of the reporting unit was the purchase price paid to acquire the reporting&#13;unit.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Prior&#13;to the acquisition of Decahedron, the Company had no record goodwill value. As a result of the acquisition of Decahedron, the&#13;Company tested and expensed 100% of the goodwill allocated to the acquisition costs, an amount equal to $1,949,884 for the period&#13;ending September 30, 2017.&lt;/font&gt;&lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="From2017-01-01to2017-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company adopted FASB ASC 820-Fair Value Measurements and Disclosures, or ASC 820, for assets and liabilities measured at fair&#13;value on a recurring basis. ASC 820 establishes a common definition for fair value to be applied to existing generally accepted&#13;accounting principles that require the use of fair value measurements establishes a framework for measuring fair value and expands&#13;disclosure about such fair value measurements. The adoption of ASC 820 did not have an impact on the Company&amp;#146;s financial&#13;position or operating results, but did expand certain disclosures.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;ASC&#13;820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction&#13;between market participants at the measurement date. Additionally, ASC 820 requires the use of valuation techniques that maximize&#13;the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Level&#13;1:&amp;#160;Observable inputs such as quoted prices (unadjusted)&amp;#160;in active markets for identical assets or liabilities.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Level&#13;2:&amp;#160;Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar&#13;assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not&#13;active.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Level&#13;3:&amp;#160;Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed&#13;by us, which reflect those that a market participant would use.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company did not have any Level 2 or Level 3 assets or liabilities as of September 30, 2017.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Cash&#13;is considered to be highly liquid and easily tradable as of September 30, 2017 and therefore classified as Level 1 within our&#13;fair value hierarchy.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;addition, FASB ASC 825-10-25 Fair Value Option, or ASC 825-10-25, was effective for January 1, 2008. ASC 825-10-25 expands opportunities&#13;to use fair value measurements in financial reporting and permits entities to choose to measure many financial instruments and&#13;certain other items at fair value. The Company did not elect the fair value options for any of its qualifying financial instruments.&lt;/font&gt;&lt;/p&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2017-01-01to2017-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;We&#13;consider revenue recognizable when persuasive evidence of an arrangement exists, the price is fixed or determinable, goods or&#13;services have been delivered, and collectability is reasonably assured. These criteria are assumed to have been met if a customer&#13;orders an item, the goods or services have been shipped or delivered to the customer, and we have sufficient evidence of collectability,&#13;such a payment history with the customer. Revenue that is billed and received in advance such as recurring weekly or monthly services&#13;are initially deferred and recognized as revenue over the period the services are provided.&lt;/font&gt;&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="From2017-01-01to2017-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company records stock based compensation in accordance with ASC section 718, &amp;#147;Stock Compensation&amp;#148; and Staff Accounting&#13;Bulletin (SAB) No. 107 (SAB 107) issued by the SEC in March 2005 regarding its interpretation of ASC 718. ASC 718 requires the&#13;fair value of all stock-based employee compensation awarded to employees to be recorded as an expense over the related requisite&#13;service period. The Company values any employee or non-employee stock based compensation at fair value using the Black-Scholes&#13;Option Pricing Model.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company accounts for non-employee share-based awards in accordance with the measurement and recognition criteria of ASC 505-50&#13;&amp;#147;Equity-Based Payments to Non-Employees&amp;#148;.&lt;/font&gt;&lt;/p&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="From2017-01-01to2017-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Assets&#13;and liabilities of all foreign operations are translated at year-end rates of exchange, and the statements of operations are translated&#13;at the average rates of exchange for the year. Gains or losses resulting from translating foreign currency financial statements&#13;are accumulated in a separate component of stockholders&amp;#146; equity until the entity is sold or substantially liquidated.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Gains&#13;or losses from foreign currency transactions (transactions denominated in a currency other than the entity&amp;#146;s local currency)&#13;are included in net earnings.&lt;/font&gt;&lt;/p&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2017-01-01to2017-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company accounts for income taxes under the asset and liability method, as required by the accounting standard for income taxes&amp;#160;ASC&#13;740. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences&#13;between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis, as well as&#13;net operating loss carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply&#13;to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred&#13;tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company is liable for income taxes in the Republic of Cyprus, Greece and the United Kingdom of England. The corporate income tax&#13;rate in Cyprus is 12.5%, 29% in Greece (tax losses are carried forward for five years effective January 1, 2013) and 20% in United&#13;Kingdom of England. Losses may also be subject to limitation under certain rules regarding change of ownership.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;We&#13;regularly review deferred tax assets to assess their potential realization and establish a valuation allowance for portions of&#13;such assets to reduce the carrying value if we do not consider it to be more likely than not that the deferred tax assets will&#13;be realized. Our review includes evaluating both positive (e.g., sources of taxable income) and negative (e.g., recent historical&#13;losses) evidence that could impact the realizability of our deferred tax assets.&amp;#160;At September 30, 2017 the Company has maintained&#13;a valuation allowance against all net deferred tax assets in each jurisdiction in which it is subject to income tax.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;We&#13;recognize the impact of an uncertain tax position in our financial statements if, in management&amp;#146;s judgment, the position&#13;is&amp;#160;not&amp;#160;more-likely-then-not sustainable upon audit based on the position&amp;#146;s technical merits. This involves the&#13;identification of potential uncertain tax positions, the evaluation of applicable tax laws and an assessment of whether a liability&#13;for an uncertain tax position is necessary. As of September 30, 2017 the Company has no uncertain tax positions recorded in any&#13;jurisdiction where it is subject to income tax.&lt;/font&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2017-01-01to2017-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Basic&#13;and diluted net loss per share calculations are calculated on the basis of the weighted average number of common shares outstanding&#13;during the periods presented. The per share amounts include the dilutive effect of common stock equivalents in periods with net&#13;income. Basic and diluted loss per share for each of the periods ended September 30, 2017 and 2016 is the same due to the anti-dilutive&#13;nature of potential common stock equivalents.&lt;/font&gt;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2017-01-01to2017-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;January 2017, the FASB issued ASU 2017-04, Intangibles &amp;#150; Goodwill and Other (Topic 350), which simplifies the measurement&#13;of goodwill by eliminating Step 2 from the current goodwill impairment test in the event that there is evidence of an impairment&#13;based on qualitative or quantitative assessments. ASU 2017-04 does not change how the goodwill impairment is identified, and the&#13;Company will continue to perform a qualitative assessment annually to determine whether the two step impairment test is required.&#13;Until the adoption, current accounting standards require the impairment loss to be recognized under Step 2 of the impairment test.&#13;This requires the Company to calculate the implied fair value of goodwill by assigning fair value to the reporting unit&amp;#146;s&#13;assets and liabilities as if the reporting unit has been acquired in a business combination, then subsequently subtracting the&#13;implied goodwill from the carrying amount of the goodwill. The new standard would require the Company to determine the fair value&#13;of the reporting unit and subtract the carrying value from the fair value of the reporting unit to determine if there is an impairment.&#13;ASU 2017-04 is effective for the Company for fiscal years after December 15, 2019, and early adoption is permitted. ASU 2017-04&#13;is required to be adopted prospectively, and the adoption is effective for annual goodwill impairment tests performed in the year&#13;of adoption. The Company does not believe that the adoption of ASU No. 2017-4 will have a material effect on the Company&amp;#146;s&#13;consolidated financial position or the Company&amp;#146;s consolidated results of operations&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;January 2017, the FASB issued ASU No. 2017-01, &amp;#147;Clarifying the Definition of a Business,&amp;#148; with the objective of adding&#13;guidance to assist entities with evaluating whether transactions should be accounted for as an acquisition of assets or a business.&#13;ASU No. 2017-01 is effective for the Company&amp;#146;s fiscal year commencing on January 1, 2018. The effect of this guidance is&#13;to be applied prospectively and early adoption is permitted. The Company does not believe that the adoption of ASU No. 2017-01&#13;will have a material effect on the Company&amp;#146;s consolidated financial position or the Company&amp;#146;s consolidated results&#13;of operations.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;February 2016, the FASB issued ASU 2016-02, &amp;#147;Leases,&amp;#148; which will require lessees to recognize assets and liabilities&#13;for the rights and obligations created by most leases on the balance sheet. The changes become effective for the Company&amp;#146;s&#13;fiscal year beginning July 1, 2019. Modified retrospective adoption for all leases existing at, or entered into after, the date&#13;of initial application, is required with an option to use certain transition relief. The Company expects this ASU will increase&#13;its current assets and current liabilities, but have no net material impact on its consolidated financial statements.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;May 2014, the FASB issued ASU 2014-09--Revenue from Contracts with Customers (Topic 606). The guidance requires an entity to recognize&#13;the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The FASB&#13;delayed the effective date to annual reporting periods beginning after December 15, 2017, including interim reporting periods&#13;within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 15,&#13;2016, including interim reporting periods within that reporting period. In addition, in March and April 2016, the FASB issued&#13;new guidance intended to improve the operability and understandability of the implementation guidance on principal versus agent&#13;considerations. Both amendments permit the use of either a retrospective or cumulative effect transition method and are effective&#13;for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017, with early application permitted.&#13;The Company is currently evaluating the impact the adoption of this ASU will have on its financial statements.&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Management&#13;does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material&#13;effect on the Company&amp;#146;s financial statements.&lt;/font&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="From2017-01-01to2017-09-30_custom_DecahedronLtdMember_us-gaap_ProFormaMember" unitRef="USD" decimals="0">-524952</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="From2016-01-01to2016-09-30_custom_DecahedronLtdMember_us-gaap_ProFormaMember" unitRef="USD" decimals="0">-238528</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2016-12-31_us-gaap_WarrantMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2016-12-31_us-gaap_OptionMember" unitRef="shares" decimals="INF">120000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2017-09-30_us-gaap_OptionMember" unitRef="shares" decimals="INF">490000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2017-09-30_us-gaap_WarrantMember" unitRef="shares" decimals="INF">100400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2017-01-01to2017-09-30_us-gaap_OptionMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2017-01-01to2017-09-30_us-gaap_WarrantMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2017-01-01to2017-09-30_us-gaap_OptionMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2017-01-01to2017-09-30_us-gaap_WarrantMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod contextRef="From2017-01-01to2017-09-30_us-gaap_OptionMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod contextRef="From2017-01-01to2017-09-30_us-gaap_WarrantMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2016-12-31_us-gaap_WarrantMember" unitRef="USD_per_Share" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2016-12-31_us-gaap_OptionMember" unitRef="USD_per_Share" decimals="INF">0.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-09-30_us-gaap_OptionMember" unitRef="USD_per_Share" decimals="INF">0.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-09-30_us-gaap_WarrantMember" unitRef="USD_per_Share" decimals="INF">3.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2017-01-01to2017-09-30_us-gaap_StockOptionMember_custom_UsFinanceManagerMember_custom_OnOctoberOneTwoThousandSixteenMember" unitRef="USD_per_Share" decimals="INF">0.20</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2017-01-01to2017-09-30_us-gaap_OptionMember" unitRef="USD_per_Share" decimals="INF">0.13</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2017-01-01to2017-09-30_us-gaap_WarrantMember" unitRef="USD_per_Share" decimals="INF">3.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2017-01-01to2017-09-30_us-gaap_StockOptionMember_custom_MrOrestesVarvitsiotesMember_custom_JanuaryThreeTwoThousandSeventeenMember" unitRef="USD_per_Share" decimals="INF">0.20</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2017-01-01to2017-09-30_us-gaap_StockOptionMember_custom_EmployeeMember_custom_OnJanuaryOneTwoThousandSeventeenMember" unitRef="USD_per_Share" decimals="INF">0.10</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="From2017-01-01to2017-09-30_us-gaap_OptionMember" unitRef="USD_per_Share" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="From2017-01-01to2017-09-30_us-gaap_WarrantMember" unitRef="USD_per_Share" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice contextRef="From2017-01-01to2017-09-30_us-gaap_OptionMember" unitRef="USD_per_Share" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice contextRef="From2017-01-01to2017-09-30_us-gaap_WarrantMember" unitRef="USD_per_Share" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2017-01-01to2017-09-30_us-gaap_OptionMember">P3Y9M0D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <COSM:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2 contextRef="From2017-01-01to2017-09-30_us-gaap_OptionMember">P3Y6M29D</COSM:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2>
    <COSM:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2 contextRef="From2017-01-01to2017-09-30_us-gaap_WarrantMember">P1Y</COSM:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2017-01-01to2017-09-30_us-gaap_OptionMember">P3Y5M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2017-01-01to2017-09-30_us-gaap_WarrantMember">P0Y6M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <COSM:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4 contextRef="From2017-01-01to2017-09-30_us-gaap_OptionMember">P3Y4M28D</COSM:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4>
    <COSM:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4 contextRef="From2017-01-01to2017-09-30_us-gaap_WarrantMember">P0Y6M18D</COSM:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding contextRef="AsOf2016-12-31_us-gaap_WarrantMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding contextRef="AsOf2016-12-31_us-gaap_OptionMember" unitRef="USD" decimals="0">74400</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding contextRef="AsOf2017-09-30_us-gaap_OptionMember" unitRef="USD" decimals="0">191600</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding contextRef="AsOf2017-09-30_us-gaap_WarrantMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested contextRef="From2017-01-01to2017-09-30_us-gaap_OptionMember" unitRef="USD" decimals="0">150800</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested contextRef="From2017-01-01to2017-09-30_us-gaap_WarrantMember" unitRef="USD" xsi:nil="true" />
    <COSM:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited contextRef="From2017-01-01to2017-09-30_us-gaap_OptionMember" unitRef="USD" xsi:nil="true" />
    <COSM:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited contextRef="From2017-01-01to2017-09-30_us-gaap_WarrantMember" unitRef="USD" xsi:nil="true" />
    <COSM:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised contextRef="From2017-01-01to2017-09-30_us-gaap_OptionMember" unitRef="USD" xsi:nil="true" />
    <COSM:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised contextRef="From2017-01-01to2017-09-30_us-gaap_WarrantMember" unitRef="USD" xsi:nil="true" />
    <COSM:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpired contextRef="From2017-01-01to2017-09-30_us-gaap_OptionMember" unitRef="USD" xsi:nil="true" />
    <COSM:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpired contextRef="From2017-01-01to2017-09-30_us-gaap_WarrantMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2017-09-30_us-gaap_OptionMember" unitRef="shares" decimals="INF">397500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2017-09-30_us-gaap_WarrantMember" unitRef="shares" decimals="INF">100400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2017-09-30_us-gaap_OptionMember" unitRef="USD_per_Share" decimals="INF">0.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2017-09-30_us-gaap_WarrantMember" unitRef="USD_per_Share" decimals="INF">3.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue contextRef="AsOf2017-09-30_us-gaap_OptionMember" unitRef="USD" decimals="0">153900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue contextRef="AsOf2017-09-30_us-gaap_WarrantMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="From2017-01-01to2017-09-30_us-gaap_MinimumMember" unitRef="Pure" decimals="INF">0.7666</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="From2017-01-01to2017-09-30_us-gaap_MaximumMember" unitRef="Pure" decimals="INF">0.9086</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:FairValueAssumptionsExpectedTerm contextRef="From2017-01-01to2017-09-30">P1Y</us-gaap:FairValueAssumptionsExpectedTerm>
    <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="From2017-01-01to2017-09-30_us-gaap_MinimumMember" unitRef="Pure" decimals="INF">0.0107</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="From2017-01-01to2017-09-30_us-gaap_MaximumMember" unitRef="Pure" decimals="INF">0.0111</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:FairValueAssumptionsExpectedDividendRate contextRef="From2017-01-01to2017-09-30" unitRef="Pure" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2017-01-01to2017-09-30_us-gaap_StockOptionMember_custom_UsFinanceManagerMember_custom_OnOctoberOneTwoThousandSixteenMember" unitRef="shares" decimals="INF">120000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2017-01-01to2017-09-30_us-gaap_StockOptionMember_custom_MrOrestesVarvitsiotesMember_custom_JanuaryThreeTwoThousandSeventeenMember" unitRef="shares" decimals="INF">120000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:StockOptionPlanExpense contextRef="From2017-01-01to2017-09-30_us-gaap_StockOptionMember_custom_UsFinanceManagerMember_custom_OnOctoberOneTwoThousandSixteenMember" unitRef="USD" decimals="0">65290</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense contextRef="From2017-01-01to2017-09-30_us-gaap_StockOptionMember_custom_MrOrestesVarvitsiotesMember_custom_JanuaryThreeTwoThousandSeventeenMember" unitRef="USD" decimals="0">94830</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense contextRef="From2017-01-01to2017-09-30_us-gaap_StockOptionMember_custom_EmployeeMember_custom_OnJanuaryOneTwoThousandSeventeenMember" unitRef="USD" decimals="0">195307</us-gaap:StockOptionPlanExpense>
    <us-gaap:SharePrice contextRef="AsOf2017-09-30_us-gaap_StockOptionMember_custom_EmployeeMember_custom_OnOctoberOneTwoThousandSixteenMember" unitRef="USD_per_Share" decimals="INF">0.58</us-gaap:SharePrice>
    <us-gaap:SharePrice contextRef="AsOf2017-09-30_us-gaap_StockOptionMember_custom_MrOrestesVarvitsiotesMember_custom_JanuaryThreeTwoThousandSeventeenMember" unitRef="USD_per_Share" decimals="INF">0.82</us-gaap:SharePrice>
    <us-gaap:SharePrice contextRef="AsOf2017-09-30_us-gaap_StockOptionMember_custom_EmployeeMember_custom_JanuaryOneTwoThousandSeventeenMember" unitRef="USD_per_Share" decimals="INF">0.82</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice contextRef="AsOf2017-09-30_us-gaap_StockOptionMember_custom_EmployeeMember_custom_OnOctoberOneTwoThousandSixteenMember" unitRef="USD_per_Share" decimals="INF">0.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice contextRef="AsOf2017-09-30_us-gaap_StockOptionMember_custom_MrOrestesVarvitsiotesMember_custom_JanuaryThreeTwoThousandSeventeenMember" unitRef="USD_per_Share" decimals="INF">0.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice contextRef="AsOf2017-09-30_us-gaap_StockOptionMember_custom_EmployeeMember_custom_JanuaryOneTwoThousandSeventeenMember" unitRef="USD_per_Share" decimals="INF">0.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2017-01-01to2017-09-30_us-gaap_StockOptionMember_custom_UsFinanceManagerMember_custom_OnOctoberOneTwoThousandSixteenMember">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2017-01-01to2017-09-30_us-gaap_StockOptionMember_custom_MrOrestesVarvitsiotesMember_custom_JanuaryThreeTwoThousandSeventeenMember">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2017-01-01to2017-09-30_us-gaap_StockOptionMember_custom_EmployeeMember_custom_OnJanuaryOneTwoThousandSeventeenMember">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="From2017-01-01to2017-09-30_us-gaap_StockOptionMember_custom_UsFinanceManagerMember_custom_OnOctoberOneTwoThousandSixteenMember" unitRef="Pure" decimals="INF">1.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="From2017-01-01to2017-09-30_us-gaap_StockOptionMember_custom_MrOrestesVarvitsiotesMember_custom_JanuaryThreeTwoThousandSeventeenMember" unitRef="Pure" decimals="INF">1.5537</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="From2017-01-01to2017-09-30_us-gaap_StockOptionMember_custom_EmployeeMember_custom_OnJanuaryOneTwoThousandSeventeenMember" unitRef="Pure" decimals="INF">1.3676</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:DepreciationAndAmortization contextRef="From2016-01-01to2016-12-31_us-gaap_StockOptionMember_custom_UsFinanceManagerMember" unitRef="USD" decimals="0">16636</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From2017-01-01to2017-09-30_us-gaap_StockOptionMember_custom_AegisCapitalCorpMember" unitRef="USD" decimals="0">70796</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From2017-01-01to2017-09-30_us-gaap_StockOptionMember_custom_InternationalFinanceManagerMember" unitRef="USD" decimals="0">146079</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From2017-01-01to2017-09-30_us-gaap_StockOptionMember_custom_UsFinanceManagerMember" unitRef="USD" decimals="0">48654</us-gaap:DepreciationAndAmortization>
    <COSM:StockOptionPeriodicVesting contextRef="AsOf2017-06-30_us-gaap_StockOptionMember_custom_EmployeeMember_custom_UsFinanceManagerMember" unitRef="shares" decimals="INF">120000</COSM:StockOptionPeriodicVesting>
    <COSM:StockOptionPeriodicVesting contextRef="AsOf2017-09-30_us-gaap_StockOptionMember_custom_MrOrestesVarvitsiotesMember_custom_JanuaryThreeTwoThousandSeventeenMember" unitRef="shares" decimals="INF">90000</COSM:StockOptionPeriodicVesting>
    <COSM:StockOptionPeriodicVesting contextRef="AsOf2017-09-30_us-gaap_StockOptionMember_custom_EmployeeMember_custom_JanuaryOneTwoThousandSeventeenMember" unitRef="shares" decimals="INF">187500</COSM:StockOptionPeriodicVesting>
    <COSM:FrequencyOfPeriodicVesting contextRef="From2017-01-01to2017-09-30_us-gaap_StockOptionMember_custom_UsFinanceManagerMember_custom_OnOctoberOneTwoThousandSixteenMember">Monthly</COSM:FrequencyOfPeriodicVesting>
    <COSM:ConsiderationUnderAgreement contextRef="From2017-01-01to2017-09-30_us-gaap_StockOptionMember_custom_EmployeeMember_custom_OnJanuaryOneTwoThousandSeventeenMember" unitRef="USD" decimals="0">1000</COSM:ConsiderationUnderAgreement>
    <COSM:ShareBasedCompensationAsAnnualRetainer contextRef="AsOf2017-09-30_us-gaap_StockOptionMember_custom_EmployeeMember_custom_JanuaryOneTwoThousandSeventeenMember" unitRef="shares" decimals="INF">250000</COSM:ShareBasedCompensationAsAnnualRetainer>
    <COSM:WarrantsIssuedRatioDescription contextRef="From2017-01-01to2017-09-30_us-gaap_InvestorMember">1:1 ratio for shares </COSM:WarrantsIssuedRatioDescription>
    <us-gaap:CommitmentsFromFranchiseAgreements contextRef="From2017-08-01to2017-08-08_us-gaap_PrivatePlacementMember">&lt;p style="margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1) a cash&#13;commission of 6% of the total gross proceeds for two named investors (2) a cash commission of 4% of total gross proceeds from&#13;five named investors and (3) excluding the five named investors in &amp;#147;(2)&amp;#148; a cash commission equal to 8% of the total&#13;gross proceeds from the Offering and the issuance to the Agent or its designees of warrants covering 8% of the shares of common&#13;stock issued or issuable by the Company in the Offering. Additionally, the Agent will receive a cash fee of 8% payable within&#13;5 business days, but only in the event of, the receipt by the Company of any cash proceeds from the exercise of any warrants with&#13;an expiration equal to or less than 24 months sold in the Offering&lt;/font&gt;&lt;/p&gt;</us-gaap:CommitmentsFromFranchiseAgreements>
    <COSM:NonrefundableFee contextRef="AsOf2016-06-21_custom_CCPharmaGmbHMember" unitRef="USD" decimals="0">454800</COSM:NonrefundableFee>
    <us-gaap:CostsAndExpenses contextRef="From2016-01-01to2016-09-30_custom_CCPharmaGmbHMember" unitRef="USD" decimals="0">454800</us-gaap:CostsAndExpenses>
    <COSM:CommonStockSharesAcquiredForConsiderationValue contextRef="From2017-09-26to2017-10-02_us-gaap_SubsequentEventMember_custom_StockPurchaseAgreementMember_us-gaap_InvestorMember" unitRef="USD" decimals="0">1387</COSM:CommonStockSharesAcquiredForConsiderationValue>
    <COSM:CommonStockSharesAcquiredForConsiderationShares contextRef="From2017-09-26to2017-10-02_us-gaap_SubsequentEventMember_custom_StockPurchaseAgreementMember_us-gaap_InvestorMember" unitRef="shares" decimals="INF">1386894</COSM:CommonStockSharesAcquiredForConsiderationShares>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="From2017-10-01to2017-10-11_us-gaap_SubsequentEventMember">(1:10)</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:ConvertibleNotesPayable contextRef="AsOf2017-11-15_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_custom_SeniorConvertibleNoteOneMember_custom_InstitutionalInvestorsMember" unitRef="USD" decimals="0">3000000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable contextRef="AsOf2017-11-15_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_custom_SeniorConvertibleNoteTwoMember_custom_InstitutionalInvestorsMember" unitRef="USD" decimals="0">3350000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DebtInstrumentRedemptionDescription contextRef="From2017-11-01to2017-11-15_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_SeniorNotesMember">The Notes provide that the Company will repay the principal amount of Notes in equal monthly installments beginning on January 1, 2018 and repeating on the first business day of each calendar month thereafter until the fourteenth month anniversary date of issuance</us-gaap:DebtInstrumentRedemptionDescription>
    <us-gaap:DebtDefaultShorttermDebtDescriptionOfViolationOrEventOfDefault contextRef="From2017-11-01to2017-11-15_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_SeniorNotesMember">The Company shall pre-deliver up to 6,700,000 shares of Common Stock to the Buyers in connection therewith (the 'Pre-Delivery Shares'). Eighty-five (85%) percent of any cash proceeds received by the Buyers from the sale of Pre-Delivery Shares shall be applied against the particular installment amount due on such Installment Date under the Note. No interest will accrue under the Notes unless and until an Event of Default (as defined) has occurred and is not cured</us-gaap:DebtDefaultShorttermDebtDescriptionOfViolationOrEventOfDefault>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2017-11-15_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_SeniorNotesMember_us-gaap_ConvertibleCommonStockMember111760343" unitRef="USD_per_Share" decimals="INF">0.50</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <COSM:EventOfDefaultConverstionPriceDescription contextRef="From2017-11-01to2017-11-15_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_SeniorNotesMember">Upon an Event of Default (as defined), the Buyers may convert at an alternative conversion price equal to the lower of the then applicable Conversion Price or seventy-five (75%) percent of the Volume-Weighted Average Price (as defined, the "VWAP")</COSM:EventOfDefaultConverstionPriceDescription>
    <us-gaap:AggregateIndebtedness contextRef="AsOf2017-11-15_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_SeniorNotesMember_us-gaap_ConvertibleCommonStockMember111760343" unitRef="USD" decimals="0">12000000</us-gaap:AggregateIndebtedness>
    <COSM:CustomaryEventsOfDefaultDescription contextRef="From2017-11-01to2017-11-15_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_SeniorNotesMember">The Notes include customary Events of Default and provide that the Buyers may require the Company to redeem (regardless of whether the Event of Default has been cured) all or a portion of the Notes at a redemption premium of one hundred twenty-five (125%) percent, multiplied by the greater of the conversion rate and the then current market price. The Buyers may also require redemption of the Notes upon a Change of Control (as defined) at a premium of one hundred twenty-five (125%) percent</COSM:CustomaryEventsOfDefaultDescription>
    <us-gaap:DerivativeTermOfContract contextRef="From2017-11-01to2017-11-15_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_WarrantMember">P5Y</us-gaap:DerivativeTermOfContract>
    <COSM:ConvertibleSecuritiesTermsOfConversionFeature contextRef="From2017-11-01to2017-11-15_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_WarrantMember">The Warrants have a five year term and are exercisable into a number of shares of Common Stock equal to approximately eighty (80%) percent of the number of shares of Common Stock the Buyers would receive if the Notes were fully converted upon the date of issuance of the Notes. The Warrants are exercisable at $0.75 per share (150% of the conversion price of the Notes) subject to full ratchet anti-dilution protection</COSM:ConvertibleSecuritiesTermsOfConversionFeature>
    <COSM:TermsOfBlockerProvision contextRef="From2017-11-01to2017-11-15_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_WarrantMember">Blocker provision which prevents any holder from converting or exercising, as applicable, the Notes or the Warrants, into shares of Common Stock if its beneficial ownership of the Common Stock would exceed 4.99% (subject to adjustment not to exceed 9.99%) of the Company's issued and outstanding Common Stock (each, a "Blocker")</COSM:TermsOfBlockerProvision>
    <COSM:TermsOfAgreement contextRef="From2017-11-01to2017-11-15_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_WarrantMember_custom_RegistrationRightsAgreementMember">The Company is required to file, within thirty (30) days of the Closing, a registration statement covering one hundred fifty (150%) percent of the maximum number of shares, underlying the Notes and Warrants pursuant to a registration rights agreement with the Buyers (the "Registration Rights Agreement")</COSM:TermsOfAgreement>
    <COSM:TermsOfAgreement contextRef="From2017-11-01to2017-11-15_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_WarrantMember_custom_LeakOutAgreementMember">As a condition to the closing of the Financing, each Buyer, severally, will be required to execute a leak-out agreement (each, a "Leak-Out Agreement") restricting such Buyer's sale of shares of Common Stock underlying the Notes and Warrants on any Trading Day to not more than such Buyer's pro rata allocation of the greater of (x) sales with net proceeds of an aggregate of $20,000 or (y) twenty-five (25%) percent of the daily average trading volume of the Company's Common Stock. If after the closing of the Financing there is no Event of Default under the Notes, the VWAP of the Company's Common Stock for three (3) trading days is less than $0.15 per share, the Company may further restrict the Buyers from selling at less than $0.15 per share</COSM:TermsOfAgreement>
    <COSM:ConditionalProceedsFromSaleOfCommonStockUnderAgreement contextRef="From2017-11-01to2017-11-15_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_WarrantMember_custom_LeakOutAgreementMember" unitRef="USD" decimals="0">20000</COSM:ConditionalProceedsFromSaleOfCommonStockUnderAgreement>
    <COSM:TermsOfCommission contextRef="From2017-11-01to2017-11-15_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_WarrantMember_custom_LeakOutAgreementMember">Placement agent will receive a cash commission for this transaction equal to eight (8%) percent of the total gross proceeds of the offering and the issuance of five-year warrants to purchase eight (8%) percent of the shares of Common Stock issued or issuable in this offering (excluding shares of Common Stock issuable upon exercise of any Warrants issued to investors); however, will receive eight (8%) percent of any cash proceeds received from the exercise of any Warrants sold in the offering with an expiration equal to or less than twenty-four (24) months</COSM:TermsOfCommission>
    <COSM:AmendmentToCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2017-11-15_us-gaap_SubsequentEventMember_custom_TradeFacilityAgreementMember" unitRef="USD" decimals="0">6000000</COSM:AmendmentToCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">110561</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">154949</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DepositsAssetsNoncurrent contextRef="AsOf2016-02-28_custom_SynthesisManagementLimitedMember" unitRef="USD" decimals="0">133725</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">147662</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent contextRef="AsOf2017-08-30_custom_SynthesisManagementLimitedMember" unitRef="USD" decimals="0">213627</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent contextRef="AsOf2017-09-30_custom_SynthesisManagementLimitedMember" unitRef="USD" decimals="0">213627</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:PartnersCapitalNotesDisclosureTextBlock contextRef="From2017-01-01to2017-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Preferred Stock&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company is authorized to issue 100 million&#13;shares of preferred stock, which have liquidation preference over the common stock and are non-voting. As of September 30, 2017&#13;and December 31, 2016, no preferred shares have been issued.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Common Stock&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company is authorized to issue 300 million&#13;shares of common stock and had issued 100,000,000 in connection with the merger with Amplerissimo and had 25,585,532 shares issued&#13;prior to the merger.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Under the Exchange Agreement, the Registrant&#13;completed the acquisition of all of the issued and outstanding shares of Amplerissimo through the issuance of 100,000,000 restricted&#13;shares of Common Stock to Dimitrios Goulielmos, the sole shareholder of Amplerissimo. Immediately prior to the Exchange Agreement&#13;transaction, the Registrant had 25,585,532 shares of Common Stock issued and outstanding. Immediately after the issuance of the&#13;shares the Registrant had 125,585,532 shares of Common Stock issued and outstanding.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The consideration provided pursuant to the&#13;Exchange Agreement was the issuance of 100,000,000 shares of our common stock.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On February 10, 2017 the Company and Decahedron&#13;consummated the acquisition of Decahedron SPA. Pursuant to the terms of the Decahedron SPA, the shareholders of Decahedron received&#13;an aggregate of 1,700,000 shares of common stock of the Company, which were delivered at closing in exchange for all of the Ordinary&#13;Shares of Decahedron for the Stock Consideration.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Shares Issued for Services&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On March 1, 2017, the Company entered into&#13;a four-month consulting agreement with a third party investment advisory firm for consideration of 5,000 restricted shares of common&#13;stock to be issued during the period of the agreement for any introductions and related contributions the Company receives as a&#13;result of those introductions. As of September 30, 2017, no consideration has been earned and no shares have been issued related&#13;to this agreement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May 1, 2017, the Company entered into an&#13;8-month consulting agreement with a third party for web design services commencing on May 1, 2017 and terminating on January 1,&#13;2018. As compensation for creating, delivering and maintaining a website, the Company issued 20,000 shares of common stock on May&#13;24, 2017. The shares were valued at $14,400, which was fully recognized in the nine months ended September 30, 2017.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May 1, 2017, the Company entered into a&#13;five-month consulting agreement with a third party advisory firm for consideration of 20,000 shares of the Company&amp;#146;s common&#13;stock. The stock was issued on May 25, 2017 and fair valued at $0.72 per share or $14,400, which was fully recognized in the nine&#13;months ended September 30, 2017.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May 8, 2017, the Company entered into a&#13;one-year consulting agreement for advisory services with a third party investment relations firm. On May 18, 2017, the Company&#13;issued to the consultant 300,000 shares of the Company&amp;#146;s common stock valued at $219,000. The shares are considered to be&#13;a fully earned, nonrefundable, non-apportionable and non-ratable retainer as consideration for undertaking the agreement. In addition,&#13;the Company will pay the consultant $5,000 per month in cash for the term of the agreement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May 25, 2017, the Company entered into a&#13;20-month consulting agreement with a third party advisory firm for consideration of 200,000 shares of the Company&amp;#146;s common&#13;stock. The stock was issued on May 25, 2017 and fair valued at $0.77 per share or $154,000, which will be amortized over the length&#13;of the agreement. For the nine months ending September 30, 2017, the Company has recorded $32,874 in consulting expense related&#13;to this agreement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of September 30, 2017 and December 31, 2016,&#13;the Company had 128,253,932 and 125,870,532 shares of Common Stock issued and outstanding, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Potentially Dilutive Securities&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On October 1, 2016 the Company granted 120,000&#13;options to an employee of the Company as compensation for being appointed the US Finance Manager of the Company. The options have&#13;an exercise period of four years with an exercise price of $0.20. In the event that he ceases to work for the Company for any reason,&#13;he will be entitled to a pro rata portion of the annual options. The options vest monthly with 120,000 options fully vested as&#13;of September 30, 2017. (See Note 10)&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On January 1, 2017 the Company granted 250,000&#13;options to an employee of the Company as compensation for being appointed the International Finance Manager of the Company. The&#13;options have an exercise period of four years with an exercise price of $0.10 per share. In the event that he ceases to work for&#13;the Company for any reason, he will be entitled to a pro rata portion of the annual options. The options vest monthly with 187,500&#13;options fully vested as of September 30, 2017. (See Note 10)&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On January 3, 2017 the Company granted 120,000&#13;options to an employee of the Company as compensation for being appointed as a consultant of the Company. The options have an exercise&#13;period of five years with an exercise price of $0.20 per share. In the event that he ceases to work for the Company for any reason,&#13;he will be entitled to a pro rata portion of the annual options. The options vest monthly with 90,000 options fully vested as of&#13;September 30, 2017. (See Note 10)&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Sales Pursuant to Regulation S&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify"&gt;On April 7, 2017, the Company issued&#13;shares of common stock and warrants pursuant to a private placement conducted under the exemptions from registration under Regulation&#13;S. Each unit sold to investors consists of $35,000 face value purchase price of 50,000 shares plus warrants to purchase the number&#13;of equivalent shares. The Company retains the right to accept less than the $35,000 face value from any investor at its discretion.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify"&gt;The Company has entered into the&#13;following subscription agreements:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify"&gt;On April 10, 2017, the Company sold&#13;45,800 shares at $0.70 per share for a total purchase price of $32,060 to a private investor. The investor also received 45,800&#13;warrants that were valued using the Black Scholes valuation model to have a fair value of $2,375 (See Note 10).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05pt; text-align: justify; text-indent: 0.5in"&gt;&amp;#160; &amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify"&gt;On April 26, 2017, the Company sold&#13;46,700 shares at $0.70 per share for a total purchase price of $32,690 to a private investor. The investor also received 46,700&#13;warrants that were valued using the Black Scholes valuation model to have a fair value of $1,521 (See Note 10).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify"&gt;On May 16, 2017, the Company sold&#13;7,900 shares at $0.70 per share for a total purchase price of $5,530 to a private investor. The investor also received 7,900 warrants&#13;that were valued using the Black Scholes valuation model to have a fair value of $130 (See Note 10).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify"&gt;On July 21, 2017, the Company sold&#13;43,000 shares at $0.50 per share for a total purchase price of $21,500 to a private investor. The Company did not grant any warrants&#13;to the investor under this agreement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;No options, warrants or other potentially dilutive&#13;securities other than those disclosed above have been issued as of September 30, 2017 and December 31, 2016.&lt;/p&gt;</us-gaap:PartnersCapitalNotesDisclosureTextBlock>
    <link:footnoteLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="#Foot-00-0" xlink:label="Foot-00_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-00_loc" xlink:to="Footnote-01" order="1" />
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-01" xml:lang="en-US">(a) U.K Pharmaceutical Wholesale Distribution License</link:footnote>
    </link:footnoteLink>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>cosm-20170930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: cosm_10%2Dq1.xfr; Date: 2017%2D11%2D20T00:19:58Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +q5Zo7xRiXgOn8uEbH0sWa+PmbP9wZFwqekxtml2fTmKry8m6lgm7ivv8CA2wesG -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2016-01-31" xmlns:us-roles="http://fasb.org/us-roles/2016-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2016-01-31" xmlns:COSM="http://primeestatesdevelopmentsinc.com/20170930" elementFormDefault="qualified" targetNamespace="http://primeestatesdevelopmentsinc.com/20170930">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
	  <link:definition>00000001 - Document - Document and Entity Information</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
	  <link:definition>00000002 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical" id="ConsolidatedBalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/ConsolidatedStatementsOfOperationsAndOtherComprehensiveIncomeLoss" id="ConsolidatedStatementsOfOperationsAndOtherComprehensiveIncomeLoss">
	  <link:definition>00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME (LOSS) (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
	  <link:definition>00000005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/BasisOfPresentation" id="BasisOfPresentation">
	  <link:definition>00000006 - Disclosure - BASIS OF PRESENTATION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcern" id="OrganizationNatureOfBusinessAndGoingConcern">
	  <link:definition>00000007 - Disclosure - ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd." id="AcquisitionOfDecahedronLtd.">
	  <link:definition>00000008 - Disclosure - ACQUISITION OF DECAHEDRON, LTD.</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/PrepaidDeferredFinancingCosts" id="PrepaidDeferredFinancingCosts">
	  <link:definition>00000009 - Disclosure - PREPAID DEFERRED FINANCING COSTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/IncomeTaxes" id="IncomeTaxes">
	  <link:definition>00000010 - Disclosure - INCOME TAXES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/CapitalStructure" id="CapitalStructure">
	  <link:definition>00000011 - Disclosure - CAPITAL STRUCTURE</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
	  <link:definition>00000012 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/Debt" id="Debt">
	  <link:definition>00000013 - Disclosure - DEBT</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
	  <link:definition>00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrants" id="StockOptionsAndWarrants">
	  <link:definition>00000015 - Disclosure - STOCK OPTIONS AND WARRANTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000016 - Disclosure - SUBSEQUENT EVENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernPolicies" id="OrganizationNatureOfBusinessAndGoingConcernPolicies">
	  <link:definition>00000017 - Disclosure - ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernTables" id="OrganizationNatureOfBusinessAndGoingConcernTables">
	  <link:definition>00000018 - Disclosure - ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtdTable" id="AcquisitionOfDecahedronLtdTable">
	  <link:definition>00000019 - Disclosure - ACQUISITION OF DECAHEDRON, LTD (Table)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsTables" id="StockOptionsAndWarrantsTables">
	  <link:definition>00000020 - Disclosure - STOCK OPTIONS AND WARRANTS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernDetails" id="OrganizationNatureOfBusinessAndGoingConcernDetails">
	  <link:definition>00000021 - Disclosure - ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernDetailsNarrative" id="OrganizationNatureOfBusinessAndGoingConcernDetailsNarrative">
	  <link:definition>00000022 - Disclosure - ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.Details" id="AcquisitionOfDecahedronLtd.Details">
	  <link:definition>00000023 - Disclosure - ACQUISITION OF DECAHEDRON, LTD. (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.Details1" id="AcquisitionOfDecahedronLtd.Details1">
	  <link:definition>00000024 - Disclosure - ACQUISITION OF DECAHEDRON, LTD. (Details 1)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.Details2" id="AcquisitionOfDecahedronLtd.Details2">
	  <link:definition>00000025 - Disclosure - ACQUISITION OF DECAHEDRON, LTD. (Details 2)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.DetailsNarrative" id="AcquisitionOfDecahedronLtd.DetailsNarrative">
	  <link:definition>00000026 - Disclosure - ACQUISITION OF DECAHEDRON, LTD. (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/PrepaidDeferredFinancingCostsDetailsNarrative" id="PrepaidDeferredFinancingCostsDetailsNarrative">
	  <link:definition>00000027 - Disclosure - PREPAID DEFERRED FINANCING COSTS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
	  <link:definition>00000028 - Disclosure - INCOME TAXES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/CapitalStructureDetailsNarrative" id="CapitalStructureDetailsNarrative">
	  <link:definition>00000029 - Disclosure - CAPITAL STRUCTURE (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative">
	  <link:definition>00000030 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/DebtDetailsNarrative" id="DebtDetailsNarrative">
	  <link:definition>00000031 - Disclosure - DEBT (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
	  <link:definition>00000032 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsDetails" id="StockOptionsAndWarrantsDetails">
	  <link:definition>00000033 - Disclosure - STOCK OPTIONS AND WARRANTS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsDetails1" id="StockOptionsAndWarrantsDetails1">
	  <link:definition>00000034 - Disclosure - STOCK OPTIONS AND WARRANTS (Details 1)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsDetails2" id="StockOptionsAndWarrantsDetails2">
	  <link:definition>00000035 - Disclosure - STOCK OPTIONS AND WARRANTS (Details 2)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsDetailsNarrative" id="StockOptionsAndWarrantsDetailsNarrative">
	  <link:definition>00000036 - Disclosure - STOCK OPTIONS AND WARRANTS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://primeestatesdevelopmentsinc.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
	  <link:definition>00000037 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="cosm-20170930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="cosm-20170930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="cosm-20170930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="cosm-20170930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-types-2016-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2016-01-31" schemaLocation="http://xbrl.sec.gov/country/2016/country-2016-01-31.xsd" />
    <import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" />
    <element id="COSM_DescriptionForPeriodicInventorySystemMaintainance" name="DescriptionForPeriodicInventorySystemMaintainance" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_WorkingCapitalDeficit" name="WorkingCapitalDeficit" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_AmendmentToMaturityDate" name="AmendmentToMaturityDate" nillable="true" xbrli:periodType="duration" type="xbrli:dateItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_PaymentOfMiscellaneousBills" name="PaymentOfMiscellaneousBills" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_UnauditedAllocationOfPurchasePriceTableTextBlock" name="UnauditedAllocationOfPurchasePriceTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_IntangibleAssetsTableTextBlock" name="IntangibleAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_UnauditedSupplementalProFormaDataTableTextBlock" name="UnauditedSupplementalProFormaDataTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_ImpairmentOfGoodwillPercent" name="ImpairmentOfGoodwillPercent" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedValueOfCommonStockIssuedAtAcquisition" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedValueOfCommonStockIssuedAtAcquisition" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_AdjustmentRelatedToOtherAssetsAndAccountsPayable" name="AdjustmentRelatedToOtherAssetsAndAccountsPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_AmendedMaturityDate" name="AmendedMaturityDate" nillable="true" xbrli:periodType="duration" type="xbrli:dateItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_DebtInstrumentDecreaseAccruedInterestForgiveness" name="DebtInstrumentDecreaseAccruedInterestForgiveness" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_OperatingLeasePeriodicPayment" name="OperatingLeasePeriodicPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_FrequencyOfPeriodicPayment" name="FrequencyOfPeriodicPayment" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_CreditFaciltyOriginationFeePercentage" name="CreditFaciltyOriginationFeePercentage" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_WarrantsWereValuedTableTextBlock" name="WarrantsWereValuedTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_WarrantsTableTextBlock" name="WarrantsTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_ConsultingAgreementPeriod" name="ConsultingAgreementPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_DescriptionForPrepaidBalancePercentage" name="DescriptionForPrepaidBalancePercentage" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_MonthlyCreditFeePercentage" name="MonthlyCreditFeePercentage" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_PrepaidDeferredFinancingFees" name="PrepaidDeferredFinancingFees" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_DeferredFinancingFees" name="DeferredFinancingFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_PaymentOfLoansPayable" name="PaymentOfLoansPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_ReversalOfProceedsDueFromNoteholderDueToRepaymentOfNote" name="ReversalOfProceedsDueFromNoteholderDueToRepaymentOfNote" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_AcquisitionOfDecahedron" name="AcquisitionOfDecahedron" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_Note3AcquisitionOfDecahedronLtdTextBlock" name="Note3AcquisitionOfDecahedronLtdTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_PrepaidDeferredFinancingCostsTextBlock" name="PrepaidDeferredFinancingCostsTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_FixedAssetsPolicyTextBlock" name="FixedAssetsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited" name="SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised" name="SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpired" name="SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpired" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_StockOptionPeriodicVesting" name="StockOptionPeriodicVesting" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_FrequencyOfPeriodicVesting" name="FrequencyOfPeriodicVesting" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_ConsiderationUnderAgreement" name="ConsiderationUnderAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_ShareBasedCompensationAsAnnualRetainer" name="ShareBasedCompensationAsAnnualRetainer" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_WarrantsIssuedRatioDescription" name="WarrantsIssuedRatioDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_NonrefundableFee" name="NonrefundableFee" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_CommonStockSharesAcquiredForConsiderationValue" name="CommonStockSharesAcquiredForConsiderationValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_CommonStockSharesAcquiredForConsiderationShares" name="CommonStockSharesAcquiredForConsiderationShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_EventOfDefaultConverstionPriceDescription" name="EventOfDefaultConverstionPriceDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_CustomaryEventsOfDefaultDescription" name="CustomaryEventsOfDefaultDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_ConvertibleSecuritiesTermsOfConversionFeature" name="ConvertibleSecuritiesTermsOfConversionFeature" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_TermsOfBlockerProvision" name="TermsOfBlockerProvision" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_TermsOfAgreement" name="TermsOfAgreement" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_ConditionalProceedsFromSaleOfCommonStockUnderAgreement" name="ConditionalProceedsFromSaleOfCommonStockUnderAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_TermsOfCommission" name="TermsOfCommission" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_AmendmentToCreditFacilityMaximumBorrowingCapacity" name="AmendmentToCreditFacilityMaximumBorrowingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_DirectorAndFormerChiefExecutiveOfficerMember" name="DirectorAndFormerChiefExecutiveOfficerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_GreenEraMember" name="GreenEraMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_FormerChiefFinancialOfficerMember" name="FormerChiefFinancialOfficerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_LoanAgreementMember" name="LoanAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_LoanAgreementOneMember" name="LoanAgreementOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_ChicagoMember" name="ChicagoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_CyprusMember" name="CyprusMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_GreeceMember" name="GreeceMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_LoanAgreementTwoMember" name="LoanAgreementTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_LoanAgreementThreeMember" name="LoanAgreementThreeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_LoansOneMember" name="LoansOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_UnitedStatesMember" name="UnitedStatesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_AmplerissimoLtdMember" name="AmplerissimoLtdMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_RepublicOfCyprusMember" name="RepublicOfCyprusMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_SynthesisManagementLimitedMember" name="SynthesisManagementLimitedMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_PriorToMergerMember" name="PriorToMergerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_ExchangeAgreementMember" name="ExchangeAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_HellenicAmericanSecuritiesMember" name="HellenicAmericanSecuritiesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_ConsultingServicesMember" name="ConsultingServicesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_FormerDirectorMember" name="FormerDirectorMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_EmployeeMember" name="EmployeeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_PotentiallyDilutiveSecuritiesMember" name="PotentiallyDilutiveSecuritiesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_DocPharmaSaMember" name="DocPharmaSaMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_OnNovemberOneTwoThousandsFifteenMember" name="OnNovemberOneTwoThousandsFifteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_GrigoriosSiokasMember" name="GrigoriosSiokasMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_OnOctoberOneTwoThousandSixteenMember" name="OnOctoberOneTwoThousandSixteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_OuraniaMatsoukiMember" name="OuraniaMatsoukiMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_KonstantinosVassilopoulosMember" name="KonstantinosVassilopoulosMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_DimitriosGoulielmosMember" name="DimitriosGoulielmosMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_NovemberFifteenStockPurchaseAgreementMember" name="NovemberFifteenStockPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_MaloneBaileyMember" name="MaloneBaileyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_AccountingFeesMember" name="AccountingFeesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_TerzisMember" name="TerzisMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_TheAmplerissimoTaxLiabilityMember" name="TheAmplerissimoTaxLiabilityMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_AngeloDrakopoulosMember" name="AngeloDrakopoulosMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_LoanAgreementFourMember" name="LoanAgreementFourMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_PanagiotisDrakopoulosMember" name="PanagiotisDrakopoulosMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_LoanAgreementFiveMember" name="LoanAgreementFiveMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_LoanAgreementSixMember" name="LoanAgreementSixMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_ThirdPartyMember" name="ThirdPartyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_LoanAgreementSevenMember" name="LoanAgreementSevenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_LoanAgreementEightMember" name="LoanAgreementEightMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_LoanAgreementNineMember" name="LoanAgreementNineMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_LoanAgreementTenMember" name="LoanAgreementTenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_LoanAgreementElevenMember" name="LoanAgreementElevenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_LoanAgreementTwelveMember" name="LoanAgreementTwelveMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_LoanAgreementThirteenMember" name="LoanAgreementThirteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_LoanAgreementFourteenMember" name="LoanAgreementFourteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_LoanFacilityAgreementMember" name="LoanFacilityAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_SkyPharmMember" name="SkyPharmMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_SynthesisFacilityAgreementMember" name="SynthesisFacilityAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_AmendmentToLoanFacilityAgreementMember" name="AmendmentToLoanFacilityAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_SecondAmendmentToLoanFacilityAgreementMember" name="SecondAmendmentToLoanFacilityAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_OtherObligationsMember" name="OtherObligationsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_AmplerissimoMember" name="AmplerissimoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_FirstFloorMember" name="FirstFloorMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_AdditionalSpaceMember" name="AdditionalSpaceMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_IntellectualPropertySaleAgreementMember" name="IntellectualPropertySaleAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember" name="AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_ConclusionOfPreclinicalTrialsMember" name="ConclusionOfPreclinicalTrialsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_ConclusionOfPhaseOneTestingMember" name="ConclusionOfPhaseOneTestingMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_ConclusionOfPhaseTwoTestingMember" name="ConclusionOfPhaseTwoTestingMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_ConclusionOfPhaseThreeTestingMember" name="ConclusionOfPhaseThreeTestingMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_SharePurchaseAgreementMember" name="SharePurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_UsFinanceManagerMember" name="UsFinanceManagerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_StockPurchaseAgreementMember" name="StockPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_DecahedronLtdMember" name="DecahedronLtdMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_DirectorAndOfficerMember" name="DirectorAndOfficerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_GbpMember" name="GbpMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_PreliminaryAllocationAsOfFebruaryTenTwoThousandSeventeenMember" name="PreliminaryAllocationAsOfFebruaryTenTwoThousandSeventeenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_AllocationAdjustmentsMember" name="AllocationAdjustmentsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_FinalAllocationMember" name="FinalAllocationMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_LicensesMember" name="LicensesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_ConsultingAgreementMember" name="ConsultingAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_ArKoEuropeanBusinessServicesMember" name="ArKoEuropeanBusinessServicesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_OnJanuaryOneTwoThousandSeventeenMember" name="OnJanuaryOneTwoThousandSeventeenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_OnJanuaryThreeTwoThousandSeventeenMember" name="OnJanuaryThreeTwoThousandSeventeenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_BridgeLoansMember" name="BridgeLoansMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_MediHelmSAMember" name="MediHelmSAMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_DecahedronMember" name="DecahedronMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_MrOrestesVarvitsiotesMember" name="MrOrestesVarvitsiotesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_JanuaryThreeTwoThousandSeventeenMember" name="JanuaryThreeTwoThousandSeventeenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_JanuaryOneTwoThousandSeventeenMember" name="JanuaryOneTwoThousandSeventeenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_InternationalFinanceManagerMember" name="InternationalFinanceManagerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_AegisCapitalCorpMember" name="AegisCapitalCorpMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_UnitedKingdomofEnglandMember" name="UnitedKingdomofEnglandMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_ConsultingAgreementOneMember" name="ConsultingAgreementOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_ConsultingAgreementTwoMember" name="ConsultingAgreementTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_ConsultingAgreementThreeMember" name="ConsultingAgreementThreeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_ConsultingAgreementFourMember" name="ConsultingAgreementFourMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_MrSiokasMember" name="MrSiokasMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_SecuritiesPurchaseAgreementMember" name="SecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_BuyerMember" name="BuyerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_PreDeliverySharesMember" name="PreDeliverySharesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_VWAPMember" name="VWAPMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_CCPharmaGmbHMember" name="CCPharmaGmbHMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_PostMergerMember" name="PostMergerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_TradeFacilityAgreementMember" name="TradeFacilityAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_SeniorConvertibleNoteOneMember" name="SeniorConvertibleNoteOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_InstitutionalInvestorsMember" name="InstitutionalInvestorsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_SeniorConvertibleNoteTwoMember" name="SeniorConvertibleNoteTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_RegistrationRightsAgreementMember" name="RegistrationRightsAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_LeakOutAgreementMember" name="LeakOutAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_ConsolidatedBalanceSheetsAbstract" name="ConsolidatedBalanceSheetsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_ConsolidatedBalanceSheetsParentheticalAbstract" name="ConsolidatedBalanceSheetsParentheticalAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_ConsolidatedStatementsOfOperationsAndOtherComprehensiveIncomeLossUnauditedAbstract" name="ConsolidatedStatementsOfOperationsAndOtherComprehensiveIncomeLossUnauditedAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_ConsolidatedStatementsOfCashFlowsUnauditedAbstract" name="ConsolidatedStatementsOfCashFlowsUnauditedAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_NotesToFinancialStatementsAbstract" name="NotesToFinancialStatementsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_OrganizationNatureOfBusinessAndGoingConcernPoliciesAbstract" name="OrganizationNatureOfBusinessAndGoingConcernPoliciesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_OrganizationNatureOfBusinessAndGoingConcernTablesAbstract" name="OrganizationNatureOfBusinessAndGoingConcernTablesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_AcquisitionOfDecahedronLtdTableAbstract" name="AcquisitionOfDecahedronLtdTableAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_StockOptionsAndWarrantsTablesAbstract" name="StockOptionsAndWarrantsTablesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_OrganizationAndNatureOfBusinessDetailsAbstract" name="OrganizationAndNatureOfBusinessDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_OrganizationAndNatureOfBusinessDetailsNarrativeAbstract" name="OrganizationAndNatureOfBusinessDetailsNarrativeAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_AllCurrenciesDomain" name="AllCurrenciesDomain" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_IncomeTaxesDetailsNarrativeAbstract" name="IncomeTaxesDetailsNarrativeAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_CapitalStructureDetailsNarrativeAbstract" name="CapitalStructureDetailsNarrativeAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_RelatedPartyTransactionsDetailsNarrativeAbstract" name="RelatedPartyTransactionsDetailsNarrativeAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_DebtDetailsNarrativeAbstract" name="DebtDetailsNarrativeAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_StockOptionsAndWarrantsDetails2Abstract" name="StockOptionsAndWarrantsDetails2Abstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_WeightedAverageRemainingContractualTerm" name="WeightedAverageRemainingContractualTerm" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm3" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm3" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_StockOptionsAndWarrantsDetails1Abstract" name="StockOptionsAndWarrantsDetails1Abstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="COSM_VolumeweightedAveragePriceInPercentage" name="VolumeweightedAveragePriceInPercentage" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>cosm-20170930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: cosm_10%2Dq1.xfr; Date: 2017%2D11%2D20T00:19:58Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/DocumentAndEntityInformation" xlink:href="cosm-20170930.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/ConsolidatedBalanceSheets" xlink:href="cosm-20170930.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="cosm-20170930.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/ConsolidatedStatementsOfOperationsAndOtherComprehensiveIncomeLoss" xlink:href="cosm-20170930.xsd#ConsolidatedStatementsOfOperationsAndOtherComprehensiveIncomeLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="cosm-20170930.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/BasisOfPresentation" xlink:href="cosm-20170930.xsd#BasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcern" xlink:href="cosm-20170930.xsd#OrganizationNatureOfBusinessAndGoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd." xlink:href="cosm-20170930.xsd#AcquisitionOfDecahedronLtd." xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/PrepaidDeferredFinancingCosts" xlink:href="cosm-20170930.xsd#PrepaidDeferredFinancingCosts" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/IncomeTaxes" xlink:href="cosm-20170930.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/CapitalStructure" xlink:href="cosm-20170930.xsd#CapitalStructure" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/RelatedPartyTransactions" xlink:href="cosm-20170930.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/Debt" xlink:href="cosm-20170930.xsd#Debt" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/CommitmentsAndContingencies" xlink:href="cosm-20170930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrants" xlink:href="cosm-20170930.xsd#StockOptionsAndWarrants" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/SubsequentEvents" xlink:href="cosm-20170930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernPolicies" xlink:href="cosm-20170930.xsd#OrganizationNatureOfBusinessAndGoingConcernPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernTables" xlink:href="cosm-20170930.xsd#OrganizationNatureOfBusinessAndGoingConcernTables" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtdTable" xlink:href="cosm-20170930.xsd#AcquisitionOfDecahedronLtdTable" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsTables" xlink:href="cosm-20170930.xsd#StockOptionsAndWarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernDetails" xlink:href="cosm-20170930.xsd#OrganizationNatureOfBusinessAndGoingConcernDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernDetailsNarrative" xlink:href="cosm-20170930.xsd#OrganizationNatureOfBusinessAndGoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.Details" xlink:href="cosm-20170930.xsd#AcquisitionOfDecahedronLtd.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.Details1" xlink:href="cosm-20170930.xsd#AcquisitionOfDecahedronLtd.Details1" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.Details2" xlink:href="cosm-20170930.xsd#AcquisitionOfDecahedronLtd.Details2" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.DetailsNarrative" xlink:href="cosm-20170930.xsd#AcquisitionOfDecahedronLtd.DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/PrepaidDeferredFinancingCostsDetailsNarrative" xlink:href="cosm-20170930.xsd#PrepaidDeferredFinancingCostsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/IncomeTaxesDetailsNarrative" xlink:href="cosm-20170930.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/CapitalStructureDetailsNarrative" xlink:href="cosm-20170930.xsd#CapitalStructureDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="cosm-20170930.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/DebtDetailsNarrative" xlink:href="cosm-20170930.xsd#DebtDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="cosm-20170930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsDetails" xlink:href="cosm-20170930.xsd#StockOptionsAndWarrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsDetails1" xlink:href="cosm-20170930.xsd#StockOptionsAndWarrantsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsDetails2" xlink:href="cosm-20170930.xsd#StockOptionsAndWarrantsDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsDetailsNarrative" xlink:href="cosm-20170930.xsd#StockOptionsAndWarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/SubsequentEventsDetailsNarrative" xlink:href="cosm-20170930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryGross" xlink:label="loc_us-gaapInventoryGross" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_PrepaidDeferredFinancingFees" xlink:label="loc_COSMPrepaidDeferredFinancingFees" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_COSMPrepaidDeferredFinancingFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetIncludingGoodwill" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapIntangibleAssetsNetIncludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilities" xlink:label="loc_us-gaapAccountsPayableAndOtherAccruedLiabilities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndOtherAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LoansPayable" xlink:label="loc_us-gaapLoansPayable" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLoansPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLoansPayable" xlink:label="loc_us-gaapOtherLoansPayable" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLoansPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxesPayableCurrent" xlink:label="loc_us-gaapTaxesPayableCurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapTaxesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/ConsolidatedStatementsOfOperationsAndOtherComprehensiveIncomeLoss" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME (LOSS) (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaapOtherDepreciationAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapOtherDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="loc_us-gaapGainLossOnSalesOfAssetsAndAssetImpairmentCharges" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet" xlink:label="loc_us-gaapOtherOperatingIncomeExpenseNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpenseOther" xlink:label="loc_us-gaapInterestExpenseOther" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherOperatingIncomeExpenseNet" xlink:to="loc_us-gaapInterestExpenseOther" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherOperatingIncomeExpenseNet" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherExpenses" xlink:label="loc_us-gaapOtherExpenses" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherOperatingIncomeExpenseNet" xlink:to="loc_us-gaapOtherExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherOperatingIncomeExpenseNet" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaapOtherIncome" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherOperatingIncomeExpenseNet" xlink:to="loc_us-gaapOtherIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOtherOperatingIncomeExpenseNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossUnrealized" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossUnrealized" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaapOtherDepreciationAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOtherDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="loc_us-gaapGainLossOnSalesOfAssetsAndAssetImpairmentCharges" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedTaxesPayable" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedTaxesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredRevenue" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredRevenue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfAcquisitionCosts" xlink:label="loc_us-gaapAmortizationOfAcquisitionCosts" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapAmortizationOfAcquisitionCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfNotesPayable" xlink:label="loc_us-gaapProceedsFromRepaymentsOfNotesPayable" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRepaymentsOfNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_PaymentOfLoansPayable" xlink:label="loc_COSMPaymentOfLoansPayable" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_COSMPaymentOfLoansPayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromContributedCapital" xlink:label="loc_us-gaapProceedsFromContributedCapital" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromContributedCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DeferredFinancingFees" xlink:label="loc_COSMDeferredFinancingFees" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_COSMDeferredFinancingFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashAndCashEquivalents" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/BasisOfPresentation" xlink:title="00000006 - Disclosure - BASIS OF PRESENTATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcern" xlink:title="00000007 - Disclosure - ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd." xlink:title="00000008 - Disclosure - ACQUISITION OF DECAHEDRON, LTD." />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/PrepaidDeferredFinancingCosts" xlink:title="00000009 - Disclosure - PREPAID DEFERRED FINANCING COSTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/IncomeTaxes" xlink:title="00000010 - Disclosure - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/CapitalStructure" xlink:title="00000011 - Disclosure - CAPITAL STRUCTURE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/RelatedPartyTransactions" xlink:title="00000012 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/Debt" xlink:title="00000013 - Disclosure - DEBT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/CommitmentsAndContingencies" xlink:title="00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrants" xlink:title="00000015 - Disclosure - STOCK OPTIONS AND WARRANTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/SubsequentEvents" xlink:title="00000016 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernPolicies" xlink:title="00000017 - Disclosure - ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernTables" xlink:title="00000018 - Disclosure - ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtdTable" xlink:title="00000019 - Disclosure - ACQUISITION OF DECAHEDRON, LTD (Table)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsTables" xlink:title="00000020 - Disclosure - STOCK OPTIONS AND WARRANTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernDetails" xlink:title="00000021 - Disclosure - ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernDetailsNarrative" xlink:title="00000022 - Disclosure - ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.Details" xlink:title="00000023 - Disclosure - ACQUISITION OF DECAHEDRON, LTD. (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.Details1" xlink:title="00000024 - Disclosure - ACQUISITION OF DECAHEDRON, LTD. (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.Details2" xlink:title="00000025 - Disclosure - ACQUISITION OF DECAHEDRON, LTD. (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.DetailsNarrative" xlink:title="00000026 - Disclosure - ACQUISITION OF DECAHEDRON, LTD. (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/PrepaidDeferredFinancingCostsDetailsNarrative" xlink:title="00000027 - Disclosure - PREPAID DEFERRED FINANCING COSTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000028 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/CapitalStructureDetailsNarrative" xlink:title="00000029 - Disclosure - CAPITAL STRUCTURE (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000030 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/DebtDetailsNarrative" xlink:title="00000031 - Disclosure - DEBT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000032 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsDetails" xlink:title="00000033 - Disclosure - STOCK OPTIONS AND WARRANTS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsDetails1" xlink:title="00000034 - Disclosure - STOCK OPTIONS AND WARRANTS (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsDetails2" xlink:title="00000035 - Disclosure - STOCK OPTIONS AND WARRANTS (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsDetailsNarrative" xlink:title="00000036 - Disclosure - STOCK OPTIONS AND WARRANTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000037 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>cosm-20170930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: cosm_10%2Dq1.xfr; Date: 2017%2D11%2D20T00:19:58Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/DocumentAndEntityInformation" xlink:href="cosm-20170930.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/ConsolidatedBalanceSheets" xlink:href="cosm-20170930.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="cosm-20170930.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/ConsolidatedStatementsOfOperationsAndOtherComprehensiveIncomeLoss" xlink:href="cosm-20170930.xsd#ConsolidatedStatementsOfOperationsAndOtherComprehensiveIncomeLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="cosm-20170930.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/BasisOfPresentation" xlink:href="cosm-20170930.xsd#BasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcern" xlink:href="cosm-20170930.xsd#OrganizationNatureOfBusinessAndGoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd." xlink:href="cosm-20170930.xsd#AcquisitionOfDecahedronLtd." xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/PrepaidDeferredFinancingCosts" xlink:href="cosm-20170930.xsd#PrepaidDeferredFinancingCosts" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/IncomeTaxes" xlink:href="cosm-20170930.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/CapitalStructure" xlink:href="cosm-20170930.xsd#CapitalStructure" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/RelatedPartyTransactions" xlink:href="cosm-20170930.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/Debt" xlink:href="cosm-20170930.xsd#Debt" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/CommitmentsAndContingencies" xlink:href="cosm-20170930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrants" xlink:href="cosm-20170930.xsd#StockOptionsAndWarrants" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/SubsequentEvents" xlink:href="cosm-20170930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernPolicies" xlink:href="cosm-20170930.xsd#OrganizationNatureOfBusinessAndGoingConcernPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernTables" xlink:href="cosm-20170930.xsd#OrganizationNatureOfBusinessAndGoingConcernTables" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtdTable" xlink:href="cosm-20170930.xsd#AcquisitionOfDecahedronLtdTable" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsTables" xlink:href="cosm-20170930.xsd#StockOptionsAndWarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernDetails" xlink:href="cosm-20170930.xsd#OrganizationNatureOfBusinessAndGoingConcernDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernDetailsNarrative" xlink:href="cosm-20170930.xsd#OrganizationNatureOfBusinessAndGoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.Details" xlink:href="cosm-20170930.xsd#AcquisitionOfDecahedronLtd.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.Details1" xlink:href="cosm-20170930.xsd#AcquisitionOfDecahedronLtd.Details1" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.Details2" xlink:href="cosm-20170930.xsd#AcquisitionOfDecahedronLtd.Details2" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.DetailsNarrative" xlink:href="cosm-20170930.xsd#AcquisitionOfDecahedronLtd.DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/PrepaidDeferredFinancingCostsDetailsNarrative" xlink:href="cosm-20170930.xsd#PrepaidDeferredFinancingCostsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/IncomeTaxesDetailsNarrative" xlink:href="cosm-20170930.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/CapitalStructureDetailsNarrative" xlink:href="cosm-20170930.xsd#CapitalStructureDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="cosm-20170930.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/DebtDetailsNarrative" xlink:href="cosm-20170930.xsd#DebtDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="cosm-20170930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsDetails" xlink:href="cosm-20170930.xsd#StockOptionsAndWarrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsDetails1" xlink:href="cosm-20170930.xsd#StockOptionsAndWarrantsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsDetails2" xlink:href="cosm-20170930.xsd#StockOptionsAndWarrantsDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsDetailsNarrative" xlink:href="cosm-20170930.xsd#StockOptionsAndWarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/SubsequentEventsDetailsNarrative" xlink:href="cosm-20170930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/ConsolidatedStatementsOfOperationsAndOtherComprehensiveIncomeLoss" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME (LOSS) (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/BasisOfPresentation" xlink:title="00000006 - Disclosure - BASIS OF PRESENTATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcern" xlink:title="00000007 - Disclosure - ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN" />
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd." xlink:title="00000008 - Disclosure - ACQUISITION OF DECAHEDRON, LTD." />
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/PrepaidDeferredFinancingCosts" xlink:title="00000009 - Disclosure - PREPAID DEFERRED FINANCING COSTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/IncomeTaxes" xlink:title="00000010 - Disclosure - INCOME TAXES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/CapitalStructure" xlink:title="00000011 - Disclosure - CAPITAL STRUCTURE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/RelatedPartyTransactions" xlink:title="00000012 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/Debt" xlink:title="00000013 - Disclosure - DEBT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/CommitmentsAndContingencies" xlink:title="00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrants" xlink:title="00000015 - Disclosure - STOCK OPTIONS AND WARRANTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/SubsequentEvents" xlink:title="00000016 - Disclosure - SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernPolicies" xlink:title="00000017 - Disclosure - ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernTables" xlink:title="00000018 - Disclosure - ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtdTable" xlink:title="00000019 - Disclosure - ACQUISITION OF DECAHEDRON, LTD (Table)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsTables" xlink:title="00000020 - Disclosure - STOCK OPTIONS AND WARRANTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernDetails" xlink:title="00000021 - Disclosure - ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_50" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernDetailsNarrative" xlink:title="00000022 - Disclosure - ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_us-gaapStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaapSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementGeographicalAxis" xlink:to="loc_us-gaapSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaapSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementGeographicalAxis" xlink:to="loc_us-gaapSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_CyprusMember" xlink:label="loc_COSMCyprusMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentGeographicalDomain" xlink:to="loc_COSMCyprusMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_GreeceMember" xlink:label="loc_COSMGreeceMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentGeographicalDomain" xlink:to="loc_COSMGreeceMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_UnitedKingdomofEnglandMember" xlink:label="loc_COSMUnitedKingdomofEnglandMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentGeographicalDomain" xlink:to="loc_COSMUnitedKingdomofEnglandMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_StockPurchaseAgreementMember" xlink:label="loc_COSMStockPurchaseAgreementMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_COSMStockPurchaseAgreementMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DecahedronLtdMember" xlink:label="loc_COSMDecahedronLtdMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMDecahedronLtdMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AmplerissimoLtdMember" xlink:label="loc_COSMAmplerissimoLtdMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMAmplerissimoLtdMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTitleOfIndividualAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrencyAxis" xlink:label="loc_us-gaapCurrencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapCurrencyAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AllCurrenciesDomain" xlink:label="loc_COSMAllCurrenciesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapCurrencyAxis" xlink:to="loc_COSMAllCurrenciesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AllCurrenciesDomain" xlink:label="loc_COSMAllCurrenciesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCurrencyAxis" xlink:to="loc_COSMAllCurrenciesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityIncorporationStateCountryName" xlink:label="loc_deiEntityIncorporationStateCountryName_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryName_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="loc_deiEntityIncorporationDateOfIncorporation_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationDateOfIncorporation_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_WorkingCapitalDeficit" xlink:label="loc_COSMWorkingCapitalDeficit_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMWorkingCapitalDeficit_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DescriptionForPeriodicInventorySystemMaintainance" xlink:label="loc_COSMDescriptionForPeriodicInventorySystemMaintainance_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMDescriptionForPeriodicInventorySystemMaintainance_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciation_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_90" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets_90" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetImpairment_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetImpairment_90" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ImpairmentOfGoodwillPercent" xlink:label="loc_COSMImpairmentOfGoodwillPercent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMImpairmentOfGoodwillPercent_90" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations_90" xlink:type="arc" order="13" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.Details" xlink:title="00000023 - Disclosure - ACQUISITION OF DECAHEDRON, LTD. (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaapRelatedPartyTransactionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DecahedronLtdMember" xlink:label="loc_COSMDecahedronLtdMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_COSMDecahedronLtdMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_PreliminaryAllocationAsOfFebruaryTenTwoThousandSeventeenMember" xlink:label="loc_COSMPreliminaryAllocationAsOfFebruaryTenTwoThousandSeventeenMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_COSMPreliminaryAllocationAsOfFebruaryTenTwoThousandSeventeenMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AllocationAdjustmentsMember" xlink:label="loc_COSMAllocationAdjustmentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_COSMAllocationAdjustmentsMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_FinalAllocationMember" xlink:label="loc_COSMFinalAllocationMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_COSMFinalAllocationMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_40" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_40" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_40" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationLiabilityAbstract_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_40" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationLiabilityAbstract_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedValueOfCommonStockIssuedAtAcquisition" xlink:label="loc_COSMBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedValueOfCommonStockIssuedAtAcquisition_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationContingentConsiderationLiabilityAbstract_40" xlink:to="loc_COSMBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedValueOfCommonStockIssuedAtAcquisition_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationContingentConsiderationLiabilityAbstract_40" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_40" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.Details1" xlink:title="00000024 - Disclosure - ACQUISITION OF DECAHEDRON, LTD. (Details 1)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LicensesMember" xlink:label="loc_COSMLicensesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_COSMLicensesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_40" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.Details2" xlink:title="00000025 - Disclosure - ACQUISITION OF DECAHEDRON, LTD. (Details 2)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaapRelatedPartyTransactionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DecahedronLtdMember" xlink:label="loc_COSMDecahedronLtdMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_COSMDecahedronLtdMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProFormaMember" xlink:label="loc_us-gaapProFormaMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_us-gaapProFormaMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaRevenue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaRevenue_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostOfRevenue_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGrossProfit_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingExpenses_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss_30" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.DetailsNarrative" xlink:title="00000026 - Disclosure - ACQUISITION OF DECAHEDRON, LTD. (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AcquisitionRelatedCostsMember" xlink:label="loc_us-gaapAcquisitionRelatedCostsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_us-gaapAcquisitionRelatedCostsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionNameOfAcquiredEntity" xlink:label="loc_us-gaapBusinessAcquisitionNameOfAcquiredEntity_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionNameOfAcquiredEntity_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="loc_us-gaapNumberOfBusinessesAcquired_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNumberOfBusinessesAcquired_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:label="loc_us-gaapBusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockOtherSharesOutstanding" xlink:label="loc_us-gaapCommonStockOtherSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockOtherSharesOutstanding_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AdjustmentRelatedToOtherAssetsAndAccountsPayable" xlink:label="loc_COSMAdjustmentRelatedToOtherAssetsAndAccountsPayable_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMAdjustmentRelatedToOtherAssetsAndAccountsPayable_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaRevenue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaRevenue_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetImpairment_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetImpairment_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ImpairmentOfGoodwillPercent" xlink:label="loc_COSMImpairmentOfGoodwillPercent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMImpairmentOfGoodwillPercent_40" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/PrepaidDeferredFinancingCostsDetailsNarrative" xlink:title="00000027 - Disclosure - PREPAID DEFERRED FINANCING COSTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SynthesisManagementLimitedMember" xlink:label="loc_COSMSynthesisManagementLimitedMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMSynthesisManagementLimitedMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaapDepositsAssetsNoncurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepositsAssetsNoncurrent_50" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000028 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/CapitalStructureDetailsNarrative" xlink:title="00000029 - Disclosure - CAPITAL STRUCTURE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareholdersEquityClassAxis" xlink:label="loc_us-gaapShareholdersEquityClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShareholdersEquityClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByShareholdersEquityClassDomain" xlink:label="loc_us-gaapFairValueByShareholdersEquityClassDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShareholdersEquityClassAxis" xlink:to="loc_us-gaapFairValueByShareholdersEquityClassDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByShareholdersEquityClassDomain" xlink:label="loc_us-gaapFairValueByShareholdersEquityClassDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareholdersEquityClassAxis" xlink:to="loc_us-gaapFairValueByShareholdersEquityClassDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_PostMergerMember" xlink:label="loc_COSMPostMergerMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueByShareholdersEquityClassDomain" xlink:to="loc_COSMPostMergerMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_PriorToMergerMember" xlink:label="loc_COSMPriorToMergerMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueByShareholdersEquityClassDomain" xlink:to="loc_COSMPriorToMergerMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityIssuedInBusinessCombinationMember" xlink:label="loc_us-gaapEquityIssuedInBusinessCombinationMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueByShareholdersEquityClassDomain" xlink:to="loc_us-gaapEquityIssuedInBusinessCombinationMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DimitriosGoulielmosMember" xlink:label="loc_COSMDimitriosGoulielmosMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueByShareholdersEquityClassDomain" xlink:to="loc_COSMDimitriosGoulielmosMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_PotentiallyDilutiveSecuritiesMember" xlink:label="loc_COSMPotentiallyDilutiveSecuritiesMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_COSMPotentiallyDilutiveSecuritiesMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AmplerissimoLtdMember" xlink:label="loc_COSMAmplerissimoLtdMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMAmplerissimoLtdMember_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapInvestorMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ArKoEuropeanBusinessServicesMember" xlink:label="loc_COSMArKoEuropeanBusinessServicesMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMArKoEuropeanBusinessServicesMember_220" xlink:type="arc" order="221" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DecahedronLtdMember" xlink:label="loc_COSMDecahedronLtdMember_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMDecahedronLtdMember_310" xlink:type="arc" order="312" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ExchangeAgreementMember" xlink:label="loc_COSMExchangeAgreementMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_COSMExchangeAgreementMember_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConsultingAgreementFourMember" xlink:label="loc_COSMConsultingAgreementFourMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_COSMConsultingAgreementFourMember_220" xlink:type="arc" order="222" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConsultingAgreementThreeMember" xlink:label="loc_COSMConsultingAgreementThreeMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_COSMConsultingAgreementThreeMember_240" xlink:type="arc" order="242" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConsultingAgreementTwoMember" xlink:label="loc_COSMConsultingAgreementTwoMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_COSMConsultingAgreementTwoMember_260" xlink:type="arc" order="262" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConsultingAgreementOneMember" xlink:label="loc_COSMConsultingAgreementOneMember_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_COSMConsultingAgreementOneMember_280" xlink:type="arc" order="282" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConsultingAgreementMember" xlink:label="loc_COSMConsultingAgreementMember_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_COSMConsultingAgreementMember_300" xlink:type="arc" order="301" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_StockPurchaseAgreementMember" xlink:label="loc_COSMStockPurchaseAgreementMember_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_COSMStockPurchaseAgreementMember_310" xlink:type="arc" order="311" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="loc_us-gaapDeferredRevenueArrangementTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDeferredRevenueArrangementTypeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="loc_us-gaapDeferredRevenueArrangementTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDeferredRevenueArrangementTypeAxis" xlink:to="loc_us-gaapDeferredRevenueArrangementTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="loc_us-gaapDeferredRevenueArrangementTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDeferredRevenueArrangementTypeAxis" xlink:to="loc_us-gaapDeferredRevenueArrangementTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubscriptionArrangementMember" xlink:label="loc_us-gaapSubscriptionArrangementMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredRevenueArrangementTypeDomain" xlink:to="loc_us-gaapSubscriptionArrangementMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_140" xlink:type="arc" order="142" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTitleOfIndividualAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_EmployeeMember" xlink:label="loc_COSMEmployeeMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_COSMEmployeeMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreationDateAxis" xlink:label="loc_us-gaapCreationDateAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapCreationDateAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefaultFinancialStatementsDateMember" xlink:label="loc_us-gaapDefaultFinancialStatementsDateMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapCreationDateAxis" xlink:to="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefaultFinancialStatementsDateMember" xlink:label="loc_us-gaapDefaultFinancialStatementsDateMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCreationDateAxis" xlink:to="loc_us-gaapDefaultFinancialStatementsDateMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_OnJanuaryThreeTwoThousandSeventeenMember" xlink:label="loc_COSMOnJanuaryThreeTwoThousandSeventeenMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:to="loc_COSMOnJanuaryThreeTwoThousandSeventeenMember_160" xlink:type="arc" order="163" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_OnJanuaryOneTwoThousandSeventeenMember" xlink:label="loc_COSMOnJanuaryOneTwoThousandSeventeenMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:to="loc_COSMOnJanuaryOneTwoThousandSeventeenMember_180" xlink:type="arc" order="183" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_OnOctoberOneTwoThousandSixteenMember" xlink:label="loc_COSMOnOctoberOneTwoThousandSixteenMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:to="loc_COSMOnOctoberOneTwoThousandSixteenMember_200" xlink:type="arc" order="203" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_330" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_330" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_330" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_330" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_330" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_330" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_330" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_330" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_330" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_330" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentRepurchaseAgreementDateOfAgreement" xlink:label="loc_investInvestmentRepurchaseAgreementDateOfAgreement_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_investInvestmentRepurchaseAgreementDateOfAgreement_330" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentMaturityDate1" xlink:label="loc_investInvestmentMaturityDate1_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_investInvestmentMaturityDate1_330" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConsultingAgreementPeriod" xlink:label="loc_COSMConsultingAgreementPeriod_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMConsultingAgreementPeriod_330" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockValue_330" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_330" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther_330" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaapRestructuringCharges_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRestructuringCharges_330" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherRestructuringCosts" xlink:label="loc_us-gaapOtherRestructuringCosts_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherRestructuringCosts_330" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesSubscribedButUnissued" xlink:label="loc_us-gaapCommonStockSharesSubscribedButUnissued_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesSubscribedButUnissued_330" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross" xlink:label="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensationGross_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensationGross_330" xlink:type="arc" order="19" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000030 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DimitriosGoulielmosMember" xlink:label="loc_COSMDimitriosGoulielmosMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMDimitriosGoulielmosMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_KonstantinosVassilopoulosMember" xlink:label="loc_COSMKonstantinosVassilopoulosMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMKonstantinosVassilopoulosMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_OuraniaMatsoukiMember" xlink:label="loc_COSMOuraniaMatsoukiMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMOuraniaMatsoukiMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_MrSiokasMember" xlink:label="loc_COSMMrSiokasMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMMrSiokasMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_GrigoriosSiokasMember" xlink:label="loc_COSMGrigoriosSiokasMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMGrigoriosSiokasMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DocPharmaSaMember" xlink:label="loc_COSMDocPharmaSaMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMDocPharmaSaMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnderlyingAssetClassAxis" xlink:label="loc_us-gaapUnderlyingAssetClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapUnderlyingAssetClassAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnderlyingAssetClassDomain" xlink:label="loc_us-gaapUnderlyingAssetClassDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapUnderlyingAssetClassAxis" xlink:to="loc_us-gaapUnderlyingAssetClassDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnderlyingAssetClassDomain" xlink:label="loc_us-gaapUnderlyingAssetClassDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapUnderlyingAssetClassAxis" xlink:to="loc_us-gaapUnderlyingAssetClassDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LoansPayableMember" xlink:label="loc_us-gaapLoansPayableMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapUnderlyingAssetClassDomain" xlink:to="loc_us-gaapLoansPayableMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreationDateAxis" xlink:label="loc_us-gaapCreationDateAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapCreationDateAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefaultFinancialStatementsDateMember" xlink:label="loc_us-gaapDefaultFinancialStatementsDateMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapCreationDateAxis" xlink:to="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefaultFinancialStatementsDateMember" xlink:label="loc_us-gaapDefaultFinancialStatementsDateMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCreationDateAxis" xlink:to="loc_us-gaapDefaultFinancialStatementsDateMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_OnOctoberOneTwoThousandSixteenMember" xlink:label="loc_COSMOnOctoberOneTwoThousandSixteenMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:to="loc_COSMOnOctoberOneTwoThousandSixteenMember_160" xlink:type="arc" order="162" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_OnNovemberOneTwoThousandsFifteenMember" xlink:label="loc_COSMOnNovemberOneTwoThousandsFifteenMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:to="loc_COSMOnNovemberOneTwoThousandsFifteenMember_180" xlink:type="arc" order="183" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementMember" xlink:label="loc_COSMLoanAgreementMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_COSMLoanAgreementMember_180" xlink:type="arc" order="182" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaapRelatedPartyTransactionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DirectorsAndOfficersLiabilityInsuranceMember" xlink:label="loc_us-gaapDirectorsAndOfficersLiabilityInsuranceMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_us-gaapDirectorsAndOfficersLiabilityInsuranceMember_220" xlink:type="arc" order="221" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTitleOfIndividualAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_MediHelmSAMember" xlink:label="loc_COSMMediHelmSAMember_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_COSMMediHelmSAMember_270" xlink:type="arc" order="272" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentDecreaseForgiveness" xlink:label="loc_us-gaapDebtInstrumentDecreaseForgiveness_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentDecreaseForgiveness_290" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DebtInstrumentDecreaseAccruedInterestForgiveness" xlink:label="loc_COSMDebtInstrumentDecreaseAccruedInterestForgiveness_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMDebtInstrumentDecreaseAccruedInterestForgiveness_290" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidInterest" xlink:label="loc_us-gaapPrepaidInterest_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPrepaidInterest_290" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DescriptionForPrepaidBalancePercentage" xlink:label="loc_COSMDescriptionForPrepaidBalancePercentage_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMDescriptionForPrepaidBalancePercentage_290" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent_290" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_290" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCredit_290" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt_290" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_290" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_PaymentOfMiscellaneousBills" xlink:label="loc_COSMPaymentOfMiscellaneousBills_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMPaymentOfMiscellaneousBills_290" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="loc_us-gaapLineOfCreditFacilityInterestRateDuringPeriod_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityInterestRateDuringPeriod_290" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_290" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent_290" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockOtherValueOutstanding" xlink:label="loc_us-gaapCommonStockOtherValueOutstanding_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockOtherValueOutstanding_290" xlink:type="arc" order="13" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/DebtDetailsNarrative" xlink:title="00000031 - Disclosure - DEBT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_BridgeLoansMember" xlink:label="loc_COSMBridgeLoansMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_COSMBridgeLoansMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SecondAmendmentToLoanFacilityAgreementMember" xlink:label="loc_COSMSecondAmendmentToLoanFacilityAgreementMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_COSMSecondAmendmentToLoanFacilityAgreementMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AmendmentToLoanFacilityAgreementMember" xlink:label="loc_COSMAmendmentToLoanFacilityAgreementMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_COSMAmendmentToLoanFacilityAgreementMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanFacilityAgreementMember" xlink:label="loc_COSMLoanFacilityAgreementMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_COSMLoanFacilityAgreementMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementElevenMember" xlink:label="loc_COSMLoanAgreementElevenMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_COSMLoanAgreementElevenMember_190" xlink:type="arc" order="191" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementTenMember" xlink:label="loc_COSMLoanAgreementTenMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_COSMLoanAgreementTenMember_230" xlink:type="arc" order="231" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementNineMember" xlink:label="loc_COSMLoanAgreementNineMember_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_COSMLoanAgreementNineMember_270" xlink:type="arc" order="271" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementEightMember" xlink:label="loc_COSMLoanAgreementEightMember_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_COSMLoanAgreementEightMember_300" xlink:type="arc" order="301" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementSevenMember" xlink:label="loc_COSMLoanAgreementSevenMember_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_COSMLoanAgreementSevenMember_330" xlink:type="arc" order="331" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementSixMember" xlink:label="loc_COSMLoanAgreementSixMember_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_COSMLoanAgreementSixMember_360" xlink:type="arc" order="361" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementFiveMember" xlink:label="loc_COSMLoanAgreementFiveMember_390" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_COSMLoanAgreementFiveMember_390" xlink:type="arc" order="391" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementFourMember" xlink:label="loc_COSMLoanAgreementFourMember_420" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_COSMLoanAgreementFourMember_420" xlink:type="arc" order="421" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementThreeMember" xlink:label="loc_COSMLoanAgreementThreeMember_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_COSMLoanAgreementThreeMember_460" xlink:type="arc" order="461" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementTwoMember" xlink:label="loc_COSMLoanAgreementTwoMember_510" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_COSMLoanAgreementTwoMember_510" xlink:type="arc" order="511" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementOneMember" xlink:label="loc_COSMLoanAgreementOneMember_560" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_COSMLoanAgreementOneMember_560" xlink:type="arc" order="561" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DecahedronMember" xlink:label="loc_COSMDecahedronMember_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_COSMDecahedronMember_610" xlink:type="arc" order="612" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SkyPharmMember" xlink:label="loc_COSMSkyPharmMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMSkyPharmMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_GrigoriosSiokasMember" xlink:label="loc_COSMGrigoriosSiokasMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMGrigoriosSiokasMember_160" xlink:type="arc" order="163" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_PanagiotisDrakopoulosMember" xlink:label="loc_COSMPanagiotisDrakopoulosMember_390" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMPanagiotisDrakopoulosMember_390" xlink:type="arc" order="392" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AngeloDrakopoulosMember" xlink:label="loc_COSMAngeloDrakopoulosMember_560" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMAngeloDrakopoulosMember_560" xlink:type="arc" order="562" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SynthesisFacilityAgreementMember" xlink:label="loc_COSMSynthesisFacilityAgreementMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_COSMSynthesisFacilityAgreementMember_160" xlink:type="arc" order="162" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_690" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt_690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt_690" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_PaymentOfMiscellaneousBills" xlink:label="loc_COSMPaymentOfMiscellaneousBills_690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMPaymentOfMiscellaneousBills_690" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="loc_us-gaapLineOfCreditFacilityInterestRateDuringPeriod_690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityInterestRateDuringPeriod_690" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="loc_us-gaapLineOfCreditFacilityExpirationDate1_690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityExpirationDate1_690" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AmendedMaturityDate" xlink:label="loc_COSMAmendedMaturityDate_690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMAmendedMaturityDate_690" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit_690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCredit_690" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent_690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent_690" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt_690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRepaymentsOfDebt_690" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfAccountsReceivableSecuritization" xlink:label="loc_us-gaapRepaymentsOfAccountsReceivableSecuritization_690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRepaymentsOfAccountsReceivableSecuritization_690" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityDescription" xlink:label="loc_us-gaapLineOfCreditFacilityDescription_690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityDescription_690" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_690" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount_690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount_690" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium_690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium_690" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm_690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm_690" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_CreditFaciltyOriginationFeePercentage" xlink:label="loc_COSMCreditFaciltyOriginationFeePercentage_690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMCreditFaciltyOriginationFeePercentage_690" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_MonthlyCreditFeePercentage" xlink:label="loc_COSMMonthlyCreditFeePercentage_690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMMonthlyCreditFeePercentage_690" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees_690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfessionalFees_690" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfDeferredLoanOriginationFeesNet" xlink:label="loc_us-gaapAmortizationOfDeferredLoanOriginationFeesNet_690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfDeferredLoanOriginationFeesNet_690" xlink:type="arc" order="18" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000032 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_CCPharmaGmbHMember" xlink:label="loc_COSMCCPharmaGmbHMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMCCPharmaGmbHMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember" xlink:label="loc_COSMAnastasiosTsekasAndOlgaPartheneaGeorgatwouMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMAnastasiosTsekasAndOlgaPartheneaGeorgatwouMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SkyPharmMember" xlink:label="loc_COSMSkyPharmMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMSkyPharmMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AmplerissimoMember" xlink:label="loc_COSMAmplerissimoMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMAmplerissimoMember_190" xlink:type="arc" order="191" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaapRelatedPartyTransactionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DecahedronMember" xlink:label="loc_COSMDecahedronMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_COSMDecahedronMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_IntellectualPropertySaleAgreementMember" xlink:label="loc_COSMIntellectualPropertySaleAgreementMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_COSMIntellectualPropertySaleAgreementMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreationDateAxis" xlink:label="loc_us-gaapCreationDateAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapCreationDateAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefaultFinancialStatementsDateMember" xlink:label="loc_us-gaapDefaultFinancialStatementsDateMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapCreationDateAxis" xlink:to="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefaultFinancialStatementsDateMember" xlink:label="loc_us-gaapDefaultFinancialStatementsDateMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCreationDateAxis" xlink:to="loc_us-gaapDefaultFinancialStatementsDateMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_OnOctoberOneTwoThousandSixteenMember" xlink:label="loc_COSMOnOctoberOneTwoThousandSixteenMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:to="loc_COSMOnOctoberOneTwoThousandSixteenMember_50" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseArrangementTypeAxis" xlink:label="loc_us-gaapLeaseArrangementTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapLeaseArrangementTypeAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseArrangementTypeDomain" xlink:label="loc_us-gaapLeaseArrangementTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLeaseArrangementTypeAxis" xlink:to="loc_us-gaapLeaseArrangementTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseArrangementTypeDomain" xlink:label="loc_us-gaapLeaseArrangementTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLeaseArrangementTypeAxis" xlink:to="loc_us-gaapLeaseArrangementTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConclusionOfPhaseThreeTestingMember" xlink:label="loc_COSMConclusionOfPhaseThreeTestingMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLeaseArrangementTypeDomain" xlink:to="loc_COSMConclusionOfPhaseThreeTestingMember_60" xlink:type="arc" order="63" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConclusionOfPhaseTwoTestingMember" xlink:label="loc_COSMConclusionOfPhaseTwoTestingMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLeaseArrangementTypeDomain" xlink:to="loc_COSMConclusionOfPhaseTwoTestingMember_70" xlink:type="arc" order="73" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConclusionOfPhaseOneTestingMember" xlink:label="loc_COSMConclusionOfPhaseOneTestingMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLeaseArrangementTypeDomain" xlink:to="loc_COSMConclusionOfPhaseOneTestingMember_80" xlink:type="arc" order="83" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConclusionOfPreclinicalTrialsMember" xlink:label="loc_COSMConclusionOfPreclinicalTrialsMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLeaseArrangementTypeDomain" xlink:to="loc_COSMConclusionOfPreclinicalTrialsMember_90" xlink:type="arc" order="93" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AdditionalSpaceMember" xlink:label="loc_COSMAdditionalSpaceMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLeaseArrangementTypeDomain" xlink:to="loc_COSMAdditionalSpaceMember_150" xlink:type="arc" order="152" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_FirstFloorMember" xlink:label="loc_COSMFirstFloorMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLeaseArrangementTypeDomain" xlink:to="loc_COSMFirstFloorMember_160" xlink:type="arc" order="162" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_OperatingLeasePeriodicPayment" xlink:label="loc_COSMOperatingLeasePeriodicPayment_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMOperatingLeasePeriodicPayment_320" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_FrequencyOfPeriodicPayment" xlink:label="loc_COSMFrequencyOfPeriodicPayment_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMFrequencyOfPeriodicPayment_320" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="loc_us-gaapOperatingLeasesRentExpenseNet_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeasesRentExpenseNet_320" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="loc_us-gaapLeaseExpirationDate1_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLeaseExpirationDate1_320" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AmendmentToMaturityDate" xlink:label="loc_COSMAmendmentToMaturityDate_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMAmendmentToMaturityDate_320" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract" xlink:label="loc_us-gaapLesseeLeasingArrangementsOperatingLeasesTermOfContract_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeLeasingArrangementsOperatingLeasesTermOfContract_320" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_320" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsFromFranchiseAgreements" xlink:label="loc_us-gaapCommitmentsFromFranchiseAgreements_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommitmentsFromFranchiseAgreements_320" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_NonrefundableFee" xlink:label="loc_COSMNonrefundableFee_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMNonrefundableFee_320" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostsAndExpenses_320" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsDetails" xlink:title="00000033 - Disclosure - STOCK OPTIONS AND WARRANTS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OptionMember" xlink:label="loc_us-gaapOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapOptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_20" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_20" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_20" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_20" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_20" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_20" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_20" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_20" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_20" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_20" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_20" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_20" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_WeightedAverageRemainingContractualTerm" xlink:label="loc_COSMWeightedAverageRemainingContractualTerm_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMWeightedAverageRemainingContractualTerm_20" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_COSMWeightedAverageRemainingContractualTerm_20" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_20" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2" xlink:label="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_COSMWeightedAverageRemainingContractualTerm_20" xlink:to="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2_20" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm" xlink:label="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_COSMWeightedAverageRemainingContractualTerm_20" xlink:to="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm_20" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_COSMWeightedAverageRemainingContractualTerm_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_20" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm3" xlink:label="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm3_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_COSMWeightedAverageRemainingContractualTerm_20" xlink:to="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm3_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_COSMWeightedAverageRemainingContractualTerm_20" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4" xlink:label="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_COSMWeightedAverageRemainingContractualTerm_20" xlink:to="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_20" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_20" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_20" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_20" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_20" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited" xlink:label="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_20" xlink:to="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited_20" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised" xlink:label="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_20" xlink:to="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised_20" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpired" xlink:label="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpired_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_20" xlink:to="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpired_20" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_20" xlink:type="arc" order="31" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsDetails1" xlink:title="00000034 - Disclosure - STOCK OPTIONS AND WARRANTS (Details 1)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapFairValueAssumptionsExpectedVolatilityRate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAssumptionsExpectedVolatilityRate_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm" xlink:label="loc_us-gaapFairValueAssumptionsExpectedTerm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAssumptionsExpectedTerm_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapFairValueAssumptionsRiskFreeInterestRate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAssumptionsRiskFreeInterestRate_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapFairValueAssumptionsExpectedDividendRate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAssumptionsExpectedDividendRate_40" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsDetails2" xlink:title="00000035 - Disclosure - STOCK OPTIONS AND WARRANTS (Details 2)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_20" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_20" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_20" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_20" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_20" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_20" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_20" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_20" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_20" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_20" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_20" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_20" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_WeightedAverageRemainingContractualTerm" xlink:label="loc_COSMWeightedAverageRemainingContractualTerm_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMWeightedAverageRemainingContractualTerm_20" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_COSMWeightedAverageRemainingContractualTerm_20" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_20" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2" xlink:label="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_COSMWeightedAverageRemainingContractualTerm_20" xlink:to="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2_20" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm" xlink:label="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_COSMWeightedAverageRemainingContractualTerm_20" xlink:to="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm_20" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_COSMWeightedAverageRemainingContractualTerm_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_20" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm3" xlink:label="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm3_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_COSMWeightedAverageRemainingContractualTerm_20" xlink:to="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm3_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_COSMWeightedAverageRemainingContractualTerm_20" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4" xlink:label="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_COSMWeightedAverageRemainingContractualTerm_20" xlink:to="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_20" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_20" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_20" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_20" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_20" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited" xlink:label="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_20" xlink:to="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited_20" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised" xlink:label="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_20" xlink:to="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised_20" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpired" xlink:label="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpired_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_20" xlink:to="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpired_20" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_20" xlink:type="arc" order="31" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsDetailsNarrative" xlink:title="00000036 - Disclosure - STOCK OPTIONS AND WARRANTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapStockOptionMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_MrOrestesVarvitsiotesMember" xlink:label="loc_COSMMrOrestesVarvitsiotesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_COSMMrOrestesVarvitsiotesMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_EmployeeMember" xlink:label="loc_COSMEmployeeMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_COSMEmployeeMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_InternationalFinanceManagerMember" xlink:label="loc_COSMInternationalFinanceManagerMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_COSMInternationalFinanceManagerMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_UsFinanceManagerMember" xlink:label="loc_COSMUsFinanceManagerMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_COSMUsFinanceManagerMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreationDateAxis" xlink:label="loc_us-gaapCreationDateAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapCreationDateAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefaultFinancialStatementsDateMember" xlink:label="loc_us-gaapDefaultFinancialStatementsDateMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapCreationDateAxis" xlink:to="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefaultFinancialStatementsDateMember" xlink:label="loc_us-gaapDefaultFinancialStatementsDateMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCreationDateAxis" xlink:to="loc_us-gaapDefaultFinancialStatementsDateMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_JanuaryThreeTwoThousandSeventeenMember" xlink:label="loc_COSMJanuaryThreeTwoThousandSeventeenMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:to="loc_COSMJanuaryThreeTwoThousandSeventeenMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_JanuaryOneTwoThousandSeventeenMember" xlink:label="loc_COSMJanuaryOneTwoThousandSeventeenMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:to="loc_COSMJanuaryOneTwoThousandSeventeenMember_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_OnJanuaryOneTwoThousandSeventeenMember" xlink:label="loc_COSMOnJanuaryOneTwoThousandSeventeenMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:to="loc_COSMOnJanuaryOneTwoThousandSeventeenMember_50" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_OnOctoberOneTwoThousandSixteenMember" xlink:label="loc_COSMOnOctoberOneTwoThousandSixteenMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:to="loc_COSMOnOctoberOneTwoThousandSixteenMember_100" xlink:type="arc" order="103" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapInvestorMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AegisCapitalCorpMember" xlink:label="loc_COSMAegisCapitalCorpMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMAegisCapitalCorpMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaapStockOptionPlanExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockOptionPlanExpense_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharePrice_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_130" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciationAndAmortization_130" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_130" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_StockOptionPeriodicVesting" xlink:label="loc_COSMStockOptionPeriodicVesting_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMStockOptionPeriodicVesting_130" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_FrequencyOfPeriodicVesting" xlink:label="loc_COSMFrequencyOfPeriodicVesting_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMFrequencyOfPeriodicVesting_130" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConsiderationUnderAgreement" xlink:label="loc_COSMConsiderationUnderAgreement_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMConsiderationUnderAgreement_130" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ShareBasedCompensationAsAnnualRetainer" xlink:label="loc_COSMShareBasedCompensationAsAnnualRetainer_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMShareBasedCompensationAsAnnualRetainer_130" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_WarrantsIssuedRatioDescription" xlink:label="loc_COSMWarrantsIssuedRatioDescription_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMWarrantsIssuedRatioDescription_130" xlink:type="arc" order="15" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000037 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis" xlink:label="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain" xlink:label="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentAxis" xlink:to="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain" xlink:label="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentAxis" xlink:to="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_TradeFacilityAgreementMember" xlink:label="loc_COSMTradeFacilityAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentDomain" xlink:to="loc_COSMTradeFacilityAgreementMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SecuritiesPurchaseAgreementMember" xlink:label="loc_COSMSecuritiesPurchaseAgreementMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentDomain" xlink:to="loc_COSMSecuritiesPurchaseAgreementMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_StockPurchaseAgreementMember" xlink:label="loc_COSMStockPurchaseAgreementMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentDomain" xlink:to="loc_COSMStockPurchaseAgreementMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeniorNotesMember" xlink:label="loc_us-gaapSeniorNotesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_us-gaapSeniorNotesMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SeniorConvertibleNoteOneMember" xlink:label="loc_COSMSeniorConvertibleNoteOneMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_COSMSeniorConvertibleNoteOneMember_30" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SeniorConvertibleNoteTwoMember" xlink:label="loc_COSMSeniorConvertibleNoteTwoMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_COSMSeniorConvertibleNoteTwoMember_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTitleOfIndividualAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_InstitutionalInvestorsMember" xlink:label="loc_COSMInstitutionalInvestorsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_COSMInstitutionalInvestorsMember_30" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_50" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_RegistrationRightsAgreementMember" xlink:label="loc_COSMRegistrationRightsAgreementMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_COSMRegistrationRightsAgreementMember_70" xlink:type="arc" order="74" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LeakOutAgreementMember" xlink:label="loc_COSMLeakOutAgreementMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_COSMLeakOutAgreementMember_80" xlink:type="arc" order="84" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapInvestorMember_90" xlink:type="arc" order="93" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_CommonStockSharesAcquiredForConsiderationValue" xlink:label="loc_COSMCommonStockSharesAcquiredForConsiderationValue_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMCommonStockSharesAcquiredForConsiderationValue_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_CommonStockSharesAcquiredForConsiderationShares" xlink:label="loc_COSMCommonStockSharesAcquiredForConsiderationShares_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMCommonStockSharesAcquiredForConsiderationShares_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit_120" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConvertibleNotesPayable_120" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_120" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_120" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentRedemptionDescription" xlink:label="loc_us-gaapDebtInstrumentRedemptionDescription_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentRedemptionDescription_120" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDefaultShorttermDebtDescriptionOfViolationOrEventOfDefault" xlink:label="loc_us-gaapDebtDefaultShorttermDebtDescriptionOfViolationOrEventOfDefault_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtDefaultShorttermDebtDescriptionOfViolationOrEventOfDefault_120" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_120" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_EventOfDefaultConverstionPriceDescription" xlink:label="loc_COSMEventOfDefaultConverstionPriceDescription_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMEventOfDefaultConverstionPriceDescription_120" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_VolumeweightedAveragePriceInPercentage" xlink:label="loc_COSMVolumeweightedAveragePriceInPercentage_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMVolumeweightedAveragePriceInPercentage_120" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AggregateIndebtedness" xlink:label="loc_us-gaapAggregateIndebtedness_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAggregateIndebtedness_120" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_CustomaryEventsOfDefaultDescription" xlink:label="loc_COSMCustomaryEventsOfDefaultDescription_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMCustomaryEventsOfDefaultDescription_120" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeTermOfContract" xlink:label="loc_us-gaapDerivativeTermOfContract_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeTermOfContract_120" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConvertibleSecuritiesTermsOfConversionFeature" xlink:label="loc_COSMConvertibleSecuritiesTermsOfConversionFeature_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMConvertibleSecuritiesTermsOfConversionFeature_120" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_TermsOfBlockerProvision" xlink:label="loc_COSMTermsOfBlockerProvision_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMTermsOfBlockerProvision_120" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_TermsOfAgreement" xlink:label="loc_COSMTermsOfAgreement_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMTermsOfAgreement_120" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConditionalProceedsFromSaleOfCommonStockUnderAgreement" xlink:label="loc_COSMConditionalProceedsFromSaleOfCommonStockUnderAgreement_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMConditionalProceedsFromSaleOfCommonStockUnderAgreement_120" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_TermsOfCommission" xlink:label="loc_COSMTermsOfCommission_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMTermsOfCommission_120" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_120" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AmendmentToCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_COSMAmendmentToCreditFacilityMaximumBorrowingCapacity_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMAmendmentToCreditFacilityMaximumBorrowingCapacity_120" xlink:type="arc" order="20" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>cosm-20170930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: cosm_10%2Dq1.xfr; Date: 2017%2D11%2D20T00:19:58Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinimumMember" xlink:to="us-gaap_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RangeAxis_lbl" xml:lang="en-US">Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaximumMember" xlink:to="us-gaap_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xml:lang="en-US">Office and computer equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AmplerissimoLtdMember" xlink:label="COSM_AmplerissimoLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_AmplerissimoLtdMember" xlink:to="COSM_AmplerissimoLtdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_AmplerissimoLtdMember_lbl" xml:lang="en-US">Amplerissimo Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SynthesisManagementLimitedMember" xlink:label="COSM_SynthesisManagementLimitedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_SynthesisManagementLimitedMember" xlink:to="COSM_SynthesisManagementLimitedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_SynthesisManagementLimitedMember_lbl" xml:lang="en-US">Synthesis Management Limited [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_PriorToMergerMember" xlink:label="COSM_PriorToMergerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_PriorToMergerMember" xlink:to="COSM_PriorToMergerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_PriorToMergerMember_lbl" xml:lang="en-US">Prior to merger [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareholdersEquityClassAxis" xlink:label="us-gaap_ShareholdersEquityClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareholdersEquityClassAxis" xlink:to="us-gaap_ShareholdersEquityClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareholdersEquityClassAxis_lbl" xml:lang="en-US">Shareholders' Equity Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityIssuedInBusinessCombinationMember" xlink:label="us-gaap_EquityIssuedInBusinessCombinationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityIssuedInBusinessCombinationMember" xlink:to="us-gaap_EquityIssuedInBusinessCombinationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityIssuedInBusinessCombinationMember_lbl" xml:lang="en-US">Equity issued in merger [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockMember_lbl" xml:lang="en-US">Restricted Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ExchangeAgreementMember" xlink:label="COSM_ExchangeAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_ExchangeAgreementMember" xlink:to="COSM_ExchangeAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_ExchangeAgreementMember_lbl" xml:lang="en-US">Exchange agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DocPharmaSaMember" xlink:label="COSM_DocPharmaSaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_DocPharmaSaMember" xlink:to="COSM_DocPharmaSaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_DocPharmaSaMember_lbl" xml:lang="en-US">DOC Pharma S.A. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementMember" xlink:label="COSM_LoanAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_LoanAgreementMember" xlink:to="COSM_LoanAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_LoanAgreementMember_lbl" xml:lang="en-US">Loan agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_OnNovemberOneTwoThousandsFifteenMember" xlink:label="COSM_OnNovemberOneTwoThousandsFifteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_OnNovemberOneTwoThousandsFifteenMember" xlink:to="COSM_OnNovemberOneTwoThousandsFifteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_OnNovemberOneTwoThousandsFifteenMember_lbl" xml:lang="en-US">On November 1, 2015 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreationDateAxis" xlink:label="us-gaap_CreationDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreationDateAxis" xlink:to="us-gaap_CreationDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CreationDateAxis_lbl" xml:lang="en-US">Report Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_GrigoriosSiokasMember" xlink:label="COSM_GrigoriosSiokasMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_GrigoriosSiokasMember" xlink:to="COSM_GrigoriosSiokasMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_GrigoriosSiokasMember_lbl" xml:lang="en-US">Grigorios Siokas [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_OnOctoberOneTwoThousandSixteenMember" xlink:label="COSM_OnOctoberOneTwoThousandSixteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_OnOctoberOneTwoThousandSixteenMember" xlink:to="COSM_OnOctoberOneTwoThousandSixteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_OnOctoberOneTwoThousandSixteenMember_lbl" xml:lang="en-US">On October 1, 2016 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LoansPayableMember" xlink:label="us-gaap_LoansPayableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayableMember" xlink:to="us-gaap_LoansPayableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansPayableMember_lbl" xml:lang="en-US">Loan payable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnderlyingAssetClassAxis" xlink:label="us-gaap_UnderlyingAssetClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnderlyingAssetClassAxis" xlink:to="us-gaap_UnderlyingAssetClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnderlyingAssetClassAxis_lbl" xml:lang="en-US">Underlying Asset Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_OuraniaMatsoukiMember" xlink:label="COSM_OuraniaMatsoukiMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_OuraniaMatsoukiMember" xlink:to="COSM_OuraniaMatsoukiMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_OuraniaMatsoukiMember_lbl" xml:lang="en-US">Ourania Matsouki [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_KonstantinosVassilopoulosMember" xlink:label="COSM_KonstantinosVassilopoulosMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_KonstantinosVassilopoulosMember" xlink:to="COSM_KonstantinosVassilopoulosMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_KonstantinosVassilopoulosMember_lbl" xml:lang="en-US">Konstantinos Vassilopoulos [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DimitriosGoulielmosMember" xlink:label="COSM_DimitriosGoulielmosMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_DimitriosGoulielmosMember" xlink:to="COSM_DimitriosGoulielmosMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_DimitriosGoulielmosMember_lbl" xml:lang="en-US">Dimitrios Goulielmos [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementOneMember" xlink:label="COSM_LoanAgreementOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_LoanAgreementOneMember" xlink:to="COSM_LoanAgreementOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_LoanAgreementOneMember_lbl" xml:lang="en-US">Loan Agreement 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AngeloDrakopoulosMember" xlink:label="COSM_AngeloDrakopoulosMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_AngeloDrakopoulosMember" xlink:to="COSM_AngeloDrakopoulosMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_AngeloDrakopoulosMember_lbl" xml:lang="en-US">Angelo Drakopoulos [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementTwoMember" xlink:label="COSM_LoanAgreementTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_LoanAgreementTwoMember" xlink:to="COSM_LoanAgreementTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_LoanAgreementTwoMember_lbl" xml:lang="en-US">Loan Agreement 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementThreeMember" xlink:label="COSM_LoanAgreementThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_LoanAgreementThreeMember" xlink:to="COSM_LoanAgreementThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_LoanAgreementThreeMember_lbl" xml:lang="en-US">Loan Agreement 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementFourMember" xlink:label="COSM_LoanAgreementFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_LoanAgreementFourMember" xlink:to="COSM_LoanAgreementFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_LoanAgreementFourMember_lbl" xml:lang="en-US">Loan Agreement 4 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_PanagiotisDrakopoulosMember" xlink:label="COSM_PanagiotisDrakopoulosMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_PanagiotisDrakopoulosMember" xlink:to="COSM_PanagiotisDrakopoulosMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_PanagiotisDrakopoulosMember_lbl" xml:lang="en-US">Panagiotis Drakopoulos [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementFiveMember" xlink:label="COSM_LoanAgreementFiveMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_LoanAgreementFiveMember" xlink:to="COSM_LoanAgreementFiveMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_LoanAgreementFiveMember_lbl" xml:lang="en-US">Loan Agreement 5 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementSevenMember" xlink:label="COSM_LoanAgreementSevenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_LoanAgreementSevenMember" xlink:to="COSM_LoanAgreementSevenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_LoanAgreementSevenMember_lbl" xml:lang="en-US">Loan Agreement 7 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementSixMember" xlink:label="COSM_LoanAgreementSixMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_LoanAgreementSixMember" xlink:to="COSM_LoanAgreementSixMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_LoanAgreementSixMember_lbl" xml:lang="en-US">Loan Agreement 6 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementNineMember" xlink:label="COSM_LoanAgreementNineMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_LoanAgreementNineMember" xlink:to="COSM_LoanAgreementNineMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_LoanAgreementNineMember_lbl" xml:lang="en-US">Loan Agreement 9 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementEightMember" xlink:label="COSM_LoanAgreementEightMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_LoanAgreementEightMember" xlink:to="COSM_LoanAgreementEightMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_LoanAgreementEightMember_lbl" xml:lang="en-US">Loan Agreement 8 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementTenMember" xlink:label="COSM_LoanAgreementTenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_LoanAgreementTenMember" xlink:to="COSM_LoanAgreementTenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_LoanAgreementTenMember_lbl" xml:lang="en-US">Loan Agreement 10 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementElevenMember" xlink:label="COSM_LoanAgreementElevenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_LoanAgreementElevenMember" xlink:to="COSM_LoanAgreementElevenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_LoanAgreementElevenMember_lbl" xml:lang="en-US">Loan Agreement 11 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanFacilityAgreementMember" xlink:label="COSM_LoanFacilityAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_LoanFacilityAgreementMember" xlink:to="COSM_LoanFacilityAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_LoanFacilityAgreementMember_lbl" xml:lang="en-US">Loan facility agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SkyPharmMember" xlink:label="COSM_SkyPharmMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_SkyPharmMember" xlink:to="COSM_SkyPharmMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_SkyPharmMember_lbl" xml:lang="en-US">SkyPharm [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SynthesisFacilityAgreementMember" xlink:label="COSM_SynthesisFacilityAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_SynthesisFacilityAgreementMember" xlink:to="COSM_SynthesisFacilityAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_SynthesisFacilityAgreementMember_lbl" xml:lang="en-US">Synthesis facility agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AmendmentToLoanFacilityAgreementMember" xlink:label="COSM_AmendmentToLoanFacilityAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_AmendmentToLoanFacilityAgreementMember" xlink:to="COSM_AmendmentToLoanFacilityAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_AmendmentToLoanFacilityAgreementMember_lbl" xml:lang="en-US">Amendment to loan facility agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SecondAmendmentToLoanFacilityAgreementMember" xlink:label="COSM_SecondAmendmentToLoanFacilityAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_SecondAmendmentToLoanFacilityAgreementMember" xlink:to="COSM_SecondAmendmentToLoanFacilityAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_SecondAmendmentToLoanFacilityAgreementMember_lbl" xml:lang="en-US">Second amendment to loan facility agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AmplerissimoMember" xlink:label="COSM_AmplerissimoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_AmplerissimoMember" xlink:to="COSM_AmplerissimoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_AmplerissimoMember_lbl" xml:lang="en-US">Amplerissimo [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_FirstFloorMember" xlink:label="COSM_FirstFloorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_FirstFloorMember" xlink:to="COSM_FirstFloorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_FirstFloorMember_lbl" xml:lang="en-US">First Floor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseArrangementTypeAxis" xlink:label="us-gaap_LeaseArrangementTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseArrangementTypeAxis" xlink:to="us-gaap_LeaseArrangementTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LeaseArrangementTypeAxis_lbl" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AdditionalSpaceMember" xlink:label="COSM_AdditionalSpaceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_AdditionalSpaceMember" xlink:to="COSM_AdditionalSpaceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_AdditionalSpaceMember_lbl" xml:lang="en-US">Additional space [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_IntellectualPropertySaleAgreementMember" xlink:label="COSM_IntellectualPropertySaleAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_IntellectualPropertySaleAgreementMember" xlink:to="COSM_IntellectualPropertySaleAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_IntellectualPropertySaleAgreementMember_lbl" xml:lang="en-US">Intellectual property sale agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember" xlink:label="COSM_AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember" xlink:to="COSM_AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember_lbl" xml:lang="en-US">Anastasios Tsekas and Olga Parthenea Georgatsou [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConclusionOfPreclinicalTrialsMember" xlink:label="COSM_ConclusionOfPreclinicalTrialsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_ConclusionOfPreclinicalTrialsMember" xlink:to="COSM_ConclusionOfPreclinicalTrialsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_ConclusionOfPreclinicalTrialsMember_lbl" xml:lang="en-US">Conclusion of Preclinical Trials [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConclusionOfPhaseOneTestingMember" xlink:label="COSM_ConclusionOfPhaseOneTestingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_ConclusionOfPhaseOneTestingMember" xlink:to="COSM_ConclusionOfPhaseOneTestingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_ConclusionOfPhaseOneTestingMember_lbl" xml:lang="en-US">conclusion of Phase I testing [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConclusionOfPhaseTwoTestingMember" xlink:label="COSM_ConclusionOfPhaseTwoTestingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_ConclusionOfPhaseTwoTestingMember" xlink:to="COSM_ConclusionOfPhaseTwoTestingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_ConclusionOfPhaseTwoTestingMember_lbl" xml:lang="en-US">Conclusion of Phase II testing [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConclusionOfPhaseThreeTestingMember" xlink:label="COSM_ConclusionOfPhaseThreeTestingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_ConclusionOfPhaseThreeTestingMember" xlink:to="COSM_ConclusionOfPhaseThreeTestingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_ConclusionOfPhaseThreeTestingMember_lbl" xml:lang="en-US">Conclusion of Phase III testing [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockOptionMember" xlink:label="us-gaap_StockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionMember" xlink:to="us-gaap_StockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionMember_lbl" xml:lang="en-US">Stock Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeInstrumentRiskAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentRiskAxis_lbl" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_EmployeeMember" xlink:label="COSM_EmployeeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_EmployeeMember" xlink:to="COSM_EmployeeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_EmployeeMember_lbl" xml:lang="en-US">Employee [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="us-gaap_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_UsFinanceManagerMember" xlink:label="COSM_UsFinanceManagerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_UsFinanceManagerMember" xlink:to="COSM_UsFinanceManagerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_UsFinanceManagerMember_lbl" xml:lang="en-US">US Finance Manager [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_StockPurchaseAgreementMember" xlink:label="COSM_StockPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_StockPurchaseAgreementMember" xlink:to="COSM_StockPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_StockPurchaseAgreementMember_lbl" xml:lang="en-US">Stock Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DecahedronLtdMember" xlink:label="COSM_DecahedronLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_DecahedronLtdMember" xlink:to="COSM_DecahedronLtdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_DecahedronLtdMember_lbl" xml:lang="en-US">Decahedron Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_CyprusMember" xlink:label="COSM_CyprusMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_CyprusMember" xlink:to="COSM_CyprusMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_CyprusMember_lbl" xml:lang="en-US">Cyprus [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_StatementGeographicalAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_GreeceMember" xlink:label="COSM_GreeceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_GreeceMember" xlink:to="COSM_GreeceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_GreeceMember_lbl" xml:lang="en-US">Greece [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_PreliminaryAllocationAsOfFebruaryTenTwoThousandSeventeenMember" xlink:label="COSM_PreliminaryAllocationAsOfFebruaryTenTwoThousandSeventeenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_PreliminaryAllocationAsOfFebruaryTenTwoThousandSeventeenMember" xlink:to="COSM_PreliminaryAllocationAsOfFebruaryTenTwoThousandSeventeenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_PreliminaryAllocationAsOfFebruaryTenTwoThousandSeventeenMember_lbl" xml:lang="en-US">Preliminary Allocation as of February 10, 2017 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AllocationAdjustmentsMember" xlink:label="COSM_AllocationAdjustmentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_AllocationAdjustmentsMember" xlink:to="COSM_AllocationAdjustmentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_AllocationAdjustmentsMember_lbl" xml:lang="en-US">Allocation Adjustments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_FinalAllocationMember" xlink:label="COSM_FinalAllocationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_FinalAllocationMember" xlink:to="COSM_FinalAllocationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_FinalAllocationMember_lbl" xml:lang="en-US">Final Allocation [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LicensesMember" xlink:label="COSM_LicensesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_LicensesMember" xlink:to="COSM_LicensesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_LicensesMember_lbl" xml:lang="en-US">Licenses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProFormaMember" xlink:label="us-gaap_ProFormaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProFormaMember" xlink:to="us-gaap_ProFormaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProFormaMember_lbl" xml:lang="en-US">Proforma [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConsultingAgreementMember" xlink:label="COSM_ConsultingAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_ConsultingAgreementMember" xlink:to="COSM_ConsultingAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_ConsultingAgreementMember_lbl" xml:lang="en-US">Consulting Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ArKoEuropeanBusinessServicesMember" xlink:label="COSM_ArKoEuropeanBusinessServicesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_ArKoEuropeanBusinessServicesMember" xlink:to="COSM_ArKoEuropeanBusinessServicesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_ArKoEuropeanBusinessServicesMember_lbl" xml:lang="en-US">ArKo European Business &amp; Services [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_PotentiallyDilutiveSecuritiesMember" xlink:label="COSM_PotentiallyDilutiveSecuritiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_PotentiallyDilutiveSecuritiesMember" xlink:to="COSM_PotentiallyDilutiveSecuritiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_PotentiallyDilutiveSecuritiesMember_lbl" xml:lang="en-US">Potentially dilutive securities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_OnJanuaryOneTwoThousandSeventeenMember" xlink:label="COSM_OnJanuaryOneTwoThousandSeventeenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_OnJanuaryOneTwoThousandSeventeenMember" xlink:to="COSM_OnJanuaryOneTwoThousandSeventeenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_OnJanuaryOneTwoThousandSeventeenMember_lbl" xml:lang="en-US">On January 1, 2017 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_OnJanuaryThreeTwoThousandSeventeenMember" xlink:label="COSM_OnJanuaryThreeTwoThousandSeventeenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_OnJanuaryThreeTwoThousandSeventeenMember" xlink:to="COSM_OnJanuaryThreeTwoThousandSeventeenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_OnJanuaryThreeTwoThousandSeventeenMember_lbl" xml:lang="en-US">On January 3, 2017 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_BridgeLoansMember" xlink:label="COSM_BridgeLoansMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_BridgeLoansMember" xlink:to="COSM_BridgeLoansMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_BridgeLoansMember_lbl" xml:lang="en-US">Bridge Loans [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_MediHelmSAMember" xlink:label="COSM_MediHelmSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_MediHelmSAMember" xlink:to="COSM_MediHelmSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_MediHelmSAMember_lbl" xml:lang="en-US">MediHelm S.A. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DecahedronMember" xlink:label="COSM_DecahedronMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_DecahedronMember" xlink:to="COSM_DecahedronMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_DecahedronMember_lbl" xml:lang="en-US">Decahedron [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_UnitedKingdomofEnglandMember" xlink:label="COSM_UnitedKingdomofEnglandMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_UnitedKingdomofEnglandMember" xlink:to="COSM_UnitedKingdomofEnglandMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_UnitedKingdomofEnglandMember_lbl" xml:lang="en-US">United Kingdom of England [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConsultingAgreementOneMember" xlink:label="COSM_ConsultingAgreementOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_ConsultingAgreementOneMember" xlink:to="COSM_ConsultingAgreementOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_ConsultingAgreementOneMember_lbl" xml:lang="en-US">Consulting Agreement one [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConsultingAgreementTwoMember" xlink:label="COSM_ConsultingAgreementTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_ConsultingAgreementTwoMember" xlink:to="COSM_ConsultingAgreementTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_ConsultingAgreementTwoMember_lbl" xml:lang="en-US">Consulting Agreement Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConsultingAgreementThreeMember" xlink:label="COSM_ConsultingAgreementThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_ConsultingAgreementThreeMember" xlink:to="COSM_ConsultingAgreementThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_ConsultingAgreementThreeMember_lbl" xml:lang="en-US">Consulting agreement Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConsultingAgreementFourMember" xlink:label="COSM_ConsultingAgreementFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_ConsultingAgreementFourMember" xlink:to="COSM_ConsultingAgreementFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_ConsultingAgreementFourMember_lbl" xml:lang="en-US">Consulting agreement Four [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrivatePlacementMember_lbl" xml:lang="en-US">Private Placement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestorMember" xlink:label="us-gaap_InvestorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestorMember" xlink:to="us-gaap_InvestorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestorMember_lbl" xml:lang="en-US">Private investor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubscriptionArrangementMember" xlink:label="us-gaap_SubscriptionArrangementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubscriptionArrangementMember" xlink:to="us-gaap_SubscriptionArrangementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubscriptionArrangementMember_lbl" xml:lang="en-US">Subscription Arrangement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis_lbl" xml:lang="en-US">Deferred Revenue Arrangement Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_MrSiokasMember" xlink:label="COSM_MrSiokasMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_MrSiokasMember" xlink:to="COSM_MrSiokasMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_MrSiokasMember_lbl" xml:lang="en-US">Mr. Siokas [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AcquisitionRelatedCostsMember" xlink:label="us-gaap_AcquisitionRelatedCostsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcquisitionRelatedCostsMember" xlink:to="us-gaap_AcquisitionRelatedCostsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcquisitionRelatedCostsMember_lbl" xml:lang="en-US">Acquisition [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OptionMember" xlink:label="us-gaap_OptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OptionMember" xlink:to="us-gaap_OptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OptionMember_lbl" xml:lang="en-US">Options [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DirectorsAndOfficersLiabilityInsuranceMember" xlink:label="us-gaap_DirectorsAndOfficersLiabilityInsuranceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DirectorsAndOfficersLiabilityInsuranceMember" xlink:to="us-gaap_DirectorsAndOfficersLiabilityInsuranceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DirectorsAndOfficersLiabilityInsuranceMember_lbl" xml:lang="en-US">Officers and directors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestorMember" xlink:to="us-gaap_InvestorMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InvestorMember_2_lbl" xml:lang="en-US">Investor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_MrOrestesVarvitsiotesMember" xlink:label="COSM_MrOrestesVarvitsiotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_MrOrestesVarvitsiotesMember" xlink:to="COSM_MrOrestesVarvitsiotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_MrOrestesVarvitsiotesMember_lbl" xml:lang="en-US">Mr. Orestes Varvitsiotes [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_JanuaryThreeTwoThousandSeventeenMember" xlink:label="COSM_JanuaryThreeTwoThousandSeventeenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_JanuaryThreeTwoThousandSeventeenMember" xlink:to="COSM_JanuaryThreeTwoThousandSeventeenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_JanuaryThreeTwoThousandSeventeenMember_lbl" xml:lang="en-US">January 3, 2017 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AegisCapitalCorpMember" xlink:label="COSM_AegisCapitalCorpMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_AegisCapitalCorpMember" xlink:to="COSM_AegisCapitalCorpMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_AegisCapitalCorpMember_lbl" xml:lang="en-US">Aegis capital corp [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_JanuaryOneTwoThousandSeventeenMember" xlink:label="COSM_JanuaryOneTwoThousandSeventeenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_JanuaryOneTwoThousandSeventeenMember" xlink:to="COSM_JanuaryOneTwoThousandSeventeenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_JanuaryOneTwoThousandSeventeenMember_lbl" xml:lang="en-US">January 1, 2017 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_InternationalFinanceManagerMember" xlink:label="COSM_InternationalFinanceManagerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_InternationalFinanceManagerMember" xlink:to="COSM_InternationalFinanceManagerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_InternationalFinanceManagerMember_lbl" xml:lang="en-US">International Finance Manager [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis" xlink:label="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis" xlink:to="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis_lbl" xml:lang="en-US">Purchase Commitment, Excluding Long-term Commitment [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SecuritiesPurchaseAgreementMember" xlink:label="COSM_SecuritiesPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_SecuritiesPurchaseAgreementMember" xlink:to="COSM_SecuritiesPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_SecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeniorNotesMember" xlink:label="us-gaap_SeniorNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeniorNotesMember" xlink:to="us-gaap_SeniorNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeniorNotesMember_lbl" xml:lang="en-US">Senior Convertible Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_CCPharmaGmbHMember" xlink:label="COSM_CCPharmaGmbHMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_CCPharmaGmbHMember" xlink:to="COSM_CCPharmaGmbHMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_CCPharmaGmbHMember_lbl" xml:lang="en-US">CC Pharma GmbH [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_PostMergerMember" xlink:label="COSM_PostMergerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_PostMergerMember" xlink:to="COSM_PostMergerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_PostMergerMember_lbl" xml:lang="en-US">Post Merger [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_TradeFacilityAgreementMember" xlink:label="COSM_TradeFacilityAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_TradeFacilityAgreementMember" xlink:to="COSM_TradeFacilityAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_TradeFacilityAgreementMember_lbl" xml:lang="en-US">Trade Facility Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SeniorConvertibleNoteOneMember" xlink:label="COSM_SeniorConvertibleNoteOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_SeniorConvertibleNoteOneMember" xlink:to="COSM_SeniorConvertibleNoteOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_SeniorConvertibleNoteOneMember_lbl" xml:lang="en-US">Senior Convertible Note 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_InstitutionalInvestorsMember" xlink:label="COSM_InstitutionalInvestorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_InstitutionalInvestorsMember" xlink:to="COSM_InstitutionalInvestorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_InstitutionalInvestorsMember_lbl" xml:lang="en-US">Institutional investors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SeniorConvertibleNoteTwoMember" xlink:label="COSM_SeniorConvertibleNoteTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_SeniorConvertibleNoteTwoMember" xlink:to="COSM_SeniorConvertibleNoteTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_SeniorConvertibleNoteTwoMember_lbl" xml:lang="en-US">Senior Convertible Note 2 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WarrantMember_2_lbl" xml:lang="en-US">Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_RegistrationRightsAgreementMember" xlink:label="COSM_RegistrationRightsAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_RegistrationRightsAgreementMember" xlink:to="COSM_RegistrationRightsAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_RegistrationRightsAgreementMember_lbl" xml:lang="en-US">Registration Rights Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LeakOutAgreementMember" xlink:label="COSM_LeakOutAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_LeakOutAgreementMember" xlink:to="COSM_LeakOutAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_LeakOutAgreementMember_lbl" xml:lang="en-US">Leak-out Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DocumentAndEntityInformationAbstract" xlink:label="COSM_DocumentAndEntityInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_DocumentAndEntityInformationAbstract" xlink:to="COSM_DocumentAndEntityInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US">Document And Entity Information</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Is Entity a Well-known Seasoned Issuer?</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Is Entity a Voluntary Filer?</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Is Entity's Reporting Status Current?</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConsolidatedBalanceSheetsAbstract" xlink:label="COSM_ConsolidatedBalanceSheetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_ConsolidatedBalanceSheetsAbstract" xlink:to="COSM_ConsolidatedBalanceSheetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_ConsolidatedBalanceSheetsAbstract_lbl" xml:lang="en-US">Consolidated Balance Sheets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">CURRENT ASSETS:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryGross" xlink:label="us-gaap_InventoryGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryGross" xlink:to="us-gaap_InventoryGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryGross_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_PrepaidDeferredFinancingFees" xlink:label="COSM_PrepaidDeferredFinancingFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_PrepaidDeferredFinancingFees" xlink:to="COSM_PrepaidDeferredFinancingFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_PrepaidDeferredFinancingFees_lbl" xml:lang="en-US">Prepaid deferred financing fees</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets - related party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">TOTAL CURRENT ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetIncludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetIncludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetIncludingGoodwill_lbl" xml:lang="en-US">Intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">TOTAL ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">CURRENT LIABILITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilities" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndOtherAccruedLiabilities" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued expenses - related party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Notes payable, net of unamortized discount of $154,949 and $110,561, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="us-gaap_AccountsPayableRelatedPartiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:to="us-gaap_AccountsPayableRelatedPartiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableRelatedPartiesCurrent_lbl" xml:lang="en-US">Notes payable - related party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LoansPayable" xlink:label="us-gaap_LoansPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayable" xlink:to="us-gaap_LoansPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansPayable_lbl" xml:lang="en-US">Loans payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLoansPayable" xlink:label="us-gaap_OtherLoansPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLoansPayable" xlink:to="us-gaap_OtherLoansPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLoansPayable_lbl" xml:lang="en-US">Loans payable - related party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxesPayableCurrent" xlink:label="us-gaap_TaxesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxesPayableCurrent" xlink:to="us-gaap_TaxesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxesPayableCurrent_lbl" xml:lang="en-US">Taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">TOTAL CURRENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">TOTAL LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and Contingencies (see Note 9)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">STOCKHOLDERS' DEFICIT:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, $0.001 par value; 100,000,000 shares authorized; 0 shares issued and outstanding as of September 30, 2017 and December 31, 2016, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $0.001 par value; 300,000,000 shares authorized; 128,253,932 and 125,870,532 shares issued and outstanding as of September 30, 2017 and December 31, 2016, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">TOTAL STOCKHOLDERS' DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConsolidatedBalanceSheetsParentheticalAbstract" xlink:label="COSM_ConsolidatedBalanceSheetsParentheticalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_ConsolidatedBalanceSheetsParentheticalAbstract" xlink:to="COSM_ConsolidatedBalanceSheetsParentheticalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_ConsolidatedBalanceSheetsParentheticalAbstract_lbl" xml:lang="en-US">Consolidated Balance Sheets Parenthetical</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_lbl" xml:lang="en-US">Notes payable, net of unamortized discount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_2_lbl" xml:lang="en-US">SHAREHOLDERS' EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares, outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares, outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConsolidatedStatementsOfOperationsAndOtherComprehensiveIncomeLossUnauditedAbstract" xlink:label="COSM_ConsolidatedStatementsOfOperationsAndOtherComprehensiveIncomeLossUnauditedAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_ConsolidatedStatementsOfOperationsAndOtherComprehensiveIncomeLossUnauditedAbstract" xlink:to="COSM_ConsolidatedStatementsOfOperationsAndOtherComprehensiveIncomeLossUnauditedAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_ConsolidatedStatementsOfOperationsAndOtherComprehensiveIncomeLossUnauditedAbstract_lbl" xml:lang="en-US">Consolidated Statements Of Operations And Other Comprehensive Income Loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US">REVENUE</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">COST OF REVENUE</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">GROSS PROFIT</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">OPERATING EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="us-gaap_OtherDepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherDepreciationAndAmortization" xlink:to="us-gaap_OtherDepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherDepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:to="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_lbl" xml:lang="en-US">Impairment of goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">TOTAL OPERATING EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">GAIN (LOSS) FROM OPERATIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_OtherIncomeAndExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract_lbl" xml:lang="en-US">OTHER INCOME (EXPENSE)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncome" xlink:label="us-gaap_OtherIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncome_lbl" xml:lang="en-US">Other income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpenseOther" xlink:label="us-gaap_InterestExpenseOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseOther" xlink:to="us-gaap_InterestExpenseOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpenseOther_lbl" xml:lang="en-US">Interest expense - related party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherExpenses" xlink:label="us-gaap_OtherExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherExpenses" xlink:to="us-gaap_OtherExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherExpenses_lbl" xml:lang="en-US">Other expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xml:lang="en-US">Foreign currency transaction gain (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="us-gaap_OtherOperatingIncomeExpenseNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet_lbl" xml:lang="en-US">TOTAL OTHER INCOME (EXPENSE)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">LOSS BEFORE INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">INCOME TAX EXPENSE</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">NET LOSS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_lbl" xml:lang="en-US">OTHER COMPREHENSIVE LOSS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossUnrealized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized_lbl" xml:lang="en-US">Foreign currency translation loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">TOTAL OTHER COMPREHENSIVE LOSS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">BASIC AND DILUTED NET LOSS PER SHARE</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xml:lang="en-US">WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Basic and Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConsolidatedStatementsOfCashFlowsUnauditedAbstract" xlink:label="COSM_ConsolidatedStatementsOfCashFlowsUnauditedAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_ConsolidatedStatementsOfCashFlowsUnauditedAbstract" xlink:to="COSM_ConsolidatedStatementsOfCashFlowsUnauditedAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_ConsolidatedStatementsOfCashFlowsUnauditedAbstract_lbl" xml:lang="en-US">Consolidated Statements Of Cash Flows</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to Reconcile Net Loss to Net Cash Used In Operating Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xml:lang="en-US">Amortization of debt discount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xml:lang="en-US">Issuance of common stock for services</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:to="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_2_lbl" xml:lang="en-US">Loss on goodwill impairment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in Assets and Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl" xml:lang="en-US">Prepaid expenses - related party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued expenses - related party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:label="us-gaap_IncreaseDecreaseInAccruedTaxesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:to="us-gaap_IncreaseDecreaseInAccruedTaxesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedTaxesPayable_lbl" xml:lang="en-US">Taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xml:lang="en-US">Deferred revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">NET CASH USED IN OPERATING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of fixed assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfAcquisitionCosts" xlink:label="us-gaap_AmortizationOfAcquisitionCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfAcquisitionCosts" xlink:to="us-gaap_AmortizationOfAcquisitionCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfAcquisitionCosts_lbl" xml:lang="en-US">Cash received from acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfNotesPayable" xlink:label="us-gaap_ProceedsFromRepaymentsOfNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepaymentsOfNotesPayable" xlink:to="us-gaap_ProceedsFromRepaymentsOfNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRepaymentsOfNotesPayable_lbl" xml:lang="en-US">Payment of related party note payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US">Payment of note payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xml:lang="en-US">Proceeds from note payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xml:lang="en-US">Payment of related party loan</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xml:lang="en-US">Proceeds from related party loan</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_PaymentOfLoansPayable" xlink:label="COSM_PaymentOfLoansPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_PaymentOfLoansPayable" xlink:to="COSM_PaymentOfLoansPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="COSM_PaymentOfLoansPayable_lbl" xml:lang="en-US">Payment of loans payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xml:lang="en-US">Sale of common stock and warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DeferredFinancingFees" xlink:label="COSM_DeferredFinancingFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_DeferredFinancingFees" xlink:to="COSM_DeferredFinancingFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_DeferredFinancingFees_lbl" xml:lang="en-US">Deferred financing fees</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromContributedCapital" xlink:label="us-gaap_ProceedsFromContributedCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromContributedCapital" xlink:to="us-gaap_ProceedsFromContributedCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromContributedCapital_lbl" xml:lang="en-US">Capital contribution</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">NET CASH PROVIDED BY FINANCING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_lbl" xml:lang="en-US">Effect of exchange rate changes on cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US">NET INCREASE IN CASH</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">CASH AT BEGINNING OF PERIOD</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xml:lang="en-US">CASH AT END OF PERIOD</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental Disclosure of Cash Flow Information</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="us-gaap_InterestPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaid_lbl" xml:lang="en-US">Cash paid during the period: Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xml:lang="en-US">Cash paid during the period: Income Tax</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Supplemental Disclosure of Non-Cash Investing and Financing Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AcquisitionOfDecahedron" xlink:label="COSM_AcquisitionOfDecahedron" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_AcquisitionOfDecahedron" xlink:to="COSM_AcquisitionOfDecahedron_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_AcquisitionOfDecahedron_lbl" xml:lang="en-US">Acquisition of Decahedron</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ReversalOfProceedsDueFromNoteholderDueToRepaymentOfNote" xlink:label="COSM_ReversalOfProceedsDueFromNoteholderDueToRepaymentOfNote" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_ReversalOfProceedsDueFromNoteholderDueToRepaymentOfNote" xlink:to="COSM_ReversalOfProceedsDueFromNoteholderDueToRepaymentOfNote_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_ReversalOfProceedsDueFromNoteholderDueToRepaymentOfNote_lbl" xml:lang="en-US">Reversal of proceeds due from noteholder due to repayment of note</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_NotesToFinancialStatementsAbstract" xlink:label="COSM_NotesToFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_NotesToFinancialStatementsAbstract" xlink:to="COSM_NotesToFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_NotesToFinancialStatementsAbstract_lbl" xml:lang="en-US">Notes to Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xml:lang="en-US">NOTE 1- BASIS OF PRESENTATION</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NatureOfOperations_lbl" xml:lang="en-US">NOTE 2 - ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_Note3AcquisitionOfDecahedronLtdTextBlock" xlink:label="COSM_Note3AcquisitionOfDecahedronLtdTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_Note3AcquisitionOfDecahedronLtdTextBlock" xlink:to="COSM_Note3AcquisitionOfDecahedronLtdTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_Note3AcquisitionOfDecahedronLtdTextBlock_lbl" xml:lang="en-US">NOTE 3- ACQUISITION OF DECAHEDRON, LTD.</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_PrepaidDeferredFinancingCostsTextBlock" xlink:label="COSM_PrepaidDeferredFinancingCostsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_PrepaidDeferredFinancingCostsTextBlock" xlink:to="COSM_PrepaidDeferredFinancingCostsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_PrepaidDeferredFinancingCostsTextBlock_lbl" xml:lang="en-US">NOTE 4 - PREPAID DEFERRED FINANCING COSTS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 5 - INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PartnersCapitalNotesDisclosureTextBlock" xlink:label="us-gaap_PartnersCapitalNotesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PartnersCapitalNotesDisclosureTextBlock" xlink:to="us-gaap_PartnersCapitalNotesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PartnersCapitalNotesDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 6 - CAPITAL STRUCTURE</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 7 - RELATED PARTY TRANSACTIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 8 - DEBT</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 9 - COMMITMENTS AND CONTINGENCIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfStockByClassTextBlock" xlink:label="us-gaap_ScheduleOfStockByClassTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTextBlock" xlink:to="us-gaap_ScheduleOfStockByClassTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockByClassTextBlock_lbl" xml:lang="en-US">NOTE 10 - STOCK OPTIONS AND WARRANTS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">NOTE 11 - SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_OrganizationNatureOfBusinessAndGoingConcernPoliciesAbstract" xlink:label="COSM_OrganizationNatureOfBusinessAndGoingConcernPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_OrganizationNatureOfBusinessAndGoingConcernPoliciesAbstract" xlink:to="COSM_OrganizationNatureOfBusinessAndGoingConcernPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_OrganizationNatureOfBusinessAndGoingConcernPoliciesAbstract_lbl" xml:lang="en-US">Organization Nature Of Business And Going Concern Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Basis of Financial Statement Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xml:lang="en-US">Reclassifications to Prior Period Financial Statements and Adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PolicyLoansReceivablePolicy" xlink:label="us-gaap_PolicyLoansReceivablePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PolicyLoansReceivablePolicy" xlink:to="us-gaap_PolicyLoansReceivablePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PolicyLoansReceivablePolicy_lbl" xml:lang="en-US">Account Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_FixedAssetsPolicyTextBlock" xlink:label="COSM_FixedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_FixedAssetsPolicyTextBlock" xlink:to="COSM_FixedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_FixedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Fixed Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xml:lang="en-US">Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xml:lang="en-US">Goodwill and Intangibles</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xml:lang="en-US">Fair Value Measurement</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xml:lang="en-US">Stock-based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Foreign Currency Translations and Transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Basic and Diluted Net Income (Loss) per Common Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_OrganizationNatureOfBusinessAndGoingConcernTablesAbstract" xlink:label="COSM_OrganizationNatureOfBusinessAndGoingConcernTablesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_OrganizationNatureOfBusinessAndGoingConcernTablesAbstract" xlink:to="COSM_OrganizationNatureOfBusinessAndGoingConcernTablesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_OrganizationNatureOfBusinessAndGoingConcernTablesAbstract_lbl" xml:lang="en-US">Organization Nature Of Business And Going Concern Tables</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of Calculation of Fixed Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AcquisitionOfDecahedronLtdTableAbstract" xlink:label="COSM_AcquisitionOfDecahedronLtdTableAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_AcquisitionOfDecahedronLtdTableAbstract" xlink:to="COSM_AcquisitionOfDecahedronLtdTableAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_AcquisitionOfDecahedronLtdTableAbstract_lbl" xml:lang="en-US">Acquisition Of Decahedron Ltd Table</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_UnauditedAllocationOfPurchasePriceTableTextBlock" xlink:label="COSM_UnauditedAllocationOfPurchasePriceTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_UnauditedAllocationOfPurchasePriceTableTextBlock" xlink:to="COSM_UnauditedAllocationOfPurchasePriceTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_UnauditedAllocationOfPurchasePriceTableTextBlock_lbl" xml:lang="en-US">Unaudited allocation of purchase price</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_IntangibleAssetsTableTextBlock" xlink:label="COSM_IntangibleAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_IntangibleAssetsTableTextBlock" xlink:to="COSM_IntangibleAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_IntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">Intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_UnauditedSupplementalProFormaDataTableTextBlock" xlink:label="COSM_UnauditedSupplementalProFormaDataTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_UnauditedSupplementalProFormaDataTableTextBlock" xlink:to="COSM_UnauditedSupplementalProFormaDataTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_UnauditedSupplementalProFormaDataTableTextBlock_lbl" xml:lang="en-US">Unaudited Supplemental Pro Forma Data</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_StockOptionsAndWarrantsTablesAbstract" xlink:label="COSM_StockOptionsAndWarrantsTablesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_StockOptionsAndWarrantsTablesAbstract" xlink:to="COSM_StockOptionsAndWarrantsTablesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_StockOptionsAndWarrantsTablesAbstract_lbl" xml:lang="en-US">Stock Options And Warrants Tables</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of option activity during the year</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_WarrantsWereValuedTableTextBlock" xlink:label="COSM_WarrantsWereValuedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_WarrantsWereValuedTableTextBlock" xlink:to="COSM_WarrantsWereValuedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_WarrantsWereValuedTableTextBlock_lbl" xml:lang="en-US">warrants were valued</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_WarrantsTableTextBlock" xlink:label="COSM_WarrantsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_WarrantsTableTextBlock" xlink:to="COSM_WarrantsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_WarrantsTableTextBlock_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Estimated Useful Life</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrencyAxis" xlink:label="us-gaap_CurrencyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrencyAxis" xlink:to="us-gaap_CurrencyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrencyAxis_lbl" xml:lang="en-US">Currency [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityIncorporationStateCountryName" xlink:label="dei_EntityIncorporationStateCountryName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryName" xlink:to="dei_EntityIncorporationStateCountryName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryName_lbl" xml:lang="en-US">State or country of incorporation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="dei_EntityIncorporationDateOfIncorporation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationDateOfIncorporation" xlink:to="dei_EntityIncorporationDateOfIncorporation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationDateOfIncorporation_lbl" xml:lang="en-US">Date of incorporation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Equity ownership percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xml:lang="en-US">Common stock shares reserved</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_WorkingCapitalDeficit" xlink:label="COSM_WorkingCapitalDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_WorkingCapitalDeficit" xlink:to="COSM_WorkingCapitalDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_WorkingCapitalDeficit_lbl" xml:lang="en-US">Working capital deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DescriptionForPeriodicInventorySystemMaintainance" xlink:label="COSM_DescriptionForPeriodicInventorySystemMaintainance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_DescriptionForPeriodicInventorySystemMaintainance" xlink:to="COSM_DescriptionForPeriodicInventorySystemMaintainance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_DescriptionForPeriodicInventorySystemMaintainance_lbl" xml:lang="en-US">Description for periodic inventory system maintainance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Intangible asset, useful life</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:label="us-gaap_GoodwillAndIntangibleAssetImpairment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:to="us-gaap_GoodwillAndIntangibleAssetImpairment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetImpairment_lbl" xml:lang="en-US">Impairment of goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ImpairmentOfGoodwillPercent" xlink:label="COSM_ImpairmentOfGoodwillPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_ImpairmentOfGoodwillPercent" xlink:to="COSM_ImpairmentOfGoodwillPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_ImpairmentOfGoodwillPercent_lbl" xml:lang="en-US">Impairment of goodwill, percent</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Income tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_lbl" xml:lang="en-US">Current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_lbl" xml:lang="en-US">Intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_lbl" xml:lang="en-US">Total assets acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_lbl" xml:lang="en-US">Liabilities assumed:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_lbl" xml:lang="en-US">Debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_lbl" xml:lang="en-US">Total liabilities assumed</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xml:lang="en-US">Net assets acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract_lbl" xml:lang="en-US">Consideration:</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedValueOfCommonStockIssuedAtAcquisition" xlink:label="COSM_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedValueOfCommonStockIssuedAtAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedValueOfCommonStockIssuedAtAcquisition" xlink:to="COSM_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedValueOfCommonStockIssuedAtAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedValueOfCommonStockIssuedAtAcquisition_lbl" xml:lang="en-US">Value of Common Stock Issued at Acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_2_lbl" xml:lang="en-US">Useful Life (Years)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl" xml:lang="en-US">Revenues</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CostOfRevenue_2_lbl" xml:lang="en-US">Cost of revenues</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other income (expense)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xml:lang="en-US">Net Loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionNameOfAcquiredEntity" xlink:label="us-gaap_BusinessAcquisitionNameOfAcquiredEntity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionNameOfAcquiredEntity" xlink:to="us-gaap_BusinessAcquisitionNameOfAcquiredEntity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionNameOfAcquiredEntity_lbl" xml:lang="en-US">Business acquisition, name of acquired entity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xml:lang="en-US">Business acquisition outstanding percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="us-gaap_NumberOfBusinessesAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfBusinessesAcquired" xlink:to="us-gaap_NumberOfBusinessesAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NumberOfBusinessesAcquired_lbl" xml:lang="en-US">Number of businesses acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:label="us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:to="us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_lbl" xml:lang="en-US">Business acquisition outstanding shares value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockOtherSharesOutstanding" xlink:label="us-gaap_CommonStockOtherSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockOtherSharesOutstanding" xlink:to="us-gaap_CommonStockOtherSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockOtherSharesOutstanding_lbl" xml:lang="en-US">Business acquisition outstanding shares in exchange</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AdjustmentRelatedToOtherAssetsAndAccountsPayable" xlink:label="COSM_AdjustmentRelatedToOtherAssetsAndAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_AdjustmentRelatedToOtherAssetsAndAccountsPayable" xlink:to="COSM_AdjustmentRelatedToOtherAssetsAndAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_AdjustmentRelatedToOtherAssetsAndAccountsPayable_lbl" xml:lang="en-US">Adjustment related to other assets and accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="us-gaap_DepositsAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsNoncurrent" xlink:to="us-gaap_DepositsAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositsAssetsNoncurrent_lbl" xml:lang="en-US">Advanced for additional financing</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_IncomeTaxesDetailsNarrativeAbstract" xlink:label="COSM_IncomeTaxesDetailsNarrativeAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_IncomeTaxesDetailsNarrativeAbstract" xlink:to="COSM_IncomeTaxesDetailsNarrativeAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_IncomeTaxesDetailsNarrativeAbstract_lbl" xml:lang="en-US">Income Taxes Details Narrative</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_lbl" xml:lang="en-US">Income tax, penalties and interest expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_2_lbl" xml:lang="en-US">Common stock shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xml:lang="en-US">Restricted shares of common stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_2_lbl" xml:lang="en-US">Preferred stock shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xml:lang="en-US">Stock options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US">Exercise period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xml:lang="en-US">Stock options vested</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentRepurchaseAgreementDateOfAgreement" xlink:label="invest_InvestmentRepurchaseAgreementDateOfAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="invest_InvestmentRepurchaseAgreementDateOfAgreement" xlink:to="invest_InvestmentRepurchaseAgreementDateOfAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="invest_InvestmentRepurchaseAgreementDateOfAgreement_lbl" xml:lang="en-US">Commencing agreement date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentMaturityDate1" xlink:label="invest_InvestmentMaturityDate1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="invest_InvestmentMaturityDate1" xlink:to="invest_InvestmentMaturityDate1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="invest_InvestmentMaturityDate1_lbl" xml:lang="en-US">Commencing terminating date</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConsultingAgreementPeriod" xlink:label="COSM_ConsultingAgreementPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_ConsultingAgreementPeriod" xlink:to="COSM_ConsultingAgreementPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_ConsultingAgreementPeriod_lbl" xml:lang="en-US">Consulting agreement period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockValue_2_lbl" xml:lang="en-US">Common stock vlaue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Common stock value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="us-gaap_RestructuringCharges" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCharges" xlink:to="us-gaap_RestructuringCharges_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringCharges_lbl" xml:lang="en-US">Consultant charges</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherRestructuringCosts" xlink:label="us-gaap_OtherRestructuringCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherRestructuringCosts" xlink:to="us-gaap_OtherRestructuringCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherRestructuringCosts_lbl" xml:lang="en-US">Monthly consultant charges</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesSubscribedButUnissued" xlink:label="us-gaap_CommonStockSharesSubscribedButUnissued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesSubscribedButUnissued" xlink:to="us-gaap_CommonStockSharesSubscribedButUnissued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesSubscribedButUnissued_lbl" xml:lang="en-US">Common Stock Shares Subscribed</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross" xlink:to="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross_lbl" xml:lang="en-US">Stock options granted fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentDecreaseForgiveness" xlink:label="us-gaap_DebtInstrumentDecreaseForgiveness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDecreaseForgiveness" xlink:to="us-gaap_DebtInstrumentDecreaseForgiveness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentDecreaseForgiveness_lbl" xml:lang="en-US">Aggregate forgiveness of related party notes</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DebtInstrumentDecreaseAccruedInterestForgiveness" xlink:label="COSM_DebtInstrumentDecreaseAccruedInterestForgiveness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_DebtInstrumentDecreaseAccruedInterestForgiveness" xlink:to="COSM_DebtInstrumentDecreaseAccruedInterestForgiveness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_DebtInstrumentDecreaseAccruedInterestForgiveness_lbl" xml:lang="en-US">Debt instrument decrease accrued interest forgiveness</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidInterest" xlink:label="us-gaap_PrepaidInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidInterest" xlink:to="us-gaap_PrepaidInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidInterest_lbl" xml:lang="en-US">Prepaid balance</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DescriptionForPrepaidBalancePercentage" xlink:label="COSM_DescriptionForPrepaidBalancePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_DescriptionForPrepaidBalancePercentage" xlink:to="COSM_DescriptionForPrepaidBalancePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_DescriptionForPrepaidBalancePercentage_lbl" xml:lang="en-US">Description for prepaid balance percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToRelatedPartiesCurrent_lbl" xml:lang="en-US">Due to related party</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesIssued_2_lbl" xml:lang="en-US">Shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCredit" xlink:to="us-gaap_LineOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCredit_lbl" xml:lang="en-US">Debt outstanding amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_2_lbl" xml:lang="en-US">Repayment of related party debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xml:lang="en-US">Short term debt, borrowing capacity</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_PaymentOfMiscellaneousBills" xlink:label="COSM_PaymentOfMiscellaneousBills" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_PaymentOfMiscellaneousBills" xlink:to="COSM_PaymentOfMiscellaneousBills_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_PaymentOfMiscellaneousBills_lbl" xml:lang="en-US">Payment of miscellaneous bills</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:to="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl" xml:lang="en-US">Interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US">Maturity date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockOtherValueOutstanding" xlink:label="us-gaap_CommonStockOtherValueOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockOtherValueOutstanding" xlink:to="us-gaap_CommonStockOtherValueOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockOtherValueOutstanding_lbl" xml:lang="en-US">Principal outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_2_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2_lbl" xml:lang="en-US">Short term debt borrowing capacity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xml:lang="en-US">Proceeds from debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_PaymentOfMiscellaneousBills" xlink:to="COSM_PaymentOfMiscellaneousBills_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="COSM_PaymentOfMiscellaneousBills_2_lbl" xml:lang="en-US">Repayments of outstanding bill</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityExpirationDate1" xlink:to="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" xml:lang="en-US">Maturity date</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AmendedMaturityDate" xlink:label="COSM_AmendedMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_AmendedMaturityDate" xlink:to="COSM_AmendedMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_AmendedMaturityDate_lbl" xml:lang="en-US">Amended maturity date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfDebt_lbl" xml:lang="en-US">Repayment of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfAccountsReceivableSecuritization" xlink:label="us-gaap_RepaymentsOfAccountsReceivableSecuritization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfAccountsReceivableSecuritization" xlink:to="us-gaap_RepaymentsOfAccountsReceivableSecuritization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfAccountsReceivableSecuritization_lbl" xml:lang="en-US">Repayments of accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityDescription" xlink:label="us-gaap_LineOfCreditFacilityDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityDescription" xlink:to="us-gaap_LineOfCreditFacilityDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityDescription_lbl" xml:lang="en-US">Description for the repayment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xml:lang="en-US">Debt discount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xml:lang="en-US">Amortization of debt discount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="us-gaap_DebtInstrumentTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTerm" xlink:to="us-gaap_DebtInstrumentTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTerm_lbl" xml:lang="en-US">Term of credit facility</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_CreditFaciltyOriginationFeePercentage" xlink:label="COSM_CreditFaciltyOriginationFeePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_CreditFaciltyOriginationFeePercentage" xlink:to="COSM_CreditFaciltyOriginationFeePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_CreditFaciltyOriginationFeePercentage_lbl" xml:lang="en-US">Credit facilty origination fee, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_MonthlyCreditFeePercentage" xlink:label="COSM_MonthlyCreditFeePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_MonthlyCreditFeePercentage" xlink:to="COSM_MonthlyCreditFeePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_MonthlyCreditFeePercentage_lbl" xml:lang="en-US">Monthly credit fee, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfessionalFees_lbl" xml:lang="en-US">Monthly fees</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfDeferredLoanOriginationFeesNet" xlink:label="us-gaap_AmortizationOfDeferredLoanOriginationFeesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDeferredLoanOriginationFeesNet" xlink:to="us-gaap_AmortizationOfDeferredLoanOriginationFeesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfDeferredLoanOriginationFeesNet_lbl" xml:lang="en-US">Origination fees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseArrangementTypeAxis" xlink:to="us-gaap_LeaseArrangementTypeAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseArrangementTypeAxis_2_lbl" xml:lang="en-US">Lease Arrangement, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_OperatingLeasePeriodicPayment" xlink:label="COSM_OperatingLeasePeriodicPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_OperatingLeasePeriodicPayment" xlink:to="COSM_OperatingLeasePeriodicPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_OperatingLeasePeriodicPayment_lbl" xml:lang="en-US">Operating lease periodic payment</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_FrequencyOfPeriodicPayment" xlink:label="COSM_FrequencyOfPeriodicPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_FrequencyOfPeriodicPayment" xlink:to="COSM_FrequencyOfPeriodicPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_FrequencyOfPeriodicPayment_lbl" xml:lang="en-US">Frequency of periodic payment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="us-gaap_OperatingLeasesRentExpenseNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesRentExpenseNet" xlink:to="us-gaap_OperatingLeasesRentExpenseNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesRentExpenseNet_lbl" xml:lang="en-US">Operating lease rental expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseExpirationDate1" xlink:to="us-gaap_LeaseExpirationDate1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xml:lang="en-US">Operating lease expiration date</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AmendmentToMaturityDate" xlink:label="COSM_AmendmentToMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_AmendmentToMaturityDate" xlink:to="COSM_AmendmentToMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_AmendmentToMaturityDate_lbl" xml:lang="en-US">Operating lease renewal date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract" xlink:label="us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract" xlink:to="us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract_lbl" xml:lang="en-US">Term of operating lease</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsFromFranchiseAgreements" xlink:label="us-gaap_CommitmentsFromFranchiseAgreements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsFromFranchiseAgreements" xlink:to="us-gaap_CommitmentsFromFranchiseAgreements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsFromFranchiseAgreements_lbl" xml:lang="en-US">Commitments and contingencies description</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_NonrefundableFee" xlink:label="COSM_NonrefundableFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_NonrefundableFee" xlink:to="COSM_NonrefundableFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_NonrefundableFee_lbl" xml:lang="en-US">Non-refundable fee</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US">Expense paid</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xml:lang="en-US">Number of Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Outstanding, December 31, 2016</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_2_lbl" xml:lang="en-US">Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xml:lang="en-US">Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Outstanding, September 30, 2017</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Exercisable at September 30, 2017</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_lbl" xml:lang="en-US">Weighted Average Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Outstanding, December 31, 2016</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Outstanding, September 30, 2017</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercisable at September 30, 2017</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_WeightedAverageRemainingContractualTerm" xlink:label="COSM_WeightedAverageRemainingContractualTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_WeightedAverageRemainingContractualTerm" xlink:to="COSM_WeightedAverageRemainingContractualTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_WeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Outstanding, December 31, 2016</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2" xlink:label="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2" xlink:to="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm" xlink:label="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm" xlink:to="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US">Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_lbl" xml:lang="en-US">Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm3" xlink:label="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm3" xlink:to="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm3_lbl" xml:lang="en-US">Expired</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Outstanding, September 30, 2017</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4" xlink:label="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4" xlink:to="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4_lbl" xml:lang="en-US">Exercisable at September 30, 2017</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_lbl" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_lbl" xml:lang="en-US">Outstanding, December 31, 2016</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_lbl" xml:lang="en-US">Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited" xlink:label="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited" xlink:to="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited_lbl" xml:lang="en-US">Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised" xlink:label="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised" xlink:to="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised_lbl" xml:lang="en-US">Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpired" xlink:label="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpired" xlink:to="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpired_lbl" xml:lang="en-US">Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_2_lbl" xml:lang="en-US">Outstanding, September 30, 2017</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xml:lang="en-US">Exercisable at September 30, 2017</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_FairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_FairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm" xlink:label="us-gaap_FairValueAssumptionsExpectedTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsExpectedTerm" xlink:to="us-gaap_FairValueAssumptionsExpectedTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssumptionsExpectedTerm_lbl" xml:lang="en-US">Expected term (in years)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_FairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_FairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk-free interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_FairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_FairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Expected dividend yield</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Stock options granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xml:lang="en-US">Stock options forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="us-gaap_StockOptionPlanExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionPlanExpense" xlink:to="us-gaap_StockOptionPlanExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionPlanExpense_lbl" xml:lang="en-US">Stock options value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Stock price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl" xml:lang="en-US">Exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Option term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Volatility rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Amortization expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xml:lang="en-US">Stock options vested</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_StockOptionPeriodicVesting" xlink:label="COSM_StockOptionPeriodicVesting" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_StockOptionPeriodicVesting" xlink:to="COSM_StockOptionPeriodicVesting_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_StockOptionPeriodicVesting_lbl" xml:lang="en-US">Stock option periodic vesting</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_FrequencyOfPeriodicVesting" xlink:label="COSM_FrequencyOfPeriodicVesting" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_FrequencyOfPeriodicVesting" xlink:to="COSM_FrequencyOfPeriodicVesting_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_FrequencyOfPeriodicVesting_lbl" xml:lang="en-US">Frequency of periodic vesting</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConsiderationUnderAgreement" xlink:label="COSM_ConsiderationUnderAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_ConsiderationUnderAgreement" xlink:to="COSM_ConsiderationUnderAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_ConsiderationUnderAgreement_lbl" xml:lang="en-US">Consideration under agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ShareBasedCompensationAsAnnualRetainer" xlink:label="COSM_ShareBasedCompensationAsAnnualRetainer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_ShareBasedCompensationAsAnnualRetainer" xlink:to="COSM_ShareBasedCompensationAsAnnualRetainer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_ShareBasedCompensationAsAnnualRetainer_lbl" xml:lang="en-US">Share based compensation as annual retainer</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_WarrantsIssuedRatioDescription" xlink:label="COSM_WarrantsIssuedRatioDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_WarrantsIssuedRatioDescription" xlink:to="COSM_WarrantsIssuedRatioDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_WarrantsIssuedRatioDescription_lbl" xml:lang="en-US">Warrants issued ratio description</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_CommonStockSharesAcquiredForConsiderationValue" xlink:label="COSM_CommonStockSharesAcquiredForConsiderationValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_CommonStockSharesAcquiredForConsiderationValue" xlink:to="COSM_CommonStockSharesAcquiredForConsiderationValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_CommonStockSharesAcquiredForConsiderationValue_lbl" xml:lang="en-US">Common stock shares acquired for consideration, value</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_CommonStockSharesAcquiredForConsiderationShares" xlink:label="COSM_CommonStockSharesAcquiredForConsiderationShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_CommonStockSharesAcquiredForConsiderationShares" xlink:to="COSM_CommonStockSharesAcquiredForConsiderationShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_CommonStockSharesAcquiredForConsiderationShares_lbl" xml:lang="en-US">Common stock shares acquired for consideration, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xml:lang="en-US">Reverse stock split</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="us-gaap_ConvertibleNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="us-gaap_ConvertibleNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayable_lbl" xml:lang="en-US">Convertible notes payable, principal amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2_lbl" xml:lang="en-US">Common stock shares issuable upon conversion of debt/convertible securities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentRedemptionDescription" xlink:label="us-gaap_DebtInstrumentRedemptionDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionDescription" xlink:to="us-gaap_DebtInstrumentRedemptionDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentRedemptionDescription_lbl" xml:lang="en-US">Repayment of convertible notes, description</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDefaultShorttermDebtDescriptionOfViolationOrEventOfDefault" xlink:label="us-gaap_DebtDefaultShorttermDebtDescriptionOfViolationOrEventOfDefault" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDefaultShorttermDebtDescriptionOfViolationOrEventOfDefault" xlink:to="us-gaap_DebtDefaultShorttermDebtDescriptionOfViolationOrEventOfDefault_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDefaultShorttermDebtDescriptionOfViolationOrEventOfDefault_lbl" xml:lang="en-US">Event of default, description</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xml:lang="en-US">Conversion Price</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_EventOfDefaultConverstionPriceDescription" xlink:label="COSM_EventOfDefaultConverstionPriceDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_EventOfDefaultConverstionPriceDescription" xlink:to="COSM_EventOfDefaultConverstionPriceDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_EventOfDefaultConverstionPriceDescription_lbl" xml:lang="en-US">Event of default converstion price, description</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_VolumeweightedAveragePriceInPercentage" xlink:label="COSM_VolumeweightedAveragePriceInPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_VolumeweightedAveragePriceInPercentage" xlink:to="COSM_VolumeweightedAveragePriceInPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_VolumeweightedAveragePriceInPercentage_lbl" xml:lang="en-US">Volume-Weighted Average Price in percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AggregateIndebtedness" xlink:label="us-gaap_AggregateIndebtedness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AggregateIndebtedness" xlink:to="us-gaap_AggregateIndebtedness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AggregateIndebtedness_lbl" xml:lang="en-US">Amount of senior secured indebtness</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_CustomaryEventsOfDefaultDescription" xlink:label="COSM_CustomaryEventsOfDefaultDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_CustomaryEventsOfDefaultDescription" xlink:to="COSM_CustomaryEventsOfDefaultDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_CustomaryEventsOfDefaultDescription_lbl" xml:lang="en-US">Customary events of default, description</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeTermOfContract" xlink:label="us-gaap_DerivativeTermOfContract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeTermOfContract" xlink:to="us-gaap_DerivativeTermOfContract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeTermOfContract_lbl" xml:lang="en-US">Maturity period</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConvertibleSecuritiesTermsOfConversionFeature" xlink:label="COSM_ConvertibleSecuritiesTermsOfConversionFeature" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_ConvertibleSecuritiesTermsOfConversionFeature" xlink:to="COSM_ConvertibleSecuritiesTermsOfConversionFeature_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_ConvertibleSecuritiesTermsOfConversionFeature_lbl" xml:lang="en-US">Convertible securities, terms of conversion feature</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_TermsOfBlockerProvision" xlink:label="COSM_TermsOfBlockerProvision" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_TermsOfBlockerProvision" xlink:to="COSM_TermsOfBlockerProvision_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_TermsOfBlockerProvision_lbl" xml:lang="en-US">Terms of Blocker Provision</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_TermsOfAgreement" xlink:label="COSM_TermsOfAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_TermsOfAgreement" xlink:to="COSM_TermsOfAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_TermsOfAgreement_lbl" xml:lang="en-US">Terms of agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConditionalProceedsFromSaleOfCommonStockUnderAgreement" xlink:label="COSM_ConditionalProceedsFromSaleOfCommonStockUnderAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_ConditionalProceedsFromSaleOfCommonStockUnderAgreement" xlink:to="COSM_ConditionalProceedsFromSaleOfCommonStockUnderAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_ConditionalProceedsFromSaleOfCommonStockUnderAgreement_lbl" xml:lang="en-US">Conditional proceeds from sale of common stock under the agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_TermsOfCommission" xlink:label="COSM_TermsOfCommission" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_TermsOfCommission" xlink:to="COSM_TermsOfCommission_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_TermsOfCommission_lbl" xml:lang="en-US">Terms of commission to placement agent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3_lbl" xml:lang="en-US">Credit facility maximum borrowing capacity</link:label>
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AmendmentToCreditFacilityMaximumBorrowingCapacity" xlink:label="COSM_AmendmentToCreditFacilityMaximumBorrowingCapacity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_AmendmentToCreditFacilityMaximumBorrowingCapacity" xlink:to="COSM_AmendmentToCreditFacilityMaximumBorrowingCapacity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_AmendmentToCreditFacilityMaximumBorrowingCapacity_lbl" xml:lang="en-US">Amendment to credit facility maximum borrowing capacity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:to="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_3_lbl" xml:lang="en-US">Gain (Loss) on Sale of Assets and Asset Impairment Charges</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseOther" xlink:to="us-gaap_InterestExpenseOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseOther_2_lbl" xml:lang="en-US">Interest Expense, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_2_lbl" xml:lang="en-US">Interest Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherExpenses" xlink:to="us-gaap_OtherExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherExpenses_2_lbl" xml:lang="en-US">Other Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="us-gaap_OtherOperatingIncomeExpenseNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet_2_lbl" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_2_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Current Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Accounts Payable and Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:to="us-gaap_IncreaseDecreaseInAccruedTaxesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedTaxesPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accrued Taxes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_2_lbl" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfNotesPayable_2_lbl" xml:lang="en-US">Repayments of Notes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_PaymentOfLoansPayable" xlink:to="COSM_PaymentOfLoansPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_PaymentOfLoansPayable_2_lbl" xml:lang="en-US">PaymentOfLoansPayable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_2_lbl" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_2_lbl" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityExpirationDate1" xlink:to="us-gaap_LineOfCreditFacilityExpirationDate1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1_2_lbl" xml:lang="en-US">Line of Credit Facility, Expiration Date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_2_lbl" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2" xlink:to="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2_2_lbl" xml:lang="en-US">SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm" xlink:to="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm_2_lbl" xml:lang="en-US">SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm3" xlink:to="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm3_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm3_2_lbl" xml:lang="en-US">SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm3</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited" xlink:to="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited_2_lbl" xml:lang="en-US">SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised" xlink:to="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised_2_lbl" xml:lang="en-US">SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpired" xlink:to="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpired_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpired_2_lbl" xml:lang="en-US">SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>cosm-20170930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: cosm_10%2Dq1.xfr; Date: 2017%2D11%2D20T00:19:58Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/DocumentAndEntityInformation" xlink:href="cosm-20170930.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/ConsolidatedBalanceSheets" xlink:href="cosm-20170930.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="cosm-20170930.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/ConsolidatedStatementsOfOperationsAndOtherComprehensiveIncomeLoss" xlink:href="cosm-20170930.xsd#ConsolidatedStatementsOfOperationsAndOtherComprehensiveIncomeLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="cosm-20170930.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/BasisOfPresentation" xlink:href="cosm-20170930.xsd#BasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcern" xlink:href="cosm-20170930.xsd#OrganizationNatureOfBusinessAndGoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd." xlink:href="cosm-20170930.xsd#AcquisitionOfDecahedronLtd." xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/PrepaidDeferredFinancingCosts" xlink:href="cosm-20170930.xsd#PrepaidDeferredFinancingCosts" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/IncomeTaxes" xlink:href="cosm-20170930.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/CapitalStructure" xlink:href="cosm-20170930.xsd#CapitalStructure" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/RelatedPartyTransactions" xlink:href="cosm-20170930.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/Debt" xlink:href="cosm-20170930.xsd#Debt" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/CommitmentsAndContingencies" xlink:href="cosm-20170930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrants" xlink:href="cosm-20170930.xsd#StockOptionsAndWarrants" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/SubsequentEvents" xlink:href="cosm-20170930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernPolicies" xlink:href="cosm-20170930.xsd#OrganizationNatureOfBusinessAndGoingConcernPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernTables" xlink:href="cosm-20170930.xsd#OrganizationNatureOfBusinessAndGoingConcernTables" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtdTable" xlink:href="cosm-20170930.xsd#AcquisitionOfDecahedronLtdTable" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsTables" xlink:href="cosm-20170930.xsd#StockOptionsAndWarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernDetails" xlink:href="cosm-20170930.xsd#OrganizationNatureOfBusinessAndGoingConcernDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernDetailsNarrative" xlink:href="cosm-20170930.xsd#OrganizationNatureOfBusinessAndGoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.Details" xlink:href="cosm-20170930.xsd#AcquisitionOfDecahedronLtd.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.Details1" xlink:href="cosm-20170930.xsd#AcquisitionOfDecahedronLtd.Details1" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.Details2" xlink:href="cosm-20170930.xsd#AcquisitionOfDecahedronLtd.Details2" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.DetailsNarrative" xlink:href="cosm-20170930.xsd#AcquisitionOfDecahedronLtd.DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/PrepaidDeferredFinancingCostsDetailsNarrative" xlink:href="cosm-20170930.xsd#PrepaidDeferredFinancingCostsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/IncomeTaxesDetailsNarrative" xlink:href="cosm-20170930.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/CapitalStructureDetailsNarrative" xlink:href="cosm-20170930.xsd#CapitalStructureDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="cosm-20170930.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/DebtDetailsNarrative" xlink:href="cosm-20170930.xsd#DebtDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="cosm-20170930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsDetails" xlink:href="cosm-20170930.xsd#StockOptionsAndWarrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsDetails1" xlink:href="cosm-20170930.xsd#StockOptionsAndWarrantsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsDetails2" xlink:href="cosm-20170930.xsd#StockOptionsAndWarrantsDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsDetailsNarrative" xlink:href="cosm-20170930.xsd#StockOptionsAndWarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://primeestatesdevelopmentsinc.com/role/SubsequentEventsDetailsNarrative" xlink:href="cosm-20170930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DocumentAndEntityInformationAbstract" xlink:label="loc_COSMDocumentAndEntityInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMDocumentAndEntityInformationAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMDocumentAndEntityInformationAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConsolidatedBalanceSheetsAbstract" xlink:label="loc_COSMConsolidatedBalanceSheetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMConsolidatedBalanceSheetsAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryGross" xlink:label="loc_us-gaapInventoryGross" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapInventoryGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_PrepaidDeferredFinancingFees" xlink:label="loc_COSMPrepaidDeferredFinancingFees" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_COSMPrepaidDeferredFinancingFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetIncludingGoodwill" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetIncludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMConsolidatedBalanceSheetsAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilities" xlink:label="loc_us-gaapAccountsPayableAndOtherAccruedLiabilities" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableAndOtherAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LoansPayable" xlink:label="loc_us-gaapLoansPayable" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLoansPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLoansPayable" xlink:label="loc_us-gaapOtherLoansPayable" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherLoansPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxesPayableCurrent" xlink:label="loc_us-gaapTaxesPayableCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapTaxesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMConsolidatedBalanceSheetsAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMConsolidatedBalanceSheetsAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConsolidatedBalanceSheetsParentheticalAbstract" xlink:label="loc_COSMConsolidatedBalanceSheetsParentheticalAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMConsolidatedBalanceSheetsParentheticalAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscountPremiumNet" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscountPremiumNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMConsolidatedBalanceSheetsParentheticalAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/ConsolidatedStatementsOfOperationsAndOtherComprehensiveIncomeLoss" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME (LOSS) (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConsolidatedStatementsOfOperationsAndOtherComprehensiveIncomeLossUnauditedAbstract" xlink:label="loc_COSMConsolidatedStatementsOfOperationsAndOtherComprehensiveIncomeLossUnauditedAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMConsolidatedStatementsOfOperationsAndOtherComprehensiveIncomeLossUnauditedAbstract" xlink:to="loc_us-gaapRevenuesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMConsolidatedStatementsOfOperationsAndOtherComprehensiveIncomeLossUnauditedAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaapOtherDepreciationAndAmortization" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOtherDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="loc_us-gaapGainLossOnSalesOfAssetsAndAssetImpairmentCharges" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="loc_us-gaapOtherIncomeAndExpensesAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMConsolidatedStatementsOfOperationsAndOtherComprehensiveIncomeLossUnauditedAbstract" xlink:to="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaapOtherIncome" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapOtherIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpenseOther" xlink:label="loc_us-gaapInterestExpenseOther" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapInterestExpenseOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherExpenses" xlink:label="loc_us-gaapOtherExpenses" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapOtherExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet" xlink:label="loc_us-gaapOtherOperatingIncomeExpenseNet" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapOtherOperatingIncomeExpenseNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMConsolidatedStatementsOfOperationsAndOtherComprehensiveIncomeLossUnauditedAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossUnrealized" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossUnrealized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConsolidatedStatementsOfCashFlowsUnauditedAbstract" xlink:label="loc_COSMConsolidatedStatementsOfCashFlowsUnauditedAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMConsolidatedStatementsOfCashFlowsUnauditedAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaapOtherDepreciationAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOtherDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="loc_us-gaapGainLossOnSalesOfAssetsAndAssetImpairmentCharges" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedTaxesPayable" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedTaxesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredRevenue" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfAcquisitionCosts" xlink:label="loc_us-gaapAmortizationOfAcquisitionCosts" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfAcquisitionCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfNotesPayable" xlink:label="loc_us-gaapProceedsFromRepaymentsOfNotesPayable" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromRepaymentsOfNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_PaymentOfLoansPayable" xlink:label="loc_COSMPaymentOfLoansPayable" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_COSMPaymentOfLoansPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DeferredFinancingFees" xlink:label="loc_COSMDeferredFinancingFees" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_COSMDeferredFinancingFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromContributedCapital" xlink:label="loc_us-gaapProceedsFromContributedCapital" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromContributedCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashAndCashEquivalents" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaapInterestPaid" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaapIncomeTaxesPaid" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapIncomeTaxesPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AcquisitionOfDecahedron" xlink:label="loc_COSMAcquisitionOfDecahedron" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_COSMAcquisitionOfDecahedron" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ReversalOfProceedsDueFromNoteholderDueToRepaymentOfNote" xlink:label="loc_COSMReversalOfProceedsDueFromNoteholderDueToRepaymentOfNote" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_COSMReversalOfProceedsDueFromNoteholderDueToRepaymentOfNote" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/BasisOfPresentation" xlink:title="00000006 - Disclosure - BASIS OF PRESENTATION">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_NotesToFinancialStatementsAbstract" xlink:label="loc_COSMNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcern" xlink:title="00000007 - Disclosure - ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_NotesToFinancialStatementsAbstract" xlink:label="loc_COSMNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaapNatureOfOperations" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapNatureOfOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd." xlink:title="00000008 - Disclosure - ACQUISITION OF DECAHEDRON, LTD.">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_NotesToFinancialStatementsAbstract" xlink:label="loc_COSMNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_Note3AcquisitionOfDecahedronLtdTextBlock" xlink:label="loc_COSMNote3AcquisitionOfDecahedronLtdTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMNotesToFinancialStatementsAbstract" xlink:to="loc_COSMNote3AcquisitionOfDecahedronLtdTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/PrepaidDeferredFinancingCosts" xlink:title="00000009 - Disclosure - PREPAID DEFERRED FINANCING COSTS">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_NotesToFinancialStatementsAbstract" xlink:label="loc_COSMNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_PrepaidDeferredFinancingCostsTextBlock" xlink:label="loc_COSMPrepaidDeferredFinancingCostsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMNotesToFinancialStatementsAbstract" xlink:to="loc_COSMPrepaidDeferredFinancingCostsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/IncomeTaxes" xlink:title="00000010 - Disclosure - INCOME TAXES">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_NotesToFinancialStatementsAbstract" xlink:label="loc_COSMNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/CapitalStructure" xlink:title="00000011 - Disclosure - CAPITAL STRUCTURE">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_NotesToFinancialStatementsAbstract" xlink:label="loc_COSMNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PartnersCapitalNotesDisclosureTextBlock" xlink:label="loc_us-gaapPartnersCapitalNotesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapPartnersCapitalNotesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/RelatedPartyTransactions" xlink:title="00000012 - Disclosure - RELATED PARTY TRANSACTIONS">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_NotesToFinancialStatementsAbstract" xlink:label="loc_COSMNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/Debt" xlink:title="00000013 - Disclosure - DEBT">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_NotesToFinancialStatementsAbstract" xlink:label="loc_COSMNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/CommitmentsAndContingencies" xlink:title="00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_NotesToFinancialStatementsAbstract" xlink:label="loc_COSMNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrants" xlink:title="00000015 - Disclosure - STOCK OPTIONS AND WARRANTS">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_NotesToFinancialStatementsAbstract" xlink:label="loc_COSMNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfStockByClassTextBlock" xlink:label="loc_us-gaapScheduleOfStockByClassTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapScheduleOfStockByClassTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/SubsequentEvents" xlink:title="00000016 - Disclosure - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_NotesToFinancialStatementsAbstract" xlink:label="loc_COSMNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernPolicies" xlink:title="00000017 - Disclosure - ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (Policies)">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_OrganizationNatureOfBusinessAndGoingConcernPoliciesAbstract" xlink:label="loc_COSMOrganizationNatureOfBusinessAndGoingConcernPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapBasisOfPresentationAndSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMOrganizationNatureOfBusinessAndGoingConcernPoliciesAbstract" xlink:to="loc_us-gaapBasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMOrganizationNatureOfBusinessAndGoingConcernPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMOrganizationNatureOfBusinessAndGoingConcernPoliciesAbstract" xlink:to="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMOrganizationNatureOfBusinessAndGoingConcernPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMOrganizationNatureOfBusinessAndGoingConcernPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PolicyLoansReceivablePolicy" xlink:label="loc_us-gaapPolicyLoansReceivablePolicy" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMOrganizationNatureOfBusinessAndGoingConcernPoliciesAbstract" xlink:to="loc_us-gaapPolicyLoansReceivablePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaapInventoryPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMOrganizationNatureOfBusinessAndGoingConcernPoliciesAbstract" xlink:to="loc_us-gaapInventoryPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_FixedAssetsPolicyTextBlock" xlink:label="loc_COSMFixedAssetsPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMOrganizationNatureOfBusinessAndGoingConcernPoliciesAbstract" xlink:to="loc_COSMFixedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="loc_us-gaapIntangibleAssetsFiniteLivedPolicy" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMOrganizationNatureOfBusinessAndGoingConcernPoliciesAbstract" xlink:to="loc_us-gaapIntangibleAssetsFiniteLivedPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMOrganizationNatureOfBusinessAndGoingConcernPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMOrganizationNatureOfBusinessAndGoingConcernPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMOrganizationNatureOfBusinessAndGoingConcernPoliciesAbstract" xlink:to="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMOrganizationNatureOfBusinessAndGoingConcernPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="loc_us-gaapCompensationRelatedCostsPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMOrganizationNatureOfBusinessAndGoingConcernPoliciesAbstract" xlink:to="loc_us-gaapCompensationRelatedCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMOrganizationNatureOfBusinessAndGoingConcernPoliciesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMOrganizationNatureOfBusinessAndGoingConcernPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMOrganizationNatureOfBusinessAndGoingConcernPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMOrganizationNatureOfBusinessAndGoingConcernPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernTables" xlink:title="00000018 - Disclosure - ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (Tables)">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_OrganizationNatureOfBusinessAndGoingConcernTablesAbstract" xlink:label="loc_COSMOrganizationNatureOfBusinessAndGoingConcernTablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMOrganizationNatureOfBusinessAndGoingConcernTablesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtdTable" xlink:title="00000019 - Disclosure - ACQUISITION OF DECAHEDRON, LTD (Table)">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AcquisitionOfDecahedronLtdTableAbstract" xlink:label="loc_COSMAcquisitionOfDecahedronLtdTableAbstract" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_UnauditedAllocationOfPurchasePriceTableTextBlock" xlink:label="loc_COSMUnauditedAllocationOfPurchasePriceTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMAcquisitionOfDecahedronLtdTableAbstract" xlink:to="loc_COSMUnauditedAllocationOfPurchasePriceTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_IntangibleAssetsTableTextBlock" xlink:label="loc_COSMIntangibleAssetsTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMAcquisitionOfDecahedronLtdTableAbstract" xlink:to="loc_COSMIntangibleAssetsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_UnauditedSupplementalProFormaDataTableTextBlock" xlink:label="loc_COSMUnauditedSupplementalProFormaDataTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMAcquisitionOfDecahedronLtdTableAbstract" xlink:to="loc_COSMUnauditedSupplementalProFormaDataTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsTables" xlink:title="00000020 - Disclosure - STOCK OPTIONS AND WARRANTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_StockOptionsAndWarrantsTablesAbstract" xlink:label="loc_COSMStockOptionsAndWarrantsTablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMStockOptionsAndWarrantsTablesAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_WarrantsWereValuedTableTextBlock" xlink:label="loc_COSMWarrantsWereValuedTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMStockOptionsAndWarrantsTablesAbstract" xlink:to="loc_COSMWarrantsWereValuedTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_WarrantsTableTextBlock" xlink:label="loc_COSMWarrantsTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMStockOptionsAndWarrantsTablesAbstract" xlink:to="loc_COSMWarrantsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernDetails" xlink:title="00000021 - Disclosure - ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (Details)">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_OrganizationAndNatureOfBusinessDetailsAbstract" xlink:label="loc_COSMOrganizationAndNatureOfBusinessDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMOrganizationAndNatureOfBusinessDetailsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernDetailsNarrative" xlink:title="00000022 - Disclosure - ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_OrganizationAndNatureOfBusinessDetailsNarrativeAbstract" xlink:label="loc_COSMOrganizationAndNatureOfBusinessDetailsNarrativeAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMOrganizationAndNatureOfBusinessDetailsNarrativeAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_us-gaapStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaapSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementGeographicalAxis" xlink:to="loc_us-gaapSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_CyprusMember" xlink:label="loc_COSMCyprusMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentGeographicalDomain" xlink:to="loc_COSMCyprusMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_GreeceMember" xlink:label="loc_COSMGreeceMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentGeographicalDomain" xlink:to="loc_COSMGreeceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_UnitedKingdomofEnglandMember" xlink:label="loc_COSMUnitedKingdomofEnglandMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentGeographicalDomain" xlink:to="loc_COSMUnitedKingdomofEnglandMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_StockPurchaseAgreementMember" xlink:label="loc_COSMStockPurchaseAgreementMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_COSMStockPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DecahedronLtdMember" xlink:label="loc_COSMDecahedronLtdMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMDecahedronLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AmplerissimoLtdMember" xlink:label="loc_COSMAmplerissimoLtdMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMAmplerissimoLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTitleOfIndividualAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrencyAxis" xlink:label="loc_us-gaapCurrencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapCurrencyAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AllCurrenciesDomain" xlink:label="loc_COSMAllCurrenciesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCurrencyAxis" xlink:to="loc_COSMAllCurrenciesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityIncorporationStateCountryName" xlink:label="loc_deiEntityIncorporationStateCountryName" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="loc_deiEntityIncorporationDateOfIncorporation" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationDateOfIncorporation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_WorkingCapitalDeficit" xlink:label="loc_COSMWorkingCapitalDeficit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMWorkingCapitalDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DescriptionForPeriodicInventorySystemMaintainance" xlink:label="loc_COSMDescriptionForPeriodicInventorySystemMaintainance" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMDescriptionForPeriodicInventorySystemMaintainance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetImpairment" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetImpairment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ImpairmentOfGoodwillPercent" xlink:label="loc_COSMImpairmentOfGoodwillPercent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMImpairmentOfGoodwillPercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.Details" xlink:title="00000023 - Disclosure - ACQUISITION OF DECAHEDRON, LTD. (Details)">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_NotesToFinancialStatementsAbstract" xlink:label="loc_COSMNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaapRelatedPartyTransactionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DecahedronLtdMember" xlink:label="loc_COSMDecahedronLtdMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_COSMDecahedronLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_PreliminaryAllocationAsOfFebruaryTenTwoThousandSeventeenMember" xlink:label="loc_COSMPreliminaryAllocationAsOfFebruaryTenTwoThousandSeventeenMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_COSMPreliminaryAllocationAsOfFebruaryTenTwoThousandSeventeenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AllocationAdjustmentsMember" xlink:label="loc_COSMAllocationAdjustmentsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_COSMAllocationAdjustmentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_FinalAllocationMember" xlink:label="loc_COSMFinalAllocationMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_COSMFinalAllocationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationLiabilityAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationLiabilityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedValueOfCommonStockIssuedAtAcquisition" xlink:label="loc_COSMBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedValueOfCommonStockIssuedAtAcquisition" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationContingentConsiderationLiabilityAbstract" xlink:to="loc_COSMBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedValueOfCommonStockIssuedAtAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationContingentConsiderationLiabilityAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.Details1" xlink:title="00000024 - Disclosure - ACQUISITION OF DECAHEDRON, LTD. (Details 1)">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_NotesToFinancialStatementsAbstract" xlink:label="loc_COSMNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LicensesMember" xlink:label="loc_COSMLicensesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_COSMLicensesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.Details2" xlink:title="00000025 - Disclosure - ACQUISITION OF DECAHEDRON, LTD. (Details 2)">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_NotesToFinancialStatementsAbstract" xlink:label="loc_COSMNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaapRelatedPartyTransactionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DecahedronLtdMember" xlink:label="loc_COSMDecahedronLtdMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_COSMDecahedronLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProFormaMember" xlink:label="loc_us-gaapProFormaMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_us-gaapProFormaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.DetailsNarrative" xlink:title="00000026 - Disclosure - ACQUISITION OF DECAHEDRON, LTD. (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_NotesToFinancialStatementsAbstract" xlink:label="loc_COSMNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AcquisitionRelatedCostsMember" xlink:label="loc_us-gaapAcquisitionRelatedCostsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_us-gaapAcquisitionRelatedCostsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionNameOfAcquiredEntity" xlink:label="loc_us-gaapBusinessAcquisitionNameOfAcquiredEntity" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionNameOfAcquiredEntity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="loc_us-gaapNumberOfBusinessesAcquired" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNumberOfBusinessesAcquired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:label="loc_us-gaapBusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockOtherSharesOutstanding" xlink:label="loc_us-gaapCommonStockOtherSharesOutstanding" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockOtherSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AdjustmentRelatedToOtherAssetsAndAccountsPayable" xlink:label="loc_COSMAdjustmentRelatedToOtherAssetsAndAccountsPayable" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMAdjustmentRelatedToOtherAssetsAndAccountsPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaRevenue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetImpairment" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetImpairment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ImpairmentOfGoodwillPercent" xlink:label="loc_COSMImpairmentOfGoodwillPercent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMImpairmentOfGoodwillPercent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/PrepaidDeferredFinancingCostsDetailsNarrative" xlink:title="00000027 - Disclosure - PREPAID DEFERRED FINANCING COSTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_NotesToFinancialStatementsAbstract" xlink:label="loc_COSMNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SynthesisManagementLimitedMember" xlink:label="loc_COSMSynthesisManagementLimitedMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMSynthesisManagementLimitedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaapDepositsAssetsNoncurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepositsAssetsNoncurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000028 - Disclosure - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_IncomeTaxesDetailsNarrativeAbstract" xlink:label="loc_COSMIncomeTaxesDetailsNarrativeAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMIncomeTaxesDetailsNarrativeAbstract" xlink:to="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/CapitalStructureDetailsNarrative" xlink:title="00000029 - Disclosure - CAPITAL STRUCTURE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_CapitalStructureDetailsNarrativeAbstract" xlink:label="loc_COSMCapitalStructureDetailsNarrativeAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMCapitalStructureDetailsNarrativeAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareholdersEquityClassAxis" xlink:label="loc_us-gaapShareholdersEquityClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShareholdersEquityClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByShareholdersEquityClassDomain" xlink:label="loc_us-gaapFairValueByShareholdersEquityClassDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareholdersEquityClassAxis" xlink:to="loc_us-gaapFairValueByShareholdersEquityClassDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_PostMergerMember" xlink:label="loc_COSMPostMergerMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByShareholdersEquityClassDomain" xlink:to="loc_COSMPostMergerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_PriorToMergerMember" xlink:label="loc_COSMPriorToMergerMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByShareholdersEquityClassDomain" xlink:to="loc_COSMPriorToMergerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityIssuedInBusinessCombinationMember" xlink:label="loc_us-gaapEquityIssuedInBusinessCombinationMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByShareholdersEquityClassDomain" xlink:to="loc_us-gaapEquityIssuedInBusinessCombinationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DimitriosGoulielmosMember" xlink:label="loc_COSMDimitriosGoulielmosMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByShareholdersEquityClassDomain" xlink:to="loc_COSMDimitriosGoulielmosMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_PotentiallyDilutiveSecuritiesMember" xlink:label="loc_COSMPotentiallyDilutiveSecuritiesMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_COSMPotentiallyDilutiveSecuritiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AmplerissimoLtdMember" xlink:label="loc_COSMAmplerissimoLtdMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMAmplerissimoLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapInvestorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ArKoEuropeanBusinessServicesMember" xlink:label="loc_COSMArKoEuropeanBusinessServicesMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMArKoEuropeanBusinessServicesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DecahedronLtdMember" xlink:label="loc_COSMDecahedronLtdMember" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMDecahedronLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ExchangeAgreementMember" xlink:label="loc_COSMExchangeAgreementMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_COSMExchangeAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConsultingAgreementFourMember" xlink:label="loc_COSMConsultingAgreementFourMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_COSMConsultingAgreementFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConsultingAgreementThreeMember" xlink:label="loc_COSMConsultingAgreementThreeMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_COSMConsultingAgreementThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConsultingAgreementTwoMember" xlink:label="loc_COSMConsultingAgreementTwoMember" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_COSMConsultingAgreementTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConsultingAgreementOneMember" xlink:label="loc_COSMConsultingAgreementOneMember" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_COSMConsultingAgreementOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConsultingAgreementMember" xlink:label="loc_COSMConsultingAgreementMember" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_COSMConsultingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_StockPurchaseAgreementMember" xlink:label="loc_COSMStockPurchaseAgreementMember" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_COSMStockPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="loc_us-gaapDeferredRevenueArrangementTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDeferredRevenueArrangementTypeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="loc_us-gaapDeferredRevenueArrangementTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredRevenueArrangementTypeAxis" xlink:to="loc_us-gaapDeferredRevenueArrangementTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubscriptionArrangementMember" xlink:label="loc_us-gaapSubscriptionArrangementMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredRevenueArrangementTypeDomain" xlink:to="loc_us-gaapSubscriptionArrangementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTitleOfIndividualAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_EmployeeMember" xlink:label="loc_COSMEmployeeMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_COSMEmployeeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreationDateAxis" xlink:label="loc_us-gaapCreationDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapCreationDateAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefaultFinancialStatementsDateMember" xlink:label="loc_us-gaapDefaultFinancialStatementsDateMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreationDateAxis" xlink:to="loc_us-gaapDefaultFinancialStatementsDateMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_OnJanuaryThreeTwoThousandSeventeenMember" xlink:label="loc_COSMOnJanuaryThreeTwoThousandSeventeenMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:to="loc_COSMOnJanuaryThreeTwoThousandSeventeenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_OnJanuaryOneTwoThousandSeventeenMember" xlink:label="loc_COSMOnJanuaryOneTwoThousandSeventeenMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:to="loc_COSMOnJanuaryOneTwoThousandSeventeenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_OnOctoberOneTwoThousandSixteenMember" xlink:label="loc_COSMOnOctoberOneTwoThousandSixteenMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:to="loc_COSMOnOctoberOneTwoThousandSixteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentRepurchaseAgreementDateOfAgreement" xlink:label="loc_investInvestmentRepurchaseAgreementDateOfAgreement" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_investInvestmentRepurchaseAgreementDateOfAgreement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentMaturityDate1" xlink:label="loc_investInvestmentMaturityDate1" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_investInvestmentMaturityDate1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConsultingAgreementPeriod" xlink:label="loc_COSMConsultingAgreementPeriod" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMConsultingAgreementPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaapRestructuringCharges" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRestructuringCharges" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherRestructuringCosts" xlink:label="loc_us-gaapOtherRestructuringCosts" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherRestructuringCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesSubscribedButUnissued" xlink:label="loc_us-gaapCommonStockSharesSubscribedButUnissued" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesSubscribedButUnissued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross" xlink:label="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensationGross" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensationGross" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000030 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_RelatedPartyTransactionsDetailsNarrativeAbstract" xlink:label="loc_COSMRelatedPartyTransactionsDetailsNarrativeAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMRelatedPartyTransactionsDetailsNarrativeAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DimitriosGoulielmosMember" xlink:label="loc_COSMDimitriosGoulielmosMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMDimitriosGoulielmosMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_KonstantinosVassilopoulosMember" xlink:label="loc_COSMKonstantinosVassilopoulosMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMKonstantinosVassilopoulosMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_OuraniaMatsoukiMember" xlink:label="loc_COSMOuraniaMatsoukiMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMOuraniaMatsoukiMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_MrSiokasMember" xlink:label="loc_COSMMrSiokasMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMMrSiokasMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_GrigoriosSiokasMember" xlink:label="loc_COSMGrigoriosSiokasMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMGrigoriosSiokasMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DocPharmaSaMember" xlink:label="loc_COSMDocPharmaSaMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMDocPharmaSaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnderlyingAssetClassAxis" xlink:label="loc_us-gaapUnderlyingAssetClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapUnderlyingAssetClassAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnderlyingAssetClassDomain" xlink:label="loc_us-gaapUnderlyingAssetClassDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapUnderlyingAssetClassAxis" xlink:to="loc_us-gaapUnderlyingAssetClassDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LoansPayableMember" xlink:label="loc_us-gaapLoansPayableMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapUnderlyingAssetClassDomain" xlink:to="loc_us-gaapLoansPayableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreationDateAxis" xlink:label="loc_us-gaapCreationDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapCreationDateAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefaultFinancialStatementsDateMember" xlink:label="loc_us-gaapDefaultFinancialStatementsDateMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreationDateAxis" xlink:to="loc_us-gaapDefaultFinancialStatementsDateMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_OnOctoberOneTwoThousandSixteenMember" xlink:label="loc_COSMOnOctoberOneTwoThousandSixteenMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:to="loc_COSMOnOctoberOneTwoThousandSixteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_OnNovemberOneTwoThousandsFifteenMember" xlink:label="loc_COSMOnNovemberOneTwoThousandsFifteenMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:to="loc_COSMOnNovemberOneTwoThousandsFifteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementMember" xlink:label="loc_COSMLoanAgreementMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_COSMLoanAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaapRelatedPartyTransactionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DirectorsAndOfficersLiabilityInsuranceMember" xlink:label="loc_us-gaapDirectorsAndOfficersLiabilityInsuranceMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_us-gaapDirectorsAndOfficersLiabilityInsuranceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTitleOfIndividualAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_MediHelmSAMember" xlink:label="loc_COSMMediHelmSAMember" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_COSMMediHelmSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentDecreaseForgiveness" xlink:label="loc_us-gaapDebtInstrumentDecreaseForgiveness" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentDecreaseForgiveness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DebtInstrumentDecreaseAccruedInterestForgiveness" xlink:label="loc_COSMDebtInstrumentDecreaseAccruedInterestForgiveness" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMDebtInstrumentDecreaseAccruedInterestForgiveness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidInterest" xlink:label="loc_us-gaapPrepaidInterest" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPrepaidInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DescriptionForPrepaidBalancePercentage" xlink:label="loc_COSMDescriptionForPrepaidBalancePercentage" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMDescriptionForPrepaidBalancePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_PaymentOfMiscellaneousBills" xlink:label="loc_COSMPaymentOfMiscellaneousBills" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMPaymentOfMiscellaneousBills" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="loc_us-gaapLineOfCreditFacilityInterestRateDuringPeriod" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityInterestRateDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockOtherValueOutstanding" xlink:label="loc_us-gaapCommonStockOtherValueOutstanding" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockOtherValueOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/DebtDetailsNarrative" xlink:title="00000031 - Disclosure - DEBT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DebtDetailsNarrativeAbstract" xlink:label="loc_COSMDebtDetailsNarrativeAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMDebtDetailsNarrativeAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_BridgeLoansMember" xlink:label="loc_COSMBridgeLoansMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_COSMBridgeLoansMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SecondAmendmentToLoanFacilityAgreementMember" xlink:label="loc_COSMSecondAmendmentToLoanFacilityAgreementMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_COSMSecondAmendmentToLoanFacilityAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AmendmentToLoanFacilityAgreementMember" xlink:label="loc_COSMAmendmentToLoanFacilityAgreementMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_COSMAmendmentToLoanFacilityAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanFacilityAgreementMember" xlink:label="loc_COSMLoanFacilityAgreementMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_COSMLoanFacilityAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementElevenMember" xlink:label="loc_COSMLoanAgreementElevenMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_COSMLoanAgreementElevenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementTenMember" xlink:label="loc_COSMLoanAgreementTenMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_COSMLoanAgreementTenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementNineMember" xlink:label="loc_COSMLoanAgreementNineMember" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_COSMLoanAgreementNineMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementEightMember" xlink:label="loc_COSMLoanAgreementEightMember" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_COSMLoanAgreementEightMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementSevenMember" xlink:label="loc_COSMLoanAgreementSevenMember" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_COSMLoanAgreementSevenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementSixMember" xlink:label="loc_COSMLoanAgreementSixMember" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_COSMLoanAgreementSixMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementFiveMember" xlink:label="loc_COSMLoanAgreementFiveMember" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_COSMLoanAgreementFiveMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementFourMember" xlink:label="loc_COSMLoanAgreementFourMember" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_COSMLoanAgreementFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementThreeMember" xlink:label="loc_COSMLoanAgreementThreeMember" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_COSMLoanAgreementThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementTwoMember" xlink:label="loc_COSMLoanAgreementTwoMember" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_COSMLoanAgreementTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LoanAgreementOneMember" xlink:label="loc_COSMLoanAgreementOneMember" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_COSMLoanAgreementOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DecahedronMember" xlink:label="loc_COSMDecahedronMember" />
      <link:presentationArc order="620" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_COSMDecahedronMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SkyPharmMember" xlink:label="loc_COSMSkyPharmMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMSkyPharmMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_GrigoriosSiokasMember" xlink:label="loc_COSMGrigoriosSiokasMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMGrigoriosSiokasMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_PanagiotisDrakopoulosMember" xlink:label="loc_COSMPanagiotisDrakopoulosMember" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMPanagiotisDrakopoulosMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AngeloDrakopoulosMember" xlink:label="loc_COSMAngeloDrakopoulosMember" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMAngeloDrakopoulosMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SynthesisFacilityAgreementMember" xlink:label="loc_COSMSynthesisFacilityAgreementMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_COSMSynthesisFacilityAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_PaymentOfMiscellaneousBills" xlink:label="loc_COSMPaymentOfMiscellaneousBills" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMPaymentOfMiscellaneousBills" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="loc_us-gaapLineOfCreditFacilityInterestRateDuringPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityInterestRateDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="loc_us-gaapLineOfCreditFacilityExpirationDate1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityExpirationDate1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AmendedMaturityDate" xlink:label="loc_COSMAmendedMaturityDate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMAmendedMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRepaymentsOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfAccountsReceivableSecuritization" xlink:label="loc_us-gaapRepaymentsOfAccountsReceivableSecuritization" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRepaymentsOfAccountsReceivableSecuritization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityDescription" xlink:label="loc_us-gaapLineOfCreditFacilityDescription" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_CreditFaciltyOriginationFeePercentage" xlink:label="loc_COSMCreditFaciltyOriginationFeePercentage" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMCreditFaciltyOriginationFeePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_MonthlyCreditFeePercentage" xlink:label="loc_COSMMonthlyCreditFeePercentage" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMMonthlyCreditFeePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfDeferredLoanOriginationFeesNet" xlink:label="loc_us-gaapAmortizationOfDeferredLoanOriginationFeesNet" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfDeferredLoanOriginationFeesNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000032 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_NotesToFinancialStatementsAbstract" xlink:label="loc_COSMNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_CCPharmaGmbHMember" xlink:label="loc_COSMCCPharmaGmbHMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMCCPharmaGmbHMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember" xlink:label="loc_COSMAnastasiosTsekasAndOlgaPartheneaGeorgatwouMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMAnastasiosTsekasAndOlgaPartheneaGeorgatwouMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SkyPharmMember" xlink:label="loc_COSMSkyPharmMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMSkyPharmMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AmplerissimoMember" xlink:label="loc_COSMAmplerissimoMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMAmplerissimoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaapRelatedPartyTransactionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_DecahedronMember" xlink:label="loc_COSMDecahedronMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_COSMDecahedronMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_IntellectualPropertySaleAgreementMember" xlink:label="loc_COSMIntellectualPropertySaleAgreementMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_COSMIntellectualPropertySaleAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreationDateAxis" xlink:label="loc_us-gaapCreationDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapCreationDateAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefaultFinancialStatementsDateMember" xlink:label="loc_us-gaapDefaultFinancialStatementsDateMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreationDateAxis" xlink:to="loc_us-gaapDefaultFinancialStatementsDateMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_OnOctoberOneTwoThousandSixteenMember" xlink:label="loc_COSMOnOctoberOneTwoThousandSixteenMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:to="loc_COSMOnOctoberOneTwoThousandSixteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseArrangementTypeAxis" xlink:label="loc_us-gaapLeaseArrangementTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapLeaseArrangementTypeAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseArrangementTypeDomain" xlink:label="loc_us-gaapLeaseArrangementTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeaseArrangementTypeAxis" xlink:to="loc_us-gaapLeaseArrangementTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConclusionOfPhaseThreeTestingMember" xlink:label="loc_COSMConclusionOfPhaseThreeTestingMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeaseArrangementTypeDomain" xlink:to="loc_COSMConclusionOfPhaseThreeTestingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConclusionOfPhaseTwoTestingMember" xlink:label="loc_COSMConclusionOfPhaseTwoTestingMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeaseArrangementTypeDomain" xlink:to="loc_COSMConclusionOfPhaseTwoTestingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConclusionOfPhaseOneTestingMember" xlink:label="loc_COSMConclusionOfPhaseOneTestingMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeaseArrangementTypeDomain" xlink:to="loc_COSMConclusionOfPhaseOneTestingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConclusionOfPreclinicalTrialsMember" xlink:label="loc_COSMConclusionOfPreclinicalTrialsMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeaseArrangementTypeDomain" xlink:to="loc_COSMConclusionOfPreclinicalTrialsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AdditionalSpaceMember" xlink:label="loc_COSMAdditionalSpaceMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeaseArrangementTypeDomain" xlink:to="loc_COSMAdditionalSpaceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_FirstFloorMember" xlink:label="loc_COSMFirstFloorMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeaseArrangementTypeDomain" xlink:to="loc_COSMFirstFloorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_OperatingLeasePeriodicPayment" xlink:label="loc_COSMOperatingLeasePeriodicPayment" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMOperatingLeasePeriodicPayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_FrequencyOfPeriodicPayment" xlink:label="loc_COSMFrequencyOfPeriodicPayment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMFrequencyOfPeriodicPayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="loc_us-gaapOperatingLeasesRentExpenseNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeasesRentExpenseNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="loc_us-gaapLeaseExpirationDate1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLeaseExpirationDate1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AmendmentToMaturityDate" xlink:label="loc_COSMAmendmentToMaturityDate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMAmendmentToMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract" xlink:label="loc_us-gaapLesseeLeasingArrangementsOperatingLeasesTermOfContract" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeLeasingArrangementsOperatingLeasesTermOfContract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsFromFranchiseAgreements" xlink:label="loc_us-gaapCommitmentsFromFranchiseAgreements" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommitmentsFromFranchiseAgreements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_NonrefundableFee" xlink:label="loc_COSMNonrefundableFee" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMNonrefundableFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostsAndExpenses" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsDetails" xlink:title="00000033 - Disclosure - STOCK OPTIONS AND WARRANTS (Details)">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_StockOptionsAndWarrantsDetails2Abstract" xlink:label="loc_COSMStockOptionsAndWarrantsDetails2Abstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMStockOptionsAndWarrantsDetails2Abstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OptionMember" xlink:label="loc_us-gaapOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_WeightedAverageRemainingContractualTerm" xlink:label="loc_COSMWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMWeightedAverageRemainingContractualTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMWeightedAverageRemainingContractualTerm" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2" xlink:label="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMWeightedAverageRemainingContractualTerm" xlink:to="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm" xlink:label="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMWeightedAverageRemainingContractualTerm" xlink:to="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMWeightedAverageRemainingContractualTerm" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm3" xlink:label="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm3" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMWeightedAverageRemainingContractualTerm" xlink:to="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMWeightedAverageRemainingContractualTerm" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4" xlink:label="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMWeightedAverageRemainingContractualTerm" xlink:to="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited" xlink:label="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:to="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised" xlink:label="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:to="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpired" xlink:label="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpired" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:to="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpired" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_2" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsDetails1" xlink:title="00000034 - Disclosure - STOCK OPTIONS AND WARRANTS (Details 1)">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_StockOptionsAndWarrantsDetails1Abstract" xlink:label="loc_COSMStockOptionsAndWarrantsDetails1Abstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMStockOptionsAndWarrantsDetails1Abstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm" xlink:label="loc_us-gaapFairValueAssumptionsExpectedTerm" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAssumptionsExpectedTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsDetails2" xlink:title="00000035 - Disclosure - STOCK OPTIONS AND WARRANTS (Details 2)">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_StockOptionsAndWarrantsDetails2Abstract" xlink:label="loc_COSMStockOptionsAndWarrantsDetails2Abstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMStockOptionsAndWarrantsDetails2Abstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_WeightedAverageRemainingContractualTerm" xlink:label="loc_COSMWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMWeightedAverageRemainingContractualTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMWeightedAverageRemainingContractualTerm" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2" xlink:label="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMWeightedAverageRemainingContractualTerm" xlink:to="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm" xlink:label="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMWeightedAverageRemainingContractualTerm" xlink:to="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMWeightedAverageRemainingContractualTerm" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm3" xlink:label="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm3" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMWeightedAverageRemainingContractualTerm" xlink:to="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMWeightedAverageRemainingContractualTerm" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4" xlink:label="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMWeightedAverageRemainingContractualTerm" xlink:to="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited" xlink:label="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:to="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised" xlink:label="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:to="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpired" xlink:label="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpired" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:to="loc_COSMSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpired" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_2" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsDetailsNarrative" xlink:title="00000036 - Disclosure - STOCK OPTIONS AND WARRANTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_StockOptionsAndWarrantsDetails2Abstract" xlink:label="loc_COSMStockOptionsAndWarrantsDetails2Abstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMStockOptionsAndWarrantsDetails2Abstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_MrOrestesVarvitsiotesMember" xlink:label="loc_COSMMrOrestesVarvitsiotesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_COSMMrOrestesVarvitsiotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_EmployeeMember" xlink:label="loc_COSMEmployeeMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_COSMEmployeeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_InternationalFinanceManagerMember" xlink:label="loc_COSMInternationalFinanceManagerMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_COSMInternationalFinanceManagerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_UsFinanceManagerMember" xlink:label="loc_COSMUsFinanceManagerMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_COSMUsFinanceManagerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreationDateAxis" xlink:label="loc_us-gaapCreationDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapCreationDateAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefaultFinancialStatementsDateMember" xlink:label="loc_us-gaapDefaultFinancialStatementsDateMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreationDateAxis" xlink:to="loc_us-gaapDefaultFinancialStatementsDateMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_JanuaryThreeTwoThousandSeventeenMember" xlink:label="loc_COSMJanuaryThreeTwoThousandSeventeenMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:to="loc_COSMJanuaryThreeTwoThousandSeventeenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_JanuaryOneTwoThousandSeventeenMember" xlink:label="loc_COSMJanuaryOneTwoThousandSeventeenMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:to="loc_COSMJanuaryOneTwoThousandSeventeenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_OnJanuaryOneTwoThousandSeventeenMember" xlink:label="loc_COSMOnJanuaryOneTwoThousandSeventeenMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:to="loc_COSMOnJanuaryOneTwoThousandSeventeenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_OnOctoberOneTwoThousandSixteenMember" xlink:label="loc_COSMOnOctoberOneTwoThousandSixteenMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:to="loc_COSMOnOctoberOneTwoThousandSixteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapInvestorMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AegisCapitalCorpMember" xlink:label="loc_COSMAegisCapitalCorpMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_COSMAegisCapitalCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaapStockOptionPlanExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockOptionPlanExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_StockOptionPeriodicVesting" xlink:label="loc_COSMStockOptionPeriodicVesting" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMStockOptionPeriodicVesting" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_FrequencyOfPeriodicVesting" xlink:label="loc_COSMFrequencyOfPeriodicVesting" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMFrequencyOfPeriodicVesting" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConsiderationUnderAgreement" xlink:label="loc_COSMConsiderationUnderAgreement" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMConsiderationUnderAgreement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ShareBasedCompensationAsAnnualRetainer" xlink:label="loc_COSMShareBasedCompensationAsAnnualRetainer" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMShareBasedCompensationAsAnnualRetainer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_WarrantsIssuedRatioDescription" xlink:label="loc_COSMWarrantsIssuedRatioDescription" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMWarrantsIssuedRatioDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://primeestatesdevelopmentsinc.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000037 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_NotesToFinancialStatementsAbstract" xlink:label="loc_COSMNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_COSMNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis" xlink:label="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain" xlink:label="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentAxis" xlink:to="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_TradeFacilityAgreementMember" xlink:label="loc_COSMTradeFacilityAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentDomain" xlink:to="loc_COSMTradeFacilityAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SecuritiesPurchaseAgreementMember" xlink:label="loc_COSMSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentDomain" xlink:to="loc_COSMSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_StockPurchaseAgreementMember" xlink:label="loc_COSMStockPurchaseAgreementMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPurchaseCommitmentExcludingLongtermCommitmentDomain" xlink:to="loc_COSMStockPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeniorNotesMember" xlink:label="loc_us-gaapSeniorNotesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_us-gaapSeniorNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SeniorConvertibleNoteOneMember" xlink:label="loc_COSMSeniorConvertibleNoteOneMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_COSMSeniorConvertibleNoteOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_SeniorConvertibleNoteTwoMember" xlink:label="loc_COSMSeniorConvertibleNoteTwoMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_COSMSeniorConvertibleNoteTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTitleOfIndividualAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_InstitutionalInvestorsMember" xlink:label="loc_COSMInstitutionalInvestorsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_COSMInstitutionalInvestorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_RegistrationRightsAgreementMember" xlink:label="loc_COSMRegistrationRightsAgreementMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_COSMRegistrationRightsAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_LeakOutAgreementMember" xlink:label="loc_COSMLeakOutAgreementMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_COSMLeakOutAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapInvestorMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_CommonStockSharesAcquiredForConsiderationValue" xlink:label="loc_COSMCommonStockSharesAcquiredForConsiderationValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMCommonStockSharesAcquiredForConsiderationValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_CommonStockSharesAcquiredForConsiderationShares" xlink:label="loc_COSMCommonStockSharesAcquiredForConsiderationShares" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMCommonStockSharesAcquiredForConsiderationShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConvertibleNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentRedemptionDescription" xlink:label="loc_us-gaapDebtInstrumentRedemptionDescription" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentRedemptionDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDefaultShorttermDebtDescriptionOfViolationOrEventOfDefault" xlink:label="loc_us-gaapDebtDefaultShorttermDebtDescriptionOfViolationOrEventOfDefault" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtDefaultShorttermDebtDescriptionOfViolationOrEventOfDefault" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_EventOfDefaultConverstionPriceDescription" xlink:label="loc_COSMEventOfDefaultConverstionPriceDescription" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMEventOfDefaultConverstionPriceDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_VolumeweightedAveragePriceInPercentage" xlink:label="loc_COSMVolumeweightedAveragePriceInPercentage" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMVolumeweightedAveragePriceInPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AggregateIndebtedness" xlink:label="loc_us-gaapAggregateIndebtedness" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAggregateIndebtedness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_CustomaryEventsOfDefaultDescription" xlink:label="loc_COSMCustomaryEventsOfDefaultDescription" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMCustomaryEventsOfDefaultDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeTermOfContract" xlink:label="loc_us-gaapDerivativeTermOfContract" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeTermOfContract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConvertibleSecuritiesTermsOfConversionFeature" xlink:label="loc_COSMConvertibleSecuritiesTermsOfConversionFeature" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMConvertibleSecuritiesTermsOfConversionFeature" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_TermsOfBlockerProvision" xlink:label="loc_COSMTermsOfBlockerProvision" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMTermsOfBlockerProvision" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_TermsOfAgreement" xlink:label="loc_COSMTermsOfAgreement" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMTermsOfAgreement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_ConditionalProceedsFromSaleOfCommonStockUnderAgreement" xlink:label="loc_COSMConditionalProceedsFromSaleOfCommonStockUnderAgreement" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMConditionalProceedsFromSaleOfCommonStockUnderAgreement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_TermsOfCommission" xlink:label="loc_COSMTermsOfCommission" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMTermsOfCommission" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="cosm-20170930.xsd#COSM_AmendmentToCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_COSMAmendmentToCreditFacilityMaximumBorrowingCapacity" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_COSMAmendmentToCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>cosm_ex101img1.jpg
<TEXT>
begin 644 cosm_ex101img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 1, R # 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ JM??\ 'A<_]<F_D:LU6OO^/"Y_ZY-_(T 6:*** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "JU]_QX7/\ UR;^1JS5:^_X\+G_ *Y-_(T 6:*** "BBB@ HHHH
M **** "BBB@ HHHH **** "BD(S2T %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 56OO^/"Y_ZY-_(U9JM??\>%S_UR;^1H LT444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %5K[_ (\+G_KDW\C5FJU]_P >%S_UR;^1H LT444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%5K[_CPN?^N3?R-6:K7W_'A<_P#7)OY&@"S1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 56OO
M^/"Y_P"N3?R-6:K7W_'A<_\ 7)OY&@"S1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445
M2GU*W@;:6W'/('.*3:6X%VBJ\%S%<#,;@XZC/(JQ0G< HHHI@%%%% !13'D6
M-=SL%4=R:KG4;4$CS0<=<4 6Z*CCGBE^Y(K?0U)0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 56OO^/"Y_ZY-_(U9JM??\>%S_UR;^1H LT444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !114<LT<
M*%Y& 44 245A76MYXMN.VYA3;'49VEPS;P?4]*S=6*=BN1DVI2WR[@H'D^J]
M:S8+*6Y4E?O=>:N:BMZY8E28ST"U1M+Q[20$<J>HKGJ2O+R-(KW=!Q\ZS?D%
M&[UH6NKN !,,CUJU%<VM\H5@,GL:K7&D#):!B/5332E'6+N3=/1FG%/',,HP
M/'2IJY@K<6K]&4BK]KJ;C DY'K6D:RVEH)PZHV:BN9A;V[RD9"C-+%,DR[D.
M13+N'[1:R0_WQBMT[D&=;6YU*/S[EFVM]U<\5=_LRSQCR5Q6?9WDFGQ+!=Q,
M .%8<\5.-<M3V?'J5H$2G2X%R8<QMV*FI[6*6)"LLGF'/!]JB35;1VP) #[U
M;5@PRIR*!D$-Y'/*\0R'0\@U9K-U&WD&+FVXE7DX[BIX;Z)[4S%L;1\P]* )
M9[E+<+NR2QP *BN;^*U9%D!RW3 JO9QR7,_VN<$=HU]!4.J()-2LD(!!)S]*
M -='#H&4Y!Z4ZL5#+I5UA@S6KG@_W:V%8,H8'(/2@"(W*"Z%O_&5W?A4<MZ8
MI3']GE;'<+Q4#?\ (>3C_EE_4UI4 4)-3CA16>.10?5:5-0\Q<K;RD=CMZU#
MK@_T D<8(J[9X^QPX_N"@ AN#*Q!B=,?WA1#<QSNZIG*'!S4QZ5DZ2=UU=GM
MO(_6@#7J*>9;>%I7^ZHR<5+5+5"!I\W^[0 Y[^%+(71SY9'''--_M!2BL(96
M#=,(:H7>/[!AX[+_ "K4L@!90@]D% #/MO\ TPF_[X-2P7'G@GRW3']X8J:B
M@"&:XC@7,C8]N]5?[1<GY+29E[-BH8G5]9F64_,  @/I6KP!QB@"I_:$2A?,
M5XR3CYEQ5GS5\HR Y4#.12LBN,, 0:BF54M)%48 4XQ0 MO<)<Q>9'G;TID]
MY# =K$LW]U>35?2,?8.!_$:AT?:QF:3!F\PY)ZXH F_M&;S,?8IMN?O8J9-0
M@9MC-L;.,/Q5NF-&C')4''M0 ^BD%+0 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %5K[_CPN?\ KDW\C5FJ
MU]_QX7/_ %R;^1H LT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !VKE/$TKQWL(5F ,?X=375]JX[Q43
M_:4 '_/+U]S45/@94=RDLZE5!XQZ5/#+LPR'H<CFJ$<3R1DKSCJ!2+*8^,8'
MH:X3H.NM=7BE 28;3CKVI]UIUM,AE3@]<BN7BN%8_,,'M5V*\EC!56^0]LU?
M/I9D.#6QJ6421S)MK:KG]/N5\U58@'-;$MTJ$!?F)]*TI223N1-.Y)*D;H1)
M@KWK)EM8 ^8V;%3O)),PP2?84-$\4>6P,]JFI)2V015BQ8*%5@O2KU5+/.#4
MMU&\MNZ1N48C@BNBE\)$MR4@'KBH_(BR?D7GKQ68EU?6AVW$1E4#[RU8&KVW
M.[>I'8K6@B273K60-F, GN*JZ6S1SSV^YF5#QFG2ZA+.I2TB8L?XB*GT^R-M
M&2YS(W4T 7:P9[9?[96%>$<!G7/6MVL:>-SXCB?:=@C'('N: -E5"J .@K-O
MC_Q,K0': 2>M:=9UXK-J5J<<#.: +D\"7$+1OT-9D%U)I]P+6Z_U9_U;UL5!
M=6L=U$4D'T/I0!39E.NQ8ZF+K^=:=8MC!/%J6V7)"+A6(ZBMJ@#+UW_D'M]:
MN60Q90C_ &!5/74=[#"#)S5RT!%G"#U"#/Y4 3GI6#I]N9[J\S*R8<XV\=ZW
MCTK,TQ"D]UE<9<]NM $HTXY/^E3'/O5?4;/R[!V,TC[1T)ZUKU2U/)TZ7:"3
MCC H IW@ T.,-Z"GVVFEK>-OM4P!4< ]*9>*YT2)0"6PN?RJ>VOXH[:)'9BP
M4 _+0!-;V)@93Y\C[?[QS5RJGV^(==WY5+#<)/N"@\>HH CN;&*Y8.25<=&%
M5CILP&%O91SQFEEN;NVG9GC\R G@J.14G]JVP4%F*D]B* ('M[ZVB+I<^9MY
MVL.M20W9N],DD(VL 01[TDU^;B-H[5&9V'!(P*?':FWTV1&.78$M]: #2238
MKG@Y-+-IL3S><CM&_<J>M1:4KKII"C#Y.,^M$5[=0L5NX3@='3H: %:PN?X+
MUQ]1FF3?;;*(2>:)E7[VX8JQ_:MJ!RY'X57N;B6^_<6\;;"<,Y'% &E#()8E
M<?Q#-/ID2".)4'\(Q3Z "BBB@ HHHH **** "BBB@ I#TI:* #H**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ JM??\ 'A<_]<F_D:LU6OO^/"Y_
MZY-_(T 6:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ KC?%0SJD(Y'[D<_B:[&L/7-'DOG6>(C<B[=M1
M43<6D5%V9D:/%YH?:>16C-I,<RY?._U%8:^?82?Q1MWS6M::RK+B?@^H[UQ+
MS-G?=&=<Z3/; [5WKZCTJO&^PXS^!KKXVCF3<I!!%4[O289@67Y7ZY%-Q[!S
M]&5[2("/<5!)YR15V.%W.3PM0QH%CVD=!BK\; 0]>U)(4F2P*D?W1^-,O"&
MPW2H3<<X4X!J,X9CU/&<UHY:<J(MK<NV0(SZ5;)(' S56S/##O4\DFP9ZY.
M/6NBE\)$MQGF2?\ /%OTI#DGFW)]^*>7D!^YQ[=:?O &6XK01$KOG'DD"G&2
M3_GD:42H1D-D$9S2B5",AN/I0 SS),?ZHTI>3C]V:>'4G (S2Y .,T 1EY>T
M?ZTC22CI$3^-*9HP<;OR%/W+C.: &!Y,<Q_K2&20?\LB:>)$;H<TX$$9!S0!
M%OD_YY'\Z"\O/[O]:>9$!P6YH$B$XS0 S?)WB-*'?O&13O,0C(.1[4N]1WH
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M;^1JS5:^_P"/"Y_ZY-_(T 6:*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@!.U5WNH8Y1$S@2$9 )[59KE
MO$D<@O8Y@IV"/;N'8Y-3-M*Z&E=FQ=0Q70"3(&!Z8K O=$=#FWPR_P!W/-%I
MJTL&!)\Z>_45KV^H6]UC:^&]#7&WS;FJO$YR&6YLY!AF0C^$]*V+;68Y $F^
M5NF>U6KVSBGMW9E^8*2"*Y3;ENIX-3JBU:1TX(;D'/I4RJTF!STJ"W7]W&<\
M;16U'&H5< =*NG3<B)2L5HK0#&\# I+E5C0!!CV%7<55NARO&3FMI4U&&AGS
M-O4=:#Y>M/F174;CM(.0<]Z+="BX(Q4K*&&",UI3345<3W*S1SJ=_P!HRH'0
M@5+&YD@5R,$CI3O*7N"?QI^.,8JQ%6$$:<HQ@A*4LR6ZD 8QSQG%6=HQC'%&
M!C&* *L2[+C .5V#!I;DD[@I^;8>1VJ9HD;&1TZ4*D<?I^)H 2+8(AMQC%2#
M;CC&/:HC%$3V^@-2J !@4 0P#_6?[U%L?W//7)_G4P4#..]1M A;=@Y]C0!!
MS]K'?+G^5.<[IO+;@@9''6K 4<<=*4J#R0* (+48@ Z\G^=+_P O>.,;.GXU
M*$51@#%&!NW8YZ9H BE'SQ[1SFIZ;@"EW#UH AR%NB6/4<5*74#DBAE5Q@C-
M,$$8(..GO0!&0&NU+=-ORTMRH,?R\.#Q4LD:R+AA35@16W '/N: *Y_=.\V#
M][#?2FN!O$I^\XXSV%7MH(P1G-(44]0* *T684V+T(^6F(BH9%R<;OFJ[M'I
MTZ4FQ>>.O6@!"J%,$#;56'[\8.2 6VY].*L>0GO],T_8...G2@"*?*A2@&[<
M/RHM^8SD=ZEVC.:4  <#% $-L%\H8 QDXP*:P*3A5^Z_4>E3JH484<4I4$@G
MJ.E  !@8I:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ JM??\>%S_ -<F_D:LU6OO^/"Y_P"N3?R- %FB
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *8\:2*5=0P/8T^B@#"O/#T;[GMFV,?X3TK GM+BS<!D92#P
M>U=Y3'C21<.H(/J*RG2C(N,VCCX=5G$9BE^92".>M9XSNSVS737V@+)\ULVQ
MNZGH:Q9K&>VP)TV\\'M7-.G*.YM&46;=N,QQY]!6TOW1]*SK2)FCC('0#FM(
M=*WH+0QF]1:0J"<D4M%;D"4M%% !1110 4444 %1O$C<E<FI*0]#0!6MHT>W
M1B,GUS3XY@S2 N/E;'TIUNAC@5#C(]*(X@N_.#N;/2@ 1R=Q/0=#44<DGG9<
MY1_N^U2>2?*,>[@_RI)+=6C"KP5^Z?2@!5D+3NO8"FR2M&Q! QM)!I55UF+8
M!!'KWI7C+Y)_ND 4 .CD#JIW DC-25%&&55!0# QUJ6@"M<D;H002"_./H:>
M@0G 4CZ@TLB%GC(/"G)J6@"H\LGF,B 9# <CVJ8RYB+ <CJ*;L/G%AZ@_I23
MPLRYC;:_\Z %GD8 (GWSTI/.8VV_HPXY]:7R TI=\' POL*1H<*ZKC#=J 'I
M(<%6QO'6F+*TA51@'&6/I4DL9=#M(#=C42PM&5<'+!<$=C0!*$=3G>6'O3(9
MA(IRP!!Q3PTA/*A1]<TR)&C7&P'GKF@">BD!R.F*6@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *K7W_'A<_P#7)OY&K-5K[_CPN?\ KDW\C0!9HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *9)$DJ[74,/0T^B@!JH%4!1@#I3J** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH 2EHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MWTBS#?#D;&4GC(.<_CQ6U8SFXM(Y222PR<C% %FBBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 56OO^/"Y_P"N3?R-6:K7W_'A<_\
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MF^;'&D!5-JE<DGH:GN;^*UQYBR8_O*A('.*JVVL)<WAMQ&/O,N0X)X..1VH
M?#H]O#;11#.Z-54.#S\HP*=_8UK@@!@K_?&?O_6M&B@"E<69FV;64;05^90>
M*F@@\A @=F4*  ?:IZ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !5:^_X\+G_ *Y-_(U9JM??\>%S_P!<F_D: +-%%% !1110 4444 %%%% !
M1110!0N[65I4GMV D4;65NC+Z53@T>50_FRJ=[LP"KC9E<8%;=% &!)I%Q+&
M/WFV2,!4.[.0#^E/&F72R1W*LOG G<C'((QCK6Y10!A+I4Z7SS&0,LQ5I!G
M4@=AWZ5NT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 56OO^/"Y_
MZY-_(U9JM??\>%S_ -<F_D: +-%%% !1110 4444 %%%% !14%Q=P6H!FD"9
MZ9J :K9$ ^>.>G!I-I 7:*I-JMDHR9QCZ&C^U;+9N\\8^AI<R[CLR]15 ZK9
M#_EN/P!IRZG:-TF'X@T[H5B[15'^U+/=M\\9/L:<=2M0.9A^5',@L7**I?VG
M9XSYPQ]#0-2LR,B8?D:+H+%VBJ7]I69.//''L:7^T[,])U_(T706+E%5/[1M
M<X\Y<TX7]J?^6RT70[,LT56_M"U/_+9:/M]K_P ]EHNA6+%&:KB^MFQB9>:/
MMUM_SV7\Z.9!9EFBJWVZVW;?.7(]Z&O[5>LR_G1= 6:*JC4+5NDRTIOK88_?
M+S[T706+-%5A?6Q./.7BD-_:@9\],=.#1= 6J*K?;[4_\MT_.C[=;9QYZ?G1
M<"S15;[=;?\ />/_ +ZH^W6W_/=/^^J+@6:*K?;K8?\ +=/SI?MEO_SW3_OJ
MBZ L457^V6__ #W3_OH4HNK<_P#+:/\ [Z%%P)Z*@^U0?\]D_P"^J/M=N/\
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MBB@ JM??\>%S_P!<F_D:LU6OO^/"Y_ZY-_(T 6:*** "BBB@ HHHH *0TM%
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MKB2JHBB/&6!)_.G)"[1GYDW'D(6&<4I6-DC$J290$#:PP<G-#3%I-VX\+MP
MO3MVH274&V3K: SK&'&"@<].,BHOLLA/+ CL,CFG1R1[T;:Y;;M8 CIBE\YD
M4 LZA!A<;?UR*=D%VADD+I$'8 =, D9_*H YW\8XZ<5+/(\KJQY.T9)[U'SN
MZX&.E0RD.>5BO)' [5&6/' Z=:&5EQDXIP3>N0">.M+4>@([8!';MFD,V2"W
M/KQ3O*?.0!3=I+?-P?2GJ+07><#&/:@R%CQUH P3P,T!3QP>:!B[V [$"D#E
MOSI,$-C.<=?6C8P(YI68!NPP['M2,SA@W7/J:1N_?%,W'CG!]Q3U%8G\UQC
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MBI:*8$7DQ?\ /-/^^11Y$0Z1I_WS4M% $7DQ?\\T_P"^11Y$/_/)/^^14M%
M$7D1?\\T_P"^:/L\/_/)/^^:EHI6 B^SPCI$@_X#08(B.8T_[YJ6BBP$1MX3
MUC3\J3[-#_SR3\JFHHL@(3;0GK$A_"E%O$O2-1^%2T460$7D1?\ /-?RH^SP
MY_U2?E4M%%D!#]E@S_JD_*E^SPYSY:?E4M%%D%R'[-"3DQ)^5'V:'_GDGY5-
M119!<@%I;C.(4Y]J3[%;$Y,*?E5BBBR K_8K;_GBGY4&RMO^>*?E4^*,460%
M?[#;?\\$_*C[%;_\\4_*K-%%D%RM]BML8\E,?2C[!:_\\$_*K-%%@*WV&V_Y
MXI^5)_9]I_SP3\JM44607*HL+4=($_*C[!:YSY*9/M5JBBR"Y6^Q6W7R5_*C
M[%; 8\E?RJS12Y4.[*WV&V_YXKS[4W^SK3)/D+D]:MT4[(+LJ_V?:_\ /!?R
MH-A:GK E6J*.5!=E7[!:_P#/%:3^SK3_ )X+5NBBR"[*?]FVA.3 M']FV?'[
MA>*MT4N5=@NRD=+LB3FW7GKUI#I5B1@VR8'UJ]11RKL%V41I5B/^7=?UH.DV
M).3;+GZFK])1RH+LHC2;(=+9?S-+_9=EG/V=?UJ[11RKL%V4O[+LN?\ 1UY^
MM+_9=D>MNOZU<HHY5V"[*?\ 9ED?^7=?UIK:58L<FV7/XU>HHY5V"[*)TJQ(
MQ]G7]:0Z18L03;KQ[FK]%'*NP791.DV)&#;K^M-_L:P'_+LOYFM"BCECV"[*
M/]D6/_/ 4O\ 9-E_SP6KM%'+'L',RA_8]EG/DC\Z0Z-9G/[O&?0UH44N2/8.
M9F=_8EE_SS.?K3?["L\YVM^=:=%/DCV#F?<S3HMH<?*>*='H]G'('$>3[FM"
MBCDCV#F8  # Z4M%%4(**** "BBB@ JM??\ 'A<_]<F_D:LU6OO^/"Y_ZY-_
M(T 6:*** "BBB@ HHHH **** "BBB@ HK$O?/6]>4SN88USLCD*D?AWH35I&
M$D0B_?1J6P3U7;D'^E &W17-7>I7_P!KM(5=8S)MD8XR,'M3GU6\LHXI'C$L
M<DLB<'D8W$']* .CHK"75+LQ!Q =A0.6( *^P'>G-JDI):%"Z?+DCME<]/K0
M!MT542Z)MHI/+=]^,[!TJCJRW!DC=)F2%5)=4DV,3_7Z4 ;-%<W%JER#<R0L
M94"1>4DO!Y')-3SZW+:VZF2-3(;GR-H/;GG]* -VBL"?4+R2R@F1XX_-*MP<
MD ]JF75I, &-0YNC"!GL.] &S16 NL7;)#BU)9X][;>0/0<XIDVIWDZPMM$"
M_:EC9"WS8[T =%16/<;[G4GMWN9((HXU93&^TL3G//X"HSJLL'";)8HR%+,V
M&?/<"@#<HK%_M&^:WCE6"(>8K, 7Z8_"F/J]V'/EV\94.B<OC)8X]* -VBL-
M=3NWN);?RHUDC<@LS?*1@&H)M7N;BU>2!4C5)50Y;D\C./:@#HZ*YZWU.[:Y
M7:H:(6ID*,W)(=AU^@K0@NAJ44RH61 -N]3@Y([4 :-%<W8&>TM)KHW-Q<NL
MGE!)93C[V,U*^NM'<JA@4QL64.K9^8 Y_E0!OT5S<^M7%O>*TD:%'@#*BOD9
M+#KQQQ6A'J$MS83R>68W3@8.<_2@#4HK#6[EM8HY7^TEG;&V;C^$GU/I2C69
M<1H\"++(BLB;^N1G'3K0!MT5B_VS,8)95MEVPG#Y?H<X]*=)JS);370C0P1,
M58EOFX..F* -BBL^SU W:R J%9!G(.148U IHL5TYW.R G''- &I16(VK7*I
M&_V5-LD9D7Y^PQUX]ZK?V_*-46/8!;@2F3U^4+C'YT =)17/Q^(ED$?[D9E9
M5C(/&3TR>U2PW]T=/U*678LD$CJ@!R!@ C^= &W16--_:D<;2).LB.5VJ$^9
M1W[\FH&O+R15$+R,J,5EQ&-ZG' QG^M '045@6=S<:BTKQ7BI%$VT Q\MZD\
M_A^%*S7RZTL/VW,7E>85\OKUXSGVH W<BEK!TU[^\A>5KB1=Q.W=$,#DCCGF
MK<=U.(+X.=SV^0K8QN^7- &G16 VO-;^7%<1HLTB!D^8[3QW..*E&N+@L8OW
M:QF1VSP,'''KS0!M45@#7#/"#"BES@C!.,'WQUYJ5-;C\R6*9-CQ':V#D;NP
M!]Q0!M45GR7\@\F-(<S2)OV$X 'UK'O-9ORUQ):)$(X%4,KGDL2!^E '445A
M+KD:2&)BKM$=DA&<[O8?A4L6M>;]G)B""8;E+G'% &Q16%?:Q+9ZY':E%-N;
M=Y7;OP5''YU>MKYIII+=X]DR*&QG((/3F@"_17-76M7=G:74MR5BGCC9TB*<
M''<-W_*M*/689(H9AGR9#M$G;- &G17-#7)I9I3%*H96Q';&/YG_ ![5=AUE
MMS":,J-[*I^@!_K0!L45D+KD;E56)F<R;,+2'66VHPM9"L@8ICOMZYH V**S
M+R\G6"&2 $(_+OMW;!]*;_:48TC[6)DER,*P& 6S@?3F@#5HJEIE[]NLUE;'
MF='4=C33J<8U%;,JVYNA[=,T 7Z*PK^XU&'6K.WAN(U@N"1@Q9*X!/7/M5@Z
MM'';&9HWVJQ7)&,XX)_2@#5HK$O==6"U:6&)WV^7N..%W$=?P-6+?5[:XF$:
M%AN<HI(ZD=?Y&@#3HK$BU-I+R6,W*)L8CRO+R3CWJ8:S#L+%)2JA2S;> &Z=
MZ -6BLV36+>*Y:"17# $CCKBHH]>MG*J8YED8 K&RC<V>F.: ->BLY]4CC95
M>*8.P)V%1G []:AO-76.UMIX701SD8=P>AH UZ*S%U%8XT,V6!&3(H^7_&G'
M5(S'YBI)Y9&1(5^4_K0!HT5C2:WY42N8BQ:7RPJ_SJXE]"Y4 G<S;0N.<]_Y
MT 7:*** "BBB@ HHHH **** "BBB@ HHHH *K7W_ !X7/_7)OY&K-5K[_CPN
M?^N3?R- %FBBB@ HHHH **** "BBB@ HHHH @DM;>60220HSCH2.:CCLD6YE
MN&)9G78 >R^E5W>ZN);B.WD6-HV"C<.O0D_D<56@>]:X>66>7RDS_"NS@?G0
M!K/;0R??B1N,<BE^SPX4>6N%.1QTK,CU8R2")54NS80\[>F:2749A<0Q_=+'
MYAP10!?-A9E2#;1$$Y(VCFE:RM74*UO&P'0%169'J=P+ZY$B@V\0&,=>H%3F
M6:Y#7%O.8X8PP*E1\Y&><T :2JJ*%4 *. !44]G;7)4SP1R;>FY<XJD=2:.V
MM1L,DTJ@^@Z<FF-JY\O>EN[ #+\CCG']: -'[+;[@WDID# ..U-:QM7E\UK>
M,OG.XJ,U3N+R=-5AMX]IB>W>0YZY!&/YU5BU[RX(5NT*S2! N!D,6!/;Z4 :
MPLK09Q;QC=P?E'--%A:"7S1;Q^9G.[:,YJI=:C*NC7%U"F)8\@!NA(-1OKT<
M=R\!C<F,@/A3U/I0!I/9V\BJKPHRJ,*"O2FM86;3"5K:(R#HQ49JHNJ2R&(1
MVSYE#,N2.@Q_C3%U=BJL;9U#@,I.#P?7% &C-:6]QCSH4DQTW+G%1FPM&D60
MVT1=<;6*C(Q2/>JMFL^1\W2J9UD"*1Q [>4F^3&.!_D4 :?DQX V+@# XZ4W
M[-#_ ,\UZ@].XZ5FS:K-^[:* ^6TZ1[B1T)&?YU=>]Q=&!$+%0"QSC&: '26
M=M-GS8(WR<G<N<GI2-I]DY4M:Q';C&5'&.E53JZ *YB?8RNR'CG:,G^5-76H
MVN/L_DR"<J&"''(/>@"\;6$#]VBHX4JK!?NYI+.U2SMEA3G!))]23DUA'7K@
M6;2^43*)0@3CH7Q6D-4/VF2 0R22)RRC VC&?6@"\((0A01J%)R1COUJ,:?9
MA]_V:/=DG.T=3UJC_;D6QY/)D\I'5&?C )P,=?4U;MK\7$CIY3IM!/S=\'%
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M-OJ:R6LT\B%!'*T>WN<5#%JX>:='@=61@JI_$QYH FETBUN XG#RJX(*NY(
M/H.U)<Z7!-;- JA$9PS ?T]Z>FJP2'"!V(^^ /N?6AM5LT$;-)@2$A>.N/\
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M""".HR* (3H5F9A*0^X$D?-Z]:>^CVLDZS%3YB@!6SRN.F*<VJ687(F#$@X
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M9$"%;>>A.3GUJK)J-[%?+:R"V0E"X+;CD;L#I[5:.JP13K!*V)".HZ$XSQ0
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M9=/MYHV1D'S/YF?]KUJW10!4_LZWQ"-G^I.4]JCETNWEE\QL@[]Y /4U?HH
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M_N@>#W..#5L<"EHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^F2W$[RQ%"9(_+(DY"CU%:V]?44F]<9R,4 9FG:;)9)=CS06FE,BMC[N0/\
M"ET^SN+>ZEGG?<714^]GH3S^M:$<T<J*\;!E89!'>D$L9D:,,-ZC)'I0!FC2
M?*L]D) E[DGJ,YQ[55@T>ZMYVG'ER,96D".QQRH'7'M6\\B1H7=@% R2>U-6
M:-V*JP) SB@#).ES>87'EKNW\ \#*XJO<6$]G;W+JRAWF5XF7KG"KC]*Z+(-
M&1F@#)NM.>;2X;>(*'1TD(8\9#!C_6H$TNX%XDC"+"R&3S0?G/'3I^%;N11D
M4 8=WIUT]^TUJD<19EW2K*59@,=1CG\ZC;2Y;:">267S@0S<]5.[<,?I70!@
MPR*1W5%RY 'J: ,*QT^:<17<TCQ221YDV-@DGI^E,G\/Q^7=>3$AE8J8G;KU
M!8D^YKHJC,J"01E@&(R!F@#G!HEU)<2;X841\ARI^]EL^E6+S0$GED=(8Q\R
M>7_L@#!%;0N(B^P2*6],U+0!E#35BTZXMD@C,;L66/.!R<U#;PZFD5P#RK "
M)9')(]<FMNF;UW%=PR.U &7965QI]RH$GFPM'M8[<$$=/ZTW5[2?4;6'8OR!
M@TD+C.X?2MFB@#ESI-V60BW@#(@\E\<H>X]NW2EGT:66TNH1:I]IEB97N0<%
MR?>NGHH QK+3'MC=0HBI;R(-JCINYR?Y5EPZ),D;YM8R%MUC5&&1U;=@?0BN
MMHH YFPT>;>L=U$IM1(Y2/H%4J,#';G-,CL-0A%NRP"2Y08W2?= R>AZCCVK
MJ:* .333[Y9962%D@94+Q!0-Q#$M]<BK,EK,9XIH;62,^2T:^L?7\NM='10!
MS)M]0\PH(Y?.(YG+?+C;T^M7;:UN8-2(!?[.UJ,DG/[W/^%;-% '-.FHS)'"
M(KA=I8,Y.,\G!%++97D4J@+-);94NBMEF^7'\^:Z2B@#B[;3-1MW !N8[<ER
M$50Q#%B03SZ5=O-.NIX+DR^?,1Y6Q=W7&-Q ]<UT]% '/+]ODNBWESHK%E*M
M]T+@X[_2JIM=8CM8(3-(-A&\QKG(QQCGM758%+0!S;6NI$!A<7)VP_* =N6R
M.HSUZU9OWODN?W*RLKPD#8> W'_UZVL48H YM;?4A DIDN#,KJ-N_@C!SQ^5
M598=1>X@FC%WYT=NZR%VX#';T_6NOI,#TH PK6.[F"!IK@1[QG)P??FHM6LY
M9-7WKYFU[9D!4\9KHL4M '-2G4;:\DB1Y3:J%8NS$G)SD ^G%6I8[BYTR ;F
M#^>C LN<#/ZUM8%&* ,/4C=Q+%#$SY(8^8AV#/88%113W)BF:=YEN<$1Q@G:
M1CKCZUT5)@4 <S>1W,UK?0!'W2Q29QU/[OC]:DM+BX@%E8QEF\V-2&;^''WA
M^0KHZB\F/S?-V#S,;=V.<4 8^JR:A!*/LN61P#T^[@Y;\Q^M5Y9+V:!9)U8*
MY1@G]WYQ_3FNEI,"@#'B,J:5*(=RR^8>W3+?X54:YU1+F5"5^7:(MSGYN!G(
MQZYKH\48% '*SZG>1+ (YV:620B12OW0"<X_*K,M_=374GD9:)778Q7C[A)_
M6MUX8Y'1V0%D.5)'0U)@4 <VUYJ4<\<;R(%,:LK,2-Q(&>@/?M6A?3726T;1
M[1-M&2!D UJ8%&!0!@7-U?6L[0M)F/<F^4K]T$')'XXJ*U,X6=HF$A:?<KLG
M;FNDP*,#TH Y\ZA>36K7BQ<$CRXRO(QU-0-J$D6H02+=^;&659&*$ *>M=/@
M4FU<8P* .>DUFX+R+&^W;))M)3@J,8_G5V"[\NPNYV+;U9F( R1]!6IL7^Z.
M*-B\_*.>M &$NHW?GB*25$RR_-LZ@]J(]2N)+N:)ITC2(9#%/]9[ULO;1.%R
M@^4Y Q2"VB\PN4&2,?A0!DK?WCP/+PF9Q$JE/N@XY_6I?[0GB+[L2JC%,J,;
MC@8'YFM4HA4J5!!ZC%-$484*$  .0,4 8\FHW,<BJ-S8=4<;!@$^^??TK6MF
M+0*2<GGG\:=Y$6\OY:[CU..:>J*B[5  ]!0 ZBBB@ HHHH **** "BBB@ JM
M??\ 'A<_]<F_D:LU6OO^/"Y_ZY-_(T 6:*** "BBB@ HHHH **** "BBB@#"
MDMY9KV\Q#N+, DA_AX'-']DS"&8+(?.=LE]QYXQ^%;M% '/G3)IFC B,,:[=
MRAL;R"#GBI]4L);B^M9XD#>6K+[KD$9_6MFB@#(L;66.8.8S&JP^603]]LCY
MJIMI5S%$A4R2?O'=T)#$Y)Q][MSTKHZ* .8ETS4<#RG?:9%=P2,LH4C;Z=2/
MRJ2>TOVBB0*YR"=WRY7D''M^%='10!S+V.H.ES'$)8_,+-YCD9Y.<#!Z5?L[
M6Y2TN.71W^ZKX^7Z8K7HH YB72)YPH6)XT&WS$D?=N([CFK6JZ5)>W\$L? C
M@D3<#T8[<?R-;M% '-+8W]Q&R2K-&K1HO^LP<C.>A^E2/972L0R321+))L1)
M,'!QM[_6NAHH YS3;.\MY;7?%* J!6#,-J\]L'FB]T^Z?59I8TD\N01ABCX+
M $Y YXZUT=% &))9W,NA7MJ0V75EA5FRP!' )^M5VTV\$B2Q^8&4Q +OX"@_
M-71T4 8FG6]]'>%YP1N)WG>2&].#TJ.ZL+Q9);JV>5IV<[5,AVA2,=,XK?HH
M YLV-VP*1?:45@GF;I2<G=SCGCBE_LR\M[B22&2=@LO[L-*2-A49ZGGG/6NC
MHH YHV6H)'<7&Z=IUD7RD$F!MXSQG'K5>YM+NXAN(_+G*/M8CS6.&#@\9/H.
MU=;10!SA&I-?,R K@#RR7.-N.XZ9J.QMIO[8AG9)R!&PD,C9 <G/'/ Z]*Z>
MB@#EVBG@DFCM8V=GD=LN@RF<G(;_ #UILE[?K:V^X3*HB59&QR6XS_6NJICQ
MJXPR@X.>10!STES=+,B%Y5MF8[3CYC_6B%M0%RS-&=[^7@D=@IS_ $KH?+4L
M&*@D=#BGT <W:_VHT8W389L>9@$E3^/'Y5T,?"A<DXXR:?10 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %5K[_CPN?^N3?R-6:K7W_'A<_]<F_D: +-%%% !111
M0 4444 %%%% !144DT4(S)(J ]V.*C%]:$<7,7'^V* +-%5OMUIC/VF+_OL4
M?;[0]+F(_P# Q0!9HJ WEL.MQ&/^!"D^V6N,_:(O^^A0!8HJ#[7;<?OX^>GS
M"G?:(<9\U/SH EHJ'[3!_P ]4_[ZH^TP8SYJ?]]4 345"+F ])4/_ J4W$(Y
M\U/SH EHJ+[1#C/FI^='GQ$9\Q,?6@"6BF>;&3C>N?K2AU/1A^= #J*:&4G
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MGN JQ@KOV ="P]>: -ZBL>_U.:VDN-GEA80IVN>7SZ5%9S7#V>H71<^8)75
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M110 4444 %%%% !1110 4444 %5K[_CPN?\ KDW\C5FJU]_QX7/_ %R;^1H
MLT444 %%%% !1110 4444 %%%% "8&<X&>E-,:,,%5/U%8LVN/ L<IC1DE9E
M50?F&W.<_E1+K$]OY9DCC<3X\L(>5R<<T :_D1B-HU155A@@# I$M8(X_+6&
M,+C! 4<UFIJ=S)<O:".,31MAGYVGC/%5K/5KGR4:<#:9&4R%21]\@#(X'XT
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M\AH0N%8[N.Q]:KC1;99#*K2+,>L@/-2_VE;[]NX@9V[B.,^F?6G?;X""06(
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MPP?<H[@YZ4)IG^D">60.^XL<+@<KBM RQA<EQ@]\U ;RW$D<9D&Z0G;[XYH
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M58WQG:RYP?UIKZ"!<"2.0G=$(G!<C@=^/K6X'4YPP..O--\U-ZIN&Y@2/?%
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M&_,-QM=T8Q8B&_.T\\?7WK>QSFEH R+"TN8PQ>XG4G VOM/3N*SKZ/41]LG
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M!'$;,B0)MDWIW[Y)Z\ULT4 <Y;Z<WV+RQ BL;MR04&-N3C/M6Y;1B",1!57
MZ(N!4]% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M444 %%%% !1110 4444 %5K[_CPN?^N3?R-6:K7W_'A<_P#7)OY&@"S1110
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ME^0_+T&XXI[6D+SB9E^<=#F@#&NM=G6")HH"CFX2,JW7!S_A5A=?ARQ,,HC
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MCC:S84Y_K5FTF^T6L<N0=PSE>E $]%%% !1110 4444 %%%% !1110 4444
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MN_A../TH V-Z[MNX;O3-0+<PO<O;K(IE0!F7/(!Z?RK.FL[N6_2;D!)E(PP
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MJ, 8'I3J* $P*-H]*6B@!-HSG'-)M7T'/6G44 ,**1@J"/0BCRT/51^5/HH
M3:!VHVCTI:* &[5SG SZTAC0]4!^HI]% #"BL "H('3(I/)CR3L7)Z\5)10
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MRYF4_*0."/QI/[9G\M',*JK%%!)Z%B1S[#% &_16&=7N/,,:Q*Y$K)N5N,
M_P!:@O\ 5;LV-T8X_(=(2PWM\V[GI0!T=%8UU>7$(LL,,21,7SU)"9J!M<EM
MI5MYH TIB60%3P06(H Z"BLR+4GDLI)VBVE&VC)X-,DU-XG\IEC\T@,HW'!'
MY=: -:BLF+6 Z<Q_,WW0#U^;%1KJ5VRHPMD D=D7+GC;GK^5 &U16&->0D@*
M,H0''.<^W%-N=;DBA600J!*S1Q;CR6&>OMP: -ZBJ OBEI:O(N99\  =-Q&:
MK_VG(UPRK"<(C%Q]"!Q0!KT5D?VS$+9+IB1"[*%XY.033WUJ.%S'+#(CA=V"
M!T_.@#4HK%&M*\^%1A%Y1?=W&,<?K4RZQ#N3<D@1VV+(0,,WI0!J45D+KD)'
M,$P8[2%(&2#G'?VJY)=K'!'*8W)<@*@QG)H MT5D#5'GU*.VAAD4#=YI8#Y2
M,<=:<NHN;]K=PD9#[5#$Y8>HXQ0!JT5FV^K6\Z*0<DL%..0"3C%-DU&1IV2W
M$)5!EFD<C/TXH U**R+;6XY7=9(V7:X3/;)Z5(VKVR%A+N3! Y&<Y.!T]Z -
M.BLMM:M4D9'+J58*<KT8]!^HJ634HOL!NHP67.W&.^<4 7Z*K03L\1>7RQCG
MY&R,5'8WR7OF;5*[&QSW]Z +M%4/[3@6_FM6RIB0.S$<8X_QIYU"#[++<(VY
M8U+, .>* +E%8T/B&RDBMY79HUGB$B[E/?'^-7%U"U:Y^SK.#+Z8/\^E %VB
ML\:BK7CVZ1,WEG#MQQ4YO+=5W&50N"<Y["@"S1587UNT9D$HV@X)]Z=]IC.S
M:=VX9&#0!/14(NH"6'FK\OWN>E*)HRP <$GIS0!+15(ZG;"=X=_SHX1AZ$]*
ML>?%@'S$P?\ :% $M%,\U-V-ZY/;-12W44) D8+E@HR>I/2@"Q13#(H."0.,
M\TN]=N[(QZYH =14,=U#+NV.#M;:?K4FX9QD9/;- #J*3</4?G1D>M "T5$\
MT:.B,P#.<*/6GAU8D \CK0 ZBBB@ HHHH **0D 9-(K*Z[E((/<4 .HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "JU]_P >%S_UR;^1JS5:^_X\
M+G_KDW\C0!9HHHH **** "BBB@ HHHH ***KW986<Q0X;8<?7% %BBL./5)X
M$D,Z+LA90[#/(('/YFE?4KA& *P*/*\S#,<L,\ >^* -NDP/2L&;6YC"S+$!
MN!"I_&/ESG%%O>WNR*3=$X6V+OR>2#_/% &\0#U I-JYW8&?7%8$7B%)EWI'
MG(^YM.X<?E5@ZC)' KRO;*S@%%!)/K@@4 ;&U<YP,^M&!Z"N>769IKE74)Y
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MCT]:J1ZFVV:65H%AC8C@DGKCF@"=]+MC"8PGRY! )X! P*IQZ%&UP9IW<L
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MWOK4T.G6XV%T61E0+\PS[Y_6KB2))NVL&VG!QV-4EU:W:79R/G9,D=P ?ZT
M22Z=%+'(F2H>02''J,?X5771X0ZL7R5(/W0,X.>:NF]MP5!E7Y_N^]0)J5N^
MGM>AOW*AB3CTSG^5 "R:;%(9"2?GE64_48_PJ06FR!XXY"I8YSC-0Q:DKQ)(
M\31JY&TD@Y![\5;$T; D.IQP>>E %)=+"I*OG$>;]_:H (^E/@TZ.UF$D3,H
MV;"O7-1#5X1N>2-XXP6"N>C8Z_RJY'=P2Q+(LJ;2 <[AWH J3Z6LUQ--YK#S
M5 *X[@@@_I3ETW*77FR[I+A=K,% P,8JYYT7'[U.1D?,*:+F \">,]OOB@"@
MFBJMDML9B=L(A#8YP,?X4VST5+1DQ,[*CEP&8]3[5=N;Z"V=4D9MS#("J2<?
MA2S7<,%OY\K;8^.2#W]J *MSIIN)6;<BEO\ EHJX<>V15#4-(N/LLQB?>0C)
M'&%'\3 \_E70@@C(((/>HFNH%8 RIDG'6@#-GL9]ZRCRVD:5#MQ\H !Y_6G#
M2F+Q.T@RI8L%Z#=CI^5:A=,#YEYZ<]:C%S$[JBL"S D#UQ0!BIX=5;4VY8,N
MPKO9B2V?45>6P9+Q98]BH,<<G(^G05?25')"L"0<'ZTK.JXR0,G ^M &6VD@
MWTLQ$9621'.1SP>E5VT-Q+*RM&5:1F5&SA00.GY5MM*B.JLP#-]T>M'G)DC<
M,@X//2@#-_LG$:X(\Q9%8,>2 .V:9>:7+/=>>&1ANC(5NVULFM1)HY#A'5N,
M\'M3F954LQ  Y)- &=>VLTCM(@+#:H" ]P<Y]*;/;74FGP*0"Z,&>-> PSTK
M5!!&013"Z@X+ $#)&>U '.KIE\H=@616<D1J <9'7FIUL+]+I=UQ*ZY4AMJ_
M*!C(]?7\ZWL@C((I"0!DD #O0!AQZ5/YF]GE'R/QYAY))Q^F*8;.^\[ FG&0
MH5@ 0N /?-;B2Q2@F.1'QUVL#4M '.0VUP]_:R/;3H8G;>[R9!X/(&:DN(;G
M[=,(H[@-(Z[95?Y ,<Y&?PZ5O$@#)(I: ,C3S<33S>:[;(F,:8/##/7ZBH67
M4EN_+!=HPQ4.#Q@\@_@.*VE14&%  SG %/H P66Z%Y&5\\;9-C#=D;,'G^56
M;!II6=GD8B',0_VR.Y_*M3@CM34147"@ 9SP* .?NFNGA=%\XSDD. ?EV^U;
M5E"+>RBB"XVKC%6:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *K7W_'A<_\ 7)OY&K-5K[_CPN?^N3?R- %FBBB@ HHHH **** "BBB@ I"
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M6A?S PW@J0"6(XSZ_6MFB@#,DT^665)FD7S Z,0!Q\IJH^D26YNID;?YEN$
M ^8,"2"/SK>HH I6%N]K;JA )8;G;N6J&#3#%<>8Q5@)&<<<\@#^E:=% & -
M$F#1$RHWE,"F<\#=DCBKUM926^G&VQ"Q^;&5^4Y)//YUHT4 <])H,LK/^_\
M)1L$K$3@'U&>GX5(]M*M_;0+R"G[XA3C /!^O K=I,<YH Q?[#C^RNC.S.2Y
M7).%+9[?0TC:;<PR1F IY:QJCJ .<#&>>*W** ,*UTB==S3L&8QN@]LOG^5/
M.CD&8HJ LL87VQC/\JVJ* ,K4+0W$J2)"S2*I"R*^TK_ (BHY[&]O$MX99=B
MQKEY  2SXQT].M;-% %"TBFBL!!+EF1=@8'EAZ_6L^UTV4A$G@(CBP4+N"QX
M[XZUOT4 <VVGZ@8FB\MOE&(V60?K5ZWM;B.YMV:/"HCJQW#OC'\JUJ* ,"?3
M+L2R36K%9GE8[BW 4X[4V.RN8I5=8I%C5D+*S[B2,Y-=#10!SL5C.U]9RR1R
M>9$S&5R^02<=!_A2R:?,;F\V1N#-*ISN."O]*Z&B@#E+>WNK:T$,$3H?*527
M#'@,Q89ZYP:O>3--H%Y&=Y#QL(Q@@@8]^>M;M% '-LUPCP!1<;MJB(!3M]]W
M_P!>IKVVD;4WF/F FS*+M!QNYK>I,4 <PTVJ6[-"KN85"_O&CR1P..!5O?<R
M:,SSAI2'!P%*L5#<\5N8%&* .<>\/GE;&%HH2H+RK$05Y'8\9_"E:ZO,C=-(
MD 1F279\SL"< C%=#L7&,#'TI#&A !4$#H,4 <_//<36[>9*Z']UB,+][.TD
M^M:%M-/]JFCD8R8!9<8VCG@?6M QH3DJ"?7% 15)(4#/7 H PDU"Y\Q2LOF,
M[,'BV_ZL#/-7+6XG\\PRL7S%OW8Q@^E: BC!+!%!/4@4[8N<X% '.#4+JTCA
M$ %RTDK!H\\J.>:D2[U"X2,-&J99?F\P-@\\<&MT0Q@Y"*#Z@4HBC7[J*/H*
M ,9]4G0^4H5I1(XYX!"D>OUJK]L;4/LZY^2:56*AB"!SZ5T1AC)R47/TI%@B
M4@K&HQTP.E &?=7LL$TJIY06% V'SEL__JJ.T\][:]F\Q%E9V",2=JCMP:U'
MABD;<R D=R*<(T"E=HVGJ,4 8?F7 +P*[^<Q#<NOS#OCTJ2"YEN)5@$KPLI(
M;=@L2.WH?_KUI&RMR"#&,'WI#90-$$,8V@Y'//YT 4;U+E$MWAOI 3(J,5"G
M<"?I3X1=/?2$W$OEH^W: N#P.O&:T!!$$5=@VJ<@>E.5%4DJ,;CD^] #Z***
M "BBB@ HHHH **** "BBB@ JM??\>%S_ -<F_D:LU6OO^/"Y_P"N3?R- %FB
MBB@ HHHH **** "BBB@ II4,,, 0>QIU% #!%&OW448]!2>1%D'RUR.G%244
M 1?9XMC)Y:[6ZC'6F_98=AC\M=IQD?3I4]% $$=K#"[/'&%9NIIDFGVLLOFO
M"I?UJU10!5&GVHD+B!=Q&":8-,LQ"T0@ 1N2,FKM% % :/8!=OV=<9SU-23V
M%M<LK2Q!BHP.<<5;HH JFPMC;^1Y8\O.<>]+]BA^R_9U4JGL:LT4 4/[*M0#
MA",_>(/WOK3O[.AW;@"#NW#!Z&KM% %(:=;K:1VJJ5CC(* 'H12+IEN%D!!/
MF A\GKFKU% %#^RX!TW;=XDVYXW#H:?<V0N0P:610R[6"D<BKE% &5)I$,AC
M#RRF*-@PB)&W(Y!Z9J:*P6)U*RR[%)(CR-HJ_10!333H4M_(Y*;]_/KG-3S0
M)-"T1&%/7%2T4 48]-1+A)M[%D&%J.;28)HHT.<QNSJ?<YS_ #K2HH QQI+K
M*RI.R1,FT@8Y]:(=%2'8@E8QH25!Z]",9_&MBB@#*BT@0^4BRGRHI/,52.<\
M_P"-:@R!R<FEHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *K7W_
M !X7/_7)OY&K-5K[_CPN?^N3?R- %FBBB@ HHHH **** "BBB@ HHJ"[F-O:
MR3!"Y120H[T 3T5E1ZFPMUEG\E0Q'1^@]^*N?;(0,EP,KN&?3.* +-%85MK4
M\L8EE@B6-FD"[)"3\N>HQQTJY#JEK+"7\P JH9ACIG_]= &C150:E:D*1,OS
M#(IO]I6@)!G7C&>#WZ4 7:*H3WICNEMXT4L5WDL<#'^-.O+Y;.U$S(S,Q "+
MU)H NT4Q75D#@@J1D&J<^JVT"*^_<I<(2!T)S_A0!?HJM]NM]B-YHVOT-1PZ
MA'/<F%5;(=USV^7&?YT 7:*IW>H06:_.<G<%P/>GR7L,<,DF[.Q<D"@"S14,
M=PLA;D#:<<FG":,G =2?K0!)13/,0KN##'KFCS8\9WK^= #Z*J7%];VJ!Y95
M ) Z^IP*F\Y 0"0,C.30!+130ZD9# CUS1YB?WA^= #J*8)$/\0&?4T;U.0&
M!(]#0 ^BJZW<#G E4_,5Z]ZFWKD#<.>G- #J*@GNX;8 S2!0>E2)(CHK*P(;
MD&@!]%)D9QD9J/SHQ((RPW$$@>PH EHI,BEH ***3<,XR,F@!:*** "BD) &
M2< 4 @C(((H 6BBD+ =2!0 M%%)D#O0 M%)D4M !129&<9YHR/6@!:*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *K7W_'A<_\ 7)OY
M&K-5K[_CPN?^N3?R- %FBBB@ HHHH **** "BBB@ J.5/,C*[BN1U':I*J7M
MY'9PB67.TL%_,XH KMHUK*6-PHE+D%LCKCI22V)>:U4$F.(DL2>H[#\#BK)O
M[<*K&3[QP!@Y_*HUU2U>]:U$GSJ@?..,$XZT -MM*MK:W>*.-<MN);;S\Q)/
M\Z;+I*R3Q3+,Z-&@C&.A ]1WJTMW;L"5F0@$@\]QUH%]:F(R><FP'!.: *L6
MEI&A7S&.01G&.K;JEDTZ.02@D_O H/X8_P *E-Y;#;F>,;AE<MC-,N[R.U\M
M2"\DC;40=6/6@".ZL?M.T-(NU1@ QAB/?-(^F+,(1+-(PB7:,'&?>K"7B,Q5
M@4(&6W=J6>Y2"!I<[@!D 'DT ,M;;[-:BW#EE487(Z#L*J?V2S% \Q*I*L@4
M#C@$8_6IUU*$\2YA;(!$G&,^]6/M$&5_?1_-ROS#F@#+ET::0R@7+".5V8KZ
M9.?QJQ;::]O>&;S<J7=\8_O8_P *O&>%<YE08ZY;I2K)&Q*JZDCJ : ,B]TF
M:Z9D$JB%I1*>/FSZ5&NC3)"T(DW*L96-FD)//J*U%OH'N6@5B64X/RG&?3-/
M-Y MVMJ9!YS+N"^U &<=)DRQ$B@R2EG_ -P@ C]*C&C.MZSJ?W18N#YC CIQ
MCICBMPD 9)P*3<N,@C!H H2V<B::MO;! P(R#P".]9UOH<@6<3",[F=HUR2%
MRH'?WK=>9(@"YP"0!]339)HHL;W"Y( SZG@4 <Y<:#=S0)!L@8B5)#,Q.X $
M' X]JU;O3Y+FX0D@QA4!!/7#9/Z5J9%5#?VJW'DF8"0G&,'K]>E &8FE7D:,
MBNH5I", GB,]OYT3:=<F0QQ*%&\,LV[!4 #C\<5O9%)O4,%+#)Z"@#$^QW*O
M*KP^:TF/+DS_ *OC_&G:=9W44H,Y?*9RVT -^77\:VLBC(H P8-*82,'@V@2
MO)E>C9SC^=1)87YE<R/)R5\O"CY .HSG(KH\BD#J20"..M &?=12K>)<)$T@
M$1C^7&020<\_2LV.#4#&QG@F9B2(Q&0NP9[X-="KJXRK @''!IV0!0!S[0:@
M,*JRFY+DF7=\H7\ZA-G<R744OD74>RV=&<L"=Q*].?8UTN]>/F'/3FE)P* ,
M<M<?V6!)'(CF3;\K?,1ZYJ&-[Q+WS D_V7#*%8Y.[C!Z]*W?E?@X.*6@#F[>
M#4OLHDF-QY@AC#+O[\[N_7I5M;3SI(2GVD(H?EI#DYQ[UL@@]*6@#F()-48V
MKNLB2>8JR*6)RN>3CI39'U)?,C@0N RDRO(P4C/3U!^@KJ.*,4 <Q*;Z2RE6
M\=ANB/DB$GD\\'U_&KT4TEG;Z=OW+%M82<9YQQ^M;.!1@&@#F[>74986DD>0
M%+<NJXQE]S8S^ %0W$EW+;1N'=K[(9H,':".@]*ZK HX% ',I=ZG)!@':Y9-
MQ )(RP!Z^U7]5643V)1WPI??M[_(<9_&M? HP* .>DGU&TMAL+2$QA@-OW3N
M_P *MVUU=O93R,A+I]P$8/3FM; HP.@H Y=[R[74A)&[R@VOS$)@*2P[=ZMB
M[N&\MY"0,D*2/O<]Q6WL7&-HP?:CRTP!M&!TXZ4 9%Q?7<:LD2;Y(_G( ZJ>
MP]^13(+Z]D$:%2I=@-[*.X)Z"MO8N<X&:01HO10/H* ,ZVOI)[HVY W1Y\P_
M0\?G5!M1NX)Y8@LLF^5\, /D / Y/>MN"UC@>1U'SR-EF/4T]H(GSOC1L]<C
MK0!CQZCJ$D<C^2B".,$[NK$]*?\ ;K]9Y498RL++DCJP.?\ "M811@8"*!C&
M,4OE)S\B\]>.M &?IMY-<AQ<!5D4 E <X_&LZ[U>]^SMA8QYL3,I5N4QZUO)
M;PQ$F.)$SUVJ!FD^RVXW?N8_FZ_*.: ,^ZEN;9+!(W'S.!(6/45GVFMW5OIU
MO)>HF9E/EL"2<@_Q<<5T3PQR!0Z*VTY&1G%--K 4"F)-H& -HXH I6VHO<V<
MTP16:/. A.&X]\5 ^LR):><1 6W$;0S= ,^G6M5+:*.(Q*@"'J/6H6T^U9-I
MCXSGKR: *,NJM$2, N[8C!SCH"<X^M2)JC221 1@(P&YFR.<XXJS)IMLX.58
M9&,JQ!_2D_LVWRF0Y"8P"Y(X.>E $=QJ;17#11PM((QF1L@!12'4P9?+2%V)
M8*IXPW&?Y5)<Z;;W4R2R!PRG/R.5!^H'7\:=/I]O<1[&#+SN!1BI!]B* ,V#
M7E$DB3HX<$G 7H <=JT;:^%R9-L3JJ '<V,'(S4*Z+9HH51*,<$B1LGG/)S5
MQ+>)(FC4':PP>?PH J_VH@60M%("HR!@?-SCBF'6%^9%MY3,H):,8RH'<\U(
MNF0*ZL6<[5V %CC&<_THDTJ)Y&D1WC=\[F4]0>U $<.I/)I\<P3=-(<(GXTJ
MZK$7V$,5!*&4#Y=PZCU[&I[338;0@KN8JNU=QS@5&-*@5C@L(R[2;,\;CG)_
M4T 317L4MG]J&1$1D,>XI#?JH&^-U8G 0CDTJV,2V"V>#Y:H$'T%-:Q9T7=.
MQD4Y5]HR* &-J]JK;2YR!EN/N_6B+48W\W?E0DIC!QG)IO\ 947DR1EF/FCY
MR>I/<U+'8B-FPYVM(9,8Z$T *-1M=S*90&49(QVI/[1B-S!"N29MV#CTQ_C5
M7^QX]ZMYK;E4J#M&3GN?7I5I;20SPS23%FCW ?*!D''^% %VBBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ JM??\>%S_UR;^1JS5:^_P"/"Y_ZY-_(T 6:
M*** "BBB@ HHHH **** "J&HV;7L*(C*K)(KC<,@X.:OTUG5!EF 'J30!B/H
MKM<FZ\P&9CEE+,$Z8XQ[5*-&19692 #$%QD\$'(/YUJ^;'D#>O/3GK2&5 .N
M<''% &''X>"6\T7GD[SN!]&SD_X?2D?P_)((R955HWW87.UN,8(K?#J>A!I=
MPH Q#H8,.PE"0N%)&<?.&JW>V;7$46(TD:,Y&XD$<8X(K0S1D4 8(T>X:19I
MKDL5Z1Y^4^Q]<"FPVD]R;D2$K&A,<)Z'&<G\L5O>8A8IN!8=1FE+!5)/ ')H
M S9-)BD:,MF3#[FWG.< C^M4)-+O=K1*(]I)V, /D&>GK^5;B7,,B*ZN-K'"
MGU^E2*ZL#M(.#@X]: ,[^S Q^= 069FR>I[4EG8&V:W8#!6(J_S9R>,?6M3(
M S5>*\MIWV17$3L.RN": ,[[-=I?E[>,Q*9=TC%@5<?3L:8=.NC=O?[R)O,!
M$?&"@Z#/XUNT4 4+\3R60$<19B1N4, <=\5G)8W+P.'$J[=WEJ9,'D#'0UO!
M@V<$'!P:4D 9/ H YXVMX9%62WE<^<K[_,& HQVS4VL64UTZE5=HU:)\!L?=
M?)_2MO( !)'-!(49/2@#+L4F6\D8K)L89R[=#Z"J^)(8I8/L?F2E\K)@?-_M
M9]OZ5M[U R2 /7-+QUH P";R?RU_?1HJ$2-CODTS[/<F=9%1@R(RQMN;!.#S
M@_UKH!(C#(8'G'!I] '/(EVY:.(S+$47>S==^X;L9[8S3FM[^.)6ADD:17?:
M'/&,' _/%;N5Z9%+P: .<MVOY8(P9'5CCS0%.0W?K_2I9?-@3 ,F\.<J%8[N
M>.1[5O8%&!0!DV:S_9;ID5H\L612.0>_YU%;7E]/N\R)D!!< KT_V?U_2MOB
MC ]* .6ABNY)!N>99#,C?=X7Y6_"KTTES+H<WF-()$<J&4?,0#UK;P/2C:,8
MP* ,)GO()S+$SLLESLV;>,<\U+I=W>SG$X/W<MD#Y3Z<5L8'I30J@G"@9ZX'
M6@#!>]OE6:1"0(E5@FS[Q.<C]*F?4;L128C.^'B0E>#Z$5L[%_NBC8O/RCGK
MQ0!A-?W23N$S<(D3.K@=3_=XHNM3N8 B0$W)<_,4*C9[9/%;BQHHPJJ!["F>
M1"!@1)@\_=% %!+FXFT^WFD3RI#(NX%ATS[55BU6]=6D,&!M8E2P^3'3CKS6
MYL3;MVC [8IK01,K#8HW#!('6@#";5YUN9+?<DF(D=63'))(QZ4G]I3S0PS2
M9C=PF5R./WF#^E;$%C;P XC4D]20.:F,$1&/*3C_ &10!1MK^2:\:VV -$3Y
MA[8[8_2H9]6DCN1'&(W4E@,G!R!FM".UCCEDD4?-(<L?PQ3S;0DY,29/?;0!
ME#6',8?]W@-M<X/R<?K^%/\ [3D\Z14\K"IYFYB?F&.U:7V6#&/*3'TJ"ZT^
M.YP-QC &"% Y% %%]5NOL\EPD4?EQ[,@YR=V.GYTT:U)\S^6"N\J %8$8.,G
M/%:L=M%'"(@@*@ 8(ZXZ4X6L +'RQ\W6@#.M[FZ;49(I6CP(=X"=,\55M]8N
MG80,D1F/F/DY"A%./SYK;CMH8CE$ .,9]JB-C;-UA7@DY''7K0!5NKBXELK:
M>VW*)"&?&"P4CWJJ]_-N207$OV4 AG6,$AO0C&:V);>*6,1LGRCH 2,?E4)T
MZU( \K@>C']>>: *\$DUX))DN?+C5RJ@ 8('<U3%S?+K%]$UXS16\2.J[%YW
M9]O:M?[% 6#>7C'8$@?E2_9(3+))Y8WR*%<^H'2@"GI;S36_FR7,LI*@X>,+
MCZ<5')=W@L&NC)&L7E$\#+ UK*@5-H& !@"H_LL1@,)0>6?X: ,>'69$DDC^
M:Y"[0KX"%F.<CG XX_.K8U;>=L5N\DB_?0$?+_C^%6)-/MI<[HAR0>..13#I
MEMM"JA7'&58@D4 1-J\0E9,<*=I8,#SZ8ZU8.H1K'NY)!P1BF_V5:^8SB,#=
MR1[^M*^G0/([D'+IL/)Z4 5QJRN=J1DOG!7(/'X5(NIQ%I-Q"+&N6W<$'/2D
M&EQ !@S"0  ., \=/:D.DPGEG9BWWR<?.>Q/TH 5;V2[CW60C8JV'#]N*>E[
MYFEO>(/NHQQ[KG/ZBIH;188G1#@MU8  T0VD<-N8 ,QD$$'WZT 5WU$I:VLQ
M4?O@"?;C-']K6AW#S#E0#MV')!]!WIJZ7&"@>21TCSY:-C"YX_D:;+I$,ER+
MA7=)!&(U(QP <_TH =%JT$DT\;;AY9 'RG)R,]*M1WD$LA2-]S!=QP#6>VB1
MM-),9Y?.DQN?(Y&,5?M;-+8-M))8 $GV&* *B:O \ FPP4S-"<CG*D]OPJS]
MOM_DQ)G>,C )_/TJ*+35C0H9"R^:T@R!P6S_ (U F@Q1D%7;WR3S0!9GU"*"
M^@M6#EI@2"%R!CUJ87ML0Q\Y0%ZDG%1W-D9YXI5?:44J1Z@U3@T6.*/82"%7
M:G).![Y^E %\ZA:@X,Z ]\GI3Q=V[ $2KSTYJJVF1M)*^%)D8$Y4=L_XU!<Z
M9(Q/DM&I+,P9@<KG'3M^= &F\\49 >5%STW-BH$OXY;J2",[O+&68$8%075C
M/).LL31$[=K"5<_B*=8Z:+-IVR&,IY..: '6VJ6EU;17$<RB.4$J6..G6K0E
MC+[-Z[CSC/-9-MHA@TB.S;8S1(R*V.N>]%MI=S!.I>8N-^XGC@>GK0!MT444
M %%%% !1110 4444 %%%% !1110 56OO^/"Y_P"N3?R-6:K7W_'A<_\ 7)OY
M&@"S1110 4444 %%%% !1110 52OX99D18P"N[YN<'\*NT4 8"V=[$T)1-S
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MC>-(U".26 '4GK2165M ,10HHSG@=Z *%SJ,IT^.:% )#)L8$\ ]^::NJ20
MM<1YC:9HPP;IU_PK1-K 83"8QL)SC'?K2?9("JIY8VJQ8#'?_)H K6NI?:L@
M1%24WJ0<C'O[U7MM881PI,J>?(&;&[C Q_C6C;V4%L"(UP",<]AZ5$=,MB
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ME81VLCQJ<%P1CW[U!8Z0MG.S;RPW,RY8\$G/]:E^R7$<C+#,%A=MQ!&2/7%
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MEN2,$@ _UH V:*IV-\E]&6CR57@M[U<H **** "BBB@ HHHH **** "BBB@
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MS57+@;03V%6Z* $VC.<#/KBD**>JC\J=10 P1H!@*!CVI%B13E5 (&.!4E%
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MC?C@_E3G,^\-R!VI[7$A.54#I19AJ1;#C)4Y^E/\AV0E5XSS3A-)YN9 6[D
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MR>^*3<.U QV5YYS33CIB@LN>GY4H)[FD [&<#./QHVC=P>!3,],'-294 =J
M #OFNDTC!L_H>:YL8R*Z72?^/7J#SVK:A\1G4V-"BBBNLP"BBB@ JM??\>%S
M_P!<F_D:LU6OO^/"Y_ZY-_(T 6:*** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ Q1BBB@ Q1BBB@ Q1BBB@ P*3 ]*6B@!-H]!2;5_NC\J=10
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %5K[_CPN?\ KDW\C5FJU]_QX7/_ %R;^1H LT444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %5K[_CPN?^N3?R-6:K7W_'A<_]<F_D: +-%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !5:^_P"/"Y_ZY-_(U9JM??\ 'A<_]<F_D: +-%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !5:^_X\+G_KDW\C5FJU]_QX7/\ UR;^1H LT444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[Y/^-'_"07?_ #S@_P"^3_C0!TU%<S_PD%W_ ,\X/^^3_C1_PD%W_P \X/\
MOD_XT =-17,_\)!=_P#/.#_OD_XT?\)!=_\ /.#_ +Y/^- '345S/_"07?\
MSS@_[Y/^-'_"07?_ #S@_P"^3_C0!TU%<S_PD%W_ ,\X/^^3_C1_PD%W_P \
MX/\ OD_XT =-17,_\)!=_P#/.#_OD_XT?\)!=_\ /.#_ +Y/^- '345S/_"0
M7?\ SS@_[Y/^-'_"07?_ #S@_P"^3_C0!TU%<S_PD%W_ ,\X/^^3_C1_PD%W
M_P \X/\ OD_XT =-17,_\)!=_P#/.#_OD_XT?\)!=_\ /.#_ +Y/^- '345S
M/_"07?\ SS@_[Y/^-'_"07?_ #S@_P"^3_C0!TU%<S_PD%W_ ,\X/^^3_C1_
MPD%W_P \X/\ OD_XT =-17,_\)!=_P#/.#_OD_XT?\)!=_\ /.#_ +Y/^- '
M345S/_"07?\ SS@_[Y/^-'_"07?_ #S@_P"^3_C0!TU%<S_PD%W_ ,\X/^^3
M_C1_PD%W_P \X/\ OD_XT =-17,_\)!=_P#/.#_OD_XT?\)!=_\ /.#_ +Y/
M^- '345S/_"07?\ SS@_[Y/^-'_"07?_ #S@_P"^3_C0!TU%<S_PD%W_ ,\X
M/^^3_C1_PD%W_P \X/\ OD_XT =-17,_\)!=_P#/.#_OD_XT?\)!=_\ /.#_
M +Y/^- '345S/_"07?\ SS@_[Y/^-'_"07?_ #S@_P"^3_C0!TU%<S_PD%W_
M ,\X/^^3_C1_PD%W_P \X/\ OD_XT =-17,_\)!=_P#/.#_OD_XT?\)!=_\
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0[^P7/[N'_5-_"?3ZT ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>cosm_ex101img2.jpg
<TEXT>
begin 644 cosm_ex101img2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 1, R # 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ JM??\ 'A<_]<F_D:LU6OO^/"Y_ZY-_(T 6:*** "BBB@ H
MHHH 09[TM%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !5:^_P"/"Y_ZY-_(U9JM??\ 'A<_]<F_D: +-%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !5:^_X\+G_KDW\C5FJU]_QX7/\ UR;^1H LT444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %5K[_CPN?\ KDW\C5FJU]_QX7/_ %R;^1H LT444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %5K[_CPN?^N3?R-6:K7W_'A<_]<F_D: +-%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M 0-@'//3^5 &G16#=Z[+;Z-J%\MOEK5V4(QQG'K5M-4B8*3'(%R%9L#"GT-
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M2*OS%\!1G)Z\TEYHT-X)U:1UCGP9$4]<5;^VV^,^:.N,=Z0ZA:J<&=,]^>E
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M'\YX;FMNB@#.CLMD<Z% R2+C:6X)[U6MH=0@EE9$*P^6!'"T@(#<]#^5;5%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5:^_P"/
M"Y_ZY-_(U9JM??\ 'A<_]<F_D: +-%%% !1110 4444 %%%% !1110 4444
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MS;7S&?RAECDCM^5 %2SO[N;69;>542%84<+_ ! G/^%,GUAH]^V+@EE0Y_B
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MI,B*PP%8,,>U0?V9;X=<'#S&8_[QH AEUNUC7)W<H&Z=CG_"HK36FNM:DL1
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MZ59FU."*VDGY94?9QW-5+S18VMY#;9$WDF)"3P/>K:V2+8):JS*% R1C/ZT
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M44 %5K[_ (\+G_KDW\C5FJU]_P >%S_UR;^1H LT444 %%%% !1110 4444
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MKG[.MQ&9O[@;FL9=(N1<3QAD*O $#LF<9)S_ #IUKI-P))HV(6,7*R!\?,P
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MJYD '[L1(ZYZ\Y_PH OT5E?VU'MB/DR9ER5&1T%.&K0O'E4?=D#81@X/?Z4
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MN("C22,BHISNP<"K#:OLD2%K643LQ41Y'IGKTH UZ*R(=9CGDC5(G&_^)B
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M7%>2Q,A<?<')H T:*S%U>W,QC)P5.&&02#Z8ZU&^JL7MA' 66:383N' XYH
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M%-I5& #JIQNP<\_E4G]IQ?V4+_8XC*AMI&#R1_C3VU.V1=S%@=VT)M.XGZ4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %5K[_ (\+G_KDW\C5FJU]_P >%S_UR;^1
MH LT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %5K[_CPN?^N3?R-6:K7W_'A<_P#7)OY&@"S1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 56OO^/"Y_P"N3?R-6:K7W_'A<_\ 7)OY&@"S1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 56OO^/"Y_ZY-_(U9JM??\>%S_UR;^1H LT444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %5K[_ (\+G_KDW\C5FJU]_P >%S_UR;^1H LT444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %5K[_CPN?^N3?R-6:K7W_'A<_P#7)OY&@"S1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 56OO^/"Y_P"N3?R-6:K7W_'A<_\ 7)OY&@"S1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 56OO^/"Y_ZY-_(U9JM??\>%S_UR;^1H LT444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5K[_
M (\+G_KDW\C5FJU]_P >%S_UR;^1H LT444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5K[_CPN
M?^N3?R-6:K7W_'A<_P#7)OY&@"S1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 56OO^/"Y_P"N
M3?R-6:K7W_'A<_\ 7)OY&@"S1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 56OO^/"Y_ZY-_(U
M9JM??\>%S_UR;^1H LT444 %%':B@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JU]_P >%S_UR;^1JS5:
M^_X\+G_KDW\C0!9HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *K7W_'A<_P#7)OY&K-5K[_CP
MN?\ KDW\C0!9HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *K7W_'A<_\ 7)OY&K-5K[_CPN?^
MN3?R- %FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ JM??\>%S_UR;^1JS5:^_P"/"Y_ZY-_(
MT 6:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "JU]_P >%S_UR;^1JS5:^_X\+G_KDW\C0!9H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *K7W_'A<_P#7)OY&K-5K[_CPN?\ KDW\C0!9HHHH
M .U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %5K[_CPN?^N3?R-6:K7W_'A<_]<F_D: +-%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !5:^_P"/"Y_ZY-_(U9JM??\ 'A<_]<F_D: +-%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !5:^_X\+G_KDW\C5FJU]_QX7/\ UR;^1H LT444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %5K[_CPN?\ KDW\C5FJU]_QX7/_ %R;^1H LT444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %5K[_CPN?^N3?R-6:K7W_'A<_]<F_D: +-%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5:^
M_P"/"Y_ZY-_(U9JM??\ 'A<_]<F_D: +-%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5:^_X\
M+G_KDW\C5FJU]_QX7/\ UR;^1H LT444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5K[_CPN?\
MKDW\C5FJU]_QX7/_ %R;^1H LT444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5K[_CPN?^N3?R
M-6:K7W_'A<_]<F_D: +-%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !5:^_P"/"Y_ZY-_(U9JM
M??\ 'A<_]<F_D: +-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !5:^_X\+G_KDW\C5FJU]_QX
M7/\ UR;^1H LT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !12=Z6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *K7W_ !X7/_7)OY&K-5K[_CPN
M?^N3?R- %FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ JM??\>%S_ -<F_D:LU6OO^/"Y_P"N
M3?R- %FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BDSSBEH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *K7W_ !X7/_7)OY&K-5K[_CPN?^N3
M?R- %FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ JM??\>%S_ -<F_D:LU6OO^/"Y_P"N3?R-
M %FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ JM??\>%S_P!<F_D:LU6OO^/"Y_ZY-_(T 6:*
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "JU]_QX7/_7)OY&K-5K[_ (\+G_KDW\C0!9HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *K7W_ !X7/_7)OY&K-5K[_CPN?^N3?R- %FBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ JM??\>%S_ -<F_D:LU6OO^/"Y_P"N3?R- %FBBB@ HHHH ***
M@-Y;K(8S*H8=1F@">BH/M< .#*OYTHNX#TE7\Z )J*@^V6X_Y:K^=.^TP_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<F_D: +-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !5:^_P"/"Y_ZY-_(U9JM??\ 'A<_]<F_
MD: +-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !5:^_X\+G_KDW\C5FJU]_QX7/\ UR;^1H L
MT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %5K[_CPN?\ KDW\C5FJU]_QX7/_ %R;^1H LT44
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %5K[_CPN?^N3?R-6:K7W_'A<_]<F_D: +-%<S_ ,)!
M=_\ /.#_ +Y/^-'_  D%W_SS@_[Y/^- '345S/\ PD%W_P \X/\ OD_XT?\
M"07?_/.#_OD_XT =-17,_P#"07?_ #S@_P"^3_C1_P )!=_\\X/^^3_C0!TU
M%<S_ ,)!=_\ /.#_ +Y/^-'_  D%W_SS@_[Y/^- '345S/\ PD%W_P \X/\
MOD_XT?\ "07?_/.#_OD_XT =-17,_P#"07?_ #S@_P"^3_C1_P )!=_\\X/^
M^3_C0!TU%<S_ ,)!=_\ /.#_ +Y/^-'_  D%W_SS@_[Y/^- '345S/\ PD%W
M_P \X/\ OD_XT?\ "07?_/.#_OD_XT =-17,_P#"07?_ #S@_P"^3_C1_P )
M!=_\\X/^^3_C0!TU%<S_ ,)!=_\ /.#_ +Y/^-'_  D%W_SS@_[Y/^- '345
MS/\ PD%W_P \X/\ OD_XT?\ "07?_/.#_OD_XT =-17,_P#"07?_ #S@_P"^
M3_C1_P )!=_\\X/^^3_C0!TU%<S_ ,)!=_\ /.#_ +Y/^-'_  D%W_SS@_[Y
M/^- '345S/\ PD%W_P \X/\ OD_XT?\ "07?_/.#_OD_XT =-17,_P#"07?_
M #S@_P"^3_C1_P )!=_\\X/^^3_C0!TU%<S_ ,)!=_\ /.#_ +Y/^-'_  D%
MW_SS@_[Y/^- '345S/\ PD%W_P \X/\ OD_XT?\ "07?_/.#_OD_XT =-17,
M_P#"07?_ #S@_P"^3_C1_P )!=_\\X/^^3_C0!TU%<S_ ,)!=_\ /.#_ +Y/
M^-'_  D%W_SS@_[Y/^- '345S/\ PD%W_P \X/\ OD_XT?\ "07?_/.#_OD_
MXT =-17,_P#"07?_ #S@_P"^3_C1_P )!=_\\X/^^3_C0!TU%<S_ ,)!=_\
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M\X/^^3_C0!TU%<S_ ,)!=_\ /.#_ +Y/^-'_  D%W_SS@_[Y/^- '345S/\
MPD%W_P \X/\ OD_XT?\ "07?_/.#_OD_XT =-17,_P#"07?_ #S@_P"^3_C1
M_P )!=_\\X/^^3_C0!TU%<S_ ,)!=_\ /.#_ +Y/^-'_  D%W_SS@_[Y/^-
M'345S/\ PD%W_P \X/\ OD_XT?\ "07?_/.#_OD_XT =-17,_P#"07?_ #S@
M_P"^3_C1_P )!=_\\X/^^3_C0!TU%<S_ ,)!=_\ /.#_ +Y/^-'_  D%W_SS
M@_[Y/^- '345S/\ PD%W_P \X/\ OD_XT?\ "07?_/.#_OD_XT =-17,_P#"
M07?_ #S@_P"^3_C1_P )!=_\\X/^^3_C0!TU%<S_ ,)!=_\ /.#_ +Y/^-'_
M  D%W_SS@_[Y/^- '345S/\ PD%W_P \X/\ OD_XT?\ "07?_/.#_OD_XT =
M-17,_P#"07?_ #S@_P"^3_C1_P )!=_\\X/^^3_C0!TU%<S_ ,)!=_\ /.#_
M +Y/^-'_  D%W_SS@_[Y/^- '345S/\ PD%W_P \X/\ OD_XT?\ "07?_/.#
M_OD_XT =-17,_P#"07?_ #S@_P"^3_C1_P )!=_\\X/^^3_C0!TU%<S_ ,)!
M=_\ /.#_ +Y/^-'_  D%W_SS@_[Y/^- '345S/\ PD%W_P \X/\ OD_XT?\
M"07?_/.#_OD_XT =-17,_P#"07?_ #S@_P"^3_C1_P )!=_\\X/^^3_C0!TU
M%<S_ ,)!=_\ /.#_ +Y/^-'_  D%W_SS@_[Y/^- '356OO\ CPN?^N3?R-87
@_"07?_/.#_OD_P"-0WOB"[^P7/[N'_5-_"?3ZT ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>cosm_ex101img3.jpg
<TEXT>
begin 644 cosm_ex101img3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 1, R # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ JM??\ 'A<_]<F_D:LU6OO^/"Y_ZY-_(T 6:*** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "JU]_QX7/\ UR;^1JS5:^_X\+G_ *Y-_(T 6:*** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "JU]_QX7/_ %R;^1JS5:^_X\+G_KDW\C0!9HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH *K7W_'A<_]<F_D:LU6OO\ CPN?^N3?R- %FBBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JM
M??\ 'A<_]<F_D:LU6OO^/"Y_ZY-_(T 6:*** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7+S*HB26,,-QY4G.*L&5V7;'( -O^J9<=N<&E[:0<B.@.OP?\\W]^11_PD$
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M6OO^/"Y_ZY-_(U9JM??\>%S_ -<F_D: +-%%% !1110 4444 %%%% !1110
M45$UQ"C[&D4-Z5)D4 +1129% "T4A( R30&!&0>* %HIH92,@@_2ER* %HHH
MH **:64'!(SUQ2@@C(- "T44A8*"2< 4 +12 @C(.0:6@ HHI,B@!:*3(IN]
M2<!AD=1F@!]%,+J#@L/6G @C(- "T44F10 M%%)D4 +12!@>AI"RJ,D@ =Z
M'44@((R#Q32Z@@%@">@H ?112;@3C/2@!:*9O4L5##<.HSTIV10 M%)D4@=6
MZ,#0 ZBBF"1&QA@<],&@!]%)D4TR('"%AN(R!0 ^BD+*O4@49!&0>* %HHI
MP(R#0 M%)D4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@^QV_G>=Y2[P<@X[^OUJS0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 56OO^/"Y_ZY-_(U9JM??\>%S_ -<F_D: +-%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7+8!9J .@HK$DU:X";4MU,BLX<[N/E /ZYJS97TL]P8Y8E3,8D7#9ZDC'Z4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 56OO^/"Y_P"N3?R-6:K7W_'A<_\ 7)OY&@"S1110 4444 %%%% !1110
M 4444 %%%% !29Q7*Z'=^(IO$%]'J=NL=DO^IQC'7C]*Z2Y&;68#/W#T/M0!
M-D49%<[]F^S6ML3YL<4A'G,92W&/<\<XIM]'!+);+:^=<1B7E8YR!]T]\\T
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 56OO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JU]_QX
M7/\ UR;^1JS5:^_X\+G_ *Y-_(T 6:*** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG9%8NH1SS7-BKC*@%WP,C<!Q4+7=U$L'VB=T+Q[AMCSN;CCVH Z#(H+ #)(
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M4M% "8HQ2T4 )@48%+10 F!1@4M% "8%&!2T4 )@5&\4<FW>@;:<C(Z&I:*
M&&-"ZN5&Y>A]*=@4M% "8%+124 &!1@4M% $4L,<R[9%W+D'%28%+10 F!Z4
M;1Z4M% "8%&!2T4 )@48%+10 FT9SBC I:* $P*,"EHH 3 ]*,"EHH J1V4,
M<WF@,6[98D#Z#M5K%+10 F!Z48%+10 FT8Z4;1Z4M% ";1Z=:-HZ8I:* $VC
M&,"C:/2EHH 3 HVCTI:* $P*,"EHH 3:/2C:/2EHH 3:#U%&T>E+10 FT>E(
M$5>B@?2G44 ,*(<94''(XHV*&W!1N]<4^B@")8(ED9P@W,<DTCP1O&R%?E;A
ML<9J:B@!BHJ(% X P!3BH/44M% "!5 P ,4@10<A1FG44 ,,:,,%0?J*7:N<
M[1D4ZB@!@C0$D*!GKQ3MJ\\=>M+10 P1H%*A1@]1BG!0HP  /:EHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *K7W_'A<_]<F_D:LU6
MOO\ CPN?^N3?R- %FBBB@ HHHH **** "BBB@ HHHH *#THHH Y;0_$5_JFL
M7UE<Z>;>.WSM<J1NYQU/'O707DKPVDDB#+ <?XU,%4,2% )ZG%.(!&",@T <
M_+=SV"P2K=&Y,^ R-C"Y[\?E1K>J7-MI]XT)17M_+R<<G<5Z?G6REE;QEBL2
MC=UHEL[>=MTL2L>G- &+;:_+/MVV[$%BF64C&,\G/TJ_<:@\%E#*VSS9" %
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M(5+H&V?=SVH P[G79+*?[//$6D*(P:.-F'S$CH/I5@ZE))IKSQPNI#A,LA7
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MY'YXJ$MJ@G)D:<*RJR;>F3U'X5TN*,"@"&W8M'AB2Z\,<8R:GI,4M !1110
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M,?RJ!-;@=BK+(CK]Y67G[N>*MPWJW%JT\:M@#(##% #5T^T7=B(#> &]\?\
MZJ)-.M)557A!522 ?6B:^BMK:*68D&3&%'))QG%49-?BW-Y,32(L+2;AZA@I
M'ZT 73I=J4VE#PVX'/(-.33[6.V:W6(>4Q+,OJ2<U576[78A?<K%%9AC[NX9
M /YU;BO8Y8I955]L;%22.N/2@!PM+?<C!!E"2OL:!86XG:;9\[')-4HM<M9@
MWEB4NKA#'M^;)!(_E39]?A2VEDCBE<Q#YQM^X?1O2@"W_95H&W+'@]\=ZFFM
MXIP@D7<$8,OL16;+K1BU"UM?()\^!YM^>%VXX_6G1:[;/&OF*Z2L%(C(Y;/3
M% %V:R@N,^8N22#GZ=*@_L>SSN",&R22#R<]:D:ZDGM&DM /,'\,G&/K52QU
M.>6RCN+N)4\Q@J+&=Q)/Y4 68M)M(&5HH]NW' [XJUY$9E$NWYP,9JJVIVZ,
M5<E6 . 1UQZ57&MQ?VA+:/&Z,B*XSU;)/;\* +C6-NTAD*?,<Y/U&#4(T:R
MVA"$W;MN>,^M-N]36WT_[3&%<;@N&; &?4\T)JL:P1RSE%\S.-C;LX_ 4 22
MZ7:R[=R$%!A2#TYS33I<#,KEI#(.-^1N(]#Q3O[3@V,P#G8V&&.1QFFG5;0'
M.\D;E4L!P">G\Z +1MXR8B5YC^[[<8JO-IEO<3B5]V[C(!X.#D4'48%4NVY4
M'1R.#SCC\:5M0C^QW$Z#)A0N4;CH,T *-.@4M@OM)SLS\HJ/^QK/:5VL<KMY
M/0;MW\ZAL-7-U:?:)(XPI .(GW=?J!5@:E;.RK&Q=B,X49QSCG\: (QIP:\G
MGD)VR1B/ ZD<<GWIM[IWF06Z6X56MR"GJ.,<&I%U)&9P I503D'_ &L8IMAJ
ML5Y$SD&,AW7#=]K$$_I0!';Z/&D.'DD$C%B[(<;LG)!JT=,M3(',?1-F.V*M
M1NLL:NIRK#(-/H SUTN!(C%ND:,KM"DC@>W%2S6,$ZSAP?WP ?GKCI5NB@"I
M/913R([[@R @8/4'M4,ND6LJH"'!10%(/2M&B@"G'8Q1V;6VYV1LY)/-/DLH
M9(]A!P7W\'O5FB@#/MM-AMB-K2-C&-QSTZ?SI3I=OYLLGSYESNY]1BK]% &4
MFAVD<XE0."&#GGJ15Q;.-+7[,N1'@C\ZLT4 4?[-B&W!;Y7WCGOQ_A5ZBB@
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M11A!]U1@#T%2U +B+^)U4G. 6'-2%T'5ASSUH ?14$MW##'YC.-OKFE\^/(
M8$'N".* )J*KO=0H%S(OS,%X/<T3W<%O;-<22 1KU;K0!8HJD=2MUC5B6#/]
MU".337U.TC*@N<L-V I.!ZT 7Z*HC4H#>"U ?S#R..,5):WL-WGRMW'<C&:
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MP,]^.];M% &%_81,,:^: RLC%@.N%(_K3ETF;[/]G>6+RTP(R%^8C_:-;=%
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M_P"$@M<9*N/PH_X2&TQGY_IBCVD>X<K[&O161_PD-IG $A_X#3O[>M,9^?\
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MG\TP/N P>..F*5E?8>O<CG**R%"^&0-AAZBJP;G'7!S5R6VN)E4F%B5&,XJ
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MT'_/&/\ [Y%344P(/LEN.D$8_P" BC[+;YSY$>?]T5/12L%R#[-!_P \8_\
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MGEW,;_A'K?((=ABKUI8168^098]6/6K=+35.*=TA.3>X44459(4444 %%%%
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MGVLB2W DBM=K!E&2W'7CZU/:7NHS7$0ECDC9GY4K\NV@#:>ZMXY/+>>)7/\
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MQ$I 9^V2,]/QJU'JL;W45NT;*\J[T/4%?6@#1HIB,6&2N.:?0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5:^_P"/"Y_Z
MY-_(U9JM??\ 'A<_]<F_D: +-%%% !1110 4444 %%%% !1110 4444 %%%%
M "8I:** $Q2T44 %)@9S2T4 %)M%+10 FT>E(R*PP:=10!%#!'!$L4:[448
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M]Z '4444 %%)G-+0 444F1G&>: %HHHH **0$$9'(H)Q0 M%%% !112$@=:
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MP,YP* ,)Y[N"]U!A(Q7<@C4C(4'&3_.K$4\L]E<*\_W#A9@I&?PK4P#U ]*
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MHH **** "BBB@ I&.!FEICKN0KDC(QD=J *]K>K<R21[&5DZ@BH9;]8[]+;
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MYESNSG_"@#2S2U@/JER8QG&)HV8 <-&1CK^=3/J$\)**KR%I'PRC.T#''ZT
M;-%9%EJ-S>;2T0AP!O5SSS5>TU.Y^P1^8 T[!?F/3+,1S^5 &_16*^IW/"1P
MH\@9U<E\ ;0#QQ[U8FOI3:P-;HIDFZ!VP!CKS0!I45E6NH7%Q.(?)3<HS*0_
M Y[<<UJT %%%% !1110 4444 %%%% !5:^_X\+G_ *Y-_(U9JM??\>%S_P!<
MF_D: +-%%% !1110 4444 %%%% !2$A02>@I:BEC\V%X\XW*1GZT 55U6V:Y
M:$/]V/>6QQUQ4_VVWP#YHY.!69/H[W))EGP0B*NWC[K;AS4G]F2_?WCS2V=V
M\\<8_&@"\;V 2^7Y@W^GX9J&;5+.")I'E^56"G [DX_K5673I[B9PSJJ;@V\
M?>)"@?SH?29948/*"S*HY).2&!S^E %][^V0L#(-P&2*?#=0W"%HW! &3[51
M&GN$:,^659BQ8C)Y_P#UU-'8;))2& 5XA'@=L#% #IM1MH;:6<R;EB^]CKUQ
M4@NX5BCDD)3> 0&ZUFMI$DML8G:-2(Q&"O< @Y/OQ5F_LI;MT"LOEA2"I)!S
MZ\4 7/M4(D\LR+O],TX2QG&&'(R/I61_8[!58NOF!D9F[G"D?UJ73;8CSF?[
MH)CBR.53_.* +,>H1RL-J2;"<+)CY34XN8&W8E4[>O/2LPZ?>K;PVZ2HL<1P
M'#$$K[CI59M"E:*-/W*".,IA<XDZ?>X]J -S[5!Y>_S%V^N:9!?VUQ&CQR A
M_N^]9/\ 9%P+L7 6WQ@@P<[/][IUHMM%EM!!Y0A#1\9R< >PQ0!OT4BYVC/6
MEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "DP*6B@ HHHH 3 HP/2EHH *3 I:* "DP*6B@ HHHH K/9VT
MDWFO"A?U(YJQ@>E+10 4444 %%%% "8'I1@>E+10 F!2T44 (5!Z@4;5SG S
M2T4 -**WWE!QZTI /4#FEHH 8J(B[54!?0"@1HHP% !]J?10 SRH]V[8N[UQ
M37@BD=7>-69>A(Z5+10!#]F@RY\I/G^]QUI#:V[(5,*%2<D;>]3T4 0_9H-R
MMY2;EZ''2F_9+?RV3R4VL,,-O!JQ10! EM#&@1(D51G  Z426L$L0B>)&C'1
M2.*GHH @AMH( !%$B # VC'%3T44 %%%% !1110 4444 %%%% !5:^_X\+G_
M *Y-_(U9JM??\>%S_P!<F_D: +-%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% "4M%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'([5>BLDCLVMR20P()^M,BOC-=O$D>8T.TMGG/TI9-0BCOH[3!+NNXGLH]Z
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MI["UMXHG&Z'&"XSD5GIX>=(Y 9(V9^NY#@?AFNAHH R%TEL.C2+L)? 48QN
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBIEU/=9/.4VE6V88$9/L.M3_ -G6NUAY0PV,\GM3VLX&@$+)F,'(&>] &?\
MVN\J[8H?WHW9W<=!GO26>JN\,:RQ'SFQP#U!.,_A5]M/M64 Q# .>IIR6=O&
MR,D8!C&%/H* *2:N.2\95 K-ECC.,]/RIBZXK-L\EMS8V8Z<G'-7?[/M<@F(
M'&<9)[T#3;0*5$(P?<T 9MOJMTUIK$LD:J]HS!%SZ(&YIJ:]+';)<3VYV%4+
M%6'REB!_6M5-/M8XYHUB 6?_ %@R?FXQ_*F_V;:?9_(\D>5Q\N3VZ4 4;G6S
M&CB.(%AC:=P(/.*O37AAM5F:,$E<D;P,<9[TT:19 8\D8[<GBI)K"">-(Y%)
M5!@<^V* ,ZYUQOL4DUK 7V>7DDX W$?T-6SJ*A4&S+LQ4KN QCO]*&TBS9"G
ME$(<94$X..G\A4CV%M(9"4^:10I.>P__ %4 5?[9CRJ+"SRF3R]BL#@X)Z].
M@IT>KK,2(X';8<28_@/]:E@TRV@D+*I+LP8D]R!C/ZTJZ9;QEO++(')+@'[W
MUH ;#JD,T_EC;@MM4[P<GZ=:4ZH@E9?+;8C[&D/ !I\5A#%+YB#&#D+@<&F?
MV7&S2;Y'9'<N4SQDT 1C5H!)Y<F%.>NX$8]>.E2OJD*S>4%=G^;@#^[C/\ZA
M;2(1"43YFV%!O'&#]/I4T&GQ0I",LS1(4W$\G.,D_E0!&-7@(SA@IV[-PQNS
MGU^E))K-JFT?.S$,2%4G&,9S^=32Z;!+&B?,-F-I'48H73H50 Y)VD%N,G/6
M@!+'41>O/L0A(VVAO[U10:S#(L>]70R?=RIP:EL].CL=XB=]K]5., ^M0II0
M1"!,\FU"L8DQA<]>E $TVHQQVMU-$CRFWSN5!R2!G J#^TF%LDS>2P9U!VM]
MT$]_I5N&T$-GY".RG&-XQG/K5-]"MY2QFDEDW%202!]TY'0"@"TE] [. V"O
M)!'4=L5G_P!LSQV[W,JPF':Q14/S<9Z\^U6&TL&:W/F$1P]1W;T!]A4PTNV%
MJ]N%X=64MWYSG^= $46K6\L(DQ)G )41MGD?J*G.IVH9091EEW@8[5$VDQ-+
M')YDB[$"8!P"!3(='@C0KO=LH4RV,X+;OZT 3)JEI(VU9#NSC!4C%+-J CNA
M;+'ND*[L%@O\Z0:9"/-Y;]XRL3QQMQC^5/FM$N"V\GE=O&./H: $N[P6D*.R
M$LY "#]:L-*JPF3(*A=WX55?2X9?+$K.ZI'L4$]/?ZU,MN!:?9]Q*;-F3UQT
MH CAU&VG@$JRKC:"1G/6IOMD!VXE7+=.:H_V+;B2!E9PL2!-@QAA[T]-(MT3
M"[MP8LKYY7)SB@":6\BAND@D(4NA8$GC@C_&IO/B,FP2)NZXS4-Q8QW$OF/G
M<$*?@<?X55M= M;55"F1BO1F;)H OBZ@(8^='\O7YAQ3EFC="ZNI4=6!XK/7
M1+=8U3+$JNW<3R1[U.NGHMO<0!V"S.6/MGTH F%W;'&+B(Y.!AQUH^TP;F43
M1EE&6&\9'UJK)I$+O*R_+O"@8'3&?\:@?0_-NEG:<[E## & ^<?>]>E %V+4
M+:9Y561<1'#-GC\ZLAT*A@P(/0YZUCG1'\QY4G\N1B"0J_+^56#ISFT2+SOW
MB2B7=C@D=L>E %XS1+]Z1!VY85'/>06X7S)%!8@ 9Y.:HII#&=YII=SLS-@?
M=!( _I4']BS;!&9TD7S%D+.#N!!Z ^G% &V)$)QN7(ZC-13W4,$8>6154L%!
MSW)P/UK,719E5E-[(P(89/7D5:N],6YT^*V#8\MT<$\\J0?Z4 7(YXY1E&!I
MV]3G# XZX-9,NCEHT$<QCD!8LZGKD$5+I^G36C.9;DRY3:!C]: '6^KVMY.8
M8A,2"1N:%@O'7DC%:.1CK6:FFO#9/#'-\[$D%N@R<U532;E$0&Y$@4GY6SCG
MZ'- &PUPBOL)^;TQ1%/',"4<-@X..U9S:=.9MXE4 @+@9XP,<55_LR>P@D:%
MR9?,#IMR=QZ'/YT =!2%@.M4&M)3:B-9B)@=VX^IZ_A4,6GW"0M&]QN.,*?Q
MR<T 7UN(F;:LBDY(X/<=:>[I$A=V"J.I)P*QK?12DDF\C:99)!ACR6.15AM/
ME;21:RD2.OO0!=%W;F/S/.CV],[A2M<P*BLTT85NA+#!K*>PN)(UW#E7RH4J
M&_'L?RJ6&SN8V\R6-)R1@(<?+_2@"X^HV<<@C>[@5ST4R#)I\=W;ROLCN(G;
M^ZK@FLZ32_.U&RN7BB AB=7  ZG&/Y&K%C8?8XDR=S@8/ X_'% &C10.E% !
M1110 4444 %%%% !1110 4444 %%%% !5:^_X\+G_KDW\C5FJU]_QX7/_7)O
MY&@"S1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;'^-:T5['*45,EFSQZ8]: +=%9CZO%'.\3QR+M'#8&&/H.:C_MN#'S13)(2
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MNJNI5@"IZ@USW]KSM.R%_*4(S+^[SNP3@=*$UF=Y9U*X>)HP(0O+!@"?YYH
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M7WF"+</XM@S4J(B#"*% X  Q4E% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !5:^_P"/"Y_ZY-_(U9JM??\ 'A<_]<F_D: +-%%% !1110 4444
M%%%% !115:[O([.+>^22<*HZDT 6:*ACF\V 2JIY&0.]9L&NQRS7$;V\L1@<
M)(6' )QC^8H V**K"]MBFX3)MSC.[O1/=16\/FNWRGICO]* +-%5H+M)\_(\
M9!QB1=IJ0W$0."ZYQGK0!+15:*[@FB$B."I) .>IJ7S8]VW<,^F: )**894
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M 5P/6IY;I(2H*L68$@*,GBJ\.DV\,J2!G9DP%R>@%3S6BS2+('9& (RIZ@T
M0V]_]IOGCCYB6-7#8ZYST_*H8]6=H99&A&4!/EAOF'U%6[:QAM&)BR!M"X]
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MS:PE578,*NT>PH SO[9PN6MI$SMV@CU^E7)+T);1RA2QD(55'J:5[*!QT=2
M!E6(.!0;& VJP;2(T^[@X(_&@"FFI/<:I%;1J47!,F0#R.U(VHSB[FB\HE4E
M5%QW!-7(;"W@=7C0[U&-Q.2?K2_88/M#3[3O8@GGC(]J *O]N6^2NR3>HRZX
M^[]:LW-_':P+,P9D(S\HZ"F/I5HSE]A#,<DAB,TZXT^"Z"B3=\H*\,1P: $_
MM*+<P"N=J[B<=L9IO]HQ;$<AE#$@ @9/&:>=.A,RRDON487YCQQBHVTN$(VU
M2SDEAECU(Q0 TZM"-P\N3>K!2F!G)Z?SI1JT!C+!9/E!+#'*@=<TRSTTQN\D
MY)9F##YB>F/\*FBTN"+S=N[]Z"&Y]: (QK$! ^5PS?<4X!?C/'/I2G5;?*@;
MF8H7*@= #@Y^AI)])MIS&S+\\8 1B,[>,?RIZ:7 A+*""8C$<>A.3^M "V=]
M]KN;B,1D)$5VO_>!&:OU2M[%;65GC=L,%!7Z# J[0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !5:^_P"/"Y_ZY-_(U9JM
M??\ 'A<_]<F_D: +-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MTV:XCMX]\K;5SC-8\%C=1NJ[0&5BSS[\[_;';-27FEO/HL=J!N=2"06ZX]Z
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M&&5L\YR0?Y4EGJTTR[7A5IFD9456QP* -JBH+6X%U LH4KG^%NHJ>@ HHHH
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M\J0(J]% ^@IU)F@ VCT'Y4WRTY^5>>O%/HH 9Y4>,;%P/:@QH1@J.N>E/HH
MC\B/<6V+D]\4GV>+G$:\^U2T4 1B&,9P@&>O%"PHBE54!3U&*DHH A^RP[]_
MEKNQC.*5H(F&&13QCIVJ6B@"%;:%&!6-01THEM89G5Y(U9EZ$U-10 P1JJD
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MG\M"JC)VC.#BB-7=7?R _(R=^#4+SO(&W ,3WQS3/,;8%[9IWL]";.VI;1)
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MU'XC.IL7Z***ZS$**** "JU]_P >%S_UR;^1JS5:^_X\+G_KDW\C0!9HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@!,4M%% !1110 4444 %)@4M% !28'I2T4 )@>E&T>@I:* $VKZ#\J3:O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "JU]_P >%S_UR;^1JS5:^_X\+G_KDW\C0!9HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*K7W_'A<_P#7)OY&K-5K[_CPN?\ KDW\C0!9HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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'3Z?6@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>cosm_ex101img4.jpg
<TEXT>
begin 644 cosm_ex101img4.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 1, R # 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ JM??\ 'A<_]<F_D:LU6OO^/"Y_ZY-_(T 6:*** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!"
M0!DTM%% !1110 56OO\ CPN?^N3?R-6:K7W_ !X7/_7)OY&@"S1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 56OO^/"Y_ZY-_(U9JM??\>%S_ -<F_D: +-%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !5:^_X\+G_ *Y-_(U9JM??\>%S_P!<F_D: +-%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%)2T %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %5K[_CPN?^N3?R-6:K7W_'A<_P#7)OY&@"S1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MH Z6BL*XOI_M=S$L\<3Q$>7&RY\P8S_]:JC:I>")?)GCFD<8?"_ZHEN_TZ4
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MI7+1%FVMRAY0C!)^M &^RAU*D<$8-"1I&@1% 4= *YLZG?VX'VAHF,@!4JA
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M444 %5K[_CPN?^N3?R-6:K7W_'A<_P#7)OY&@"S1110 4444 %%%% !1110
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MJXF<("P<C[I)'\S4MQI\,[;V:16( +(Y4X'THLKX7GGX0J(I3'D]\8Y_6KM
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MB&/W9 (XZ?2M.B@"A!IR6\F8Y'$8)81YX!-..G0%9U*\3.'<9ZD8_P *NT4
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MJ_10!!-;1S6S0%<(PQ@<50CT6VB1U^=MZ[22?Q/YD5K44 9L.DQ07:7".P9
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M98X(^S1X*[>G;KB@#/GU.^M]1BCD2/R_*9V"G))R /YU(-7G62.![=#-)C:
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MLRY"[FSB@"[1110 4444 %%%% !1110 56OO^/"Y_P"N3?R-6:K7W_'A<_\
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M<@LS$$9'S8S_ "I8M,V:HMS_  I$$'/6@"5]21+@PD%GS@*HY-1PZM;W+*(
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M.A**&;GH#WK.?1Y%U5KZ&1 =B(J,/E&,Y-5W\/3B6YDBFB#7482;(/;/3\Z
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MK^U5D4S)ESA<'.34L=Q%)&LBNNUNG-8D6DW*O$S&,K&Y*K@94'Z41:',MO'
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M44 %%%% !5:^_P"/"Y_ZY-_(U9JM??\ 'A<_]<F_D: +-%%% !1110 4444
M%%%% !1110!G7=DT^IV-T& 6W9R1ZY4C^M4WT>;,[1LFZ:7<Q(SQC&.:W:3(
MH Y=-!O3I[V\\L<TCG(D8?<&[( _"I[70KJ"="]V9$!!)(&?IG&:W1-&TK1!
MQO49(SR*DR.HH S?LDUO?7%Q!L;[1M+A^Q  _+ JE<:-=3+(RW 21I0^0,Y&
M.G/:MG[1'Y_D[AYFW?CVSBE\^+SA#YB^85W!<\X]: ,--%GC!+%9E967RWP
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M$@?HH R/T-=#10!AZG93S7;R10EV:W\M'#XVODD'\*K6-AJL5VAN)$8@@M*
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MD\2AG#GY7;H?YUT%,DC65"C@%3U!H JV/F"W7S=V]_G.>V>WX5=HHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "JU]_P >%S_UR;^1JS5:^_X\
M+G_KDW\C0!9HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *K7W_'A<_P#7)OY&K-5K[_CPN?\
MKDW\C0!9HHHH **** "BBB@ HHHH **** *<E];17(@>3;(5+X(/0=?Y4L%]
M#<R-&FX,!D9'4>HJK>Z:]W?Q3;U$:1LA'<[@1_6I+>TFC9&DE!\M=B #MZ_E
M0 -J!%W+$J#;$<-DX)XSP.]1PZHTBO*8L1*"1@_-QZBF7^E3WTG_ !\+&FY6
M#*@WK@@X!].*BFT>2:X22:90$SS&NTOD$?-CTSG\* )OM]W]E>86>,1>:NYN
M,>A]\5"-5O#:VLIM8PURP" OT!4GFK<5I=>4\4]PK1^68U 'MC)IR:<H@LXF
M(<6V,9&<X7% $B7?EVGG7A2/GG:<BA-2M'<(LP+'IP:6[LUN;<0@A%!!X'I5
M*31"]NL:3%&6X:<,/4Y_QH NQWUM*<)*"<[<8(YJ1[J&.,R/( @.TGWK#FT:
MZCLY]K[IWV[2AY4CODUH-IF_3X;8ORA#,W]XB@"S]OMMVWS1G..G>F#4[,_\
MMU&1GD$50;0BUQ(3+^Y>0R8W'()]NE5;G1KZZN(EDDC*I R*X'0\8S0!NM=P
MK(5,B_*"6YZ4?;K;>$\X;CSBLY=%D9YI)9E+RJ00!P,TDNA*^H/=+(0) H==
MYQQGMT[T :4MW!"0)'P2,XP31]NM@S*9E!4<U5GLI3<//;RJKO&$.\9 QT(_
M.JK:*TBM')*&CW,XXP<D#].* +5UJ]M#$&2168NJ '/5C@5/]M@1-TDJK\F\
M^P'>L^;0_-U/[6)@%Q"-F/[C%OUS4[Z2KPSQE_\ 6P&'D=,Y_P : + U.S)
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MEP6;:J18R3^) JC/H\EU,DT@A5DX"QLR@\=\=ZL/I@>TAMP=JH^XX<^_0]:
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M?'H\JP1J=Q<0 ,?-/WQCGK]: .@R,X[T9&<>E8ME;7<-\6:-BI#;GDDSSGC
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !28&<XI:* "BBB@
MI, =!2T4 %%%% !1110 4444 %%%% !1110 4UE5AA@"/<4ZB@ HHHH ;M7.
M[ SZXIU%% !1110 4444 %%%% !1110 4444 %%%% !1110 @4*, 4UD5_O
M''J*?10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %5K[_CPN?\ KDW\C5FJU]_QX7/_ %R;^1H LT444 %%%% !1110 4444 %%
M%% !1110 5'Y2>9YFT;\8S[5)10 4444 %%%% !1110 4444 %%%% !1110
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M/J#Q6QO4-M+#/IFCS$QG>OYT 8[:5*]FUF7B$>" ^/G_ !I4T=VO8[F<P_*
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ML:[F(51U).!3ACJ,<T 87]A;H+4S.99H4"9)P,=^!]!226-X(Y(DVF-Y788
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MGDCF-F6;9#N.X9 Q[XJ.YL+N6RF@N(Y9)'BQ&5;@=>M=510!BZ=%/!,L;(S
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M-B[MV!GUH YR.34W: .TR2^8%E4#C&#EL^E.>[U">TW0[]T<BQR$#'(SN/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5K[_ (\+G_KD
MW\C5FJU]_P >%S_UR;^1H LT444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5K[_CPN?^N3?R-6
M:K7W_'A<_P#7)OY&@"S1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 56OO^/"Y_P"N3?R-6:K7
MW_'A<_\ 7)OY&@"S1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 56OO^/"Y_ZY-_(U9JM??\>%
MS_UR;^1H LT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %5K[_ (\+G_KDW\C5FJU]_P >%S_U
MR;^1H LT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %5K[_CPN?^N3?R-6:K7W_'A<_P#7)OY&
M@"S1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 56OO^/"Y_P"N3?R-6:K7W_'A<_\ 7)OY&@"S
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 56OO^/"Y_ZY-_(U9JM??\>%S_UR;^1H LT444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %5K[_ (\+G_KDW\C5FJU]_P >%S_UR;^1H LT444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %5K[_CPN?^N3?R-6:K7W_'A<_P#7)OY&@"S1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 56OO^/"Y_P"N3?R-6:K7W_'A<_\ 7)OY&@"S1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 56OO^/"Y_ZY-_(U9JM??\>%S_UR;^1H LT444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M5K[_ (\+G_KDW\C5FJU]_P >%S_UR;^1H LT444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5K[
M_CPN?^N3?R-6:K7W_'A<_P#7)OY&@"S1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 56OO^/"Y
M_P"N3?R-6:K7W_'A<_\ 7)OY&@"S1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 56OO^/"Y_ZY
M-_(U9JM??\>%S_UR;^1H LT444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5K[_ (\+G_KDW\C5
MFJU]_P >%S_UR;^1H LT444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %5K[_CPN?^N3?R-6:K7W
M_'A<_P#7)OY&@"S1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 56OO^/"Y_P"N3?R-6:K7W_'A
M<_\ 7)OY&@"S1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 56OO^/"Y_ZY-_(U9JM??\>%S_UR
M;^1H LT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %5K[_ (\+G_KDW\C5FJU]_P >%S_UR;^1
MH LT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %5K[_CPN?^N3?R-6:K7W_'A<_P#7)OY&@"S1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 56OO^/"Y_P"N3?R-6:K7W_'A<_\ 7)OY&@"S1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 56OO^/"Y_ZY-_(U9JM??\>%S_UR;^1H LT444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %5K[_ (\+G_KDW\C5FJU]_P >%S_UR;^1H LT444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %5K[_CPN?^N3?R-6:K7W_'A<_P#7)OY&@"S1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 56OO^/"Y_P"N3?R-6:K7W_'A<_\ 7)OY&@"S1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 56OO^/"Y_ZY-_(U9JM??\>%S_UR;^1H LT444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5K[_
M (\+G_KDW\C5FJU]_P >%S_UR;^1H LT444 %%%% !11VJD^JV<;NC3 ,APP
M]* +M%4!J]D5+><,#K3O[4M,C]Z.:GF0%VBJO]H6W_/5::=3M0?]:*.9 7**
MIC4[1EW"5<4)JEF_2933N@+E%5#J5H.LZCG'6C^TK0C(G3&<=:+H"W14'VR
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M4%^@S318E3MD('&0!5@Z?? \H^!T.:3[#>YP%?GKS2Y'V'?S*Z6C&$/E1NZ
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M 56OO^/"Y_ZY-_(U9JM??\>%S_UR;^1H LT444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5K[_
M (\+G_KDW\C5FJU]_P >%S_UR;^1H LT444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5K[_CPN
M?^N3?R-6:K7W_'A<_P#7)OY&@"S1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 56OO^/"Y_P"N
M3?R-6:K7W_'A<_\ 7)OY&@"S1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 56OO^/"Y_ZY-_(U
M9JM??\>%S_UR;^1H LT5S/\ PD%W_P \X/\ OD_XT?\ "07?_/.#_OD_XT =
M-17,_P#"07?_ #S@_P"^3_C1_P )!=_\\X/^^3_C0!TU%<S_ ,)!=_\ /.#_
M +Y/^-'_  D%W_SS@_[Y/^- '345S/\ PD%W_P \X/\ OD_XT?\ "07?_/.#
M_OD_XT =-17,_P#"07?_ #S@_P"^3_C1_P )!=_\\X/^^3_C0!TU%<S_ ,)!
M=_\ /.#_ +Y/^-'_  D%W_SS@_[Y/^- '345S/\ PD%W_P \X/\ OD_XT?\
M"07?_/.#_OD_XT =-17,_P#"07?_ #S@_P"^3_C1_P )!=_\\X/^^3_C0!TU
M%<S_ ,)!=_\ /.#_ +Y/^-'_  D%W_SS@_[Y/^- '345S/\ PD%W_P \X/\
MOD_XT?\ "07?_/.#_OD_XT =-17,_P#"07?_ #S@_P"^3_C1_P )!=_\\X/^
M^3_C0!TU%<S_ ,)!=_\ /.#_ +Y/^-'_  D%W_SS@_[Y/^- '345S/\ PD%W
M_P \X/\ OD_XT?\ "07?_/.#_OD_XT =-17,_P#"07?_ #S@_P"^3_C1_P )
M!=_\\X/^^3_C0!TU%<S_ ,)!=_\ /.#_ +Y/^-'_  D%W_SS@_[Y/^- '345
MS/\ PD%W_P \X/\ OD_XT?\ "07?_/.#_OD_XT =-17,_P#"07?_ #S@_P"^
M3_C1_P )!=_\\X/^^3_C0!TU%<S_ ,)!=_\ /.#_ +Y/^-'_  D%W_SS@_[Y
M/^- '345S/\ PD%W_P \X/\ OD_XT?\ "07?_/.#_OD_XT =-17,_P#"07?_
M #S@_P"^3_C1_P )!=_\\X/^^3_C0!TU%<S_ ,)!=_\ /.#_ +Y/^-'_  D%
MW_SS@_[Y/^- '345S/\ PD%W_P \X/\ OD_XT?\ "07?_/.#_OD_XT =-17,
M_P#"07?_ #S@_P"^3_C1_P )!=_\\X/^^3_C0!TU%<S_ ,)!=_\ /.#_ +Y/
M^-'_  D%W_SS@_[Y/^- '345S/\ PD%W_P \X/\ OD_XT?\ "07?_/.#_OD_
MXT =-17,_P#"07?_ #S@_P"^3_C1_P )!=_\\X/^^3_C0!TU%<S_ ,)!=_\
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M\X/^^3_C0!TU%<S_ ,)!=_\ /.#_ +Y/^-'_  D%W_SS@_[Y/^- '345S/\
MPD%W_P \X/\ OD_XT?\ "07?_/.#_OD_XT =-17,_P#"07?_ #S@_P"^3_C1
M_P )!=_\\X/^^3_C0!TU%<S_ ,)!=_\ /.#_ +Y/^-'_  D%W_SS@_[Y/^-
M'345S/\ PD%W_P \X/\ OD_XT?\ "07?_/.#_OD_XT =-17,_P#"07?_ #S@
M_P"^3_C1_P )!=_\\X/^^3_C0!TU%<S_ ,)!=_\ /.#_ +Y/^-'_  D%W_SS
M@_[Y/^- '345S/\ PD%W_P \X/\ OD_XT?\ "07?_/.#_OD_XT =-17,_P#"
M07?_ #S@_P"^3_C1_P )!=_\\X/^^3_C0!TU%<S_ ,)!=_\ /.#_ +Y/^-'_
M  D%W_SS@_[Y/^- '345S/\ PD%W_P \X/\ OD_XT?\ "07?_/.#_OD_XT =
M-17,_P#"07?_ #S@_P"^3_C1_P )!=_\\X/^^3_C0!TU%<S_ ,)!=_\ /.#_
M +Y/^-'_  D%W_SS@_[Y/^- '345S/\ PD%W_P \X/\ OD_XT?\ "07?_/.#
M_OD_XT =-5:^_P"/"Y_ZY-_(UA?\)!=_\\X/^^3_ (U#>^(+O[!<_NX?]4W\
')]/K0!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>cosm_ex101img5.jpg
<TEXT>
begin 644 cosm_ex101img5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 1, R # 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ JM??\ 'A<_]<F_D:LU6OO^/"Y_ZY-_(T 6:*** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "JU]_QX7/\ UR;^1JS5:^_X\+G_ *Y-_(T 6:*** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "JU]_QX7/_ %R;^1JS5:^_X\+G_KDW\C0!9HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH *K7W_'A<_]<F_D:LU6OO\ CPN?^N3?R- %FBBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JM
M??\ 'A<_]<F_D:LU6OO^/"Y_ZY-_(T 6:*** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGS17)OE(HFSRV[/O4YMBT0?S!&H R<>M'MYA[-=SI/[3M-VWS?TI_P!OMO\
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MBCK?[7L\9\T\?[)IIUJR"Y,C?]\&N1,G. :-^2/FZ=C1]8EV'[%'8#6;(_\
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M(7=U_AQG_"KPOXI87:$A]L?F>W3.* +FT=Z7BJLMX(K%;E\*"%)_''^-4O\
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MH[T ,D021.AZ,"#6>FE%8FA>YD>$C 0J!C\1S6G10!D_V-&RD3RR3$JJ@MV
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M=,9YQCZYH U**S/[8MPX1DF$A. FSGIG^55)-?Q-<".%FCC165L=<D CZC-
M&]168=9M4D:-Q(LBL%*E><D9%:"MN4, 1D9YH ?1110 4444 %%%% !1110
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M]_QX7/\ UR;^1H LT444 %%%% !1110 4444 %-?[A^E.IK_ '#]* ,S1?\
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M"0L8G?:93]WIDX[T ;]%9']MVWS[@RE0&49!W@G Q@^OK4$6N22+JA-JRFR
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M+0 5C7'_ ",-O_US/]:V:Q[G/_"06W _U?7\ZB>PX[FQ1115B"BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M74T4 <U'X8:/:3-#)M&U5>(E5&<\#-7KW29;B6"6&=(VCC\LY3((]N>*UZ*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "L6<G_ (26 ;O^61X_.MJL2;'_  DT Q_R
MR//YU,BHFW1115$A1110 4444 %%%% !5:^_X\+G_KDW\C5FJU]_QX7/_7)O
MY&@"S1110 4444 %%%% !1110 4Q_N$^U/IDO^K;Z4 9^CY-JS'H7./SJI<W
M+S:I<027+VJ0(&0J<;O?W],5;T?_ (]& Z!SC\ZM3VEM<,K30I(R'*EES@U$
M/A14MS);7@F^)$$LL?'7&[Y<Y]LU5A\174C&9X(E18LM&)"2&+X':N@-E:F5
MY3;QF1QAFVC)'O3$TZS1 B6L2J 0 $'&>M628C^([H;E2SB9T(WD2':03C@X
MYI6\17BR^3]@0R %F_>\8SC@XZ^U;L=E:Q1A([>-$'154 4V;3[.XQYUK%)@
MY&Y <&@# ?7;N>XMU2!8HWDVYW?,0%)QTXY%2P:Y-=1)*\:PNDJAXU?.00>O
M%;,NGVTQBS&H\I]Z8'0X(_J::-.M$"+'"B*K[]J+@$^_YT 7J*** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K%D7_
M (J6)N_E'^M;58KG_BIHQ@<P_P!34RV&C:HHHJA!1110 4444 %%%% !5:^_
MX\+G_KDW\C5FJU]_QX7/_7)OY&@"S1110 4444 %%%% !1110 4R3_5M]*?3
M7^XWTH SM(!%HV?[Y_G6G69I'-JW.<.?YUI5$/A14MQ:***LD***2@!:***
M"BDI>] !1110 444G- "T44=Z "BDI: "BBB@ HI*6@ HI.]% "T4E+0 44E
M% "T444 %%%)0 M%)10 M%%% !124O>@ HI.]% "T4E% "T4E+0 44E% "T4
M4E "T444 %%)2T %%%% !1110 4444 %%)10 M%)2T %%%% !1110 4444 %
M%)10 M%%% !1110 4444 %%%% "5B2+GQ1$V.D1!/YUMUDO_ ,A^/C^ \_G4
MRV'$UZ***H04444 %%%% !1110 56OO^/"Y_ZY-_(U9JM??\>%S_ -<F_D:
M+-%%% !1110 4444 %%%% !3)?\ 5M]*?3)?]6WTH S=#!%K)EB?WAHO=3>T
MO(H/LCR>:3M8, .!D_RHT,8M).O^L/6IKRQ-U<6\P?;Y.[CURI']:B'PH<MQ
MMMJUG=6YF6XB"@D,#(/EYQS1J&J6^GZ<UXY\R($#,?/4@=OK65<>&B]JD<3Q
MAE!X93M8[L\XYJS_ &)NT,:<Y09;<VP';][/&3FK$6AK-F;S[,955_($Y+'
M"D@#/YBK/V^U*AEN86!Z$2#FN>'A:9(YF2[5KB52FYUR-N\$#\  *AM?"MU
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M^EQ+/<VTLQ.&!1MH7/89ZUU$48CB1,_= % $E%%% !1^-+24 %+244 %%%%
M!111C- !WI:2C% $<LJPQ/*YPJ*68^@%9O\ ;=NI961U?8KJ"/O*3@'/UK0G
MC\RWDCP#O4K@].:Y\:!<&9YY%B<B-8TC<G& V>QH T+C4Y8)(]ULVQE)/?\
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M%+10 E9$I;_A(H1CCRSS^=;%8TS?\5' N/\ EF><?6IEL-;FS1115""BBB@
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M[YI_5WW#VR['%#?NSC)HPV3Q@^AKM/LL'_/)/RH-K >L2?E1]7?</;>1Q1W
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MGSQ[AROL;%%8_P#PD-M_SSDS]*#XAM0VW8_UQ1SQ[ARLV**QQXAMB<;'I?\
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M[;>,5J/X>O$F;"JZ?PG--&A7@! AXQT)KA=.?8ZE.)E XR".*.<X ]R:U/[
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 48HHH **** $
MQ1BEHH *3%+10 F*,4M% !1110 F*,4M% !1110 4F*6B@!,4M%% "8I:**
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M.*02Q+(IRK#(J2HH4:.%$9MQ48)QUJ6@ HHHH **** "DI:* "BBB@ HHHH
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MHHHH **3M10 M%)WH% "T4E&: %HI#1F@!:**2@!:*3-% "T4F:* %HHI,T
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M1EFGC"C'S%@ <].:;=:C;6D*2S2J$<X4CG/TK'3P](KC=*I021N%(XPJLO\
M6K-YH\L^D6MFDB;H2N69<YP,4 7HM1LIK87"7,1B/\6\8&:?<WL%I:-=2R#R
M5&=R\Y^F.M8,WAF4Q(L$RIM\OY=O!V@@_P ZN3Z+)<6-G:-<E(X2&?8.6(Z=
M>U &DM_:M%')]HC"R#*%F R*/[0L\E?M4&0<$>8.M<G>Z!?0[K:!_-CDC\I"
MR$E5'3D=#[U;D\+3F")8YXPP#!]RG#9Q_A0!TAN8 S*9HP5&6&X<"DM[F*Y5
MFA=756VDJ<C-<\_AF[:2XQ=J$EW8^4Y&0!CZ<5LZ79R64$JRE"SR%_D7 ' '
M]* -#O124M !24N.:.AH BGF2W@>5\[4&3@9-9YUJ/=$T<,C0R+N\S& /;ZU
M?N(VFMY(U(!92,D<5F?V0S6L=O)-E8QP%&!G/>@"_)>1P6HN)P44XXZGGI47
M]J6NP-N<DG&P(=P^HZU7N=.N&TM+>*0/(KJ=S>@;-5Y?#BS73WDCJUPY^;J%
MQC'0&@#4BO[>:39&VYAUP,X^OI4)U>S4G,AX)'"GDCJ!ZT^PT^.Q$H3_ ):8
M) [8&*C728PL8S]R1W''][/^- #_ .U+0*KF4;6 .[L,],^GXU%-K=E$DC;R
MVS(^4=2#@@>IJ!=!*)+"LW[J;'F CGCICTI)O#R26\<*2% DK2Y ZYSQ^M $
MT&N6TUR\)5T*JC98?WAGGTJU<:A;V\@25\$C)&,X'OZ51&B92ZW2_O+A8U9@
M.FT=JGN],::XDEBE"&50DFX9X'I0!;BNX9]YC?<$."1T_.H(]4M9@61R1MW#
MY3\P]1ZTMGIXL;*2WC;<"S%<^]9,.AW<EK;)/,B-!'L5$!P0>H8]^G;% &H=
M5M BG><MG"[3NXZ\=:C&MVYT9=3"R>21G&TY_*HK31Q;7"S,R_*9"  <?-CU
M^E/32671!IYD4[5VJ^W^= $L6L6DDK1E]C!RGS<<\?XTXZM9A"QF  ('/&<^
MGK5*ZT%;RR:WEDQOG$K,@P>W%06_AM8GC9S&3&Z,I4-T!SSDT :QU&U$JQE\
M,>.1P#Z9]:K76O65M TF\NP( 11RQ)P,?C56?PW%<7LLK[#'*^]LEMP/MSCM
MZ4Y]#EF$2S31;(74QA4P>#GF@#;B<R1(Y4J6&<'M3Z0#  I: %I#1WHH ***
M* "D[TM% !111B@ HI*6@ HHHH .]'.:*.U "&EHYHH **,44 %9$(_XJ"8_
M[/\ 2M?M6/;<Z]<'=GCI^%1/=%1ZFS1115DA1110 4444 %%%% !5:^_X\+G
M_KDW\C5FJU]_QX7/_7)OY&@"S1110 4444 %%%% !1110 57O&"VDS'H$8G\
MJL56OQNL+@>L;?RI/8"KHKAM,B;L<_SK1)%9VAC&E0CV/\ZY^"/4YKF]N8D?
M]W-E7,W4 <C;CO\ 6IA\**E\3.PR*7(Q7'KK6K3%8HY+<M))@,$)\L8S@C/)
M]Z5-=OXXB3L#1OM$+)\T_/53V_7I5DG79HW"N;TW4KJXO[AI)XY0EN[")%P4
M(;@'WJF?$&H;0L;P3/* 594($1) VL.Y_P * .PR*7(K!EU6XMM"EN)V1;A'
M:,,$R"0<9Q21ZO<-X=2\RAF8[?,VX4?[1'I0!O$BC<*XX^)[J.Z@A,L#MOV.
M5C.'X/.<\=/>HIM;U.ZDAB@E1)ENU!(7Y=I#''OT'/% ';9&: 17/WVH70T2
MPNQ(D,TDB;R1E>0<U2_X26X-SIZA543JF]2G]X'OVZ>E '6Y%+FN,'B6Y<*7
M4>8IR<':OX^HK>T+49-2L#++C>KE3A<=/:@#4R.YI<BC%% "9'>BEQ10 4=*
M.E'- !]:44G6C% !Q1D444 '%&1110 A(Z4N11VI* #BC('4T4O% "<>HHR.
ME**.] "<9I<CUHI: #-&:2CM0 M%)P:,4 % -+CVI* #(]:.#1BCI0 >U':E
MI*  =:7BBB@ ZT4"B@ HHHH **** #ZT444 %)S2]Z3% !BE[4E*: #M1110
M 4444 +28HHH *.:*6@!*6DI.: %Q1T%)TH[\4 +111WH ***3F@!:**.M !
MVXHHSS10 5DVJ_\ $ZN3@C_]5:U8]J['7;A<G:.WX5$MT4NILT4459(4444
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M'J;-%%%62%%%% !1110 4444 %5K[_CPN?\ KDW\C5FJU]_QX7/_ %R;^1H
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MC@9;&>U227EO%(L<DT:NWW5+#)H LT566]MG8JL\1(." XH>]M8W"/<1*QZ
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M1SZTG.: %HQ1S1S0 4M)S2<XH =12<T<T +24GXTO- !12TG.: #M0*.:.:
M%I*.:.: "EIO-+0 &CO1FCM0 44<T<T %'>CFB@ [TM)S1S0 M(:** "EI**
M %H[4G-'O0 449HZT  HHHH 6D[T4M !1110 4444 %%%)0 M)2T4 %%)2T
M%%%)0 M)2T4 %%%)0 M%)10 M%%% !2=Z6B@ HHHH 3%+110 4E+10 4444
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MQ!3(ZKN8*,GJ3VJ:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@!,4M%% !1110 F**6B@ I*6B@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** $H[TM% "4M%% !24M% !1110 E+110
M4444 %%%% !1110 G:LO3N;VZ;C[W%:M8^E#_3+L_P"U42W12V9L44459(44
M44 %%%% !1110 56OO\ CPN?^N3?R-6:K7W_ !X7/_7)OY&@"S1110 4444
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M%% !1110 4444 )VK)TCF:Z(R!OK6K*T<G=<AEQB0U+W12V9K44451(4444
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M&[! -O(?H*/:5>P<D#7_ +>'7R3COS3AKJ'/[KZ?-6-]AN@.(&Z^E+]BN_\
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M%% !1110 4444 %%%% !12;AZBC</4?G0 M%-WKZC\Z7<OJ* %HI-P]11D4
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ME^^.E6H;B*X3?$X9:XG/'IFMSP](Q>1#TQFM(57)V)E!)7.@HHHK<R"BBB@
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M)L[G*CR)N3_<-=)I%@UI$6D&';MZ5I8HJX4E%W)E-O06BBBM2 HHHH ****
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M%MLDZ*=H;!/8G /YT 6Z*J1ZA:2D!)T8G.,'TH_M*SVEOM"8!P>: +=%9_\
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M<CWKI:* ,*6UF:6*2&%DB4Y\LGD?A50:;<0W=U=.I$KP*$E!^Z1G.:ZBDP*
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ML$>.H/>MW8O]T?E2X'H* , :E=/<0Q031RAR [;?N9_&G7.H2VCNS,H196!
M^\V .@[UN!%'10/PH**>J@_A0!@?VI?,9&5(N,XC+_-C'I3;"YEG\12;ITEC
M^S*1LZ Y;/XUT.Q<YVC\J BJ<A0#["@#FK/5+@00K')'.Y$C.@^\H4D_K6I!
MJ'G6,UYP(5!*$<\ <_KFKS0HR,H&W<,948-$4$<,"PHH" 8Q0!DP7TEY::@L
MA7]VAVLGH5S_ %JLK)916PLV#AD)F4MGC;G/YUT(1 " H /7BA8HUSA ,^U
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M#^(XQ2_:K? /GQX/3YA5-K";^ST@5D+;PTF>C#N*KIH[K'<KF,"0$( /NY%
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M0?PI=J^@I:* &&*,GE%/X4%%(P5!'H13Z* &>5&<91>.G%(88R<E%/U%244
M1F&,]8T_[YH\I,8V+@C!&*DHH C\J/=NV+N]<<TI1=N-HQUQBGT4 48M/6.Y
M$Y<L5SM&!QGK5KRH]Q;8N3R3BI** &JJHN%  ]!3J** "BBB@ HHHH ****
M"BBB@ JM??\ 'A<_]<F_D:LU6OO^/"Y_ZY-_(T 6:*** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ IK*&7##(-.HH .@HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2E0D@;<NX8[B@">BDW#.,U&)XFF:(.#(HR5[B@"6BDR/6C(]: %HI,CUHR*
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M<?A1<6PG*,&*.F<,*4W<"KDR#KC'O41U"#RW8$_(,D,-I/YT +9V<5FI6($
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M2!YI)Y) LK1X$0Z=CTJ!;W43,?*'VEXL_,1M!'?TS73;01@@&D"*HP% ^@H
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MC. S E_/+D[S]WGWK88A1D]** .>.EW0C@# R"*6-PN_L <_SJU?V5Q-?+-
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MJU::C</=K',J[7:15V@C&UB!^@K8$:*NU44+Z 4;$!R%&?I0!R\-Q=M+Y0N
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MM\$6(R)YN?FD\@E1[8SSGUKIMH]!2%%(Y _*@#"U.6]N=-LC!*D+RSHK[E+
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M)P'YP"32JY"A3M9,$E">:/;2#D1NC6+3NQ'X4AU>U'0L<^@KGH8UD7>ZD\$
M ]/<T^! (E<@[LL,#\*%6D#@CH/[6MLXRWY4T:Q;%B/GX[XKG+@,C#D<C/\
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MY-_(T 6:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "JU]_P >%S_UR;^1JS5:^_X\+G_KDW\C
M0!9HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *K7W_'A<_P#7)OY&K-5K[_CPN?\ KDW\C0!9
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *K7W_'A<_\ 7)OY&K-5K[_CPN?^N3?R- %FBBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ JM??\>%S_UR;^1JS5:^_P"/"Y_ZY-_(T 6:*** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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5:AO?$%W]@N?W</\ JF_A/I]: /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>cosm_ex101img6.jpg
<TEXT>
begin 644 cosm_ex101img6.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 1, R # 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ JM??\ 'A<_]<F_D:LU6OO^/"Y_ZY-_(T 6:*** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "JU]_QX7/\ UR;^1JS5:^_X\+G_ *Y-_(T 6:*** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "JU]_QX7/_ %R;^1JS5:^_X\+G_KDW\C0!9HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH *K7W_'A<_]<F_D:LU6OO\ CPN?^N3?R- %FBBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JM
M??\ 'A<_]<F_D:LU6OO^/"Y_ZY-_(T 6:*** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&0/45BR6TZR1L8Y6W;U+ 9*$G(/Y<4VQM[D-;(T1412%BY4KD<CIVZT =#3
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MFL+3(9_[469X9T40;7,@QELFHIK>[FMI(_+G\]DE$C'[K9!V_P!* .@2>*1
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MB@ HHHH **** "BBB@ JM??\>%S_ -<F_D:LU6OO^/"Y_P"N3?R- %FBBB@
MHH[44 %%%% !1110 4444 %%9E]//#*XAV@B-3DC_:P?TI3=M+IHFC)9MP!R
MN/XL'B@#2HK"TZ^O97@-P05E=UP$QMP3C^5,GU"<(Q297?>R^2$YQSW_ %H
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MIDV&3EPF[ V XY- '245SSZC?*#)A0JLBE-O7<P&?R-6+RXEBU+*S^6OV;<
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M:-WKBC8I;<0,CO3Z* &A%!)  S2>6A(.T9'3CI3Z* $VC&*38,8Q3J* &")
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MV*=L7&,<>E.HH :$51@ "C8N<X&?6G44 ,:-6&" :9+;QSA1(,A6W >]344
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M#$_-Z8_^M7644 9SH;C1Y;=%8,83'AACG;62=/G"[X$E1T6,)DGL>:Z>B@#
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MY-_(T 6:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "JU]_P >%S_UR;^1JS5:^_X\+G_KDW\C
M0!9HHHH **** "BBB@ HHHH **** (FFB1PC2*K'H">34=S=16D/FRDA<XX4
MD_D*S-2A=M3BF26565 H18@RM\W<D<5>O+9[NWB0C!# L,XH E@NHKA-T;'
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M[T ;4=Y;RQB1)5*$;MV>,4_SXMH;S$P>ASUKG8M)O45#L^6-47RMPPV&)/\
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M0KF:S\M-N]DE$A)^\67"_K5ZXL)9=/LHA$FZ IN0X[8Z?E0!JB6-G*!U+#J
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MT?K0!M^8F<;A^=.!S7+SV%QI]A#.)"IMXF9R7SEARN?6MS31(;-9)@1)+\[
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M!&".*6B@!GEIC&T8I=@QC'%.HH 8$7.=HR:=M'IUI:* $VKZ=:38N<X%.HH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#10!A2V]W+%<QRQ,[R B-A)@ %<>OKFK%G:3VUY@9\C[.HY;/SY.?TQ6I2T
M8(TV?;EC)N,;Y_>'ELG'?Z5&;:_:X7*.@4 %A)P1MP3UZUT5(0#0!CZ;-<W4
M,TSCA,Q1#/#8.,G\167>:7J-[;2)Y+*&*$J9>,AP3CGTS75*JHNU5 'H!3Z
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MFW'&!G_&NGHH Y9H]3CG9'#&+<5@QDD>YQ_6MBWMYO)N/.9F=V(&3V[5HT4
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MZ4R'6;B=TB6U42,')!DX 7'M[UI265K*)1) C"7'F9'WL=,TD5A:VY!BA1"
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MYI$C4-O;.1_=P2,G\JJC7/*4-<02)&7=1)QCY<_X59M+$6]W<W+$%YF&/]D
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M&T8&QRO\J *MY?/%8));LCR2$*A)X^M6;&Y^UV<<QP"PY ]:8FFVT9BVQ\1
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MF."3<70!3CD$XR*8VA1RWJ2R@&%-V$WL0=PQT/ _"KL.E6L'W$;J#RY/0Y%
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M<SQSL(Y%B59H\L1Q@J<YJ2WU":6[D@D*\HS(4&00/>@#9HKB;N_O5T.79/\
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MT%%9:7=W*$*>6/-SLR.@'KS3["\GN5B>5%59 < =L4 :-%%% !1110 4444
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M% &YL3.<#([T;$)R0":S;&YDFN45GR#%NQ[[C58ZK/:Q33.JRQJY 53\WY4
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MZYZ?RH TBH)!(Z=*A^RP;MWEKG&,XK-GUR&#4?LC8+ *3USSGI^5;"G(!]:
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M%?[PQP:K1ZK%+)&B1N=X!R< #G%/GU"*WNDA=6PQ W@C )Z#UH 4:?"+J"8
M 0 B-<=,\&II+.WF??)$K-C;G'4>GTJB-=M_+\UDD5&SY9./GQUQ3_[6C5&+
MPR*XVX0XR0QP#^= %L65NK[Q$H/T]L4W^S[0 @0)@]L>^?YU6.KP*N]HW6(Y
MQ(<8.!S_ (4C:Q"BYDAE1B 40XRP)P".: +BV5NA)6)<D8)QR:1[*WD^]$I^
M39R/X<YQ55]56,MF)V /."/E^N33(M:C9YP\3*$95CY'SY7/'- %J>QAFB*[
M$#;-@8KG ZTVQT];02EG\QY<;R1C.!BB#45N)8P@^1P1SU##M5^@#.ETFTDA
M>/R@-PQG'(&0<#\JE&FVPR?+^8G)?^+\ZN44 5OL=OQ^Z7A2N<=CUJ)=+M%C
M9/+R& !)//'2KU% %22PMY>63GGD'!YZT?8+41K&($"*00H' QTJW10!233;
M6--BQX&,#GH/05.]K#(ZNZ LHP#4U% %;[)%YJR8;</0]?KZU850HP*6B@ H
MHHH **** "BBB@ HHHH **** "BBB@ JM??\>%S_ -<F_D:LU6OO^/"Y_P"N
M3?R- %FBBB@ HHHH **** "BBB@ HHHH S[G3(+J;S9#(&V[3M<KD9SVH;2[
M:1T<J59  -K$9QZUH44 9L>D6D<S2*K$L22I<D<C!XI8M*MH49%#;6(."Q.,
M'-:-% &6VBV;RF7:RN6+DAB,D@C^1I+?0K2WE24>8\B+M5G<G ]*U:* ,X:5
M:BZ^T*&5@V_:"0,^N*L16L<4LDH'SR'YB3FK-% $1@0S>;CYL8S5&?1K6X9G
M8,'+[PP8Y!K3HH R)M"LYL;O,QL",!(?G Z9YYJ,:'F_$Q8",2^8%5VY/N.E
M;=% %"TTV"Q=C#N ;C!8X%6(8$@#;!RS%B3W-3T4 9LVE6UQ.\CAOW@"NH8@
M,!ZC\:)M*MIIQ*3(IXRJ.0#CU K2HH S_P"RK?[29@9 20Q4.=I(]JLBW19C
M-CYRH4_05/10!1;3+=[AYBI#N"&PQYR,4V32[9[=8MG"!@F2>,C%:%% &58Z
M8UK=/<.X9C&(P Q( !SWIYTJV,FX[RNXMLWG;DCTK2HH S(M'M8F8J&.<#!8
MX&#G^=(=&M3+))AOWA)8!CC)&/Y5J44 9S:5;,(\!@T0 1@QR,#'\J8=$MB6
M):0[\%LN>2.E:E% &8^BVKJ5P1\Y<$'D$YS_ #J86$(@AAP2D)!4%B<X&.?6
MKM% $-Q ES T,@RC#!P<53;2+=U^<N[<89G)QCI6E10!F'1[<Q^62Y0G)&X\
MG^E2?V3;EV=LL3ZFK]% &8FC6J#'SD!#&H+'Y5/:IDL(4DF< [I@ _)YQ5VB
M@"A_9EOM0;3\DOFCD_>HFTN*=W+O(4<Y9-QP:OT4 97]B6?EM%M/E,I79D]"
M,&G'1X24;S9=R'Y#O/%:=% &=;Z3;6L>R,-CR_+R6).,D_S)JM<:*DEI]FB;
M;&9%<@L> "#@?6MJB@"M)9Q2"(,,K$<JO:I)X$N(6BD7*FI:* ,@Z':LYD=I
M'EVA0[.3@ YXJU%IL$2D<DE2I)/8]:NT4 9?]BVPDW*648 *@]<# I;C2;><
M#.Y<(4X)Z'FM.B@"C;Z=%;1/$A;8RJN"<\ 8J*;1K.=[=WC^>WX0@D=L<^M:
M=% &3_8EN4PSNS!0B,3RH'84]M&@??N9B&8MC/<]:TZ* ,V?2X9I/,W,KY4@
M@^F<<?C2VFE0V<@>)G&$"8)SD"M&B@#-&CQY >5GB#[Q&>@-)%H\$;JQ9G*8
M";C]T#M6G10!G-I<1<NK,C%V?(/][&?Y"F1:1!!8P6L3,JP'*$G)_7K6I10!
MF1Z5%&J('8HAS@\\YSUHETBWENC.2P)97(SU(.16G10!@+X<3[!Y#REF&[:=
MQPN[.<?G5Z+2XD^9V9WPHW$]E.0/SK1HH RIM&BE1UWL%(;:F>%)&,TZ+2(E
M$9E=I'1%0$]@#G^=:=% &=+I4,D[R[BK.I1N^0:B.C0<\]U*Y ."!C//M6M1
M0!2M]/CMF5D8Y4$?F<U=HHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ JM??\>%S_ -<F_D:LU6OO^/"Y_P"N3?R- %FB
MBB@ HHHH **** "BBB@ HHHH **** "BBDS0 M%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%)FEH **** "BBB@ HHHH **3-+0 4444
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M )[XH S(M3NQ%LEDVW3@?NY$"A?4Y!.15N[^VQ6<S+?)YBX93Y0_EFIQIML
MP9"X8;?G.[ ]!GI4B6$"(Z;2V\88L<G% &3]IO\ =9Q&Z/[V$R.ZP@\Y''7W
MJYJUU-9:)/<1R#S8T!#LO&<]<5H+;QH4*K@HNU?84V>UBN87AF7=&_W@>] &
M/'J%R)PAF$T/F*IE\O;G(.1C\*DAUU9@&54V.A>-LG]>.*U)K>.=55QD*VX<
M]#4']F6^W;A]N,!=QPOT]* *HUKY/F1 P9E)+';Q[XI8=8BFN @QM:3RP><D
M_P"%3OI-M(A1O,*M]X;S\WU]:ECL(8I \89<=%#?+^5 %9]6\N=E:)A&LPA+
MGU-9VH>(YHM,:YMX1AT9H68]=O7(K;:R@<DL@.9!(?\ >'>H&TBS=65HLH5*
MA<\*#UP.U %5-;A\U8W(W JKXSG<?_UTV[U6ZAUF6U2-6A6!) >Y)8C'Z5?3
M3;>-PZ!@1C^(\X]:5["WENA<LG[T +D'J!R* *9U@JLH,8WPL0Z[O8'C\Z?8
M:A+>W%R H\I,;/7H#S4[Z5:O,\NPAW^\0<9XQ4MO8PVSLT2E2PYYZT 9$>LW
M0CMWDB!W+(S@=@I;^@JRVKKA2B$[F &[@#Y0U6AIUNJ[0AQAA@GL<Y_G0VG6
M[1&/#*A^\%8C/&.?PH 2XOTM]GF#&]-P]#CDC\J@DUA5MS,J97CDGKD9JW+8
M6\\$<,D8*1XVCTQ5=M'M&ACB"LBHQ9=C$$9SG^= $<FM*L1D2"1U"*QQ[D#'
MZTV?6XK6YBAF0AI...<'&>?RJY'IUO'$8PI*G&<MGITJ*31[26<S,K;BV[ 8
MXSC&<4 9USXC*0.$@=)C&)8P_1EW!3_.M)=33SO)9&$H<(5^H)_I39]&LKAD
M:2(DI%Y2G/1<@_S I4T\?VD+MCD)'L09R3TY/OQ0 RYU46MS,A5WV,B@!>/F
M!/7\*GDOUCM(IF1BTI"J@ZDGM2RV$4K.Q+J9"-VUB,X&!1_9UN+6.V"D1QD%
M,'D$=\T 5Y-5\M@C6TOFX+,@ R ._7WIAUN+S0L<$TJ$J Z 8).<8Y]JLOIT
M#\DR;L$;MYR0?>G+86ZA0L>T(X=0. ".G\Z *9UT&5HDM9GD7.\ #Y<?C2)K
MJ,SX7?E@(@/XJE?1HGO9)]SJ'!R%<C)/6G?V)9 \1D<C&&Z8H KR>(H8XW<V
M\^V)=TI"CY![\U(VMQI$2T,HDR L9 RV>G>ICI5J8)82K%94V/EN2/\ )IT^
MEVMQ@R)DC&#GD8H IMX@MUD\ORIBRH)),*,(O/7GVIT.LF3[43:RE89?+79@
M[A@'/)]ZG&CVGERIL;][%Y3G=U7G_$T'2;?.1N'S;OO<9P!_("@!G]LP;E C
ME.4$A(4849(YY]JO0SI+O*$G:<$_AG^M54TZ*W@9(DR?*,8#-G(Y//XFK%A:
M_8[1(<Y(ZF@"S1110 4444 %%%% !1110 56OO\ CPN?^N3?R-6:K7W_ !X7
M/_7)OY&@"S1110 4444 %%%% !1110 4444 9AU,)<722QD)"RJK#^(G&!^9
MI_\ :2M;7+K&PE@4LT;=>F:6;3H9GD8Y'F$,0/[PZ']!2Q6$4<<RDEVF!$CD
M\GC'X4 5/[:\M8FFMI%5XU=CD?)DXYY]ZEAUFSFN5B20'>2J$,#N(Z\=>U2'
M3(7@\F1BPVA,GT!R!45MHMG:RJ\4:#825^09!/7GK0 ^75H8VD"H[+'PT@'R
M@^E5_P"V?]%61HBCL!MW=&.>15F3289'<[F5)#ET!X)IG]CPE0C2.RJ/D!_A
M]Z %&JIM&(VD;DD)V .">::VM0;T549O,3<C9'/&>F<U#=Z9*B*+20JY5E9C
MC)!Y-%KH$,,<(9R611GCN!CKUH =#K*O;6TLL3(\Z!DBZDGT]*E_M:+>(O)D
M\[:S&/C( QGV[THTF$)$N]B81B-NZCM4D6FPI*9B2\I5E+GOGK0!%;ZM;W4R
M)"&8.H8-D#@_7FI9-2B29DVL55MK2#H#Z5'%I$,+6^UCM@ "#:,\>_6I&TN%
MIF<,RJ[;V0="WK0 RTOIKFUFG,)&UB$3(R<56&LE$1YVB0%U##D%0?K6E%:I
M# 84R%))ZU4;289I5DN6,Y4\;P/R]Z )#JENJ,S;@%4,,C[P]JH3:S/"\Q"1
MR*LOEA$)W <<GVYJTVE*9[7!!C@)(SU[8%6!I]N%G 109R2[ <\C% %2+6X7
MRKQLL@0/M.!D$D?TJ9=7MVC5U#$,I?@= .M1SZ);S2K*68.JJH[C )/3\:?%
MI,$41C!;!0I^!_\ UT -&L1$D>3+PH<\#[I.,_H:=>Z@]L82BC9(,EW!P/RJ
M?^SH<,.?FB\D\_P\_P"-)<61FB6-9WC 78< '(_&@"&_U,6=FDJE'DD^XN[
M;UP:M6MPMU;),A!##L>_>JZ:3 /*$F)4B^XCJ"%J:ULTM$,<1VQY)"=AF@"I
M!K"R1DO"P;>RJH(.0,\_I5B?4;>"".4M_K#A!D L?3FH/[(C!RDCHP8LI '&
M>H_4U--IT$L$49 S$<HQ .#Z\T 0C6;=E#(KM\I9L?P@'!_6G_VO;;2X),8
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M _'I3TO+=TD=7^6(D.<'@U2N-'\X2QK<,D4S[G4 '-7$LU2WDA!R'8L21ZT
M12:M;(D<FYC&[;0=IH_M:R**XG!4@'.T\ ^OI^-10:2(B-TS,H;*J3D+],U7
M'A]4MYX([AA'. )#@$X'I0!:GUBTAD1-S.S3"'Y5/!/O3;?6;>6)IG)2+<54
M[#SC\*D;2D\I41\;9_.''>JLNA>9:"W^TR! I7 ..O>@"_'?+)<^2%/)8 _3
M'^-*]]!$2'?&&VXQDYJ&/3C'<K,)3\I)Q]<9_E2?V:#>+<&0G;(S@8]0/\*
M'W&IV]O;Q3DEXY9%C4J,\L<"B#5+:;<-Q4J3D-[5"-)VZ9;V@ER8)%D#'N0V
M:BGT))X%B,I7[Y8KU)88H TX;F&XSY;9Q[8J>J%C8FU)9B"VT*""3P/K5^@
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M(6!P0#T/6LI-"F1F?[0K/)%Y+[ER N3]WT/-6/[(;RW42C<TR2@[?[N./TH
MV**09V_-U]J6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "JU]_P >%S_UR;^1JS5:^_X\+G_KDW\C0!9HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH *K7W_'A<_P#7)OY&K-5K[_CPN?\ KDW\C0!9HHHH **** "B
MBB@ HHHH **** "BL>?5)()W!5!$DRQ').3G&"/SI^IRW,;0F)F$/)DV8W?K
M0!JT5SW]I2[UF-PWV8X".B@]\'<,]<\5:M9;BZ3SS>>7EB FT= <4 :]%<P)
MKV.]U51=R,MNT8C4\XW $_SK6MFDAM997,QV@G$O7@?6@#1HK$&KW3('%JH&
MQ9"2_P#"<?KS31K3"=E*(R<[-C$MU[\4 ;M%5+:[2ZWM'S&IP&[-ZUGWNLR6
M]P8U6(JQ**=QR&]QB@#;HK(BO[AM%L[E@IFF"YP>,D9JO::Q=&RL7G2'?-&&
MD8L0,^W% &_16-J6HSP^=':I&7BC#L7;'7ICUZ5%%K$HMHW94.20[L< 8Q0!
MO45C?VO+Y<MR85^RH"2V[YN/:H7\0;&VM$ RQB1UR<[3G&..O% &_17/6NKS
MFSDGN54D.VP(>P (!JQ_:\ZGRWMU\XE,;6RN&..M &S15*QO3=I)N3;)&^Q@
M#D9JC+K#1QHYC5?-9ECW$\XZYP* -NBL)M>'EF5(28TP)"3@@DXX]:ECUN-X
MH7*E1(7&#U&T$_TH V**PEUX.C%8PQVAE(SC&<<TZSU*XN=8:#$?V<0[\@\Y
MR* -NBLRVU+S[Y[?"X )!4D]#CFA=1DD=FCAS"K,F[/.1G/'X4 :=%8IUA_^
M?<_(H>3G[H/3\>:5M9(\XK%D(,J,\GGK]* -FBL[^T@--^UE<GH%4]35>'7
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MXGV264SK+Y8.2%V_ABDTJ]:]@8RX$JGYE'8'D?IB@#1HK,N-3^SWC1E&=0
MJCDL>?Y4K:O&J9,,VX'#+@97Z\T :5%97]LVV"0'*\!3@?,3S@4?VW 5^6*8
MOSE !D8_&@#5HK'L-974+J18XV$"QK()#[C.#3_[2"JTS(QA9PD6WJQYY^E
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MA;56.GW,RPL)81G8W?\ &JCZ_);1--/:OY21J\A4C"9_&@#3N-.MKIP\L8+
M8^H]_6A]-M9(Q&T8V#L.AK/NM=\J&X\J F1$9XR2"&Q]/K5V6_>&SBF: L[X
MR@(R* 'G3;4L[&(?."&'8Y]J<]A;NRLT8RH &..!5-=80SI&MO)L9%;>< <Y
M_,\5&-<+E42SE:1S\J!ER0.O?B@"\NG6J^9B(8DSN!Z<^U$6G6L/W8AG(.3R
M>.E4UUQ'D$4$$DLP7=)&" 4'OD^QHDUH09+0.R@_,05^4?3- &E';1PR.\8P
M7.6YZFHI+&"2-8RN%4DC:<$9ZUGPZV[RW)FA9(HI&52.=RA V?UI_P#;:!6#
MVLJR *RQDC+!C@$<^M $M[H]O>Q!3E6  !!]#D9]:<NDVD<RS&/,BC@D\#C!
MP/I2#54.GM=>4^5;8T61N#9QCTJN-<3S=DEK/& P21FQA">@//?(Z>M %O\
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M6S,21XD55S]V0@MDY(/KS4G]DVHF\Q0Z\8V*Y"],=.G2JSZZHGV(FY3$TFX
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MXH^,%5)J,ZQ:#S#N;;& 6<(=HS[T 65M8EMV@V QMG(/?-0Q:7:0QLB185@
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M0"._UK9HH Y\>'Y(_,\J9/WH*OO&<#MBKMGI_P!G5?,<.RQB->.%'M]:TZ*
M,)=#RJQR2*4CC,<>!U!_O?E5Z_L3=16XC95:&19!D<<5?HH PH-%F 433*<
M@LI(+?X?A4G]C'A-X,:@JH(YQ[^M;-% &#/8S6DOG1%&!D+!&0E0" .@^E6]
M"MY;;2H8Y_\ 6#)/YFM.B@ HHHH **** "BBB@ HHHH **** "JU]_QX7/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MA6W<KG!H4>X.78>4"*J@@D38SC/84S8GF(NX[R<\CCK3Q'<H?,$3?,^_[G?
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MQ"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *K7W_'A<_P#7)OY&K-5K[_CPN?\ KDW\C0!9HHHH ***
M* "BBB@ HHHH *1N5/TI:1ONF@#C9(IVDD*H[ ,0,"E6VG*?ZE\^XKH],&89
M"><N:O;1Z5RJ@I*YM[5IG&BVN W,3#\*3[++\W[IO7I79[1Z"C:/04_J_F'M
MF<5]EF.<1-QZ"C[--_SS;CVKM,#T%&!Z"CZOYA[9]CB_LTXY,3$>XIODS%L!
M&_*NWVKZ"F[%_NBCZOYA[7R.),$F0?+;CVII@GS@1DGTQ7<[5]!^5&U?04?5
M_,/:^1Q"02X/[HCZB@12,Q"J>.HQ7;[1Z"C8O]T?E1]7\P]MY'$>4SG(4_0"
ME:.55Y0@?2NVV+_='Y4;%_NC\J/J_F'MO(X<Q.3M )/M2K Y;;M/3TKMMB_W
M1^5&Q?[HH^K^8O:^1Q"V\@5LJ?RZ4H@E9<LA_*NVV+Z#\J-B^@_*CZOYC]J<
M2L$@'W#SZ4>5(#@KG\*[;8G]T?E1L3^Z/RH]AYA[8XAH7ST-,\HC^$UW7E)_
M='Y4>5'_ '!^5'U?S#VOD<+Y3=,=>E&UR,$=.U=QY,?]Q?RI?)3^XOY4OJ_F
M'MO(X4JPP=O&:"C'HI]Z[KR(CU1?RH\B+_GFOY4_J_F'MO(X5HY&P0,"C:QX
MQ7<^1%_<7\J/L\/_ #S7\J7U=]Q^V\CA@C>E+L<#CK7;_9H/^>:\^U'V>'_G
MFOY4?5WW#VWD</L/7;]* DF%RHKN/LT'_/)?RI?L\/\ SS7\J/J[[A[5=CAM
MK=#G% 1L'C(KN/LT'_/)?RH^RP?\\E_*CZN^XO:^1PX5B3@$\4NQCR%-=M]C
MMQTA3\J/LEOT\I/RH^KON'M?(XC8P(&#BG>6V>E=K]E@_P">2_E2?8[?_GBG
MY4?5WW'[;R.+VMNQC]*01NO;K7:FRMC_ ,L4_*D^Q6V<^2GY4?5WW#VWD<45
M;.,=:0HP.<'I7:_V?:Y_U*?E1]@M?^>*?E1]7?</:HXI4;N.].V$=>?PKL_L
M%K_SP3\J0Z?:$Y,"?E1[!]Q>U1Q>UMQ.W%.*,%X!-=F-/M!T@3\J3^SK/_G@
MGY4>P8_:HX[:<?=YI.2<"NR.G6A_Y8)^5)_9EG_SP3\J7U>7<?MD<<N3QGCO
MQ2%6P0 =OK7:?V=:?\\$_*D_LVT(_P!0GY4_82%[5''JIPHP>#3L'G*XKKO[
M-L\8\A/RH_LVTQCR$_*CV,@]JCE8R5*@@  UV4?^K7Z5B:O:06]JKQ1!3Y@!
MQZ5MQ_ZM?I6E*#BVF14ES),?1116QF%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5:^_
MX\+G_KDW\C5FJU]_QX7/_7)OY&@"S1110 4444 %%%% !1110 4U_NGZ4ZFO
M]T_2@"EIC*UN=IS\Q_G5^L_25*V[@]=YJEKZ33"WCBN#'\Q+H)3&7&.Q%1#X
M1RW-VBN.BUV:%X(HO,D9HMH:=\ 'S,<]>W>I8_$6H23O"D-NQCB>1F#G&%)'
M''M5B.LHKE%\37<DI,5CNA2-&<[AD[E#<?G5JPO[NZUJ$2F-89+4R*D;D_Q#
M!/OB@#H:*YW4K^\MO$$<4'EM&+-Y&21RH.&'(]Z+'Q"][-';B ).P5V5CP$8
M9!_E0!T5%0%F^S%BP#;,Y!X!KE+?5)M,1VGEEGE:(R#,FZ-SD=#U7KTQ0!V5
M%<TGB65)&CN8(U*%-SQN64!@3UQ[4LVOW4*REK6,&*)'8%SG<V<#ITXH Z2B
MN9N/$%Y!N0VL+.A^=ED)51^6?TK5GNR^B27<3#)B+*5H T:*Y*VO+RSMOMDA
MN%MTA9I6NVRI/;&"3ZT0^)[BXN8[6.V@\YVZF0A=OKG&<T =;17*R^+3$BN8
M8R FZ4!SD<D<<>U17'B2XDDADA14MA<"-CN.]A@$\?C0!U]%<O<>)IK:-2UM
M&6D*>4 Y_B?;SQQ4O_"12F66W6WC^TQ%MX+G;@+NX./2@#HZ*YJ+Q0LJ7!%O
MCRIHXN3UW;>?PW5%8>(YY;-G,2R&(N96)QP'(&/7@4 =516)IVN?;[PQ%%C4
MC*@D[CQGTQ^M;= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 9FM?\ 'HO_ %T%:"?<7Z5FZ[_QY+SC
M]XO-:,/^J7G/%0OB8^A)1115B"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JM??\>%S_
M -<F_D:LU6OO^/"Y_P"N3?R- %FBBB@ HHHH **** "BBB@ IK_=-.IK_</T
MH I:9N-NV[D[S_.K$UM!<A1-#')M.1O4'%5],S]F;_?/\ZOU,-ARW,VYTJUF
MA\M8HH\< B,' SGI]:6TTFULXMJQ(6((+; "03DBM&BJ$4AIMGN5S;1;E  .
MT= ,#]*6WL+6UD,L,*(Y&-P'..N*N44 5)]/M;B599H4:11M#$<X]*AATR&*
M\DN3AF= @&T *OI6C10 Q8U6,1@ *!C'M5";1;&6WEA6"./S%VED4 @5I44
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MVUQG/S'^=7*I:;@VF1W8_P Z9JL\]O9;[<J'+JN6&>"P']:F.R&]S1HKG/\
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M>['J1[8Q6G0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 9VI<M"/]JKXZ"L_4O\ 7VQ_
MVJT1TJ5\3'T%HHHJA!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 56OO^/"Y_ZY-_(U9J
MM??\>%S_ -<F_D: +-%%% !1110 4444 %%%% !45Q_QZR_[A_E4M0W )MY
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M- #J*A\Z+<%\Q=QZ#/XU(KJZY5@1ZB@!U%-R,XSSUQ3J "BDR*3<"2 >1UH
M=1110 445&TL:.$9P&/(!- $E%%% !1129% "T444 %%%% !1110 444F1ZT
M +1110 44F1FEH **3(I: "BBB@ HHHH ***3(H 6BBB@ HI,BEH **3(I:
M"BBB@ HHHH ***3(H 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&5"D%CT'3^5 $$VKK%<>3Y9)(.U@1@G'2G6NIM)I%K=S1D23JN$7NQ&<4_\
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MLBS^8>6,,.F.E %!-<=+^ZAN(51(A'L.[JS G!/X5;@U>.>=((XR9&!)PV0
M/>G?V7;;F<@EW"AF/?' /UJ:&RBA=7&3(H(#'KS_ /JH N44U1M4#.<=S3J
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M?G1O7^\/SH =12;AZC\Z-P]10 M%-W#U%+N'J* %HI-P]11D>M "T4F11D4
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M10 4444 %%%% !1110 4444 %%%% !BDQ2T4 %%%% !1110 4444 )@4M%%
M"8'I1@>E+10 F!Z"C:OH/RI:* $VKZ#\J-J^@_*EHH ;M7^Z/RHV)_='Y4ZB
M@!AC0]44_A2^6G]U?RIU% #/*C_N+^5'E1_W%_*GT4 1>1#_ ,\D_P"^11Y$
M7_/)/^^14M%*P$?DQ?\ /-?RI5C1>551]!3Z*+ %%%%, HHHH *K7W_'A<_]
M<F_D:LU6OO\ CPN?^N3?R- %FBBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JM??\ 'A<_]<F_
MD:LU6OO^/"Y_ZY-_(T 6:*** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JU]_QX7/\ UR;^1JS5
M:^_X\+G_ *Y-_(T 6:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "JU]_QX7/_ %R;^1JS5:^_
MX\+G_KDW\C0!9HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BDS2T %%%% !1110 4444 %%%% !5:^_X\+G_KDW\C5FJU]_QX7/
M_7)OY&@"S1110 57>!G;(N)5]EQ_A5BB@"L;5S_R]3#\1_A1]F?_ )^IOT_P
MJS10!6^ROC_CZF_,?X4?9G_Y^IOT_P *LT4 5OL[_P#/S+^G^%'V=_\ GYE_
M3_"K-% %?[,W_/Q+^8_PH^S/_P _,WYC_"K%% %;[*__ #]3?F/\*/LS_P#/
MU-^G^%6:* *WV5_^?J;\Q_A1]G?_ )^9OT_PJS10!6^SO_S\R_I_A3OL[8_X
M^)?T_P *GHH @\AO^>\A_+_"C[-Q_K9/SJ>B@"'[/_TT?\Z! 1_RU>IJ* (?
MLX_YZ/\ G1]G_P"FC_G4U% $/V<?WW_.CR !P[?G4U% $/D#^^Q_&E^SK_>;
M\ZEHH B^SIZM^=)]F3'?\ZFHH A^S)ZM^=+Y">I_.I:* (?LZ_WF_.E\A/4_
MG4M% $1@4]S^=)]G3U/YU-10!%]G3W_.C[.GO^=2T4 0_98_?\Z/LL1Z@_G4
MU% $ MHA_"?S-'V:(=C^9J>B@"#[/%Z'\S1]GB]#^9J>B@"#[-%_=_4TOD1?
MW?U-344 0_9X?[GZFD-M"?X/U-3T4 0?9XO[O3W-+]GBSG;^IJ:B@"'R(O[O
MZFCR(O[OZFIJ* (?(B_N_J:/(B_N_J:FHH @^S1?W?U-'V:+^[^IJ>B@"'[/
M#_<_4T>1'_=_4U-10!%Y$7]S]32?9XO[I_,U-10!#Y$?]W]32^1'_=_4U+10
M!%Y,?]W]32>1'_=_4U-10!#Y$?\ =_4TOD1?W/U-2T4 0^1%_=_4TOD1?W/U
M-2T4 0_9XAT4_F:7R8SV/YFI:* (O(B_N?J:/(CS]W]34M% $/D19SM/YFCR
M(O[OZFIJ* (?(B_N_J:401CL?S-2T4 1?9TSGG\Z/LZ>_P"=2T4 1>0GJ?SI
M/LZ]F;\ZFHH B-NI_B;\Z;]F7^^_YU/10!#]F7^\WYT?9UQC<WYU-10!!]F7
M&-[_ )TW[&O_ #T?\ZLT4 5_L@QCS9/SI/L:_P#/23\ZLT4 5_L@_P">L@_&
MCR"/^6TGYBK%% $'DM_SUD_2CR&'2>7]/\*GHH A\EO^>\GZ?X4AMV_Y^)?T
M_P *GHH KBW<#_CYE/UQ_A2^0W_/Q+^G^%3T4 0^2W_/>3]/\*/);_GO)^G^
M%344 -12JX+%O<U!??\ 'A<_]<F_D:LU6OO^/"Y_ZY-_(T 6:*YG_A(+O_GG
M!_WR?\:/^$@N_P#GG!_WR?\ &@#IJ*YG_A(+O_GG!_WR?\:/^$@N_P#GG!_W
MR?\ &@#IJ*YG_A(+O_GG!_WR?\:/^$@N_P#GG!_WR?\ &@#IJ*YG_A(+O_GG
M!_WR?\:/^$@N_P#GG!_WR?\ &@#IJ*YG_A(+O_GG!_WR?\:/^$@N_P#GG!_W
MR?\ &@#IJ*YG_A(+O_GG!_WR?\:/^$@N_P#GG!_WR?\ &@#IJ*YG_A(+O_GG
M!_WR?\:/^$@N_P#GG!_WR?\ &@#IJ*YG_A(+O_GG!_WR?\:/^$@N_P#GG!_W
MR?\ &@#IJ*YG_A(+O_GG!_WR?\:/^$@N_P#GG!_WR?\ &@#IJ*YG_A(+O_GG
M!_WR?\:/^$@N_P#GG!_WR?\ &@#IJ*YG_A(+O_GG!_WR?\:/^$@N_P#GG!_W
MR?\ &@#IJ*YG_A(+O_GG!_WR?\:/^$@N_P#GG!_WR?\ &@#IJ*YG_A(+O_GG
M!_WR?\:/^$@N_P#GG!_WR?\ &@#IJ*YG_A(+O_GG!_WR?\:/^$@N_P#GG!_W
MR?\ &@#IJ*YG_A(+O_GG!_WR?\:/^$@N_P#GG!_WR?\ &@#IJ*YG_A(+O_GG
M!_WR?\:/^$@N_P#GG!_WR?\ &@#IJ*YG_A(+O_GG!_WR?\:/^$@N_P#GG!_W
MR?\ &@#IJ*YG_A(+O_GG!_WR?\:/^$@N_P#GG!_WR?\ &@#IJ*YG_A(+O_GG
M!_WR?\:/^$@N_P#GG!_WR?\ &@#IJ*YG_A(+O_GG!_WR?\:/^$@N_P#GG!_W
MR?\ &@#IJ*YG_A(+O_GG!_WR?\:/^$@N_P#GG!_WR?\ &@#IJ*YG_A(+O_GG
M!_WR?\:/^$@N_P#GG!_WR?\ &@#IJ*YG_A(+O_GG!_WR?\:/^$@N_P#GG!_W
MR?\ &@#IJ*YG_A(+O_GG!_WR?\:/^$@N_P#GG!_WR?\ &@#IJ*YG_A(+O_GG
M!_WR?\:/^$@N_P#GG!_WR?\ &@#IJ*YG_A(+O_GG!_WR?\:/^$@N_P#GG!_W
MR?\ &@#IJ*YG_A(+O_GG!_WR?\:/^$@N_P#GG!_WR?\ &@#IJ*YG_A(+O_GG
M!_WR?\:/^$@N_P#GG!_WR?\ &@#IJ*YG_A(+O_GG!_WR?\:/^$@N_P#GG!_W
MR?\ &@#IJ*YG_A(+O_GG!_WR?\:/^$@N_P#GG!_WR?\ &@#IJ*YG_A(+O_GG
M!_WR?\:/^$@N_P#GG!_WR?\ &@#IJ*YG_A(+O_GG!_WR?\:/^$@N_P#GG!_W
MR?\ &@#IJ*YG_A(+O_GG!_WR?\:/^$@N_P#GG!_WR?\ &@#IJ*YG_A(+O_GG
M!_WR?\:/^$@N_P#GG!_WR?\ &@#IJ*YG_A(+O_GG!_WR?\:/^$@N_P#GG!_W
MR?\ &@#IJ*YG_A(+O_GG!_WR?\:/^$@N_P#GG!_WR?\ &@#IJ*YG_A(+O_GG
M!_WR?\:/^$@N_P#GG!_WR?\ &@#IJ*YG_A(+O_GG!_WR?\:/^$@N_P#GG!_W
MR?\ &@#IJ*YG_A(+O_GG!_WR?\:/^$@N_P#GG!_WR?\ &@#IJ*YG_A(+O_GG
M!_WR?\:/^$@N_P#GG!_WR?\ &@#IJ*YG_A(+O_GG!_WR?\:/^$@N_P#GG!_W
MR?\ &@#IJ*YG_A(+O_GG!_WR?\:/^$@N_P#GG!_WR?\ &@#IJ*YG_A(+O_GG
M!_WR?\:/^$@N_P#GG!_WR?\ &@#IJ*YG_A(+O_GG!_WR?\:/^$@N_P#GG!_W
MR?\ &@#IJ*YG_A(+O_GG!_WR?\:/^$@N_P#GG!_WR?\ &@#IJ*YG_A(+O_GG
M!_WR?\:/^$@N_P#GG!_WR?\ &@#IJ*YG_A(+O_GG!_WR?\:/^$@N_P#GG!_W
MR?\ &@#IJ*YG_A(+O_GG!_WR?\:/^$@N_P#GG!_WR?\ &@#IJ*YG_A(+O_GG
M!_WR?\:/^$@N_P#GG!_WR?\ &@#IJK7W_'A<_P#7)OY&L+_A(+O_ )YP?]\G
6_&H;WQ!=_8+G]W#_ *IOX3Z?6@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>cosm_ex101img7.jpg
<TEXT>
begin 644 cosm_ex101img7.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 1, R # 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ JM??\ 'A<_]<F_D:LU6OO^/"Y_ZY-_(T 6:*** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "JU]_QX7/\ UR;^1JS5:^_X\+G_ *Y-_(T 6:*** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBD(SB@!:*** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ JM??\ 'A<_]<F_D:LU6OO^/"Y_ZY-_(T 6:*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "JU]_QX7/\ UR;^1JS5:^_X\+G_ *Y-_(T 6:*** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BF$G=@=.]/H **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ JM??\ 'A<_]<F_D:LU6OO^/"Y_ZY-_(T 6:*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBJT]W
M#;+NFE5/3/4_A0!8HK'&OVS,^V.9D0X9Q&<#]*U(9DGB62-@RGH13E&4=T)-
M,EHHHI#"BBB@ HHHH *8[K&A9C@#J:?6=>LL\R6.3\XWOC^Z/\BA*[ MP99=
MY.=W(^E34@ 4 #@"EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JM??\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+)J,S6%LQ" 9GD4]!Z#WJ8IM@]"G!96^IZAYR6L:6D+9!V\NWM[5T( & /\
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M8]^E>?6^,ZZ7PC=OY4PJ=V>/PI[*<TP!LXK(L,'KT]J0C>M.V\'.*0\<>]-
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MKJ="_P"/(_[U6#IEF%/[E>E5]$;=:-CIO.,55.FX2U)G-21JT445TF04444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %5K[_CPN?^N3?R-6:K7W_'A<_P#7)OY&@"S1110
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M.;9S_P!-#4OXD-;&G1115""BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH3E>N>G%:V0.M1'=C8M&***L04<&BFEE7EB />@!W:BC-)0 M%!..: P(S0
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M*O5A+%<EU)'?\: .MHK#NUE.L6D<-U."_P \B!OE"CV]^E;E !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 T_<_"LK0"38')S^\/:M1_N'Z5FZ%L_L_* !2YQBI?Q(:V
M-6BBBJ$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX^\>E"FI25@<6EJ:=%%%:D!1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ JM??\ 'A<_]<F_D:LU6OO^/"Y_ZY-_(T 6:***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "JU]_QX7/\ UR;^1JS5:^_X\+G_ *Y-_(T 6:*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ H[T44 %%%% !5:^_X\+G_KDW\C5FJU]_QX7/_7)OY&@"S1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 56OO\ CPN?^N3?R-6:K7W_ !X7/_7)OY&@"S1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 56OO^/"Y_ZY-_(U9JM??\>%S_ -<F_D: +-%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !5:^_X\+G_ *Y-_(U9JM??\>%S_P!<F_D: +-%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M5:^_X\+G_KDW\C5FJU]_QX7/_7)OY&@"S1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 56OO\
MCPN?^N3?R-6:K7W_ !X7/_7)OY&@"S1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 56OO^/"Y_
MZY-_(U9JM??\>%S_ -<F_D: +-%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5:^_X\+G_ *Y-
M_(U9JM??\>%S_P!<F_D: +-%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5:^_X\+G_KDW\C5F
MJU]_QX7/_7)OY&@"S1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 56OO\ CPN?^N3?R-6:K7W_
M !X7/_7)OY&@"S1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 56OO^/"Y_ZY-_(U9JM??\>%S_
M -<F_D: +-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !5:^_X\+G_ *Y-_(U9JM??\>%S_P!<
MF_D: +-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !5:^_X\+G_KDW\C5FJU]_QX7/_7)OY&@"
MS1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 56OO\ CPN?^N3?R-6:K7W_ !X7/_7)OY&@"S11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 56OO^/"Y_ZY-_(U9JM??\>%S_ -<F_D: +-%%% !1
M110 4444 %%%% "*"!R<TM%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %5K[_CPN?^N3?R-6:K7W_'A<_P#7)OY&@"S1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 56OO^/"Y_P"N3?R-6:K7W_'A<_\ 7)OY&@"S1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 56OO^/"Y_ZY-_(U9JM??\>%S_UR;^1H LT444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %5K[_ (\+G_KDW\C5FJU]_P >%S_UR;^1H LT444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %5K[_CPN?^N3?R-6:K7W_'A<_P#7)OY&@"S1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M56OO^/"Y_P"N3?R-6:K7W_'A<_\ 7)OY&@"S1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 56O
MO^/"Y_ZY-_(U9JM??\>%S_UR;^1H LT444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5K[_ (\+
MG_KDW\C5FJU]_P >%S_UR;^1H LT444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5K[_CPN?^N3
M?R-6:K7W_'A<_P#7)OY&@"S1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 56OO^/"Y_P"N3?R-
M6:K7W_'A<_\ 7)OY&@"S1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 56OO^/"Y_ZY-_(U9JM?
M?\>%S_UR;^1H LT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %5K[_ (\+G_KDW\C5FJU]_P >
M%S_UR;^1H LT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %5K[_CPN?^N3?R-6:K7W_'A<_P#7
M)OY&@"S1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 56OO^/"Y_P"N3?R-6:K7W_'A<_\ 7)OY
M&@"S1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 56OO^/"Y_ZY-_(U9JM??\>%S_UR;^1H LT4
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %5K[_ (\+G_KDW\C5FJU]_P >%S_UR;^1H LT444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %5K[_CPN?^N3?R-6:K7W_'A<_P#7)OY&@"S1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 56OO^/"Y_P"N3?R-6:K7W_'A<_\ 7)OY&@"S1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 56OO^/"Y_ZY-_(U9JM??\>%S_UR;^1H LT444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %5K[_ (\+G_KDW\C5FJU]_P >%S_UR;^1H LT444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%5K[_CPN?^N3?R-6:K7W_'A<_P#7)OY&@"S1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 56OO
M^/"Y_P"N3?R-6:K7W_'A<_\ 7)OY&@"S1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 56OO^/"
MY_ZY-_(U9JM??\>%S_UR;^1H LT444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8YUY$3\^J&FT^P)C/(;=@'WSFG?9WW'C..M.9)S]^.0X_P!@TO\ I"@$1O\
M7;2L%QOV=Y#C:"O8YQ3$MG,I08  SS4YCNBV1&WK]VH\7#$L8G]/NGI2LPN'
MDR!@N.2N:5[9A]XJ,#/WJ<OVHC&Q\ 8Y3M2".<H4,9P?5,T6"XGV:7[P4_6D
M$#E XQR>F:E(N&4JV[;Z8-">>AP$^4>JT-=@38P6KEOZTPP-\VU<X(YJ<O.6
M!"X] !099E15*Y&<_=H2!ME7[/)D#:,D\<CFFD'=M.,]*L,9 ^XI@]N.E0^6
MV<X//7BC4:8P]\\^U(%&[CO4GE'(X/ITI-NQN:+ - YR:7('I2A#QDG\J5HG
MP3CCZ4@(\\CBE[CG@]Z7R^."*79C QR:+#N-)QTI2>>M*5P!QFF@YR."!0 9
M+#&>!VH/K^E*$(/ ^M&T@\"@!K#(W<YIIR"/UJ38W)Z>U(3G *T &<\#I3,9
M^IIRA@,9HVG)XH !D8&!0003W_&EVG"MZTP<,,CJ>U (53QP,4-UYR<TNU@N
M #STH(QU'-(0)@L23TI.V >II0NT8 YHXV].:!H=D=#36!QD<@T[YL\#/%(2
M2,8Q0 T'L?Y4FQ!T]:<HR3STH*GKU% #>,XYXI!@L1R:D&.X'-)MP>!0 X 8
MSW]ZV=!YG<_[-8H'S=ZV=! %S(,_PUI2^)$S^$Z&BBBNXY@HHHH *K7W_'A<
M_P#7)OY&K-5K[_CPN?\ KDW\C0!9HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *2EHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I,"EHH 3 ]*,#TI:*
M$P/04;1Z#\J6B@!,#THVCT%+10 FT>@HVKZ#\J6B@!NU?[H_*C8G]T?E3J*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 56
MOO\ CPN?^N3?R-6:K7W_ !X7/_7)OY&@"S1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 56OO^
M/"Y_ZY-_(U9JM??\>%S_ -<F_D: +-%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5:^_X\+G_
M *Y-_(U9JM??\>%S_P!<F_D: +-%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5:^_X\+G_KDW
M\C5FJU]_QX7/_7)OY&@"S1110 'I59Q=[OD>+;[J?\:LT4 4LWX[0M] 1_6F
MB34.<P1^WS=:OT4 4A)?'K#&/^!4IDOLX$*8]=U7** *N;L_PQK]>:=_I7JG
MY58HH KXN?[T8_X"?\:,76?O1?\ ?)_QJQ10!7Q=?WHO^^3_ (T8N<_>C_(_
MXU8HH @_TCU3\C2?Z3ZQ_D:L44 0#[1CED_[Y-&+C/#Q_P#?)_QJ>B@" "X_
MOQ_]\G_&C;<_WX_^^3_C4]% $'[_ /O1_P#?)I MSW>/_OD_XU8HH @VW']^
M/_OD_P"-&+C'WX_^^3_C4]% $&+C^_'_ -\G_&C%Q_?C_P"^3_C4]% $&+C/
MWX\?[I_QI=MQ_?C_ .^3_C4U% $'[_\ O)_WR:/W_P#>C_[Y-3T4 0?O_P"]
M'_WR:4+<=VC_ .^3_C4U% $/[_\ O)_WR:7;-C[R9^E2T4 1!9O[Z?E1MF_O
M)^52T4 1;9O[R?E3<3YY9/R-3T4 0_O_ .\G_?)I,3_WD_[Y-3T4 0$3]G3_
M +Y-+LG_ +Z?]\U-10!#MGQ]]/RI=DO]\?E4M% $6R7_ )Z#\J-DO]\?E4M%
M $6R3^^/RHV2?W_TJ6B@"+9)_P ]!^5&R7_GH/RJ6B@"+9)_?'Y4%)<\./RJ
M6B@"+9)_?'Y4;)?^>@_*I:* (3'*?^6N/PH\N7'^M_2IJ* (?+E_YZ?I1Y<O
M_/3]*FHH BV28_UGZ4GER?\ /7]*FHH A\N7_GK^E*(Y.\I/X5+10!%Y<G_/
M3]*/+D_YZ?I4M% $>Q\??_2EVO\ WJ?10!'L?^^/RHV2?WQ^5244 1A9.[_I
M2>7)G_6?I4M% $>R3^^/RI-LW]]?RJ6B@"())_?'Y4;)?[X_*I:* (MLO]\?
ME2[9/[R_E4E% $>V7^\OY4;9/[R_E4E% $6)<_>7'THVS?WD_*I:* (L3?WD
M_*FXN,_>C_[Y-3T4 5]MS_?B_P"^3_C2;;O_ )Z0_P#?!_QJS10!6*W?:2+_
M +X/^-*%NL<R1?@I_P :L44 0;;G'WX_^^3_ (T;;G^_'_WR?\:GHH KE;KM
M)%_WR?\ &@+=8Y>+/^Z?\:L44 5]MU_?B_[Y/^-&+K_GI%_WR?\ &K%% %<B
MZSP\6/\ =/\ C30+S)RT6/\ =/\ C5JB@"J?MG8Q?D?\:0->]TC/T-6Z* *I
M>\[1)^=&^\[Q)_WU5JB@!D9<H/, #>@J&^_X\+G_ *Y-_(U9JM??\>%S_P!<
MF_D: +-%<S_PD%W_ ,\X/^^3_C1_PD%W_P \X/\ OD_XT =-17,_\)!=_P#/
M.#_OD_XT?\)!=_\ /.#_ +Y/^- '345S/_"07?\ SS@_[Y/^-'_"07?_ #S@
M_P"^3_C0!TU%<S_PD%W_ ,\X/^^3_C1_PD%W_P \X/\ OD_XT =-17,_\)!=
M_P#/.#_OD_XT?\)!=_\ /.#_ +Y/^- '345S/_"07?\ SS@_[Y/^-'_"07?_
M #S@_P"^3_C0!TU%<S_PD%W_ ,\X/^^3_C1_PD%W_P \X/\ OD_XT =-17,_
M\)!=_P#/.#_OD_XT?\)!=_\ /.#_ +Y/^- '345S/_"07?\ SS@_[Y/^-'_"
M07?_ #S@_P"^3_C0!TU%<S_PD%W_ ,\X/^^3_C1_PD%W_P \X/\ OD_XT =-
M17,_\)!=_P#/.#_OD_XT?\)!=_\ /.#_ +Y/^- '345S/_"07?\ SS@_[Y/^
M-'_"07?_ #S@_P"^3_C0!TU%<S_PD%W_ ,\X/^^3_C1_PD%W_P \X/\ OD_X
MT =-17,_\)!=_P#/.#_OD_XT?\)!=_\ /.#_ +Y/^- '345S/_"07?\ SS@_
M[Y/^-'_"07?_ #S@_P"^3_C0!TU%<S_PD%W_ ,\X/^^3_C1_PD%W_P \X/\
MOD_XT =-17,_\)!=_P#/.#_OD_XT?\)!=_\ /.#_ +Y/^- '345S/_"07?\
MSS@_[Y/^-'_"07?_ #S@_P"^3_C0!TU%<S_PD%W_ ,\X/^^3_C1_PD%W_P \
MX/\ OD_XT =-17,_\)!=_P#/.#_OD_XT?\)!=_\ /.#_ +Y/^- '345S/_"0
M7?\ SS@_[Y/^-'_"07?_ #S@_P"^3_C0!TU%<S_PD%W_ ,\X/^^3_C1_PD%W
M_P \X/\ OD_XT =-17,_\)!=_P#/.#_OD_XT?\)!=_\ /.#_ +Y/^- '345S
M/_"07?\ SS@_[Y/^-'_"07?_ #S@_P"^3_C0!TU%<S_PD%W_ ,\X/^^3_C1_
MPD%W_P \X/\ OD_XT =-17,_\)!=_P#/.#_OD_XT?\)!=_\ /.#_ +Y/^- '
M345S/_"07?\ SS@_[Y/^-'_"07?_ #S@_P"^3_C0!TU%<S_PD%W_ ,\X/^^3
M_C1_PD%W_P \X/\ OD_XT =-17,_\)!=_P#/.#_OD_XT?\)!=_\ /.#_ +Y/
M^- '345S/_"07?\ SS@_[Y/^-'_"07?_ #S@_P"^3_C0!TU%<S_PD%W_ ,\X
M/^^3_C1_PD%W_P \X/\ OD_XT =-17,_\)!=_P#/.#_OD_XT?\)!=_\ /.#_
M +Y/^- '345S/_"07?\ SS@_[Y/^-'_"07?_ #S@_P"^3_C0!TU%<S_PD%W_
M ,\X/^^3_C1_PD%W_P \X/\ OD_XT =-17,_\)!=_P#/.#_OD_XT?\)!=_\
M/.#_ +Y/^- '345S/_"07?\ SS@_[Y/^-'_"07?_ #S@_P"^3_C0!TU%<S_P
MD%W_ ,\X/^^3_C1_PD%W_P \X/\ OD_XT =-17,_\)!=_P#/.#_OD_XT?\)!
M=_\ /.#_ +Y/^- '345S/_"07?\ SS@_[Y/^-'_"07?_ #S@_P"^3_C0!TU%
M<S_PD%W_ ,\X/^^3_C1_PD%W_P \X/\ OD_XT =-17,_\)!=_P#/.#_OD_XT
M?\)!=_\ /.#_ +Y/^- '345S/_"07?\ SS@_[Y/^-'_"07?_ #S@_P"^3_C0
M!TU%<S_PD%W_ ,\X/^^3_C1_PD%W_P \X/\ OD_XT =-17,_\)!=_P#/.#_O
MD_XT?\)!=_\ /.#_ +Y/^- '345S/_"07?\ SS@_[Y/^-'_"07?_ #S@_P"^
M3_C0!TU%<S_PD%W_ ,\X/^^3_C1_PD%W_P \X/\ OD_XT =-17,_\)!=_P#/
M.#_OD_XT?\)!=_\ /.#_ +Y/^- '345S/_"07?\ SS@_[Y/^-'_"07?_ #S@
M_P"^3_C0!TU%<S_PD%W_ ,\X/^^3_C1_PD%W_P \X/\ OD_XT =-5:^_X\+G
F_KDW\C6%_P )!=_\\X/^^3_C4-[X@N_L%S^[A_U3?PGT^M '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>cosm_ex101img8.jpg
<TEXT>
begin 644 cosm_ex101img8.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 1, R # 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ JM??\ 'A<_]<F_D:LU6OO^/"Y_ZY-_(T 6:*** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "JU]_QX7/\ UR;^1JS5:^_X\+G_ *Y-_(T 6:*** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "JU]_QX7/_ %R;^1JS5:^_X\+G_KDW\C0!9HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH *K7W_'A<_]<F_D:LU6OO\ CPN?^N3?R- %FBBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JM
M??\ 'A<_]<F_D:LU6OO^/"Y_ZY-_(T 6:*** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML!UI(V@)=MS.JXV[6'.:?M)BY8G1_P!NPD@"-C^(I/[>AQ_JGSZ9K"E5(D9
MQ!#XS[8%13HJ(&0\9ZAP:7MIAR1.@_X2"+_GD^._(I?[?AW8\M_SKEB3S@=J
M49R<G/I2]O(KV2.J_MZ#<!L;\Z3^WX<_ZIL>N17*C(Y.>:.3DY(%/V\@]DCJ
MUUZ ]8V!^M)_;T/.(WX/K7+AN_>DW%L^AH]O(/9(ZS^VX-N2K?3--&O0''[M
MA^(KE5+8QZ]*"Q/RY]J7MY![)'6'7(/[K>U+_;<'96Q7*(2#G/3L:<6Y!!_"
MCV\@]DCJ!K<)."C >N:0Z[ #@JU<QN]<\TW(QGMFAUYA[)'4'78O^>3'\12C
M7(2/N,/Q%<ON^M!;Y=P(Z4>WD'LD=,NNPM_RS<#ZTX:Y 1RK ^E<J#D_+Z<T
MX'*E<GVI^WD'LD=1_;L&?N-CUS2?V] 0<1MQ[URO\62>:<,=\XH]O(/9(ZI=
M<@)P484?VY;[<[6^F:Y49W??('84K9 ZT>WD'LD=1_;D&W.QO;FD&O09P48?
MCFN3+9'X4JD9SDGBE[>0>R1U+:_ "1L<GTS3CKT  (C8Y]ZY,R N2,Y'J:"W
M;!P31[>0_9(ZP:]!_<;\Z;_;\.1B)C^(KEPP /I3 XR.3P,T>WF'LD=;_;T
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M.GZBQR5?G@TV33+W<P\IB&.6/K77T4>QB'.SDET[4-P/E'CCGTH;3+PDCR6
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MBB@ HHHH **BFN(;9-TSA%]33(KRWG ,<JMDX'O0!8HI,CUI: "BDR/6C(H
M6BHGECC*AW"ECA<GJ:<75<9(&3@9H ?1110 44A(49)P!2!E90P.0>AH =12
M9%&10 M%)D49% "T4P.I) 89'44^@ HIC.B#+, />G;EXYZ]* %HII900"1D
M]*1Y$C7<[!1ZF@!]%)D'!S2T %%%)D4 +12%@!DG I 00"""#W% #J*C:5$Q
MN8#)P,GK2F1 <%AG.,9H ?12;AG&>31D4 +129%&10 M%%)D4 +1129% "T4
M@((R""*6@ HHHH **:6"C)( '>A65ERIR#WH =130RDX!!IU !1110 4444
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MGK^-0V;:A).48N(D<[23G<-@(YZ]:Z"DP* ,72Y-0><FY '7>NXG!SQC\,5
M\U^TO[O>BNS*^XD[<9Q],^U=#BC% &).D]SH+1XD$A8#.[DC=SS]*B7[9!(8
MXC(60J$3^$KCG)KH,48% '/I)<(LOEA@V#@X_P!OG],TC3ZGLG^S[GCW!8F9
M>3QU_/BNAP*,"@#GQ-?&T1YG*.K!6&"-Q YQCWZ5LVCE[=&8,&*C(;J*GP*6
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JU]_P >%S_U
MR;^1JS5:^_X\+G_KDW\C0!9HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK?=(-80TNY-TSN\VUI-_$@POMC%:=M:&*P2#>RL%P64\T 6R0.O>F-*BD L
M2<#)ZU0U59(M,9X=\DT6&C&>68=!5$Z5=,RRF68EXP&"R!=K<Y/(/K^E &\)
M%+;0PR.V:?67;6LT-UN"%8\<[GW9^G'%:E !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5K[_CPN?^N3?R-6:K
M7W_'A<_]<F_D: +-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !5:^_P"/"Y_ZY-_(U9JM??\
M'A<_]<F_D: +-%%% !1110 4444 %%%% !1110 456NIS;PF01M)CJ%(_K0D
MQGM?-A&&93M#\<^] %FBL"RU:Z,9>_2(9D,:"$DY(/N*O'4H4EV2!DR"03CG
M')% &C16-_;:"ZV/&R)Y/F#=@%OF &/SJPVH*UA+<1 ;H^"K=CGOB@#1HK(3
M5)(XX7NC;@2MM7RF+=B?3VIR:Q;NCLBN2NW*D '!&0?RH U:*S)-8M8T#_,R
ME0Y('0'O^M/_ +4M]S<GRUSF3'RY'44 :%%4(-1AN4D,9^>,9*G]*KV6I3S6
MBW,P@$93<1&Y+#\Z ->BLP:O;L!L#LV2"JC)&.O\Z235%7E0NW#G)R,;<?XT
M :E%9>G:O'?23(4,;1S-$,_Q8 .?UJ>:_B2P^U(P*D?)GC<>PH NT5G1ZI"U
MK#,V0902%')&.M-_MFQV[O.^79OS@],D?S!H TZ*S?[9M-H(?+%MH3N3C/\
M*F-KEBK8\PGY0Q(4G )Q_.@#5HK-&KV95L2?,K;"F.<XS_(YI'UJQ158RDAL
M=%/&3C^= &G15#3=174;4SJI4!V7GV)']*LRSQQ1^8[ +D#/U.* )J*SY]6M
M()3&9,N#RJC.*4:G;-<K K%F;'(' R,C]* +]%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM#2B+F&43LJQXRJ@+NP,<XZUJT4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !5:^_X\+G_KDW\C5FJU]_QX7/\ UR;^1H LT444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4J#RWMQ0!T=%8,-U-;^';>1CFYGC7: 2<L1GC/XFF6>IW21):2@?:4?8SRG
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M/HH ;L7=NVC=ZXHVK_=''M3J* $VCT%-\M,8V+CTQ3Z* &[$_NCTZ4H50,
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9OZ;B"#^0H Z>D) &2>E<Q%IM^L<:JF)_+4-)(2<''.*T=*L[BWMY4E4*2,
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M.AN8IXQ)$WEJS!#_ '5Q_CFK$5D\<]Y/ERTC[D4D8/R@>GM0!I9J&2=(OOL
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M# [@Y!_,5H44 93:.LG+W#ERQ9FP/FRNW^5(ND<KON7?:@1<J!@ @C^5:U%
M&1>Z-'<1'YF+ <?]];J;;Z?.WVAYYFW3%?O*I/ Q]*V:* *#Z<LEM#"96Q%W
M[G@C^M5CH46+39,ZM:Q".-@![<_I6Q10!0ELWFLI+>2Y<E_XP ".?:JXT7Y9
M ;C_ %AR<1J,?3CBM>B@"H]BDEQ',6.4C:/'J#C_  JC_8J"%8EE "#]VPC4
M%2/?%;-% &%;Z/,M[<S//AG<,K@#..>*L6NCI;1Q)YS/Y>S!(Z[<_P"-:M%
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M8YVD@\_]\UO44 8TNC&4.#-@%V<<?WCFI$TD_:FN99097=6( X^7./YUJT4
M8 T&13/BYR)3N&[^ ^PJ]_9V=/GM'<%92<G'8UHT4 9EQIPE\D1L(T0$%!P&
MSCG]*CM-,EM"NR8'.-^1GH>U:]% &,=$W*4,QV%5'Y,3_6HWTR57L(U(_=$^
M8X[KUP:W:* *5[:+=0QQEMH219/^^3G^E9[^'XI;Z2Y+L1)()&'FL ",= #C
MM6[10!0735"0*2#Y1<@X_O9_QJ-M+4Q!?E.$VX(P.N>U:=% &=;6'E6)MI97
M=23SO.1SGKUINH6S/I_E0AMX("'/(YYY/M6G10!@7/AV&>6-\L,*%8"5U!_
M'G\:T+;3_L]PTB-M0C&P$D?K5^B@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "JU]_QX7/_7)OY&K-5K[_ (\+G_KDW\C0
M!9HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MN3?R-6:K7W_'A<_]<F_D: +-%%% !1110 4444 %%%% !1110 4444 %%%%
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MBJ,90@ET!<*Q!.!VXX'O3XI/W:R*%\QXR",#WH]I/N%H]BRWB"< ?=S]*/\
MA()E/(!JDHWP;<;6 ))*C!_&L_+9^[Q2]K/N-0B^AO\ _"03'@*HSWI&U^X
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MW ^=)@?2MVBE[*'8.=F$WAR%O^6\@]@!_A2?\(W$.D[C\!6]13]G#L'/+N8
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M*>A%/H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0O)3L:*Y,;8(Y!48J*32)A>2W$;DAP5V"3:,$]>E;]% &5/8YTR*U2%)1&
M)&QT'KCK5-]*OOE;S%=BCHQ=R=H)!';G&*Z&B@#E[32KGR9HBJ(!-N\SOD9Z
M?G2Q:3=W-M'F..$*C8&>3G'7\JZ>B@#%DTZY8K("-X9R5#X'S8[X]J7^R/+7
M<BAI/DP2^"-N>^/>MFB@"M91RQ6RK.5,G?%6:** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
MK7W_ !X7/_7)OY&K-5K[_CPN?^N3?R- %FBBB@ HHHH **** "BBB@ HHHH
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M&W&/\:F?1X&7&]P2NUR,#>/>I(],ABN$F0L'3.#]>M %^BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "JU]_P >%S_UR;^1JS5:^_X\+G_KDW\C0!9HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M44 %%%% !1110 4444 %5K[_ (\+G_KDW\C5FJU]_P >%S_UR;^1H LT444
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M5V;$B9V@GH*V:* ,:WTF6*[$C3[D$AD"[?ZU9ETN*>ZFEFRZR*%VYXXK0HH
MPSHTN\ .@"9VOM^9L^M.DTJ8W?VC,3G!!1URO-;5% &)<:1-+,DHEQM8DH ,
M'./7Z4MOI=Q!<0L'!V !F('(]*VJ* ,2YTRYGN&D,@QY@9>/X?3UJQI]G-;-
M+N(V,/E&!D'\*TZ* .>ET64%/+<E=A4J".#DG//U_2H;[3;B*T,>TR;YD_>@
M_,!D"NGI" >M &,^GW4WD@G:L8VD9SGGK3'TJ=8;=8Y'S&[,X5A\V<XZUNT4
M 8#:5-Y,L14S>8!AW;E/:K%UI\LOV4IP\493<#]T[2,UKT4 96GV4MM(I88
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M2N,,.!Z\4>9=#8D?VKS0!Y8V?)MQWXKHZ3 H P+F6]@MXOFG+N"Q8)NP?[N
M*KR:C>[K;;YXEED52IC.W:0?UZ5T^!4/V6$S"4H/,'>@#%L[K4=VZ7S&(C.^
M,QD?-QT/YU<-M<1)$HE82/EI70=36I@>E+0!SBW%_!9V\DKSNTB'?A1\AXP>
ME/M;B]FN(E:20('DRVS&X#;C^9K?V@]11M'I0!SUO)J MEF+2%C<*@C*XPN:
MLZ;<7<TJ^=N (.]7_A/;Z5L;1Z4!0#D#K0!@SRWYENS&[JD<99 %^\U))=WD
M3.WF.YV%@HQA<+GD=:W]H]*;L7^Z.?:@#$%[=W.I)#$Q6$H"7"]^],%]=^<P
MC+L'5MH?!VD ^GTK?"*.B@?A1L7.=H_*@#GX[N\\Q[>:5DC63!G( P-H/TZ\
M4_[?=BZ6/(* #:Q8#?SZ?X5N%$(Y4'/M1Y:9!VCCIQ0 JYVC/7'-.HHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *K7W_'A<_\ 7)OY&K-5K[_CPN?^N3?R- %FBBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JM?
M?\>%S_UR;^1JS5:^_P"/"Y_ZY-_(T 6:*** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JU]_P >
M%S_UR;^1JS5:^_X\+G_KDW\C0!9HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *K7W_'A<_P#7
M)OY&K-5K[_CPN?\ KDW\C0!9HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *K7W_'A<_\ 7)OY
M&K-5K[_CPN?^N3?R- %FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JM??\>%S_UR;^1JS5:^
M_P"/"Y_ZY-_(T 6:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "JU]_P >%S_UR;^1JS5:^_X\
M+G_KDW\C0!9HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *K7W_'A<_P#7)OY&K-5K[_CPN?\
MKDW\C0!9HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *K7W_'A<_\ 7)OY&K-5K[_CPN?^N3?R
M- %FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ JM??\>%S_UR;^1JS5:^_P"/"Y_ZY-_(T 6:
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "JU]_P >%S_UR;^1JS5:^_X\+G_KDW\C0!9HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *K7W_'A<_P#7)OY&K-5K[_CPN?\ KDW\C0!9HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *K7W_'A<_\ 7)OY&K-5K[_CPN?^N3?R- %FBBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ JM??\>%S_UR;^1JS5:^_P"/"Y_ZY-_(T 6:*** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "JU]_P >%S_UR;^1JS5:^_X\+G_KDW\C0!9HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*K7W_'A<_P#7)OY&K-5K[_CPN?\ KDW\C0!9HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !5:^_X\+G_KDW\C5FJU]_QX
M7/\ UR;^1H LT444 %%%% !7,ZNSG4B"?E"C&:Z:N6U=LZBZ@$X]>E95OA+I
M[E0DGHV!1N;&/>HQD<<XIY&"",\UR&]AQ=L<GGM3=Q)^\?6D(&#SCO3<D8I
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MPN0FW8(,_>8XQ2_9)!U4=/45(4NMP)5N/]FE*W#<A6R>"=M%AW(O):-]A/7
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MA1C!-.P.E(/E!-. )&<#I2&-V$MGCK2':6^E/&<<"F[2#D@<"@!V1G=3>P;
M]Z4]/:@ A:8#23CIGGTI=Q)^;]:!D+QUI,'.2:6H#C]TTN/;WIG4X'>G'=M[
M"F  8/7K3CP0#3%7D\]J<1QUSB@!.^.V>*<PVCK3'/3'ZT[&1S2 /E P.U')
M')'M2?0"E52OXTP$7)YSQTJ_I7_(0@'N?Y&J).<8'2M#1ANO8R<Y7-53^)$R
MV.IHHHKO.8**** "JU]_QX7/_7)OY&K-5K[_ (\+G_KDW\C0!9HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!12'/:EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JM??\>%S
M_P!<F_D:LU6OO^/"Y_ZY-_(T 6:*** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JU]_QX7/_7)O
MY&K-5K[_ (\+G_KDW\C0!9HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *K7W_ !X7/_7)OY&K
M-5K[_CPN?^N3?R- %FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MWR?\: .FHKF?^$@N_P#GG!_WR?\ &C_A(+O_ )YP?]\G_&@#IJ*YG_A(+O\
MYYP?]\G_ !H_X2"[_P"><'_?)_QH Z:BN9_X2"[_ .><'_?)_P :/^$@N_\
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MN9_X2"[_ .><'_?)_P :/^$@N_\ GG!_WR?\: .FHKF?^$@N_P#GG!_WR?\
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6846563968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Nov. 20, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_DocumentAndEntityInformationAbstract', window );"><strong>Document And Entity Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Cosmos Holdings Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001474167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Is Entity a Well-known Seasoned Issuer?</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Is Entity a Voluntary Filer?</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Is Entity's Reporting Status Current?</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Smaller Reporting Company<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">126,867,038<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6847045120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,352,172<span></span>
</td>
<td class="nump">$ 716,590<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">2,858,518<span></span>
</td>
<td class="nump">661,850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryGross', window );">Inventory</a></td>
<td class="nump">2,096,818<span></span>
</td>
<td class="nump">464,219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_PrepaidDeferredFinancingFees', window );">Prepaid deferred financing fees</a></td>
<td class="nump">361,289<span></span>
</td>
<td class="nump">131,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">2,904,989<span></span>
</td>
<td class="nump">646,530<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets - related party</a></td>
<td class="nump">481,450<span></span>
</td>
<td class="nump">15,523<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">TOTAL CURRENT ASSETS</a></td>
<td class="nump">10,055,236<span></span>
</td>
<td class="nump">2,636,612<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets</a></td>
<td class="nump">656,382<span></span>
</td>
<td class="nump">429,203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">79,521<span></span>
</td>
<td class="nump">52,715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">44,012<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">10,835,151<span></span>
</td>
<td class="nump">3,118,530<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">2,338,047<span></span>
</td>
<td class="nump">577,932<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilities', window );">Accounts payable and accrued expenses - related party</a></td>
<td class="nump">981<span></span>
</td>
<td class="nump">13,759<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Notes payable, net of unamortized discount of $154,949 and $110,561, respectively</a></td>
<td class="nump">9,274,201<span></span>
</td>
<td class="nump">2,872,472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrent', window );">Notes payable - related party</a></td>
<td class="nump">116,358<span></span>
</td>
<td class="nump">160,391<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Loans payable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">17,938<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLoansPayable', window );">Loans payable - related party</a></td>
<td class="nump">559,557<span></span>
</td>
<td class="nump">148,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Taxes payable</a></td>
<td class="nump">1,313,030<span></span>
</td>
<td class="nump">1,080,590<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">TOTAL CURRENT LIABILITIES</a></td>
<td class="nump">13,602,174<span></span>
</td>
<td class="nump">4,871,332<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="nump">13,602,174<span></span>
</td>
<td class="nump">4,871,332<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (see Note 9)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS' DEFICIT:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value; 100,000,000 shares authorized; 0 shares issued and outstanding as of September 30, 2017 and December 31, 2016, respectively</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value; 300,000,000 shares authorized; 128,253,932 and 125,870,532 shares issued and outstanding as of September 30, 2017 and December 31, 2016, respectively</a></td>
<td class="nump">128,254<span></span>
</td>
<td class="nump">125,871<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">2,409,735<span></span>
</td>
<td class="nump">174,009<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,228,614)<span></span>
</td>
<td class="num">(1,050,463)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(4,076,398)<span></span>
</td>
<td class="num">(1,002,219)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">TOTAL STOCKHOLDERS' DEFICIT</a></td>
<td class="num">(2,767,023)<span></span>
</td>
<td class="num">(1,752,802)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT</a></td>
<td class="nump">$ 10,835,151<span></span>
</td>
<td class="nump">$ 3,118,530<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_PrepaidDeferredFinancingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_PrepaidDeferredFinancingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(1),(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred and payable to vendors for goods and services received, and accrued liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16)(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term loans payable classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6787-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Assets<br> -URI http://asc.fasb.org/extlink&amp;oid=6509628<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6847133200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Notes payable, net of unamortized discount</a></td>
<td class="nump">$ 154,949<span></span>
</td>
<td class="nump">$ 110,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>SHAREHOLDERS' EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares, outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">128,253,932<span></span>
</td>
<td class="nump">125,870,532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares, outstanding</a></td>
<td class="nump">128,253,932<span></span>
</td>
<td class="nump">125,870,532<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28567-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28541-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=64930739&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28551-108399<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6847889344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 9,546,951<span></span>
</td>
<td class="nump">$ 1,414,503<span></span>
</td>
<td class="nump">$ 19,775,398<span></span>
</td>
<td class="nump">$ 3,506,804<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">COST OF REVENUE</a></td>
<td class="nump">8,772,138<span></span>
</td>
<td class="nump">1,269,553<span></span>
</td>
<td class="nump">18,156,795<span></span>
</td>
<td class="nump">3,192,472<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">GROSS PROFIT</a></td>
<td class="nump">774,813<span></span>
</td>
<td class="nump">144,950<span></span>
</td>
<td class="nump">1,618,603<span></span>
</td>
<td class="nump">314,332<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>OPERATING EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">752,198<span></span>
</td>
<td class="nump">173,498<span></span>
</td>
<td class="nump">2,416,540<span></span>
</td>
<td class="nump">466,293<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherDepreciationAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">6,167<span></span>
</td>
<td class="nump">2,421<span></span>
</td>
<td class="nump">17,199<span></span>
</td>
<td class="nump">6,956<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Impairment of goodwill</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,949,884<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">TOTAL OPERATING EXPENSES</a></td>
<td class="nump">758,365<span></span>
</td>
<td class="nump">175,919<span></span>
</td>
<td class="nump">4,383,623<span></span>
</td>
<td class="nump">473,249<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">GAIN (LOSS) FROM OPERATIONS</a></td>
<td class="nump">16,448<span></span>
</td>
<td class="num">(30,969)<span></span>
</td>
<td class="num">(2,765,020)<span></span>
</td>
<td class="num">(158,917)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>OTHER INCOME (EXPENSE)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseOther', window );">Interest expense - related party</a></td>
<td class="num">(66)<span></span>
</td>
<td class="num">(919)<span></span>
</td>
<td class="num">(198)<span></span>
</td>
<td class="num">(2,741)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(291,224)<span></span>
</td>
<td class="num">(53,794)<span></span>
</td>
<td class="num">(572,679)<span></span>
</td>
<td class="num">(103,803)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherExpenses', window );">Other expense</a></td>
<td class="num">(13,295)<span></span>
</td>
<td class="num">(3,388)<span></span>
</td>
<td class="num">(26,529)<span></span>
</td>
<td class="num">(4,539)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency transaction gain (loss)</a></td>
<td class="nump">89,966<span></span>
</td>
<td class="num">(5,555)<span></span>
</td>
<td class="nump">292,937<span></span>
</td>
<td class="num">(7,043)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">TOTAL OTHER INCOME (EXPENSE)</a></td>
<td class="num">(214,619)<span></span>
</td>
<td class="num">(63,656)<span></span>
</td>
<td class="num">(306,469)<span></span>
</td>
<td class="num">(118,107)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">LOSS BEFORE INCOME TAXES</a></td>
<td class="num">(198,171)<span></span>
</td>
<td class="num">(94,625)<span></span>
</td>
<td class="num">(3,071,489)<span></span>
</td>
<td class="num">(277,024)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">INCOME TAX EXPENSE</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="num">(2,690)<span></span>
</td>
<td class="num">(773)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">NET LOSS</a></td>
<td class="num">(198,171)<span></span>
</td>
<td class="num">(94,613)<span></span>
</td>
<td class="num">(3,074,179)<span></span>
</td>
<td class="num">(277,797)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract', window );"><strong>OTHER COMPREHENSIVE LOSS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Foreign currency translation loss</a></td>
<td class="num">(51,474)<span></span>
</td>
<td class="num">(16,622)<span></span>
</td>
<td class="num">(178,151)<span></span>
</td>
<td class="num">(38,185)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">TOTAL OTHER COMPREHENSIVE LOSS</a></td>
<td class="num">$ (249,645)<span></span>
</td>
<td class="num">$ (111,235)<span></span>
</td>
<td class="num">$ (3,252,330)<span></span>
</td>
<td class="num">$ (315,982)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">BASIC AND DILUTED NET LOSS PER SHARE</a></td>
<td class="nump">$ (0.00)<span></span>
</td>
<td class="nump">$ (0.00)<span></span>
</td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="nump">$ (0.00)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and Diluted</a></td>
<td class="nump">128,236,217<span></span>
</td>
<td class="nump">125,630,532<span></span>
</td>
<td class="nump">127,647,201<span></span>
</td>
<td class="nump">125,630,532<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64836518&amp;loc=d3e30700-110894<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64836518&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64836518&amp;loc=d3e30690-110894<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64836518&amp;loc=d3e30700-110894<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Income Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5624177-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph -4<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=66004921&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4,6)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6839896928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (3,074,179)<span></span>
</td>
<td class="num">$ (277,797)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to Reconcile Net Loss to Net Cash Used In Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherDepreciationAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">17,199<span></span>
</td>
<td class="nump">6,956<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount</a></td>
<td class="nump">87,677<span></span>
</td>
<td class="nump">5,885<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">265,529<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Issuance of common stock for services</a></td>
<td class="nump">401,800<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Loss on goodwill impairment</a></td>
<td class="nump">1,949,884<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in Assets and Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(2,137,831)<span></span>
</td>
<td class="num">(316,012)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(1,627,085)<span></span>
</td>
<td class="num">(189,435)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses</a></td>
<td class="num">(2,242,785)<span></span>
</td>
<td class="num">(198,627)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther', window );">Prepaid expenses - related party</a></td>
<td class="num">(465,927)<span></span>
</td>
<td class="num">(119,796)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets', window );">Other assets</a></td>
<td class="num">(166,896)<span></span>
</td>
<td class="num">(55,880)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">1,056,165<span></span>
</td>
<td class="nump">70,681<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses - related party</a></td>
<td class="num">(12,778)<span></span>
</td>
<td class="num">(135,117)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable', window );">Taxes payable</a></td>
<td class="nump">209,667<span></span>
</td>
<td class="nump">36,331<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(62,210)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">NET CASH USED IN OPERATING ACTIVITIES</a></td>
<td class="num">(5,739,560)<span></span>
</td>
<td class="num">(1,235,021)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of fixed assets</a></td>
<td class="num">(13,925)<span></span>
</td>
<td class="num">(11,880)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfAcquisitionCosts', window );">Cash received from acquisition</a></td>
<td class="nump">40,858<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES</a></td>
<td class="nump">26,933<span></span>
</td>
<td class="num">(11,880)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfNotesPayable', window );">Payment of related party note payable</a></td>
<td class="num">(63,200)<span></span>
</td>
<td class="num">(44,952)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Payment of note payable</a></td>
<td class="num">(461,888)<span></span>
</td>
<td class="num">(148,904)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from note payable</a></td>
<td class="nump">6,891,203<span></span>
</td>
<td class="nump">1,968,940<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Payment of related party loan</a></td>
<td class="num">(232,051)<span></span>
</td>
<td class="num">(21,914)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from related party loan</a></td>
<td class="nump">625,641<span></span>
</td>
<td class="nump">51,127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_PaymentOfLoansPayable', window );">Payment of loans payable</a></td>
<td class="num">(20,082)<span></span>
</td>
<td class="num">(33,714)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Sale of common stock and warrants</a></td>
<td class="nump">91,780<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_DeferredFinancingFees', window );">Deferred financing fees</a></td>
<td class="num">(213,626)<span></span>
</td>
<td class="num">(140,475)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromContributedCapital', window );">Capital contribution</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">NET CASH PROVIDED BY FINANCING ACTIVITIES</a></td>
<td class="nump">6,617,777<span></span>
</td>
<td class="nump">1,630,248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash</a></td>
<td class="num">(269,568)<span></span>
</td>
<td class="nump">38,377<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">NET INCREASE IN CASH</a></td>
<td class="nump">635,582<span></span>
</td>
<td class="nump">421,724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">CASH AT BEGINNING OF PERIOD</a></td>
<td class="nump">716,590<span></span>
</td>
<td class="nump">198,049<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">CASH AT END OF PERIOD</a></td>
<td class="nump">1,352,172<span></span>
</td>
<td class="nump">619,773<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Disclosure of Cash Flow Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Cash paid during the period: Interest</a></td>
<td class="nump">127,157<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid during the period: Income Tax</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental Disclosure of Non-Cash Investing and Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_AcquisitionOfDecahedron', window );">Acquisition of Decahedron</a></td>
<td class="nump">1,479,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_ReversalOfProceedsDueFromNoteholderDueToRepaymentOfNote', window );">Reversal of proceeds due from noteholder due to repayment of note</a></td>
<td class="nump">$ 11,813<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_AcquisitionOfDecahedron">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_AcquisitionOfDecahedron</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_DeferredFinancingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_DeferredFinancingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_PaymentOfLoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_PaymentOfLoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_ReversalOfProceedsDueFromNoteholderDueToRepaymentOfNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_ReversalOfProceedsDueFromNoteholderDueToRepaymentOfNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of capitalized costs associated with acquisition of business. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpensesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for interest during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromContributedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received by a corporation from a shareholder during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromContributedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from long-term debt supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6837432432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">NOTE 1- BASIS OF PRESENTATION</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
terms &#147;COSM,&#148; &#147;we,&#148; &#147;the Company,&#148; and &#147;us&#148; as used in this report refer to Cosmos
Holdings Inc. The accompanying unaudited consolidated balance sheet as of September 30, 2017 and unaudited consolidated statements
of operations for the three and nine months ended September 30, 2017 have been prepared in accordance with generally accepted
accounting principles for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X.
Accordingly, they do not include all of the information and footnotes required by U.S. generally accepted accounting principles
for complete financial statements. In the opinion of management of COSM, all adjustments (consisting of normal recurring accruals)
considered necessary for a fair presentation have been included. Operating results for the nine months ended September 30, 2017,
are not necessarily indicative of the results that may be expected for the year ending December 31, 2017, or any other period.
These unaudited consolidated financial statements and notes should be read in conjunction with the financial statements for each
of the two years ended December 31, 2016 and 2015, included in the Company&#146;s Annual Report on Form 10-K. The accompanying
consolidated balance sheet as of December 31, 2016 has been derived from the audited financial statements filed in our Form 10-K
and is included for comparison purposes in the accompanying balance sheet. Certain prior year amounts have been reclassified to
conform to current year presentation.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6765521888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">NOTE 2 - ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Cosmos
Holdings, Inc. (&#147;Cosmos&#148;, &#147;The Company&#148;, &#147;we&#148;, or &#147;us&#148;) was incorporated in the
State of Nevada under the name Prime Estates and Developments, Inc. on July 21, 2009 for the purpose of acquiring and operating
commercial real estate and real estate related assets.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
September 27, 2013 (the &#147;Closing&#148;), Cosmos Holding Inc. a Nevada corporation (&#147;Cosmos Holdings, Inc.&#148;
or the &#147;Registrant&#148;), closed a reverse take-over transaction by which it acquired a private company whose principal
activities are the trading of products, providing representation, and provision of consulting services to various sectors. Pursuant
to a Share Exchange Agreement (the &#147;Exchange Agreement&#148;) between the Registrant and Amplerissimo Ltd, a company incorporated
in Cyprus (&#147;Amplerissimo&#148;), the Registrant acquired 100% of Amplerissimo&#146;s issued and outstanding common stock.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
August 1, 2014, we, through our Cypriot subsidiary Amplerissimo, formed SkyPharm S.A. a Greek corporation (&#147;SkyPharm&#148;)
whose principal activities and operations are the development, marketing and sales of pharmaceutical, wellness and cosmetic products.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
February 10, 2017, the Company and Decahedron Ltd, a UK Corporation (&#147;Decahedron&#148;) consummated the transactions contemplated
by the Stock Purchase Agreement, dated November 17, 2016 as amended (the &#147;Decahedron SPA&#148;). Pursuant to the terms
of the Decahedron SPA, the shareholders of Decahedron received an aggregate of 1,700,000 shares of common stock of the Company
(the &#147;Stock Consideration&#148;), which were delivered following the closing in exchange for all of the Ordinary Shares
of Decahedron for the Stock Consideration. In accordance with the terms of the SPA, Mr. Lazarou remained as a director and officer
of Decahedron.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">We
are currently focusing our existing operations on expanding the business of SkyPharm and our new subsidiary Decahedron, we have
concentrated our efforts on becoming an international pharmaceutical company. The Company&#146;s focus will be on Branded Pharmaceuticals,
Over-the-Counter (OTC) medicines, and Generic Pharmaceuticals. The Company also intends to expand into Cosmetic-Beauty Products
as well as Food Supplements and we target areas where we can build and maintain a strong position. The Company uses a differentiated
operating model based on a lean, nimble and decentralized structure, an emphasis on low risk license acquisition as well as Research
&#38; Development and our ability to be better owners of pharmaceutical assets than others. This operating model and the execution
of our corporate strategy are enabling the Company to achieve sustainable growth and create shareholder value.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">We
regularly evaluate and, where appropriate, execute on opportunities to expand through the acquisition of branded pharmaceutical
products and pharmaceutical companies in areas that will serve patients that we believe will offer above average growth characteristics
and attractive margins. In particular, we look to continue to enhance our pharmaceutical and over the counter product lines by
acquiring or licensing rights to additional products and regularly evaluate selective acquisition opportunities.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Going
Concern</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company&#146;s consolidated financial statements are prepared using U.S. GAAP applicable to a going concern, which contemplates
the realization of assets and liquidation of liabilities in the normal course of business. The Company generated a net loss of
$3,074,179 for the nine months ended September 30, 2017, and has a working capital deficit of $3,546,938 and an accumulated deficit
of $4,076,398 as of September 30, 2017. These conditions raise substantial doubt of the Company&#146;s ability to continue as
a going concern. The Company has not yet established an adequate ongoing source of revenues sufficient to cover its operating
costs and to allow it to continue as a going concern. The ability of the Company to continue as a going concern is dependent on
the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain
adequate capital, it could be forced to cease development of operations.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
order to continue as a going concern, develop a reliable source of revenues, and achieve a profitable level of operations the
Company will need, among other things, additional capital resources. Management&#146;s plans to continue as a going concern include
raising additional capital through increased sales of product and by sale of common shares. However, management cannot provide
any assurances that the Company will be successful in accomplishing any of its plans. The ability of the Company to continue as
a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually
secure other sources of financing and attain profitable operations. The accompanying consolidated financial statements do not
include any adjustments that might be necessary if the Company is unable to continue as a going concern.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Summary
of Significant Accounting Policies</i></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Basis
of Financial Statement Presentation</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
accompanying consolidated financial statements have been prepared in accordance with principles generally accepted in the United
States of America.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Principles
of Consolidation</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Our
consolidated accounts include our accounts and the accounts of our wholly-owned subsidiaries, Amplerissimo Ltd, SkyPharm S.A.
and Decahedron Ltd. All significant intercompany balances and transactions have been eliminated.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Reclassifications
to Prior Period Financial Statements and Adjustments</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Certain
reclassifications have been made in the Company&#146;s financial statements of the prior year to conform to the current year
presentation. These reclassifications have no impact on previously reported net income.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Use
of Estimates</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires management
to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets
and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting
period. Actual results could differ from those estimates.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Cash
and Cash Equivalents</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">For
purposes of the statement of cash flows, the Company considers all highly liquid investments purchased with an original maturity
of three months or less to be cash equivalents. As of September 30, 2017 and December 31, 2016, there were no cash equivalents.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company maintains bank accounts in the United States denominated in U.S. Dollars and in the Republic of Cyprus, in Greece and
in Bulgaria all of them denominated in Euros. The Company also maintains bank accounts in the United Kingdom of Great Britain,
dominated in Euros and Great Britain Pound (British Pounds Sterling).</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Account
Receivable </b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Accounts
receivable are stated at their net realizable value. The allowance for doubtful accounts against gross accounts receivable reflects
the best estimate of probable losses inherent in the receivables portfolio determined on the basis of historical experience, specific
allowances for known troubled accounts and other currently available information.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Inventory
</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Inventory
is stated at the lower of cost or market value using the weighted average method. Inventory consists primarily of finished goods
and packaging materials, i.e. packaged pharmaceutical products and the wrappers and containers they are sold in. A periodic inventory
system is maintained by 100% count.&#160;Inventory is replaced periodically to maintain the optimum stock on hand available for
immediate shipment.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">We
write-down inventories to net realizable value based on forecasted demand and market conditions, which may differ from actual
results.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Fixed
Assets</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Fixed
assets are stated at cost, less accumulated depreciation. Depreciation is provided on a straight-line basis over the useful lives
(except for leasehold improvements which are depreciated over the lesser of the lease term or the useful life) of the assets as
follows:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size-adjust: none; font-stretch: normal">
<tr>
    <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 9%; border-bottom-style: solid; border-bottom-width: 1pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Estimated
    Useful Life</b></font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: bottom; font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Furniture
    and fixtures</font></td>
    <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; font: 12pt Times New Roman, Times, Serif; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">5-7
    years</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: bottom; font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Office
    and computer equipment</font></td>
    <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; font: 12pt Times New Roman, Times, Serif; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">3-5
    years</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Depreciation
expense was $10,831 and $6,956 for the nine months ended September 30, 2017 and 2016, respectively.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Intangible
Assets</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Intangible
assets with definite useful lives are recorded on the basis of cost and are amortized on a straight-line basis over their estimated
useful lives. The Company uses a useful life of 5 years for an import/export license. The Company evaluates the remaining useful
life of intangible assets annually to determine whether events and circumstances warrant a revision to the remaining amortization
period. If the estimate of the intangible asset&#146;s remaining useful life is changed, the remaining carrying amount of the
intangible asset will be amortized prospectively over that revised remaining useful life. At September 30, 2017, no revision to
the remaining amortization period of the intangible assets was made.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Amortization
expense was $6,368 and $0 for the nine months ended September 30, 2017 and 2016, respectively.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Impairment
of Long-Lived Assets</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
accordance with ASC 360-10, Long-lived assets, which include property and equipment and intangible assets, are reviewed for impairment
whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability
of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted
future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted
future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair
value of the assets. Fair value is generally determined using the asset&#146;s expected future discounted cash flows or market
value, if readily determinable.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Goodwill
and Intangibles </b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company periodically reviews the carrying value of intangible assets not subject to amortization, including goodwill, to determine
whether impairment may exist. Goodwill and certain intangible assets are assessed annually, or when certain triggering events
occur, for impairment using fair value measurement techniques. These events could include a significant change in the business
climate, legal factors, a decline in operating performance, competition, sale or disposition of a significant portion of the business,
or other factors. Specifically, goodwill impairment is determined using a two-step process. The first step of the goodwill impairment
test is used to identify potential impairment by comparing the fair value of a reporting unit with its carrying amount, including
goodwill. The Company uses level 3 inputs and a discounted cash flow methodology to estimate the fair value of a reporting unit.
A discounted cash flow analysis requires one to make various judgmental assumptions including assumptions about future cash flows,
growth rates, and discount rates. The assumptions about future cash flows and growth rates are based on the Company&#146;s budget
and long-term plans. Discount rate assumptions are based on an assessment of the risk inherent in the respective reporting units.
If the fair value of a reporting unit exceeds its carrying amount, goodwill of the reporting unit is considered not impaired and
the second step of the impairment test is unnecessary. If the carrying amount of a reporting unit exceeds its fair value, the
second step of the goodwill impairment test is performed to measure the amount of impairment loss, if any. The second step of
the goodwill impairment test compares the implied fair value of the reporting unit&#146;s goodwill with the carrying amount of
that goodwill. If the carrying amount of the reporting unit&#146;s goodwill exceeds the implied fair value of that goodwill,
an impairment loss is recognized in an amount equal to that excess. The implied fair value of goodwill is determined in the same
manner as the amount of goodwill recognized in a business combination. That is, the fair value of the reporting unit is allocated
to all of the assets and liabilities of that unit (including any unrecognized intangible assets) as if the reporting unit had
been acquired in a business combination and the fair value of the reporting unit was the purchase price paid to acquire the reporting
unit.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Prior
to the acquisition of Decahedron, the Company had no record goodwill value. As a result of the acquisition of Decahedron, the
Company tested and expensed 100% of the goodwill allocated to the acquisition costs, an amount equal to $1,949,884 for the period
ending September 30, 2017.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Fair
Value Measurement</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company adopted FASB ASC 820-Fair Value Measurements and Disclosures, or ASC 820, for assets and liabilities measured at fair
value on a recurring basis. ASC 820 establishes a common definition for fair value to be applied to existing generally accepted
accounting principles that require the use of fair value measurements establishes a framework for measuring fair value and expands
disclosure about such fair value measurements. The adoption of ASC 820 did not have an impact on the Company&#146;s financial
position or operating results, but did expand certain disclosures.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">ASC
820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction
between market participants at the measurement date. Additionally, ASC 820 requires the use of valuation techniques that maximize
the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level
1:&#160;Observable inputs such as quoted prices (unadjusted)&#160;in active markets for identical assets or liabilities.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level
2:&#160;Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar
assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not
active.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level
3:&#160;Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed
by us, which reflect those that a market participant would use.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company did not have any Level 2 or Level 3 assets or liabilities as of September 30, 2017.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Cash
is considered to be highly liquid and easily tradable as of September 30, 2017 and therefore classified as Level 1 within our
fair value hierarchy.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
addition, FASB ASC 825-10-25 Fair Value Option, or ASC 825-10-25, was effective for January 1, 2008. ASC 825-10-25 expands opportunities
to use fair value measurements in financial reporting and permits entities to choose to measure many financial instruments and
certain other items at fair value. The Company did not elect the fair value options for any of its qualifying financial instruments.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Revenue
Recognition</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">We
consider revenue recognizable when persuasive evidence of an arrangement exists, the price is fixed or determinable, goods or
services have been delivered, and collectability is reasonably assured. These criteria are assumed to have been met if a customer
orders an item, the goods or services have been shipped or delivered to the customer, and we have sufficient evidence of collectability,
such a payment history with the customer. Revenue that is billed and received in advance such as recurring weekly or monthly services
are initially deferred and recognized as revenue over the period the services are provided.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Stock-based
Compensation</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company records stock based compensation in accordance with ASC section 718, &#147;Stock Compensation&#148; and Staff Accounting
Bulletin (SAB) No. 107 (SAB 107) issued by the SEC in March 2005 regarding its interpretation of ASC 718. ASC 718 requires the
fair value of all stock-based employee compensation awarded to employees to be recorded as an expense over the related requisite
service period. The Company values any employee or non-employee stock based compensation at fair value using the Black-Scholes
Option Pricing Model.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company accounts for non-employee share-based awards in accordance with the measurement and recognition criteria of ASC 505-50
&#147;Equity-Based Payments to Non-Employees&#148;.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Foreign
Currency Translations and Transactions</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Assets
and liabilities of all foreign operations are translated at year-end rates of exchange, and the statements of operations are translated
at the average rates of exchange for the year. Gains or losses resulting from translating foreign currency financial statements
are accumulated in a separate component of stockholders&#146; equity until the entity is sold or substantially liquidated.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Gains
or losses from foreign currency transactions (transactions denominated in a currency other than the entity&#146;s local currency)
are included in net earnings.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Income
Taxes</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company accounts for income taxes under the asset and liability method, as required by the accounting standard for income taxes&#160;ASC
740. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences
between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis, as well as
net operating loss carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply
to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred
tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company is liable for income taxes in the Republic of Cyprus, Greece and the United Kingdom of England. The corporate income tax
rate in Cyprus is 12.5%, 29% in Greece (tax losses are carried forward for five years effective January 1, 2013) and 20% in United
Kingdom of England. Losses may also be subject to limitation under certain rules regarding change of ownership.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">We
regularly review deferred tax assets to assess their potential realization and establish a valuation allowance for portions of
such assets to reduce the carrying value if we do not consider it to be more likely than not that the deferred tax assets will
be realized. Our review includes evaluating both positive (e.g., sources of taxable income) and negative (e.g., recent historical
losses) evidence that could impact the realizability of our deferred tax assets.&#160;At September 30, 2017 the Company has maintained
a valuation allowance against all net deferred tax assets in each jurisdiction in which it is subject to income tax.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">We
recognize the impact of an uncertain tax position in our financial statements if, in management&#146;s judgment, the position
is&#160;not&#160;more-likely-then-not sustainable upon audit based on the position&#146;s technical merits. This involves the
identification of potential uncertain tax positions, the evaluation of applicable tax laws and an assessment of whether a liability
for an uncertain tax position is necessary. As of September 30, 2017 the Company has no uncertain tax positions recorded in any
jurisdiction where it is subject to income tax.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Basic
and Diluted Net Income (Loss) per Common Share</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Basic
and diluted net loss per share calculations are calculated on the basis of the weighted average number of common shares outstanding
during the periods presented. The per share amounts include the dilutive effect of common stock equivalents in periods with net
income. Basic and diluted loss per share for each of the periods ended September 30, 2017 and 2016 is the same due to the anti-dilutive
nature of potential common stock equivalents.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Recent
Accounting Pronouncements</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
January 2017, the FASB issued ASU 2017-04, Intangibles &#150; Goodwill and Other (Topic 350), which simplifies the measurement
of goodwill by eliminating Step 2 from the current goodwill impairment test in the event that there is evidence of an impairment
based on qualitative or quantitative assessments. ASU 2017-04 does not change how the goodwill impairment is identified, and the
Company will continue to perform a qualitative assessment annually to determine whether the two step impairment test is required.
Until the adoption, current accounting standards require the impairment loss to be recognized under Step 2 of the impairment test.
This requires the Company to calculate the implied fair value of goodwill by assigning fair value to the reporting unit&#146;s
assets and liabilities as if the reporting unit has been acquired in a business combination, then subsequently subtracting the
implied goodwill from the carrying amount of the goodwill. The new standard would require the Company to determine the fair value
of the reporting unit and subtract the carrying value from the fair value of the reporting unit to determine if there is an impairment.
ASU 2017-04 is effective for the Company for fiscal years after December 15, 2019, and early adoption is permitted. ASU 2017-04
is required to be adopted prospectively, and the adoption is effective for annual goodwill impairment tests performed in the year
of adoption. The Company does not believe that the adoption of ASU No. 2017-4 will have a material effect on the Company&#146;s
consolidated financial position or the Company&#146;s consolidated results of operations</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
January 2017, the FASB issued ASU No. 2017-01, &#147;Clarifying the Definition of a Business,&#148; with the objective of adding
guidance to assist entities with evaluating whether transactions should be accounted for as an acquisition of assets or a business.
ASU No. 2017-01 is effective for the Company&#146;s fiscal year commencing on January 1, 2018. The effect of this guidance is
to be applied prospectively and early adoption is permitted. The Company does not believe that the adoption of ASU No. 2017-01
will have a material effect on the Company&#146;s consolidated financial position or the Company&#146;s consolidated results
of operations.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
February 2016, the FASB issued ASU 2016-02, &#147;Leases,&#148; which will require lessees to recognize assets and liabilities
for the rights and obligations created by most leases on the balance sheet. The changes become effective for the Company&#146;s
fiscal year beginning July 1, 2019. Modified retrospective adoption for all leases existing at, or entered into after, the date
of initial application, is required with an option to use certain transition relief. The Company expects this ASU will increase
its current assets and current liabilities, but have no net material impact on its consolidated financial statements.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
May 2014, the FASB issued ASU 2014-09--Revenue from Contracts with Customers (Topic 606). The guidance requires an entity to recognize
the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The FASB
delayed the effective date to annual reporting periods beginning after December 15, 2017, including interim reporting periods
within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 15,
2016, including interim reporting periods within that reporting period. In addition, in March and April 2016, the FASB issued
new guidance intended to improve the operability and understandability of the implementation guidance on principal versus agent
considerations. Both amendments permit the use of either a retrospective or cumulative effect transition method and are effective
for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017, with early application permitted.
The Company is currently evaluating the impact the adoption of this ASU will have on its financial statements.&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Management
does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material
effect on the Company&#146;s financial statements.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6003-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=SL51803626-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6837566016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITION OF DECAHEDRON, LTD.<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_Note3AcquisitionOfDecahedronLtdTextBlock', window );">NOTE 3- ACQUISITION OF DECAHEDRON, LTD.</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
February 10, 2017, the Company completed the acquisition pursuant to the Decahedron SPA acquiring 100% of the outstanding shares
of Decahedron, a United Kingdom company. Decahedron is a pharmaceuticals wholesaler which specializes in imports and exports of
branded and generic pharmaceutical products within the EEA and around the world. At closing, the Company acquired 100% of Decahedron&#146;s
outstanding shares in exchange for 1,700,000 shares of Cosmos common stock valued at $1,479,000 (the &#147;Acquisition&#148;).</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company recognized the Decahedron assets acquired and liabilities assumed based upon the fair value of such assets and liabilities
measured as of the date of acquisition. The aggregate purchase price for Decahedron has been allocated to the tangible and identifiable
intangible assets acquired and liabilities assumed based on their estimated fair values at the date of acquisition. The excess
of the purchase price over the fair value of the acquired net assets represents cost and revenue synergies specific to the Company,
as well as non-capitalizable intangible assets, such as the license held by Decahedron for the wholesale of pharmaceuticals in
the United Kingdome and Europe, the remainder has been allocated to goodwill, none of which is tax deductible.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">During
the nine months ended September&#160;30, 2017, we recorded an adjustment of $28,002 primarily related to other assets and an adjustment
of the accounts payable associated with the Decahedron acquisition. We finalized our allocation of the purchase price during the
nine months ended September&#160;30, 2017. The final unaudited allocation of purchase price as of September&#160;30, 2017, is
as follows:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" id="hdcell" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Preliminary
    Allocation as of </b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>February
    10, </b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Allocation</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Final</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2017</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Adjustments</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Allocation</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Current
    assets</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td id="ffcell" style="vertical-align: bottom; width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,537</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,537</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Intangible
    assets</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">50,000</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">50,000</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Other
    assets</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">305,400</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(216,562</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">88,838</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Total
    assets acquired</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">361,937</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(216,562</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">145,375</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Liabilities
    assumed:</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Debt</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">804,819</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(188,560</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">616,259</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Total
    liabilities assumed</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">804,819</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(188,560</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">616,259</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Net
    assets acquired</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(442,882</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(28,002</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(470,884</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Consideration:</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Value
    of Common Stock Issued at Acquisition</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,479,000</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,479,000</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Goodwill</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,921,882</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">28,002</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,949,884</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
components of the acquired intangible assets were as follows (in thousands):</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; font-size-adjust: none; font-stretch: normal">
<tr style="vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Amount</b></font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Useful
    Life</b><br />
    <b>(Years)</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Licenses
    (a)</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">50,000</font></td>
    <td style="vertical-align: bottom; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5</font></td>
    <td style="vertical-align: bottom; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">50,000</font></td>
    <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">_____________</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">(a)
U.K Pharmaceutical Wholesale Distribution License</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Unaudited
Supplemental Pro Forma Data</i></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
pro forma statements of operations data for the nine months ended September 30, 2017, below, give effect to the Decahedron Acquisition,
described above, as if it had occurred at January 1, 2017. These amounts have been calculated after applying our accounting policies
and adjusting the results of Decahedron intangible amortization that would have been charged assuming the fair value adjustments
had been applied and incurred since January 1, 2017. This pro forma data is presented for informational purposes only and does
not purport to be indicative of our future results of operations.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Revenue
of $2,622,547 and net loss of $255,672 since the acquisition date are included in the consolidated statement of operations and
comprehensive income (loss) for nine months ended September 30, 2017.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Unaudited
proforma results of operations for the nine months ended September 30, 2017 and 2016 as though the Company acquired Decahedron
on the first of each fiscal year are set forth below.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="6" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Nine
    Months Ended</b><br />
    <b>September 30,</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2017</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Revenues</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">19,968,845</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,007,806</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Cost
    of revenues</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">18,356,228</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4,672,794</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Gross
    profit</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,612,617</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">335,012</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white">
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Operating
    expenses</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4,411,620</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">614,515</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Operating
    loss</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2,799,003</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(279,503</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Other
    income (expense)</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(524,952</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(238,528</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Net
    Loss</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(3,323,955</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(518,031</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
purchase price exceeded the estimated fair value of the net assets acquired by $1,949,884 which was recorded as Goodwill. Goodwill
represents the difference between the total purchase price for the net assets purchased from Decahedron and the aggregate fair
values of tangible and intangible assets acquired, less liabilities assumed. At the conclusion of the acquisition, goodwill was
reviewed for impairment and it was determined that indicators of impairment existed.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2017, after our assessment of the totality of the events that could impair goodwill, it was the Company&#146;s
conclusion &#147;it is not more likely than not&#148; that the Goodwill was impaired. Therefore, the Company was not required
to conduct a two-step quantitative goodwill impairment test. No events have occurred after September 30, 2017 that would affect
the Company&#146;s conclusion as of the September 30, 2017 assessment date. As a result of the Company&#146;s assessment, 100%
of the goodwill of $1,949,884 was recorded as an impairment of goodwill.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_Note3AcquisitionOfDecahedronLtdTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_Note3AcquisitionOfDecahedronLtdTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6651072640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PREPAID DEFERRED FINANCING COSTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_PrepaidDeferredFinancingCostsTextBlock', window );">NOTE 4 - PREPAID DEFERRED FINANCING COSTS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
February 28, 2016, the Company entered into an agreement with Synthesis Management Limited (&#147;Synthesis Management&#148;)
for the purpose of securing additional financing for the Company. On September 28, 2016, the Company advanced &#128;125,000 ($133,725)
to Synthesis Management. These advances are refundable if funding is not secured and if funding is secured, the amount will be
applied to the note on day one as debt discount. As of September 30, 2017, the outstanding balance on the advance is &#128;125,000
($147,662).</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
August, 2017 the Company entered into an agreement with Synthesis Multi Asset Architecture (&#147;Synthesis Architecture&#148;)
for the purpose of securing additional financing for the Company. On August 14, 2017, the Company advanced Synthesis Architecture
&#128;180,840 ($213,627). These advances are refundable if funding is not secured and if funding is secured, the amount will be
applied to the note on day one as debt discount. As of September 30, 2017, the outstanding balance on the advance is &#128;180,840
($213,627).</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_PrepaidDeferredFinancingCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_PrepaidDeferredFinancingCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6837561488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">NOTE 5 - INCOME TAXES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">At
September 30, 2017, the Company&#146;s effective tax rate differs from the US federal statutory tax rate primarily due to a valuation
allowance recorded against net deferred tax assets in all jurisdictions in which the Company operates. At December 31, 2016, the
Company&#146;s effective tax rate differed from the US federal statutory tax rate primarily due to earnings taxed at the lower
income tax rate in Cyprus.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">We
regularly review deferred tax assets to assess their potential realization and establish a valuation allowance for portions of
such assets to reduce the carrying value if we do not consider it to be more likely than not that the deferred tax assets will
be realized. Our review includes evaluating both positive (e.g., sources of taxable income) and negative (e.g., recent historical
losses) evidence that could impact the realizability of our deferred tax assets. At September 30, 2017, the Company has a maintained
a valuation allowance against all net deferred tax assets in each jurisdiction in which it is subject to income tax.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2017 the Company has no uncertain tax positions recorded in any jurisdiction where it is subject to income tax.
The Company has recorded $63,724 of interest and penalties as interest expense for the nine months ended September 30, 2017 in
accordance with this policy.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32718-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6665738192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL STRUCTURE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PartnersCapitalNotesDisclosureTextBlock', window );">NOTE 6 - CAPITAL STRUCTURE</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Preferred Stock</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is authorized to issue 100 million
shares of preferred stock, which have liquidation preference over the common stock and are non-voting. As of September 30, 2017
and December 31, 2016, no preferred shares have been issued.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Common Stock</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is authorized to issue 300 million
shares of common stock and had issued 100,000,000 in connection with the merger with Amplerissimo and had 25,585,532 shares issued
prior to the merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under the Exchange Agreement, the Registrant
completed the acquisition of all of the issued and outstanding shares of Amplerissimo through the issuance of 100,000,000 restricted
shares of Common Stock to Dimitrios Goulielmos, the sole shareholder of Amplerissimo. Immediately prior to the Exchange Agreement
transaction, the Registrant had 25,585,532 shares of Common Stock issued and outstanding. Immediately after the issuance of the
shares the Registrant had 125,585,532 shares of Common Stock issued and outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consideration provided pursuant to the
Exchange Agreement was the issuance of 100,000,000 shares of our common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 10, 2017 the Company and Decahedron
consummated the acquisition of Decahedron SPA. Pursuant to the terms of the Decahedron SPA, the shareholders of Decahedron received
an aggregate of 1,700,000 shares of common stock of the Company, which were delivered at closing in exchange for all of the Ordinary
Shares of Decahedron for the Stock Consideration.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Shares Issued for Services</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 1, 2017, the Company entered into
a four-month consulting agreement with a third party investment advisory firm for consideration of 5,000 restricted shares of common
stock to be issued during the period of the agreement for any introductions and related contributions the Company receives as a
result of those introductions. As of September 30, 2017, no consideration has been earned and no shares have been issued related
to this agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 1, 2017, the Company entered into an
8-month consulting agreement with a third party for web design services commencing on May 1, 2017 and terminating on January 1,
2018. As compensation for creating, delivering and maintaining a website, the Company issued 20,000 shares of common stock on May
24, 2017. The shares were valued at $14,400, which was fully recognized in the nine months ended September 30, 2017.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 1, 2017, the Company entered into a
five-month consulting agreement with a third party advisory firm for consideration of 20,000 shares of the Company&#146;s common
stock. The stock was issued on May 25, 2017 and fair valued at $0.72 per share or $14,400, which was fully recognized in the nine
months ended September 30, 2017.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 8, 2017, the Company entered into a
one-year consulting agreement for advisory services with a third party investment relations firm. On May 18, 2017, the Company
issued to the consultant 300,000 shares of the Company&#146;s common stock valued at $219,000. The shares are considered to be
a fully earned, nonrefundable, non-apportionable and non-ratable retainer as consideration for undertaking the agreement. In addition,
the Company will pay the consultant $5,000 per month in cash for the term of the agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 25, 2017, the Company entered into a
20-month consulting agreement with a third party advisory firm for consideration of 200,000 shares of the Company&#146;s common
stock. The stock was issued on May 25, 2017 and fair valued at $0.77 per share or $154,000, which will be amortized over the length
of the agreement. For the nine months ending September 30, 2017, the Company has recorded $32,874 in consulting expense related
to this agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of September 30, 2017 and December 31, 2016,
the Company had 128,253,932 and 125,870,532 shares of Common Stock issued and outstanding, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Potentially Dilutive Securities</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 1, 2016 the Company granted 120,000
options to an employee of the Company as compensation for being appointed the US Finance Manager of the Company. The options have
an exercise period of four years with an exercise price of $0.20. In the event that he ceases to work for the Company for any reason,
he will be entitled to a pro rata portion of the annual options. The options vest monthly with 120,000 options fully vested as
of September 30, 2017. (See Note 10)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 1, 2017 the Company granted 250,000
options to an employee of the Company as compensation for being appointed the International Finance Manager of the Company. The
options have an exercise period of four years with an exercise price of $0.10 per share. In the event that he ceases to work for
the Company for any reason, he will be entitled to a pro rata portion of the annual options. The options vest monthly with 187,500
options fully vested as of September 30, 2017. (See Note 10)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 3, 2017 the Company granted 120,000
options to an employee of the Company as compensation for being appointed as a consultant of the Company. The options have an exercise
period of five years with an exercise price of $0.20 per share. In the event that he ceases to work for the Company for any reason,
he will be entitled to a pro rata portion of the annual options. The options vest monthly with 90,000 options fully vested as of
September 30, 2017. (See Note 10)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Sales Pursuant to Regulation S</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify">On April 7, 2017, the Company issued
shares of common stock and warrants pursuant to a private placement conducted under the exemptions from registration under Regulation
S. Each unit sold to investors consists of $35,000 face value purchase price of 50,000 shares plus warrants to purchase the number
of equivalent shares. The Company retains the right to accept less than the $35,000 face value from any investor at its discretion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify">The Company has entered into the
following subscription agreements:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify">On April 10, 2017, the Company sold
45,800 shares at $0.70 per share for a total purchase price of $32,060 to a private investor. The investor also received 45,800
warrants that were valued using the Black Scholes valuation model to have a fair value of $2,375 (See Note 10).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05pt; text-align: justify; text-indent: 0.5in">&#160; &#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify">On April 26, 2017, the Company sold
46,700 shares at $0.70 per share for a total purchase price of $32,690 to a private investor. The investor also received 46,700
warrants that were valued using the Black Scholes valuation model to have a fair value of $1,521 (See Note 10).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify">On May 16, 2017, the Company sold
7,900 shares at $0.70 per share for a total purchase price of $5,530 to a private investor. The investor also received 7,900 warrants
that were valued using the Black Scholes valuation model to have a fair value of $130 (See Note 10).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify">On July 21, 2017, the Company sold
43,000 shares at $0.50 per share for a total purchase price of $21,500 to a private investor. The Company did not grant any warrants
to the investor under this agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">No options, warrants or other potentially dilutive
securities other than those disclosed above have been issued as of September 30, 2017 and December 31, 2016.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PartnersCapitalNotesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the formation, structure, control and ownership of the partnership. Disclosures related to accounts comprising partners' capital. Includes balances of general partners' capital account, limited partners' capital account, preferred partners' capital account and total partners' capital account and units outstanding; accumulated other comprehensive income; amount and nature of changes to amount of partner's capital and units outstanding by class, rights and privileges for each class of units; distribution policies and distributions paid by unit class; impact of and correction of an error in previously issued financial statements; limitations of partners' liability; redemption, conversion and distribution policies; and deferred compensation related to the issuance of units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 272<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6373374&amp;loc=d3e70478-108055<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB TOPIC 4.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187171-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 272<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6373374&amp;loc=d3e70434-108055<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PartnersCapitalNotesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6837561488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">NOTE 7 - RELATED PARTY TRANSACTIONS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
the date of our inception, we issued 20 million shares of our common stock to our three officers and directors which were recorded
at no value (offsetting increases and decreases in Common Stock and Additional Paid in Capital).</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>DOC
Pharma S.A.</i></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2017, the Company has a prepaid balance of &#128;347,914 ($410,991) to DOC Pharma S.A., this comprises over 10.3%
of the Company&#146;s total prepaid balance. As of December 31, 2016, the Company owed &#128;65 ($69) to DOC Pharma S.A.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
November 1, 2015, the Company entered into a &#128;12,000 ($12,662) Loan Agreement with DOC Pharma S.A, pursuant to which DOC
Pharma S.A., paid existing bills of the Company in the amount of &#128;12,000, excluding the Vendor Bills. The loan bears an interest
rate of 2% per annum and was due and payable in full on October 31, 2016. As of September 30, 2017, the Company has an outstanding
principal balance under this note of &#128;12,000 ($14,176) and accrued interest expense of $612.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Grigorios
Siokas</i></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
October 1, 2016, the Company borrowed &#128;5,000 ($5,276) from Mr. Siokas related to its subsidiary&#146;s purchase of additional
capital of SkyPharm. The loan is non-interest bearing and has a maturity date of October 1, 2017. During the nine months ending
September 30, 2017, the Company borrowed an additional &#128;1,000 ($1,181). The outstanding balance as of September 30, 2017
was &#128;6,000 ($7,088).</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">During
the year ended December 31, 2016, the Company borrowed &#128;90,500 ($95,496) as additional loans payable from Mr. Siokas. During
the nine months ended September 30, 2017, the Company borrowed an additional &#128;473,621 ($559,488) and paid back &#128;123,000
($145,300) of these loans. These loans have no formal agreements and bear no interest. As 1of September 30, 2017, the Company
has an outstanding principal balance under these loans of &#128;441,121 ($521,096).</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2017, the Company has recorded &#128;59,646 ($70,459) in prepayments to Mr. Siokas for board of directors fees.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Ourania
Matsouki</i></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">During
the year ended December 31, 2016, the Company borrowed &#128;44,995 ($47,479) from Mrs. Matsouki. During the nine months ended
September 30, 2017, the Company borrowed an additional &#128;55,000 ($64,982) and paid back &#128;73,437 ($86,751). These loans
have no formal agreement and bear no interest. As of September 30, 2017, the Company has an outstanding principal balance under
these loans of &#128;26,558 ($31,373).</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Konstantinos
Vassilopoulos</i></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">During
the year ended December 31, 2016, Konstantinos Vassilopoulos, US Finance Manager, paid $10,179 of existing bills of the Company.
During the nine months ended September 30, 2017, the Company paid back $9,810. There is no formal agreement related to these transactions.
As of September 30, 2017 the outstanding balance under this loan is $369.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Dimitrios
Goulielmos</i></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
November 21, 2014, SkyPharm entered into a Loan Agreement with Dimitrios Goulielmos, former Chief Executive Officer and a current
director of the Company, pursuant to which the Borrower borrowed &#128;330,000 ($401,115) from Mr. Goulielmos. The Loan bears
an interest rate of 2% per annum and was due and payable in full on May 11, 2015. On November 4, 2015, &#128;130,000 ($142,860)
in principal and the related accrued interest of &#128;733 ($806) was forgiven and the remaining balance of &#128;200,000 will
no longer accrue interest as part of the stock purchase agreement with Grigorios Siokas on November 4, 2015 referenced above.
As of December 31, 2016, &#128;60,000 ($63,312) of the loan was paid back. During the nine months ended September 30, 2017 an
additional &#128;53,500 ($63,200) was paid back and a principal balance of &#128;86,500 ($102,182) and &#128;0.00 of accrued interest
remains.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
connection with the Decahedron SPA, on February 9, 2017, Decahedron, Medihelm S.A. and Nikolaos Lazarou entered into a liability
transfer agreement whereby the loan previously provided Decahedron to the Mr. Lazarou prior to the acquisition would be cancelled
in exchange for Mr. Lazarou&#146;s personal assumption of approximately &#163;172,310 ($220,988) owed to MediHelm S.A., a creditor
of Decahedron.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Except
as set forth above, we have not entered into any material transactions with any director, executive officer, and promoter, beneficial
owner of five percent or more of our common stock, or family members of such persons.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39678-107864<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6765644368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">NOTE 8 - DEBT</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
March 4, 2015, the Company entered into a $9,000 Loan Agreement with Mr. Angelo Drakopoulos, pursuant to which Mr. Drakopoulos
paid a $9,000 outstanding bill on behalf of the Company. The loan bears an interest rate of 8% per annum and was due and payable
in full on May 5, 2016. As of September 30, 2017, the Company has an outstanding principal balance under this note of $9,000 and
accrued interest expense of $1,345.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
November 5, 2015, the Company entered into a Loan Agreement pursuant to which the Company borrowed &#128;20,000 ($21,812), of
which proceeds of &#128;10,000 ($10,906) have been received as of December 31 2016. The loan bears an interest rate of 1% per
annum and was due and payable in full on November 5, 2016. The Company repaid &#128;2,000 ($2,110) as of December 31, 2016. The
Company has repaid an additional &#128;8,000 ($9,450) as of September 30, 2017. The Company has accrued interest expense of &#128;435
($514) and an outstanding balance under this note of &#128;10,000 ($11,813) as of September 30, 2017.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
November 5, 2015, the Company entered into a Loan Agreement pursuant to which the Company borrowed &#128;80,000 ($87,248) of which
proceeds of &#128;70,000 ($76,342) have been received as of December 31, 2016. The loan bears an interest rate of 5% per annum
and was due and payable in full on November 5, 2016. As of December 31, 2016, the outstanding balance was &#128;65,000 ($68,588).
During the nine months ended September 30, 2017, the Company repaid &#128;55,000 ($64,972) and reversed the &#128;10,000 ($11,813)
receivable that was never received.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
November 16, 2015, the Company entered into a Loan Agreement with Panagiotis Drakopoulos, former Director and former Chief Executive
Officer, pursuant to which the Company borrowed &#128;40,000 ($43,624) as a note payable from Mr. Drakopoulos. The note bears
an interest rate of 6% per annum and was due and payable in full on November 15, 2016. The Company repaid &#128;10,000 ($11,813)
during the nine months ended September 30, 2017. As of September 30, 2017, the Company has an outstanding principal balance under
this note of &#128;30,000 ($35,439) and accrued interest expense of &#128;4,064 ($4,801).</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">During
the year ended December 31, 2015, the Company borrowed &#128;30,000 ($32,718) as a loan payable from Mr. Panagiotis Drakopoulos,
former Director and former Chief Executive Officer. The loan had no formal agreement and bore no interest. During the year ended
December 31, 2016, the Company repaid &#128;13,000 ($13,718) of the loan. During the nine months ended September 30, 2016 the
Company repaid the remaining &#128;17,000 ($20,082). As of September 30, 2017, the loan has no outstanding balance.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
February 5, 2016, the Company entered into a Loan Agreement pursuant to which the Company borrowed &#128;20,000 ($21,104). The
loan bore an interest rate of 6% and had no maturity date. During the nine months ended September 30, 2017, the Company repaid
the loan and accrued interest of &#128;1,020 ($1,204) in full.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
March 4, 2016, the Company entered into a Loan Agreement pursuant to which the Company borrowed &#128;50,000 ($52,760) from a
third party. On May 04, 2016, the Company entered into a Loan Agreement pursuant to which the Company borrowed an additional &#128;50,000
($52,760). The loans bore an interest rate of 6% and a maturity date of March 4, 2017 and May 4, 2017, respectively. During the
nine months ended September 30, 2017, the Company repaid both loans and accrued interest of &#128;750 ($886) in full.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
April 19, 2016, the Company entered into a Loan Agreement pursuant to which the Company borrowed &#128;100,000 ($105,520). The
loan bore an interest rate of 6% and matured on April 19, 2017. During the nine months ended September 30, 2017, the Company repaid
the loan and accrued interest of &#128;3,100 ($3,662) in full.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
April 22, 2016, the Company entered into a Loan Agreement pursuant to which the Company borrowed &#128;38,000 ($40,098). The loan
bore an interest rate of 6% and matured on April 22, 2017. During the nine months ended September 30, 2017, the Company repaid
the loan and accrued interest of &#128;1,777 ($2,099) in full.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
May 24, 2016, the Company entered into a Loan Agreement pursuant to which the Company borrowed &#128;50,000 ($52,760). The loan
bears an interest rate of 6% and matured on May 24, 2017. During the nine months ended September 30, 2017, the Company repaid
the principal balance of &#128;50,000 ($59,065) in full. The Company has accrued interest expense of &#128;2,798 ($3,305) as of
September 30, 2017.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
October 18, 2016, the Company entered into a Loan Agreement pursuant to which the Company borrowed &#128;10,000 ($10,552). The
loan bears an interest rate of 10% and will mature on October 18, 2017. During the nine months ended September 30, 2017, the Company
repaid the principal balance of &#128;10,000 ($11,813) in full. The Company has accrued interest expense of &#128;239 ($283) as
of September 30, 2017.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><u>Loan
Facility Agreement</u></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
August 4, 2016, the Company&#146;s wholly owned subsidiary SkyPharm entered into a Loan Facility Agreement, guaranteed by Grigorios
Siokas, with Synthesis Peer-To Peer-Income Fund (the &#147;Loan Facility&#148; the &#147;Lender&#148;). The Loan Facility
initially provided SkyPharm with a credit facility of up to $1,292,769 (&#128;1,225,141). Any advance under the Loan Facility
accrues interest at a rate of 10% per annum and requires quarterly interest payments commencing on September 30, 2016. The amounts
owed under the Loan Facility shall be repayable upon the earlier of (i) three months following the demand of the Lender; or (ii)
August 31, 2018. No prepayment is permitted pursuant to the terms of the Loan Facility. The Synthesis Facility Agreement as amended
is secured by a personal guaranty of Grigorios Siokas, which is secured by a pledge of 10,000,000 shares of common stock of the
Company owned by Mr. Siokas.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
September 13, 2016, Sky Pharm entered into a First Deed of Amendment with the Loan Facility increasing the maximum loan amount
to $1,533,020 as a result of the Lender having advanced $240,251 (&#128;227,629) to SkyPharm.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
March 23, 2017, SkyPharm entered into an Amended and Restated Loan Facility Agreement (the &#147;A&#38;R Loan Facility&#148;),
with the Loan Facility which increased the loan amount to an aggregate total of $2,664,960 (&#128;2,491,083) as a result of the
lender having advanced $174,000 (&#128;164,898) in September 2016, $100,000 (&#128;94,769)&#160;in October 2016, $250,000 (&#128;236,922)
in November 2016, $452,471 (&#128;428,800) in December 2016, $155,516 (&#128;131,648) in January 2017 and $342,327 (&#128;289,788)
in July 2017. The A&#38;R Loan Facility amends and restates certain provisions of the Loan Facility Agreement, dated as of August
4, 2016, by and among the same parties. Advances under the A&#38;R Loan Facility continue to accrue interest at a rate of 10%
per annum from the applicable date of each drawdown and require quarterly interest payments. The A&#38;R Facility now permits
prepayments at any time. The amounts owed under the A&#38;R Loan Facility shall be repayable upon the earlier of (i) seventy five
days following the demand of the Lender; or (ii) August 31, 2018. The A&#38;R Loan Facility is secured by a personal guaranty
of Grigorios Siokas, which is secured by a pledge of 10,000,000 shares of common stock of the Company owned by Mr. Siokas (the
&#147;Pledged Shares&#148;). The A&#38;R Loan Facility was also amended to provide additional affirmative and negative covenants
of Sky Pharm and the Guarantor during the term of loans remain outstanding, including, but not limited to, the consent of the
Lender in connection with (i) the Company or any of its subsidiaries incurring any additional indebtedness; or (ii) in the event
of any increase in the Company&#146;s issued and outstanding shares of Common Stock, the Pledged Shares shall be increased to
an amount equal to a minimum of ten percent (10%) of the issued and outstanding shares of the Company.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2017, the outstanding balance under this note was $3,007,287 (&#128;2,545,744) and accrued interest expense of
$143,761 (&#128;121,697) has been recorded.&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company recorded &#128;120,000 ($141,756) in debt discounts related to this note. The debt discounts are being amortized over
the term of the debt. During the year ended December 31, 2016 the Company amortized a total of $14,507 (&#128;13,748). Amortization
of the debt discounts for the nine months ended September 30, 2017 was $52,796 (&#128;47,368).</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><u>Bridge
Loans</u></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
March 16, 2017 and March 20, 2017, SkyPharm entered into loan agreements with the Synthesis Peer-To Peer-Income Fund (the &#147;Bridge
Loans&#148;). The Bridge Loans provided to SkyPharm loans of &#128;42,326 ($50,000) and &#128;100,000 ($118,130), respectively.
The Bridge Loans accrue interest at a rate of 10% per annum and were repayable on April 16, 2017 and April 20, 2017, respectively
together with all other amounts then accrued and unpaid. On April 16, 2017, the maturity dates were amended for no additional
consideration of change in terms and conditions. The maturity dates of both loans were amended and they matured on May 16, 2017
and May 20, 2017, respectively. The Company has accrued interest expense of an aggregate total of &#128;7,335 ($8,665) for both
loans and the outstanding balances of these loans was &#128;42,326 ($50,000) and &#128;100,000 ($118,130), respectively, as of
September 30, 2017.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
May 5, 2017, SkyPharm entered into a loan agreement with Synthesis Peer-To-Peer Income Fund for &#128;30,449 ($34,745). The loan
accrues interest at a rate of 10% per annum and matures on September 30, 2017. The Company as accrued interest expense of &#128;1,201
($1,418) and the outstanding balance on this loan was &#128;29,413 ($34,745) as of September 30, 2017.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><u>Trade
Facility Agreements</u></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
April 10, 2017, Decahedron entered into a Trade Finance Facility Agreement (the &#147;Decahedron Facility&#148;) with Synthesis
Structured Commodity Trade Finance Limited (the &#147;Lender&#148;). The Decahedron Facility provides the following material
terms:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size-adjust: none; font-stretch: normal">
<tr>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td>
    <td colspan="2" style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
    Lender will provide Decahedron a facility of up to &#128;2,750,000 ($2,941,950) secured against Decahedron&#146;s receivables
    from the sale of branded and generic pharmaceutical sales.</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td>
    <td colspan="2" style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
    total facility will be calculated as 95% of the agreed upon value of Decahedron&#146;s receivables.</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td>
    <td colspan="2" style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
    term of the Decahedron Facility will be for 12 months.</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td>
    <td colspan="2" style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
    obligations of Decahedron are guaranteed by the Company pursuant to a Cross Guarantee and Indemnity Agreement.</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td>
    <td colspan="2" style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
    Lender has the right to make payments directly to Decahedron&#146;s suppliers.</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td>
    <td colspan="2" style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
    following fees should be paid in connection with the Decahedron Facility:</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr>
    <td style="width: 4%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 4%; font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 4%; font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">o</font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">2%
    of the maximum principal amount as an origination fee.</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">o</font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">A
    one percent (1%) monthly fee.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
current draw on the Decahedron Facility is $0.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
May 12, 2017, SkyPharm entered into a Trade Finance Facility Agreement (the &#147;SkyPharm Facility&#148;) with Synthesis Structured
Commodity Trade Finance Limited (the &#147;Lender&#148;). The SkyPharm Facility provides the following material terms:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size-adjust: none; font-stretch: normal">
<tr>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td>
    <td colspan="2" style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
    Lender will provide SkyPharm a facility of up to &#128;2,000,000 ($2,282,200) secured against SkyPharm&#146;s receivables
    from the sale of branded and generic pharmaceutical sales. In the event that accounts receivable becomes uncollectible, the
    Company will be obligated to pay back the notes in full.</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td>
    <td colspan="2" style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
    total facility will be calculated as 95% of the agreed upon value of Decahedron&#146;s receivables.</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td>
    <td colspan="2" style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
    term of the SkyPharm Facility will be for 12 months.</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td>
    <td colspan="2" style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
    obligations of SkyPharm are guaranteed by the Company pursuant to a Cross Guarantee and Indemnity Agreement.</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td>
    <td colspan="2" style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
    Lender has the right to make payments directly to SkyPharm&#146;s suppliers.</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td>
    <td colspan="2" style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
    following fees should be paid in connection with the SkyPharm Facility:</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr>
    <td style="width: 4%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 4%; font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 4%; font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">o</font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">2%
    of the maximum principal amount as an origination fee.</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">o</font></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">A
    one percent (1%) monthly fee.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
current draw on the SkyPharm Facility is &#128;5,216,910 ($6,162,736) and the Company has accrued &#128;170,711 ($201,661) in
monthly fees related to this agreement. The Company obtained consents from Synthesis Peer-to-Peer Income Fund in connection with
obtaining the Lender. On November 16, 2017, the Company&#160;signed an amendment to the agreement for the additional proceeds
borrowed.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company has recorded a total debt discount of &#128;104,338 in origination fees associated with these loans, which will be amortized
over the term of the agreements. Amortization of debt discount for the nine months ended September 30, 2017 was &#128;31,295 ($34,881).</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">None
of the above loans were made by any related parties.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20,22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6837596032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">NOTE 9 - COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Legal
Matters</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">From
time to time, the Company may be involved in litigation relating to claims arising out of the Company&#146;s operations in the
normal course of business. As of September 30, 2017, there were no pending or threatened lawsuits that could reasonably be expected
to have a material effect on the results of the Company&#146;s operations.&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Operating
Leases</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company conducts its operations from an office located in Chicago, Illinois for which beginning in January 2015, the monthly rent
expense is $730, which has been paid through December 31, 2015. The lease expired as of November 30, 2015, however, the Company
has negotiated and entered into a new lease that commenced as of September 1, 2016 at a rate of $709 per month. Rent expense for
the three and nine months ended September 30, 2017 was $2,126 and $6,377, respectively. Rent expense for the three and nine months
ended September 30, 2016, was $2,126 and $2,834, respectively.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
offices of Amplerissimo are located in Cyprus for which we paid approximately &#128;110 ($122) per month on a month to month basis.
Rent expense for the three and nine months ended September 30, 2017 was &#128;330 ($368) and &#128;990 ($1,103), respectively.
Rent expense for the three and nine months ended September 30, 2016 was &#128;330 ($368) and &#128;990 ($1,105), respectively.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
offices of SkyPharm are located in Greece, Thessaloniki, for which we paid approximately &#128;4,325 ($4,802) per month under
a six year lease that commenced September 2014. In December 2015, the lease was revised to include an additional rental of the
first floor at a rate of &#128;800 ($886) per month. The lease was further revised in March 2016 to include another additional
rental of the first floor at a rate of &#128;800 ($886) per month beginning in May 2016. On May 30, 2016, the lease was revised
again to include an additional rental of space at a rate of &#128;1,825 ($2,021) per month beginning in June 2016. On March 23,
2017, SkyPharm entered into an additional three year lease at a rate of &#128;1,250 per month that commenced May 2017. Rent expense
for the three and nine months ended September 30, 2017 was &#128;27,000 ($30,094) and &#128;76,000 ($84,710), respectively. Rent
expense for the three and nine months ended September 30, 2016 was &#128;23,250 ($25,961) and &#128;57,425 ($64,127), respectively.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
offices of Decahedron are located in Flex Meadow, Harlow, for which we pay approximately &#8356;1,908 ($2,415) per month, under
a one year amendment to a lease dated October 25, 2011, which commenced on October 25, 2016. Rent expense from the date of acquisition
through September 30, 2017 was &#8356;15,267 ($19,580).</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Intellectual
Property Sale Agreement</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
October 1, 2016, the Company entered into an Intellectual Property Sale Agreement with Anastasios Tsekas and Olga Parthenea Georgatsou
(the &#147;IPSA&#148;) for the purchase of certain intellectual property rights relating to proprietary pharmaceutical formulas
and any related technical information arising or related thereto (the &#147;Intellectual Property&#148;). The IPSA provides
that the sellers shall be entitled to an aggregate of 2,000,000 shares of common stock of the Company, none of which have been
issued to date, and issuable as follows in equal parts to each seller:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size-adjust: none; font-stretch: normal">
<tr>
    <td style="width: 4%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: top; width: 4%; font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td>
    <td style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">500,000
    shares upon the successful conclusion of Preclinical Trials.</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td>
    <td style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">500,000
    shares upon the conclusion of Phase I testing.</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td>
    <td style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">500,000
    shares upon the conclusion of Phase II testing.</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#183;</font></td>
    <td style="vertical-align: top; font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">500,000
    shares upon the conclusion of Phase III testing.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company has agreed to pay Anastasios Tsekas &#128;1,500 per month until the first issuance of the shares referenced above. The
Company has also agreed that in the event the Company disposes of the Intellectual Property prior to the periods referenced above,
the sellers shall be entitled to the issuance of all the shares referenced above. The Company is in the process of locating a
suitable lab to conduct the Preclincal trial phase, which has not yet begun as of the date of filing.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Letter
of Intent</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
June 21, 2017, the Company signed a new Letter of Intent (LOI) to acquire the outstanding shares of CC Pharma GmbH, a leading
re-importer of EU pharmaceuticals to Germany. Under the terms of the LOI, Cosmos Holdings holds the exclusive right to complete
its due diligence process and complete the transaction by October 31, 2017. In connection with the non-binding LOI, the Company
is required to pay a non-refundable fee of &#128;400,000 ($454,800) to the shareholders of CC Pharma GmbH in connection with the
costs of due diligence and the exclusive right to negotiate the terms of the definitive agreements. On July 6, 2017, the Company
paid the &#128;400,000 ($454,800) to CC Pharma GmbH and the Company has recorded an expense of &#128;400,000 ($454,800) for the
nine months ended September 30, 2017. The Company did not enter into any definitive agreements by October 31, 2017 and is currently
negotiating with CC Pharma for an extension. The Company makes no assurances that the parties will enter into any definitive agreements
in the future.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Placement
Agreement</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05pt; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
August 8, 2017, the Company entered into an agreement with a third party placement agent (the &#147;Agent&#148;) who will serve
as the Company&#146;s exclusive placement agent or sole book running manager with respect to any offerings of equity or equity-linked
securities as well as any debt offering with the two organizations named in the agreement (the &#147;Offering&#148;) for a period
of 120 days. In the event that an Offering is agreed upon by the Agent and the Company, the Company shall provide payment as follows:
(1) a cash commission of 6% of the total gross proceeds for two named investors (2) a cash commission of 4% of total gross proceeds
from five named investors and (3) excluding the five named investors in &#147;(2)&#148; a cash commission equal to 8% of the
total gross proceeds from the Offering and the issuance to the Agent or its designees of warrants covering 8% of the shares of
common stock issued or issuable by the Company in the Offering. Additionally, the Agent will receive a cash fee of 8% payable
within 5 business days, but only in the event of, the receipt by the Company of any cash proceeds from the exercise of any warrants
with an expiration equal to or less than 24 months sold in the Offering.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6449706&amp;loc=d3e16207-108621<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14435-108349<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=73718637&amp;loc=d3e25287-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6648358592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK OPTIONS AND WARRANTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockByClassTextBlock', window );">NOTE 10 - STOCK OPTIONS AND WARRANTS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
October 1, 2016 the Company granted 120,000 options to an employee of the Company as compensation for being appointed the US Finance
Manager of the Company. The options have an exercise period of four years with an exercise price of $.20 per share. In the event
that he ceases to work for the Company for any reason, he will be entitled to a pro rata portion of the annual options. The options
vest monthly with 120,000 options fully vested as of September 30, 2017. The options were valued at $65,290 using the Black Scholes
Option Pricing Model with the following inputs: stock price on measurement date: $0.58; Exercise price: $0.20; Option term: 4
years; Computed volatility: 159%. The Company expensed $16,636 in the year ended December 31, 2016. As of September 30, 2017 the
Company has expensed an additional $48,654.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
January 1, 2017 the Company entered into an agreement whereby the employee was granted compensation of &#128;1,000 per month and
an annual retainer of 250,000 stock options as compensation for being appointed the International Finance Manager of the Company.
The options have an exercise period of four years with an exercise price of $0.10. In the event that he ceases to work for the
Company for any reason, he will be entitled to a pro rata portion of the annual options. The options vest monthly, with a total
of 187,500 options fully vested as of September 30, 2017. The options were valued at $195,307 using the Black Scholes Option Pricing
Model with the following inputs: stock price on measurement date: $0.82; Exercise price: $0.10; Option term: 4 years; Computed
volatility: 136.76%. The fair value of the options will be amortized over a year with $146,079 expensed during the nine months
ended September 30, 2017.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
January 3, 2017 the Company determined to create an advisory board and appointed Mr. Orestes Varvitsiotes as its first member.
Mr. Varvitsiotes is a registered broker dealer who is currently engaged with Aegis Capital Corp. In connection therewith, the
Company entered into an Advisory Board Member Consulting Agreement, dated as of January 3, 2017 whereby an annual retainer of
120,000 stock options was granted as compensation for services. The options have an exercise period of five years with an exercise
price of $0.20. In the event that he ceases to work for the Company for any reason, he will be entitled to a pro rata portion
of the annual options. The options vest monthly, with a total of 90,000 options fully vested as of September 30, 2017. The options
were valued at $94,830 using the Black Scholes Option Pricing Model, with the following inputs: stock price on measurement date:
$0.82; Exercise price: $0.20; Option term: 5 years; Computed volatility: 155.37%. The fair value of the options will be amortized
over the year with $70,796 expensed during the nine months ended September 30, 2017.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">A
summary of the Company&#146;s option activity during the nine months ended September 30, 2017 is presented below:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" id="hdcell" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Remaining</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Aggregate</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Number
    of</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Exercise</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Contractual</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Intrinsic</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Options</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Shares</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Price</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Term</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Value</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Balance
    Outstanding, December 31, 2016</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td id="ffcell" style="vertical-align: bottom; width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">120,000</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.20</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3.75</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">74,400</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">370,000</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">.13</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3.58</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">150,800</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Expired</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Balance
    Outstanding, September 30, 2017</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">490,000</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">.15</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3.44</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">191,600</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Exercisable,
    September 30, 2017</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">397,500</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">.15</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3.41</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">153,900</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
connection with a private placement that took place on April 7, 2017, the Company issued warrants at a 1:1 ratio for shares purchased
by investors. The warrants were valued using the Black Scholes valuation model. A summary of the Company&#146;s warrant activity
for the nine months ending September 30, 2017 is as follows:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;<b>September
    30,</b><br />
    <b>2017</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Volatility</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">76.66%-90.86</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Expected
    term (in years)</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Risk-free
    interest rate</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.07% - 1.11</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">%
    </font></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Expected
    dividend yield</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Remaining</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Aggregate</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Number
    of</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Exercise</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Contractual</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Intrinsic</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Warrants</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Shares</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Price</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Term</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Value</b></font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Balance
    Outstanding, December 31, 2016</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100,400</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3.00</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Expired</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Balance
    Outstanding, September 30, 2017</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100,400</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3.00</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">.55</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Exercisable,
    September 30, 2017</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100,400</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3.00</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">.55</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information.  Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=d3e177068-122764<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21553-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65888546&amp;loc=d3e21300-112643<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21521-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21538-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6761249584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">NOTE 11 - SUBSEQUENT EVENTS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><u>Purchase
of Treasury Shares</u></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05pt; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.05pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Effective
October 2, 2017, the Company entered into to a stock purchase agreement dated September 30, 2017, whereby for consideration of
$1,387 the Company purchased 1,386,894 shares of its common stock from a third party investor. The shares were transferred to
the Company on October 17, 2017 and will be held in treasury.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.4pt; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.4pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><u>Reverse
Stock Split</u></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
October 11, 2017, the Company authorized a one-for-ten (1:10) reverse stock split whereby the Company decreased, by a ratio of
one-for-ten (1:10) the number of issued and outstanding shares of Common Stock. The reverse stock split was approved and filed
in the state of Nevada, and reported on Form 8-K filed on October 11, 2017; however it had not been approved by FINRA as of the
date of filing, and therefore the financial statements are not retroactively restated to reflect the split. The Company anticipates
that the reverse split will be effective on November 21, 2017.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.4pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><u>November
15, 2017 Securities Purchase Agreement</u></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
November 15, 2017, the Company entered into a Securities Purchase Agreement (the &#147;SPA&#148;) with certain institutional
investors (the &#147;Buyers&#148;) with which it had no prior relationship, pursuant to which the Company has agreed to issue
for a purchase price of $3,000,000,&#160;$3,350,000 in aggregate principal amount of Senior Convertible Notes (the &#147;Notes&#148;)
to the Buyers, convertible into 6,700,000 shares of the Company&#146;s common stock, par value $.001 per share (the &#147;Common
Stock&#148;) and warrants to purchase an aggregate of 5,360,003 shares of Common Stock (the &#147;Warrants&#148;.)</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Notes provide that the Company will repay the principal amount of Notes in equal monthly installments beginning on January 1,
2018 and repeating on the first business day of each calendar month thereafter until the fourteenth month anniversary date of
issuance (each a &#147;Installment Date&#148;), and, subject to the Blocker (as defined below), the Company shall pre-deliver
up to 6,700,000 shares of Common Stock to the Buyers in connection therewith (the &#147;Pre-Delivery Shares&#148;). Eighty-five
(85%) percent of any cash proceeds received by the Buyers from the sale of Pre-Delivery Shares shall be applied against the particular
installment amount due on such Installment Date under the Note. No interest will accrue under the Notes unless and until an Event
of Default (as defined) has occurred and is not cured.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Notes are convertible at any time by the Holder into shares of Common Stock at the rate of $0.50 per share, subject to full ratchet
anti-dilution adjustment (the &#147;Conversion Price&#148;). Upon an Event of Default (as defined), the Buyers may convert at
an alternative conversion price equal to the lower of the then applicable Conversion Price or seventy-five (75%) percent of the
Volume-Weighted Average Price (as defined, the &#147;VWAP&#148;).</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Notes are senior in right of payment to all existing and future indebtedness of the Company except Permitted Indebtedness (as
defined in the Note), including $12 million of senior secured indebtedness of the Company and its subsidiaries under an existing
senior loan agreement, plus defined amounts of purchase money indebtedness in connection with bona fide acquisitions.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Notes include customary Events of Default and provide that the Buyers may require the Company to redeem (regardless of whether
the Event of Default has been cured) all or a portion of the Notes at a redemption premium of one hundred twenty-five (125%) percent,
multiplied by the greater of the conversion rate and the then current market price. The Buyers may also require redemption of
the Notes upon a Change of Control (as defined) at a premium of one hundred twenty-five (125%) percent.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Warrants have a five year term and are exercisable into a number of shares of Common Stock equal to approximately eighty (80%)
percent of the number of shares of Common Stock the Buyers would receive if the Notes were fully converted upon the date of issuance
of the Notes. The Warrants are exercisable at $0.75 per share (150% of the conversion price of the Notes) subject to full ratchet
anti-dilution protection. The Warrants will be exercisable on a cashless basis if a registration statement is not effective covering
the resale of the underlying Warrant Shares.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Conversion
of the Notes and exercise of the Warrants are each subject to a blocker provision which prevents any holder from converting or
exercising, as applicable, the Notes or the Warrants, into shares of Common Stock if its beneficial ownership of the Common Stock
would exceed 4.99% (subject to adjustment not to exceed 9.99%) of the Company&#146;s issued and outstanding Common Stock (each,
a &#147;Blocker&#148;).</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company is required to file, within thirty (30) days of the Closing, a registration statement covering one hundred fifty (150%)
percent of the maximum number of shares, underlying the Notes and Warrants pursuant to a registration rights agreement with the
Buyers (the &#147;Registration Rights Agreement&#148;).</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">As
a condition to the closing of the Financing, each Buyer, severally, will be required to execute a leak-out agreement (each, a
&#147;Leak-Out Agreement&#148;) restricting such Buyer&#146;s sale of shares of Common Stock underlying the Notes and Warrants
on any Trading Day to not more than such Buyer&#146;s pro rata allocation of the greater of (x) sales with net proceeds of an
aggregate of $20,000 or (y) twenty-five (25%) percent of the daily average trading volume of the Company&#146;s Common Stock.
If after the closing of the Financing&#160;there is no&#160;Event of Default&#160;under the Notes, the VWAP of the Company&#146;s
Common Stock for three (3) trading days is less than $0.15 per share, the Company may further restrict the Buyers from selling
at less than $0.15 per share; provided that the portion of the Notes subject to redemption on each Installment Date shall thereafter
double.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Roth
Capital Partners, LLC (&#147;Roth&#148;), as the Company&#146;s exclusive placement agent, will receive a cash commission for
this transaction equal to eight (8%) percent of the total gross proceeds of the offering and the issuance of five-year warrants
to purchase eight (8%) percent of the shares of Common Stock issued or issuable in this offering (excluding shares of Common Stock
issuable upon exercise of any Warrants issued to investors); however, will receive eight (8%) percent of any cash proceeds received
from the exercise of any Warrants sold in the offering with an expiration equal to or less than twenty-four (24) months.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><u>Amendment
of Trade Facility Agreement</u></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
November 16, 2017, SkyPharm signed an amended agreement with Synthesis Structured Commodity Trade Finance Limited that increased
the maximum aggregate facility limit from &#128;2,000,000 to &#128;6,000,000. All other terms of the original agreement remain
the same (see Note 8).&#160;</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6834700752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_OrganizationNatureOfBusinessAndGoingConcernPoliciesAbstract', window );"><strong>Organization Nature Of Business And Going Concern Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Financial Statement Presentation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
accompanying consolidated financial statements have been prepared in accordance with principles generally accepted in the United
States of America.</font></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Our
consolidated accounts include our accounts and the accounts of our wholly-owned subsidiaries, Amplerissimo Ltd, SkyPharm S.A.
and Decahedron Ltd. All significant intercompany balances and transactions have been eliminated.</font></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications to Prior Period Financial Statements and Adjustments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Certain
reclassifications have been made in the Company&#146;s financial statements of the prior year to conform to the current year
presentation. These reclassifications have no impact on previously reported net income.</font></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires management
to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets
and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting
period. Actual results could differ from those estimates.</font></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">For
purposes of the statement of cash flows, the Company considers all highly liquid investments purchased with an original maturity
of three months or less to be cash equivalents. As of September 30, 2017 and December 31, 2016, there were no cash equivalents.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company maintains bank accounts in the United States denominated in U.S. Dollars and in the Republic of Cyprus, in Greece and
in Bulgaria all of them denominated in Euros. The Company also maintains bank accounts in the United Kingdom of Great Britain,
dominated in Euros and Great Britain Pound (British Pounds Sterling).</font></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyLoansReceivablePolicy', window );">Account Receivable</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Accounts
receivable are stated at their net realizable value. The allowance for doubtful accounts against gross accounts receivable reflects
the best estimate of probable losses inherent in the receivables portfolio determined on the basis of historical experience, specific
allowances for known troubled accounts and other currently available information.</font></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Inventory
is stated at the lower of cost or market value using the weighted average method. Inventory consists primarily of finished goods
and packaging materials, i.e. packaged pharmaceutical products and the wrappers and containers they are sold in. A periodic inventory
system is maintained by 100% count.&#160;Inventory is replaced periodically to maintain the optimum stock on hand available for
immediate shipment.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">We
write-down inventories to net realizable value based on forecasted demand and market conditions, which may differ from actual
results.</font></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_FixedAssetsPolicyTextBlock', window );">Fixed Assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Fixed
assets are stated at cost, less accumulated depreciation. Depreciation is provided on a straight-line basis over the useful lives
(except for leasehold improvements which are depreciated over the lesser of the lease term or the useful life) of the assets as
follows:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size-adjust: none; font-stretch: normal">
<tr>
    <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 9%; border-bottom-style: solid; border-bottom-width: 1pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Estimated
    Useful Life</b></font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: bottom; font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Furniture
    and fixtures</font></td>
    <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; font: 12pt Times New Roman, Times, Serif; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">5-7
    years</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: bottom; font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Office
    and computer equipment</font></td>
    <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; font: 12pt Times New Roman, Times, Serif; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">3-5
    years</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Depreciation
expense was $10,831 and $6,956 for the nine months ended September 30, 2017 and 2016, respectively.</font></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Intangible Assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Intangible
assets with definite useful lives are recorded on the basis of cost and are amortized on a straight-line basis over their estimated
useful lives. The Company uses a useful life of 5 years for an import/export license. The Company evaluates the remaining useful
life of intangible assets annually to determine whether events and circumstances warrant a revision to the remaining amortization
period. If the estimate of the intangible asset&#146;s remaining useful life is changed, the remaining carrying amount of the
intangible asset will be amortized prospectively over that revised remaining useful life. At September 30, 2017, no revision to
the remaining amortization period of the intangible assets was made.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Amortization
expense was $6,368 and $0 for the nine months ended September 30, 2017 and 2016, respectively.</font></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
accordance with ASC 360-10, Long-lived assets, which include property and equipment and intangible assets, are reviewed for impairment
whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability
of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted
future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted
future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair
value of the assets. Fair value is generally determined using the asset&#146;s expected future discounted cash flows or market
value, if readily determinable.</font></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Intangibles</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company periodically reviews the carrying value of intangible assets not subject to amortization, including goodwill, to determine
whether impairment may exist. Goodwill and certain intangible assets are assessed annually, or when certain triggering events
occur, for impairment using fair value measurement techniques. These events could include a significant change in the business
climate, legal factors, a decline in operating performance, competition, sale or disposition of a significant portion of the business,
or other factors. Specifically, goodwill impairment is determined using a two-step process. The first step of the goodwill impairment
test is used to identify potential impairment by comparing the fair value of a reporting unit with its carrying amount, including
goodwill. The Company uses level 3 inputs and a discounted cash flow methodology to estimate the fair value of a reporting unit.
A discounted cash flow analysis requires one to make various judgmental assumptions including assumptions about future cash flows,
growth rates, and discount rates. The assumptions about future cash flows and growth rates are based on the Company&#146;s budget
and long-term plans. Discount rate assumptions are based on an assessment of the risk inherent in the respective reporting units.
If the fair value of a reporting unit exceeds its carrying amount, goodwill of the reporting unit is considered not impaired and
the second step of the impairment test is unnecessary. If the carrying amount of a reporting unit exceeds its fair value, the
second step of the goodwill impairment test is performed to measure the amount of impairment loss, if any. The second step of
the goodwill impairment test compares the implied fair value of the reporting unit&#146;s goodwill with the carrying amount of
that goodwill. If the carrying amount of the reporting unit&#146;s goodwill exceeds the implied fair value of that goodwill,
an impairment loss is recognized in an amount equal to that excess. The implied fair value of goodwill is determined in the same
manner as the amount of goodwill recognized in a business combination. That is, the fair value of the reporting unit is allocated
to all of the assets and liabilities of that unit (including any unrecognized intangible assets) as if the reporting unit had
been acquired in a business combination and the fair value of the reporting unit was the purchase price paid to acquire the reporting
unit.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Prior
to the acquisition of Decahedron, the Company had no record goodwill value. As a result of the acquisition of Decahedron, the
Company tested and expensed 100% of the goodwill allocated to the acquisition costs, an amount equal to $1,949,884 for the period
ending September 30, 2017.</font></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurement</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company adopted FASB ASC 820-Fair Value Measurements and Disclosures, or ASC 820, for assets and liabilities measured at fair
value on a recurring basis. ASC 820 establishes a common definition for fair value to be applied to existing generally accepted
accounting principles that require the use of fair value measurements establishes a framework for measuring fair value and expands
disclosure about such fair value measurements. The adoption of ASC 820 did not have an impact on the Company&#146;s financial
position or operating results, but did expand certain disclosures.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">ASC
820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction
between market participants at the measurement date. Additionally, ASC 820 requires the use of valuation techniques that maximize
the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level
1:&#160;Observable inputs such as quoted prices (unadjusted)&#160;in active markets for identical assets or liabilities.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level
2:&#160;Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar
assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not
active.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level
3:&#160;Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed
by us, which reflect those that a market participant would use.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company did not have any Level 2 or Level 3 assets or liabilities as of September 30, 2017.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Cash
is considered to be highly liquid and easily tradable as of September 30, 2017 and therefore classified as Level 1 within our
fair value hierarchy.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
addition, FASB ASC 825-10-25 Fair Value Option, or ASC 825-10-25, was effective for January 1, 2008. ASC 825-10-25 expands opportunities
to use fair value measurements in financial reporting and permits entities to choose to measure many financial instruments and
certain other items at fair value. The Company did not elect the fair value options for any of its qualifying financial instruments.</font></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">We
consider revenue recognizable when persuasive evidence of an arrangement exists, the price is fixed or determinable, goods or
services have been delivered, and collectability is reasonably assured. These criteria are assumed to have been met if a customer
orders an item, the goods or services have been shipped or delivered to the customer, and we have sufficient evidence of collectability,
such a payment history with the customer. Revenue that is billed and received in advance such as recurring weekly or monthly services
are initially deferred and recognized as revenue over the period the services are provided.</font></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Stock-based Compensation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company records stock based compensation in accordance with ASC section 718, &#147;Stock Compensation&#148; and Staff Accounting
Bulletin (SAB) No. 107 (SAB 107) issued by the SEC in March 2005 regarding its interpretation of ASC 718. ASC 718 requires the
fair value of all stock-based employee compensation awarded to employees to be recorded as an expense over the related requisite
service period. The Company values any employee or non-employee stock based compensation at fair value using the Black-Scholes
Option Pricing Model.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company accounts for non-employee share-based awards in accordance with the measurement and recognition criteria of ASC 505-50
&#147;Equity-Based Payments to Non-Employees&#148;.</font></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translations and Transactions</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Assets
and liabilities of all foreign operations are translated at year-end rates of exchange, and the statements of operations are translated
at the average rates of exchange for the year. Gains or losses resulting from translating foreign currency financial statements
are accumulated in a separate component of stockholders&#146; equity until the entity is sold or substantially liquidated.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Gains
or losses from foreign currency transactions (transactions denominated in a currency other than the entity&#146;s local currency)
are included in net earnings.</font></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company accounts for income taxes under the asset and liability method, as required by the accounting standard for income taxes&#160;ASC
740. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences
between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis, as well as
net operating loss carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply
to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred
tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company is liable for income taxes in the Republic of Cyprus, Greece and the United Kingdom of England. The corporate income tax
rate in Cyprus is 12.5%, 29% in Greece (tax losses are carried forward for five years effective January 1, 2013) and 20% in United
Kingdom of England. Losses may also be subject to limitation under certain rules regarding change of ownership.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">We
regularly review deferred tax assets to assess their potential realization and establish a valuation allowance for portions of
such assets to reduce the carrying value if we do not consider it to be more likely than not that the deferred tax assets will
be realized. Our review includes evaluating both positive (e.g., sources of taxable income) and negative (e.g., recent historical
losses) evidence that could impact the realizability of our deferred tax assets.&#160;At September 30, 2017 the Company has maintained
a valuation allowance against all net deferred tax assets in each jurisdiction in which it is subject to income tax.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">We
recognize the impact of an uncertain tax position in our financial statements if, in management&#146;s judgment, the position
is&#160;not&#160;more-likely-then-not sustainable upon audit based on the position&#146;s technical merits. This involves the
identification of potential uncertain tax positions, the evaluation of applicable tax laws and an assessment of whether a liability
for an uncertain tax position is necessary. As of September 30, 2017 the Company has no uncertain tax positions recorded in any
jurisdiction where it is subject to income tax.</font></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Basic and Diluted Net Income (Loss) per Common Share</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Basic
and diluted net loss per share calculations are calculated on the basis of the weighted average number of common shares outstanding
during the periods presented. The per share amounts include the dilutive effect of common stock equivalents in periods with net
income. Basic and diluted loss per share for each of the periods ended September 30, 2017 and 2016 is the same due to the anti-dilutive
nature of potential common stock equivalents.</font></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
January 2017, the FASB issued ASU 2017-04, Intangibles &#150; Goodwill and Other (Topic 350), which simplifies the measurement
of goodwill by eliminating Step 2 from the current goodwill impairment test in the event that there is evidence of an impairment
based on qualitative or quantitative assessments. ASU 2017-04 does not change how the goodwill impairment is identified, and the
Company will continue to perform a qualitative assessment annually to determine whether the two step impairment test is required.
Until the adoption, current accounting standards require the impairment loss to be recognized under Step 2 of the impairment test.
This requires the Company to calculate the implied fair value of goodwill by assigning fair value to the reporting unit&#146;s
assets and liabilities as if the reporting unit has been acquired in a business combination, then subsequently subtracting the
implied goodwill from the carrying amount of the goodwill. The new standard would require the Company to determine the fair value
of the reporting unit and subtract the carrying value from the fair value of the reporting unit to determine if there is an impairment.
ASU 2017-04 is effective for the Company for fiscal years after December 15, 2019, and early adoption is permitted. ASU 2017-04
is required to be adopted prospectively, and the adoption is effective for annual goodwill impairment tests performed in the year
of adoption. The Company does not believe that the adoption of ASU No. 2017-4 will have a material effect on the Company&#146;s
consolidated financial position or the Company&#146;s consolidated results of operations</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
January 2017, the FASB issued ASU No. 2017-01, &#147;Clarifying the Definition of a Business,&#148; with the objective of adding
guidance to assist entities with evaluating whether transactions should be accounted for as an acquisition of assets or a business.
ASU No. 2017-01 is effective for the Company&#146;s fiscal year commencing on January 1, 2018. The effect of this guidance is
to be applied prospectively and early adoption is permitted. The Company does not believe that the adoption of ASU No. 2017-01
will have a material effect on the Company&#146;s consolidated financial position or the Company&#146;s consolidated results
of operations.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35pt; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
February 2016, the FASB issued ASU 2016-02, &#147;Leases,&#148; which will require lessees to recognize assets and liabilities
for the rights and obligations created by most leases on the balance sheet. The changes become effective for the Company&#146;s
fiscal year beginning July 1, 2019. Modified retrospective adoption for all leases existing at, or entered into after, the date
of initial application, is required with an option to use certain transition relief. The Company expects this ASU will increase
its current assets and current liabilities, but have no net material impact on its consolidated financial statements.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
May 2014, the FASB issued ASU 2014-09--Revenue from Contracts with Customers (Topic 606). The guidance requires an entity to recognize
the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The FASB
delayed the effective date to annual reporting periods beginning after December 15, 2017, including interim reporting periods
within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 15,
2016, including interim reporting periods within that reporting period. In addition, in March and April 2016, the FASB issued
new guidance intended to improve the operability and understandability of the implementation guidance on principal versus agent
considerations. Both amendments permit the use of either a retrospective or cumulative effect transition method and are effective
for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017, with early application permitted.
The Company is currently evaluating the impact the adoption of this ASU will have on its financial statements.&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Management
does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material
effect on the Company&#146;s financial statements.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_FixedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_FixedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_OrganizationNatureOfBusinessAndGoingConcernPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_OrganizationNatureOfBusinessAndGoingConcernPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 305<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4273-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18726-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=d3e5614-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.3A-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355100-122828<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.3A-02)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355033-122828<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=64802544&amp;loc=d3e202-110218<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32840-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65884525&amp;loc=d3e40913-109327<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32809-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e32247-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e32280-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66092785&amp;loc=d3e4492-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66092785&amp;loc=d3e4556-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyLoansReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for policy loans receivable, including the basis for determining the amount reported for loans made to policyholders against and secured by future policy benefits. May also disclose the range of interest rates charged to policyholders on such loans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyLoansReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.B.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6061-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6143-108592<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6132-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6638645264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_OrganizationNatureOfBusinessAndGoingConcernTablesAbstract', window );"><strong>Organization Nature Of Business And Going Concern Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Calculation of Fixed Assets</a></td>
<td class="text"><p style="margin: 0pt"></p>

<table cellspacing="0" cellpadding="0" style="width: 100%">
<tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 9%; border-bottom-style: solid; border-bottom-width: 1pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><font style="font-size: 10pt"><b>Estimated Useful Life</b></font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: bottom; font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font-size: 10pt">Furniture and fixtures</font></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; font: 12pt Times New Roman, Times, Serif; text-align: center"><font style="font-size: 10pt">5-7 years</font></td>
    <td>&#160;</td></tr>
<tr style="background-color: white">
    <td style="vertical-align: bottom; font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font-size: 10pt">Office and computer equipment</font></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; font: 12pt Times New Roman, Times, Serif; text-align: center"><font style="font-size: 10pt">3-5 years</font></td>
    <td>&#160;</td></tr>
</table>


<p style="margin: 0pt"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_OrganizationNatureOfBusinessAndGoingConcernTablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_OrganizationNatureOfBusinessAndGoingConcernTablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6647428480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITION OF DECAHEDRON, LTD (Table)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_AcquisitionOfDecahedronLtdTableAbstract', window );"><strong>Acquisition Of Decahedron Ltd Table</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_UnauditedAllocationOfPurchasePriceTableTextBlock', window );">Unaudited allocation of purchase price</a></td>
<td class="text"><p style="margin: 0pt"></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" id="hdcell" style="text-align: center"><font style="font-size: 10pt"><b>Preliminary Allocation as of </b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>February 10, </b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Allocation</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Final</b></font></td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font-size: 10pt"><b>2017</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font-size: 10pt"><b>Adjustments</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font-size: 10pt"><b>Allocation</b></font></td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">Current assets</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font-size: 10pt">$</font></td>
    <td id="ffcell" style="vertical-align: bottom; width: 9%; text-align: right"><font style="font-size: 10pt">6,537</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font-size: 10pt">$</font></td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font-size: 10pt">$</font></td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font-size: 10pt">6,537</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">Intangible assets</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">50,000</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">50,000</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">Other assets</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font-size: 10pt">305,400</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font-size: 10pt">(216,562</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font-size: 10pt">)</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font-size: 10pt">88,838</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">Total assets acquired</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font-size: 10pt">361,937</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font-size: 10pt">(216,562</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font-size: 10pt">)</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font-size: 10pt">145,375</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">Liabilities assumed:</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">Debt</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font-size: 10pt">804,819</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font-size: 10pt">(188,560</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font-size: 10pt">)</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font-size: 10pt">616,259</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">Total liabilities assumed</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font-size: 10pt">804,819</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font-size: 10pt">(188,560</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font-size: 10pt">)</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font-size: 10pt">616,259</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">Net assets acquired</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font-size: 10pt">(442,882</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font-size: 10pt">)</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font-size: 10pt">(28,002</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font-size: 10pt">)</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font-size: 10pt">(470,884</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font-size: 10pt">)</font></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">Consideration:</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">Value of Common Stock Issued at Acquisition</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font-size: 10pt">1,479,000</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font-size: 10pt">1,479,000</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">Goodwill</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font-size: 10pt">$</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font-size: 10pt">1,921,882</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font-size: 10pt">$</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font-size: 10pt">28,002</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font-size: 10pt">$</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font-size: 10pt">1,949,884</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
</table>


<p style="margin: 0pt"></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_IntangibleAssetsTableTextBlock', window );">Intangible assets</a></td>
<td class="text"><p style="margin: 0pt"></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font-size: 10pt"><b>Amount</b></font></td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font-size: 10pt"><b>Useful Life</b></font><br />
<font style="font-size: 10pt"><b>(Years)</b></font></td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">Licenses (a)</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font-size: 10pt">$</font></td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font-size: 10pt">50,000</font></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font-size: 10pt">5</font></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font-size: 10pt">$</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font-size: 10pt">50,000</font></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
</table>


<p style="margin: 0pt"></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_UnauditedSupplementalProFormaDataTableTextBlock', window );">Unaudited Supplemental Pro Forma Data</a></td>
<td class="text"><p style="margin: 0pt"></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="6" id="hdcell" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font-size: 10pt"><b>Nine Months Ended</b></font><br />
<font style="font-size: 10pt"><b>September 30,</b></font></td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font-size: 10pt"><b>2017</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font-size: 10pt"><b>2016</b></font></td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">Revenues</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font-size: 10pt">$</font></td>
    <td id="ffcell" style="vertical-align: bottom; width: 9%; text-align: right"><font style="font-size: 10pt">19,968,845</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font-size: 10pt">$</font></td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font-size: 10pt">5,007,806</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">Cost of revenues</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">18,356,228</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">4,672,794</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">Gross profit</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">1,612,617</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">335,012</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: white">
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">Operating expenses</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">4,411,620</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">614,515</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">Operating loss</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">(2,799,003</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font-size: 10pt">)</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">(279,503</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font-size: 10pt">)</font></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">Other income (expense)</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font-size: 10pt">(524,952</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font-size: 10pt">)</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font-size: 10pt">(238,528</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font-size: 10pt">)</font></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">Net Loss</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font-size: 10pt">$</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font-size: 10pt">(3,323,955</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font-size: 10pt">)</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font-size: 10pt">$</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font-size: 10pt">(518,031</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font-size: 10pt">)</font></td></tr>
</table>


<p style="margin: 0pt"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_AcquisitionOfDecahedronLtdTableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_AcquisitionOfDecahedronLtdTableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_IntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_IntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_UnauditedAllocationOfPurchasePriceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_UnauditedAllocationOfPurchasePriceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_UnauditedSupplementalProFormaDataTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_UnauditedSupplementalProFormaDataTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6841380704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK OPTIONS AND WARRANTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_StockOptionsAndWarrantsTablesAbstract', window );"><strong>Stock Options And Warrants Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of option activity during the year</a></td>
<td class="text"><p style="margin: 0pt"></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" id="hdcell" style="text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Average</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Average</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Remaining</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Aggregate</b></font></td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Number of</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Exercise</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Contractual</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Intrinsic</b></font></td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: justify"><font style="font-size: 10pt"><b>Options</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font-size: 10pt"><b>Shares</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font-size: 10pt"><b>Price</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font-size: 10pt"><b>Term</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font-size: 10pt"><b>Value</b></font></td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">Balance Outstanding, December 31, 2016</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td>
    <td id="ffcell" style="vertical-align: bottom; width: 9%; text-align: right"><font style="font-size: 10pt">120,000</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font-size: 10pt">$</font></td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font-size: 10pt">0.20</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font-size: 10pt">3.75</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font-size: 10pt">$</font></td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font-size: 10pt">74,400</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"><font style="font-size: 10pt">Granted</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">370,000</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">.13</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">3.58</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">150,800</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"><font style="font-size: 10pt">Forfeited</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"><font style="font-size: 10pt">Exercised</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"><font style="font-size: 10pt">Expired</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">Balance Outstanding, September 30, 2017</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font-size: 10pt">490,000</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font-size: 10pt">$</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font-size: 10pt">.15</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font-size: 10pt">3.44</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font-size: 10pt">191,600</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">Exercisable, September 30, 2017</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font-size: 10pt">397,500</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font-size: 10pt">$</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font-size: 10pt">.15</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font-size: 10pt">3.41</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font-size: 10pt">$</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font-size: 10pt">153,900</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
</table>


<p style="margin: 0pt"></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_WarrantsWereValuedTableTextBlock', window );">warrants were valued</a></td>
<td class="text"><p style="margin: 0pt"></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" id="hdcell" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font-size: 10pt">&#160;<b>September 30,</b></font><br />
<font style="font-size: 10pt"><b>2017</b></font></td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: bottom; text-align: justify"><font style="font-size: 10pt">Volatility</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font-size: 10pt">76.66%-90.86</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font-size: 10pt">%</font></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">Expected term (in years)</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td id="ffcell" style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">1</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">Risk-free interest rate</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1.07% - 1.11</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font-size: 10pt">% </font></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">Expected dividend yield</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">None</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
</table>


<p style="margin: 0pt"></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_WarrantsTableTextBlock', window );">Warrants</a></td>
<td class="text"><p style="margin: 0pt"></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" id="hdcell" style="text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Average</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Average</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Remaining</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Aggregate</b></font></td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Number of</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Exercise</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Contractual</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Intrinsic</b></font></td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify"><font style="font-size: 10pt"><b>Warrants</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font-size: 10pt"><b>Shares</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font-size: 10pt"><b>Price</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font-size: 10pt"><b>Term</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: center"><font style="font-size: 10pt"><b>Value</b></font></td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">Balance Outstanding, December 31, 2016</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td>
    <td id="ffcell" style="vertical-align: bottom; width: 9%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font-size: 10pt">$</font></td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font style="font-size: 10pt">$</font></td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify">&#160;</td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"><font style="font-size: 10pt">Granted</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">100,400</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">3.00</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">1</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"><font style="font-size: 10pt">Forfeited</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"><font style="font-size: 10pt">Exercised</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 11.25pt; text-align: justify"><font style="font-size: 10pt">Expired</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 1pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">Balance Outstanding, September 30, 2017</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font-size: 10pt">100,400</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font-size: 10pt">$</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font-size: 10pt">3.00</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font-size: 10pt">.55</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font-size: 10pt">$</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt">Exercisable, September 30, 2017</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font-size: 10pt">100,400</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font-size: 10pt">$</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font-size: 10pt">3.00</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font-size: 10pt">.55</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: justify"><font style="font-size: 10pt">$</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
</table>


<p style="margin: 0pt"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_StockOptionsAndWarrantsTablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_StockOptionsAndWarrantsTablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_WarrantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_WarrantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_WarrantsWereValuedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_WarrantsWereValuedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6767904144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Office and computer equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Office and computer equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6847231968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Feb. 10, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Sep. 27, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryName', window );">State or country of incorporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nevada<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationDateOfIncorporation', window );">Date of incorporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul. 21,  2009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (198,171)<span></span>
</td>
<td class="num">$ (94,613)<span></span>
</td>
<td class="num">$ (3,074,179)<span></span>
</td>
<td class="num">$ (277,797)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_WorkingCapitalDeficit', window );">Working capital deficit</a></td>
<td class="num">(3,546,938)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,546,938)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">$ (4,076,398)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,076,398)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,002,219)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_DescriptionForPeriodicInventorySystemMaintainance', window );">Description for periodic inventory system maintainance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">A periodic
inventory system is maintained by 100% count</font></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,831<span></span>
</td>
<td class="nump">6,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,368<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Impairment of goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,949,884<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_ImpairmentOfGoodwillPercent', window );">Impairment of goodwill, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_AmplerissimoLtdMember', window );">Amplerissimo Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=COSM_StockPurchaseAgreementMember', window );">Stock Purchase Agreement [Member] | Decahedron Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock shares reserved</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementGeographicalAxis=COSM_CyprusMember', window );">Cyprus [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Income tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementGeographicalAxis=COSM_GreeceMember', window );">Greece [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Income tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementGeographicalAxis=COSM_UnitedKingdomofEnglandMember', window );">United Kingdom of England [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Income tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_DescriptionForPeriodicInventorySystemMaintainance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_DescriptionForPeriodicInventorySystemMaintainance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_ImpairmentOfGoodwillPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_ImpairmentOfGoodwillPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_WorkingCapitalDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_WorkingCapitalDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationDateOfIncorporation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when an entity was incorporated</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationDateOfIncorporation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>State or Country Name where an entity is incorporated</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66011266&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_AmplerissimoLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_AmplerissimoLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=COSM_StockPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=COSM_StockPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_DecahedronLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_DecahedronLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=COSM_CyprusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=COSM_CyprusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=COSM_GreeceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=COSM_GreeceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=COSM_UnitedKingdomofEnglandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=COSM_UnitedKingdomofEnglandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6839815600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACQUISITION OF DECAHEDRON, LTD. (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=COSM_DecahedronLtdMember', window );">Decahedron Ltd [Member] | Preliminary Allocation as of February 10, 2017 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Current assets</a></td>
<td class="nump">6,537<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Other assets</a></td>
<td class="nump">305,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="nump">361,937<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract', window );"><strong>Liabilities assumed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt', window );">Debt</a></td>
<td class="nump">804,819<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Total liabilities assumed</a></td>
<td class="nump">804,819<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="num">(442,882)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Consideration:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedValueOfCommonStockIssuedAtAcquisition', window );">Value of Common Stock Issued at Acquisition</a></td>
<td class="nump">1,479,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Goodwill</a></td>
<td class="nump">1,921,882<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=COSM_DecahedronLtdMember', window );">Decahedron Ltd [Member] | Allocation Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Current assets</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Other assets</a></td>
<td class="num">(216,562)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="num">(216,562)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract', window );"><strong>Liabilities assumed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt', window );">Debt</a></td>
<td class="num">(188,560)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Total liabilities assumed</a></td>
<td class="num">(188,560)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="num">(28,002)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Consideration:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedValueOfCommonStockIssuedAtAcquisition', window );">Value of Common Stock Issued at Acquisition</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Goodwill</a></td>
<td class="nump">28,002<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=COSM_DecahedronLtdMember', window );">Decahedron Ltd [Member] | Final Allocation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Current assets</a></td>
<td class="nump">6,537<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Other assets</a></td>
<td class="nump">88,838<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="nump">145,375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract', window );"><strong>Liabilities assumed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt', window );">Debt</a></td>
<td class="nump">616,259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Total liabilities assumed</a></td>
<td class="nump">616,259<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="num">(470,884)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Consideration:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedValueOfCommonStockIssuedAtAcquisition', window );">Value of Common Stock Issued at Acquisition</a></td>
<td class="nump">1,479,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Goodwill</a></td>
<td class="nump">$ 1,949,884<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedValueOfCommonStockIssuedAtAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedValueOfCommonStockIssuedAtAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=73531372&amp;loc=d3e2207-128464<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=73531372&amp;loc=d3e2207-128464<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=COSM_DecahedronLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=COSM_DecahedronLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=COSM_PreliminaryAllocationAsOfFebruaryTenTwoThousandSeventeenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=COSM_PreliminaryAllocationAsOfFebruaryTenTwoThousandSeventeenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=COSM_AllocationAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=COSM_AllocationAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=COSM_FinalAllocationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=COSM_FinalAllocationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6847127088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITION OF DECAHEDRON, LTD. (Details 1)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr><th class="th" colspan="2">
<div>Sep. 30, 2017 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life (Years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=COSM_LicensesMember', window );">Licenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">(a) U.K Pharmaceutical Wholesale Distribution License</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=73531372&amp;loc=d3e2207-128464<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=COSM_LicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=COSM_LicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6761087344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITION OF DECAHEDRON, LTD. (Details 2) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenues</a></td>
<td class="nump">$ 8,772,138<span></span>
</td>
<td class="nump">$ 1,269,553<span></span>
</td>
<td class="nump">$ 18,156,795<span></span>
</td>
<td class="nump">$ 3,192,472<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">774,813<span></span>
</td>
<td class="nump">144,950<span></span>
</td>
<td class="nump">1,618,603<span></span>
</td>
<td class="nump">314,332<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="nump">758,365<span></span>
</td>
<td class="nump">175,919<span></span>
</td>
<td class="nump">4,383,623<span></span>
</td>
<td class="nump">473,249<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="nump">$ 16,448<span></span>
</td>
<td class="num">$ (30,969)<span></span>
</td>
<td class="num">(2,765,020)<span></span>
</td>
<td class="num">(158,917)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=COSM_DecahedronLtdMember', window );">Decahedron Ltd [Member] | Proforma [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,968,845<span></span>
</td>
<td class="nump">5,007,806<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,356,228<span></span>
</td>
<td class="nump">4,672,794<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,612,617<span></span>
</td>
<td class="nump">335,012<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,411,620<span></span>
</td>
<td class="nump">614,515<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,799,003)<span></span>
</td>
<td class="num">(279,503)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(524,952)<span></span>
</td>
<td class="num">(238,528)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,323,955)<span></span>
</td>
<td class="num">$ (518,031)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)-(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)-(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=COSM_DecahedronLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=COSM_DecahedronLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_ProFormaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_ProFormaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6834919776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITION OF DECAHEDRON, LTD. (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2017 </div>
<div>USD ($) </div>
<div>Integer </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionNameOfAcquiredEntity', window );">Business acquisition, name of acquired entity</a></td>
<td class="text">DECAHEDRON, LTD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Business acquisition outstanding percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired | Integer</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Business acquisition outstanding shares value</a></td>
<td class="nump">$ 1,479,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockOtherSharesOutstanding', window );">Business acquisition outstanding shares in exchange | shares</a></td>
<td class="nump">1,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_AdjustmentRelatedToOtherAssetsAndAccountsPayable', window );">Adjustment related to other assets and accounts payable</a></td>
<td class="nump">$ 28,002<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Impairment of goodwill</a></td>
<td class="nump">$ 1,949,884<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_ImpairmentOfGoodwillPercent', window );">Impairment of goodwill, percent</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_AcquisitionRelatedCostsMember', window );">Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenues</a></td>
<td class="nump">$ 2,622,547<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net Loss</a></td>
<td class="nump">$ 255,672<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_AdjustmentRelatedToOtherAssetsAndAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_AdjustmentRelatedToOtherAssetsAndAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_ImpairmentOfGoodwillPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_ImpairmentOfGoodwillPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionNameOfAcquiredEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the acquired entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionNameOfAcquiredEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)-(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)-(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockOtherSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares of other common stock instruments held by shareholders, such as exchangeable shares. May be all or portion of the number of common shares authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockOtherSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_AcquisitionRelatedCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_AcquisitionRelatedCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6648533456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PREPAID DEFERRED FINANCING COSTS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Aug. 30, 2017</div></th>
<th class="th"><div>Feb. 28, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Advanced for additional financing</a></td>
<td class="nump">$ 147,662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_SynthesisManagementLimitedMember', window );">Synthesis Management Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Advanced for additional financing</a></td>
<td class="nump">$ 213,627<span></span>
</td>
<td class="nump">$ 213,627<span></span>
</td>
<td class="nump">$ 133,725<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_SynthesisManagementLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_SynthesisManagementLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6665760064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2017 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_IncomeTaxesDetailsNarrativeAbstract', window );"><strong>Income Taxes Details Narrative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense', window );">Income tax, penalties and interest expense</a></td>
<td class="nump">$ 63,724<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_IncomeTaxesDetailsNarrativeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_IncomeTaxesDetailsNarrativeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6853429856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL STRUCTURE (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 10, 2017</div></th>
<th class="th"><div>Apr. 07, 2017</div></th>
<th class="th"><div>Mar. 01, 2017</div></th>
<th class="th"><div>Jul. 21, 2017</div></th>
<th class="th"><div>May 25, 2017</div></th>
<th class="th"><div>May 18, 2017</div></th>
<th class="th"><div>May 16, 2017</div></th>
<th class="th"><div>Apr. 26, 2017</div></th>
<th class="th"><div>May 25, 2017</div></th>
<th class="th"><div>May 24, 2017</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Feb. 10, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128,253,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,870,532<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128,253,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,870,532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock vlaue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 128,254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,871<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember', window );">Private investor [Member] | Subscription Arrangement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Stock options granted</a></td>
<td class="nump">45,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share</a></td>
<td class="nump">$ 0.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ .50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.70<span></span>
</td>
<td class="nump">$ 0.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Common stock value</a></td>
<td class="nump">$ 32,060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,530<span></span>
</td>
<td class="nump">$ 32,690<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesSubscribedButUnissued', window );">Common Stock Shares Subscribed</a></td>
<td class="nump">45,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,900<span></span>
</td>
<td class="nump">46,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross', window );">Stock options granted fair value</a></td>
<td class="nump">$ 2,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 130<span></span>
</td>
<td class="nump">$ 1,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_ArKoEuropeanBusinessServicesMember', window );">ArKo European Business &amp; Services [Member] | Consulting agreement Four [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_InvestmentRepurchaseAgreementDateOfAgreement', window );">Commencing agreement date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May 25,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_ConsultingAgreementPeriod', window );">Consulting agreement period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock vlaue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 154,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 154,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ .77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ .77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Consultant charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_ArKoEuropeanBusinessServicesMember', window );">ArKo European Business &amp; Services [Member] | Consulting agreement Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_InvestmentRepurchaseAgreementDateOfAgreement', window );">Commencing agreement date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May  08,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_ConsultingAgreementPeriod', window );">Consulting agreement period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock vlaue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 219,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherRestructuringCosts', window );">Monthly consultant charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_ArKoEuropeanBusinessServicesMember', window );">ArKo European Business &amp; Services [Member] | Consulting Agreement Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_InvestmentRepurchaseAgreementDateOfAgreement', window );">Commencing agreement date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May  01,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_ConsultingAgreementPeriod', window );">Consulting agreement period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock vlaue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ .72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ .72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_ArKoEuropeanBusinessServicesMember', window );">ArKo European Business &amp; Services [Member] | Consulting Agreement one [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_InvestmentRepurchaseAgreementDateOfAgreement', window );">Commencing agreement date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May  01,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_InvestmentMaturityDate1', window );">Commencing terminating date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan.  01,  2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_ConsultingAgreementPeriod', window );">Consulting agreement period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock vlaue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_ArKoEuropeanBusinessServicesMember', window );">ArKo European Business &amp; Services [Member] | Consulting Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_DecahedronLtdMember', window );">Decahedron Ltd [Member] | Stock Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock shares reserved</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=COSM_PotentiallyDilutiveSecuritiesMember', window );">Potentially dilutive securities [Member] | Employee [Member] | On January 3, 2017 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Exercise period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Stock options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=COSM_PotentiallyDilutiveSecuritiesMember', window );">Potentially dilutive securities [Member] | Employee [Member] | On January 1, 2017 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Exercise period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Stock options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">187,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=COSM_PotentiallyDilutiveSecuritiesMember', window );">Potentially dilutive securities [Member] | Employee [Member] | On October 1, 2016 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Exercise period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Stock options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=COSM_PotentiallyDilutiveSecuritiesMember', window );">Potentially dilutive securities [Member] | Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock vlaue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross', window );">Stock options granted fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareholdersEquityClassAxis=COSM_PostMergerMember', window );">Post Merger [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,585,532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,585,532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareholdersEquityClassAxis=COSM_PriorToMergerMember', window );">Prior to merger [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,585,532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareholdersEquityClassAxis=us-gaap_EquityIssuedInBusinessCombinationMember', window );">Equity issued in merger [Member] | Restricted Stock [Member] | Amplerissimo Ltd [Member] | Exchange agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareholdersEquityClassAxis=COSM_DimitriosGoulielmosMember', window );">Dimitrios Goulielmos [Member] | Restricted Stock [Member] | Amplerissimo Ltd [Member] | Exchange agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_ConsultingAgreementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_ConsultingAgreementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_invest_InvestmentMaturityDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maturity date of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 12<br> -Section 12<br> -Sentence Column A<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">invest_InvestmentMaturityDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>invest_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_invest_InvestmentRepurchaseAgreementDateOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the repurchase agreement was made.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 12<br> -Section 12<br> -Footnote 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">invest_InvestmentRepurchaseAgreementDateOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>invest_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesSubscribedButUnissued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesSubscribedButUnissued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140864-122747<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140864-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the balance sheet date, the number of shares into which fully vested and expected to vest stock options outstanding can be converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, before forfeitures, of stock or other type of equity granted of any equity-based compensation plan other than an employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueArrangementTypeAxis=us-gaap_SubscriptionArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueArrangementTypeAxis=us-gaap_SubscriptionArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_ArKoEuropeanBusinessServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_ArKoEuropeanBusinessServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=COSM_ConsultingAgreementFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=COSM_ConsultingAgreementFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=COSM_ConsultingAgreementThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=COSM_ConsultingAgreementThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=COSM_ConsultingAgreementTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=COSM_ConsultingAgreementTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=COSM_ConsultingAgreementOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=COSM_ConsultingAgreementOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=COSM_ConsultingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=COSM_ConsultingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_DecahedronLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_DecahedronLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=COSM_StockPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=COSM_StockPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=COSM_PotentiallyDilutiveSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=COSM_PotentiallyDilutiveSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=COSM_EmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=COSM_EmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreationDateAxis=COSM_OnJanuaryThreeTwoThousandSeventeenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreationDateAxis=COSM_OnJanuaryThreeTwoThousandSeventeenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreationDateAxis=COSM_OnJanuaryOneTwoThousandSeventeenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreationDateAxis=COSM_OnJanuaryOneTwoThousandSeventeenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreationDateAxis=COSM_OnOctoberOneTwoThousandSixteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreationDateAxis=COSM_OnOctoberOneTwoThousandSixteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityClassAxis=COSM_PostMergerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityClassAxis=COSM_PostMergerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityClassAxis=COSM_PriorToMergerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityClassAxis=COSM_PriorToMergerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityClassAxis=us-gaap_EquityIssuedInBusinessCombinationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityClassAxis=us-gaap_EquityIssuedInBusinessCombinationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_AmplerissimoLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_AmplerissimoLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=COSM_ExchangeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=COSM_ExchangeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityClassAxis=COSM_DimitriosGoulielmosMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityClassAxis=COSM_DimitriosGoulielmosMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6853093648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 04, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 21, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2017 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2017 </div>
<div>EUR (&#8364;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 04, 2015 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jul. 22, 2009 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128,253,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,870,532<span></span>
</td>
<td class="nump">128,253,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Repayment of related party debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 232,051<span></span>
</td>
<td class="nump">$ 21,914<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=us-gaap_DirectorsAndOfficersLiabilityInsuranceMember', window );">Officers and directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_DimitriosGoulielmosMember', window );">Dimitrios Goulielmos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDecreaseForgiveness', window );">Aggregate forgiveness of related party notes</a></td>
<td class="nump">$ 142,860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_DebtInstrumentDecreaseAccruedInterestForgiveness', window );">Debt instrument decrease accrued interest forgiveness</a></td>
<td class="nump">$ 806<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 401,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Debt outstanding amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Repayment of related party debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May 11,  2015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued interest | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_DimitriosGoulielmosMember', window );">Dimitrios Goulielmos [Member] | MediHelm S.A. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">220,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_KonstantinosVassilopoulosMember', window );">Konstantinos Vassilopoulos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Debt outstanding amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Repayment of related party debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_PaymentOfMiscellaneousBills', window );">Payment of miscellaneous bills</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_OuraniaMatsoukiMember', window );">Ourania Matsouki [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,479<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Debt outstanding amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Repayment of related party debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_MrSiokasMember', window );">Mr. Siokas [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidInterest', window );">Prepaid balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,459<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_GrigoriosSiokasMember', window );">Grigorios Siokas [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Debt outstanding amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Short term debt, borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_GrigoriosSiokasMember', window );">Grigorios Siokas [Member] | On October 1, 2016 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Oct.  01,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_GrigoriosSiokasMember', window );">Grigorios Siokas [Member] | Loan payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 559,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Debt outstanding amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">521,096<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Repayment of related party debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_DocPharmaSaMember', window );">DOC Pharma S.A. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidInterest', window );">Prepaid balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 410,991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_DescriptionForPrepaidBalancePercentage', window );">Description for prepaid balance percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">over 10.3% of the Company&#146;s
total prepaid balance</font></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_DocPharmaSaMember', window );">DOC Pharma S.A. [Member] | Loan agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Debt outstanding amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_DocPharmaSaMember', window );">DOC Pharma S.A. [Member] | On November 1, 2015 [Member] | Loan agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Short term debt, borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_PaymentOfMiscellaneousBills', window );">Payment of miscellaneous bills</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Oct. 31,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_DebtInstrumentDecreaseAccruedInterestForgiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_DebtInstrumentDecreaseAccruedInterestForgiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_DescriptionForPrepaidBalancePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_DescriptionForPrepaidBalancePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_PaymentOfMiscellaneousBills">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_PaymentOfMiscellaneousBills</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDecreaseForgiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease for amounts of indebtedness forgiven by the holder of the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDecreaseForgiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for interest that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Assets<br> -URI http://asc.fasb.org/extlink&amp;oid=6509628<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6787-107765<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5865-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=us-gaap_DirectorsAndOfficersLiabilityInsuranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=us-gaap_DirectorsAndOfficersLiabilityInsuranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_DimitriosGoulielmosMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_DimitriosGoulielmosMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=COSM_MediHelmSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=COSM_MediHelmSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_KonstantinosVassilopoulosMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_KonstantinosVassilopoulosMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_OuraniaMatsoukiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_OuraniaMatsoukiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_MrSiokasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_MrSiokasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_GrigoriosSiokasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_GrigoriosSiokasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreationDateAxis=COSM_OnOctoberOneTwoThousandSixteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreationDateAxis=COSM_OnOctoberOneTwoThousandSixteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnderlyingAssetClassAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnderlyingAssetClassAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_DocPharmaSaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_DocPharmaSaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=COSM_LoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=COSM_LoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreationDateAxis=COSM_OnNovemberOneTwoThousandsFifteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreationDateAxis=COSM_OnNovemberOneTwoThousandsFifteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6864496176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="8">1 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 12, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 05, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 10, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 16, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 04, 2016 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 04, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 05, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 05, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 04, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 23, 2017 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 20, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 18, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 24, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 22, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 19, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 16, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2017 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 13, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 04, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_SkyPharmMember', window );">SkyPharm [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Short term debt borrowing capacity</a></td>
<td class="nump">$ 2,282,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,162,736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityDescription', window );">Description for the repayment</a></td>
<td class="text">The total facility will be calculated as 95% of the agreed upon value of Decahedrons receivables.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,881<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of credit facility</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_CreditFaciltyOriginationFeePercentage', window );">Credit facilty origination fee, percentage</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_MonthlyCreditFeePercentage', window );">Monthly credit fee, percentage</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Monthly fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">201,661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredLoanOriginationFeesNet', window );">Origination fees | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 104,338<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_GrigoriosSiokasMember', window );">Grigorios Siokas [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Short term debt borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Debt outstanding amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=COSM_BridgeLoansMember', window );">Bridge Loans [Member] | SkyPharm [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Short term debt borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 30,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr. 16,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr. 20,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_AmendedMaturityDate', window );">Amended maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May 16,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May 20,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Debt outstanding amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=COSM_SecondAmendmentToLoanFacilityAgreementMember', window );">Second amendment to loan facility agreement [Member] | SkyPharm [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Short term debt borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,664,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 452,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 452,471<span></span>
</td>
<td class="nump">$ 342,327<span></span>
</td>
<td class="nump">$ 155,516<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 174,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug.  04,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Debt outstanding amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,007,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,761<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityDescription', window );">Description for the repayment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="margin: 0">The amounts owed under the A&#38;R Loan Facility shall be repayable upon the earlier of (i) seventy five
days following the demand of the Lender; or (ii) August 31, 2018.</p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock shares reserved | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141,756<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141,756<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=COSM_AmendmentToLoanFacilityAgreementMember', window );">Amendment to loan facility agreement [Member] | SkyPharm [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Short term debt borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,533,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Debt outstanding amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 240,251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=COSM_LoanFacilityAgreementMember', window );">Loan facility agreement [Member] | SkyPharm [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Short term debt borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,292,769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityDescription', window );">Description for the repayment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The amounts
owed under the Loan Facility shall be repayable upon the earlier of (i) three months following the demand of the lender; or (ii)
August 31, 2018. No prepayment is permitted pursuant to the terms of the Loan Facility</font></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=COSM_LoanFacilityAgreementMember', window );">Loan facility agreement [Member] | Grigorios Siokas [Member] | Synthesis facility agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock shares reserved | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=COSM_LoanAgreementElevenMember', window );">Loan Agreement 11 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Short term debt borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Oct. 18,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,813<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=COSM_LoanAgreementTenMember', window );">Loan Agreement 10 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Short term debt borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May 24,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=COSM_LoanAgreementNineMember', window );">Loan Agreement 9 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Short term debt borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,098<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr. 22,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,099<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=COSM_LoanAgreementEightMember', window );">Loan Agreement 8 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Short term debt borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 105,520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr. 19,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=COSM_LoanAgreementSevenMember', window );">Loan Agreement 7 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Short term debt borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar.  04,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=COSM_LoanAgreementSixMember', window );">Loan Agreement 6 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Short term debt borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=COSM_LoanAgreementFiveMember', window );">Loan Agreement 5 [Member] | Panagiotis Drakopoulos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Short term debt borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,718<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,718<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=COSM_LoanAgreementFourMember', window );">Loan Agreement 4 [Member] | Panagiotis Drakopoulos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Short term debt borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 15,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Debt outstanding amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,813<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=COSM_LoanAgreementThreeMember', window );">Loan Agreement 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Short term debt borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87,248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov.  05,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Debt outstanding amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfAccountsReceivableSecuritization', window );">Repayments of accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,813<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=COSM_LoanAgreementTwoMember', window );">Loan Agreement 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Short term debt borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov.  05,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Debt outstanding amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,813<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=COSM_LoanAgreementOneMember', window );">Loan Agreement 1 [Member] | Angelo Drakopoulos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Short term debt borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_PaymentOfMiscellaneousBills', window );">Repayments of outstanding bill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May  05,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Debt outstanding amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=COSM_DecahedronMember', window );">Decahedron [member] | SkyPharm [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Short term debt borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,941,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityDescription', window );">Description for the repayment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The total facility will be calculated as 95% of the agreed upon value of Decahedrons receivables<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_CreditFaciltyOriginationFeePercentage', window );">Credit facilty origination fee, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_MonthlyCreditFeePercentage', window );">Monthly credit fee, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_AmendedMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_AmendedMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_CreditFaciltyOriginationFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_CreditFaciltyOriginationFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_MonthlyCreditFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_MonthlyCreditFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_PaymentOfMiscellaneousBills">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_PaymentOfMiscellaneousBills</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28541-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDeferredLoanOriginationFeesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net increase(decrease) in interest income during the period representing the allocation of deferred loan origination fees less deferred loan origination costs using the effective interest method over the term of the debt arrangement to which they pertain taking into account the effect of prepayments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Direct Loan Origination Costs<br> -URI http://asc.fasb.org/extlink&amp;oid=6510860<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 30<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6378273&amp;loc=d3e8446-111530<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6962437&amp;loc=d3e7402-111529<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65893827&amp;loc=d3e8622-111531<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDeferredLoanOriginationFeesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=64930739&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the terms of a credit facility arrangement. Terms typically include interest rate, collateral required, guarantees required, repayment requirements, and restrictions on use of assets and activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the credit facility terminates, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.2(a),(b),(c),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488393&amp;loc=d3e606610-122999<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 225<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=6488370&amp;loc=d3e13550-115849<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfAccountsReceivableSecuritization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repayments of securitizations of receivables treated as collateralized borrowings, which are classified as financing transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfAccountsReceivableSecuritization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_SkyPharmMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_SkyPharmMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_GrigoriosSiokasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_GrigoriosSiokasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=COSM_BridgeLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=COSM_BridgeLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=COSM_SecondAmendmentToLoanFacilityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=COSM_SecondAmendmentToLoanFacilityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=COSM_AmendmentToLoanFacilityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=COSM_AmendmentToLoanFacilityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=COSM_LoanFacilityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=COSM_LoanFacilityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=COSM_SynthesisFacilityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=COSM_SynthesisFacilityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=COSM_LoanAgreementElevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=COSM_LoanAgreementElevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=COSM_LoanAgreementTenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=COSM_LoanAgreementTenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=COSM_LoanAgreementNineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=COSM_LoanAgreementNineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=COSM_LoanAgreementEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=COSM_LoanAgreementEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=COSM_LoanAgreementSevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=COSM_LoanAgreementSevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=COSM_LoanAgreementSixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=COSM_LoanAgreementSixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=COSM_LoanAgreementFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=COSM_LoanAgreementFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_PanagiotisDrakopoulosMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_PanagiotisDrakopoulosMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=COSM_LoanAgreementFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=COSM_LoanAgreementFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=COSM_LoanAgreementThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=COSM_LoanAgreementThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=COSM_LoanAgreementTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=COSM_LoanAgreementTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=COSM_LoanAgreementOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=COSM_LoanAgreementOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_AngeloDrakopoulosMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_AngeloDrakopoulosMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=COSM_DecahedronMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=COSM_DecahedronMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6857183424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="8">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 08, 2017</div></th>
<th class="th">
<div>May 31, 2017 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Oct. 25, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2012 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2017 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2017 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 21, 2016 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_OperatingLeasePeriodicPayment', window );">Operating lease periodic payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_FrequencyOfPeriodicPayment', window );">Frequency of periodic payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Monthly<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Monthly<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Operating lease rental expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,126<span></span>
</td>
<td class="nump">$ 2,126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,377<span></span>
</td>
<td class="nump">$ 2,834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Operating lease expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 30,  2015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=COSM_DecahedronMember', window );">Decahedron [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_OperatingLeasePeriodicPayment', window );">Operating lease periodic payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Operating lease rental expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract', window );">Term of operating lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsFromFranchiseAgreements', window );">Commitments and contingencies description</a></td>
<td class="text"><p style="margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">(1) a cash
commission of 6% of the total gross proceeds for two named investors (2) a cash commission of 4% of total gross proceeds from
five named investors and (3) excluding the five named investors in &#147;(2)&#148; a cash commission equal to 8% of the total
gross proceeds from the Offering and the issuance to the Agent or its designees of warrants covering 8% of the shares of common
stock issued or issuable by the Company in the Offering. Additionally, the Agent will receive a cash fee of 8% payable within
5 business days, but only in the event of, the receipt by the Company of any cash proceeds from the exercise of any warrants with
an expiration equal to or less than 24 months sold in the Offering</font></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_CCPharmaGmbHMember', window );">CC Pharma GmbH [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_NonrefundableFee', window );">Non-refundable fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 454,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Expense paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">454,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember', window );">Anastasios Tsekas and Olga Parthenea Georgatsou [Member] | Intellectual property sale agreement [Member] | On October 1, 2016 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_OperatingLeasePeriodicPayment', window );">Operating lease periodic payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock shares reserved | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember', window );">Anastasios Tsekas and Olga Parthenea Georgatsou [Member] | Intellectual property sale agreement [Member] | On October 1, 2016 [Member] | Conclusion of Phase III testing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock shares reserved | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember', window );">Anastasios Tsekas and Olga Parthenea Georgatsou [Member] | Intellectual property sale agreement [Member] | On October 1, 2016 [Member] | Conclusion of Phase II testing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock shares reserved | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember', window );">Anastasios Tsekas and Olga Parthenea Georgatsou [Member] | Intellectual property sale agreement [Member] | On October 1, 2016 [Member] | conclusion of Phase I testing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock shares reserved | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember', window );">Anastasios Tsekas and Olga Parthenea Georgatsou [Member] | Intellectual property sale agreement [Member] | On October 1, 2016 [Member] | Conclusion of Preclinical Trials [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock shares reserved | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_SkyPharmMember', window );">SkyPharm [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_OperatingLeasePeriodicPayment', window );">Operating lease periodic payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Operating lease rental expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,094<span></span>
</td>
<td class="nump">25,961<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84,710<span></span>
</td>
<td class="nump">64,127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract', window );">Term of operating lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_SkyPharmMember', window );">SkyPharm [Member] | Additional space [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_OperatingLeasePeriodicPayment', window );">Operating lease periodic payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,021<span></span>
</td>
<td class="nump">$ 886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_SkyPharmMember', window );">SkyPharm [Member] | First Floor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_OperatingLeasePeriodicPayment', window );">Operating lease periodic payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_AmplerissimoMember', window );">Amplerissimo [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_OperatingLeasePeriodicPayment', window );">Operating lease periodic payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_FrequencyOfPeriodicPayment', window );">Frequency of periodic payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Monthly<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Operating lease rental expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 368<span></span>
</td>
<td class="nump">$ 368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,105<span></span>
</td>
<td class="nump">$ 1,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Operating lease expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul. 31,  2013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_AmendmentToMaturityDate', window );">Operating lease renewal date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul. 31,  2015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_AmendmentToMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_AmendmentToMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_FrequencyOfPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_FrequencyOfPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_NonrefundableFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_NonrefundableFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_OperatingLeasePeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_OperatingLeasePeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsFromFranchiseAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes all significant commitments and obligations resulting from franchise agreements, including a description of the services that the franchisor has agreed to provide for agreements that have not yet been substantially performed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 952<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6490765&amp;loc=d3e67606-108037<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsFromFranchiseAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date which lease or group of leases is set to expire, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of the lessee's leasing arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=COSM_DecahedronMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=COSM_DecahedronMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_CCPharmaGmbHMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_CCPharmaGmbHMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=COSM_IntellectualPropertySaleAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=COSM_IntellectualPropertySaleAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreationDateAxis=COSM_OnOctoberOneTwoThousandSixteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreationDateAxis=COSM_OnOctoberOneTwoThousandSixteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseArrangementTypeAxis=COSM_ConclusionOfPhaseThreeTestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseArrangementTypeAxis=COSM_ConclusionOfPhaseThreeTestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseArrangementTypeAxis=COSM_ConclusionOfPhaseTwoTestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseArrangementTypeAxis=COSM_ConclusionOfPhaseTwoTestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseArrangementTypeAxis=COSM_ConclusionOfPhaseOneTestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseArrangementTypeAxis=COSM_ConclusionOfPhaseOneTestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseArrangementTypeAxis=COSM_ConclusionOfPreclinicalTrialsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseArrangementTypeAxis=COSM_ConclusionOfPreclinicalTrialsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_SkyPharmMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_SkyPharmMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseArrangementTypeAxis=COSM_AdditionalSpaceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseArrangementTypeAxis=COSM_AdditionalSpaceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseArrangementTypeAxis=COSM_FirstFloorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseArrangementTypeAxis=COSM_FirstFloorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_AmplerissimoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_AmplerissimoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6853741088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK OPTIONS AND WARRANTS (Details) - Options [Member]<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2017 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, December 31, 2016 | shares</a></td>
<td class="nump">120,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Granted | shares</a></td>
<td class="nump">370,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Expired | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, September 30, 2017 | shares</a></td>
<td class="nump">490,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at September 30, 2017 | shares</a></td>
<td class="nump">397,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, December 31, 2016 | $ / shares</a></td>
<td class="nump">$ 0.20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted | $ / shares</a></td>
<td class="nump">0.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Expired | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, September 30, 2017 | $ / shares</a></td>
<td class="nump">0.15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable at September 30, 2017 | $ / shares</a></td>
<td class="nump">$ 0.15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_WeightedAverageRemainingContractualTerm', window );"><strong>Weighted Average Remaining Contractual Term</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Outstanding, December 31, 2016</a></td>
<td class="text">3 years 9 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2', window );">Granted</a></td>
<td class="text">3 years 6 months 29 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding, September 30, 2017</a></td>
<td class="text">3 years 5 months 9 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4', window );">Exercisable at September 30, 2017</a></td>
<td class="text">3 years 4 months 28 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Outstanding, December 31, 2016 | $</a></td>
<td class="nump">$ 74,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested', window );">Granted | $</a></td>
<td class="nump">150,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited', window );">Forfeited | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised', window );">Exercised | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpired', window );">Expired | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Outstanding, September 30, 2017 | $</a></td>
<td class="nump">191,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Exercisable at September 30, 2017 | $</a></td>
<td class="nump">$ 153,900<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_WeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_WeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of fully vested and expected to vest options that are exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of equity-based compensation awards outstanding. Excludes stock and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of equity-based compensation awards vested. Excludes stock and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_OptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_OptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6768084304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK OPTIONS AND WARRANTS (Details 1)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedTerm', window );">Expected term (in years)</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedVolatilityRate', window );">Volatility</a></td>
<td class="nump">76.66%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.07%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedVolatilityRate', window );">Volatility</a></td>
<td class="nump">90.86%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.11%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected dividends to be paid to holders of the underlying shares or financial instruments (expressed as a percentage of the share or instrument's price).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExpectedTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period the instrument, asset or liability is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsExpectedTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Measure of dispersion, in percentage terms (for instance, the standard deviation or variance), for a given stock price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Risk-free interest rate assumption used in valuing an instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6834943440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK OPTIONS AND WARRANTS (Details 2) - Warrant [Member]<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2017 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, December 31, 2016 | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Granted | shares</a></td>
<td class="nump">100,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Expired | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, September 30, 2017 | shares</a></td>
<td class="nump">100,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at September 30, 2017 | shares</a></td>
<td class="nump">100,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, December 31, 2016 | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted | $ / shares</a></td>
<td class="nump">3.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Expired | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, September 30, 2017 | $ / shares</a></td>
<td class="nump">3.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable at September 30, 2017 | $ / shares</a></td>
<td class="nump">$ 3.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_WeightedAverageRemainingContractualTerm', window );"><strong>Weighted Average Remaining Contractual Term</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2', window );">Granted</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding, September 30, 2017</a></td>
<td class="text">6 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4', window );">Exercisable at September 30, 2017</a></td>
<td class="text">6 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Outstanding, December 31, 2016 | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested', window );">Granted | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited', window );">Forfeited | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised', window );">Exercised | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpired', window );">Expired | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Outstanding, September 30, 2017 | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Exercisable at September 30, 2017 | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_WeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_WeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of fully vested and expected to vest options that are exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of equity-based compensation awards outstanding. Excludes stock and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of equity-based compensation awards vested. Excludes stock and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6851002080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK OPTIONS AND WARRANTS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember', window );">Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_WarrantsIssuedRatioDescription', window );">Warrants issued ratio description</a></td>
<td class="text">1:1 ratio for shares <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_StockOptionMember', window );">Stock Option [Member] | Aegis capital corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Amortization expense</a></td>
<td class="nump">$ 70,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_StockOptionMember', window );">Stock Option [Member] | Mr. Orestes Varvitsiotes [member] | January 3, 2017 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options granted</a></td>
<td class="nump">120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Exercise period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="nump">$ 0.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock options value</a></td>
<td class="nump">$ 94,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Stock price</a></td>
<td class="nump">$ 0.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="nump">$ 0.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Option term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility rate</a></td>
<td class="nump">155.37%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_StockOptionPeriodicVesting', window );">Stock option periodic vesting</a></td>
<td class="nump">90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_StockOptionMember', window );">Stock Option [Member] | Employee [Member] | January 1, 2017 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Stock price</a></td>
<td class="nump">$ 0.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_StockOptionPeriodicVesting', window );">Stock option periodic vesting</a></td>
<td class="nump">187,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_ShareBasedCompensationAsAnnualRetainer', window );">Share based compensation as annual retainer</a></td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_StockOptionMember', window );">Stock Option [Member] | Employee [Member] | On January 1, 2017 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Exercise period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock options value</a></td>
<td class="nump">$ 195,307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Option term</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility rate</a></td>
<td class="nump">136.76%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_ConsiderationUnderAgreement', window );">Consideration under agreement</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_StockOptionMember', window );">Stock Option [Member] | Employee [Member] | On October 1, 2016 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Stock price</a></td>
<td class="nump">$ 0.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="nump">$ 0.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_StockOptionMember', window );">Stock Option [Member] | International Finance Manager [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Amortization expense</a></td>
<td class="nump">$ 146,079<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_StockOptionMember', window );">Stock Option [Member] | US Finance Manager [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Amortization expense</a></td>
<td class="nump">$ 48,654<span></span>
</td>
<td class="nump">$ 16,636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_StockOptionPeriodicVesting', window );">Stock option periodic vesting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_StockOptionMember', window );">Stock Option [Member] | US Finance Manager [Member] | On October 1, 2016 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options granted</a></td>
<td class="nump">120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Exercise period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="nump">$ 0.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock options value</a></td>
<td class="nump">$ 65,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Option term</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility rate</a></td>
<td class="nump">159.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_FrequencyOfPeriodicVesting', window );">Frequency of periodic vesting</a></td>
<td class="text">Monthly<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_ConsiderationUnderAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_ConsiderationUnderAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_FrequencyOfPeriodicVesting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_FrequencyOfPeriodicVesting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_ShareBasedCompensationAsAnnualRetainer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_ShareBasedCompensationAsAnnualRetainer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_StockOptionPeriodicVesting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_StockOptionPeriodicVesting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_WarrantsIssuedRatioDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_WarrantsIssuedRatioDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncash expense that accounts for the value of stock or unit options distributed to employees as compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_AegisCapitalCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_AegisCapitalCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=COSM_MrOrestesVarvitsiotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=COSM_MrOrestesVarvitsiotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreationDateAxis=COSM_JanuaryThreeTwoThousandSeventeenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreationDateAxis=COSM_JanuaryThreeTwoThousandSeventeenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=COSM_EmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=COSM_EmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreationDateAxis=COSM_JanuaryOneTwoThousandSeventeenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreationDateAxis=COSM_JanuaryOneTwoThousandSeventeenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreationDateAxis=COSM_OnJanuaryOneTwoThousandSeventeenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreationDateAxis=COSM_OnJanuaryOneTwoThousandSeventeenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreationDateAxis=COSM_OnOctoberOneTwoThousandSixteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreationDateAxis=COSM_OnOctoberOneTwoThousandSixteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=COSM_InternationalFinanceManagerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=COSM_InternationalFinanceManagerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=COSM_UsFinanceManagerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=COSM_UsFinanceManagerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6848743376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 11, 2017</div></th>
<th class="th"><div>Oct. 02, 2017</div></th>
<th class="th"><div>Nov. 15, 2017</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split</a></td>
<td class="text">(1:10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Trade Facility Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_AmendmentToCreditFacilityMaximumBorrowingCapacity', window );">Amendment to credit facility maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Securities Purchase Agreement [Member] | Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock shares issuable upon conversion of debt/convertible securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,360,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeTermOfContract', window );">Maturity period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_ConvertibleSecuritiesTermsOfConversionFeature', window );">Convertible securities, terms of conversion feature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Warrants have a five year term and are exercisable into a number of shares of Common Stock equal to approximately eighty (80%) percent of the number of shares of Common Stock the Buyers would receive if the Notes were fully converted upon the date of issuance of the Notes. The Warrants are exercisable at $0.75 per share (150% of the conversion price of the Notes) subject to full ratchet anti-dilution protection<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_TermsOfBlockerProvision', window );">Terms of Blocker Provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Blocker provision which prevents any holder from converting or exercising, as applicable, the Notes or the Warrants, into shares of Common Stock if its beneficial ownership of the Common Stock would exceed 4.99% (subject to adjustment not to exceed 9.99%) of the Company's issued and outstanding Common Stock (each, a "Blocker")<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Securities Purchase Agreement [Member] | Warrants [Member] | Registration Rights Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_TermsOfAgreement', window );">Terms of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Company is required to file, within thirty (30) days of the Closing, a registration statement covering one hundred fifty (150%) percent of the maximum number of shares, underlying the Notes and Warrants pursuant to a registration rights agreement with the Buyers (the "Registration Rights Agreement")<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Securities Purchase Agreement [Member] | Warrants [Member] | Leak-out Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_TermsOfAgreement', window );">Terms of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">As a condition to the closing of the Financing, each Buyer, severally, will be required to execute a leak-out agreement (each, a "Leak-Out Agreement") restricting such Buyer's sale of shares of Common Stock underlying the Notes and Warrants on any Trading Day to not more than such Buyer's pro rata allocation of the greater of (x) sales with net proceeds of an aggregate of $20,000 or (y) twenty-five (25%) percent of the daily average trading volume of the Company's Common Stock. If after the closing of the Financing there is no Event of Default under the Notes, the VWAP of the Company's Common Stock for three (3) trading days is less than $0.15 per share, the Company may further restrict the Buyers from selling at less than $0.15 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_ConditionalProceedsFromSaleOfCommonStockUnderAgreement', window );">Conditional proceeds from sale of common stock under the agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_TermsOfCommission', window );">Terms of commission to placement agent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Placement agent will receive a cash commission for this transaction equal to eight (8%) percent of the total gross proceeds of the offering and the issuance of five-year warrants to purchase eight (8%) percent of the shares of Common Stock issued or issuable in this offering (excluding shares of Common Stock issuable upon exercise of any Warrants issued to investors); however, will receive eight (8%) percent of any cash proceeds received from the exercise of any Warrants sold in the offering with an expiration equal to or less than twenty-four (24) months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Securities Purchase Agreement [Member] | Senior Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock shares issuable upon conversion of debt/convertible securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionDescription', window );">Repayment of convertible notes, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Notes provide that the Company will repay the principal amount of Notes in equal monthly installments beginning on January 1, 2018 and repeating on the first business day of each calendar month thereafter until the fourteenth month anniversary date of issuance<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDefaultShorttermDebtDescriptionOfViolationOrEventOfDefault', window );">Event of default, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Company shall pre-deliver up to 6,700,000 shares of Common Stock to the Buyers in connection therewith (the 'Pre-Delivery Shares'). Eighty-five (85%) percent of any cash proceeds received by the Buyers from the sale of Pre-Delivery Shares shall be applied against the particular installment amount due on such Installment Date under the Note. No interest will accrue under the Notes unless and until an Event of Default (as defined) has occurred and is not cured<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_EventOfDefaultConverstionPriceDescription', window );">Event of default converstion price, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Upon an Event of Default (as defined), the Buyers may convert at an alternative conversion price equal to the lower of the then applicable Conversion Price or seventy-five (75%) percent of the Volume-Weighted Average Price (as defined, the "VWAP")<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AggregateIndebtedness', window );">Amount of senior secured indebtness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_CustomaryEventsOfDefaultDescription', window );">Customary events of default, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Notes include customary Events of Default and provide that the Buyers may require the Company to redeem (regardless of whether the Event of Default has been cured) all or a portion of the Notes at a redemption premium of one hundred twenty-five (125%) percent, multiplied by the greater of the conversion rate and the then current market price. The Buyers may also require redemption of the Notes upon a Change of Control (as defined) at a premium of one hundred twenty-five (125%) percent<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Securities Purchase Agreement [Member] | Senior Convertible Note 1 [Member] | Institutional investors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible notes payable, principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Securities Purchase Agreement [Member] | Senior Convertible Note 2 [Member] | Institutional investors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible notes payable, principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Stock Purchase Agreement [Member] | Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_CommonStockSharesAcquiredForConsiderationValue', window );">Common stock shares acquired for consideration, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_COSM_CommonStockSharesAcquiredForConsiderationShares', window );">Common stock shares acquired for consideration, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,386,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_AmendmentToCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_AmendmentToCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_CommonStockSharesAcquiredForConsiderationShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_CommonStockSharesAcquiredForConsiderationShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_CommonStockSharesAcquiredForConsiderationValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_CommonStockSharesAcquiredForConsiderationValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_ConditionalProceedsFromSaleOfCommonStockUnderAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_ConditionalProceedsFromSaleOfCommonStockUnderAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_ConvertibleSecuritiesTermsOfConversionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_ConvertibleSecuritiesTermsOfConversionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_CustomaryEventsOfDefaultDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_CustomaryEventsOfDefaultDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_EventOfDefaultConverstionPriceDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_EventOfDefaultConverstionPriceDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_TermsOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_TermsOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_TermsOfBlockerProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_TermsOfBlockerProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_COSM_TermsOfCommission">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">COSM_TermsOfCommission</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>COSM_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AggregateIndebtedness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total current liabilities of the broker-dealer, less certain exceptions as defined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Rule 15c3-1<br> -Number 240<br> -Section 15c3-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AggregateIndebtedness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488278&amp;loc=d3e603758-122996<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDefaultShorttermDebtDescriptionOfViolationOrEventOfDefault">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discussion of the facts and amounts pertaining to each failure to comply with an affirmative or negative covenant of a short-term debt instrument, including violating payment terms or an inability to meet certain minimum financial requirements or achieve or maintain certain financial ratios. The discussion would generally be expected to also include whether or not the failure can and will be overcome and a description of the terms of any waivers, including the amount of the waiver and the period of time covered by the waiver.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=SL6230698-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDefaultShorttermDebtDescriptionOfViolationOrEventOfDefault</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6928298&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of debt redemption features under terms of the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=6479336&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis=COSM_TradeFacilityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis=COSM_TradeFacilityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis=COSM_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis=COSM_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=COSM_RegistrationRightsAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=COSM_RegistrationRightsAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=COSM_LeakOutAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=COSM_LeakOutAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=COSM_SeniorConvertibleNoteOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=COSM_SeniorConvertibleNoteOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=COSM_InstitutionalInvestorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=COSM_InstitutionalInvestorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=COSM_SeniorConvertibleNoteTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=COSM_SeniorConvertibleNoteTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis=COSM_StockPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis=COSM_StockPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>56
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M_O"["CMO[,[^8^.+H&SAUUW(+U!+ P04    "  2771+F5R<(Q &  "<)P
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M'[KNL)"L&U\4WO2LR?\"4$L#!!0    ( !)==$MYF]77/00  *H3   8
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M3"O%+3%<*?X<K-.!08OK#):H,DL$&7X"=Q2H(V S^3+!AQKB,HL>;,:/C%)
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M*%0SD6W6WY%]1]!VN/^#\2.D^ ]02P,$%     @ $EUT2UB;,_(D!0  $A@
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MM_YLYC&;#:>'Y0>1]1M7?P!02P,$%     @ $EUT2XA:6]*U 0  T@,  !@
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MX_%E8_\;8SQ@*LD-CE"''VPQ)#0^'#_@V4YC-AG>]/,/8LLW+O\"4$L#!!0
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M\R\;^]\@.O"I)'=^A#K_P19#0N/"\>#/9AJSR7#8SS^(+=^X_ -02P,$%
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M_C>(#KR4Y,Z/4.<_V&I(:%PXWONSF<=L-AP.RP]BZS<N_P!02P,$%     @
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MV7A\V=C_VA@/*"6YP1%J\8,MAH+:A^,'/-MIS";#FW[^06SYQL4?4$L#!!0
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M-H 30!F73N"E#\0@$>$HK) $%9* 0N8H[#'T+!#G1(!#?.[#@!!)4T=? ,9
ML-1QM_1Q& C&5]31H#H:4,<===171P5F3K;G/@PXE2 ==3Z,8.L-N>H".(X1
MD6%U+*B.!=0YNV[&_-W$"''WIH^ZPZEDKCCFD;Y#G-$4.6N\# "!"@D\+(\'
MY?& O"OY$4$'PG<@W=TH_&65D@E!W-/F VF:<I&R,",99"1OWR<+Z3,2F#*$
MG$5;^D#"..+RR@T':;@>I+=O@,4 <@XM8N <IF4 B#%-X<JIA2LU"FZ?V\4
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M-9<XQ:^.IZ'KK7>0JAA9!]_ ?A\OVEED96D& =(,2B(-;8D?TM,Y]_@ ^#'
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M;"]W;W)K<VAE971S+W-H965T,CDN>&ULE5K;4MM($/T5ES\@]EQZ)%&&JH5
M(!B*RM;N/BL@P!7;\DH"LG^_DBP[5L]I>9*'^,+I[C.7<WHD>?:1%S_*URRK
M1C]7RW5Y.GZMJLW)9%(^OF:KM/R4;[)U_9?GO%BE5?VQ>)F4FR)+G]J@U7*B
MIU,W6:6+]?ALUG[W4)S-\K=JN5AG#\6H?%NMTN*_\VR9?YR.U7CWQ;?%RVO5
M?#$YFVW2E^S/K/IK\U#4GR;[+$^+5;8N%_EZ5&3/I^,_U,F]2YJ %O'W(OLH
M#]Z/FJ%\S_,?S8>;I]/QM&&4+;/'JDF1UB_OV46V7#:9:A[_=DG'^YI-X.'[
M7?:K=O#U8+ZG97:1+_]9/%6OI^-X/'K*GM.W9?4M_[C.N@'1>-2-?IZ]9\L:
MWC"I:SSFR[+]?_3X5E;YJLM24UFE/[>OBW7[^M'EWX7A -T%Z'V LH,!I@LP
MH0&V"["A =0%4&B ZP+<KP :#(BZ@"BT0MP%Q+\"S&! T@4DH174=+=RT^"0
M_6*KT(&KW7*KX/56NP57P2NN=DNN^)I/MMNWU</GM$K/9D7^,2JVDMZDC7.H
MDQI:)V^^;176_K'61%E_^WYFE)I-WIM,'>9\B]$]C.YC+A#&]#&?$<;V,9<(
M0WW,%<*X/N8+PD1]S#7"Q'W,#<(D?<S7 #ZW *.G?<S<Q[!9O@,(R[+< \RO
M04WJW;#?$AIO"=TFL <)(LYT"Z$6LFXA2L>:3&(8XWN$I#B:T@&R1\I@4L8G
MQ;;IW 230LA!4A:3LAXIHSDKZ]4RT^X?8Q6"[+$BS(H *S8#<_)G0& 5@NRQ
M<IB5 ZR80<RWF(BO(/.(>P2KET]A/A'F$P$^%F>(<8889&!6=1Y[LV<IYG-\
M U NDN8WP6P2P(:9T/D6DQS4F7YBIGB)\G#C#,AS,XSIC:AIR+ W30$79M#G
M'>AP-]3.ZM@47P*85L17XAK B Q?+UC3)<*"*:GU*C"\A ]/A>R@2P0SGIBO
M 2Q*O.V(DLG[40EM1/E]Q/"9/.] O64Q$7':/DKYBP) I 534$*;47Z?,4;*
M(70%Y;<%WD"OE&_V&KCOU^.X/B6A)2C0$WA7O((@(Q027%X!FS>6%T(@$@H)
M]JV0?QM>* );PH)9/HKK<Q(:@D(=P7%. &0<)S0,ZK,1&H("3FXBSB8!3A9'
M0B/4@E%K8-1&.G0*;JA]-^2J^:)]8S(#:M#2 1<YD^:U$"@1"@ENHI&;6%X(
M@*PT(L%R-#J)&E[(@A:8R+,G>(D&-F$5KT5^'Y4K"6:B@4]8X82N!9_0OD]X
M9MQA/)-EHCP*ZQ,23$(C:6M>"H"L8,5:T+]&^K>\$ !90?U&4+]!QS1NQ<8_
M,BEKO3D^"NLS$KS$H),5-V($LL3Y#(/Z; 2[,<!)K&#F1KK\!=>_;.YNC7]9
M.[ _C6 E!E@)WY^W""3M3R/XB$$^$O%"""1T%B/8B DXD]PBD!7LW@A>8P+.
M)+<&G#4&=KC@(@88!$DY!(,P0/O$C/QS!Z(@([>"0UC@$"3=:A$T;7TE:F+;
MY<[Z!P05#9P0K"!9"R1+POZV@F0MZ.O\_L#<HEM1 WRE&U% C_RVR1R M'2^
MMX)H+= C>8,B<.TO+;<@6@OT2(X7<M[L)0.3)\C6 MF2<*O""GJT 3>#YM:_
MSZ-I@*^@6XMTZRTV @G&28)L"<F6#ZH#]1=;N&(F0=L$NJRWV 2T'4<DWAP5
MI$U(VH+1DR!M"I$V_9ZT29 VA4@;@J35EFX;ATB;?D/:)$B;0J1-OK0'9T_0
M-@%M.RF'H&T*T/8%^=H>D#8)TB9T]]7P4N":7>[)3A"W0]?L[$AYX<"-SH%2
M@KP=D+<3+,()LG4!3Z4<?-A$,8G/=9P@<!?PN,G!ITB#U02).Z!>)^40U.M\
M]?KSXS_+.4)8>I8#%.R$DX03E.F.7YC/G7_%?>SADZ!A!S3LA.M<)XC3!9R7
MY\X_+TN4)P</Z9N?UMREQ<MB78Z^YU65K]J'\L]Y7F5UVNFG.N%KEC[M/RRS
MYZIY&]7OB^U/6K8?JGS3_5QGLO_-T-G_4$L#!!0    ( !)==$M.J5B)G@0
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MV],5>QH'-P<)ND,,B(WB6".9)Z@P] I!'^XN%()>YLR0%&9> >8MERRS<4
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M]4X!B'(J$Y7(2"7*_)/EOMX3896)3F0@ 2+_9+FSYS71\TQT(J,"H#R$SE(
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M/6PWC2P6@U%5ABR*DK J5NM@.A[NS9OIN/[HRM5:SIM1^U%51?/?I2SK[22
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M4_6]V;V1WEUT]4:_;0\/K_RG_P-02P,$%     @ $EUT2^ID^.(R P  8@X
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M*0?V4BJATXGO])R/NN";&I78J_XVT_?M4/4,#25/8T47367E^A]02P,$%
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MSO.!0:WM-C5[.8ZH\:!%/XU?,O\'%'\!4$L#!!0    ( !)==$N V1#' 0,
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M4S,WVZ[33H5]9I)O3>]YQ2>S17+N @V:=:^A5QHR*A(3?;2@R&)-O>&<,AR
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MA^^EU,*DDMZ9U7@T)ZVQ48J][FZGYE[UQXV^H64S'*62\3RW^@=02P,$%
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MWKOI(FKZ4/)@+MFB\TW?ZC]02P,$%     @ $EUT2WD:S?EI P  6A   !D
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M1>P>D>2]Q0''_)OFI:5_7 E,W^0^793-HZ+J6U;P:7CJ0=%] 7:(I:3[8K4
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M E ))8"H\ 'R<476JV*Q+XY85EX -1+OZ$U40,/AUBR]/?SUMGQ]=2S;<82
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MN]H'7WBPV+!4B;1Y"*<9/'E6HBQN;Y+Y#P $5EB)6FPE/[+KQ3<N%!=QY91
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MRR(O$,>8VL]SH^+4-5\B9Z58^\?77^@O1]UA'"2N ;V.NC^&J6'</O_@IG@
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M3J0:GUMEE=<,P=-$/+]>7;Z&C(WXDS"B=M[C.I>9=@$N.0B\!\85YGV4D:/
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M>!8X.XN]3^0<;]K1?E"GKCJZ='?K6-4^31X"2DZW[0]>*X! 6'F;=EZ->OV
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MZ /H8@4&2LUU5GQ-T'UA:NZ+<)>W15EZ>*0IDJ.XCQ\E1>T3L&19S:L)S&@
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M<@\EZ<[;I+@PD.ST<T&*HI\ 9Z=JSA&0.&G+U%/)O'6L0@XV.=V:FRI(D'V
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M7*HM]80OPS,Y;,-*']!D-3WX0>IAG\F/5O"]-474M]6IZM?RTNQ9WY:L%#A
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M30'LK^TZ/:H;0;*$=XHX<N#X^9?C*S^7T[O'B@4'T!DG]\!G-,*/4A>S1G2
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M&\9$E"J 9L/.;/9#=."?T"D "'G,\.='9_CH84U"/-/@,#0E$)BQ4359--]
MCGJIW7X*+WH'.$9#(BY#]\[!H'M(B5%V1ZM"P+H+F6S.E\]REMD25T.R:!"X
M=EBH$WKLXUJ(319[PEX4P8ZD/*66QXG:B# +3_/Z[+_XF5^T5KJ%W7$%8+5=
MU51=FC-$]#2<YD @(K2FC\6D(Y6<J:84Z\.>!TRFG%_^]0@KS[VT2KK2*#':
M]06>N(0GZCLD'PIP&*("TLOIX[9GAE#Q#@Q_%MB&E%!N2X-/G28DNQ%_U^SP
M2?*6S]IH)IR>R@:<;/8$Z,'W0^[DPM>4DXQTD^&PN9EO4;_1?":PZ9X.0XG6
M;RJ@@,(X73,1M7,C)_A&:ND.8@M<<^8<]D#6Z[XK9U-/!DDW-)::K<.L")7<
M]@V8X':6TA4@I:10/0!1)G91LYF"F&@Q\@T27]-"'<-5K3*N-$Q&+"5!U@]B
M;>>R/WHM'FW2=IO>Y;$\7Y_)F38:9B.;H\Y78!;%%KAV)_J,7?\T80'+VG)R
M 'W\>$(M,Y&$X0GG WA=HG7<FC/J)<]RZ3T VB^EL+H,:2^@O#31KC7#5@/-
M._-K)1?AB./,2GV^@VGW%W>)KV9Z;28=^.P^#ERJ<?LJQKY+>E,]K=4R95?F
M9MV5AS^ZA@H!K-M/LMO)879FU=K/^RFR83+[2U)ME95@FMD!3@J4ODFN63\'
M>:@U5^O0CI8>-K;0N=; AAPN.UI!OJ*%H!2;293"^$+5<4W;E8J:/3.MUQMW
MV5Y>8_T5G-OV-@TJ9J3YC3_BCIM-<ST:=F0_J%+F Q&VLFU,)/[\X?CB_'\=
M8\)Q'%T<WWSY?!9=OH_>?;D^OSB[YASD#Y?G%Q^P%\S)V>>+Z."J #T.K./#
MQF)>>4)TP0-D+I? U\0S>0PT]J%@90D@5^:1+E5?Z1UIRW#(]S9V<6UUFRM.
MI:#/U%]$S0I;CA'+P2]A  X^PM&ZUDB(&VQ*_=W93T!]R\H%SPU%E!!W+LI&
M:H%&$U'@(8S_643_DB,FF.N-]G8%= 7VGC1RPZ_<:FP[RAY;3G2Y+4UP"-M1
M35T!2"3VE\K'["\*GG7-$VJ.:A-J,I2 0?>/CYN%1RDX\YMJA;V2='B"\1')
M* ,]'#4_\BO.=1B1MG^ES?A3O1VL4R2 ' _4 ,[G=+Y*8#>XM$U0OZ+8R17G
MB;5@!7_LV&KT#90ZX5 .CEFMK>XV10V6VMN:MZ*.4"''==@VI]I+K*"VFJGX
M'/#/YL%#73(#*JIF:-L03JB$'7#?(&^6O(TIHG:648>O!@2_,$,^JS9DVS=@
M@53"R!YH@L_3"KNL\'C<VPX(HX4:!/>\^:6KU%HYE=1.$1/7=G.I[I3]&G9>
MO92C)=Q B>U@.;[G9(/G4T& 59;<(H/-9"GLT 5ZXI:'OO.L"2Y;HG=,XYU-
MX(G8'3[-%SNW0];QUIK<E)16^3EC_!*J=YSW".3$.27:&HH;3"TRE)L:0B@J
M#TS-=E\HI_%[](\S@/0W#/TTR> ]*%&@P02%S\YL1!A1I0XF\81JJV8R5.3D
MNP>-8852#+ZD55 ,&9?-H-+>"BGM?<V."6\:DI7]!3=JA!VD[@A[DOR%-;7,
M:?5:>C77\^UOE);(&-!%DW_UN:O'TB-AZ8LT+X1MX0-?.M>=Z!08:R*U8O+2
MY_0!-.9L3LR=^B?%KI$/9?K#3^^VJSO@P D[3>DFUO4/G&U+G7]L_=3HGGS9
MIO\**+8HR//X 8T\[-:.;\6@T=<_0ML/G@+A3'WG\<<,($@_HD8$!BHL?-C
MP6/>!9Q>&V7N>*+R9UU3)(&3#ICXLI)8&VQE!;H$/D)Q89FR@NEE))71%D/#
M9(,M%ISXD\@9:_MMS4<EK:$B#>F6.F@+59&_OBQNN9 >WB=W.Z)2;KL(>$U
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MW=%'2B_:17ZF[K XOCZ)!N/N$8[?H/=7]#X?,G:C&\F%8-N)D<EB&1"KM#4
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M)KGXJV,-C.+>,?>BN4L$L9A.RD#*?9:"_L2XX#1T:2S9C65/G5'XTDN["2N
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M+4YE#)4+4?C&>L2ON?7GK]"'=D"-T@&]^& *5:U]9[(LGDFC?"9,9".A\EF
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M*%N.L"HE#^EH_0 E[X!YA<6]MJ_$C#W@[>_<00AR>#VB0"Y.E(>IC$P0? '
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M@2*&H_T!9Z1AYS;A^*<@^0Y02P,$%     @ $EUT2^$%89 _ P  BA@   \
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M$!/3A4WLB_?G"^N9+0C,IC&%<&*%H(/.;8B)"843"P7'Y! 3W9P06P6-3>Y
M3$PXG%@X..808F+*X<3*P3%'$!/S#B?V#HXYAIB8A3BQA= LFT,+<<Q"G-A"
M,,]F/2]M=);7S-=5I=OJ#<3$+,2)+?0F]3YDA9B8A3BQA=Y/Q#M>6"[!+.00
M6ZC-QO\RV!\@'Z8?A[PLAF3HK <Q,?TXQ/K!<HY7HXU6QXCU@V(Z4#\.IA_G
M:#N>%A/JQ\'TXU!O>U!,J!\'TX]#K)\WN[-W%TP'TX_3Z:>_+]<OTU56I$O?
MO*(V]Q<Z7X05:P^["L-PU&X"5D]Y[II[03$M=5=@;_O8_S=P_1M02P,$%
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M4$L! A0#%     @ $EUT2S-9$"KN    *P(  !$              ( !F0$
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ $EUT2YE<G",0!@  G"<
M !,              ( !M@(  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    "  2771+W$IFO7P"  #B"   &               @ 'W"   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ $EUT2WF;U=<]!   JA,
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M965T-BYX;6Q02P$"% ,4    "  2771+B%I;TK4!  #2 P  &
M    @ &('P  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @
M$EUT2R(A=F:U 0  T@,  !@              ( !<R$  'AL+W=O<FMS:&5E
M=',O<VAE970X+GAM;%!+ 0(4 Q0    ( !)==$N62$\3M0$  -(#   8
M          "  5XC  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4
M    "  2771+DC*B"K4!  #2 P  &0              @ %))0  >&PO=V]R
M:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( !)==$L1Q;#^M@$  -(#
M   9              "  34G  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL
M4$L! A0#%     @ $EUT2^NMT'>W 0  T@,  !D              ( !(BD
M 'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    "  2771+"FH8
MN+0!  #2 P  &0              @ $0*P  >&PO=V]R:W-H965T<R]S:&5E
M=#$S+GAM;%!+ 0(4 Q0    ( !)==$NCS87'MP$  -(#   9
M  "  ?LL  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @
M$EUT2\G<_*>W 0  T@,  !D              ( !Z2X  'AL+W=O<FMS:&5E
M=',O<VAE970Q-2YX;6Q02P$"% ,4    "  2771+,\PA,K4!  #2 P  &0
M            @ '7,   >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4
M Q0    ( !)==$O.QS(7H (  *L*   9              "  <,R  !X;"]W
M;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ $EUT2V(N9YBU 0
MT@,  !D              ( !FC4  'AL+W=O<FMS:&5E=',O<VAE970Q."YX
M;6Q02P$"% ,4    "  2771+?V/B?-0!  "<!   &0              @ &&
M-P  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( !)==$O<
M"C1GTP$  )P$   9              "  9$Y  !X;"]W;W)K<VAE971S+W-H
M965T,C N>&UL4$L! A0#%     @ $EUT2XL3T[+S 0  R 4  !D
M     ( !FSL  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( !)==$N550MD4P(  '\'   9              "
M >1*  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ $EUT
M2ZI3A[?5 0  NP0  !D              ( !;DT  'AL+W=O<FMS:&5E=',O
M<VAE970R-RYX;6Q02P$"% ,4    "  2771+73NY>L !  #6 P  &0
M        @ %Z3P  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0
M   ( !)==$LIESR^^@4  #\D   9              "  7%1  !X;"]W;W)K
M<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ $EUT2TZI6(F>!   GQ<
M !D              ( !HE<  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q0
M2P$"% ,4    "  2771+-XDH[@H)  "O.0  &0              @ %W7
M>&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( !)==$L<C+F3
M?@0  /X7   9              "  ;AE  !X;"]W;W)K<VAE971S+W-H965T
M,S(N>&UL4$L! A0#%     @ $EUT2^ID^.(R P  8@X  !D
M ( !;6H  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    "  2
M771+,)>.[00"   /!@  &0              @ '6;0  >&PO=V]R:W-H965T
M<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( !)==$N V1#' 0,  -L-   9
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M  !X;"]S:&%R9613=')I;F=S+GAM;%!+ 0(4 Q0    ( !)==$L&Q40R6@(
M "$,   -              "  <(" 0!X;"]S='EL97,N>&UL4$L! A0#%
M  @ $EUT2^$%89 _ P  BA@   \              ( !1P4! 'AL+W=O<FMB
M;V]K+GAM;%!+ 0(4 Q0    ( !)==$O9UYQ$DP$  "07   :
M  "  ;,( 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (
M !)==$NF'')?GP$  ),7   3              "  7X* 0!;0V]N=&5N=%]4
?>7!E<UTN>&UL4$L%!@     N "X = P  $X, 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.8.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>210</ContextCount>
  <ElementCount>272</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>99</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME (LOSS) (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/ConsolidatedStatementsOfOperationsAndOtherComprehensiveIncomeLoss</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME (LOSS) (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Disclosure - BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/BasisOfPresentation</Role>
      <ShortName>BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcern</Role>
      <ShortName>ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - ACQUISITION OF DECAHEDRON, LTD.</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.</Role>
      <ShortName>ACQUISITION OF DECAHEDRON, LTD.</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - PREPAID DEFERRED FINANCING COSTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/PrepaidDeferredFinancingCosts</Role>
      <ShortName>PREPAID DEFERRED FINANCING COSTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/IncomeTaxes</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - CAPITAL STRUCTURE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/CapitalStructure</Role>
      <ShortName>CAPITAL STRUCTURE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/RelatedPartyTransactions</Role>
      <ShortName>RELATED PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/Debt</Role>
      <ShortName>DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/CommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - STOCK OPTIONS AND WARRANTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrants</Role>
      <ShortName>STOCK OPTIONS AND WARRANTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernPolicies</Role>
      <ShortName>ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernTables</Role>
      <ShortName>ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcern</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - ACQUISITION OF DECAHEDRON, LTD (Table)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtdTable</Role>
      <ShortName>ACQUISITION OF DECAHEDRON, LTD (Table)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - STOCK OPTIONS AND WARRANTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsTables</Role>
      <ShortName>STOCK OPTIONS AND WARRANTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrants</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernDetails</Role>
      <ShortName>ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernTables</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernDetailsNarrative</Role>
      <ShortName>ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://primeestatesdevelopmentsinc.com/role/OrganizationNatureOfBusinessAndGoingConcernTables</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - ACQUISITION OF DECAHEDRON, LTD. (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.Details</Role>
      <ShortName>ACQUISITION OF DECAHEDRON, LTD. (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtdTable</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - ACQUISITION OF DECAHEDRON, LTD. (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.Details1</Role>
      <ShortName>ACQUISITION OF DECAHEDRON, LTD. (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtdTable</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - ACQUISITION OF DECAHEDRON, LTD. (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.Details2</Role>
      <ShortName>ACQUISITION OF DECAHEDRON, LTD. (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtdTable</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - ACQUISITION OF DECAHEDRON, LTD. (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtd.DetailsNarrative</Role>
      <ShortName>ACQUISITION OF DECAHEDRON, LTD. (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://primeestatesdevelopmentsinc.com/role/AcquisitionOfDecahedronLtdTable</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - PREPAID DEFERRED FINANCING COSTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/PrepaidDeferredFinancingCostsDetailsNarrative</Role>
      <ShortName>PREPAID DEFERRED FINANCING COSTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://primeestatesdevelopmentsinc.com/role/PrepaidDeferredFinancingCosts</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - INCOME TAXES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>INCOME TAXES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://primeestatesdevelopmentsinc.com/role/IncomeTaxes</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - CAPITAL STRUCTURE (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/CapitalStructureDetailsNarrative</Role>
      <ShortName>CAPITAL STRUCTURE (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://primeestatesdevelopmentsinc.com/role/CapitalStructure</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/RelatedPartyTransactionsDetailsNarrative</Role>
      <ShortName>RELATED PARTY TRANSACTIONS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://primeestatesdevelopmentsinc.com/role/RelatedPartyTransactions</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - DEBT (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/DebtDetailsNarrative</Role>
      <ShortName>DEBT (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://primeestatesdevelopmentsinc.com/role/Debt</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://primeestatesdevelopmentsinc.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - STOCK OPTIONS AND WARRANTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsDetails</Role>
      <ShortName>STOCK OPTIONS AND WARRANTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - STOCK OPTIONS AND WARRANTS (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsDetails1</Role>
      <ShortName>STOCK OPTIONS AND WARRANTS (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - STOCK OPTIONS AND WARRANTS (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsDetails2</Role>
      <ShortName>STOCK OPTIONS AND WARRANTS (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - STOCK OPTIONS AND WARRANTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsDetailsNarrative</Role>
      <ShortName>STOCK OPTIONS AND WARRANTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://primeestatesdevelopmentsinc.com/role/StockOptionsAndWarrantsTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="cosm-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://primeestatesdevelopmentsinc.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>SUBSEQUENT EVENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://primeestatesdevelopmentsinc.com/role/SubsequentEvents</ParentRole>
      <Position>37</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>cosm-20170930.xml</File>
    <File>cosm-20170930.xsd</File>
    <File>cosm-20170930_cal.xml</File>
    <File>cosm-20170930_def.xml</File>
    <File>cosm-20170930_lab.xml</File>
    <File>cosm-20170930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2016-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2014-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/invest/2013-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>62
<FILENAME>0001477932-17-005712-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001477932-17-005712-xbrl.zip
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M12L@J7VWBB8GQH= KD!N<PZ4[(2RLI'! [XM:[O/6=O]GI*%WWUVGQ"!OE\
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M?*&^IH[P1=%U73$ZPY>FD]IW:#6TD/M>48:*UIWAK;U]O'8PG1E*TXGTM?Z
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M7(SI6(/&47\T'')HK$M%&Z,PN%$8^V.FP1UJ[Y&,PMGZ)F10N7*!B%BQ, W
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M !-.XS&Q$?Q%,H1 Z91 ^2=*/4;QEMP!?Y454;R!RD,OB?,KTS<>X' 66S4
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M>>S_2-Q_Q!IADH4Z.2"7#F6VF1:EE'*L*YG+ #F(C20W'?STB779J74)+S_
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M&]8 TSY>RTJJ[:2A.Y^$"N:"Y>9CE*RGCB2J%6CQBF/O'2@; 4;U+.,H:!Q
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MR@#7<TZ!8Z9@[\))_?JL]8P^KSB61I^+@'2N7_EE,,L6+TGG>V9?BN]+],-
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M/D8/@KD79-Y"S+QX.LV3A!.C_R&B7"1KK\TO//9@.:GT!/DW4[@<WCN1,O*
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MK,/XB(-$1X8M(".D.$LT,SZ6#(S?;&VLG>+ZAL?>6P[-5!BGFH-=Q_C,KF"
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MD((OK?&XP?P]Q'S4(3H_0VDKX_W62, FXCLP[QCMK\DIM&L8^ZU!WR+\'2.
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M*@XBE;;E_7FF1X41()^40"@^C15;_6*N<(XL>C'W)4]1G">4>YMZ%K_T54G
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M#>(WB/]4H&P0OT'\>GC_'[Z8='-:R9Z?TP[(8Q;GDU!NH8_.?1J:-5W?CEA
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M#HS46XB9%\49<#98FGDU[,#[#W]\.?$$ 0\O)AAFZMWP:$K(QG=GN)>P-Y+
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M!\92U3F$4T"FSE94M99%.9.JX9[#]LAWYLMPWW=W+VVW?#KXLTS,YYYM#$O
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MF1HX3YON]DM1;1!$27)@YW).5W4<SPX/YTPQ,X/#X)V1G*XE[NM^ZG0B&^>
MN4S%RV^ FZS4LQ[K();58Y5CR8J8('7F+#OF@!.=*RNV16E$ D5)CFIA\9,9
M;",VJE?PR09-B6%6&C6J&(G1@\F:]0BJ^]3X[5>Z1:G]J3/$FYU#OO+ E:P@
M@N%:2^@VVH@-AMPVNE&.CI!?_P^X3:=!<E#QG2H?NEDLY%\LJ?YE6Q=^S&:?
MB(#_I5[T+X#M/3;(YJ^?D5N0'OOGV=MGV%,[6(HPQ2&EOQWU.[UQOV,7>360
M/[ZD@;.DP?TLJ=,=]3NCNRZ)XEQ4Z>+6J)S8>M;7:WN)JH4YP=PW+JY*3VV
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M_<V#E$A)?B1MVA0)#K=H;)D<#7_SY)##A5WW><W3A+I'35=GLTVO^:/#T;^
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MG1JAJJX6.").A?V.KU96TSO5(TZ3UA7'JGD!=HAL&U2I5CA327UAF"$S22T
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MMNO*G0"_@;O$%RV)RF98/$*@K?:"8T+X( 5'*V3/N6ST4^]T26X63"&]3#W
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M87WL#,?F9^N(5QZO&\0)Z'VZ(V6,4%&&&I,?A><!TQ"/\HAA^./&L$82 NA
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M$L2'<D.&G#!"GHV9?YGJ1L^G]3MW7RNW&87"2Q"OC-24^\UKJ?RP3W_'*A^
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MPO06&]EFJ8W^ND$AABO_ U!+ P04    "  2771+X;$RHO,R  #MT0, %0
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M*(*,T=[V[G.Q/)EZ\@T)[(![,U+PB>W.-HM<\2,CRC=[&EW-;$@J"-2 94H
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M$Q"")>=P*K=H+UKIZQ"._P;PEA'.@M,E<\+XF4?4JO!M;C/%WB:].\ /AW>
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M NR .ZA"P2>V>X@,<E67ZY(N9D(E5")7 H0\+*),C#"'.I2$(^KXP=2A0KX
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MO$)9U+>_%_\1M;[X;_X_4$L#!!0    ( !)==$L\+-&@%E4  /3T!  5
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M"LY)- 1EGS>U&FKT4*DX]9AWFX9)NDH^X/0!IW+N",6LT44!LF:(0 8&*>3
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MJ /^?@/]4<Q=Y;BE<]?;N\6GJPLR?SW[&_JZG,A^(QSL01.Y#MW?=R:K; @
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MXEGP7[LBO_0=CFCMCE7"+"E/5^-@YK,4^]FM]R(H 36R#7N%VD>:UU1L']B
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M< 3/.2:G+GU-A^Q_W$->7^^3F2B96K%3+"]_M;U/.YC]@L.'1[)&FCWAU'O
MU8SS-@U]/+O/5"$H0+ =4R\_Z.>P.KTS ?;E3 $'O(V^XZE44:F+*F7$M%^'
MVVG-;%2O:OH9F/KIQ^0Z!K[2B:;MJD>_\N,@ ],/=T@$J*MG@XX\INCNAT0
MJLL?_M4.ZO:'>_SQC/P'M_FXC_9TKT-PVN*BAP^&<53=?.1+/FA?'XCAZ,[M
MI[%_U)$C9"I61KHCXB $1QA ,HW]7_K)H8-5YIZ80(U0-EX_F.VJHW,9%E[&
MJSW,A+I7\KH//D>-65_:<:B#,<OXZ<<T.@U\I1,=J((9<6P?LXX:728^?)5<
M'>U!O<,;+XQI(;7RQO7.BP1Y?(>I6KMH.M"8^OZIH9[S+;T18+5G;;4^:C6
M: N 1I=[?;>\']PM96].EM;&"1+KHXZ;5\V-0'9A.._9[FVW>U G&8WLF_^]
MR,4Z@6%ME'3XDNL1UP$&*'L<CNV?Z' .3(>&\;9?=7<&T)N_\,Y\)-?[QJZH
MY[_MPOREJ6^2+?)'G*X>O5B[KR9[8[+T-\ P'L4FTY2?YR!;45, A.)Q(+^<
MR8Y<P<PNWL'P_^]>]?SB'8 )QCLH_=VQ_2-.08]G;W"XI^MO%SA%<DQ[@WN\
MZD/N#8Z \6KV!L?;;OE8>J+1?KC]/TSABT?!.)K1?H^7?+#1?@0&YYW<L>''
M?!=XS O3+H)F#P\I?O!R?$7>5QAGH?_)BW9&]W_=X#F*R<"A7OM!I@3[@G'N
M,Z"\ :Y2=:6%:C7$]+Y0I]%RRU"^8 ?2JW8=@I?OU'NT\("]'>SV?1SME6&;
MK^T3SG)Y.D17:%ZU)^F^<J=.I( "98L2QFLXDL"&L;;69[L'73@>  W\K8F#
MO?+]=RCVA@*ES\-X#9,%0$#I];+$Q\[1O-Y>+TS![!C*E]WKK>6$AM/KV2$K
MD)=?8GG-/;[SNEWV=P;D2^_M[9< \!;V_]N]*G9KH-[7=OT^OLA+W,52O"R&
MZ),?5PG]5>L<4?(&)[J-NP>>HXC!/=1K/^35[]%@@#H2AZ_B2,_C+[TP+4X(
MLVRWJ6(/BS?P*8G(2XR(F[TC5DO>^Y &;/;3X8:U.Y:Y-I@SY<&0^XQMA.!3
M4W!OS%P-"@W[-[-,=8Z"<HI+3Y4(RHD,^CJ,T0OVTNP;N+2["[-?+U-,/3\F
M+S$?Z _%ZJYIJ#)*1T>1+FA:*@#WZ4E%3]=$%H6E,$J)-%QV5OWI(GP* QP'
M(T?KKKIK=JJ,,G66;5W0[%0 ECK/H)1%+R&.(%WOV&,2WDU<_3Y-LH/? E4]
MZ9C6D8I7-5VM8_88*)N=TYO8[WNL["5*"C7TH ]7 ,P?AU5\P23VL&&DFD/K
M8\^U?3S5'8Z/=1,8+SN(15M =9N:XL*W!"R=\,29=-=9(FR]5K04,%</FI,$
M,S55PE,[LB=@MP6T"6A=Y8A5^T* A6A4.5 +#D#R'6-'<O&J;,)DQ@8//(KE
MB/&+.\BL4ONTHQOD][7T*$;TL8?\N@WF@R=^-7C@4=R8,'YQ!XE-T3X-UH@V
MI8E<* D392<=@/KBX1S2@)-B*T\^XC'3]&S:PF-A]5<KMLI/PP&=_ES@;8K]
ML'@)<3#;)&D>_I/]4_("E1HV.XL!]#;)%>)@R*G'R-VS;XD@7"RO83!K^O"I
MFQT-?W(6O54]_B@&B)$OU6YH8/'L5[/@&F>W9E>,-3;5)9?6;AW; 0Y]BI3/
M6:&5MG=11 NYN<HA%77N_\WPJ9B!MJ4*8PC1F8@BERG^;8=C_V6Q-J"(2MH:
M1?20:XK(16%01(N/NPQ;*:!D;8LBY\1/A0$NJBU^C,E/LX<4,T\ILDDI;HTD
M!J!KEBAD8=!$#[#/DXX&VE$5Y%4Z4UZIY,?5;!;'.R^ZP[D7QMST;I"FW>N*
MQJ9T+Q=JU6!P:A!6;J2BRHAM@2&_I8Z\#'FL 926+4Q5X\Y+B[-MLGC'-!HN
M3"YPYJ?A5K#4-=*P5]'."'I3R$XI#H-,1ABYLG6E$@J9%F+."@6-WF3CV6:3
MQ&RRQ7B<S?S?=O0"ZF62=ORFZ"[;J!8LCGIC3&L-A$/485!O%&9^N*2-H(Q-
MP#/6#/+*=F@$%G%RK99.#A/+L"\]B[_N]4ZJ)N 1M&O<<(86?STRBG9 [\O1
M0@3(WB$%_9A$!%U67,N^PT_D9UR\E&T42K/OFFA:#^4R,X6+ZU*K.2?K<*S<
MQ9A"KB(IE81!0-+-"+(\I)MS28ZS6^^%;M1)7H!4VB;1-)#;Y)*(@B&4&I]@
M[5I)HYB*HVTA?T(C5F(_W)+EA;=)=NJ5[*2?IG;HY]XVS+VH\-QW.,/I$_/K
MESL:[$WGPUXLCG :W B\^.3Q)I@,;G19P"['[[;D3SYC1487F<F:K!+N\^_\
M%E$R[._2, _5(YX=3MQZZ2)=YAX]2*83Q5N<LO>B88%,#?1WUX)6?6G2H;T4
M4F#P!:%5DS#F#@>X" R0;RT,TK1[FFYL2O=47:L&9E@QQ\K/4[;%N1[U)7Y_
MO#DYY";$X8AY@=?>+LJ7CTF:TVBQXG<UT,7Z4\@B4LB/Z?R)&+=8ERJ*][=/
MH[;IO/\+Z#-]?(N@.L'>9G APD]EWP@*,: ]HNG\K3GC>3U18$'0L@#@ ?KN
MW+:!67+GK5 &Q=XAB,5K!38KO#U$-+MD3Z[;:<J'YA4XS<'# &5K^W"##:IW
MX(PUG7-L%%R=)ZS6(46,!FWCH+Y1PK]/240ZR.?N_4UF ;O;Z1.,Y!<B^TTU
MK3%OF"DU[<S48'!N$%9!5#%1/JWNZJ)2O7!O*&2!064+, ;B5M([NBK'08RE
M.3DDLC8'6"7<]F J%'1.,!-T@ICB7>'$,AR'25ILEA!NA4R7:DYUEK4CZ_R-
ME[XP-YK5?E@S8AJIV3NS,C>B.:?2ZSBGTD"@W-2KTD28J4)?+J3A$UD"/6%Z
M%VNQKFIF2N>E,G&[BP$UZ.[<7RSKG&:& /OT^N#E=$/WI8QRG"ZVL5IQ+.L=
M9(HO8P#+M<4EIF DH2"#&K 9_SC<L'9$I+FV<X:-AJPZ>6H.%$[8W<RLV2ID
MR\UUT=)$O"R!GQ&=7W%ZFR9/8289+*6BUKBF 5NS2B('@S]J<'VFK"I&E/*H
M5IB6$,K(:U[&-@7D,=9] 5 ?71=-77_MJ4.HB0,*0CII\B)"*!_C(+LD+WGI
M19AZL?K4S2@*?U1+-@>H/4QMCU0CFH'!OKVP"\:NJC&T+5M#]'VCC+17#%ZM
M,_;B2D#^B"?G=#T&;S9AIAG$VD*V?1</L.^\&@D8_)'!DKHOOY9$>8*VD>>S
M#T\HH/G\$ZYQKL.8LCW%A+V7GL_NTW_PGL/-;G.6I&GR.8P?SKTM^4O^(EKW
M#-'_QSNK'RZGL7"J.(I1V+F.S]31NM1'FZ(!=%^U@/RRB8DZ^(QP** \6B7#
M/F.;RR,:L>8@1AM8.Y#!+<!P,&-A\QN093O4[?@'X>N4.\19AO/L?)>FO0F'
M4,!R=)9R3UB(B_L83.H$E7).7[+\[8)[K9KWZ6ST].YI-PJQBK"\%*#7JP#7
M?]4M4=?\;4'1O'&8K]KD';O*.,U=/Q"]85X*T(M6@!,F?2A%_Q45PFB6YVEX
MO\M9^#,9,V\]&%2?Q8'9U]'I /I6QE 5/05Y<5!^.T<?Z;T7QM=)EBUBNGU
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M3!.DMUW:O[HF/Y%?5[\B_T,?3W[S?P%02P,$%     @ $EUT2]]O<]H!0@
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MX\9#U:8$1F4VX=#B?.*;7:";,;[(C FC<;"GH1C+E@=3Y36\%6;WBN.Y3G
MQOL\AN$ ?;Q;D0Q7;UT_UYZF8!!A#*C_&JX-G)3%38[RA]OD(V^8)H-H(^,*
MK;_P=USG98"O!E88C&.5R"=^KZ?M_IBVWM.*LFTF1(#<7.83KGTES$3FDFQ%
M)"V58K2WJM![(LRG"=EKPQ="%P]\*VWSY=1;D-W?QWR#5>4_O/(\:E/DQ U
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M:<G:."5^' 5M/K$@5\-8?'IGNH$YLIL-X?JYS 2,*LRQA--9"%T8&WNI7TW
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M^$X8$C_-O'#,XA7A"BE.%;#P7W!OU[8,?1"P(2-PK#L=1O91.^JUY[0E#D4
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M,Y90VG[VAO?Y2MB8Q8\TD:]>TM8UR0&EH=8NCW6YYDZ;0;GJT%10/G';"TM
M-][.'$&?D"#I\XE//>%(7;!501/\51H,"HW#._TYY%U#'_+HVT2_VA3;0=GN
M\)XMF3FF<Y"8.Y\=(UPV=@D![KPGNLR6-S%C\3<:+3K>BO\E7<O/1F:C0)%S
MGT&Z"G<JV[U3\7IIHSHDIS3(_;;BRCCGI1?-QP&_)KO5T<H<,DH1N?V+^#]1
MT(#_YO\#4$L! A0#%     @ $EUT2]G-=59T[   K-,* !$
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M !4              ( !(ID! &-O<VTM,C Q-S Y,S!?<')E+GAM;%!+!08
1    !@ & (H!  !6VP$    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
